#1.3
2429	29	8	25
id	type	name	description	target	belongs_to	pc	median_tau_score	ts_pc	BRD-A58048407-summary	BRD-K21680192-summary	BRD-A26711594-summary	BRD-K13646352-summary	BRD-K78485176-summary	BRD-A65280694-summary	BRD-K67080878-summary	BRD-A24228527-summary	BRD-A64977602-summary	BRD-A19736161-summary	BRD-K77771411-summary	BRD-K52020312-summary	BRD-K35960502-summary	BRD-K85606544-summary	BRD-A01787639-summary	BRD-K81528515-summary	BRD-K18895904-summary	BRD-K91263825-summary	BRD-K05395900-summary	BRD-K76775527-summary	BRD-K28912512-summary	BRD-A03623303-summary	BRD-K07237224-summary	BRD-K02113016-summary	BRD-K76810206-summary	BRD-K15502390-summary	BRD-K44353683-summary	BRD-K74141488-summary	BRD-A53576514-summary
cell_id	na	na	na	na	na	na	na	na	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary	summary
_id	na	na	na	na	na	na	na	na	BRD-A58048407	BRD-K21680192	BRD-A26711594	BRD-K13646352	BRD-K78485176	BRD-A65280694	BRD-K67080878	BRD-A24228527	BRD-A64977602	BRD-A19736161	BRD-K77771411	BRD-K52020312	BRD-K35960502	BRD-K85606544	BRD-A01787639	BRD-K81528515	BRD-K18895904	BRD-K91263825	BRD-K05395900	BRD-K76775527	BRD-K28912512	BRD-A03623303	BRD-K07237224	BRD-K02113016	BRD-K76810206	BRD-K15502390	BRD-K44353683	BRD-K74141488	BRD-A53576514
name	na	na	na	na	na	na	na	na	nimodipine	mitoxantrone	nicardipine	midostaurin	olmesartan	molindone	milrinone	ofloxacin	mirtazapine	ondansetron	moxonidine	metronidazole	niclosamide	neratinib	naftopidil	nilotinib	olanzapine	nortriptyline	nicotine	nimesulide	nicotinamide	metoprolol	moclobemide	olaparib	nicergoline	nevirapine	nateglinide	naftifine	orphenadrine
type	na	na	na	na	na	na	na	na	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp		trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp		trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp
moiety	na	na	na	na	na	na	na	na	nimodipine	mitoxantrone	nicardipine	midostaurin	olmesartan	molindone		ofloxacin	mirtazapine	ondansetron	moxonidine	metronidazole	niclosamide	neratinib	naftopidil	nilotinib	olanzapine		nicotine	nimesulide	nicotinamide	metoprolol	moclobemide	olaparib	nicergoline	nevirapine	nateglinide	naftifine	orphenadrine
moa	na	na	na	na	na	na	na	na	Calcium channel blocker	Topoisomerase inhibitor	Calcium channel blocker	FLT3 inhibitor|KIT inhibitor|PKC inhibitor	Angiotensin receptor antagonist	Dopamine receptor antagonist		Bacterial DNA gyrase inhibitor	Adrenergic receptor antagonist|Serotonin receptor antagonist	Serotonin receptor antagonist	Imidazoline receptor agonist	DNA inhibitor	DNA replication inhibitor|STAT inhibitor	EGFR inhibitor	Adrenergic receptor antagonist	Bcr-Abl kinase inhibitor|Abl kinase inhibitor	Dopamine receptor antagonist|Serotonin receptor antagonist		Acetylcholine receptor agonist	Cyclooxygenase inhibitor	Protein synthesis stimulant	Adrenergic receptor antagonist	Monoamine oxidase inhibitor	PARP inhibitor	Adrenergic receptor antagonist	Reverse transcriptase inhibitor	Insulin secretagogue	Fungal squalene epoxidase inhibitor	Acetylcholine receptor antagonist
gene_targets	na	na	na	na	na	na	na	na	CACNA1C|NR3C2|CACNA1D|CACNA1F|CACNA1S	TOP2A	CACNA1C	FLT3|KIT	AGTR1	DRD2|HTR2A		-666	ADRA2A|HTR2A|HTR2C|ADRA2C|ADRA2B|HTR3A	HTR3A	NISCH	CYP2C9|CYP3A4	STAT3	EGFR|ERBB2|ERBB4	-666	ABL1|KIT|BCR	DRD2|HTR2A|HTR2C|DRD3|DRD4|DRD1|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR6|HTR7		CHRNA10|CHRNA4|CHRNA9|CHRNB2	PTGS2|LTF	PARP1	ADRB1|ADRB2	MAOA	PARP1|PARP2	ADRA1A	CYP2B6|CYP3A4|CYP1A2|CYP2A6|CYP2C9|CYP2D6|CYP3A5	ABCC8|KCNJ11	-666	-666
gene_ids	na	na	na	na	na	na	na	na	775|4306|776|778|779	7153	775	2322|3815	185	1813|3356		-666	150|3356|3358|152|151|3359	3359	11188	1559|1576	6774	1956|2064|2066	-666	25|3815|613	1813|3356|3358|1814|1815|1812|3269|3350|3351|3352|3354|3362|3363		57053|1137|55584|1141	5743|4057	142	153|154	4128	142|10038	148	1555|1576|1544|1548|1559|1565|1577	6833|3767	-666	-666
inchikey	na	na	na	na	na	na	na	na	UIAGMCDKSXEBJQ-UHFFFAOYSA-N	KKZJGLLVHKMTCM-UHFFFAOYSA-N	ZBBHBTPTTSWHBA-UHFFFAOYSA-N	BMGQWWVMWDBQGC-IIFHNQTCSA-N	UQGKUQLKSCSZGY-UHFFFAOYSA-N	KLPWJLBORRMFGK-UHFFFAOYSA-N		GSDSWSVVBLHKDQ-UHFFFAOYSA-N	RONZAEMNMFQXRA-UHFFFAOYSA-N	FELGMEQIXOGIFQ-UHFFFAOYSA-N	WPNJAUFVNXKLIM-UHFFFAOYSA-N	VAOCPAMSLUNLGC-UHFFFAOYSA-N	RJMUSRYZPJIFPJ-UHFFFAOYSA-N	JWNPDZNEKVCWMY-VQHVLOKHSA-N	HRRBJVNMSRJFHQ-UHFFFAOYSA-N	HHZIURLSWUIHRB-UHFFFAOYSA-N	KVWDHTXUZHCGIO-UHFFFAOYSA-N		SNICXCGAKADSCV-JTQLQIEISA-N	HYWYRSMBCFDLJT-UHFFFAOYSA-N	DFPAKSUCGFBDDF-UHFFFAOYSA-N	IUBSYMUCCVWXPE-UHFFFAOYSA-N	YHXISWVBGDMDLQ-UHFFFAOYSA-N	FDLYAMZZIXQODN-UHFFFAOYSA-N	YSEXMKHXIOCEJA-FVFQAYNVSA-N	NQDJXKOVJZTUJA-UHFFFAOYSA-N	OELFLUMRDSZNSF-BRWVUGGUSA-N	OZGNYLLQHRPOBR-DHZHZOJOSA-N	QVYRGXJJSLMXQH-UHFFFAOYSA-N
smiles	na	na	na	na	na	na	na	na	COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C	OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12	COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1	CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1	CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12		CC1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O	CN1CCN2C(C1)c1ccccc1Cc1cccnc21	Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C	COc1nc(C)nc(Cl)c1NC1=NCCN1	Cc1ncc(n1CCO)[N+]([O-])=O	Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1	Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F	CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12		CN1CCC[C@H]1c1cccnc1	CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O	NC(=O)c1cccnc1	COCCc1ccc(OCC(O)CNC(C)C)cc1	Clc1ccc(cc1)C(=O)NCCN1CCOCC1	Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O	CN(C\C=C\c1ccccc1)Cc1cccc2ccccc12	CN(C)CCOC(c1ccccc1)c1ccccc1C
pubchem_cid	na	na	na	na	na	na	na	na	-666.00	4212.00	-666.00	-666.00	-666.00	-666.00		-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00		-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00	-666.00
cell_ids	na	na	na	na	na	na	na	na	A375|A549|HA1E|HCC515|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HT29|MCF7|PC3	A375|A549|HA1E|HCC515|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HT29|MCF7|PC3|VCAP		A375|A549|HA1E|HCC515|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HT29|MCF7|PC3|VCAP		A375|A549|HA1E|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HT29|MCF7|PC3|VCAP	MCF7	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP	A375|A549|HA1E|HCC515|HEPG2|HT29|MCF7|PC3|VCAP
pert_itimes	na	na	na	na	na	na	na	na	24 h	24 h	24 h	6 h	6 h	24 h		6 h	6 h	6 h	6 h	6 h	24 h	6 h	6 h	24 h	6 h		24 h	6 h	6 h	6 h	6 h	24 h	6 h	6 h	6 h	6 h	6 h
pert_idoses	na	na	na	na	na	na	na	na	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM		10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM		10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM	10 µM
num_cell	na	na	na	na	na	na	na	na	8.00	6.00	8.00	9.00	9.00	7.00		8.00	9.00	9.00	9.00	7.00	8.00	9.00	7.00	9.00	7.00		7.00	9.00	9.00	9.00	7.00	1.00	9.00	8.00	7.00	9.00	9.00
num_time	na	na	na	na	na	na	na	na	1.00	1.00	1.00	1.00	1.00	1.00		1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00		1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
num_dose	na	na	na	na	na	na	na	na	1.00	1.00	1.00	1.00	1.00	1.00		1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00		1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
tas_q75	na	na	na	na	na	na	na	na	0.21	0.79	0.42	0.37	0.42	0.29		0.28	0.27	0.29	0.18	0.33	0.71	0.37	0.19	0.59	0.15		0.21	0.26	0.34	0.16	0.18	0.21	0.25	0.18	0.21	0.17	0.28
icc	na	na	na	na	na	na	na	na	0.40	0.73	0.41	0.63	0.49	0.50		0.52	0.42	0.36	0.36	0.45	0.73	0.67	0.39	0.60	0.30		0.44	0.43	0.50	0.41	0.38	1.00	0.42	0.40	0.40	0.34	0.46
url	na	na	na	na	na	na	na	na	BRD-A58048407	BRD-K21680192	BRD-A26711594	BRD-K13646352	BRD-K78485176	BRD-A65280694		BRD-A24228527	BRD-A64977602	BRD-A19736161	BRD-K77771411	BRD-K52020312	BRD-K35960502	BRD-K85606544	BRD-A01787639	BRD-K81528515	BRD-K18895904		BRD-K05395900	BRD-K76775527	BRD-K28912512	BRD-A03623303	BRD-K07237224	BRD-K02113016	BRD-K76810206	BRD-K15502390	BRD-K44353683	BRD-K74141488	BRD-A53576514
query	na	na	na	na	na	na	na	na																													
description	na	na	na	na	na	na	na	na	calcium channel blocker|L-type calcium channel blocker	topoisomerase inhibitor|DNA intercalating drug|HCV inhibitor|immunosuppressant|Pim kinase inhibitor	calcium channel blocker|L-type calcium channel blocker	FLT3 inhibitor|KIT inhibitor|PKC inhibitor|angiogenesis inhibitor|cell cycle inhibitor|cyclin inhibitor|histamine release inhibitor|multi targeted kinase inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR antagonist|VEGFR inhibitor	angiotensin receptor antagonist|angiotensin antagonist	dopamine receptor antagonist	phosphodiesterase inhibitor	antibiotic that inhibits DNA gyrase|topoisomerase inhibitor	adrenergic receptor antagonist|serotonin receptor antagonist	serotonin receptor antagonist	imidazoline receptor agonist|adrenergic receptor agonist	DNA inhibitor	DNA replication inhibitor|STAT inhibitor	EGFR inhibitor|receptor tyrosine protein kinase inhibitor|tyrosine kinase inhibitor	adrenergic receptor antagonist|calcium channel antagonist	Bcr-Abl kinase inhibitor|Abl kinase inhibitor|discoidin domain containing receptor inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor	dopamine receptor antagonist|serotonin receptor antagonist	PI3K inhibitor|potassium channel blocker|tricyclic antidepressant (TCA)	acetylcholine receptor agonist	cyclooxygenase inhibitor|matrix metalloprotease inhibitor|prostanoid receptor inhibitor	oxidoreductase stimulant|protein synthesis stimulant	adrenergic receptor antagonist	monoamine oxidase inhibitor	PARP inhibitor|DNA repair enzyme inhibitor	adrenergic receptor antagonist	non-nucleoside reverse transcriptase inhibitor|reverse transcriptase inhibitor	insulin secretagogue|ATP-sensitive potassium channel antagonist|meglitinide|sulphonylurea receptor activator	squalene epoxidase inhibitor|steroid sulfatase inhibitor	acetylcholine receptor antagonist
target	na	na	na	na	na	na	na	na	CACNA1C|NR3C2|AHR|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CFTR	TOP2A|PIM1	CACNA1C|ADORA3|ADRA1A|ADRA1B|ADRA1D|CACNA1D|CACNA2D1|CACNB2|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|PDE1A|PDE1B	FLT3|KIT|CCNB1|FLT1|KDR|PDGFRB|PRKCA|PRKCG|VEGFA	AGTR1	DRD2|HTR2A|CHRM1|DRD5|HRH1|HTR1A	PDE3A|PDE2A|PDE3B|PDE5A	TOP2A	ADRA2A|HTR2A|HTR2C|ADRA2C|HTR3A|ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD5|HRH1|HRH3|HTR2B|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4	HTR3A|CYP2D6|CYP3A5|HTR1A|HTR1B|HTR3B|HTR4|OPRM1	NISCH|ADRA2A|ADRA2B|ADRA2C	CYP2C8|CYP2E1|CYP3A5|CYP3A7	STAT3	EGFR|ERBB2|ERBB4|KDR	ADRA1A|ADRA1D	ABL1|KIT|BCR|CYP2B6|CYP2C8|DDR1|DDR2|PDGFRA	DRD2|HTR2A|HTR2C|DRD1|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR6|HTR7|ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CYP2C8|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH2|HRH4|HTR1F|HTR2B|HTR3A|HTR5A	KCNJ10|SLC6A2|SLC6A4|ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CYP2C19|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|PGRMC1|PIK3CD|SIGMAR1	CHRNA10|CHRNA9|AOX1|CHAT|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNB2|CHRNB3|CHRNB4|CYP19A1|CYP2B6|TBXAS1|TRPA1	PTGS2|LTF|PLA2G2E|PTGS1	PARP1|AOX1|BST1|CYP2E1|LDHA|SIRT5	ADRB1|ADRB2	MAOA|CYP2C19|MAOB	PARP1|PARP2|PARP3	ADRA1A	CYP2B6|CYP2C19|CYP3A4	ABCC8|KCNJ11|CYP3A4|INS|KCNJ10|PPARG	SQLE	CYP2B6|GRIN1|GRIN2D|GRIN3A|GRIN3B|HRH1|SCN10A|SLC6A2
pc	na	na	na	na	na	na	na	na	7.31, 4.60	9.17, 4.00	6.46, 3.14	1.92, 0.89	5.55, 2.94	4.08, 2.84	2.62, 1.20	4.01, 1.53	1.86, 1.10	6.30, 3.77	4.18, 2.54	7.38, 2.51	1.64, 1.00	1.72, 1.00	12.34, 7.45	19.49, 14.55	8.42, 3.35	1.74, 0.88	6.45, 4.07	6.13, 3.24	4.10, 1.45	2.63, 1.19	1.51, 0.67	11.87, 9.09	3.77, 1.64	6.43, 3.68	1.83, 0.64	5.74, 3.17	4.77, 2.25
pc_selection	na	na	na	na	na	na	na	na	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN	NaN, NaN
BRD-K07212038	CP	selinidin	cumarin derivative with antiallergic properties			9.92, 2.29	88.34	2.61, 0.97	91.92	86.38	96.94	92.36	95.63	87.48	-5.48	18.71	96.62	-11.23	49.33	96.56	2.82	0.25	92.90	98.33	89.19	28.25	-42.99	90.86	94.48	98.41	78.87	NaN	-88.81	-29.07	95.32	71.80	89.64
BRD-K28849549	CP	mesalazine	cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor	PTGS1, PPARG, PTGS2, ALOX5, CHUK, CTNNB1, IKBKB, MPO, NAT1		11.56, 7.56	87.14	1.17, 0.58	99.66	93.54	86.14	69.08	77.83	56.00	78.46	87.14	89.31	99.93	99.12	99.61	24.23	48.33	68.21	94.28	98.73	51.03	97.97	94.38	96.76	83.54	98.16	-19.06	47.59	83.08	99.58	92.89	50.34
BRD-K60623809	CP	SU-11652	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor	KDR, PDGFRB, CAMK1G, FGF2, FGFR1, FLT1, KIT, PDGFRA		10.20, 6.94	85.06	3.73, 0.84	28.78	98.17	96.88	97.16	96.16	0.04	62.53	-73.60	97.81	15.99	60.65	86.54	93.38	88.01	97.44	99.93	85.06	91.84	90.87	71.90	97.73	86.68	65.51	-99.01	-5.50	-13.07	72.84	16.37	13.57
BRD-A49172652	CP	lansoprazole	ATPase inhibitor	ATP4A, CYP2C19, CYP3A4, CYP3A5		10.22, 5.33	84.18	1.35, 0.30	86.08	-38.97	0.28	27.02	21.73	85.45	98.90	96.11	-61.92	96.50	18.65	61.29	3.31	0.70	92.76	92.94	99.68	55.89	99.51	60.28	85.33	4.84	96.78	95.42	95.46	69.62	51.80	84.18	94.75
BRD-K89274813	CP	DMP-543	acetylcholine release enhancer			8.08, 4.23	83.61	0.77, 0.24	99.26	71.57	20.25	67.80	83.61	98.94	98.66	34.00	94.63	88.12	40.16	96.46	33.17	57.99	66.58	78.28	20.49	71.32	85.31	95.84	89.47	26.97	87.65	-80.16	96.00	95.87	61.67	99.14	99.22
BRD-A51182606	CP	chloramphenicol	30S ribosomal protein inhibitor, 50S ribosomal subunit inhibitor, antibacterial agent	CD55, CYP2C19		6.94, 3.67	83.54	1.82, 0.47	17.33	98.03	93.67	24.65	95.05	96.45	65.46	84.31	23.25	91.03	99.51	95.75	6.51	2.63	84.51	93.79	83.54	14.54	75.59	22.30	90.75	39.27	83.63	0.85	15.07	97.71	87.17	72.63	2.68
BRD-A39052811	CP	mosapride	serotonin receptor agonist, serotonin receptor antagonist	HTR4, HTR3A		10.38, 7.31	83.15	2.30, 0.74	15.28	87.26	88.77	21.43	86.66	99.05	25.10	37.73	16.37	98.13	49.33	98.17	2.04	36.57	95.53	73.67	97.32	31.44	91.58	64.59	88.86	30.89	95.59	2.42	0.46	89.11	97.72	83.15	96.99
BRD-A39172021	CP	ampiroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2		8.44, 6.22	82.85	1.59, 0.52	72.45	98.20	99.61	78.71	82.85	92.24	34.53	62.46	71.12	99.89	91.06	99.65	33.37	66.30	47.27	65.89	91.63	79.83	87.54	77.13	91.26	97.76	99.65	-2.11	29.07	85.52	99.93	92.11	10.32
BRD-K85030058	CP	benactyzine	acetylcholine receptor antagonist			10.22, 5.33	81.95	1.19, 0.39	18.77	95.06	94.57	39.37	99.01	99.58	11.60	71.70	81.95	99.82	86.46	97.75	6.87	52.10	29.93	98.20	98.27	59.91	49.80	86.88	96.17	32.06	93.28	1.02	53.62	89.46	96.56	66.43	11.46
BRD-K15025317	CP	BAY-11-7821	NFkB pathway inhibitor	RELA	NFkB pathway inhibitor	4.62, 2.31	81.37	1.55, 0.50	48.62	84.43	96.86	17.09	90.57	21.47	92.49	63.20	81.37	39.35	28.77	88.68	86.43	87.56	18.64	98.91	89.59	71.18	82.76	81.98	91.22	75.83	21.64	15.02	73.77	80.79	82.34	86.98	71.71
BRD-A64297288	CP	amlodipine	breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, ABCG2, CA1, CACNA1B, CACNA1S, CACNA2D3, CACNB1, CACNB2, SMPD1	Calcium channel blocker	11.11, 7.11	81.30	1.36, 0.33	5.90	93.59	99.05	82.95	91.45	6.40	47.15	64.87	12.86	91.24	82.44	97.76	7.54	95.51	82.33	98.39	81.30	97.18	33.94	65.53	98.10	80.25	93.43	1.87	95.42	60.64	65.25	66.10	59.49
BRD-K88304388	CP	dextrorphan	glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist	OPRM1, OPRK1, OPRD1, GRIN1, HTR1A, SLC6A2		8.00, 4.44	81.20	1.74, 0.72	77.04	91.30	77.73	48.38	58.09	89.39	62.68	84.46	8.39	88.54	98.31	99.40	2.96	79.61	75.84	93.02	34.31	25.46	99.40	52.90	34.41	92.96	99.15	2.98	81.20	98.04	98.56	82.64	90.77
BRD-K32311154	CP	nifekalant	potassium channel antagonist, potassium channel blocker			6.67, 4.89	81.18	0.98, 0.32	83.97	30.99	67.43	8.34	50.71	97.64	99.89	89.91	12.84	79.45	99.49	81.18	-46.66	24.91	34.72	-7.59	96.97	-10.54	99.61	82.31	88.18	0.70	77.44	0.00	88.68	90.69	94.40	82.00	84.80
BRD-A00520476	CP	otenzepad	acetylcholine receptor antagonist			8.89, 6.67	80.98	1.58, 0.58	57.15	96.79	86.17	60.95	94.10	70.21	51.28	93.01	89.85	99.33	99.68	99.30	66.47	48.43	-3.31	92.60	-7.16	64.91	87.70	15.28	93.51	80.98	99.40	-0.85	54.40	96.29	98.66	55.59	49.06
BRD-A24381660	CP	zeranol	estrogen receptor agonist			9.78, 5.78	80.57	1.49, 0.59	83.56	92.37	24.32	38.12	39.64	14.16	99.93	97.02	59.43	97.05	70.59	98.45	0.63	3.95	96.30	28.01	93.09	35.62	99.72	80.57	55.41	9.97	99.08	43.94	98.32	88.09	98.13	15.31	95.40
BRD-A95696066	CP	nisoxetine	dopamine transporter inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor	SLC6A2, SLC6A3, SLC6A4		10.77, 5.38	79.90	0.66, 0.16	86.09	97.99	98.94	11.26	80.37	11.13	79.90	85.94	85.74	99.72	38.54	79.81	1.48	31.92	45.51	0.56	40.62	21.79	97.97	25.64	93.69	70.90	57.60	99.61	99.07	85.90	27.57	80.74	95.54
BRD-A44133049	CP	azasetron	serotonin receptor antagonist	HTR3A, HTR3B		4.62, 2.69	79.70	0.66, 0.13	68.23	21.91	59.05	31.55	51.92	70.79	94.36	94.61	38.64	92.47	80.40	88.64	-9.44	10.54	93.20	0.74	79.70	7.21	94.44	77.56	65.17	89.65	82.86	94.22	89.79	64.25	90.77	92.23	94.16
BRD-K39621635	CP	artemether	antimalarial, interacts with heme and with COX3	ATP1A1, CYP2B6, CYP2C19, CYP3A5		10.22, 6.22	79.68	1.15, 0.26	99.47	96.65	87.09	15.78	80.90	97.07	86.22	97.95	82.48	95.16	59.16	75.91	75.07	77.62	-38.96	79.68	95.59	54.51	42.69	46.67	3.00	47.79	99.61	-96.67	59.45	54.59	99.47	96.93	98.94
BRD-K05737787	CP	isoeugenol	nitric oxide production inhibitor			10.69, 6.87	79.41	1.83, 0.56	81.61	77.21	97.55	25.93	85.67	83.32	43.07	-59.37	99.93	3.59	6.13	98.58	8.91	4.33	69.59	97.05	96.98	63.22	4.37	94.26	97.93	98.59	82.74	NaN	65.26	24.40	98.13	99.86	66.76
BRD-K15567136	CP	papaverine	phosphodiesterase inhibitor	PDE10A, PDE4B, PDE5A		5.38, 3.46	79.27	0.84, 0.20	79.27	90.59	97.78	84.54	98.63	91.00	18.97	-55.19	31.24	54.29	84.16	87.53	74.06	47.77	99.22	99.40	87.97	73.85	88.29	48.75	82.39	59.01	24.58	34.63	0.56	97.71	65.03	85.96	41.76
BRD-M72442222	CP	vicriviroc	CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist	CCR5		7.69, 4.23	78.89	0.97, 0.15	90.67	95.70	93.65	78.89	90.65	97.15	94.55	24.30	33.74	99.65	93.45	99.79	59.22	72.66	90.69	69.00	87.20	58.91	13.84	94.08	68.20	46.46	67.63	0.00	15.91	54.37	79.23	78.82	98.78
BRD-K70358946	CP	aripiprazole	serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist	DRD2, HTR1A, HTR2A, HRH1, HTR1B, HTR1D, HTR2C, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, DRD4, DRD5, HTR1E, HTR3A, HTR6, HTR7		10.22, 5.78	78.73	0.97, 0.19	98.12	70.96	68.79	88.30	54.85	47.03	8.86	87.14	59.60	91.65	97.71	93.58	88.44	78.73	4.49	99.93	12.32	94.19	98.80	19.23	32.79	1.02	91.33	-0.03	82.54	96.30	97.68	23.47	27.75
BRD-K96134740	CP	kitasamycin	protein synthesis inhibitor			12.89, 8.00	78.41	1.08, 0.34	80.20	25.90	16.68	10.54	36.61	47.36	98.05	96.34	78.41	98.52	98.00	75.28	7.08	6.20	85.38	33.00	67.63	19.06	99.18	46.50	44.03	96.17	97.64	92.36	97.53	40.04	99.49	97.85	95.26
BRD-K56429665	CP	calcipotriol	vitamin D receptor agonist	VDR	Vitamin D receptor agonist	8.98, 4.90	78.38	1.07, 0.26	97.63	65.12	98.06	70.81	76.89	31.45	41.68	27.94	41.65	43.80	92.28	97.76	79.29	83.47	79.50	94.99	95.29	88.51	97.15	76.47	71.90	82.93	13.00	85.82	78.38	98.68	64.11	62.51	11.46
BRD-K33106058	CP	cytarabine	antimetabolite, DNA polymerase inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor	POLB, POLA1	Ribonucleotide reductase inhibitor	8.00, 6.22	78.37	1.28, 0.45	83.46	97.55	36.47	65.04	71.59	17.34	98.24	78.37	24.48	99.96	98.43	98.84	83.33	67.87	74.29	99.61	86.93	34.03	82.67	48.44	68.04	46.12	84.12	6.05	63.82	94.45	96.63	82.59	74.74
BRD-K37991163	CP	paroxetine	cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2		8.85, 3.46	78.31	1.65, 0.47	35.67	73.08	61.16	95.54	38.53	6.57	24.30	13.81	55.51	81.45	33.51	78.31	89.35	96.01	92.15	95.00	88.61	99.33	83.96	43.05	70.94	62.97	80.87	82.20	98.24	43.55	86.75	29.81	88.76
BRD-K48029790	CP	OBAA	phospholipase inhibitor	PLA2G1B		5.38, 1.54	78.28	1.43, 0.38	6.98	84.16	88.90	8.87	85.25	45.70	30.01	59.22	95.99	47.89	97.51	93.29	1.97	4.51	93.85	92.17	78.28	9.89	78.46	79.06	96.47	96.89	71.89	-11.64	-49.89	97.08	65.53	93.42	73.74
BRD-K95676198	CP	JAK3-inhibitor-V	JAK inhibitor	JAK3		5.77, 3.08	78.07	1.39, 0.28	50.94	95.08	97.06	41.23	78.17	93.26	59.77	78.07	47.28	49.39	91.11	95.01	7.54	72.02	64.04	30.68	85.66	27.71	92.45	86.43	94.80	66.10	44.68	-2.92	48.37	98.45	78.56	98.34	97.60
BRD-A29485665	CP	bicalutamide	androgen receptor antagonist	AR, CYP2C19		5.00, 3.08	77.60	0.67, 0.17	87.18	71.24	90.69	39.81	90.13	77.99	32.01	40.82	23.45	25.42	62.20	88.60	13.36	26.29	90.25	88.30	96.88	8.59	88.25	95.04	87.22	75.16	81.11	4.66	36.80	48.97	80.03	77.60	84.36
BRD-K91699951	CP	benzonatate	non-narcotic cough suppressant thought to act as a local anesthetic	SCN5A		5.77, 3.46	77.55	0.69, 0.10	99.93	94.46	68.93	66.50	98.99	73.42	69.31	-37.95	80.24	94.25	45.04	86.25	3.17	9.33	81.64	90.81	98.06	21.73	78.39	87.78	89.87	64.30	42.47	-4.63	48.46	89.06	89.50	77.55	70.39
BRD-K50464341	CP	berbamine	calmodulin antagonist	CALM1	Calmodulin antagonist	7.76, 4.49	77.33	1.76, 0.69	58.27	88.13	94.99	75.49	67.97	29.57	84.75	46.46	69.47	77.33	92.58	77.40	89.61	98.98	23.78	99.61	47.31	99.20	18.52	70.70	57.77	30.38	81.25	14.92	98.10	89.14	98.63	97.10	52.89
BRD-K17561142	CP	amiodarone	acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker	KCNH2, ADRB1, CACNA1H, CACNA2D2, CHRM3, CYP2C8, KCNA7, SCN5A		6.15, 3.08	77.26	1.55, 0.49	81.66	45.69	82.13	77.78	49.28	45.65	67.11	84.13	90.60	36.25	41.05	46.51	85.52	95.50	45.28	99.44	52.86	94.29	79.86	77.26	85.46	29.25	23.91	-16.67	89.89	42.50	85.38	74.41	89.25
BRD-A68888262	CP	azelastine	histamine receptor antagonist, histamine release inhibitor, immunosuppressant	HRH1, CYP2C19		8.44, 6.67	77.09	1.81, 0.68	75.68	47.58	87.17	72.66	86.10	33.66	60.90	22.55	20.85	98.82	89.08	98.73	24.20	86.42	97.81	58.13	97.80	80.74	60.47	59.42	25.42	83.79	99.89	66.24	77.09	92.05	77.91	93.32	24.03
BRD-K63343048	CP	orlistat	cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor	PNLIP, DAGLA, FASN, LIPF, CNR1, DAGLB		11.11, 8.89	77.00	1.16, 0.32	13.71	87.42	77.00	61.02	60.43	52.20	84.02	-7.29	85.23	69.49	32.24	98.84	80.62	96.65	94.18	98.65	99.65	94.68	88.83	16.95	61.23	34.22	84.68	0.00	14.05	90.14	98.91	75.16	13.43
BRD-K34533029	CP	tyrphostin-AG-494	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		8.08, 3.85	76.93	0.81, 0.25	49.31	69.18	35.36	88.64	83.31	53.94	90.35	44.70	92.65	55.42	89.36	59.26	66.46	89.59	-12.21	97.41	15.12	77.59	87.83	96.97	85.50	32.64	11.25	-39.61	70.27	76.93	94.19	89.57	78.80
BRD-K30563334	CP	rifabutin	DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor	CYP3A4, HSP90AA1, HSP90B1		7.11, 5.33	76.88	1.76, 0.69	94.90	83.66	44.17	80.41	45.92	66.12	31.34	7.26	35.92	99.89	94.68	98.94	41.86	75.33	8.60	87.24	76.88	85.93	90.85	58.22	70.54	85.00	88.60	16.76	13.05	94.19	99.86	81.86	22.44
BRD-K25394294	CP	oxaprozin	cyclooxygenase inhibitor	PTGS1, PTGS2		7.69, 3.85	76.73	0.91, 0.16	77.35	75.24	47.64	26.39	92.11	85.80	76.73	36.50	36.03	85.89	87.08	82.92	0.60	7.94	95.94	10.28	93.06	48.13	90.32	76.89	51.12	73.71	90.02	0.04	2.82	96.22	95.25	78.16	40.22
BRD-K39915878	CP	loxapine	dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand	DRD2, DRD3, DRD4, DRD1, HRH1, HTR2A, HTR2C, HTR6, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD5, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR3A, HTR5A, HTR7, SLC6A2, SLC6A3, SLC6A4		5.38, 1.92	76.63	0.76, 0.16	79.57	12.36	1.13	67.90	10.56	91.58	69.65	81.53	75.10	90.80	96.55	82.75	2.82	18.15	95.88	2.64	79.44	34.59	84.29	83.01	30.27	5.00	86.27	67.59	79.87	76.63	41.53	83.85	92.33
BRD-A86044036	CP	flurbiprofen	cyclooxygenase inhibitor	PTGS1, PTGS2		6.53, 4.08	76.41	1.57, 0.39	98.91	90.69	93.59	51.19	92.28	24.95	87.01	46.32	47.39	98.80	69.60	98.03	2.11	5.53	96.86	78.46	82.77	7.81	83.95	73.02	58.55	59.03	89.62	-93.65	-18.51	96.30	68.48	80.59	76.41
BRD-A65076780	CP	dihydroergocristine	adrenergic receptor antagonist, prolactin inhibitor, adrenergic receptor partial agonist, dopamine receptor agonist, dopamine receptor partial agonist, dopamine receptor partial antagonist, serotonin receptor antagonist	HTR2A, ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR3A, HTR4, HTR5A, HTR6, HTR7		10.20, 4.90	76.36	1.34, 0.35	77.66	92.09	98.96	93.00	73.40	99.89	34.39	15.33	86.18	81.13	67.13	96.67	68.58	90.18	47.18	95.75	81.58	97.64	69.75	73.41	76.36	97.91	35.70	0.81	62.24	42.24	29.60	73.92	84.34
BRD-K29555132	CP	arachidonamide	cannabinoid receptor agonist	CNR1, CNR2		6.54, 3.46	76.16	1.13, 0.35	26.72	79.58	98.33	50.16	94.32	24.37	9.23	-13.94	88.74	31.61	79.69	89.94	4.57	51.28	97.05	97.38	76.16	48.32	64.41	95.12	77.09	98.73	40.76	61.14	-29.47	25.10	95.17	91.58	91.75
BRD-K61250553	CP	loperamide	opioid receptor agonist, atrial natriuretic peptide receptor antagonist	OPRM1, OPRD1, CACNA1A, CALM1, CYP2B6, CYP2C8, NPR2, OPRK1, POMC		11.54, 8.08	76.16	1.26, 0.56	50.93	47.37	97.50	75.42	91.81	30.15	36.17	41.59	57.65	79.32	61.10	90.34	76.16	94.74	85.58	83.70	86.87	99.12	33.63	62.16	95.35	83.41	66.95	-27.14	99.82	86.25	41.01	58.10	92.76
BRD-K51671335	CP	sulpiride	carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist	DRD2, CA7, DRD3, CA1, CA12	Dopamine receptor antagonist	8.00, 5.33	76.12	2.11, 0.84	13.70	79.71	90.01	68.22	78.62	52.74	47.73	15.23	14.09	99.68	79.96	99.61	10.34	5.89	77.48	90.39	8.84	59.21	97.06	60.21	76.12	95.28	99.67	4.98	3.91	94.32	85.46	93.93	1.59
BRD-A64977602	CP	mirtazapine	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA2A, HTR2A, HTR2C, ADRA2C, HTR3A, ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2B, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4		11.15, 6.92	76.07	0.50, 0.14	95.93	67.00	93.04	30.93	72.24	32.70	76.07	96.24	99.97	10.68	83.51	93.43	6.55	2.08	11.52	2.15	90.88	27.78	79.42	90.83	9.80	53.09	90.63	0.00	88.95	99.01	82.59	92.49	63.66
BRD-K76534306	CP	enrofloxacin	topoisomerase inhibitor		Bacterial DNA gyrase inhibitor	5.00, 1.92	76.01	1.13, 0.36	81.23	87.63	99.54	49.12	93.94	53.44	59.67	24.51	48.91	86.29	83.31	82.68	0.35	16.27	99.31	77.79	98.38	42.31	28.31	76.01	95.99	84.66	32.81	-99.93	7.07	38.69	74.49	86.40	84.27
BRD-K59332007	CP	linopirdine	acetylcholine release enhancer, acetylcholine release stimulant, neurotransmitter agonist, voltage-gated potassium channel blocker	KCNQ2, KCNQ3, KCNQ4, KCNQ5		5.38, 3.46	75.99	0.66, 0.20	79.22	63.87	97.88	60.66	48.03	73.25	95.44	83.47	67.66	71.91	66.35	95.30	53.24	70.99	91.12	47.84	75.99	66.97	98.31	74.63	94.17	81.01	60.09	-0.04	81.98	84.88	91.97	89.66	91.66
BRD-K69195780	CP	NAN-190	serotonin receptor agonist	HTR1A, ADRA1A, ADRA1B, ADRA1D, HTR1F		8.46, 3.46	75.89	1.16, 0.38	36.58	77.62	91.90	56.10	90.13	89.26	76.98	81.93	68.31	46.56	71.27	85.43	-2.82	64.03	48.72	2.80	87.21	89.08	48.92	99.54	85.28	85.97	75.89	0.85	73.04	99.58	22.35	75.46	84.01
BRD-K00603606	CP	ticlopidine	purinergic receptor antagonist, platelet aggregation inhibitor	P2RY12, CYP2B6, CYP2C19		6.15, 3.46	75.26	1.24, 0.18	23.27	97.18	79.39	15.34	98.20	65.91	59.91	75.37	75.26	87.69	74.23	93.62	7.30	15.75	94.93	21.82	51.63	11.31	15.37	78.39	80.29	82.51	96.34	39.24	9.28	77.62	54.67	89.09	79.57
BRD-A41450521	CP	tosufloxacin	topoisomerase inhibitor			9.78, 4.89	75.11	1.20, 0.28	98.57	82.09	99.89	40.85	88.52	7.31	24.80	36.98	97.30	93.66	82.60	98.20	63.28	68.88	99.30	24.36	93.54	60.19	99.26	75.11	29.51	25.33	93.20	35.78	74.68	69.14	83.12	77.04	39.21
BRD-K59962020	CP	CHEMBL-374350	NFkB pathway inhibitor			5.77, 3.08	74.67	1.70, 0.33	74.67	56.86	74.76	86.15	35.08	79.15	21.03	26.63	29.98	52.25	74.48	84.17	89.24	92.87	87.23	99.54	68.29	93.13	21.86	76.69	25.88	53.62	75.91	0.04	81.36	84.63	49.51	50.94	79.54
BRD-K72676686	CP	fluvoxamine	selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CYP2C19		4.62, 1.92	74.61	0.50, 0.10	39.78	77.39	93.74	83.37	82.41	69.39	85.54	20.03	39.26	58.93	80.09	93.41	9.91	63.61	93.15	74.61	96.76	89.75	39.08	80.28	75.95	67.98	43.16	0.07	78.54	20.89	52.10	87.40	22.48
BRD-K91442916	CP	CAM-9-026	ADAM10 inhibitor			4.31, 3.02	74.60	1.27, 0.26	75.67	54.31	82.13	58.58	71.59	44.32	11.98	70.69	87.84	90.34	86.76	92.93	20.30	58.96	87.28	84.08	98.77	41.52	64.22	74.60	88.02	81.85	97.35	-47.31	7.44	23.55	80.26	84.42	66.56
BRD-K47936004	CP	piribedil	dopamine receptor agonist, adrenergic receptor antagonist	DRD2, DRD3, ADRA1A, ADRA2A, ADRA2C, DRD4, HTR1A, HTR2B		6.12, 3.27	74.53	0.93, 0.11	82.92	73.38	32.34	24.43	60.39	50.57	23.78	71.09	79.94	91.46	94.39	90.32	6.24	17.76	93.80	59.19	76.47	66.54	74.53	82.03	82.73	84.84	92.21	-83.65	20.18	80.38	80.03	78.88	48.46
BRD-A70649075	CP	sulconazole	sterol demethylase inhibitor, cell wall synthesis inhibitor			5.77, 2.31	74.42	0.64, 0.11	35.97	94.70	97.75	86.27	98.77	53.68	18.10	48.16	75.14	48.04	60.62	52.44	81.61	74.42	94.32	99.43	91.78	91.81	49.60	76.76	85.69	59.25	16.41	2.90	18.54	84.02	23.89	80.62	57.05
BRD-K17953061	CP	staurosporine	PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor	CDK2, GSK3B, CAMK2B, CDK1, CDK5, CHEK1, CHRM1, CHRM2, CHRM4, CSK, DAPK1, GPR35, IKBKB, ITK, LCK, LRRK2, MAP2K4, MAP2K6, MAPKAPK2, PAK2, PDPK1, PHKG2, PIK3CG, PIM1, PKN1, PRKACB, PRKCI, PRKCQ, RPS6KA1, STK3, SYK, TNIK, ZAP70		7.73, 5.15	74.35	4.04, 1.01	74.35	98.45	74.08	89.20	93.38	29.95	76.27	-85.12	70.95	84.23	76.02	96.00	78.39	94.11	92.00	100.00	13.98	57.57	90.39	-62.41	98.14	64.64	71.08	-95.56	-30.29	-89.65	27.44	50.67	89.38
BRD-A84134924	CP	pancuronium	acetylcholine receptor antagonist	CHRM2, CHRM3, CHRNA1, CHRNA2		8.89, 5.33	74.22	1.82, 0.60	-5.18	80.91	18.40	3.45	38.25	85.51	99.65	-36.27	32.86	99.68	74.22	99.72	29.10	9.48	94.52	92.48	97.09	52.08	92.40	56.38	78.51	87.60	58.95	0.00	21.88	94.86	96.13	91.94	48.36
BRD-K57222227	CP	indometacin	cyclooxygenase inhibitor	PTGS1, PTGS2, PPARG, PTGDR2, GLO1, PLA2G2A, PPARA, PTGR2, SLC46A1		6.94, 2.86	73.98	1.18, 0.33	98.31	21.17	93.91	25.64	83.71	93.61	98.98	89.61	64.58	99.19	87.65	73.98	9.94	23.67	38.89	91.87	69.95	25.55	99.46	95.03	89.87	40.09	55.96	98.10	68.74	63.67	85.87	60.01	3.03
BRD-A16694057	CP	bisphenol-a	synthetic compound with hormone-like properties	AR, ESR2, ESRRG, PPARG		3.46, 0.38	73.97	0.36, 0.09	84.02	61.80	98.11	60.86	74.86	57.62	73.97	76.42	97.09	63.72	93.19	96.86	28.76	64.83	9.27	85.04	90.04	49.06	67.17	90.00	12.34	51.40	64.22	-0.78	68.52	91.13	78.62	92.16	82.05
BRD-K13800121	CP	parecoxib	cyclooxygenase inhibitor	LTF, PTGS2		8.44, 4.89	73.91	0.99, 0.30	94.34	93.72	88.67	26.39	51.77	17.99	98.45	98.67	96.62	54.56	94.86	98.24	0.53	40.11	73.91	60.45	89.91	52.24	27.19	40.29	96.51	36.70	98.73	-95.13	85.09	44.96	87.18	47.73	95.78
BRD-K15834839	CP	lobendazole	anthelmintic agent			3.85, 1.54	73.81	1.11, 0.27	94.66	79.46	18.91	48.95	94.18	74.84	37.22	77.98	76.74	73.81	82.72	49.74	2.78	24.38	-47.91	35.33	81.40	68.92	81.99	87.02	93.36	92.18	-3.74	-73.43	96.97	37.94	74.98	43.63	37.19
BRD-A78942461	CP	ICI-118551	adrenergic receptor antagonist			5.71, 4.08	73.76	1.08, 0.27	99.54	79.29	98.70	62.20	47.88	99.86	58.41	29.04	6.24	90.06	57.01	97.63	28.64	56.90	95.09	23.13	86.61	62.54	99.72	15.01	96.09	77.07	91.98	73.76	46.93	90.53	85.38	29.97	51.58
BRD-K60160658	CP	tiagabine	GABA uptake inhibitor, GAT inhibitor	SLC6A1, CYP2C19		9.33, 7.56	73.66	1.98, 0.76	97.79	84.72	6.08	67.75	31.00	98.15	86.08	76.94	81.91	99.79	99.93	99.93	-0.18	53.47	2.93	13.04	29.12	54.59	99.68	62.02	52.30	0.88	97.91	0.00	85.88	98.10	95.57	73.66	55.96
BRD-K69650333	CP	idarubicin	topoisomerase inhibitor, radical formation stimulant, RNA synthesis inhibitor	TOP2A	Topoisomerase inhibitor	9.78, 6.67	73.62	2.64, 0.69	4.32	99.08	97.40	24.23	98.59	84.28	73.62	-97.47	22.59	51.61	99.20	98.70	8.87	74.92	34.06	98.34	87.98	15.65	84.01	86.30	97.43	67.37	28.97	-67.00	-68.02	36.58	77.68	75.73	0.18
BRD-A29734509	CP	disopyramide	voltage-gated sodium channel blocker	SCN5A, CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2		4.62, 3.46	73.56	0.70, 0.20	90.17	80.10	9.99	16.20	90.35	41.48	85.71	91.78	80.54	86.89	82.67	84.61	-1.94	35.40	68.82	67.55	55.25	14.23	93.28	34.38	83.83	17.62	76.63	20.70	35.20	84.47	73.56	92.08	18.74
BRD-K18618618	CP	cimetidine	histamine receptor antagonist, histamine receptor inhibitor	HRH2, SLC29A4, SLC47A1, SLC47A2		5.77, 4.23	73.46	0.72, 0.26	86.65	74.71	3.31	22.56	80.91	84.48	99.40	90.03	76.28	17.48	83.22	57.97	-4.19	11.21	-62.30	16.64	-2.16	27.03	99.77	44.69	84.17	47.25	96.37	-99.19	73.46	92.54	54.23	99.75	86.11
BRD-K28936863	CP	ketotifen	histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor	HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD		2.69, 0.38	73.18	0.52, 0.07	88.59	75.55	83.19	25.13	93.99	67.11	76.76	19.91	25.49	93.93	73.69	65.20	21.73	14.92	81.09	73.18	82.48	53.16	91.04	92.33	88.64	79.45	49.87	-42.89	52.83	64.68	61.34	96.30	71.39
BRD-A39390670	CP	rabeprazole	ATPase inhibitor, gastrin inhibitor	ATP4A, CYP2C19		8.44, 3.11	73.14	0.77, 0.14	94.99	47.66	95.09	48.39	35.30	92.57	0.92	84.68	72.19	55.96	89.78	87.99	46.13	24.23	81.12	1.97	99.01	73.14	86.44	43.62	95.88	72.26	53.00	-0.04	96.09	73.65	92.40	36.77	89.13
BRD-K97061094	CP	azacyclonol	ataractive drug used to diminish hallucinations	HRH1		5.77, 3.08	73.14	0.89, 0.14	96.32	49.45	42.86	25.45	78.64	6.08	93.21	56.44	79.70	93.35	78.70	73.97	6.65	73.14	23.16	7.50	11.07	9.09	83.00	92.91	90.15	51.08	13.33	-82.78	91.26	94.78	38.26	89.39	73.80
BRD-A31575449	CP	CGP-20712	adrenergic receptor antagonist	ADRB1, ADRB3		6.15, 3.08	73.11	0.88, 0.32	91.19	4.38	47.52	30.77	90.71	70.28	13.60	67.87	51.74	87.86	6.69	93.66	33.47	79.10	79.41	78.48	96.00	89.73	24.00	99.68	78.28	73.11	68.76	0.81	88.33	91.19	61.73	99.26	51.92
BRD-K91290917	CP	amodiaquine	histamine N-methyltransferase inhibitor	HNMT, CYP2C8		5.77, 2.31	73.06	1.06, 0.34	87.30	84.52	66.63	44.38	73.35	44.92	82.73	92.38	50.41	79.82	20.09	73.06	11.39	48.88	98.48	88.76	70.19	34.43	84.24	64.21	81.25	86.82	13.33	-80.50	95.76	51.00	36.34	89.06	95.90
BRD-A66563878	CP	medetomidine	adrenergic receptor agonist, MAP kinase inhibitor	ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D		6.94, 4.90	72.99	1.22, 0.45	79.54	83.70	97.55	17.07	56.64	99.93	15.04	-11.21	60.68	98.13	74.97	98.34	2.22	35.47	97.69	43.19	79.80	72.47	21.77	79.38	78.17	71.98	87.31	-99.22	-19.11	72.99	97.85	72.48	96.12
BRD-K25224017	CP	pirenperone	serotonin receptor antagonist	HTR2A, HTR7		4.62, 2.31	72.99	0.50, 0.07	72.99	87.30	63.46	40.78	95.19	2.62	14.73	85.67	18.01	28.20	82.71	87.80	6.49	33.56	86.52	6.15	94.61	27.78	76.65	85.03	42.10	52.25	92.48	53.95	82.78	83.67	90.83	87.67	20.31
BRD-A46393198	CP	tetramisole	alkaline phosphatase inhibitor			9.62, 5.77	72.86	1.20, 0.38	99.65	82.40	88.65	22.72	98.61	6.62	46.35	85.19	82.32	40.37	51.08	70.59	31.45	22.35	97.37	69.63	92.92	17.95	96.95	90.92	86.67	89.56	72.86	-79.92	42.60	32.90	60.19	98.73	75.60
BRD-K43068349	CP	AMG-9810	TRPV antagonist	TRPV1		7.69, 3.08	72.83	0.85, 0.15	81.52	85.76	72.39	72.83	99.51	35.43	8.46	24.14	74.15	99.37	95.06	97.25	30.07	1.90	89.94	99.30	97.46	3.03	31.32	91.25	78.34	79.92	-7.48	0.78	-8.89	59.42	78.27	66.67	7.58
BRD-K42500029	CP	CGP-57380	MAP kinase inhibitor, MAPK-interacting kinase inhibitor	AURKB, LCK, MKNK1, MKNK2, SGK1		8.85, 5.00	72.82	1.36, 0.49	35.79	85.85	72.14	97.34	98.11	68.27	73.23	26.29	83.60	94.17	70.81	92.49	87.68	87.19	60.94	99.44	81.17	50.06	10.92	64.23	61.89	74.72	73.77	-0.85	-3.25	69.74	21.30	72.82	81.57
BRD-A01643550	CP	prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	Glucocorticoid receptor agonist	5.38, 2.31	72.75	0.86, 0.39	84.63	78.81	33.58	84.99	99.51	61.94	-11.87	28.18	80.51	73.52	22.91	81.32	36.46	30.03	72.75	86.50	73.36	33.16	-13.19	97.09	82.06	77.11	87.28	3.08	-61.61	53.13	65.80	96.63	45.50
BRD-A96107863	CP	nisoldipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNB2, CYP3A5	Calcium channel blocker	5.33, 3.56	72.52	1.45, 0.64	56.05	92.53	9.52	66.96	46.27	71.41	81.31	80.30	-24.59	95.92	99.05	95.51	77.38	83.37	70.45	98.80	72.52	76.22	43.60	21.75	80.23	84.14	-13.81	-84.71	-27.40	55.84	80.74	72.94	4.25
BRD-K15588452	CP	R-96544	serotonin receptor antagonist	HTR2A	Serotonin receptor antagonist	9.23, 5.38	72.50	1.30, 0.28	40.37	-28.98	17.18	73.69	87.46	26.14	-55.28	97.96	20.29	-3.98	-19.83	96.55	72.50	77.82	93.55	86.17	85.60	98.92	-33.30	99.08	62.46	28.27	41.87	32.52	93.74	15.68	77.63	88.18	87.73
BRD-A73909368	CP	dactinomycin	DNA directed RNA polymerase inhibitor, nucleic acid syntheis inhibitor, protein synthesis inhibitor	POLR2A		6.15, 3.08	72.41	2.35, 0.80	8.84	99.22	92.50	15.76	96.16	94.19	55.83	-61.81	83.27	84.28	88.47	94.09	0.00	1.52	99.37	95.00	72.41	27.61	32.48	78.23	95.58	55.01	27.37	-53.09	-0.63	0.00	74.92	49.21	84.06
BRD-K94441233	CP	mevastatin	HMGCR inhibitor	HMGCR	HMGCR inhibitor	6.92, 3.46	72.36	1.23, 0.18	24.87	77.21	47.52	94.25	95.81	15.48	22.37	83.67	25.13	6.67	30.30	72.36	78.26	89.76	87.94	5.19	76.02	93.06	-28.35	80.70	82.60	73.36	27.60	-98.32	92.08	3.70	11.43	66.86	94.04
BRD-A36074203	CP	remacemide	glutamate receptor antagonist, glutamate receptor agonist	GRIN1		6.54, 3.46	72.32	0.93, 0.22	72.32	84.48	83.14	22.06	82.32	57.58	10.60	44.51	66.10	99.44	99.03	94.69	2.78	8.96	85.38	85.57	80.62	41.49	73.33	46.07	95.70	77.35	52.36	-0.07	81.75	71.32	52.76	81.05	32.92
BRD-K84955386	CP	hyperoside	glucosidase inhibitor, free radical scavenger	ACE, AKR1B1, GAA		8.89, 8.00	72.23	2.08, 0.76	87.45	86.08	16.99	64.91	41.79	60.77	72.23	83.55	59.05	99.96	98.63	99.93	70.68	78.32	8.55	98.56	77.18	47.71	99.20	17.45	20.64	47.71	94.34	0.00	90.40	99.47	99.93	39.46	60.68
BRD-K01095011	CP	finasteride	5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor	SRD5A2, SRD5A1, AKR1D1, AR		7.31, 3.46	72.22	0.77, 0.14	96.66	50.91	34.24	25.66	73.84	31.08	15.28	72.91	98.84	93.60	42.82	97.05	4.19	22.79	72.22	28.70	91.67	41.16	87.35	51.36	53.49	96.37	74.09	8.08	24.41	80.10	89.85	83.79	92.31
BRD-K80725632	CP	lavendustin-c	epidermal growth factor receptor (EGFR) inhibitor	CAMK2A, EGFR, SRC		3.46, 1.54	72.16	1.09, 0.26	97.85	43.98	72.16	72.52	48.25	51.80	31.44	0.00	5.81	89.76	83.61	95.28	68.26	9.73	93.76	96.78	77.47	28.08	37.98	90.36	79.51	55.33	-7.01	-82.73	-40.61	74.57	78.12	93.13	83.12
BRD-K10961822	CP	latanoprost	prostanoid receptor agonist	PTGFR		9.33, 5.78	71.95	1.78, 0.70	78.93	58.81	8.84	73.36	19.28	71.95	84.50	46.17	99.79	99.59	98.30	98.80	63.14	28.19	74.41	82.16	76.90	46.33	97.17	37.10	18.89	56.90	97.11	46.90	64.24	99.23	99.01	28.39	70.77
BRD-K77771411	CP	moxonidine	imidazoline receptor agonist, adrenergic receptor agonist	NISCH, ADRA2A, ADRA2B, ADRA2C		6.15, 4.23	71.95	0.56, 0.11	67.52	47.17	84.27	18.66	79.09	71.95	78.09	93.20	80.06	87.17	99.97	68.16	3.95	25.32	84.72	8.97	58.34	19.57	89.75	40.38	77.99	30.96	83.23	-0.88	74.11	69.10	76.18	41.45	87.18
BRD-K28296557	CP	AKT-inhibitor-IV	AKT inhibitor	AKT1		11.15, 6.54	71.92	2.85, 0.60	91.79	96.14	93.48	82.21	94.30	77.42	-43.45	-63.59	9.48	56.45	7.99	71.92	99.19	97.67	93.44	99.93	36.61	82.60	79.98	58.86	81.66	56.08	31.40	79.24	63.57	46.48	39.00	4.98	26.68
BRD-K43736954	CP	cortisone	glucocorticoid receptor agonist	NR3C1		7.69, 3.46	71.88	1.11, 0.26	39.85	76.50	93.14	26.56	96.01	88.24	60.83	80.34	75.32	99.65	96.55	69.26	1.09	71.88	24.56	13.36	96.87	76.64	93.02	32.75	96.15	77.30	9.64	-36.43	53.23	27.84	70.79	60.38	77.41
BRD-K55034111	CP	pefloxacin	topoisomerase inhibitor	TOP2A		8.00, 5.33	71.76	1.27, 0.40	99.75	56.90	3.32	62.49	92.17	93.34	11.58	49.24	93.04	98.13	97.41	97.99	18.44	3.19	72.54	21.20	97.30	-36.20	87.51	63.88	31.86	3.70	88.45	22.13	86.49	88.96	99.33	71.76	37.22
BRD-K01292756	CP	pimozide	dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist	DRD2, DRD3, CACNA1I, CALM1, HRH1, HTR1A, HTR2A, KCNA10, KCNH2	Dopamine receptor antagonist	9.23, 4.23	71.75	1.60, 0.57	95.34	64.15	71.75	91.41	32.47	69.46	33.54	73.89	80.05	92.93	42.99	79.11	91.09	97.84	82.52	99.93	23.67	96.62	67.10	62.65	35.92	8.91	24.64	93.16	99.52	77.52	30.49	66.10	56.70
BRD-K97752965	CP	nicorandil	ATP channel activator, nitric oxide donor, potassium channel agonist	ABCC9, KCNJ11, KCNJ8		6.67, 4.44	71.57	2.11, 0.73	97.85	84.32	85.83	27.94	14.45	69.60	64.00	79.19	35.65	99.79	96.09	99.75	28.68	39.20	63.93	84.58	33.21	40.13	83.67	43.62	90.10	53.79	89.32	-8.58	71.57	75.22	96.68	91.73	34.08
BRD-K96402602	CP	farnesylthiotriazole	prenylated protein methyltransferase (PPMTase) inhibitor			5.00, 2.69	71.49	1.00, 0.34	33.38	47.35	95.08	27.49	71.49	63.21	45.15	35.61	75.55	41.32	80.00	86.05	6.10	38.17	98.65	13.70	88.17	39.15	7.77	97.51	89.31	98.10	96.37	-19.57	-39.12	79.40	77.67	74.59	86.11
BRD-K18779551	CP	bifemelane	acetylcholine release stimulant, adrenergic transmitter uptake inhibitor, reducing agent	SLC6A2		10.00, 6.15	71.47	0.88, 0.18	20.82	95.70	76.13	70.84	98.57	48.99	32.91	24.85	14.05	92.95	95.03	97.60	18.64	84.92	71.47	77.92	59.66	88.59	71.47	18.49	86.65	32.04	99.62	56.01	98.45	87.71	78.56	67.40	12.89
BRD-K02992638	CP	lamivudine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor			5.77, 2.69	71.39	0.59, 0.19	15.63	38.52	72.95	8.57	64.51	10.48	71.39	92.94	33.48	93.93	96.81	85.73	-2.68	5.29	49.92	5.20	78.42	13.21	92.94	43.69	98.16	72.02	66.21	9.93	78.75	90.72	88.74	76.59	76.30
BRD-A68723818	CP	brompheniramine	histamine receptor antagonist	HRH1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		4.23, 0.38	71.32	0.94, 0.28	81.17	61.25	80.78	65.40	82.59	14.81	36.09	49.34	75.81	94.21	52.95	80.44	67.25	75.67	95.81	46.28	92.44	71.32	34.57	87.34	50.38	54.51	82.28	-61.48	28.14	48.63	85.54	97.33	82.54
BRD-K52735702	CP	cefdinir	cell wall synthesis inhibitor	MPO	Bacterial cell wall synthesis inhibitor	5.77, 2.69	71.11	1.60, 0.41	45.29	27.70	98.02	12.39	83.79	-0.04	73.68	41.13	33.20	98.65	92.18	66.79	3.14	22.66	88.51	6.23	93.75	11.64	88.67	56.91	98.45	87.36	71.11	73.85	63.76	58.94	71.60	71.37	86.13
BRD-A51829654	CP	BRL-15572	serotonin receptor antagonist	HTR1D, HTR1A, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6		5.38, 2.31	71.06	1.05, 0.30	72.46	60.66	85.25	11.52	89.59	71.06	87.78	84.64	83.49	20.99	31.73	89.34	-3.31	44.63	98.25	-28.55	95.09	46.14	82.71	98.63	7.84	75.28	48.79	0.00	38.79	92.93	57.67	51.44	76.55
BRD-A30437061	CP	camptothecin	topoisomerase inhibitor, beta amyloid synthesis inhibitor, hypoxia inducible factor inhibitor	TOP1, HIF1A	Topoisomerase inhibitor	5.38, 3.46	70.99	2.19, 0.69	12.62	98.56	94.16	67.35	94.93	70.99	58.50	-32.91	86.71	76.50	92.28	86.01	82.98	77.71	96.51	99.58	76.05	37.75	64.39	41.71	96.86	74.36	34.97	-68.29	-33.67	21.87	54.55	51.29	36.52
BRD-K16485616	CP	mocetinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC11	HDAC inhibitor	6.92, 2.69	70.91	1.90, 0.51	88.01	98.24	73.05	96.55	98.49	48.34	84.56	-51.87	25.52	38.55	45.94	96.95	68.02	51.58	79.98	99.47	63.20	84.67	70.67	70.91	87.90	82.98	58.94	-2.78	-0.60	44.20	95.12	32.58	82.71
BRD-A10977446	CP	carvedilol	adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator	ADRB1, ADRB2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB3, CYP2C19, CYP2E1, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, RYR2, SELE, VCAM1, VEGFA		7.31, 3.85	70.90	0.88, 0.16	91.13	28.39	84.00	78.44	69.27	54.26	5.30	84.77	17.33	19.29	16.25	83.43	41.94	70.90	96.81	75.21	94.99	96.00	49.70	48.02	74.81	34.68	44.83	74.60	87.07	36.93	53.59	76.96	96.87
BRD-A16332958	CP	modafinil	adrenergic receptor agonist, dopamine receptor reuptake inhibitor	ADRA1B, CYP1A2, CYP2B6, CYP2C19, CYP3A4, CYP3A5, SLC6A3		9.23, 4.23	70.88	0.72, 0.18	90.52	84.39	97.76	29.77	98.87	21.36	80.49	24.27	77.71	24.54	72.78	70.88	14.45	18.18	94.17	48.84	81.76	10.42	45.79	87.76	76.18	81.19	27.01	-36.23	8.97	63.16	85.52	96.78	1.13
BRD-K98769987	CP	flumazenil	benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		7.31, 2.69	70.85	1.15, 0.22	82.50	-16.70	5.31	30.73	3.35	98.17	93.15	96.44	97.07	44.25	70.85	56.29	-2.82	0.00	82.59	-30.15	74.59	15.38	69.78	95.27	19.61	8.21	92.18	88.91	93.83	79.35	95.76	91.83	23.71
BRD-K31633810	CP	DAU-5884	acetylcholine receptor antagonist	CHRM1, CHRM3		7.69, 3.46	70.74	1.02, 0.32	7.84	88.67	97.15	19.74	98.48	10.51	84.54	22.14	25.68	98.87	89.37	70.74	9.44	16.84	91.56	45.12	96.78	26.50	85.62	84.08	92.95	90.73	68.50	-2.47	19.27	99.44	46.40	74.39	51.69
BRD-K32526544	CP	DCEBIO	intermediate conductance potassium channel activator	KCNN2, KCNN3, KCNN4	Potassium channel activator	5.77, 3.46	70.68	0.80, 0.24	89.95	8.28	98.63	12.12	93.12	47.42	38.88	58.05	66.64	32.00	16.39	77.01	8.06	5.84	36.12	70.32	94.98	71.51	84.53	79.62	85.42	99.22	70.68	87.38	74.98	94.91	57.60	97.87	5.53
BRD-K18909381	CP	CGS-12066B	serotonin receptor agonist	HTR1B, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C		7.31, 3.46	70.62	0.84, 0.18	72.57	94.24	15.77	83.79	96.99	70.62	32.41	43.97	36.36	99.65	64.19	88.27	36.35	86.09	8.67	28.40	36.66	75.06	74.94	90.60	95.89	80.99	68.71	-99.18	98.70	23.05	1.48	82.05	54.47
BRD-K48932581	CP	cetraxate	gastrin inhibitor, mucus protecting agent	GAST		6.22, 4.44	70.61	1.48, 0.39	12.43	70.61	76.65	56.66	72.54	62.54	58.07	51.27	47.81	93.30	77.92	97.85	2.50	0.34	79.66	86.38	78.71	6.14	92.97	58.27	94.25	59.05	63.62	91.53	89.62	79.37	97.15	44.43	24.59
BRD-K09416995	CP	lovastatin	HMGCR inhibitor	HMGCR, CYP3A5, HDAC2, ITGAL, NR1I2	HMGCR inhibitor	5.77, 2.69	70.59	0.77, 0.16	93.33	41.92	88.62	88.64	57.57	25.15	7.71	54.67	36.04	86.19	14.29	73.92	86.79	90.95	47.81	23.82	95.55	96.65	95.06	53.25	85.78	72.56	14.52	89.89	91.66	25.59	63.23	40.87	70.59
BRD-K86887724	CP	dofetilide	polarization inhibitor, potassium channel antagonist, potassium channel blocker	KCNH2, KCNH1, KCNJ12, KCNK2		9.78, 5.33	70.36	1.25, 0.40	30.59	94.64	88.42	55.02	96.19	71.45	20.58	70.36	37.54	94.98	99.76	99.51	2.82	43.97	96.07	91.89	94.64	14.11	70.34	72.68	67.37	92.74	13.37	-1.99	-92.49	63.82	97.07	69.13	89.74
BRD-K59456551	CP	methotrexate	dihydrofolate reductase inhibitor, disease modifying antirheumatic drug, folate receptor antagonist, immunosuppressant, thymidylate synthase inhibitor	DHFR, AOX1, FOLR1, TYMS	Dihydrofolate reductase inhibitor	8.44, 3.56	70.28	0.97, 0.23	70.28	69.44	97.22	83.03	45.47	28.37	93.08	66.01	14.21	97.61	98.17	76.32	83.34	26.72	86.49	99.31	85.81	51.11	18.86	32.11	69.77	1.13	15.57	54.66	59.77	83.29	96.96	80.20	80.87
BRD-K00673382	CP	famotidine	histamine receptor antagonist	HRH2		8.44, 5.78	70.13	1.61, 0.40	94.92	97.64	72.99	71.78	63.28	49.06	21.51	-4.04	80.01	99.86	39.53	76.18	0.25	27.53	98.17	17.16	98.55	57.31	70.13	46.26	92.52	69.79	99.72	88.70	94.85	23.19	44.71	41.55	89.73
BRD-A49160188	CP	donepezil	acetylcholinesterase inhibitor	ACHE, HTR2A		4.62, 2.69	69.83	1.13, 0.32	62.77	52.83	34.83	74.17	90.92	93.43	26.67	42.11	95.62	49.72	31.81	75.80	31.62	69.83	13.34	79.52	99.11	60.92	41.67	75.42	84.61	86.57	83.55	-99.01	12.34	52.72	90.79	86.86	71.30
BRD-K47150025	CP	KI-8751	PDGFR alpha and c-Kit inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor	KDR	PDGFR/KIT inhibitor	5.31, 2.86	69.82	2.49, 0.72	42.12	80.51	87.11	69.47	50.21	34.03	3.29	30.98	2.68	73.52	39.63	75.54	91.76	91.39	90.85	99.93	85.70	82.38	81.18	84.03	78.84	69.82	33.01	4.49	-13.22	31.44	74.86	15.27	0.00
BRD-K43389675	CP	daunorubicin	RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant	TOP2A, TOP2B	Topoisomerase inhibitor	7.69, 3.85	69.81	2.67, 0.82	15.73	99.15	81.38	1.83	99.08	77.12	69.81	-66.90	24.71	93.61	64.73	97.12	6.56	31.91	22.19	94.78	68.71	30.25	70.54	85.09	95.21	78.17	53.11	-9.59	-25.87	13.43	80.44	73.71	88.79
BRD-K68264559	CP	brimonidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, AOX1		5.77, 2.69	69.76	0.86, 0.16	26.35	54.60	95.96	70.44	90.76	19.43	71.45	90.56	88.34	60.82	47.23	77.44	7.03	34.08	82.82	38.51	46.62	48.48	78.81	96.29	69.76	57.80	56.17	87.78	56.61	98.38	57.49	93.48	85.26
BRD-K41707108	CP	ceramide	nitric oxide production inhibitor, phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator			8.57, 4.49	69.59	1.00, 0.25	87.44	79.46	84.68	69.59	61.35	99.89	96.19	71.31	23.55	65.09	79.32	98.70	0.00	26.28	-23.20	5.61	77.02	47.46	99.75	82.99	78.86	27.62	36.55	-82.27	-1.62	96.86	69.47	74.65	38.23
BRD-A91866971	CP	SQ-29548	thromboxane receptor antagonist			3.67, 0.82	69.56	0.80, 0.14	96.31	15.77	85.27	44.23	32.15	96.92	22.08	79.15	74.02	91.28	80.57	69.56	6.21	70.52	92.93	-40.89	38.93	18.15	94.05	58.28	44.25	7.35	79.57	37.66	39.21	95.66	65.92	85.89	97.56
BRD-A34817987	CP	itraconazole	cell wall synthesis inhibitor, cytochrome P450 inhibitor, sterol demethylase inhibitor, VEGFR inhibitor	CYP3A5, CYP3A7, CYP51A1, KDR		6.15, 3.08	69.54	0.97, 0.13	99.40	44.34	39.18	68.91	40.33	68.09	44.77	49.80	14.38	55.50	56.16	95.35	69.54	85.73	93.38	92.25	66.62	85.25	50.07	79.47	51.36	79.59	84.13	42.17	88.37	91.01	87.07	77.51	78.27
BRD-A44780397	CP	mifepristone	glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor	PGR, NR3C1, AR, CYP2B6, CYP2C8, CYP3A5, CYP3A7, NR1I2	Progesterone receptor antagonist	4.23, 2.69	69.50	0.90, 0.16	46.05	29.05	53.26	69.50	81.89	45.01	-0.74	-51.62	29.76	75.23	89.71	79.78	80.82	82.24	73.36	98.80	16.75	88.79	16.04	92.25	61.48	85.58	72.46	44.20	82.25	27.63	14.12	66.83	96.14
BRD-K13032584	CP	procarbazine	DNA alkylating drug, transmethylation inhibitor			5.77, 3.46	69.48	0.78, 0.17	74.27	26.55	54.47	27.31	81.96	90.17	78.51	90.54	84.83	55.20	41.33	69.48	5.25	48.70	95.88	62.77	94.74	5.63	81.65	97.84	77.34	42.69	69.71	27.73	35.56	63.63	27.54	91.61	79.46
BRD-K06147391	CP	telenzepine	acetylcholine receptor antagonist	CHRM1		6.54, 1.15	69.33	0.53, 0.17	77.66	91.19	23.70	40.84	90.65	40.37	93.13	85.77	93.99	99.47	95.95	52.13	-2.82	32.20	-20.44	55.00	39.06	39.89	69.33	95.48	93.67	88.30	54.79	-99.30	69.24	96.27	55.71	96.62	95.75
BRD-A41519720	CP	ezetimibe	cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior	NPC1L1, ANPEP, SOAT1		6.15, 3.08	69.29	0.97, 0.18	70.64	72.98	45.54	93.97	98.57	11.10	27.09	54.77	52.61	19.92	57.29	75.70	86.31	86.82	98.51	99.01	98.73	87.52	7.84	56.40	63.80	58.97	91.18	-27.71	69.29	86.79	30.98	29.84	77.79
BRD-K62959606	CP	sphingosine	ceramidase inhibitor	GLTP, PVR, TRPM3		5.38, 1.15	69.26	0.88, 0.15	96.75	96.75	51.39	73.76	95.71	89.12	30.66	17.23	16.33	50.80	42.20	97.10	93.31	96.16	62.80	98.35	83.80	51.52	65.47	69.26	50.55	33.90	78.81	-16.61	37.04	22.89	79.42	81.77	98.03
BRD-K89732114	CP	trifluoperazine	breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker	DRD2, ABCG2, ADRA1A, CALM1, CALY, CAMK2A, DRD4, HRH1, HTR2A, HTR2C, S100A4, SCN4A, SCN9A, TNNC1	Dopamine receptor antagonist	7.31, 3.08	69.24	1.24, 0.32	58.55	76.34	97.13	70.47	69.24	62.70	49.72	38.40	60.07	34.49	30.97	79.03	69.32	91.84	85.46	94.24	78.52	97.18	13.88	63.24	83.47	24.72	26.91	-91.20	75.89	64.59	51.78	70.08	76.72
BRD-K27665173	CP	D-64406	PDGFR tyrosine kinase receptor inhibitor	FLT3, PDGFRA, PDGFRB	PDGFR/KIT inhibitor	5.38, 1.54	69.19	1.03, 0.28	55.43	43.95	76.73	95.49	47.90	94.51	5.78	79.73	6.20	8.57	69.19	25.16	77.36	84.13	49.37	90.50	79.85	58.89	13.85	76.68	62.37	78.96	-5.60	6.73	0.56	72.15	73.80	89.11	94.60
BRD-A71262238	CP	nafadotride	dopamine receptor antagonist	DRD3, DRD2, HTR1A		9.23, 3.08	69.16	0.90, 0.17	74.34	82.87	95.66	15.46	84.22	33.97	85.15	84.71	57.81	87.87	69.16	63.34	5.76	58.53	43.03	18.08	84.51	62.96	99.68	64.81	97.57	57.72	96.10	-99.86	73.42	53.98	41.08	93.43	87.28
BRD-A92585442	CP	RU-28318	cytochrome P450 antagonist	NR3C2		8.16, 3.67	69.12	0.86, 0.19	98.46	34.77	93.43	23.68	52.44	97.79	82.32	58.47	71.82	84.05	81.38	96.34	19.59	54.80	68.06	35.29	95.98	40.91	81.76	84.60	56.45	47.80	70.82	0.00	34.09	97.30	84.97	56.94	69.12
BRD-K46678324	CP	RHO-kinase-inhibitor-II	ROCK inhibitor		Rho associated kinase inhibitor	6.94, 3.67	69.11	0.91, 0.23	98.50	66.59	94.42	75.22	42.18	82.29	29.31	26.09	30.24	75.82	80.16	97.25	6.31	49.52	85.66	36.02	35.82	72.52	99.72	57.93	45.39	92.14	21.68	62.75	69.11	75.61	86.49	88.75	66.70
BRD-K15935639	CP	z-leu3-VS	PGPH inhibitor, proteasome inhibitor		Proteasome inhibitor	5.34, 5.34	69.08	3.00, 0.82	66.87	25.08	99.30	78.03	93.16	20.29	-14.59	24.60	20.29	0.14	0.18	79.78	98.25	93.34	92.44	99.44	71.29	85.62	-10.51	72.66	87.37	12.20	92.52	NaN	-2.43	-28.05	73.76	32.20	0.21
BRD-K06208435	CP	YS-035	calcium channel blocker			6.15, 3.46	69.07	1.06, 0.41	23.55	54.37	91.18	34.76	80.85	29.92	99.13	79.48	34.19	46.32	74.75	86.98	3.31	1.34	83.84	-88.02	78.86	39.52	58.72	92.65	87.84	93.74	9.60	-67.50	84.04	69.07	42.13	97.29	88.46
BRD-K05181084	CP	NGB-2904	dopamine receptor antagonist	DRD3		7.69, 3.85	69.02	0.70, 0.27	69.66	83.56	42.21	48.90	74.70	80.27	63.63	74.75	98.24	15.85	21.57	88.20	1.16	84.15	28.82	3.66	11.40	61.09	99.44	75.28	67.46	88.02	75.17	28.09	11.57	72.54	69.02	99.12	23.64
BRD-K11540476	CP	EMF-BCA1-64	caspase inhibitor	CASP3		4.23, 2.31	68.95	0.66, 0.09	37.12	24.43	88.68	63.35	51.89	59.69	22.38	82.96	45.71	81.49	90.82	78.61	2.08	79.10	95.70	5.92	96.46	82.08	84.46	76.82	58.42	69.54	64.10	33.36	59.36	68.95	64.53	72.46	79.04
BRD-K60762818	CP	desipramine	norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)	SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SMPD1	Tricyclic antidepressant	8.85, 4.62	68.93	1.41, 0.42	82.06	83.30	46.88	69.06	68.36	83.04	51.59	64.77	45.94	26.68	6.47	51.81	68.93	93.40	88.34	87.74	92.80	94.34	33.25	33.61	86.89	27.76	35.00	76.57	99.93	52.27	81.66	34.68	98.91
BRD-K47631482	CP	bromhexine	mucolytic			6.54, 3.08	68.90	0.56, 0.09	42.44	82.12	96.88	15.40	68.04	89.25	68.90	70.91	65.26	96.29	65.51	66.94	13.93	-42.49	72.13	13.02	93.10	60.08	84.06	66.41	93.46	82.07	64.97	0.00	80.51	83.78	22.36	89.04	79.80
BRD-K20482099	CP	rutin	aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor	AKR1C3, AKR1B1, F10		6.15, 3.08	68.83	0.81, 0.10	77.83	51.62	75.41	12.50	93.38	0.88	8.35	57.66	71.29	14.79	7.01	89.14	22.22	53.59	99.82	88.06	97.71	48.21	41.16	95.20	44.58	85.85	81.41	99.23	55.31	46.35	68.83	87.20	91.93
BRD-K28806945	CP	L-750667	dopamine receptor antagonist	DRD4		5.00, 2.69	68.81	0.98, 0.35	75.03	68.81	84.70	68.16	94.17	10.03	97.42	-34.79	91.42	9.84	62.47	54.17	3.59	4.55	57.93	56.55	95.76	71.12	-36.85	85.83	93.39	73.68	5.29	-93.36	23.25	72.97	74.48	91.12	94.51
BRD-K71534238	CP	GW-9508	Free Fatty Acid Receptor 1 (FFAR1;  GPR40) Agonists, G protein coupled receptor agonist, G-protein coupled receptor agonist	FFAR4, FFAR1		2.69, 1.92	68.71	0.51, 0.08	91.11	81.96	72.98	34.82	90.26	54.69	86.75	72.39	69.42	60.15	72.01	86.73	0.92	18.73	68.71	9.04	60.63	24.21	44.48	83.56	84.13	56.40	49.49	-91.41	46.59	83.69	53.83	83.12	81.09
BRD-K44779798	CP	miglitol	glucosidase inhibitor, sodium/glucose cotransporter activator	GAA, MGAM, GANAB, GANC, SLC5A4		7.56, 3.11	68.68	1.74, 0.57	77.07	93.82	1.90	27.79	58.24	37.29	69.05	70.59	32.87	85.10	67.93	70.34	26.74	21.18	96.83	74.17	81.32	63.38	95.90	68.68	49.12	43.56	99.44	99.08	77.86	49.86	94.40	63.82	54.04
BRD-K22010301	CP	JLK-6	gamma secretase inhibitor, antiamyloidogenic agent	PSEN1	Gamma secretase inhibitor	3.46, 1.15	68.67	1.88, 0.56	52.09	83.97	76.68	85.79	75.31	28.16	25.62	-29.31	12.96	59.34	71.41	66.59	87.89	93.84	46.16	99.44	30.76	90.16	14.01	76.24	89.31	76.38	47.65	0.00	64.75	-6.06	75.37	80.62	68.67
BRD-K74112339	CP	acetohydroxamic-acid	inhibitor of bacterial and plant urease			8.40, 5.34	68.59	1.71, 0.42	76.32	-9.20	29.42	20.07	70.10	-3.07	99.54	73.44	29.21	82.82	99.75	80.53	-26.02	11.02	93.48	7.75	93.00	9.89	67.08	84.60	40.34	81.54	12.68	NaN	35.26	99.72	99.54	99.86	11.52
BRD-K83063356	CP	RS-102895	CC chemokine receptor antagonist, CCR antagonist	CCR2		5.31, 2.45	68.58	1.01, 0.33	73.55	24.78	58.11	70.10	34.93	55.72	12.71	68.58	8.35	89.01	77.65	73.73	69.16	15.73	85.91	81.63	71.46	24.91	90.81	27.26	11.25	6.16	14.30	80.18	75.04	92.28	17.21	69.68	8.96
BRD-K86301799	CP	dipyridamole	phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor	ADA, PDE5A, PDE10A, PDE4A, PDE7B, PDE8A, PDE8B, SLC29A1		6.92, 1.92	68.46	0.55, 0.09	52.46	13.47	72.47	60.30	85.76	6.98	81.22	83.80	94.59	61.23	72.18	79.00	7.47	15.28	45.10	3.66	72.01	2.08	97.08	94.16	78.02	21.10	76.57	98.48	43.49	86.19	34.84	61.14	68.46
BRD-K77947974	CP	fluspirilene	dopamine receptor, dopamine receptor antagonist	DRD2, HTR2A, CACNG1, HRH1, HTR1A, HTR1D, HTR1E	Dopamine receptor antagonist	8.85, 4.23	68.40	0.94, 0.14	33.57	36.53	84.99	77.59	83.73	33.12	3.22	44.67	52.69	38.05	32.48	66.96	68.40	96.91	81.31	93.03	87.63	95.84	-47.16	45.21	78.91	59.45	50.05	20.78	97.79	88.59	68.84	70.20	93.20
BRD-K57179821	CP	crotamiton	scabicidal, antipruritic			5.00, 2.69	68.38	1.06, 0.17	81.73	8.13	6.37	31.01	17.85	80.23	78.90	88.21	68.38	84.84	92.95	97.84	2.26	-10.18	91.36	41.03	67.27	19.56	73.92	92.27	61.77	25.38	85.44	83.70	80.26	96.24	42.95	59.53	65.07
BRD-K92015269	CP	GBR-12783	dopamine uptake inhibitor			6.54, 3.08	68.38	0.94, 0.19	94.81	1.92	7.17	69.36	59.64	30.77	49.07	67.37	88.26	75.29	49.93	88.63	2.82	46.88	94.58	32.67	68.38	61.87	92.39	94.21	84.18	26.18	96.82	63.81	99.68	98.84	61.82	96.44	88.99
BRD-K82357231	CP	desloratadine	histamine receptor antagonist	HRH1		10.67, 8.00	68.36	0.78, 0.17	54.46	2.57	28.09	62.43	69.99	93.55	1.13	97.99	99.72	28.72	67.42	69.92	68.35	88.23	65.74	94.98	94.87	96.09	84.49	10.66	24.76	4.67	79.21	15.09	99.19	68.36	98.63	22.74	96.57
BRD-K00610438	CP	altanserin	serotonin receptor antagonist, collagen stimulant	HTR2A, HTR2C		5.00, 1.92	68.30	0.55, 0.14	94.69	4.86	11.73	29.40	10.52	70.17	8.32	76.33	11.90	28.71	92.98	38.83	7.86	68.30	78.61	6.20	85.74	62.47	84.53	60.81	45.75	89.57	33.01	92.11	87.22	79.30	79.44	83.83	79.01
BRD-K41410256	CP	balsalazide	cyclooxygenase inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist	PTGS1, PTGS2, ALOX5, PPARG		6.54, 5.38	68.29	2.14, 0.53	6.66	81.07	93.05	20.16	88.05	15.93	33.50	39.40	1.23	99.37	72.15	66.47	2.70	77.78	74.57	73.16	68.29	34.72	98.66	74.99	99.61	72.47	83.06	9.65	61.97	68.38	21.19	68.04	12.01
BRD-K45033733	CP	famciclovir	DNA polymerase inhibitor, DNA directed DNA polymerase inhibitor		DNA polymerase inhibitor	6.54, 3.08	68.28	0.38, 0.10	98.47	42.16	87.76	49.72	96.16	89.30	69.28	81.03	68.28	98.30	83.48	83.86	-10.59	14.96	68.02	13.71	76.67	19.75	60.04	51.94	47.42	28.12	45.31	-3.38	54.46	93.59	87.48	73.20	77.41
BRD-K89125793	CP	tinidazole	anti-protozoal			6.15, 1.92	68.28	0.77, 0.15	83.55	37.24	67.33	73.34	80.03	94.47	73.11	63.00	10.71	99.82	94.95	68.28	11.11	36.90	96.37	13.07	67.15	24.94	66.50	66.12	88.60	84.14	71.58	10.34	51.47	97.12	55.67	97.10	68.94
BRD-K39987650	CP	bisacodyl	stimulant laxative			4.62, 1.92	68.12	0.64, 0.26	40.08	92.82	25.18	68.90	77.10	68.12	71.37	66.95	85.86	66.50	66.61	78.97	85.74	8.24	97.60	63.35	27.94	66.56	87.51	83.90	85.81	75.44	63.89	-5.73	-31.17	78.43	35.68	71.93	25.05
BRD-K68507560	CP	dicycloverine	acetylcholine receptor antagonist, anticholinergic	CHRM1, CHRM2, CHRM3		6.92, 2.31	68.12	0.75, 0.18	80.70	21.59	8.11	48.47	66.08	67.38	83.76	77.32	96.85	68.12	94.36	78.60	45.75	31.19	-34.83	-6.26	84.02	30.25	99.15	86.11	73.79	44.57	38.86	10.37	96.85	87.60	16.36	91.47	96.86
BRD-K65639003	CP	icariin	neuromedin receptor agonist, sorbitol dehydrogenase inhibitor	NMUR2, PDE5A, SORD		6.15, 2.31	68.11	0.50, 0.07	81.41	11.75	24.46	24.93	67.13	3.17	78.41	22.55	16.48	98.02	63.82	94.99	-2.97	45.49	75.03	29.19	75.23	7.30	68.11	40.33	42.71	77.93	94.44	97.26	80.72	70.15	85.46	91.44	70.04
BRD-K15715913	CP	fluperlapine	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HTR6, HTR7		4.23, 1.54	68.10	0.52, 0.17	83.92	68.10	95.68	44.76	94.33	24.56	57.32	19.90	17.11	88.54	57.90	93.25	9.94	54.84	62.99	4.17	81.08	57.80	88.62	77.65	98.09	83.14	68.26	-0.07	65.84	91.16	81.61	81.99	39.63
BRD-K63068307	CP	ZSTK-474	PI3K inhibitor	PIK3CG, PIK3CA, PIK3CB, PIK3CD	PI3K inhibitor	6.15, 1.92	68.10	1.91, 0.60	14.74	86.01	75.33	95.71	49.72	44.85	16.10	73.53	30.86	69.19	80.44	90.17	71.22	6.87	99.72	93.71	86.63	90.44	-12.19	47.83	68.10	32.85	77.70	-30.52	63.11	14.46	57.77	50.40	88.13
BRD-K76908866	CP	CP-724714	receptor tyrosine protein kinase inhibitor, EGFR inhibitor, tyrosine kinase inhibitor	ERBB2		1.92, 1.15	68.10	1.26, 0.22	94.47	63.76	10.33	75.58	68.99	88.14	71.63	80.47	81.56	22.98	90.52	78.94	3.59	58.16	67.32	10.20	54.22	34.56	34.51	82.97	84.17	10.15	51.10	-96.85	54.18	68.10	81.54	73.33	74.61
BRD-K07237224	CP	moclobemide	monoamine oxidase inhibitor	MAOA, CYP2C19, MAOB		9.78, 6.22	67.93	0.95, 0.32	49.25	94.89	85.62	57.47	81.85	0.03	55.95	-64.17	94.43	85.40	46.63	98.38	56.90	19.98	77.95	87.97	32.63	33.86	92.25	7.51	86.63	92.32	99.99	0.04	18.23	81.26	85.09	67.93	28.33
BRD-A04327189	CP	synephrine	adrenergic receptor agonist, L-type calcium channel activator	ADRA1A		7.31, 4.62	67.87	1.10, 0.23	95.03	31.93	32.44	23.03	3.40	85.77	91.01	36.21	99.68	99.22	66.87	98.17	-0.53	60.95	98.90	5.21	63.44	6.48	98.05	76.91	75.64	23.93	95.17	95.86	67.87	28.63	70.19	46.90	90.57
BRD-K38436528	CP	imipramine	norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers	SLC6A2, SLC6A4, CHRM2, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM3, CHRM4, CHRM5, CYP2C19, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A3	Norepinephrine reuptake inhibitor	7.76, 4.08	67.86	0.58, 0.05	72.56	50.00	67.86	47.73	83.80	49.15	18.27	88.73	83.67	99.12	35.54	42.31	47.01	83.31	90.06	76.05	99.30	74.91	77.94	56.63	66.54	13.33	49.41	-10.41	97.37	50.05	36.02	82.15	68.02
BRD-K75958195	CP	pizotifen	serotonin receptor antagonist	HTR2A, HTR1A, HTR2C	Serotonin receptor antagonist	8.08, 4.23	67.79	0.60, 0.09	16.66	44.36	50.26	53.16	94.49	8.32	62.49	47.47	14.94	54.75	45.94	92.90	67.79	73.77	89.04	68.38	96.76	86.76	35.37	79.54	72.03	16.40	90.09	48.94	85.78	87.54	92.72	93.46	33.04
BRD-K04710043	CP	hexamethylenebisacetamide	differentiation inducer, NFKB inhibitor, AKT inhibitor			6.22, 3.11	67.77	2.07, 0.75	86.34	91.76	78.18	67.77	35.68	68.17	91.22	62.64	21.82	98.87	80.64	97.00	25.67	76.55	-13.51	-4.18	25.22	35.25	99.68	3.88	83.59	47.60	78.19	0.85	62.60	90.22	96.51	34.89	19.26
BRD-K94920105	CP	DR-2313	PARP inhibitor	PARP1, PARP3		2.69, 0.77	67.74	0.99, 0.15	93.15	34.19	84.82	63.42	66.25	60.09	88.34	79.10	21.74	97.29	68.86	96.02	-2.82	78.78	23.10	32.00	63.15	35.24	92.45	89.99	68.66	47.70	71.77	89.68	88.87	65.15	61.67	2.64	67.74
BRD-K32247306	CP	primidone	GABA receptor antagonist, unidentified pharmacological activity	GABRA1, CHRNA4, CHRNA7, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2		5.00, 1.92	67.71	0.44, 0.11	88.41	27.37	80.90	40.14	93.95	39.08	21.93	88.58	43.44	67.71	66.56	46.17	1.23	4.92	65.54	9.15	93.92	18.47	50.32	79.58	68.29	70.78	25.30	76.18	68.77	90.62	79.79	80.79	85.63
BRD-A18497530	CP	5-iodotubercidin	adenosine kinase inhibitor, nucleoside transporter inhibitor	MAPK3, ADK, CSNK1G2, GSG2, LRRK2		7.31, 4.23	67.70	4.91, 1.55	9.61	99.30	90.89	39.36	98.70	71.34	37.03	-80.17	17.74	93.63	59.95	98.41	12.99	54.61	97.92	97.67	66.05	9.35	74.59	73.14	96.05	90.58	15.20	-78.88	-39.08	10.43	67.70	77.42	82.03
BRD-K64245000	CP	GW-4064	FXR agonist	NR1H4		6.54, 3.46	67.68	0.41, 0.08	99.61	27.86	74.01	70.08	51.99	89.32	28.05	31.20	9.94	45.24	65.05	68.02	28.74	64.88	82.67	69.41	40.06	12.12	83.31	97.37	46.75	67.68	28.50	96.84	68.36	89.54	37.54	85.71	89.73
BRD-K94144010	CP	cotinine	nicotine metabolite			8.00, 6.67	67.53	1.89, 0.59	62.82	97.69	50.84	55.78	88.61	82.76	67.53	6.24	66.56	92.21	83.97	99.75	68.05	12.68	51.65	81.17	91.16	11.11	89.42	65.47	71.54	59.03	99.65	-53.85	-24.78	34.04	98.10	78.20	36.00
BRD-K63675182	CP	triflupromazine	acetylcholine receptor ligand, dopamine receptor	HTR2B, CHRM1, CHRM2, CHRNA7, DRD1, DRD2	Dopamine receptor antagonist	9.23, 6.15	67.39	1.53, 0.61	23.43	29.61	38.62	88.82	96.58	67.39	27.71	-83.25	11.96	9.44	45.97	87.90	89.75	98.24	80.38	98.38	96.91	99.58	-39.19	64.43	94.26	48.05	28.90	-2.18	99.33	39.82	71.04	91.05	92.73
BRD-K95763993	CP	trapidil	calcium channel antagonist, PDGFR tyrosine kinase receptor inhibitor, platelet aggregation inhibitor, protein kinase activator	PDGFRA		3.46, 2.69	67.16	0.72, 0.22	19.19	66.22	51.56	77.96	76.16	85.02	5.53	80.80	9.55	75.67	93.38	95.42	-3.21	14.30	47.19	4.90	80.78	42.29	67.92	77.45	67.16	42.44	20.59	72.70	84.49	55.06	34.11	92.58	70.05
BRD-K95899059	CP	LY-344864	serotonin receptor agonist	HTR1F, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR7		3.27, 2.45	67.03	1.18, 0.20	87.90	15.82	73.14	73.59	42.68	88.78	73.89	67.85	63.42	87.06	51.53	85.13	24.37	29.66	97.56	56.19	39.84	55.09	84.90	78.41	67.03	27.14	25.41	76.23	74.64	84.78	23.25	50.22	56.93
BRD-K15519488	CP	CS-110266	dopamine receptor agonist	SLC6A3		8.45, 5.63	66.99	3.87, 1.32	16.20	94.54	34.10	33.21	91.17	92.78	66.92	54.01	28.37	94.99	85.43	85.27	16.67	69.29	-99.08	8.53	14.65	66.99	86.71	42.55	99.01	97.92	8.14	-95.41	99.61	80.48	41.89	98.84	77.66
BRD-K83302049	CP	protopine	acetylcholinesterase inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor	ACHE, SLC6A2, SLC6A4		3.27, 2.45	66.98	0.68, 0.18	54.31	62.93	71.24	46.52	42.49	97.78	20.45	66.98	24.48	73.22	92.12	86.57	9.46	67.23	34.06	79.86	-47.84	75.30	99.68	65.53	88.85	80.32	49.09	65.70	41.56	93.00	95.15	67.09	19.44
BRD-K66296774	CP	fluvastatin	HMGCR inhibitor	HMGCR, CYP2C8	HMGCR inhibitor	6.92, 3.46	66.93	0.69, 0.13	66.93	87.54	64.85	95.88	99.05	37.89	-28.77	-82.40	6.17	29.83	10.79	78.93	84.40	91.87	93.98	98.56	95.78	94.71	20.68	28.59	89.10	19.98	12.43	-53.91	78.45	35.97	89.27	58.50	84.46
BRD-K93201660	CP	ML-7	myosin light chain kinase inhibitor	MYLK		5.77, 3.46	66.87	0.94, 0.22	25.24	74.84	80.62	83.03	73.81	74.77	54.33	37.47	79.92	8.02	-7.72	63.16	24.34	40.06	98.16	37.61	98.35	94.71	-34.41	93.06	63.75	96.96	64.25	43.97	84.23	21.83	66.87	98.91	80.31
BRD-A30655177	CP	LFM-A13	Bruton's tyrosine kinase (BTK) inhibitor	BTK		2.31, 0.38	66.81	0.69, 0.13	67.87	42.35	85.27	64.84	55.15	56.70	56.19	86.01	85.11	88.00	38.47	67.64	2.26	1.87	74.35	20.32	94.50	48.16	76.08	83.77	79.11	78.57	29.58	33.55	66.66	86.35	46.19	85.80	66.81
BRD-K21548250	CP	moracizine	sodium channel blocker	SCN5A		5.71, 2.86	66.79	1.08, 0.42	40.78	56.59	93.14	2.11	69.40	97.99	18.13	48.37	25.12	2.40	75.11	78.87	3.14	13.93	98.17	69.99	67.82	66.79	85.08	69.80	30.73	64.61	86.52	6.77	5.60	53.90	74.23	70.73	98.06
BRD-K04430056	CP	7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3		5.38, 3.85	66.77	0.81, 0.19	95.88	67.63	64.77	22.83	68.34	28.20	66.77	80.69	23.44	92.94	90.77	77.96	-2.78	14.97	74.93	-7.42	65.65	14.51	36.55	71.98	95.31	63.88	71.72	69.13	50.35	45.40	74.42	80.14	22.49
BRD-K92984783	CP	melperone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR1A, HTR2A		10.00, 6.92	66.69	0.91, 0.20	87.70	15.22	5.60	34.43	41.78	73.88	46.35	91.90	99.68	47.27	97.86	85.27	-3.14	9.58	70.73	-12.69	79.48	34.99	88.32	86.09	54.54	17.66	8.74	66.69	98.78	78.66	52.45	70.93	86.67
BRD-K62929068	CP	6-benzylaminopurine	purinergic receptor activator			8.16, 4.90	66.68	0.53, 0.08	99.93	58.57	59.30	67.85	60.22	94.01	72.26	83.43	5.71	96.17	64.78	96.33	4.27	66.34	90.46	34.28	80.47	58.29	93.79	97.59	96.76	88.93	61.80	-4.51	43.69	97.99	66.68	66.27	29.05
BRD-K51066026	CP	aminoindazole	ionophore			10.00, 4.23	66.64	0.99, 0.36	91.82	97.99	75.64	76.36	96.77	61.91	66.64	55.69	96.17	84.02	53.33	90.43	23.92	12.39	29.86	56.63	68.19	58.10	90.33	58.29	97.99	27.80	20.58	-93.87	68.31	96.91	42.68	60.02	69.47
BRD-K93880783	CP	stavudine	DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor		Nucleoside reverse transcriptase inhibitor, Reverse transcriptase inhibitor	9.39, 5.71	66.57	0.86, 0.26	66.57	93.89	80.10	29.68	95.73	69.03	51.96	88.86	66.66	58.35	56.35	93.66	14.63	22.53	80.25	24.63	77.32	27.01	43.56	34.43	65.50	51.94	69.01	-79.76	70.67	99.58	77.98	63.30	95.63
BRD-K52850071	CP	JAK3-Inhibitor-II	JAK inhibitor, ALK tyrosine kinase receptor inhibitor, EGFR inhibitor	EGFR, ALK, JAK1, JAK2, JAK3	JAK inhibitor	6.54, 3.46	66.56	1.22, 0.42	38.57	73.37	37.58	98.94	74.27	70.20	25.69	49.65	22.75	4.81	26.65	85.05	77.72	66.57	84.47	98.87	97.32	55.56	14.00	99.22	78.35	56.40	20.31	20.99	5.27	7.43	66.56	85.13	86.71
BRD-A10903566	CP	imiloxan	adrenergic receptor antagonist	ADRA2B		8.98, 4.90	66.55	1.17, 0.44	99.75	75.74	96.03	40.88	51.46	99.58	21.89	65.68	43.36	97.43	95.51	97.64	6.44	62.63	66.55	7.47	94.90	33.77	99.51	68.30	62.46	85.59	66.52	88.82	16.47	83.72	31.55	97.99	5.79
BRD-K82561139	CP	ricinine	casein kinase inhibitor			5.00, 3.08	66.54	0.94, 0.19	66.54	96.67	97.89	53.86	99.79	21.79	69.27	41.60	83.00	61.18	93.68	85.73	-1.06	22.20	97.60	42.63	94.76	58.05	6.81	23.99	96.72	79.94	34.02	-0.85	32.29	85.06	40.78	88.22	71.63
BRD-K47639036	CP	flavoxate	acetylcholine receptor antagonist	CHRM1, CHRM2		5.38, 1.92	66.51	1.10, 0.34	88.64	-22.23	8.06	66.41	7.01	78.66	82.55	73.82	31.54	93.01	66.51	41.08	-5.00	1.90	73.25	10.15	75.90	21.73	64.26	95.19	73.10	10.14	67.88	58.98	67.46	81.45	51.66	87.49	97.28
BRD-K09778810	CP	FGIN-1-27	benzodiazepine receptor agonist, inositol monophosphatase inhibitor	TSPO		3.08, 1.54	66.47	0.65, 0.13	94.01	51.44	91.87	87.07	41.74	79.06	14.20	52.04	14.08	87.81	16.57	85.33	56.08	64.45	76.86	57.61	91.20	77.56	92.40	70.82	39.40	66.47	53.54	0.04	51.06	46.19	75.16	79.76	81.48
BRD-K49668410	CP	clarithromycin	50S ribosomal subunit inhibitor	CYP2C19, CYP3A4, CYP3A5, CYP3A7		9.78, 5.78	66.43	1.41, 0.39	60.87	92.84	83.75	39.06	44.67	66.43	99.23	21.16	53.18	99.93	96.09	96.44	36.73	63.03	69.51	20.86	66.15	47.76	67.49	98.13	90.28	95.08	90.10	1.87	5.07	94.75	98.91	60.49	-13.69
BRD-K29359156	CP	ebselen	COX inihibitor, H+/K+-ATPase inhibitor, leukotriene receptor antagonist, NADPH oxidase inhibitor, nitric oxide synthase inhibitor, PKC inhibitor, prostanoid receptor antagonist, protein kinase C inhibitor, reducing agent	ALB, LTB4R, NOX3		10.38, 5.00	66.42	1.01, 0.25	54.35	88.46	68.81	42.78	83.04	53.60	32.93	60.35	12.89	49.80	73.61	95.90	39.84	9.41	92.68	35.78	79.76	37.91	87.11	59.16	99.01	94.47	22.02	95.42	80.09	68.97	66.42	46.46	69.69
BRD-K23369905	CP	oxiconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor			5.33, 4.00	66.40	1.25, 0.40	39.93	80.99	85.99	77.53	80.44	34.31	40.61	76.96	25.83	78.99	69.72	77.97	46.07	39.42	42.31	95.54	-74.56	76.39	88.62	6.29	78.77	25.11	87.97	11.69	51.89	47.62	94.55	48.89	66.40
BRD-K27871032	CP	lysergol	ergoline alkaloid	HTR1B, HTR1D, HTR1E		4.23, 2.69	66.38	1.22, 0.39	82.09	14.52	89.25	21.06	64.38	50.76	73.57	87.62	75.87	22.00	70.19	54.73	1.20	8.92	82.36	0.42	83.88	5.18	37.86	98.52	47.95	76.36	26.33	89.17	66.38	83.87	29.66	99.93	80.06
BRD-K60770992	CP	pergolide	dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor	DRD1, DRD2, ADRA2A, ADRA2B, ADRA2C, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, KCNA5		2.31, 1.15	66.37	0.58, 0.14	47.19	48.75	86.82	44.21	80.40	43.71	16.04	85.53	97.36	92.24	34.68	74.37	4.23	69.59	64.22	1.90	17.02	39.88	44.89	71.28	84.20	51.30	58.90	66.73	89.04	68.14	69.79	68.42	66.37
BRD-K09963420	CP	saquinavir	HIV protease inhibitor, peptidase inhibitor	CYP3A4, CYP3A5		6.92, 4.23	66.36	1.15, 0.35	26.76	72.11	66.36	47.79	62.16	32.78	66.92	42.17	50.64	72.97	60.47	94.11	20.72	66.33	75.86	30.56	58.00	64.49	69.84	91.59	66.74	72.32	97.53	74.14	38.65	73.44	93.59	99.51	40.48
BRD-K52394958	CP	GR-159897	tachykinin antagonist	TACR2, TAC1	Tachykinin antagonist	5.00, 1.92	66.33	1.24, 0.28	44.14	14.59	99.61	68.85	89.40	42.92	1.20	87.84	7.11	84.54	19.71	54.19	2.75	78.80	66.33	61.82	78.77	92.99	51.61	87.88	84.56	63.19	85.48	14.99	91.69	4.09	18.58	89.65	78.67
BRD-K56745457	CP	azauridine	antiviral agent, blocks the conversion of orotic acid into UMP			4.23, 2.69	66.20	1.30, 0.32	99.61	39.43	62.50	75.46	14.09	89.89	98.46	-29.51	3.52	69.82	92.99	40.08	10.98	32.95	75.02	35.12	2.89	73.60	52.41	68.01	83.59	26.31	67.81	0.00	1.37	68.52	82.89	80.28	66.20
BRD-K62996583	CP	lidoflazine	calcium channel antagonist	SCN1A, SCN3A, SLC29A1		5.00, 3.08	66.19	0.60, 0.09	76.95	70.89	96.30	36.90	86.58	12.35	9.69	31.96	88.65	66.19	4.86	61.79	56.82	35.75	77.99	70.40	91.77	81.16	22.97	97.12	87.56	74.51	41.79	-99.19	96.10	41.80	57.43	55.81	86.50
BRD-K80639402	CP	SB-258585	serotonin receptor antagonist	HTR6		6.12, 3.67	66.15	0.99, 0.26	28.41	85.01	92.59	52.59	66.15	83.10	71.45	-29.91	22.58	23.97	99.50	98.31	13.93	86.12	95.56	59.04	74.15	87.03	98.56	48.81	90.10	87.55	59.25	2.47	38.23	76.86	57.38	39.68	53.91
BRD-K09497549	CP	kawain	calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers	MTOR		5.31, 2.86	66.02	1.07, 0.28	43.49	63.18	63.64	6.62	72.60	68.38	33.73	53.30	15.46	98.31	87.24	84.41	3.43	31.87	45.28	30.84	94.94	66.02	95.39	86.51	93.72	94.28	74.08	98.66	38.36	48.52	95.17	81.24	-3.88
BRD-K34170797	CP	fexaramine	FXR agonist	NR1H4		6.92, 4.23	65.91	1.27, 0.36	98.31	72.65	8.03	52.79	-26.58	94.33	17.67	83.98	14.24	96.05	19.80	54.82	5.88	0.88	97.83	8.96	68.69	32.94	46.80	97.52	-13.85	99.26	35.10	97.32	68.78	93.57	79.10	86.80	65.91
BRD-A93424738	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2	Glucocorticoid receptor agonist	1.54, 0.38	65.89	1.25, 0.52	74.17	83.78	2.80	79.31	73.66	65.89	75.90	-53.23	42.05	39.10	70.46	41.11	17.40	82.73	40.31	65.58	69.93	5.50	59.35	80.11	42.29	81.82	28.08	70.67	78.02	62.63	66.50	77.11	46.35
BRD-A09828896	CP	SKF-81297	dopamine receptor agonist	DRD1, DRD5		9.23, 5.00	65.88	0.83, 0.23	81.23	16.17	16.85	94.66	80.49	38.04	15.36	39.17	83.39	34.81	40.76	97.00	40.49	65.88	91.64	98.80	94.16	84.64	76.77	99.03	82.15	63.22	31.15	27.11	26.90	89.49	54.17	99.61	27.55
BRD-K92760278	CP	riboflavin	vitamin B2, required for flavoprotein enzyme reactions			6.15, 3.85	65.85	0.76, 0.19	77.26	92.98	59.53	41.42	98.66	20.36	71.43	86.52	75.02	96.54	99.93	94.43	1.52	38.84	24.53	13.87	81.49	10.69	99.58	65.85	40.40	65.19	3.07	6.18	45.40	77.94	49.35	97.53	83.64
BRD-K26015241	CP	ODQ	guanylyl cyclase inhibitor, inhibitor of soluble guanylyl cyclase, potassium channel blocker	GUCY1A2, GUCY1A3, GUCY1B3		5.38, 2.69	65.82	1.08, 0.33	65.82	38.68	47.48	30.88	19.78	59.58	98.48	87.92	47.08	97.93	91.01	70.24	3.14	27.67	-16.75	4.50	99.05	26.50	97.40	85.81	88.30	62.61	6.66	93.22	87.44	72.96	39.63	92.12	70.16
BRD-K44353683	CP	nateglinide	insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator	ABCC8, KCNJ11, CYP3A4, INS, KCNJ10, PPARG		9.78, 6.22	65.73	1.57, 0.31	20.12	67.52	15.59	40.84	86.83	21.14	81.05	73.59	41.51	79.82	87.85	95.09	3.42	30.48	95.04	92.70	95.01	6.18	45.83	81.56	53.10	65.73	93.45	6.74	45.68	61.20	99.98	98.55	51.92
BRD-K49049886	CP	CGS-15943	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3		6.94, 4.90	65.73	1.56, 0.28	95.36	65.73	99.61	80.61	49.13	68.91	4.69	18.36	41.20	70.28	24.96	93.74	81.64	59.62	99.33	96.12	44.84	72.51	83.96	21.90	47.07	57.28	61.45	58.89	69.35	83.83	77.57	37.76	24.72
BRD-K31553034	CP	zibotentan	endothelin receptor antagonist	EDNRA		3.46, 1.15	65.70	1.49, 0.32	81.78	93.90	65.08	56.14	73.43	84.92	62.91	77.27	38.48	96.64	39.10	92.18	-33.28	17.94	67.95	-36.82	81.00	52.15	77.98	69.29	97.15	31.78	86.72	91.30	45.84	23.20	65.70	48.25	30.69
BRD-K04887706	CP	AKT-inhibitor-1-2	AKT inhibitor, PI3K inhibitor	AKT1, AKT2, AKT3		6.15, 2.69	65.62	1.42, 0.28	-8.31	89.70	85.19	84.55	76.03	22.50	-13.88	-38.01	65.62	89.58	18.37	73.03	80.02	89.19	65.89	99.58	27.93	96.93	-92.31	12.98	97.36	27.86	54.79	-60.33	97.29	5.23	64.96	21.82	74.80
BRD-K54759182	CP	dosulepin	adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant	SLC6A2, SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, HRH1		5.77, 1.54	65.59	1.30, 0.30	93.14	96.66	68.39	62.38	96.96	31.68	70.21	60.53	51.11	81.98	59.97	59.76	21.99	65.59	24.48	56.05	40.00	66.75	83.91	59.36	76.56	46.22	53.87	2.26	91.59	95.95	68.42	99.30	67.34
BRD-K86595100	CP	chlordiazepoxide	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		8.46, 2.69	65.54	1.38, 0.41	29.22	95.77	95.97	47.14	59.32	0.00	65.54	89.69	9.58	95.51	77.81	71.92	2.15	2.01	58.76	19.25	96.18	41.60	67.13	81.34	98.80	39.44	90.16	-99.25	97.13	14.45	58.43	72.53	74.74
BRD-K09471561	CP	levofloxacin	topoisomerase inhibitor, DNA gyrase inhibitor	TOP2A		5.33, 3.56	65.53	1.83, 0.38	89.49	30.98	35.55	13.41	74.71	24.90	53.93	23.27	5.80	98.59	9.57	66.38	39.37	52.17	71.57	68.25	98.38	30.68	82.45	68.12	53.55	92.37	90.60	65.53	4.93	84.84	93.99	32.40	72.05
BRD-A92630576	CP	trimebutine	opioid receptor agonist, acetylcholine receptor antagonist, Sodium Channel  Blockers	CHRM1, CHRM2, CHRM3, CHRM4		9.78, 7.11	65.51	1.00, 0.30	95.64	69.91	98.91	55.66	36.17	28.73	59.49	90.52	21.41	99.68	99.79	97.95	64.85	56.34	65.51	88.27	74.53	7.33	99.15	47.68	83.78	23.98	95.10	4.47	38.32	99.58	99.93	49.81	25.23
BRD-A07824748	CP	flavanone	11-beta hydroxysteroid dehydrogenase inhibitor	ADORA3, HSD11B1		8.16, 3.67	65.50	1.26, 0.28	85.42	95.84	94.45	34.67	97.89	45.67	43.64	65.66	32.75	96.55	84.48	81.84	2.82	88.05	98.87	45.42	65.50	13.73	97.72	54.01	60.84	53.68	27.01	-1.87	78.60	39.80	86.69	95.94	3.71
BRD-K53220666	CP	trimetozine	compound with mild tranquilizing effects			5.77, 3.08	65.50	1.00, 0.33	96.86	79.11	51.01	50.40	99.58	86.53	74.89	88.27	92.43	17.74	-3.88	74.92	-2.82	1.94	66.43	4.72	94.15	33.23	65.50	98.70	53.61	41.12	63.46	93.44	30.91	44.25	68.95	97.72	56.64
BRD-K52172416	CP	anastrozole	aromatase inhibitor	CYP19A1		7.31, 5.38	65.47	1.05, 0.39	49.91	42.76	99.12	33.20	89.29	24.98	35.46	65.47	10.63	53.02	76.89	91.75	10.64	12.20	94.16	88.83	81.85	14.42	94.17	91.56	98.45	81.44	52.19	0.07	45.09	92.60	30.63	78.73	74.41
BRD-K19136521	CP	indirubin	CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor	CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2	CDK inhibitor, Glycogen synthase kinase inhibitor	4.62, 3.46	65.45	1.20, 0.28	68.55	40.02	95.90	86.62	99.20	65.45	39.66	29.54	9.54	34.87	38.73	70.44	82.62	56.37	70.04	99.54	77.80	46.69	48.50	84.37	68.83	54.76	41.32	0.00	28.40	57.11	67.72	93.69	69.01
BRD-K88789588	CP	letrozole	aromatase inhibitor, estrogen receptor antagonist	CYP19A1		4.90, 2.86	65.44	0.50, 0.11	54.46	18.01	86.82	40.91	85.62	28.96	23.01	40.56	37.52	95.83	65.16	84.86	10.66	23.02	99.37	31.51	94.48	53.25	69.86	66.33	69.17	56.07	76.92	53.20	74.31	68.66	73.95	65.44	68.54
BRD-K72541103	CP	JAK3-inhibitor-I	JAK inhibitor	JAK3	JAK inhibitor	3.46, 1.54	65.37	0.73, 0.20	11.69	65.37	81.72	92.91	86.62	87.01	36.02	55.51	30.86	30.58	76.64	89.74	1.20	73.28	94.06	10.92	99.12	59.18	10.05	84.67	81.37	67.13	15.05	0.85	16.13	13.20	88.43	62.65	92.12
BRD-K76133116	CP	benzydamine	membrane integrity inhibitor, prostanoid receptor inhibitor	PRSS1, PRSS2		7.69, 4.23	65.28	0.93, 0.26	54.44	27.68	84.66	31.11	89.45	15.75	97.10	55.74	98.61	45.55	36.70	76.77	-2.49	1.20	86.74	20.99	67.96	72.09	36.10	96.80	65.28	98.41	86.58	0.00	27.71	12.16	78.81	98.60	84.52
BRD-K51313569	CP	palbociclib	CDK inhibitor	CDK4, CDK6, CCND3	CDK inhibitor	3.85, 1.92	65.18	2.00, 0.52	11.70	66.12	98.94	63.96	65.18	90.25	-13.27	38.14	6.01	75.92	10.60	87.80	75.61	56.52	93.43	93.37	75.96	47.83	34.65	83.74	63.05	49.89	76.94	39.95	59.98	77.19	80.87	38.91	72.50
BRD-K50660797	CP	epicatechin	beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, cyclooxygenase inhibitor, DNA gyrase inhibitor, DNA polymerase beta inhibitor, fatty acid synthase inhibitor, HCV inhibitor, sodium/glucose cotransporter inhibitor	FASN, APP, BACE1, SLC5A1		4.62, 3.08	65.15	1.01, 0.33	67.59	71.22	98.10	51.12	98.48	99.72	60.04	-24.56	31.19	68.24	82.55	90.58	2.71	7.51	42.41	1.30	97.58	24.58	87.52	84.42	98.03	86.15	11.72	-1.30	-30.63	60.88	64.39	65.15	96.93
BRD-K13642330	CP	cosmosiin	cytochrome P450 inhibitor			10.69, 8.40	65.06	1.77, 0.51	54.44	97.64	93.60	25.35	98.87	40.70	-22.79	-53.30	97.05	4.79	-15.14	89.77	0.07	-21.13	88.40	99.47	80.77	29.88	-2.95	99.44	98.38	73.28	56.85	NaN	-0.28	16.85	76.69	99.79	99.47
BRD-A56245458	CP	reichstein	androgen receptor antagonist	AR		8.46, 3.85	65.03	1.27, 0.35	6.63	-69.45	3.14	45.30	13.08	-38.12	75.14	18.22	-14.25	99.89	99.72	85.42	0.00	80.37	98.06	44.04	71.72	56.22	85.66	65.03	96.60	67.93	31.98	36.81	77.18	75.61	96.83	78.83	11.70
BRD-K45068323	CP	W-13	calmodulin antagonist	CALM1, MYLK, PDE1A	Calmodulin antagonist	8.85, 4.62	65.02	0.83, 0.13	9.85	93.61	71.46	76.66	41.82	10.67	85.28	38.41	23.37	89.57	71.51	55.80	16.51	54.67	81.71	26.98	87.86	88.47	65.02	46.59	78.84	69.54	-3.85	45.56	97.89	56.14	46.40	99.10	78.42
BRD-K30480208	CP	torasemide	cytochrome P450 antagonist, diuretic, electrolyte reabsorption inhibitor, thromboxane receptor antagonist	SLC12A1, CYP2C8, SLC12A2		4.90, 2.45	65.01	0.84, 0.23	72.99	44.20	43.51	10.57	62.22	69.18	80.90	76.56	32.80	94.98	71.42	93.07	1.87	64.44	98.06	6.24	89.47	19.58	71.01	42.05	36.20	68.33	82.62	0.00	35.24	63.56	89.37	65.01	71.15
BRD-K18574842	CP	nafcillin	antibiotic	CYP3A4	Bacterial cell wall synthesis inhibitor	6.54, 2.69	64.98	0.88, 0.30	70.89	97.18	61.97	26.24	96.19	64.98	93.80	74.87	75.54	98.80	78.43	53.40	-1.44	8.96	-29.83	28.76	33.90	37.01	92.11	54.30	91.36	79.62	29.13	-42.00	21.78	98.98	87.64	83.82	58.81
BRD-A26711594	CP	nicardipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B		5.77, 3.85	64.96	0.55, 0.06	76.26	65.33	99.98	32.39	43.48	86.68	22.77	87.12	72.84	64.96	14.39	64.70	2.92	47.07	73.34	23.02	89.42	58.44	84.60	49.14	71.60	28.81	30.33	83.83	74.59	69.80	51.22	54.99	71.79
BRD-A17535965	CP	gelsemine	acetylcholine receptor antagonist, glycine receptor antagonist	GLRA3		6.94, 3.27	64.92	0.97, 0.31	16.26	97.17	98.64	61.99	93.94	89.91	98.11	-44.51	62.01	65.15	81.99	96.65	8.83	34.82	17.33	53.00	64.92	50.61	99.93	54.85	94.17	36.63	89.35	0.00	7.71	71.20	90.25	67.24	20.65
BRD-K33459542	CP	ditolylguanidine	sigma receptor agonist	GRIN1, GRIN2A, GRIN2B, SIGMAR1		4.62, 2.69	64.91	1.27, 0.42	77.75	71.53	87.67	9.65	91.51	64.91	35.37	64.46	38.21	85.74	59.58	78.23	5.46	45.27	77.49	10.04	94.47	80.90	90.14	89.82	83.55	98.22	29.13	0.00	52.31	94.73	20.26	49.20	22.23
BRD-A58157837	CP	butabindide	tripeptidyl peptidase inhibitor	TPP2		4.62, 3.46	64.87	0.98, 0.26	94.67	58.52	96.34	68.70	91.53	82.18	63.98	-51.06	12.66	27.54	74.95	84.58	1.76	0.53	91.49	5.77	64.87	29.36	47.79	97.96	87.92	97.64	54.48	91.63	22.63	38.73	74.35	44.97	70.91
BRD-K91263825	CP	nortriptyline	PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)	KCNJ10, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, PGRMC1, PIK3CD, SIGMAR1	Tricyclic antidepressant	10.77, 6.92	64.86	1.60, 0.50	40.27	30.54	73.25	93.66	76.35	25.63	-0.70	-10.63	28.20	86.09	2.26	62.40	89.53	98.10	93.55	96.29	91.75	99.97	18.76	50.40	87.98	99.05	19.96	38.44	99.44	52.25	64.86	59.53	92.05
BRD-K37814297	CP	acepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Dopamine receptor antagonist	8.11, 3.24	64.80	1.01, 0.24	66.94	41.38	64.80	12.85	91.06	3.10	85.33	30.06	17.02	98.61	38.11	60.73	0.35	88.26	73.65	24.80	97.18	88.27	78.31	25.36	86.50	75.87	11.21	-95.47	94.00	90.29	50.42	78.94	56.92
BRD-A19248578	CP	latrunculin-b	actin destabilizer, unidentified pharmacological activity	ACTA1, MKL1, SPIRE2		4.90, 0.82	64.79	1.32, 0.42	-2.43	95.59	90.79	98.59	66.65	11.51	-45.80	43.96	38.46	91.15	9.92	58.92	85.81	93.53	69.15	99.61	95.67	97.49	10.96	64.70	91.33	-14.72	64.79	94.77	57.22	19.11	74.56	36.40	59.50
BRD-K02950022	CP	BMS-299897	gamma secretase inhibitor, antiamyloidogenic agent		Gamma secretase inhibitor	6.54, 3.46	64.79	1.18, 0.15	79.79	82.06	88.86	21.73	94.14	10.69	49.73	46.84	94.85	64.79	34.04	75.40	-4.23	33.82	21.68	9.00	89.49	72.51	98.13	72.73	94.73	97.62	36.64	1.63	34.45	56.28	25.81	75.14	73.95
BRD-K60060639	CP	methyllidocaine	antiarrhythmic, phosphatidyl-inositol activator			7.31, 3.85	64.79	0.88, 0.19	79.35	48.23	40.41	46.44	99.37	64.79	99.12	47.37	70.36	12.51	32.95	95.14	16.47	54.64	90.31	58.36	48.76	17.35	89.84	98.45	54.00	67.12	21.42	95.15	49.76	99.75	87.71	86.55	79.56
BRD-K44899736	CP	RO-16-6941	monoamine oxidase inhibitor			5.38, 2.31	64.73	1.00, 0.28	22.28	84.20	85.99	44.01	90.24	32.14	13.47	64.73	78.44	13.88	95.37	72.71	5.44	3.70	89.80	28.11	76.75	76.25	21.71	57.49	81.27	97.39	30.65	1.32	11.22	93.28	59.26	81.13	66.05
BRD-A56987319	CP	SQ-22536	adenylyl cyclase inhibitor	ADCY1, ADCY5		7.69, 5.00	64.70	1.06, 0.40	7.60	30.00	82.52	4.40	45.87	64.70	84.76	93.62	68.14	67.01	49.69	24.94	3.98	0.74	77.01	4.09	85.48	82.53	80.17	84.64	44.79	98.94	30.61	0.53	76.43	58.26	46.04	85.09	99.93
BRD-K40901640	CP	cinanserin	serotonin receptor antagonist	HTR2A		9.39, 5.31	64.68	0.48, 0.09	67.41	64.68	99.13	25.14	46.56	62.78	47.73	65.54	77.22	72.58	54.41	98.52	2.78	18.47	97.70	80.64	75.50	20.75	91.02	61.99	71.09	40.40	81.57	24.80	59.65	96.89	52.59	65.61	14.60
BRD-K18816859	CP	L-694247	serotonin receptor agonist	HTR1D, HTR1A, HTR1B		5.00, 2.31	64.62	0.72, 0.08	58.76	-67.84	57.79	22.73	45.49	69.10	83.80	86.29	40.42	74.81	95.59	69.58	6.72	1.97	96.30	2.01	75.92	64.62	83.97	62.84	91.75	90.68	35.98	0.03	19.39	89.15	73.62	88.41	63.30
BRD-K08252256	CP	diclofenac	cyclooxygenase inhibitor	PTGS1, PTGS2, AKR1C3, ALOX5, ASIC1, ASIC3, CYP2C8, KCNQ2, KCNQ3, PLA2G2A, PPARG, SCN4A		6.92, 2.31	64.59	0.78, 0.19	77.59	69.90	12.24	6.76	91.06	26.71	83.77	46.57	39.70	68.96	13.60	80.37	1.23	6.26	62.04	32.63	90.87	9.34	81.47	90.03	64.59	65.33	75.84	54.84	51.10	80.05	65.07	92.17	6.04
BRD-K86958018	CP	olvanil	TRPV agonist	TRPV1, CNR1, GPR119	Cannabinoid receptor agonist	5.38, 2.31	64.50	0.86, 0.20	35.49	92.84	65.22	7.17	94.00	78.88	46.09	52.27	78.46	27.94	24.46	80.59	17.33	37.27	52.78	90.53	64.50	11.41	30.56	89.63	78.29	87.91	82.56	0.00	0.56	27.92	70.15	94.55	95.89
BRD-A41833852	CP	naloxone	opioid receptor antagonist	OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4		6.54, 1.54	64.48	1.11, 0.22	91.15	74.74	35.19	34.50	95.24	90.92	1.23	-48.67	21.07	38.29	27.12	62.22	15.99	12.42	99.47	97.22	99.68	15.13	70.57	90.32	66.13	87.39	59.29	9.57	44.50	64.48	64.91	76.56	71.06
BRD-K98530306	CP	clonidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D		3.08, 0.77	64.45	0.95, 0.27	51.23	68.43	84.79	37.98	90.75	43.08	67.50	68.29	34.04	67.28	89.11	57.80	-2.36	28.80	86.66	25.31	90.84	32.72	50.83	85.27	70.50	64.45	41.11	3.10	43.54	81.45	76.96	94.80	20.77
BRD-K49111258	CP	prazosin	adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CDK1, KCNH2, KCNH6, KCNH7		5.77, 2.69	64.44	0.56, 0.13	40.22	42.15	24.33	13.72	38.68	38.11	96.14	64.44	20.30	85.77	60.56	93.43	1.06	40.71	52.10	81.65	90.02	19.53	83.65	63.93	71.74	77.24	65.74	38.71	77.98	77.33	70.14	94.35	87.72
BRD-A11135865	CP	nor-binaltorphimine	opioid receptor antagonist			4.08, 2.04	64.41	0.80, 0.19	28.50	93.49	97.78	21.51	76.04	98.45	42.49	89.00	68.60	93.50	97.78	98.87	-3.14	22.92	69.15	39.14	22.30	53.35	89.34	82.04	38.35	67.67	50.72	-1.90	39.76	70.73	38.77	61.26	64.41
BRD-K95435023	CP	PHA-665752	c-Met inhibitor, hepatocyte growth factor receptor inhibitor	MET		8.08, 4.62	64.40	1.49, 0.38	11.10	94.50	92.47	82.40	70.54	15.72	1.37	25.03	29.16	33.00	7.74	64.40	95.38	99.15	88.90	99.40	64.31	93.85	24.01	95.89	62.26	86.54	38.08	99.30	93.24	-14.93	38.23	65.04	36.69
BRD-K22193694	CP	dioxybenzone	topical sunscreen agent			6.92, 2.69	64.36	0.84, 0.14	45.83	40.35	63.47	16.86	95.90	41.44	64.36	17.42	43.07	99.86	93.30	70.99	3.36	14.05	94.19	10.54	93.51	-0.67	83.92	58.19	70.04	64.41	88.37	88.02	37.54	92.14	35.05	99.61	66.01
BRD-K12513978	CP	fenbufen	cyclooxygenase inhibitor	PTGS1, PTGS2	Cyclooxygenase inhibitor	6.54, 3.46	64.29	0.89, 0.24	99.68	64.29	69.14	51.00	96.48	94.28	14.12	71.10	17.45	64.62	85.61	81.85	-8.45	9.84	-46.82	5.55	-43.06	10.52	92.95	87.41	83.34	63.40	41.38	86.89	75.26	94.57	31.65	47.21	-21.09
BRD-K73397362	CP	purmorphamine	smoothened receptor agonist	SMO, DHH, IHH, PTCH1		5.38, 2.31	64.29	0.73, 0.19	99.12	34.10	97.48	88.98	59.73	25.66	96.78	73.35	58.67	50.88	60.08	40.42	87.39	30.08	64.29	48.76	81.65	48.37	83.92	79.03	70.01	78.29	16.38	84.11	30.97	46.91	70.85	75.32	0.85
BRD-K59256312	CP	gabexate	serine protease inhibitor, AP inhibitor, NFkB pathway inhibitor, peptidase inhibitor, protease inhibitor	PRSS1, TPSAB1		6.54, 2.69	64.24	1.23, 0.36	25.15	60.90	31.89	41.83	55.52	30.19	35.77	67.23	76.03	85.63	81.75	82.25	-2.78	5.29	74.38	3.73	86.39	67.13	88.26	69.95	56.10	83.82	75.36	-89.74	64.24	86.15	25.92	50.32	97.36
BRD-K08417745	CP	SID-26681509	cathepsin inhibitor	CTSL		7.31, 3.85	64.21	0.13, 0.02	16.29	70.50	95.74	78.28	94.39	25.26	-17.51	51.01	16.54	84.05	45.46	91.36	97.64	98.91	96.47	99.72	57.76	95.18	64.21	79.43	83.96	49.90	38.22	92.54	61.81	42.50	45.28	39.40	62.05
BRD-K60274257	CP	dephostatin	tyrosine phosphatase inhibitor	PTPN1, PTPN6		3.46, 1.15	64.13	1.38, 0.31	15.17	66.43	97.78	57.81	76.90	89.50	1.80	33.95	57.57	39.40	60.30	94.42	62.82	0.63	80.86	90.40	85.37	26.44	-11.12	64.13	96.26	85.84	89.86	99.19	70.27	7.19	29.05	57.35	65.12
BRD-K64994968	CP	progesterone	progesterone receptor agonist	PGR, CYP17A1, NR3C2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP2C19, ESR1, OPRK1, TRPC5	Progesterone receptor agonist	4.62, 1.54	64.07	0.45, 0.11	93.55	34.93	68.09	66.07	79.98	7.86	14.12	29.52	39.61	18.21	13.77	74.83	9.48	78.23	93.46	35.70	84.94	76.25	47.13	94.16	71.73	74.58	82.01	-37.28	29.34	7.82	59.34	96.99	64.07
BRD-K92870997	CP	pterostilbene	cyclooxygenase inhibitor, FAAH inhibitor, MAP kinase inhibitor, PPAR receptor agonist	FAAH, PPARA, PTGS1, PTGS2		7.11, 4.44	64.05	1.94, 0.63	80.05	64.85	57.02	48.21	61.89	49.73	42.65	4.66	33.04	99.93	91.73	99.69	34.70	73.79	98.18	98.39	72.00	57.02	27.50	70.66	15.51	36.59	94.00	62.28	64.05	82.41	96.76	94.54	-7.50
BRD-K15086322	CP	JNJ-10191584	histamine receptor antagonist, histamine receptor silent antagonist	HRH4		7.69, 2.69	64.04	0.93, 0.32	68.26	33.20	95.12	47.35	84.71	49.49	15.82	74.00	28.22	-6.51	14.46	60.20	-4.64	2.01	89.21	83.43	99.37	60.32	-23.89	95.80	96.40	95.65	70.02	75.11	-13.44	71.57	64.04	97.08	16.82
BRD-A59985574	CP	topotecan	topoisomerase inhibitor	TOP1, TOP1MT	Topoisomerase inhibitor	6.94, 3.67	63.98	3.25, 0.84	74.68	99.22	78.80	72.40	95.16	58.87	71.24	-75.83	75.68	24.19	73.94	92.44	63.98	71.33	96.59	99.82	55.47	36.10	14.95	48.21	97.22	79.93	47.11	-93.56	-15.39	29.13	52.10	41.28	-1.62
BRD-A93206962	CP	L-755507	adrenergic receptor agonist, adrenergic receptor partial agonist	ADRB3, ADRB1, ADRB2		6.54, 3.46	63.98	0.58, 0.15	98.09	-90.10	22.74	38.28	62.36	12.81	24.46	81.97	15.60	10.97	41.88	47.80	63.98	75.53	91.44	64.30	84.50	89.11	15.60	97.22	72.21	54.16	26.91	99.15	97.87	58.95	68.90	96.15	69.58
BRD-A13188892	CP	doxazosin	adrenergic receptor antagonist	ADRA1D, ADRA1A, ADRA1B, CYP2C19, KCNH2, KCNH6, KCNH7		4.90, 2.04	63.94	1.22, 0.38	97.28	71.26	92.15	34.05	86.71	29.01	18.59	84.76	32.55	49.80	81.91	54.13	60.14	22.62	63.94	94.87	13.80	71.44	-15.13	89.01	73.60	88.64	12.04	18.90	33.47	92.59	73.99	84.32	24.76
BRD-A31159102	CP	fluoxetine	selective serotonin reuptake inhibitor (SSRI), serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, Sodium Channel  Blockers	SLC6A4, ANO1, CYP2C19, HTR2B		9.23, 4.62	63.91	1.32, 0.30	51.51	63.91	91.95	70.28	90.66	38.96	6.75	36.02	19.99	98.91	39.37	72.34	48.57	93.00	15.60	75.23	72.69	96.78	71.45	49.31	85.34	85.61	38.92	-0.85	97.10	37.47	32.07	67.20	45.08
BRD-K41713976	CP	E-4031	polarization inhibitor, potassium channel antagonist, potassium channel blocker	KCNH2, KCNH1		3.46, 2.69	63.88	0.72, 0.18	79.75	64.84	80.96	59.54	91.28	29.39	63.88	75.90	29.79	60.68	88.04	60.47	3.91	19.84	83.86	5.03	60.43	29.33	63.76	80.59	86.35	56.09	39.05	-15.22	67.46	88.68	91.54	94.08	65.46
BRD-K51018020	CP	VAMA-37	DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor	PRKDC	DNA dependent protein kinase inhibitor	5.71, 3.27	63.88	1.39, 0.48	53.19	93.49	99.61	93.94	73.48	32.48	20.77	-14.06	16.06	97.96	89.70	91.51	33.35	86.83	93.79	99.72	56.18	76.95	63.88	66.35	92.24	17.82	64.40	-7.35	61.16	30.69	27.64	59.76	3.25
BRD-A24191444	CP	ifenprodil	adrenergic receptor antagonist, glutamate receptor antagonist	GRIN1, GRIN2B		8.00, 5.33	63.87	0.90, 0.16	39.36	79.57	41.93	21.52	91.45	18.97	63.87	72.83	-9.72	79.12	38.17	82.25	4.67	15.10	91.03	31.60	99.54	43.89	69.99	29.97	83.51	79.05	74.10	0.04	18.59	98.65	75.85	98.77	3.07
BRD-K87158025	CP	benzamil	epithelial sodium channel blocker	PKD2L1, SCNN1A, SCNN1B, SCNN1G, ASIC1, SCNN1D, SLC8A1		5.38, 1.54	63.79	0.70, 0.20	18.44	32.32	81.75	79.94	64.23	34.43	38.46	63.79	18.50	90.77	74.88	40.28	2.82	72.49	94.99	90.94	6.69	78.85	57.28	65.13	70.38	83.33	56.04	6.25	57.60	35.02	35.76	82.51	89.60
BRD-A63043573	CP	cabergoline	dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor	DRD2, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1B, ADRA1D, ADRB1, ADRB2, HTR7, PRL		4.62, 2.31	63.72	1.43, 0.36	98.63	79.70	31.24	70.19	99.65	26.86	33.15	80.76	56.21	37.48	47.23	95.31	11.48	79.85	37.40	27.18	63.72	74.18	84.23	82.34	80.11	55.69	28.75	15.19	71.30	91.06	11.00	99.33	37.62
BRD-A11678676	CP	wortmannin	PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor	PIK3CA, PIK3CG, PLK1, ATM, ATR, MTOR, PI4KA, PI4KB, PIK3CD, PIK3R1, PLK3, PRKDC	PI3K inhibitor	5.77, 1.54	63.67	1.52, 0.50	6.34	61.74	72.98	99.22	30.90	36.22	7.22	28.43	59.93	71.87	80.48	83.96	91.48	91.15	94.95	99.89	96.47	95.28	6.97	63.67	35.22	43.56	71.23	-0.88	90.22	7.73	30.65	29.30	77.16
BRD-A18917088	CP	estradiol	estrogen receptor agonist	ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1	Estrogen receptor agonist	5.38, 2.69	63.65	0.52, 0.15	98.94	30.42	53.49	57.50	81.01	41.59	35.03	-86.04	14.20	46.33	51.87	94.62	65.08	65.71	81.14	98.34	49.05	77.24	25.29	77.93	79.03	96.92	97.46	-17.99	0.85	71.80	85.56	63.65	55.17
BRD-K30240666	CP	clemastine	histamine receptor antagonist	HRH1	HRH1 antagonist	7.69, 3.46	63.65	1.03, 0.26	46.41	54.62	80.85	82.88	99.14	12.60	63.65	60.54	99.33	36.22	41.42	72.78	72.76	95.42	58.83	69.70	70.96	97.18	50.41	90.52	59.75	32.59	40.90	-82.89	66.25	60.75	82.38	86.57	55.59
BRD-K52080565	CP	rilmenidine	adrenergic receptor agonist, imidazoline receptor agonist	NISCH		5.78, 4.00	63.59	1.17, 0.38	57.51	63.59	58.18	46.22	71.67	61.01	48.22	84.70	52.81	92.81	24.29	93.12	2.82	73.66	69.92	0.39	93.48	44.09	82.63	42.90	93.90	69.51	99.86	17.47	55.24	9.32	76.43	88.90	67.56
BRD-A48257147	CP	PHCCC	glutamate receptor agonist, glutamate receptor modulator	GRM1, GRM4		6.94, 4.49	63.57	1.11, 0.30	63.46	83.23	99.89	70.98	42.79	96.09	35.23	72.82	43.21	95.88	24.67	86.97	3.34	56.94	34.92	72.02	94.82	37.07	99.93	86.82	68.52	56.62	20.27	0.00	53.29	89.43	75.89	63.57	39.75
BRD-K88677950	CP	PD-198306	MAP kinase inhibitor, MEK inhibitor	MAP2K1, MAP2K2, MAPK1, MAPK3	MEK inhibitor	8.85, 6.54	63.49	1.14, 0.31	30.83	74.65	40.51	98.87	25.77	63.49	39.66	74.49	79.77	74.38	61.89	66.44	98.34	97.88	38.90	100.00	17.84	91.89	87.37	98.19	34.97	4.66	10.35	-2.66	65.27	63.17	3.94	44.45	89.22
BRD-A63667919	CP	methylergometrine	dopamine receptor antagonist, partial serotonin receptor agonist	DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C		8.08, 3.46	63.48	0.78, 0.28	67.29	41.74	95.32	72.45	90.74	9.53	19.13	89.68	68.84	93.99	65.36	97.57	6.07	11.49	20.92	64.21	20.89	38.96	24.06	89.54	92.19	89.30	26.97	-9.81	63.48	46.30	38.82	86.42	46.84
BRD-A02367930	CP	ethinyl-estradiol	DNA directed DNA polymerase stimunlant, estrogen receptor agonist, estrogenic component in oral contraceptives	CYP2C8, ESR1, ESR2, NR1I2	Estrogen receptor agonist	5.31, 2.04	63.47	1.19, 0.38	99.89	56.95	91.37	39.80	59.42	99.54	-7.65	42.07	79.62	63.47	67.15	79.22	-2.79	18.46	94.00	30.80	75.24	81.05	55.88	95.55	92.53	60.70	51.18	-99.68	-1.55	65.69	69.89	46.57	94.59
BRD-K00234327	CP	RU-24969	serotonin receptor agonist	HTR1A, HTR1B, HTR6, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A		5.00, 2.31	63.46	0.51, 0.15	73.42	71.15	83.03	17.16	70.05	63.46	57.93	34.61	65.93	96.07	57.08	77.23	-6.57	-11.93	66.62	39.02	33.93	41.16	80.55	72.76	91.53	57.58	50.73	-34.44	90.99	40.10	73.47	79.89	63.34
BRD-K21733600	CP	rofecoxib	cyclooxygenase inhibitor	PTGS2, CYP3A4, ELN		5.00, 3.08	63.43	0.57, 0.15	80.28	53.23	52.12	3.77	93.77	18.17	7.60	64.60	59.46	65.23	40.50	66.01	1.83	40.02	79.93	2.18	97.36	17.99	43.04	85.15	83.76	31.79	79.25	70.86	55.63	63.43	78.22	98.83	75.13
BRD-K81729199	CP	AQ-RA741	acetylcholine receptor antagonist			6.15, 3.46	63.41	0.85, 0.20	96.60	67.82	68.17	33.63	29.89	90.83	95.04	63.41	97.52	26.26	78.17	62.48	2.40	11.95	88.54	-2.28	44.58	22.90	67.34	96.33	93.20	27.56	18.51	4.53	55.90	97.89	52.43	90.69	99.07
BRD-K15842202	CP	eudesmic-acid	in touchstone			9.16, 6.87	63.41	1.62, 0.36	12.93	17.96	98.91	55.98	98.70	69.95	77.32	-43.13	93.27	8.07	-79.27	20.29	7.47	50.38	97.12	80.39	70.24	23.79	-24.12	98.45	96.16	87.27	62.16	NaN	-35.52	34.65	89.58	99.89	64.65
BRD-K51302260	CP	KU-C103871	GSP agonist	SMAD3		5.00, 2.69	63.40	1.35, 0.42	97.99	41.00	99.37	49.97	47.43	64.93	45.51	79.63	96.37	45.12	60.25	90.17	58.59	74.97	0.00	86.65	-27.92	55.31	99.86	5.56	6.20	37.05	74.87	15.98	85.97	63.40	89.41	70.82	84.76
BRD-K45401373	CP	betulinic-acid	apoptosis stimulant, caspase activator, diacylglycerol O acyltransferase inhibitor, HIV integrase inhibitor, NFkB pathway activator, NFKB pathway inhibitor, SARS coronavirus 3C-like protease inhibitor, topoisomerase inhibitor	CASP3, CASP8, GPBAR1, TOP1		3.85, 1.54	63.30	0.89, 0.25	14.00	20.77	89.57	75.46	75.16	4.79	93.50	-25.40	23.64	97.35	89.83	61.99	2.78	49.10	63.30	10.57	70.48	70.34	93.43	87.26	76.80	57.70	63.61	12.82	-18.58	53.62	64.51	69.15	29.74
BRD-K10995081	CP	perphenazine	dopamine receptor, dopamine receptor antagonist	DRD2, CALM1, DRD1, HRH1, HTR2A, HTR2C, HTR6, HTR7	Dopamine receptor antagonist	6.54, 3.08	63.27	1.30, 0.53	24.07	30.06	18.30	90.88	20.79	6.39	6.98	84.99	18.26	32.09	19.80	67.57	74.12	91.15	93.39	76.32	72.47	98.11	11.74	68.10	20.59	3.95	4.05	-4.97	99.82	96.96	63.27	73.69	81.55
BRD-K70778732	CP	trazodone	adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor	HTR2A, HTR2C, SLC6A4, ADRA1A, ADRA2A, HRH1, HTR1A, HTR2B		4.23, 2.69	63.24	0.77, 0.15	67.93	17.40	2.11	57.49	44.63	75.74	89.76	69.71	7.59	76.08	92.92	82.78	-0.35	35.57	89.63	15.63	87.74	10.64	90.32	42.98	63.24	46.63	-40.67	17.49	57.62	94.29	90.94	82.59	63.73
BRD-K38251852	CP	paxilline	ABC transporter expression enhancer, high conductance calcium activated potassium blocker, LXR agonist	ABCA1, KCNMA1, NR1H3	Potassium channel blocker	7.76, 4.49	63.22	0.91, 0.25	98.63	72.33	97.78	85.30	45.91	99.86	3.81	38.82	14.03	80.05	20.03	78.86	31.90	58.11	68.65	63.22	97.50	73.87	65.24	47.45	95.00	82.02	53.24	-3.69	28.13	30.17	26.37	6.49	94.79
BRD-K56957086	CP	dacinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	3.08, 0.38	63.17	1.48, 0.63	86.58	97.99	68.33	56.95	40.75	44.83	48.06	30.37	38.73	63.17	82.60	97.39	84.84	87.87	93.38	93.33	73.62	88.67	13.52	62.52	73.69	49.53	93.28	2.47	20.18	59.33	60.42	58.03	91.96
BRD-K19352500	CP	prochlorperazine	dopamine receptor antagonist, dopamine receptor	DRD2, DRD1, DRD3, DRD4	Dopamine receptor antagonist	5.77, 2.69	63.12	0.93, 0.16	30.01	31.11	87.09	66.76	91.60	42.81	10.30	-39.25	17.92	29.53	26.29	83.40	63.16	69.52	97.99	69.77	96.55	91.21	-34.66	60.42	63.12	85.80	47.14	21.19	80.48	12.28	58.92	78.48	70.82
BRD-A81772229	CP	simvastatin	HMGCR inhibitor	HMGCR, CYP2C8, CYP3A4, CYP3A5, ITGB2	HMGCR inhibitor	5.71, 2.86	63.09	2.36, 0.61	96.32	84.97	78.31	97.50	58.93	63.09	44.40	-12.44	59.62	22.59	71.01	78.75	86.30	98.56	71.96	87.57	81.87	96.26	10.68	65.83	34.43	44.96	41.27	-53.82	61.79	50.51	42.40	83.75	11.69
BRD-K49448285	CP	bisindolylmaleimide	CDK inhibitor, PKC inhibitor, leucine rich repeat kinase inhibitor	CCND1, CDK4, LRRK2, PDPK1, PIM1, PRKCA, PRKCB, PRKCI, PRKCZ	PKC inhibitor	2.45, 0.82	63.07	0.73, 0.14	58.23	56.11	58.28	88.87	61.30	68.38	9.45	82.06	24.35	11.29	79.67	80.09	80.92	69.12	66.26	98.84	88.99	73.13	52.30	16.22	8.84	84.05	63.07	-95.78	25.88	91.21	62.39	31.83	76.33
BRD-K29173907	CP	isoflupredone	glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	2.69, 1.92	63.05	1.57, 0.72	84.78	92.98	75.19	58.43	75.49	25.70	54.94	63.05	58.44	67.32	74.62	72.79	0.00	77.61	-28.02	76.49	28.56	18.11	27.06	91.76	82.00	84.59	41.00	-70.72	8.00	97.74	5.52	91.56	58.94
BRD-A67748489	CP	K3644	Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors, mitotic kinesin inhibitor	KIF11		4.62, 1.54	63.02	1.23, 0.36	44.20	23.72	87.87	14.76	86.96	7.61	61.72	83.26	11.60	44.10	78.55	96.37	0.00	1.34	97.46	12.82	90.64	63.02	99.51	64.69	71.07	81.87	62.97	89.38	29.44	53.83	81.26	28.57	94.33
BRD-K04548931	CP	pidorubicine	topoisomerase inhibitor, DNA intercalating drug	TOP2A	Topoisomerase inhibitor	8.85, 4.62	62.97	2.40, 0.72	1.87	99.51	85.80	2.08	98.77	94.87	76.64	-91.80	57.15	91.29	60.29	96.78	2.33	69.92	90.38	99.20	31.15	66.53	37.98	70.49	94.46	62.97	26.41	-31.16	-73.11	1.20	62.92	47.23	85.39
BRD-K66782112	CP	BRD-K66782112	histamine receptor antagonist	HRH2		6.15, 1.54	62.92	1.41, 0.41	44.52	61.99	84.49	65.45	92.76	-30.18	62.92	29.09	96.65	0.74	92.28	70.33	2.22	1.90	85.47	-92.74	30.54	16.18	21.32	98.41	96.66	96.37	69.35	8.39	-24.65	87.32	86.87	96.46	40.15
BRD-K25310650	CP	ormetoprim	antibiotic			5.33, 4.00	62.91	1.85, 0.74	28.95	51.59	13.19	71.92	16.49	62.91	84.70	80.92	65.59	99.65	91.55	97.50	17.96	34.23	62.05	78.79	12.29	85.89	86.36	65.10	48.11	56.05	97.55	-0.70	52.72	90.29	93.10	60.58	60.96
BRD-K39983086	CP	loteprednol	corticosteroid agonist, phospholipase inhibitor	NR3C1	Glucocorticoid receptor agonist	6.67, 3.11	62.84	1.67, 0.61	89.68	32.40	59.38	78.67	0.32	62.84	96.25	57.32	80.55	67.28	76.82	98.10	78.78	74.93	52.38	94.30	28.63	11.81	19.95	90.45	-15.19	8.42	99.65	5.91	57.26	96.89	86.18	16.73	26.81
BRD-K49372556	CP	mofezolac	cyclooxygenase inhibitor, cytochrome P450 inhibitor, platelet aggregation inhibitor			7.35, 4.49	62.78	1.19, 0.30	89.09	95.56	62.99	54.20	89.99	0.03	11.33	-27.76	13.96	99.67	16.13	91.54	11.39	17.73	99.30	70.05	98.06	32.47	30.74	58.83	81.50	62.78	90.67	64.35	-1.16	64.26	90.36	33.52	19.48
BRD-K82147103	CP	lofepramine	adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant	SLC6A2, SLC6A4		6.67, 3.56	62.76	1.72, 0.57	43.83	29.76	67.27	62.76	87.38	27.14	14.36	-5.57	8.61	94.19	40.99	98.48	12.46	63.12	85.47	40.37	99.00	82.25	41.25	90.78	52.88	96.90	94.70	62.21	71.95	68.10	92.67	17.36	24.86
BRD-A31801025	CP	formestane	aromatase inhibitor	CYP19A1	Aromatase inhibitor	4.62, 1.54	62.71	0.95, 0.25	95.83	91.10	49.63	84.28	85.42	76.76	42.50	62.71	60.33	56.25	26.65	78.76	5.92	30.39	69.58	9.99	45.45	64.90	73.37	66.40	70.94	27.60	76.71	-35.45	11.15	41.98	48.47	82.99	75.50
BRD-A10420615	CP	cyclopiazonic-acid	ATPase inhibitor	ATP2A1	ATPase inhibitor	7.31, 2.69	62.65	1.99, 0.56	64.07	44.71	90.97	95.82	1.30	32.05	17.12	73.03	28.34	25.17	26.82	80.78	95.66	26.31	49.65	99.30	89.89	84.00	22.91	80.14	62.65	63.29	28.77	2.78	95.88	24.07	43.69	67.69	72.61
BRD-A31195449	CP	TCB2	serotonin receptor agonist	HTR2A		9.62, 5.00	62.63	1.26, 0.40	92.46	96.63	29.20	16.98	99.75	94.29	16.67	34.24	12.68	98.17	3.91	62.40	1.06	13.06	85.75	7.44	95.43	29.62	98.51	99.33	88.87	53.87	85.58	48.47	62.63	99.05	64.43	98.84	18.83
BRD-A54845972	CP	dihydroergotamine	serotonin receptor agonist, adrenergic receptor partial agonist, dopamine receptor agonist	HTR1D, HTR1B, ADRA2A, DRD2, HTR1E, HTR1F, HTR2B, HTR7		5.71, 2.45	62.62	1.47, 0.50	99.89	25.50	79.35	19.03	8.13	62.62	7.61	73.90	44.92	39.28	32.38	73.18	74.50	70.80	94.29	73.04	49.14	86.72	96.16	68.18	33.41	28.03	74.83	89.71	83.89	48.82	20.80	36.56	6.86
BRD-K15916496	CP	clotrimazole	cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor	KCNN4, CYP3A4, CYP51A1, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8		6.22, 4.00	62.61	1.44, 0.69	99.12	56.36	65.74	62.61	16.12	86.51	30.92	80.68	8.55	37.49	55.29	89.62	74.75	73.22	63.57	99.09	8.41	22.99	98.43	18.53	8.98	43.82	98.66	23.16	70.67	98.58	66.99	60.57	-0.21
BRD-K89708791	CP	rifaximin	50S ribosomal subunit inhibitor, DNA directed DNA polymerase inhibitor, PXR agonist, RNA synthesis inhibitor	NR1I2, CYP3A4		6.67, 4.44	62.53	1.88, 0.56	83.79	8.81	12.78	6.07	62.53	74.53	91.97	95.36	83.13	65.86	98.06	74.92	0.11	27.29	2.10	-5.37	-21.00	6.45	99.61	0.81	-44.09	-5.77	86.66	9.95	81.78	92.04	76.77	6.73	64.13
BRD-K96144918	CP	mead-acid	KPL-1 tumor suppressor			6.54, 3.46	62.51	1.18, 0.35	40.53	11.20	95.77	37.00	24.18	74.84	98.98	74.16	76.64	62.51	60.01	13.55	-4.44	26.52	47.33	-0.46	67.12	47.45	99.30	95.13	66.66	98.31	15.09	0.00	94.99	75.57	35.27	97.10	83.38
BRD-A21858158	CP	praziquantel	membrane permeability enhancer, schistosomicide			4.23, 1.54	62.50	0.72, 0.16	18.68	74.67	97.40	24.87	90.03	68.90	10.33	25.35	34.24	14.06	93.16	82.33	0.00	18.31	69.65	21.35	80.07	48.79	75.85	37.95	74.20	83.45	14.11	-95.87	62.50	12.35	66.84	73.05	97.57
BRD-K10136726	CP	tosyllysyl-chloromethyl-ketone	chymotrypsin inhibitor			9.62, 4.62	62.44	0.97, 0.38	68.17	62.38	96.34	16.69	46.56	25.75	42.19	39.10	94.32	22.24	99.68	62.44	1.77	46.47	86.86	33.26	63.33	48.18	92.97	98.34	86.77	97.47	74.96	65.96	19.20	96.99	31.68	95.93	30.67
BRD-K23383398	CP	T-0901317	LXR agonist, ABC transporter expression enhancer, ROR inverse agonist	NR1H3, NR1H2, ABCA1, NCOA1, NCOA2, NR1I2, RORA, RORC, RXRB		8.08, 4.23	62.35	0.77, 0.18	34.10	39.64	97.60	89.35	79.43	99.58	-11.01	95.84	10.05	44.47	48.00	31.97	45.13	51.15	96.18	92.49	94.99	83.47	12.73	92.05	68.56	74.91	62.35	11.55	14.86	41.32	30.92	94.51	96.75
BRD-K18059238	CP	gamma-linolenic-acid	cyclooxygenase inhibitor, prostanoid receptor stimulant, thromboxane synthase stimulant	TBXAS1		8.46, 4.62	62.33	1.66, 0.52	13.11	96.55	82.63	23.56	98.27	19.27	73.43	-83.69	70.63	80.79	99.54	89.32	0.00	24.19	42.96	94.31	62.33	88.34	49.90	32.75	93.86	98.13	76.93	-20.78	-14.66	-6.03	21.90	76.96	26.55
BRD-K97181089	CP	amiloride	sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor	SCNN1A, ASIC1, ASIC2, SCNN1B, SCNN1G, AOC1, ASIC3, PKD2, PKD2L1, PLAU, SCNN1D, SLC9A1, TRPC7, TRPV2		6.15, 3.85	62.32	0.32, 0.06	72.68	43.02	56.26	12.80	60.07	72.81	92.68	83.40	88.53	57.75	31.04	82.72	-36.44	-1.73	62.32	0.67	65.55	29.58	65.82	69.40	36.82	30.84	85.12	-23.12	14.85	73.75	64.47	79.50	74.20
BRD-K50135270	CP	GBR-12935	dopamine uptake inhibitor	AGTR1, SLC6A3		6.54, 2.69	62.31	1.25, 0.36	92.58	52.68	49.54	74.13	99.50	76.26	14.69	66.17	77.20	8.69	16.15	61.62	4.86	74.38	43.41	51.04	91.31	92.48	20.22	93.69	74.42	97.01	22.13	0.85	23.76	62.31	37.26	98.55	87.12
BRD-K37206356	CP	rhamnetin	aldose reductase inhibitor, JNK inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, p38 MAPK inhibitor	ALOX5, MAPK8		6.15, 3.85	62.29	0.80, 0.28	19.96	87.04	89.96	84.28	99.93	26.34	30.58	55.68	43.51	92.11	59.87	62.29	50.87	87.28	89.66	98.69	80.55	19.58	19.24	58.82	93.47	83.14	49.97	0.35	16.43	96.17	94.19	95.94	32.06
BRD-K63550407	CP	erythromycin	NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor	CYP3A4, MLNR		5.00, 1.92	62.29	1.20, 0.44	92.34	57.12	74.41	72.51	57.69	15.95	62.29	77.20	79.27	66.51	64.95	92.40	14.54	27.82	46.63	59.11	87.18	12.32	39.09	96.99	47.10	44.16	29.50	-98.29	69.15	77.47	37.36	88.90	77.36
BRD-A09056319	CP	alfuzosin	adrenergic receptor antagonist	ADRA1A, ADRA1D, ADRA1B, KCNH2		5.00, 1.54	62.18	0.57, 0.11	74.38	64.38	59.24	30.67	48.00	32.87	62.18	90.99	54.64	63.44	45.28	72.28	2.11	4.11	97.04	8.90	96.46	37.69	63.74	72.85	46.82	82.26	64.83	-22.90	74.59	47.24	89.23	72.14	61.05
BRD-K32744045	CP	disulfiram	aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist	ALDH2, ALDH1A2, ALDH5A1, ALDH7A1, CYP2E1, DBH, DNMT1, TRPA1		7.11, 2.22	62.18	1.80, 0.52	13.82	95.43	18.58	75.39	78.71	-7.74	95.83	77.63	22.84	87.04	91.88	59.93	88.49	79.17	8.60	99.54	5.26	53.96	62.18	45.52	35.59	15.37	80.68	-1.83	15.13	77.54	55.72	95.40	89.81
BRD-K68143200	CP	SA-792541	caspase activator, CDC inhibitor	CASP3, CDC25A, CDC25B		5.00, 1.92	62.16	0.84, 0.23	61.43	89.56	98.06	53.49	93.45	27.07	8.56	62.16	79.16	27.46	36.13	34.23	84.02	83.96	58.80	99.54	72.23	32.25	15.91	78.77	94.33	75.43	20.55	7.33	80.36	4.17	11.25	83.62	92.28
BRD-K94649603	CP	taxifolin	apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor	APOB, APP, HMGCR		5.78, 2.22	62.16	2.00, 0.70	82.41	65.58	41.55	26.41	27.36	44.49	80.34	95.08	57.06	88.78	94.47	78.65	73.00	24.39	-21.67	91.36	30.79	21.22	62.16	27.49	76.21	24.74	91.31	-2.91	41.90	96.55	90.11	43.92	98.48
BRD-A47633927	CP	NPC-15199	ICAM 1 antagonist, increases intracellular calcium levels	ICAM1, PPARG		3.85, 0.77	62.12	0.97, 0.19	62.12	11.03	76.31	74.25	-1.16	9.08	87.44	70.54	16.78	20.39	11.47	64.51	1.37	7.71	76.08	4.73	69.12	9.55	49.13	92.26	35.20	94.39	72.59	93.42	77.14	77.90	48.00	95.63	19.93
BRD-A94543220	CP	bifonazole	cell wall synthesis inhibitor, sterol demethylase inhibitor	CYP2B6		9.33, 3.56	62.12	1.10, 0.36	58.17	62.11	62.12	57.56	52.96	62.86	9.85	-46.63	30.20	97.41	71.96	98.56	0.11	71.54	86.48	37.76	96.76	57.57	97.65	80.29	84.18	43.56	71.26	82.80	56.25	41.31	86.85	79.43	4.45
BRD-K09537769	CP	NU-7026	DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	PRKDC	DNA dependent protein kinase inhibitor, MTOR inhibitor, PI3K inhibitor	5.00, 2.69	62.10	1.02, 0.35	58.01	80.99	76.29	88.32	98.66	62.10	30.64	46.19	17.34	39.23	89.54	70.77	3.17	17.93	50.24	62.83	92.99	79.49	84.63	32.88	93.28	64.91	49.28	-76.23	1.37	11.60	38.53	89.85	77.94
BRD-K85090592	CP	pilocarpine	acetylcholine receptor agonist	CHRM3, CHRM1, CHRM2, CHRM4, CHRM5		10.22, 7.11	62.09	1.15, 0.33	11.92	87.55	82.67	16.87	96.16	77.13	35.76	50.07	13.88	99.89	8.86	93.43	5.61	4.03	75.01	83.85	99.61	62.09	25.09	48.94	76.67	46.20	62.23	86.51	53.34	37.65	82.77	89.16	55.26
BRD-K19227686	CP	phenolphthalein	weak acid used as a pH indicator			4.23, 2.31	61.96	1.25, 0.52	51.10	86.27	97.50	46.84	63.54	90.65	24.66	-19.28	67.70	65.18	83.24	85.85	11.94	1.20	97.33	55.56	95.38	44.24	-18.60	36.01	87.19	61.96	82.89	-32.76	-27.74	21.96	69.12	41.39	96.51
BRD-K39391626	CP	ethylestrenol	anabolic steroid, has some progesterone-like activity	AR	Progesterone receptor agonist, Progesterone receptor antagonist	8.44, 5.78	61.96	1.59, 0.70	4.16	94.68	27.78	70.96	70.96	73.39	5.53	56.97	10.14	99.82	57.88	99.79	65.96	61.96	69.40	96.49	52.02	55.09	95.58	66.71	87.82	55.38	98.73	-12.13	17.56	45.48	83.72	48.20	11.32
BRD-K18523449	CP	mestanolone	androgenic steroid		Androgen receptor modulator	7.11, 3.56	61.87	1.38, 0.44	12.18	79.14	65.76	37.81	1.66	48.91	43.96	62.11	-17.12	98.78	61.87	73.90	84.11	40.77	11.61	96.38	66.58	27.30	92.37	14.01	52.27	62.48	99.79	-0.88	98.46	49.58	95.26	25.32	87.31
BRD-A04553218	CP	chlorphenamine	histamine receptor antagonist	HRH1, SLC6A2, SLC6A3, SLC6A4		3.08, 1.54	61.84	0.41, 0.08	82.48	75.02	71.15	36.82	61.37	48.88	64.84	28.90	86.69	35.33	72.16	84.26	28.56	45.16	97.90	53.34	82.83	48.95	58.70	68.01	80.73	61.84	66.58	64.21	5.65	28.07	51.67	88.72	11.68
BRD-K76617868	CP	fasudil	ROCK inhibitor, calcium sensitizer, PKA inhibitor, protein kinase inhibitor, rho associated kinase inhibitor	ROCK1, ROCK2, PKIA, PRKACA	PKA inhibitor, Rho associated kinase inhibitor	4.62, 2.31	61.80	0.91, 0.25	39.52	86.07	93.65	3.60	81.36	8.49	83.82	19.84	24.10	84.00	30.17	69.18	0.00	6.64	84.32	6.09	61.80	45.97	93.77	77.09	91.42	83.45	26.85	1.30	90.91	25.76	26.39	71.37	82.05
BRD-A71203467	CP	l-stepholidine	dopamine receptor antagonist, dopamine receptor agonist	DRD2, DRD1		4.49, 2.45	61.73	1.03, 0.30	37.95	28.79	97.21	36.90	22.19	69.46	86.71	78.02	62.05	35.97	90.91	96.98	4.26	28.65	98.61	4.83	49.25	21.72	95.58	65.14	17.43	93.67	61.73	-3.31	9.19	91.19	90.33	63.74	57.16
BRD-A24122750	CP	saclofen	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	GABA receptor antagonist	5.00, 2.69	61.72	0.99, 0.32	61.72	30.04	48.56	20.25	71.67	98.10	19.14	80.83	75.83	73.40	10.02	55.70	-2.01	26.24	78.57	15.37	24.10	34.24	97.74	93.25	55.89	97.18	84.51	51.24	14.06	96.37	64.83	98.45	88.60
BRD-K14965640	CP	ibuprofen	cyclooxygenase inhibitor, NFkB pathway inhibitor	PTGS2, PTGS1, ASIC1, BCL2, CFTR, CYP2C8, FABP2, PLAT, PPARG, SLC5A8, THBD		6.54, 3.46	61.56	0.76, 0.26	65.87	2.01	37.78	6.57	48.65	69.36	88.62	86.60	22.50	94.13	29.72	20.00	4.19	6.41	86.21	4.14	96.71	67.06	83.91	61.56	58.99	99.72	12.94	97.94	46.56	79.34	43.88	61.91	68.36
BRD-K16195444	CP	oxymetazoline	adrenergic receptor agonist, unidentified pharmacological activity	ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C, CYP2C19, HTR1B, HTR1D, HTR2C		3.46, 1.54	61.53	1.47, 0.35	64.11	55.74	61.53	26.60	77.84	92.25	0.99	66.26	45.19	37.47	-24.71	66.80	0.00	14.81	51.38	7.11	49.22	78.44	15.33	95.54	83.96	97.58	69.80	98.91	63.32	38.36	13.17	85.80	93.89
BRD-K81209159	CP	herniarin	acetylcholinesterase inhibitor	ACHE, CA1, CA12, CA14, CA4, CA6, CA9		3.85, 2.69	61.45	1.57, 0.36	79.43	96.51	98.91	31.00	83.26	3.29	17.80	65.48	91.94	37.96	63.48	63.09	0.00	3.17	63.94	15.27	90.63	34.95	-17.26	54.82	98.34	49.16	61.45	-99.19	86.76	18.10	58.94	73.35	86.78
BRD-K47780086	CP	penciclovir	DNA directed DNA polymerase inhibitor			10.67, 6.22	61.41	1.18, 0.31	80.86	93.19	39.01	40.86	65.73	78.01	45.82	42.15	54.79	61.41	62.37	96.90	8.19	27.80	99.82	21.41	99.68	73.13	-18.83	82.63	69.72	26.46	66.97	-83.02	-37.32	98.19	66.17	35.95	44.85
BRD-A57382968	CP	piroxicam	cyclooxygenase inhibitor	PTGS2, PTGS1		6.92, 3.85	61.38	0.58, 0.16	40.69	76.16	62.41	17.20	80.84	98.11	12.87	61.38	50.20	30.65	77.77	94.99	-1.55	30.23	80.96	24.45	68.10	9.34	59.63	34.98	87.01	57.82	84.52	-55.88	49.98	63.29	74.31	77.57	85.22
BRD-K29905972	CP	axitinib	VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist	KDR, FLT1, FLT4, CSF1, CYP2C19, CYP3A5, KIT, PDGFRB, PLK4	VEGFR inhibitor	2.31, 1.15	61.34	0.99, 0.20	98.68	79.97	28.29	85.97	55.61	81.60	47.49	75.79	82.20	83.57	81.85	66.50	-2.92	53.54	61.34	0.67	94.14	19.52	96.45	27.73	-43.53	56.06	65.19	-19.00	72.61	30.07	54.03	47.90	71.22
BRD-K80315159	CP	DPPE	histamine receptor antagonist	ABCB1, HRH1		8.08, 3.08	61.26	0.92, 0.18	89.53	14.29	64.10	74.65	35.43	27.75	31.88	52.49	50.61	75.80	61.26	39.25	10.61	4.83	41.11	2.50	84.98	91.56	12.20	99.30	65.37	96.17	22.57	95.40	97.36	71.23	30.58	76.42	97.09
BRD-K02227374	CP	milnacipran	serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B		12.44, 6.22	61.24	1.49, 0.43	25.08	48.28	29.85	57.47	86.74	59.69	85.51	51.49	8.35	99.67	61.85	98.27	42.48	61.24	77.71	93.26	98.90	58.39	90.31	48.60	62.50	49.87	98.31	1.26	24.46	92.87	98.31	87.19	35.70
BRD-K45158365	CP	valsartan	angiotensin receptor antagonist	AGTR1		3.85, 1.54	61.21	0.73, 0.22	44.09	50.14	58.97	32.77	74.82	33.44	73.43	89.56	54.97	80.59	87.93	94.39	25.07	6.82	34.68	-3.03	96.55	33.78	76.79	66.45	27.79	74.46	61.21	13.79	39.55	78.17	84.59	69.39	70.53
BRD-K73999723	CP	telmisartan	angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist	AGTR1, PPARG, CYP2C19, CYP2J2, PPARA		5.00, 2.31	61.20	0.75, 0.19	46.85	84.33	87.49	21.70	91.36	32.78	19.25	65.89	98.80	32.37	60.38	76.24	11.18	42.72	89.73	91.85	75.82	10.43	82.52	98.11	89.54	34.79	25.21	-62.25	40.66	81.31	31.74	77.94	61.20
BRD-K67637637	CP	olopatadine	histamine receptor antagonist, histamine blocker, mediator release inhibitor	HRH1, S100A1, S100A12, S100A13, S100A2, S100B		8.08, 4.62	61.18	1.86, 0.53	10.38	79.75	97.38	34.51	79.83	64.38	26.36	70.67	41.35	99.89	84.05	52.13	5.04	67.82	-48.40	34.99	88.80	75.45	44.51	23.42	99.93	38.12	61.91	-93.00	61.18	34.69	58.84	69.09	75.37
BRD-A06784547	CP	MRS-1334	adenosine receptor antagonist			7.69, 4.23	61.10	0.56, 0.14	98.03	23.49	91.67	57.22	61.10	63.62	69.25	86.02	38.53	54.07	64.71	70.00	11.30	32.56	14.06	9.41	69.48	39.10	81.00	54.35	40.47	97.92	29.24	58.64	66.14	85.74	20.56	96.69	87.80
BRD-A82590476	CP	SDZ-NKT-343	tachykinin antagonist	TACR1	Tachykinin antagonist	5.00, 2.31	61.09	0.82, 0.22	67.20	-39.83	41.04	81.24	72.55	17.78	-10.37	49.80	14.39	6.28	34.06	61.09	76.17	65.92	90.30	96.80	91.75	91.61	-10.22	93.47	69.19	32.50	6.76	91.98	91.09	40.25	89.53	35.14	36.67
BRD-A30205217	CP	ethotoin	anticonvulsant	SCN5A		6.94, 4.08	61.04	1.16, 0.38	97.75	25.86	89.49	53.87	93.38	84.53	8.67	33.84	23.80	74.47	35.70	85.15	22.38	27.55	93.89	-1.90	99.12	67.14	47.11	71.44	82.91	89.41	61.04	4.55	-14.81	33.14	74.85	47.88	81.71
BRD-A62021152	CP	WAY-161503	serotonin receptor agonist	HTR2C		5.71, 2.86	61.01	1.43, 0.45	61.01	26.93	93.53	28.71	66.26	86.84	40.01	11.06	48.22	95.69	46.16	62.16	-10.09	58.34	84.92	16.30	94.13	28.42	99.65	41.98	82.50	84.29	15.06	0.85	45.79	99.58	84.82	90.87	70.19
BRD-K96809896	CP	SKF-86002	p38 MAPK inhibitor	ALOX5, MAPK14	P38 MAPK inhibitor	2.31, 0.77	60.98	1.01, 0.36	16.80	94.96	77.01	79.69	96.87	50.79	12.01	73.97	60.58	22.45	17.63	85.18	25.37	60.98	41.06	75.64	33.85	21.21	-20.03	75.80	82.99	93.85	60.07	-92.45	18.17	68.80	94.40	86.94	69.65
BRD-K28667793	CP	pyrazinamide	fatty acid synthase inhibitor	FASN		6.12, 4.08	60.94	1.74, 0.56	14.47	38.48	91.87	52.34	58.74	64.82	29.06	83.43	60.94	86.12	99.92	89.25	-10.61	-0.42	82.52	0.00	70.06	7.93	65.38	52.59	61.57	0.00	64.58	50.35	39.62	99.93	22.81	67.95	79.14
BRD-K89402695	CP	L-655240	platelet aggregation inhibitor, prostanoid receptor antagonist, thromboxane receptor antagonist	PTGES	Thromboxane receptor antagonist	6.15, 3.08	60.77	0.91, 0.27	26.27	80.25	93.18	34.53	98.99	10.18	50.16	60.77	95.65	98.87	59.67	86.19	9.96	50.09	34.05	74.69	93.90	44.70	60.37	72.90	96.90	92.97	57.27	-6.45	61.25	-53.30	52.11	79.82	69.21
BRD-K06426971	CP	ryuvidine	histone lyinse methyltransferase inhibitor	CDK4, CDK2		3.46, 1.54	60.75	1.86, 0.38	10.33	97.41	84.53	85.00	87.74	43.00	52.71	31.94	75.30	9.20	64.37	74.30	93.53	85.04	-69.76	99.61	-0.95	60.75	21.34	78.00	70.32	38.26	13.83	-99.05	0.56	26.05	69.58	89.88	36.09
BRD-K88868628	CP	iodoacetic-acid	cysteine peptidase inhibitor			6.94, 4.49	60.73	1.67, 0.34	71.32	79.25	35.07	65.15	98.70	11.54	28.17	54.18	27.73	13.80	4.62	64.57	93.02	87.21	-49.06	97.71	60.73	82.10	45.12	44.05	80.56	23.97	90.86	-12.33	55.87	87.36	79.65	68.21	5.85
BRD-K04412738	CP	tramadol	opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor	OPRM1, SLC6A2, SLC6A4, CHRFAM7A, CHRM3, CYP2B6, GRIN3A, HTR2C, OPRD1, OPRK1		7.69, 3.85	60.72	1.77, 0.44	66.96	86.73	99.58	50.71	91.28	50.65	16.56	70.80	22.57	99.72	57.85	78.93	0.00	34.19	63.88	13.16	96.45	53.20	34.18	39.27	99.89	71.70	60.72	-93.89	84.65	1.06	38.22	84.45	91.53
BRD-K40902647	CP	vincamine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		10.38, 4.62	60.69	0.98, 0.38	32.90	84.37	95.95	32.22	97.78	33.53	83.79	81.05	60.69	76.80	48.26	92.34	17.08	17.72	59.79	53.56	96.06	17.62	98.21	98.38	49.65	95.37	55.55	44.22	52.07	84.92	21.91	84.98	95.60
BRD-K73991644	CP	isoquercetin	aldose reductase inhibitor, falcipain inhibitor	AKR1B1, ACE		4.89, 4.00	60.68	1.64, 0.66	21.93	83.77	80.43	78.35	75.71	-3.92	-6.27	83.75	44.02	97.99	88.43	87.67	77.72	69.46	21.25	50.92	57.73	11.21	68.56	11.16	45.37	6.03	99.12	0.00	1.79	74.60	86.22	53.47	60.68
BRD-K88429204	CP	pyrimethamine	dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor	DHFR, DHFRP1, HEXA, SLC47A1, STAT3	Dihydrofolate reductase inhibitor	3.85, 1.92	60.67	0.51, 0.06	61.50	7.79	36.28	60.67	8.15	83.35	66.44	65.39	9.57	72.17	53.44	65.77	27.99	23.91	84.40	94.73	85.38	29.14	53.21	70.83	34.47	66.16	21.39	15.12	71.59	98.50	37.72	77.66	4.81
BRD-A73680854	CP	PT-630	dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor	DPP4, FAP		5.38, 1.54	60.63	1.68, 0.49	73.65	-27.16	1.62	7.87	-15.93	61.60	92.50	88.63	53.21	23.32	14.53	16.01	-77.35	0.63	98.06	-71.92	85.15	2.33	72.02	88.13	27.23	63.22	74.81	99.58	63.24	95.23	58.83	60.63	74.25
BRD-K67578145	CP	GDC-0879	RAF inhibitor	BRAF	RAF inhibitor	5.00, 1.92	60.63	1.20, 0.40	49.18	86.00	27.96	25.42	60.63	33.54	8.02	32.12	6.20	75.71	20.99	41.65	81.23	78.31	75.83	99.58	80.56	48.17	19.44	82.39	89.08	73.33	25.77	78.16	61.63	41.30	65.63	41.84	66.01
BRD-K60511616	CP	pravastatin	HMGCR inhibitor	HMGCR, SLCO1B1		4.62, 3.46	60.57	0.49, 0.17	31.71	12.74	41.71	20.39	73.62	7.00	73.14	89.45	84.62	28.65	45.12	73.58	1.20	29.22	90.34	8.08	79.03	68.41	17.17	70.36	79.28	82.11	19.30	0.03	57.63	60.57	86.53	77.25	75.83
BRD-A72758037	CP	asiatic-acid	antioxidant and antiinflammatory agent	PYGM		5.38, 2.31	60.56	0.67, 0.16	99.03	38.65	85.43	14.11	90.19	54.38	4.34	51.38	73.74	12.75	14.33	69.52	3.95	16.30	82.28	44.04	-38.61	13.93	82.46	99.61	69.45	66.40	62.50	86.34	60.56	72.35	11.57	97.85	24.42
BRD-K14221570	CP	benzopurpurin-4b	binds HIV gp120 and inhibits HIV-1 entry into the neural cell line SK-N-MC			5.00, 3.08	60.55	1.14, 0.40	21.69	60.55	92.62	11.87	91.00	80.33	54.32	25.50	5.78	67.27	58.87	88.21	-3.53	40.25	65.93	7.45	93.91	53.21	76.45	69.27	93.79	80.29	25.60	69.83	49.30	36.33	28.20	87.03	81.87
BRD-A52660433	CP	tetrindole	monoamine oxidase inhibitor	MAOA		9.39, 6.53	60.53	1.74, 0.63	15.16	24.22	82.55	89.05	76.08	43.95	51.87	70.19	60.53	68.12	26.28	62.54	93.38	99.82	-46.85	99.93	48.46	99.93	92.44	13.79	67.56	16.95	8.80	44.77	99.86	87.49	39.00	21.31	34.74
BRD-K13261168	CP	LY-16350	dopamine receptor agonist, dopamine receptor antagonist	DRD2, DRD3		3.85, 2.31	60.53	1.34, 0.36	49.34	94.09	95.04	60.81	92.02	36.19	7.43	-65.88	14.46	83.07	93.88	62.82	5.61	55.72	94.04	25.42	92.15	60.53	30.89	56.25	93.25	98.87	61.55	0.00	0.53	83.97	47.20	81.90	42.43
BRD-K90976994	CP	dehydrocholic-acid	gastrointestinal agent that stimulates bile production or the flow of bile into the duodenum			5.00, 1.54	60.49	1.48, 0.41	92.71	97.43	83.41	28.13	78.60	71.97	91.08	34.68	9.58	91.05	86.19	87.79	9.04	28.52	49.92	22.97	21.41	68.25	14.62	60.49	92.69	41.46	69.09	-98.34	36.25	26.16	58.58	95.42	61.56
BRD-K48300629	CP	zonisamide	GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker	CA1, CA12, CA7, SCN1A, CA10, CA11, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN11A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN9A		4.08, 2.45	60.47	0.80, 0.19	97.45	68.85	86.14	60.47	22.95	98.13	19.82	83.99	40.94	93.55	80.89	65.64	6.18	34.16	56.95	-2.50	76.48	10.67	45.33	64.39	43.39	-25.59	68.13	-48.52	72.04	36.12	40.31	71.44	68.77
BRD-K51541829	CP	RO-25-6981	ionotropic glutamate receptor antagonist, monamine transporter modulator	GRIN2B, SLC18A2		6.53, 3.27	60.29	1.07, 0.26	60.29	56.10	96.65	51.80	83.23	87.91	54.14	47.29	88.67	87.48	13.73	90.86	8.72	32.96	46.28	73.61	97.71	76.95	94.06	29.67	97.38	75.69	61.77	-65.01	14.76	48.88	22.46	96.23	49.75
BRD-K15868788	CP	SDZ-205-557	serotonin receptor antagonist	HTR3A, HTR3B, HTR4		3.85, 1.15	60.26	0.76, 0.10	38.72	94.19	53.52	7.96	83.40	29.25	63.57	66.39	87.77	51.88	83.00	92.95	12.22	22.40	60.26	2.68	90.10	13.15	96.13	56.49	69.61	87.60	58.29	4.23	64.65	83.88	26.23	42.26	89.83
BRD-K71266197	CP	PSB-06126	NTPDase inhibitor	ENTPD3		2.69, 1.15	60.22	0.70, 0.15	82.02	92.31	64.34	49.62	95.15	59.97	60.22	49.52	79.76	32.48	55.26	92.65	5.78	4.23	86.97	27.96	85.19	12.32	81.53	31.60	85.26	93.73	79.79	-97.11	-12.99	90.45	67.07	50.33	50.69
BRD-K78126613	CP	menadione	CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor	AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PKM, PROC, PROS1, PROZ, VKORC1, VKORC1L1		3.46, 0.77	60.22	2.21, 0.41	68.67	36.50	89.25	69.66	60.22	9.01	-32.82	38.08	42.11	23.27	15.28	81.97	87.37	93.83	93.51	99.79	83.43	59.65	48.27	65.59	54.82	62.86	69.31	97.04	54.71	26.42	48.38	67.22	21.45
BRD-K12357156	CP	AG-490	epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor	JAK2, JAK3, EGFR, STAT3		2.69, 2.31	60.21	1.31, 0.45	67.53	65.77	34.35	61.47	60.21	55.79	-15.47	-25.30	9.47	24.36	5.10	79.71	45.00	70.18	67.19	91.13	78.88	70.46	14.77	68.75	37.34	63.46	15.99	14.69	28.95	78.11	30.85	97.67	93.93
BRD-K87510569	CP	RS-504393	CC chemokine receptor antagonist	CCR2, CCL2		6.15, 3.08	60.18	1.22, 0.15	11.45	-51.95	8.52	78.45	39.56	81.42	54.21	56.87	75.25	-39.45	-54.89	63.66	71.11	60.18	85.39	98.52	66.63	90.35	-39.84	94.26	20.33	17.61	78.59	99.51	95.87	-4.23	68.57	42.34	51.55
BRD-A75935363	CP	atracurium	acetylcholine receptor antagonist	CHRNA2		6.22, 2.22	60.11	1.17, 0.34	22.87	78.02	76.53	39.87	82.30	24.82	46.16	97.08	83.41	40.67	63.21	60.11	29.60	61.84	39.55	-27.33	64.69	63.67	0.67	-47.06	94.28	46.36	81.25	-99.51	74.48	38.97	94.72	26.22	87.34
BRD-K36965586	CP	m-chlorophenylbiguanide	serotonin receptor agonist	HTR3A, HTR3B		6.92, 5.00	60.11	1.09, 0.35	53.34	-57.69	8.56	7.11	75.35	85.15	50.15	83.27	38.20	90.41	5.95	63.15	0.00	22.01	94.81	-4.67	91.64	22.71	88.26	99.68	75.19	99.12	11.55	0.00	89.93	72.21	29.28	87.55	60.11
BRD-A73859745	CP	glycodeoxycholic-acid	apoptosis activator			5.31, 1.63	60.10	0.91, 0.24	67.60	60.10	97.12	12.86	52.04	97.70	79.47	86.86	91.99	86.43	76.07	74.11	3.17	42.36	36.17	3.00	49.71	20.75	99.68	63.75	31.57	42.64	71.22	-99.51	11.59	67.51	53.38	36.22	89.48
BRD-K35531059	CP	molsidomine	activator of soluble guanylyl cyclase, nitric oxide donor, nitric oxide stimulant	GUCY1A3		4.23, 1.92	60.10	0.84, 0.31	98.48	19.93	58.78	77.76	26.65	82.19	9.12	76.21	4.32	93.59	66.79	74.45	-8.86	42.20	86.93	60.10	19.70	78.80	83.39	58.43	64.71	40.05	27.54	24.67	62.04	88.75	37.14	63.99	57.37
BRD-K72726508	CP	arcyriaflavin-a	CDK inhibitor	CCND1, CCNE1, CDK2, CDK4		7.31, 3.46	60.10	0.88, 0.23	86.54	18.96	75.47	98.92	54.64	20.45	15.26	67.15	31.22	7.66	70.59	60.10	64.86	21.62	77.65	97.36	69.08	13.01	81.69	89.25	7.64	16.44	57.23	99.19	80.98	69.90	54.03	50.98	3.71
BRD-A11813248	CP	AM-92016	glutamate receptor antagonist, ionotropic glutamate receptor antagonist, time-dependent delayed rectifier potassium current blocker	GRIN1, GRIN2B		6.15, 3.46	60.03	0.78, 0.19	83.53	21.73	25.91	34.52	87.69	91.72	29.69	43.14	44.57	79.94	10.10	48.84	24.93	62.67	76.90	88.48	58.93	89.75	98.17	64.71	36.80	60.03	43.53	4.66	99.93	73.16	4.89	79.53	71.03
BRD-K07303502	CP	arachidonyl-trifluoro-methane	cytosolic phospholipase inhibitor	PLA2G4A		7.31, 1.92	60.01	1.40, 0.15	98.41	96.66	46.95	75.50	76.99	60.01	8.45	52.53	15.51	28.90	32.35	85.32	96.19	98.52	96.83	99.47	40.61	67.89	95.02	35.71	68.13	58.83	66.90	36.14	14.76	35.01	76.76	14.01	59.40
BRD-A50684349	CP	fenoldopam	dopamine receptor agonist	DRD1, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD4, DRD5		3.46, 1.92	60.00	0.40, 0.10	61.21	-13.75	17.63	13.21	26.15	66.28	74.16	60.00	75.98	63.27	56.74	82.28	-2.88	18.65	86.10	-5.85	74.70	30.08	66.21	59.84	63.17	56.11	71.06	-0.07	45.68	77.62	87.18	82.02	28.61
BRD-K87909389	CP	alvocidib	CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor	CDK2, CDK4, CDK1, CDK6, CDK7, CDK9, CDK5, CDK8, EGFR, PYGM, BCL2, BIRC5, CCNT1, MCL1, XIAP		7.31, 3.85	59.99	2.16, 0.70	4.19	99.19	59.99	2.11	98.10	75.50	79.03	-73.60	29.12	97.05	89.29	95.79	8.41	0.00	93.46	91.87	55.46	57.92	39.07	76.31	87.05	38.47	80.02	-53.27	-0.88	1.78	67.26	39.64	91.99
BRD-A59303141	CP	quinethazone	diuretic	CA1, CA2, SLC12A1, SLC12A2, SLC12A3	Na-K-Cl transporter inhibitor	5.31, 1.63	59.98	1.09, 0.31	97.39	63.20	96.21	29.03	28.80	98.13	42.90	36.33	13.79	84.02	84.18	86.87	4.55	54.01	92.75	59.21	89.99	20.03	91.72	79.98	27.29	59.98	71.47	-0.07	55.23	84.90	70.87	56.04	34.17
BRD-K41337261	CP	ZM-306416	Src and Abl inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor	FLT1, KDR, EGFR, FLT4	SRC inhibitor, VEGFR inhibitor	4.62, 1.54	59.98	0.83, 0.25	50.56	73.77	32.04	85.22	60.28	10.19	82.90	25.31	21.76	77.44	58.39	64.26	8.93	64.98	45.03	59.98	91.42	47.53	88.98	89.24	77.69	52.30	60.43	6.18	26.72	78.08	57.01	81.28	3.96
BRD-A45889380	CP	mepacrine	NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator	TP53, AKT1, MTOR, NFKB1, PLA2G1B, PLA2G2A, PLA2G2D, PLA2G4A, PLA2G6, PLCL1	NFkB pathway inhibitor	4.23, 2.69	59.95	1.22, 0.24	42.92	98.24	93.08	44.52	71.19	24.18	22.26	28.01	27.19	59.95	2.50	57.32	76.05	60.97	60.81	30.19	66.23	69.45	92.28	74.18	75.72	33.26	71.66	87.52	58.57	15.39	65.73	37.36	30.09
BRD-A70083328	CP	secnidazole	acetylcholinesterase inhibitor, microtubule inhibitor			8.00, 3.56	59.94	1.44, 0.48	99.93	55.27	10.94	31.71	20.72	50.47	75.06	86.10	85.56	96.75	99.93	97.32	0.88	40.73	96.48	44.66	63.49	7.94	77.93	85.55	59.94	27.97	96.65	-0.04	32.00	94.44	98.59	36.56	8.17
BRD-K62858456	CP	lomerizine	calcium channel antagonist, calcium channel blocker, P glycoprotein inhibitor	ABCB1, CACNA1B, SCN5A	Calcium channel blocker	8.89, 5.78	59.94	1.78, 0.67	97.99	47.00	14.35	61.17	0.20	21.44	68.41	38.41	6.41	29.70	18.24	98.80	43.87	74.99	98.63	62.20	96.95	49.23	72.16	59.94	36.47	43.21	78.46	1.87	91.48	97.55	85.41	91.10	25.37
BRD-K79090631	CP	CGP-60474	CDK inhibitor, PKC inhibitor	CDK1, CDK2		6.92, 3.46	59.93	3.50, 1.24	4.66	99.19	68.85	1.06	89.95	94.43	40.70	-69.41	25.38	63.00	77.50	87.29	2.78	1.52	75.65	96.66	97.14	57.72	61.73	59.93	91.81	61.72	8.20	-37.10	-47.61	4.47	59.62	60.25	50.80
BRD-K67537649	CP	PQ-401	insulin growth factor receptor inhibitor	IGF1R		6.92, 2.69	59.92	0.66, 0.06	83.99	66.52	7.68	93.27	64.91	55.45	59.92	31.99	19.87	20.35	31.27	44.95	91.07	88.15	69.65	99.86	54.34	89.35	25.68	76.27	61.41	22.14	29.34	99.12	90.80	26.09	75.18	58.85	31.95
BRD-K19540840	CP	saracatinib	src inhibitor, Abl kinase inhibitor	SRC, ABL1, LCK, YES1	SRC inhibitor	7.31, 3.46	59.89	1.24, 0.47	42.74	68.58	43.93	93.79	62.21	95.05	62.50	-15.44	60.68	9.85	7.34	65.23	-2.78	95.42	99.08	86.48	91.37	92.28	9.19	59.89	48.02	25.05	27.28	-66.50	92.78	40.02	23.76	33.68	67.41
BRD-A23359898	CP	sibutramine	serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, SLC6A3, CYP2B6, CYP2C19, CYP3A5		6.67, 3.11	59.88	0.98, 0.30	53.00	52.95	73.53	37.88	77.20	37.71	74.21	88.54	68.02	59.88	21.25	69.01	31.10	29.13	84.58	23.71	86.47	6.10	48.97	67.34	74.58	10.08	29.85	40.11	68.91	24.70	93.46	69.73	97.45
BRD-A24817035	CP	laudanosine	central nervous system agent			4.08, 1.22	59.82	1.32, 0.27	95.86	20.72	89.02	13.70	73.90	98.13	6.96	25.45	11.81	49.10	81.32	97.15	2.82	59.82	45.21	61.45	54.66	38.71	89.80	82.70	69.34	76.50	65.58	7.89	-14.85	78.28	59.08	86.95	53.87
BRD-K29950728	CP	clomifene	estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist	ESR1, AR	Estrogen receptor antagonist	3.46, 2.31	59.78	0.81, 0.19	66.77	27.86	48.10	89.59	59.78	0.03	6.89	74.76	81.90	13.65	27.84	66.51	78.37	93.77	90.25	92.24	58.39	92.97	28.31	31.72	54.35	6.74	41.31	7.35	69.31	86.41	69.49	63.79	43.53
BRD-K13664374	CP	dichloroacetic-acid	pyruvate dehydrogenase kinase inhibitor, pyruvate dehydrogenase stimulant	PDK1		7.11, 3.11	59.72	1.33, 0.38	8.03	96.39	95.19	3.49	90.98	8.89	36.20	73.04	95.22	84.89	98.72	82.71	4.65	-5.91	87.21	85.00	81.35	49.81	71.69	55.73	93.24	84.24	21.46	-99.93	14.00	33.39	28.70	31.83	59.72
BRD-K52522949	CP	NCH-51	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	3.27, 0.82	59.71	2.09, 0.66	65.31	98.03	59.71	90.18	81.70	54.16	43.56	-46.36	17.51	30.42	75.95	96.12	88.44	94.52	86.85	99.58	44.96	90.41	0.11	28.69	75.03	12.95	49.70	1.30	15.17	77.77	84.54	51.72	32.23
BRD-K87226815	CP	cycloserine	glutamate receptor agonist, glutamate receptor modulator	GRIN1		5.31, 3.67	59.70	0.73, 0.23	10.38	68.56	86.75	5.19	74.81	21.83	43.43	62.70	25.93	72.85	73.10	79.55	2.67	1.66	91.15	31.23	83.64	17.30	85.18	57.45	68.55	36.15	70.37	59.70	-14.80	96.17	78.53	37.60	44.42
BRD-A63546914	CP	RO-04-5595	ionotropic glutamate receptor antagonist			9.23, 6.15	59.66	0.98, 0.31	67.21	34.22	79.23	56.19	99.58	54.48	72.10	-88.11	44.07	59.88	84.49	86.67	21.42	18.44	97.99	56.59	91.90	89.87	54.32	98.42	77.93	97.22	51.46	0.00	34.26	41.35	40.37	99.75	59.66
BRD-K13514097	CP	everolimus	mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, rotamase inhibitor	MTOR, CYP3A5, FKBP1A		3.46, 1.54	59.66	1.93, 0.51	10.37	98.10	89.90	86.27	59.66	47.21	10.43	40.73	15.61	95.34	15.70	70.08	82.66	93.56	42.32	97.61	68.56	86.07	10.01	57.57	58.64	53.99	66.46	0.85	36.89	69.83	72.06	35.96	78.53
BRD-K61401890	CP	deguelin	NADH-ubiquinone oxidoreductase (Complex I) inhibitor, AKT inhibitor, cyclooxygenase inhibitor, NFkB pathway inhibitor, phorbol ester-induced ornithine decarboxylase (ODC) activity suppressor, PI3K inhibitor	AKT1, PTGS2		5.38, 2.69	59.66	1.01, 0.14	93.17	8.69	74.88	80.33	87.76	31.65	-0.74	53.65	14.85	35.92	5.73	44.48	88.41	74.62	93.82	98.06	97.37	62.39	20.25	67.49	35.21	72.42	-8.71	0.00	10.94	59.66	54.19	88.99	87.73
BRD-K14920963	CP	erythrosine	food coloring agent			2.31, 1.15	59.62	0.68, 0.19	66.41	54.88	33.93	54.47	76.29	7.09	44.20	-80.46	29.57	59.62	58.74	92.73	10.13	68.32	69.50	83.33	82.62	61.52	89.77	94.87	71.81	89.78	76.01	-39.22	41.55	2.78	52.29	91.99	11.13
BRD-K66615216	CP	moxifloxacin	DNA gyrase inhibitor, topoisomerase inhibitor	TOP2A	Bacterial DNA gyrase inhibitor	4.62, 3.08	59.59	0.51, 0.09	86.72	59.59	29.30	40.04	20.60	79.57	17.48	84.40	11.86	64.04	56.03	92.47	5.78	3.94	63.00	7.03	86.10	9.34	84.42	56.63	76.78	60.51	64.91	0.81	33.33	62.86	96.12	93.63	24.88
BRD-K25186396	CP	tangeritin	cell cycle inhibitor			5.77, 4.23	59.58	0.98, 0.23	79.38	25.13	41.45	63.79	93.41	34.70	30.64	38.75	0.88	47.27	80.68	97.00	1.23	40.72	95.07	46.27	42.78	45.77	76.57	88.67	83.75	97.92	3.28	99.08	76.02	48.74	85.02	59.58	93.66
BRD-A79465854	CP	auranofin	disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor	IKBKB, PRDX5, TRPA1, TXNRD1, TXNRD2	NFkB pathway inhibitor	4.23, 2.69	59.55	2.74, 0.50	23.13	98.20	91.84	5.69	90.71	37.70	-21.70	-22.20	34.15	38.10	18.18	55.15	88.38	92.25	99.05	86.68	75.49	65.46	83.21	50.64	75.10	60.63	87.36	98.18	1.37	59.55	53.87	6.24	24.43
BRD-K36009368	CP	NNC-63-0532	opioid receptor agonist	OPRL1		5.77, 2.31	59.55	0.88, 0.19	65.58	45.50	15.55	60.71	58.81	14.39	92.29	-25.45	67.07	30.05	23.67	83.45	-2.01	9.88	60.75	26.32	8.77	70.21	85.87	61.72	54.13	59.55	71.99	99.65	89.30	96.49	54.74	92.08	33.12
BRD-K79116891	CP	proxymetacaine	membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker	SCN10A, SCN5A, SCN9A		6.15, 3.08	59.51	0.83, 0.20	77.76	46.16	36.86	25.58	85.66	75.51	57.71	89.57	50.43	50.59	38.25	82.73	-1.09	26.91	59.51	3.08	67.46	37.75	64.46	73.93	40.17	91.62	46.28	-48.81	76.66	80.76	76.55	63.35	68.69
BRD-K66874953	CP	pifithrin-alpha	TP53 inhibitor	TP53		3.85, 1.54	59.49	0.52, 0.11	51.88	40.21	87.50	67.97	87.65	60.30	60.05	80.68	29.30	92.34	14.18	82.64	13.88	27.04	88.13	59.49	76.29	37.26	29.87	59.41	55.17	83.14	38.67	1.37	7.71	61.89	65.22	91.58	59.39
BRD-K34776109	CP	glimepiride	insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea	ABCC8, KCNJ11, KCNJ1	KCNJ11 modulator	3.46, 1.15	59.40	0.68, 0.13	19.82	39.95	80.55	53.21	84.88	80.74	87.46	74.13	65.32	30.11	28.10	72.29	13.58	10.98	81.15	27.31	94.26	18.70	91.81	19.07	87.95	92.13	59.40	-0.53	-9.81	62.98	48.18	58.14	91.90
BRD-K59037100	CP	oxybenzone	lipase inhibitor	LIPE		7.69, 5.00	59.22	1.25, 0.38	54.73	12.00	91.87	47.28	16.92	52.33	20.82	63.83	82.17	94.69	69.74	38.92	0.00	0.00	98.21	4.76	95.17	68.63	20.12	99.06	39.04	94.83	59.22	35.47	43.03	73.17	70.46	82.67	98.09
BRD-K04196797	CP	oxcarbazepine	voltage-gated sodium channel blocker, Sodium Channel  Blockers	CYP2C19, CYP3A4, CYP3A5, SCN1A, SCN3A, SCN5A		8.00, 4.89	59.19	1.35, 0.35	13.16	48.28	43.93	18.71	75.02	59.19	78.45	83.25	4.58	99.89	97.52	60.41	3.54	17.37	99.31	62.83	98.77	17.89	49.07	58.76	77.83	69.62	96.12	99.12	48.59	17.86	16.27	61.50	27.40
BRD-K46435977	CP	valaciclovir	DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor		DNA polymerase inhibitor	10.22, 7.11	59.18	1.90, 0.66	99.89	87.94	34.91	47.31	64.50	59.18	96.53	98.81	47.08	99.84	99.72	36.45	20.88	37.36	19.80	-0.42	6.48	28.66	95.43	48.25	69.68	56.50	99.68	27.73	68.89	78.51	90.94	31.90	77.44
BRD-K42095107	CP	daidzein	estrogen receptor agonist	ESRRA, ESRRB, ESRRG, TRPC5	Estrogen receptor agonist	4.49, 1.63	59.16	1.38, 0.39	46.62	55.33	23.08	60.89	71.31	91.44	51.89	41.79	87.84	68.25	92.54	89.13	7.90	41.93	91.95	4.72	45.69	49.90	70.61	73.66	25.80	90.25	26.37	59.16	42.38	88.35	61.64	83.94	31.11
BRD-K64341947	CP	CFM-1571	guanylate cyclase activator			4.62, 2.31	59.08	0.94, 0.24	19.97	59.56	7.09	74.30	96.80	-15.34	7.38	-63.29	92.46	6.12	59.08	82.38	12.80	83.79	62.12	12.46	59.80	90.63	38.83	62.10	69.52	10.10	26.94	-60.54	90.90	62.22	26.64	62.65	54.44
BRD-K94887716	CP	TFMPP	serotonin receptor agonist, serotonin receptor antagonist			7.56, 2.67	59.05	1.41, 0.39	19.50	90.44	62.34	29.03	94.81	16.39	96.80	89.25	97.14	98.89	17.24	55.55	2.22	68.17	36.30	50.39	53.83	57.37	98.66	28.13	81.23	65.57	33.93	-51.86	86.47	87.92	59.05	31.84	96.05
BRD-K45117373	CP	Y-26763	potassium channel activator, potassium channel agonist	ABCC9, KCNJ8	Potassium channel activator	7.31, 3.46	59.04	0.83, 0.22	91.08	86.49	77.24	44.77	99.82	30.40	27.72	51.72	80.39	40.25	67.98	92.05	-2.78	32.68	73.79	19.70	67.52	23.73	27.02	98.41	90.86	96.45	38.91	-6.24	35.33	88.85	43.87	99.47	59.04
BRD-K79092138	CP	nitrofural	POXB inhibitor			3.67, 1.22	58.92	1.19, 0.31	35.31	80.90	77.76	53.96	56.17	35.89	3.83	30.67	87.43	81.58	36.33	47.06	58.92	59.08	80.73	93.55	68.72	61.68	83.46	57.68	63.83	71.00	56.86	69.65	31.23	47.02	12.74	36.26	59.03
BRD-A55946879	CP	BW-B70C	lipoxygenase inhibitor	ALOX5		4.08, 2.04	58.85	1.08, 0.33	30.87	63.16	93.51	92.75	81.95	90.86	31.35	69.10	89.41	37.04	58.44	58.85	59.99	68.22	35.77	97.24	50.81	93.06	82.72	43.21	82.99	48.72	27.26	-0.81	36.72	58.06	68.90	9.04	55.98
BRD-A45140972	CP	meclocycline	tetracycline antibiotic		Bacterial 30S ribosomal subunit inhibitor	6.92, 2.69	58.82	0.55, 0.11	98.44	76.65	58.82	74.16	55.99	76.05	99.41	55.14	35.32	45.47	72.15	51.73	59.03	59.18	96.42	4.76	67.74	17.75	93.35	63.37	19.68	33.80	56.37	15.52	52.93	66.00	38.29	90.15	-2.47
BRD-A78322124	CP	dobutamine	adrenergic receptor agonist	ADRB1, ADRB2, ADRA1A	Beta-adrenergic receptor agonist	4.23, 1.54	58.81	0.75, 0.14	75.31	14.87	72.56	58.51	48.24	12.67	49.26	64.17	90.85	95.32	57.65	58.81	7.97	14.91	61.77	70.95	76.82	79.18	56.65	19.25	72.23	94.49	17.05	2.29	89.70	53.07	38.73	59.86	72.35
BRD-K53979406	CP	ALX-5407	glycine transporter inhibitor, GlyT-1 inhibitor	SLC6A9		4.49, 2.45	58.78	1.20, 0.44	98.31	12.72	37.96	61.81	12.73	91.25	59.87	83.82	89.37	73.74	13.47	50.45	2.22	46.47	75.86	4.09	83.44	24.51	94.30	64.06	58.78	52.11	39.18	62.15	55.17	87.68	14.30	20.14	70.32
BRD-K21283037	CP	riluzole	glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker	KCND3, KCNK10, KCNK2, KCNK4, KCNN4, SCN5A, SLC7A11		4.62, 3.46	58.74	0.35, 0.05	58.15	74.83	79.64	40.57	79.51	62.17	9.70	77.04	53.99	39.49	44.77	93.61	2.26	-6.65	94.27	27.87	90.90	58.74	44.28	81.19	41.52	60.63	86.14	-10.41	-87.49	63.88	40.82	81.40	79.69
BRD-K64310881	CP	MW-STK33-3B	large conductance potassium channel activator			3.67, 2.04	58.69	1.39, 0.25	23.46	20.45	90.55	20.52	79.75	-5.91	68.66	53.92	81.34	58.69	70.72	72.48	11.16	2.17	62.72	64.01	89.23	-2.50	20.39	94.34	48.46	41.29	24.08	2.78	78.02	64.31	69.23	75.55	2.68
BRD-K06980535	CP	promazine	dopamine receptor, dopamine receptor antagonist	CHRM5, DRD2, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, DRD1, DRD3, DRD4, HRH1, HTR2A, HTR2C	Dopamine receptor antagonist	6.92, 3.46	58.68	1.41, 0.49	84.26	25.31	72.90	63.88	49.61	18.31	43.02	58.16	24.34	16.79	18.13	73.85	61.45	92.17	79.95	70.69	77.98	96.91	33.28	58.68	58.04	49.87	31.08	43.94	98.66	44.99	64.38	75.58	71.21
BRD-K53737926	CP	amitriptyline	norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HTR6, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1	Serotonin receptor antagonist	5.00, 1.54	58.63	1.08, 0.27	14.23	80.73	71.69	47.01	76.76	30.42	60.42	-22.66	15.45	90.23	49.09	47.39	52.66	84.02	90.47	88.02	90.65	97.17	53.70	6.22	64.42	27.89	21.67	-99.08	92.44	83.93	58.63	72.65	50.09
BRD-K12932420	CP	YM-976	phosphodiesterase inhibitor, tumor necrosis factor production inhibitor	PDE4A, PDE4B, PDE4C, PDE4D, TNF		5.77, 2.69	58.62	0.73, 0.27	26.47	33.29	18.31	20.67	85.68	25.06	9.12	70.84	96.94	93.48	23.69	13.54	-5.01	11.83	69.30	3.86	87.26	63.58	79.46	54.87	69.15	58.62	24.93	89.68	72.44	73.55	29.41	97.40	68.10
BRD-K52219182	CP	BRD-K52219182	phosphodiesterase inhibitor			3.46, 1.92	58.62	0.65, 0.14	67.09	15.68	83.88	32.45	79.57	97.23	57.46	48.33	78.51	58.62	90.15	69.30	-1.87	19.07	93.75	36.06	56.88	51.77	95.06	82.64	57.04	53.69	30.93	91.99	37.42	88.15	14.09	70.13	75.88
BRD-K28307902	CP	flutamide	androgen receptor antagonist	AR, AHR, CYP2C19		2.69, 1.54	58.61	0.97, 0.23	58.61	91.30	93.05	47.61	74.87	17.81	81.60	60.54	32.77	91.98	77.94	69.90	8.16	6.22	34.65	75.40	49.57	12.65	83.08	87.93	64.84	55.30	32.51	5.27	51.64	40.98	73.22	82.90	46.73
BRD-A02713983	CP	dihydrodeoxygedunin	growth factor receptor activator	NTRK2		6.12, 2.45	58.59	1.14, 0.33	33.69	58.59	96.30	23.40	89.30	97.71	60.02	37.20	18.11	68.50	49.65	82.72	12.79	76.70	68.40	65.70	36.53	70.76	42.58	25.19	93.89	39.63	26.28	2.96	77.72	17.14	71.95	73.13	33.63
BRD-K46556543	CP	canrenoic-acid	aldosterone antagonist			7.69, 3.46	58.58	1.34, 0.40	4.44	79.42	93.33	26.49	99.82	58.58	25.41	-33.11	43.85	52.89	97.48	92.92	3.17	28.67	76.95	49.28	98.25	52.32	70.66	56.49	95.36	78.97	70.61	0.00	-19.52	91.13	41.54	90.08	70.91
BRD-K88679075	CP	methandriol	androgenic horomone		Androgen receptor modulator	8.89, 5.78	58.58	2.10, 0.76	52.56	94.02	20.67	58.58	28.79	73.49	94.54	7.26	50.73	97.57	97.49	99.44	76.14	70.21	44.98	92.70	48.75	48.58	51.30	39.59	77.02	52.81	99.79	-4.48	12.89	99.72	98.10	84.45	41.47
BRD-K86509404	CP	iso-olomoucine	cyclin-related kinase inhibitor			6.12, 3.27	58.55	1.30, 0.28	96.80	14.31	83.99	8.13	10.59	93.50	36.75	67.37	14.41	89.73	44.74	85.13	7.05	33.54	89.89	7.30	93.20	58.55	84.46	31.11	32.27	40.45	89.91	98.21	10.77	71.32	92.62	97.83	50.95
BRD-K99029477	CP	prometon	photosynthesis inhibitor			5.34, 0.76	58.53	2.05, 0.64	49.84	88.37	95.42	82.14	90.01	95.05	71.06	55.32	72.59	5.73	3.91	96.48	2.78	0.11	97.64	2.04	17.01	26.06	19.39	71.33	75.26	56.20	14.55	NaN	26.39	60.86	69.84	17.72	92.10
BRD-K08890269	CP	CO-102862	sodium channel blocker	SCN2A, SCN4A, SCN9A		8.08, 4.23	58.53	0.98, 0.20	5.14	39.46	74.08	44.21	76.35	11.32	90.89	53.33	26.89	98.73	92.63	26.80	24.64	21.20	-13.20	24.07	80.78	71.80	58.53	31.23	88.60	96.61	20.56	54.44	63.56	89.46	75.00	76.86	69.61
BRD-K50859149	CP	sulfafurazole	endothelin receptor antagonist, FOLP inhibitor		Dihydrofolate reductase inhibitor	6.92, 3.85	58.49	1.09, 0.25	60.82	-96.09	79.61	8.76	76.35	30.72	58.49	96.46	18.03	81.39	47.53	70.89	2.50	-0.56	89.17	4.03	96.83	27.18	92.38	74.41	40.49	42.79	22.78	0.21	57.80	99.58	63.63	73.88	96.75
BRD-K32821942	CP	azathioprine	dehydrogenase inhibitor, immunosuppressant, purine antagonist	HPRT1, IMPDH1, PPAT	IMPDH inhibitor	4.49, 2.86	58.48	0.22, 0.05	89.03	20.37	57.81	56.46	43.53	78.01	33.47	87.02	6.50	31.10	44.06	57.50	70.61	52.29	83.14	71.53	90.56	34.05	84.05	49.46	81.36	72.35	35.27	0.00	89.94	82.55	58.48	80.71	74.30
BRD-K27721098	CP	clopidogrel	purinergic receptor antagonist, platelet aggregation inhibitor, purinergic receptor inhibitor	P2RY12, CYP2B6, CYP2C19, CYP3A5		5.38, 3.46	58.43	2.81, 0.70	2.50	79.45	92.38	12.57	68.09	16.03	65.68	31.84	78.39	99.24	60.71	43.01	1.44	21.28	43.58	53.85	94.51	61.11	62.19	66.06	99.15	88.63	31.71	-66.74	-27.45	-6.76	33.02	58.43	85.18
BRD-K72903603	CP	zidovudine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	TERT	Reverse transcriptase inhibitor	7.35, 2.86	58.40	0.92, 0.39	41.42	43.30	41.15	56.57	31.42	68.35	49.00	85.15	3.31	36.32	95.39	88.31	27.57	0.00	92.74	93.79	83.57	45.85	96.37	98.34	59.42	85.09	58.40	87.79	13.08	95.79	42.79	83.85	25.43
BRD-K89348303	CP	ramipril	angiotensin converting enzyme inhibitor	ACE		7.35, 2.45	58.40	0.77, 0.11	93.55	8.66	31.02	31.55	3.31	25.21	72.21	92.16	78.59	58.88	30.41	86.84	20.69	12.86	75.63	-2.18	89.46	28.13	58.68	51.90	27.42	44.81	11.89	95.88	66.28	93.78	83.28	64.89	58.40
BRD-K54210043	CP	NS-1619	calcium channel activator, large conductance potassium channel activator	KCNMA1, KCNT1, KCNT2, KCNU1		7.31, 3.08	58.38	0.84, 0.17	64.66	22.76	49.98	61.40	82.01	19.66	94.88	86.68	83.62	69.18	3.00	59.37	2.96	15.08	-69.25	28.30	29.15	20.06	96.23	97.78	50.94	12.77	44.85	99.15	70.84	83.87	58.38	66.29	19.39
BRD-K70487031	CP	flupentixol	dopamine receptor antagonist	DRD2, DRD1, ADRA1A, CHRM1, DRD3, DRD5, HTR2A		7.31, 3.08	58.37	1.06, 0.28	71.69	2.34	29.37	78.54	58.37	23.28	15.85	15.33	23.50	71.58	19.83	89.52	88.07	92.45	51.13	97.64	94.99	97.63	11.72	99.89	87.37	43.66	10.03	0.00	98.41	23.94	55.78	95.39	73.89
BRD-A42571354	CP	cetirizine	histamine receptor antagonist	HRH1		5.00, 1.92	58.35	0.81, 0.11	95.86	26.59	45.67	28.78	70.95	68.60	80.41	66.45	4.01	86.95	95.57	73.72	0.91	4.90	89.93	11.04	46.60	14.15	42.93	57.88	48.35	64.76	58.35	71.41	41.97	73.51	27.17	84.29	79.71
BRD-A08709697	CP	heliotrine	in touchstone			5.71, 2.04	58.34	1.08, 0.38	14.15	77.63	34.63	1.59	73.73	92.78	17.89	54.65	7.79	92.10	42.69	97.53	-4.18	15.07	81.57	3.10	96.76	68.84	95.87	22.73	65.85	58.34	20.30	61.30	19.48	92.92	38.81	94.05	70.94
BRD-A34706053	CP	CGP-12177	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3		6.92, 4.62	58.26	0.94, 0.32	58.26	18.72	8.74	25.93	78.64	41.64	98.98	60.22	89.38	79.25	59.46	67.14	7.38	18.50	-29.88	-7.72	64.83	-6.39	95.24	97.99	62.35	84.10	5.64	1.90	50.20	63.06	31.59	99.61	20.37
BRD-A05352148	CP	ipratropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		5.00, 3.08	58.25	0.75, 0.27	57.97	42.83	85.72	25.19	99.26	38.05	23.60	69.36	44.53	36.39	30.19	84.86	-0.92	15.12	96.83	58.25	89.07	56.05	92.68	77.43	92.18	91.34	45.17	1.08	39.63	66.85	63.61	83.39	88.37
BRD-K97118047	CP	4,5,6,7-tetrabromobenzotriazole	casein kinase inhibitor	CSNK2A1, AKT1, CHEK1, CSNK2A2, CSNK2B, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1		3.85, 2.69	58.23	0.66, 0.16	88.41	-49.74	87.07	10.08	42.69	7.89	1.20	58.23	13.97	71.85	32.83	56.31	-4.72	37.21	82.19	9.42	75.72	37.03	98.17	97.05	58.67	98.59	61.10	83.47	76.31	48.77	52.47	77.31	62.28
BRD-K91904471	CP	SD-169	p38 MAPK inhibitor	MAPK14		6.94, 2.86	58.22	1.19, 0.34	44.87	66.01	99.40	9.59	84.81	99.82	7.95	29.40	25.31	63.09	37.68	96.74	4.84	21.28	33.04	2.54	63.45	55.97	65.73	60.60	82.10	96.50	71.63	-0.88	20.35	27.88	58.22	96.75	77.16
BRD-K13169950	CP	NSC-3852	HDAC inhibitor	HDAC1	HDAC inhibitor	5.38, 1.54	58.17	2.16, 0.67	83.71	97.60	59.28	63.35	70.09	17.71	14.51	-24.57	39.96	76.80	27.49	73.99	95.81	95.60	-71.63	99.58	22.06	82.42	33.83	67.98	57.12	95.64	58.17	-3.97	24.37	15.92	84.96	29.13	42.89
BRD-K04993501	CP	cefixime	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	6.15, 4.23	58.10	1.49, 0.43	-24.77	59.23	63.95	65.74	69.16	85.46	84.23	86.99	25.60	96.84	28.28	26.73	0.00	64.41	-21.31	16.86	21.93	10.09	54.55	46.88	99.33	65.51	58.10	-88.00	81.24	34.52	75.58	85.33	54.17
BRD-K11696279	CP	BU-239	imidazoline receptor agonist, imidazoline receptor ligand		Imidazoline ligand	3.85, 2.31	58.10	1.22, 0.47	17.94	62.42	8.57	13.67	78.78	4.23	97.23	52.65	21.49	72.83	88.26	73.51	-11.60	40.76	42.71	4.09	74.28	52.17	58.10	78.94	71.80	81.21	19.50	-39.14	80.18	93.04	6.36	98.17	63.02
BRD-K39339537	CP	epirizole	cyclooxygenase inhibitor	PTGS1, PTGS2		5.00, 3.08	58.09	0.57, 0.10	70.24	23.58	48.87	21.57	33.72	30.86	47.81	71.76	24.43	70.90	96.19	66.98	-2.01	-1.44	87.27	1.16	75.10	27.01	91.16	86.63	81.60	72.71	15.09	0.42	65.89	52.43	58.09	73.51	89.92
BRD-K05395900	CP	nicotine	acetylcholine receptor agonist	CHRNA10, CHRNA9, AOX1, CHAT, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB2, CHRNB3, CHRNB4, CYP19A1, CYP2B6, TBXAS1, TRPA1		9.39, 6.94	58.00	0.69, 0.14	68.82	39.90	98.76	-3.95	42.21	71.75	84.73	94.32	62.09	50.01	29.27	56.24	0.11	1.80	85.71	8.16	90.09	19.59	99.96	79.60	28.45	54.69	71.91	99.47	56.23	79.89	58.04	50.78	58.00
BRD-K67783091	CP	haloperidol	dopamine receptor antagonist	DRD2, DRD1, DRD3, HTR2A, CYP3A7, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2B, HTR7, KCNH1		1.15, 1.15	58.00	1.23, 0.23	92.19	46.52	49.97	30.22	69.72	77.71	22.33	37.11	36.82	58.00	64.10	61.94	28.80	52.42	79.80	28.50	87.96	83.76	49.19	84.97	84.71	61.74	50.11	-88.79	69.11	49.17	78.04	36.08	87.69
BRD-K90259198	CP	W-7	calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker	CALM1, CALM2, KCNA5, KCNH2, TNNC1, TNNI3		7.31, 3.46	58.00	1.80, 0.43	53.60	83.61	66.02	7.16	96.27	48.32	91.20	68.53	29.39	98.66	64.93	31.36	1.97	65.72	-87.87	37.40	45.83	67.26	97.45	58.00	97.25	97.86	-5.57	-98.57	72.20	35.99	27.42	97.08	26.46
BRD-K00532621	CP	midazolam	benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist	CYP3A5, CYP3A7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3	Benzodiazepine receptor agonist	4.89, 3.11	57.98	1.90, 0.82	0.28	95.74	37.90	79.05	40.34	91.94	16.97	69.40	44.20	91.32	99.86	98.45	70.58	0.13	21.39	66.12	12.03	57.98	89.79	46.68	81.53	18.66	94.95	0.00	28.16	98.98	96.36	16.59	33.93
BRD-K92723993	CP	imatinib	PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor	ABL1, KIT, PDGFRA, BCR, CSF1R, PDGFRB, ABCG2, CYP2C19, CYP2C8, CYP3A5, DDR1, NTRK1, RET		4.23, 1.15	57.98	1.03, 0.19	39.33	69.19	74.36	26.87	70.75	86.70	58.34	57.98	17.96	21.16	20.66	73.62	18.93	15.27	80.39	80.22	67.87	38.35	44.95	64.52	96.88	62.50	24.32	-94.48	53.56	35.69	74.13	56.25	67.93
BRD-K39823328	CP	VU-0366037-2	glutamate receptor modulator	GRM4		2.69, 1.54	57.97	0.86, 0.16	2.61	79.96	70.81	20.59	73.48	57.97	70.66	18.57	74.30	95.01	77.67	69.01	0.00	30.30	89.54	85.83	52.75	19.94	27.00	90.53	17.68	54.78	12.04	-1.16	3.39	87.39	80.31	83.59	29.82
BRD-K92778217	CP	mefenamic-acid	cyclooxygenase inhibitor	PTGS2, PTGS1, KCNQ1, TRPM3		5.77, 3.85	57.97	1.11, 0.33	42.17	53.98	25.97	30.97	80.74	81.20	64.53	95.98	48.26	65.52	41.31	77.24	12.95	6.98	45.34	6.94	83.04	76.61	65.21	57.97	44.49	83.60	35.48	-47.71	84.43	82.37	23.05	88.76	95.63
BRD-K59273480	CP	propentofylline	acetylcholinesterase inhibitor, adenosine reuptake inhibitor, adenosine uptake inhibitor, phosphodiesterase inhibitor	ACHE		4.08, 1.22	57.95	0.77, 0.18	37.87	47.05	79.42	0.39	57.95	52.11	56.74	63.09	39.27	90.77	43.40	80.81	-4.45	60.75	81.19	10.26	85.28	57.41	99.65	86.82	84.34	81.37	38.10	55.46	33.16	88.39	77.89	80.25	23.84
BRD-K04877770	CP	FTase-inhibitor-B581	farnesyltransferase inhibitor, protein farnesyltransferase inhibitor			4.23, 3.08	57.90	0.83, 0.30	65.65	16.56	91.89	20.24	99.08	76.10	4.64	45.69	13.25	-5.61	15.11	57.90	-2.43	-15.18	83.52	50.94	95.67	55.99	68.85	98.41	78.94	98.32	60.22	14.12	13.77	22.88	90.12	97.13	80.13
BRD-K41567364	CP	SB-334867	orexin receptor antagonist	HCRTR1, HCRTR2		6.92, 4.62	57.87	1.28, 0.47	58.05	56.14	86.36	58.94	89.01	99.75	-1.13	57.87	18.60	5.11	17.58	66.44	1.87	2.41	99.72	71.48	96.93	22.44	-25.12	93.32	48.31	67.96	6.69	1.11	17.57	47.01	89.60	70.31	98.80
BRD-K83988098	CP	alvespimycin	HSP inhibitor, HSP antagonist	HSP90AA1	HSP inhibitor	6.54, 3.46	57.85	1.89, 0.56	3.41	97.92	94.23	57.85	81.75	27.84	-0.70	65.36	16.70	29.40	46.71	97.57	93.38	92.56	2.29	99.86	79.01	69.98	21.18	91.77	74.01	38.32	20.30	-51.34	0.78	25.23	70.28	23.56	57.85
BRD-K59574735	CP	ubenimex	leukotriene hydrolase inhibitor, alanine aminopeptidase inhibitor, aminopeptidase B inhibitor, immunostimulant, peptidase inhibitor	LTA4H, ANPEP, RNPEP		2.31, 1.15	57.83	0.56, 0.08	10.24	70.16	7.23	30.13	69.21	27.54	71.78	44.77	12.31	97.39	66.34	87.50	2.43	33.32	91.90	51.23	31.49	22.57	83.70	57.83	53.87	64.30	58.87	64.47	79.16	71.51	32.17	70.91	55.85
BRD-A14395271	CP	mesoridazine	dopamine receptor antagonist	DRD2, HTR2A		3.46, 1.15	57.78	0.33, 0.07	74.46	24.70	85.72	52.48	50.33	44.03	23.78	73.56	22.26	59.22	57.78	78.44	2.08	17.09	81.17	13.08	87.74	63.57	52.73	76.80	53.55	70.34	40.62	20.91	72.62	95.34	59.50	77.21	34.57
BRD-A02176148	CP	tubaic-acid	mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor	MT-ND1		3.08, 1.15	57.76	1.09, 0.36	58.74	64.27	75.48	66.37	76.97	25.71	50.18	35.36	17.42	95.95	78.64	95.32	-11.28	10.90	81.16	54.57	91.54	16.35	43.59	91.37	26.84	51.21	29.11	46.11	22.91	93.90	57.76	75.96	80.34
BRD-A77291778	CP	cyclopentolate	acetylcholine receptor antagonist	CHRM1		3.85, 1.15	57.76	0.55, 0.11	93.67	-9.04	88.51	7.63	73.34	1.83	59.74	56.24	57.76	38.00	80.28	58.94	1.94	12.56	91.55	19.40	43.32	5.55	82.05	86.12	-6.73	72.00	79.98	91.10	78.70	13.34	31.55	57.40	66.70
BRD-K96471533	CP	nitazoxanide	pyruvate ferredoxin oxidoreductase inhibitor, pyruvate synthase inhibitor			8.00, 4.44	57.70	1.03, 0.27	81.96	71.96	11.72	91.98	67.70	29.85	55.52	50.10	-5.78	99.79	26.27	90.42	94.40	71.40	10.10	99.72	94.99	90.23	25.47	34.20	66.10	27.85	81.25	8.91	57.70	52.60	34.90	10.64	60.73
BRD-K57033106	CP	tripelennamine	histamine receptor antagonist	HRH1		6.54, 3.08	57.65	0.50, 0.18	23.28	39.45	43.19	14.67	60.35	15.92	57.98	72.08	71.26	92.93	11.95	68.72	0.11	27.55	96.83	2.72	93.11	24.98	56.54	47.57	-55.36	13.72	82.80	99.12	57.65	61.28	65.59	57.99	97.13
BRD-K11717138	CP	benzbromarone	calcium-activated chloride channel blocker, uric acid diuretic	ABCC1, SLC22A12		5.38, 2.31	57.64	0.52, 0.11	58.43	36.96	63.78	5.00	44.31	59.35	60.37	62.34	35.72	6.83	62.10	81.68	1.30	22.93	52.62	23.85	89.00	15.06	96.53	77.52	90.75	57.58	69.13	65.95	57.64	70.41	26.48	49.78	38.27
BRD-A93659613	CP	GR-89696	opioid receptor agonist	OPRK1		4.23, 3.46	57.63	0.76, 0.16	53.76	-3.77	69.68	26.19	81.28	5.03	75.50	80.96	57.63	14.90	63.32	36.26	10.63	3.04	84.92	1.09	62.76	28.92	30.43	89.90	8.42	63.61	66.07	10.11	42.20	80.61	73.29	91.79	92.25
BRD-K93188295	CP	ARC-239	adrenergic receptor antagonist	ADRA2B, ADRA2A, ADRA2C		8.98, 3.67	57.63	1.82, 0.45	99.75	10.68	46.27	5.19	26.12	67.31	22.64	90.61	96.59	99.72	99.15	75.37	8.91	11.13	81.70	5.17	60.04	19.07	94.93	96.56	26.54	0.00	56.44	99.40	57.63	84.82	32.46	43.76	82.07
BRD-K53857191	CP	risperidone	dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist	DRD2, HTR2A, ADRA1A, ADRA1B, DRD3, HRH1, HTR1A, HTR1D, HTR2C, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CYP3A5, DRD1, DRD4, HTR1B, HTR1E, HTR1F, HTR6, HTR7		4.23, 3.08	57.59	0.63, 0.11	14.88	91.49	44.45	40.94	72.64	57.59	68.82	57.61	18.34	39.53	55.79	90.64	5.52	66.89	61.97	34.62	80.35	17.91	59.09	68.27	76.14	18.25	43.85	-0.28	80.86	90.34	55.75	79.87	44.77
BRD-K68402494	CP	ML-9	myosin light chain kinase inhibitor	MLCK, TRPC6, PKA, PKC		3.27, 1.63	57.55	1.17, 0.38	68.37	24.05	91.66	49.95	21.64	61.92	-19.65	34.77	12.33	57.55	74.28	93.07	6.87	51.13	99.05	27.89	81.09	93.16	65.16	88.18	61.42	46.91	26.83	83.27	31.19	53.32	74.57	41.53	67.07
BRD-K38323065	CP	phenacetin	cyclooxygenase inhibitor	PTGS1	Cyclooxygenase inhibitor	3.08, 1.92	57.54	0.81, 0.15	99.47	-34.56	5.96	9.88	60.14	75.19	19.23	93.59	18.55	73.51	51.30	84.48	-3.52	-4.54	98.80	2.08	97.96	-19.21	76.74	81.58	53.51	43.87	35.70	99.28	57.54	74.27	57.72	83.49	39.09
BRD-K91336023	CP	mesulergine	dopamine receptor agonist	HTR2A, HTR2C, HTR7, HTR2B, HTR3A, HTR3B, HTR6		5.31, 2.86	57.51	0.94, 0.19	22.08	28.81	71.93	17.42	14.85	91.44	83.77	92.13	61.56	94.68	98.86	69.27	19.79	27.09	61.85	2.15	96.55	57.51	98.10	49.19	39.40	18.03	18.37	0.00	92.90	68.71	50.25	61.92	48.52
BRD-A58564983	CP	selamectin	nematocide			8.08, 4.23	57.50	1.74, 0.50	90.97	92.51	75.16	97.92	90.89	0.04	7.51	27.89	27.80	55.88	12.93	70.50	97.82	96.97	90.61	100.00	82.79	91.13	45.24	97.68	45.89	54.47	33.58	63.78	57.50	12.15	38.79	50.52	32.95
BRD-K12906962	CP	dichlorobenzamil	sodium/calcium exchange inhibitor		T-type calcium channel blocker	10.00, 6.15	57.46	1.47, 0.39	7.41	39.16	68.94	98.56	21.20	10.19	14.32	57.69	57.53	6.56	25.66	79.27	94.55	92.64	88.89	99.79	80.72	98.87	15.52	57.46	27.05	11.76	21.65	0.85	99.72	23.61	74.55	4.69	92.61
BRD-K06221026	CP	DUP-697	cyclooxygenase inhibitor	PTGS2		5.38, 3.85	57.39	0.72, 0.19	17.52	76.59	83.80	48.39	56.16	24.93	20.78	67.03	65.80	93.48	92.79	27.35	2.80	48.95	67.11	56.47	55.71	61.57	59.93	54.70	98.87	58.31	15.12	-0.07	57.39	55.98	73.61	79.20	89.52
BRD-K77171813	CP	proxyfan	histamine receptor modulator	HRH3		5.00, 1.54	57.37	0.90, 0.24	60.58	-23.95	2.85	68.01	40.56	19.32	64.58	53.22	7.64	81.10	73.93	81.86	4.21	56.91	-63.11	76.75	86.92	70.73	64.42	42.47	80.43	98.20	24.20	87.78	32.12	95.61	50.52	57.37	45.77
BRD-K36616567	CP	doxepin	histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant	HRH1, HRH2, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A3		5.38, 2.69	57.35	0.76, 0.17	48.37	39.49	70.50	16.38	98.35	26.15	24.97	-41.51	55.65	61.30	15.01	28.90	4.34	47.65	84.20	54.16	72.79	93.28	57.35	96.86	59.40	86.77	40.98	88.10	90.28	51.10	78.02	80.48	97.53
BRD-K26429091	CP	J-104129	acetylcholine receptor antagonist	CHRM3		9.62, 5.00	57.34	1.17, 0.33	49.87	54.98	78.36	44.66	94.37	15.23	81.01	-83.06	57.34	38.28	25.07	54.12	2.11	57.88	97.60	26.37	68.30	89.75	89.30	99.93	50.49	95.87	31.65	41.42	75.62	96.26	13.84	99.15	96.70
BRD-A10355991	CP	norketamine	glutamate receptor antagonist	CYP2B6, CYP2C19, CYP3A5, GRIN1		5.77, 1.92	57.32	1.31, 0.39	31.18	32.56	57.32	64.25	47.14	65.66	69.21	98.10	58.10	8.10	3.70	74.48	-19.59	2.89	93.38	2.22	97.30	29.48	87.49	98.41	93.30	88.04	28.71	31.15	52.80	20.40	29.85	81.34	96.56
BRD-K51476772	CP	ST-638	tyrosine kinase inhibitor			4.49, 2.45	57.24	0.95, 0.25	94.04	79.46	1.53	33.64	4.62	98.09	69.30	38.41	31.26	31.36	48.01	61.62	4.32	66.85	69.57	19.64	74.11	80.92	81.77	92.99	55.61	47.07	40.22	81.22	94.22	78.15	50.63	57.24	18.09
BRD-K57569181	CP	pentoxifylline	phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor	TNF, ACHE, ADORA1, ADORA2A, ADRA2B, CHIA, NT5E, PDE4A, PDE4B, PDE5A		5.77, 2.31	57.24	0.63, 0.14	80.81	36.66	67.26	8.88	76.91	12.80	53.30	81.23	57.24	78.63	55.71	66.01	-0.49	13.66	94.28	28.73	97.24	45.31	59.64	83.60	51.32	44.87	13.27	0.88	10.43	86.19	67.32	83.98	80.86
BRD-K94080537	CP	diethyltoluamide	DEET, activator of fly antenna ionotropic receptor IR40a			6.15, 4.23	57.24	0.78, 0.18	94.42	31.31	22.67	50.82	14.74	89.33	13.27	62.51	51.14	12.08	14.52	75.17	6.49	11.97	71.27	3.10	67.34	36.95	72.61	99.89	57.24	98.73	76.25	56.65	14.30	84.52	64.72	70.09	84.39
BRD-K34581968	CP	BMS-536924	insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, AKT1, CCNE1, CDK2, CYP3A4, ERBB2, INSR, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB	IGF-1 inhibitor	4.62, 2.69	57.22	2.15, 0.73	-5.24	85.81	79.02	98.51	57.22	66.12	25.12	-62.12	41.24	86.07	20.02	47.38	14.68	77.11	91.63	99.26	94.14	67.71	70.51	56.64	81.68	11.95	46.86	-37.15	51.91	68.46	43.81	8.43	64.90
BRD-K81521265	CP	dicyclohexylurea	epoxide hydolase inhibitor	EPHX2		5.00, 1.92	57.21	1.08, 0.45	22.30	80.60	21.80	57.21	92.17	18.91	35.55	24.58	51.99	77.55	39.63	69.35	13.74	9.07	96.86	67.86	98.03	41.64	21.94	98.52	58.28	76.29	71.81	-7.69	20.17	76.24	78.01	97.01	15.28
BRD-A60245366	CP	AS-601245	JNK inhibitor	GSK3B, MAPK10, MAPK8, MAPK9, PIM1		5.00, 2.69	57.20	1.81, 0.65	0.00	98.94	78.79	41.91	96.57	57.20	41.50	-70.56	81.17	64.02	78.33	82.03	2.10	7.52	83.96	90.33	75.06	10.41	61.10	25.42	76.49	19.97	59.23	-94.06	-74.38	19.82	37.43	51.68	90.58
BRD-A65282128	CP	cefazolin	cell wall synthesis inhibitor	PON1, SLC22A8		7.76, 3.27	57.16	1.34, 0.35	96.00	43.83	7.91	87.32	53.23	55.26	81.95	56.59	74.46	26.50	88.42	95.32	2.57	50.33	99.19	17.14	85.89	57.16	87.68	39.53	35.22	90.64	28.86	-14.20	60.26	95.57	65.56	81.56	26.60
BRD-K23335153	CP	AMN-082	glutamate receptor positive allosteric modulator	GRM7		3.46, 0.38	57.15	1.10, 0.32	99.72	78.43	77.21	57.44	74.77	5.46	24.91	37.78	57.15	73.56	45.59	70.47	21.38	35.15	30.47	19.47	18.87	35.04	74.91	68.52	-8.39	20.61	71.07	-58.20	88.21	62.97	38.24	69.40	85.96
BRD-K35559145	CP	levomepromazine	dopamine receptor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C	Dopamine receptor antagonist	8.46, 4.23	57.10	0.80, 0.26	8.91	43.26	95.15	60.39	41.67	4.95	81.48	58.54	13.48	66.28	92.59	57.10	3.80	11.94	52.38	13.73	95.46	79.38	41.03	39.70	84.61	83.50	51.88	-99.08	58.57	59.91	17.25	96.91	98.56
BRD-K73196317	CP	urapidil	adrenergic receptor antagonist, serotonin receptor agonist	HTR1A		7.56, 2.67	57.07	1.93, 0.51	79.00	96.79	73.88	41.29	96.10	21.90	57.07	22.52	17.43	99.72	93.00	96.42	13.22	4.12	91.54	51.84	91.32	36.47	86.77	55.25	83.27	17.92	92.21	44.80	3.59	55.33	60.69	61.96	10.24
BRD-K67352070	CP	TC-2559	acetylcholine receptor agonist, acetylcholine receptor ligand	CHRNA4		6.54, 2.31	57.05	1.17, 0.38	56.48	82.97	70.12	20.60	90.31	11.55	90.15	-81.30	22.49	94.82	99.37	77.34	2.22	43.88	67.96	97.66	92.98	42.91	50.93	64.52	87.73	85.48	13.25	21.48	-6.96	57.05	66.28	56.62	38.09
BRD-K83508485	CP	FK-888	tachykinin antagonist	TACR1, TACR2	Tachykinin antagonist	5.77, 3.08	57.02	1.00, 0.35	7.43	59.05	7.31	72.35	52.73	41.43	70.70	63.60	5.43	12.61	58.96	72.28	69.03	89.75	27.70	99.58	12.12	86.25	95.63	55.61	15.59	19.30	9.52	-58.48	90.14	15.29	57.02	76.07	68.89
BRD-K93332168	CP	isocarboxazid	monoamine oxidase inhibitor	MAOA, MAOB		7.31, 4.62	57.01	1.28, 0.35	40.22	-52.59	90.16	13.20	98.59	66.67	51.50	85.82	11.10	75.31	88.53	44.88	2.68	10.64	85.91	25.16	98.27	5.46	77.66	96.50	57.50	90.11	3.03	-0.04	14.29	87.04	40.90	99.86	57.01
BRD-K60460488	CP	nelfinavir	HIV protease inhibitor, proteasome inhibitor	CYP2C19, CYP3A5, CYP3A7	HIV protease inhibitor	7.31, 3.85	57.00	1.32, 0.41	92.15	15.69	56.05	94.89	29.21	0.02	15.44	37.56	28.14	14.80	36.13	99.15	89.20	64.82	94.11	98.59	67.96	91.63	89.77	42.99	36.92	5.36	63.04	98.55	58.05	83.17	57.00	41.82	-41.87
BRD-A95939040	CP	sertaconazole	sterol demethylase inhibitor, cell wall synthesis inhibitor			6.54, 3.85	56.96	0.74, 0.25	72.13	14.84	4.88	60.69	12.45	7.12	99.58	87.54	63.64	97.97	51.35	19.55	16.66	18.17	87.87	38.57	72.87	42.10	56.96	57.91	51.27	32.04	58.37	9.96	94.17	93.30	12.74	98.52	69.28
BRD-K09485525	CP	GANT-61	GLI antagonist	DHH, IHH		3.08, 1.15	56.96	0.76, 0.11	65.48	56.96	81.25	68.95	77.71	36.07	40.13	25.39	27.73	32.60	80.07	68.93	23.08	85.80	11.18	68.09	49.65	94.64	-26.92	70.17	60.47	41.10	50.81	-3.77	86.03	5.96	69.33	79.67	48.38
BRD-K08996725	CP	zolantidine	histamine receptor antagonist			7.69, 4.23	56.94	1.06, 0.39	41.27	33.48	31.59	86.50	55.37	9.75	56.25	46.41	72.89	2.64	-20.46	66.93	77.35	83.82	81.84	95.69	34.61	94.61	56.94	99.47	22.02	58.63	82.30	-24.21	95.42	55.95	32.20	98.84	90.71
BRD-K12994359	CP	valdecoxib	cyclooxygenase inhibitor	PTGS2, CA12, CYP2C19		5.77, 3.85	56.94	0.34, 0.05	43.08	60.59	58.98	98.45	49.48	98.94	16.77	53.61	17.74	57.08	13.32	62.14	90.52	79.68	82.52	99.30	93.13	76.22	50.18	74.26	46.02	41.36	49.64	7.29	11.97	46.81	24.65	56.94	63.42
BRD-A31521121	CP	methocarbamol	muscle relaxant	CA1		8.46, 5.77	56.93	1.09, 0.24	14.28	21.47	80.25	20.56	76.19	49.30	86.48	69.53	21.15	13.50	43.84	84.45	0.00	12.15	88.05	10.32	53.82	62.33	95.51	97.22	77.01	99.58	15.58	9.50	13.26	98.73	56.93	97.05	89.73
BRD-K55591206	CP	epigallocatechin	AP inhibitor, aromatase inhibitor, bacterial efflux pump inhibitor, beta amyloid aggregation inhibitor, beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, DNA gyrase inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, enoyl-(acyl-carrier protein) reductase Fabl inhibitor, fatty acid synthase inhibitor, HCV inhibitor, indoleamine 2,3-dioxygenase inhibitor, NFkB pathway inhibitor, nitric oxide synthase inhibitor, PDGFR tyrosine kinase receptor inhibitor, PPAR receptor agonist, prolyl endopeptidase inhibitor, proteasome inhibitor, sodium/glucose cotransporter inhibitor, telomerase inhibitor, tumor NADH oxidase inhibitor, VEGFR inhibitor	FASN, APP, BACE1, CYP19A1, DYRK1A, ELANE, ENOX2, EP300, IDO1, KAT2B, KDR, MMP14, MMP2, PPARA, PREP, SLC5A1		4.90, 3.27	56.89	0.55, 0.10	61.54	16.49	4.02	30.28	4.09	89.24	53.87	64.05	91.02	87.76	78.47	96.12	-0.58	15.79	90.85	31.96	76.24	38.72	56.89	58.90	73.25	88.72	11.00	59.05	27.70	54.14	73.45	43.71	48.15
BRD-K07736136	CP	VX-702	p38 MAPK inhibitor	MAPK14, MAPK11, MAPK12	P38 MAPK inhibitor	2.31, 0.77	56.85	1.49, 0.30	96.99	56.85	71.26	55.66	76.90	61.03	76.33	-35.48	0.63	62.79	43.93	94.24	36.37	31.32	85.53	98.06	93.00	67.06	76.75	29.23	34.51	55.48	41.88	-33.29	10.24	17.33	95.56	70.71	56.34
BRD-K47717570	CP	NBQX	glutamate receptor antagonist, kainate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B		6.54, 2.69	56.85	0.85, 0.19	32.78	13.01	96.68	15.69	97.53	90.35	4.34	59.68	10.03	50.69	77.24	64.27	-2.11	1.69	56.85	7.68	41.82	26.21	97.78	93.33	82.75	73.70	74.08	95.30	26.90	18.30	47.77	66.01	97.26
BRD-K96271548	CP	coumaric-acid	antioxidant			3.85, 1.54	56.85	1.19, 0.32	10.38	89.62	87.44	22.15	89.61	36.38	44.92	38.03	87.54	67.60	69.92	97.25	2.64	27.25	90.42	1.13	75.91	42.95	35.20	83.43	91.08	89.77	43.65	-83.64	-0.99	67.74	15.79	99.08	56.85
BRD-M41783010	CP	acamprosate	glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5		4.86, 3.24	56.83	1.35, 0.39	53.07	86.35	7.68	45.99	92.17	15.06	99.12	82.53	70.02	97.99	78.43	46.34	0.00	0.03	95.38	2.18	92.16	52.92	56.83	-76.36	50.28	63.50	58.47	-99.93	36.25	65.50	59.38	46.71	85.44
BRD-K17110974	CP	aristolochic-acid	phospholipase inhibitor			5.77, 2.31	56.82	0.75, 0.11	90.37	95.93	57.57	24.93	89.29	41.11	90.46	-52.14	52.91	40.91	43.66	93.84	11.85	28.82	55.51	89.17	20.53	10.91	99.72	93.88	76.36	79.38	43.04	98.33	-11.13	52.74	70.50	93.37	56.82
BRD-K60038276	CP	irbesartan	angiotensin receptor antagonist, liver bile acid transporter inhibitor	AGTR1, JUN, SLC10A1	Angiotensin receptor antagonist	4.62, 2.69	56.82	0.58, 0.17	57.62	81.95	48.32	21.47	96.18	10.80	22.92	42.43	63.07	14.73	53.41	83.10	-0.67	18.56	60.64	7.33	68.90	28.04	85.15	73.52	65.62	42.44	65.08	62.39	53.71	56.82	37.79	61.74	61.48
BRD-K95739795	CP	tetrabenazine	vesicular monoamine transporter inhibitor	SLC18A2, DRD2, SLC18A1		4.08, 2.04	56.82	1.45, 0.44	29.07	-9.32	6.26	18.16	8.02	65.68	-1.82	57.00	9.08	99.82	87.47	82.32	2.26	31.14	91.62	90.84	73.41	8.60	71.14	56.82	45.88	41.92	33.04	84.18	68.86	96.34	57.39	65.41	30.45
BRD-K51918615	CP	iodophenpropit	histamine receptor antagonist, histamine receptor inhibitor, ionotropic glutamate receptor antagonist	HRH3, HRH4, GRIN2B		4.62, 1.54	56.78	1.10, 0.33	4.90	-49.66	65.84	75.52	23.59	17.72	0.99	89.64	56.78	4.99	-14.84	52.66	81.19	63.93	97.89	21.66	90.76	92.62	-17.53	86.69	35.05	61.50	55.30	95.00	96.27	33.35	34.56	82.69	58.31
BRD-K39746403	CP	erythromycin	NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor	CYP3A4, MLNR		9.23, 6.15	56.74	0.74, 0.14	99.13	14.45	13.20	64.72	-1.16	18.69	80.88	82.63	64.74	67.22	11.45	32.61	26.06	75.51	-29.82	3.85	91.58	87.39	95.53	99.34	23.19	1.52	44.06	99.30	99.93	36.22	43.02	56.74	92.72
BRD-A91008255	CP	bepridil	calcium channel blocker, L-type calcium channel blocker	ATP1A1, CACNA1A, CACNA1C, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, SCN5A, TNNC1		3.85, 2.31	56.70	0.27, 0.05	52.05	25.53	31.26	65.21	67.75	34.63	31.58	87.46	74.31	25.77	48.10	87.76	22.84	43.90	64.08	37.21	93.72	83.27	56.70	64.31	73.36	57.77	76.65	9.61	55.32	34.40	19.75	86.87	96.66
BRD-A91452556	CP	estradiol-cypionate	estrogen receptor agonist	ESR1	Estrogen receptor agonist	3.46, 0.77	56.70	1.38, 0.34	79.49	92.18	34.15	48.01	84.89	81.52	27.72	42.48	22.04	44.58	15.26	86.28	40.14	55.22	88.43	15.03	86.20	78.94	26.35	86.15	69.92	96.86	71.59	67.79	12.68	56.70	92.89	40.08	36.19
BRD-K83837640	CP	JNJ-26854165	HDAC inhibitor, MDM inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2		5.77, 3.85	56.60	1.40, 0.39	56.79	33.51	34.39	67.58	15.52	81.48	6.37	38.94	20.46	55.82	51.13	82.04	81.71	84.15	35.95	71.57	69.67	92.50	12.98	44.79	45.29	3.52	64.41	97.65	82.86	75.81	56.60	0.00	98.56
BRD-A40639672	CP	ketorolac	cyclooxygenase inhibitor	PTGS1, PTGS2		5.00, 2.69	56.53	0.77, 0.16	26.03	66.08	56.85	71.08	85.14	58.56	83.20	55.80	17.57	50.22	73.35	62.33	31.61	24.66	72.45	69.21	76.61	1.23	70.20	36.42	56.53	52.72	44.67	28.19	11.11	78.97	46.43	59.25	54.66
BRD-K37194137	CP	III606050	cytochrome P450 inhibitor			6.53, 2.86	56.47	1.08, 0.27	50.96	75.96	20.29	89.80	62.78	20.30	21.58	44.17	5.16	6.41	65.73	80.43	87.17	90.37	63.64	99.61	74.02	76.96	56.47	58.92	44.01	69.60	22.91	0.85	8.48	97.30	18.25	3.05	50.54
BRD-K06159959	CP	CCMQ	inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites			6.92, 3.85	56.46	1.33, 0.48	98.80	67.39	58.22	28.60	92.43	28.40	42.44	20.48	56.46	67.46	94.03	84.97	2.50	56.40	12.02	73.63	8.87	46.10	95.27	73.96	63.80	76.45	5.64	-62.82	57.20	55.96	23.83	99.15	14.69
BRD-K65146499	CP	nabumetone	cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor	PTGS2, AKR1C3, CYP2B6, CYP2C19, CYP2E1, PTGS1	Cyclooxygenase inhibitor	6.53, 2.86	56.46	1.57, 0.33	99.89	16.49	-22.70	9.42	-37.74	89.22	47.64	87.87	2.72	96.52	80.91	65.38	2.40	28.53	99.40	2.01	75.20	6.13	72.16	98.38	7.51	52.24	16.77	99.08	60.31	56.46	63.27	68.37	36.08
BRD-A66435872	CP	HTMT	histamine receptor agonist	HRH4		7.69, 3.85	56.44	1.00, 0.24	94.39	37.45	98.45	40.74	58.47	85.40	58.37	14.76	13.29	99.02	89.90	91.53	13.99	40.73	94.91	51.44	63.32	25.51	88.20	55.28	97.47	56.44	54.23	-0.07	34.23	51.51	29.29	85.27	71.32
BRD-K40645748	CP	mefloquine	acidifying agent non gastric, adenosine receptor antagonist, calmodulin antagonist, hemoglobin antagonist, pannexin inhibitor	ADORA2A, HBA1, PANX1		7.76, 5.31	56.44	1.34, 0.28	35.56	31.66	56.44	90.20	61.80	33.14	0.00	87.56	56.21	2.11	21.31	78.59	77.79	84.33	83.37	98.52	97.94	97.18	7.78	81.31	18.62	32.46	40.07	5.10	95.38	51.37	17.83	64.15	64.63
BRD-K44497846	CP	enalapril	angiotensin converting enzyme inhibitor, angiotensin receptor blocker	ACE		5.31, 2.45	56.41	1.09, 0.33	90.41	32.43	22.87	17.99	25.11	85.86	34.74	69.37	3.28	60.71	71.02	64.92	-1.83	0.00	97.92	2.86	75.82	8.82	88.84	69.53	-62.42	56.41	13.31	-12.68	7.00	98.84	59.49	94.08	58.23
BRD-K22503835	CP	scriptaid	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	3.85, 0.77	56.39	1.80, 0.59	20.89	97.89	34.49	82.28	59.37	35.59	10.09	-21.18	56.77	54.91	16.15	58.99	88.97	87.22	83.70	96.76	12.72	86.60	18.83	49.88	68.57	47.88	82.58	56.39	31.06	3.24	71.54	14.80	60.81
BRD-A83695761	CP	chromanol	potassium channel blocker		Potassium channel blocker	6.53, 4.08	56.35	1.01, 0.31	81.50	56.35	91.20	18.93	33.16	99.22	63.31	59.22	39.78	59.04	22.39	76.87	-16.72	10.31	38.94	2.64	28.27	57.14	98.59	81.06	74.87	62.15	71.59	-1.87	51.11	92.24	48.57	50.65	48.28
BRD-K66896231	CP	BRD-K66896231	acetylcholinesterase inhibitor	ACHE		5.33, 3.56	56.21	1.90, 0.75	40.58	21.42	82.10	26.89	34.99	42.63	81.13	56.21	41.49	53.34	54.13	96.58	66.33	2.30	99.16	2.82	47.37	71.35	81.09	46.96	-24.49	52.32	97.78	61.59	68.23	94.75	57.87	61.47	63.85
BRD-K36198571	CP	WAY-170523	metalloproteinase inhibitor	MMP13		5.38, 1.92	56.20	1.30, 0.38	13.54	89.89	63.41	93.35	85.31	17.93	-28.13	13.03	22.24	58.28	15.65	64.57	94.61	94.15	88.11	99.61	77.51	96.12	27.82	38.25	73.61	45.86	22.96	97.22	49.61	23.17	56.20	-20.42	36.13
BRD-K06753942	CP	nobiletin	MEK phosphorylation inhibitor, nitric oxide synthase expression inhibitor, P glycoprotein inhibitor, tyrosinase inhibitor	ABCB1, MAP2K1, TYR		7.31, 3.85	56.09	0.42, 0.13	4.85	89.14	88.94	52.96	81.76	80.50	24.71	-50.87	59.53	30.14	71.14	77.63	2.11	35.40	98.45	97.24	77.04	89.21	36.45	44.22	63.09	56.09	41.26	-96.61	3.88	92.22	23.25	47.28	80.34
BRD-K33860217	CP	CP-94253	serotonin receptor agonist	HTR1B		8.46, 5.00	56.03	1.03, 0.28	41.60	50.64	72.57	70.47	56.03	95.53	17.66	42.05	91.39	76.59	56.50	85.56	2.33	5.42	78.18	2.50	95.17	43.17	37.54	99.89	55.61	74.15	15.34	88.71	75.47	36.88	33.77	55.91	99.58
BRD-K29178788	CP	dictamnine	furoquinoline alkaloid that causes smooth muscle contraction			6.87, 4.58	55.99	1.32, 0.44	-15.38	40.50	95.58	19.75	99.05	22.55	14.44	71.55	79.25	4.13	59.33	52.65	-0.60	12.17	97.60	72.13	73.38	43.17	38.22	65.09	91.47	98.77	37.83	NaN	10.45	26.42	89.54	80.13	98.66
BRD-A04706586	CP	bucladesine	adenosine receptor agonist, cAMP stimulant, vasodilator	PRKACA		3.85, 2.31	55.96	0.68, 0.18	99.93	28.00	91.46	42.72	62.26	89.91	54.71	72.58	68.76	45.76	29.18	85.17	-13.24	19.07	64.25	-65.44	75.53	47.79	40.81	77.69	87.86	53.53	55.96	-23.71	31.66	62.49	15.00	79.97	72.68
BRD-K21680192	CP	mitoxantrone	topoisomerase inhibitor, DNA intercalating drug, HCV inhibitor, immunosuppressant, Pim kinase inhibitor	TOP2A, PIM1	Topoisomerase inhibitor	6.12, 4.08	55.93	2.56, 0.70	56.23	99.72	96.33	52.77	97.19	92.14	61.55	-80.36	92.33	5.74	91.60	87.49	50.83	59.65	98.48	99.44	34.76	30.24	-24.02	50.49	91.78	51.15	36.13	-25.32	-29.44	39.21	55.93	55.20	56.06
BRD-K50018155	CP	RS-67506	serotonin receptor partial agonist	HTR4		5.38, 3.46	55.92	0.85, 0.16	78.66	38.28	77.53	10.68	55.92	13.65	99.44	55.85	81.84	39.57	21.87	5.92	-2.11	4.33	15.27	-95.69	75.64	46.76	99.23	96.51	57.73	83.40	26.76	98.80	99.37	91.17	28.30	86.68	95.61
BRD-K21936341	CP	oxotremorine	acetylcholine receptor agonist	CHRM2, CHRM1, CHRM3, CHRM4		7.35, 4.08	55.89	1.61, 0.50	91.44	60.45	37.66	23.34	73.55	84.52	8.32	54.65	13.22	98.97	29.85	90.26	29.76	41.33	94.65	12.58	55.89	37.76	56.89	91.33	83.62	28.27	53.63	98.91	5.76	55.97	69.16	97.43	-12.82
BRD-K23583188	CP	lavendustin-a	EGFR inhibitor, tyrosine kinase inhibitor	EGFR, LCK		5.77, 2.69	55.80	1.42, 0.33	28.22	25.12	9.54	21.11	30.47	77.39	14.53	88.60	33.93	33.46	28.75	96.03	6.44	5.29	78.05	2.66	71.92	25.78	94.86	98.01	55.80	75.48	61.68	90.22	89.71	65.51	30.11	67.27	83.43
BRD-K24132293	CP	piperlongumine	glutathione transferase inhibitor			3.85, 1.54	55.80	2.11, 0.70	73.52	98.20	59.17	43.13	64.19	35.19	1.38	32.50	39.08	33.28	5.95	67.70	86.31	95.93	74.64	98.04	90.52	71.36	31.25	55.23	80.61	71.48	55.80	68.61	2.47	24.80	42.77	13.25	51.85
BRD-A92177080	CP	betamethasone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	2.69, 0.77	55.75	1.30, 0.82	86.11	76.47	4.03	74.29	44.30	84.25	40.29	49.08	31.26	46.19	55.75	69.13	16.94	56.12	69.56	85.84	77.01	11.84	50.87	64.54	24.30	90.31	28.60	1.87	16.39	69.07	87.59	64.47	40.03
BRD-K45435259	CP	SCH-23390	dopamine receptor antagonist	DRD1, DRD5, HTR2C, KCNJ4, KCNJ6		6.92, 2.69	55.75	1.02, 0.28	12.59	86.40	46.54	69.53	84.04	38.69	49.37	22.67	98.04	90.44	74.84	45.36	0.92	8.83	81.17	15.46	30.80	40.06	99.17	65.29	80.28	56.07	11.82	-93.68	37.07	94.19	55.75	56.38	94.09
BRD-K40992116	CP	parachlorophenol	disinfectant			3.08, 1.15	55.68	1.11, 0.33	39.36	57.96	90.99	65.78	98.84	19.05	49.01	55.68	49.05	25.15	55.38	37.24	8.91	41.65	91.06	58.69	76.81	85.90	54.95	81.15	89.18	57.30	35.29	-40.93	18.18	83.05	41.07	93.61	78.92
BRD-A53077924	CP	tianeptine	selective serotonin reuptake enhancer (SSRE), serotonin reuptake enhancer, serotonin uptake enhancer	SLC6A4		5.31, 2.04	55.65	1.05, 0.33	15.63	74.79	96.34	10.55	48.77	45.60	65.04	65.54	68.50	98.10	90.60	84.08	10.78	80.24	34.70	1.87	19.38	35.21	98.80	73.10	85.13	89.38	21.79	-88.83	30.32	22.81	55.65	31.93	78.76
BRD-K09635314	CP	M-3M3FBS	phospholipase activator	PLCB2, PLCB3, PLCD1, PLCG1, PLCG2		1.92, 1.15	55.64	0.63, 0.10	86.66	53.44	44.43	10.07	59.37	90.92	72.75	69.22	22.24	73.50	59.60	70.79	2.75	10.21	55.83	10.00	53.23	9.28	73.03	64.03	30.26	73.41	16.34	-73.27	38.27	55.64	43.69	93.34	57.29
BRD-A26334849	CP	propafenone	antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker	KCNH2, SCN5A, ADRB1, ADRB2, KCNA5, KCNK2, KCNK3		6.54, 2.31	55.61	0.89, 0.17	28.76	92.14	78.96	40.01	95.13	13.32	63.82	89.25	27.31	95.42	91.16	90.61	5.10	21.40	36.23	4.26	89.79	46.39	12.25	6.61	55.61	12.82	79.86	-0.81	79.64	94.54	43.58	81.61	98.64
BRD-A11990600	CP	lorazepam	chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	Benzodiazepine receptor agonist	7.56, 4.00	55.53	1.08, 0.33	54.56	52.71	81.16	20.03	71.95	19.36	83.44	99.31	94.77	81.56	74.66	90.92	21.48	4.75	7.89	41.07	94.67	63.43	38.87	6.76	98.84	16.19	23.16	1.68	77.08	68.63	96.67	19.67	55.53
BRD-K14282469	CP	LY-165163	serotonin receptor antagonist	HTR1A, HTR1D	Serotonin receptor antagonist	6.92, 3.08	55.53	0.91, 0.23	37.80	40.80	19.78	82.98	36.92	53.69	97.06	55.53	12.88	12.78	12.55	40.20	44.73	68.65	83.42	81.87	42.35	94.22	61.98	65.69	64.57	91.56	42.50	51.72	85.69	69.88	75.39	96.75	44.72
BRD-K46056750	CP	AZD-7762	CHK inhibitor	CHEK1, CHEK2		8.85, 5.38	55.52	1.49, 0.57	43.62	96.76	85.62	99.75	81.41	94.96	1.59	-10.85	26.45	97.55	15.31	96.22	57.64	91.39	98.91	98.93	52.26	94.36	-49.25	21.42	89.62	76.36	16.97	-12.93	55.52	43.71	26.88	15.79	38.35
BRD-K33818169	CP	GW-3965	LXR agonist, ABC transporter expression enhancer	NR1H2, NR1H3, ABCA1		4.62, 3.08	55.49	0.90, 0.35	71.33	25.18	42.29	56.33	18.39	98.10	39.49	74.28	5.60	81.39	88.90	70.02	17.56	68.83	87.69	45.89	10.25	16.26	40.60	57.37	55.49	19.20	26.56	97.36	30.92	87.17	15.56	76.27	94.50
BRD-K33193182	CP	methylnorlichexanthone	Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor	AURKB, KDR, PIM1		5.34, 1.53	55.49	0.85, 0.25	89.92	-67.15	78.67	21.13	25.90	46.42	95.84	89.37	41.60	96.91	96.06	63.14	-5.78	12.95	48.07	-3.22	98.20	22.89	88.47	55.45	-41.30	66.43	19.68	NaN	84.29	67.96	55.52	50.12	99.26
BRD-K18742343	CP	H-8	PKA inhibitor	PKIA, PRKACA	PKA inhibitor	4.23, 0.77	55.43	1.00, 0.30	90.33	73.76	39.05	20.29	65.27	47.18	59.64	48.39	22.44	95.43	71.24	88.21	0.00	10.41	63.83	-24.04	34.13	17.54	60.27	84.11	55.43	91.93	46.47	30.88	79.15	73.31	8.89	88.49	12.20
BRD-K93645900	CP	tadalafil	phosphodiesterase inhibitor	PDE5A, PDE11A		4.23, 1.54	55.43	0.43, 0.08	30.54	24.39	11.26	23.59	65.43	28.43	42.76	79.14	88.30	90.79	61.13	75.75	-2.43	-4.32	19.07	19.28	78.11	43.97	57.66	55.43	87.84	44.66	56.88	0.00	75.12	78.29	85.13	79.08	2.78
BRD-K94919853	CP	10H-phenothiazin-10-yl)(p-tolyl)methanone	BCHE inhibitor	BCHE		3.67, 1.63	55.43	0.89, 0.24	88.48	55.43	66.76	8.23	65.43	27.07	14.04	77.61	70.93	99.22	27.18	55.81	5.37	4.33	69.72	-42.04	70.08	13.23	21.82	35.11	-41.34	52.70	82.52	-28.12	6.91	66.05	57.54	60.68	96.48
BRD-K66353228	CP	zoxazolamine	IKCa channel activator			3.85, 0.77	55.39	0.56, 0.11	8.11	63.33	95.70	55.26	90.56	23.58	43.57	55.39	9.55	46.09	21.35	32.15	17.99	-10.51	69.64	0.99	81.52	12.60	95.51	83.05	82.74	67.20	71.69	94.22	57.55	16.75	55.57	69.73	46.93
BRD-K72420232	CP	WZ-4002	EGFR inhibitor	EGFR, ERBB2	EGFR inhibitor	4.62, 1.92	55.35	1.35, 0.40	67.47	73.62	91.26	92.17	25.05	22.17	74.51	86.53	29.41	6.28	29.19	55.35	77.69	95.14	80.40	98.34	30.29	87.27	69.40	30.30	14.43	43.48	48.82	49.87	91.43	50.82	31.08	32.20	66.15
BRD-K02637541	CP	celecoxib	cyclooxygenase inhibitor, caspase activator	PTGS2, CA12, CASP3, CYP2C19, PDPK1		2.69, 1.54	55.34	0.74, 0.09	96.20	65.09	38.07	32.65	17.95	56.42	54.51	54.92	50.35	89.15	66.50	54.14	16.50	33.44	61.11	69.85	93.45	45.36	90.23	83.11	65.95	28.26	38.34	-42.79	69.68	53.40	63.20	55.34	78.89
BRD-A37776212	CP	ICI-204448	opioid receptor agonist	OPRK1		4.08, 1.22	55.33	0.93, 0.23	94.92	46.14	55.33	12.09	35.88	91.38	83.53	72.11	17.06	90.24	81.60	98.20	5.21	23.68	61.28	-2.41	78.03	54.41	99.05	35.07	67.15	15.53	29.11	-0.85	48.36	95.67	70.99	32.88	87.96
BRD-K10974103	CP	diloxanide	unidentified pharmacological activity			4.23, 1.92	55.30	0.47, 0.09	19.22	24.89	85.33	63.13	66.62	19.41	32.49	57.81	39.26	49.65	55.30	54.56	3.31	17.86	98.02	63.07	88.61	79.22	47.23	83.71	79.19	35.20	87.54	49.92	28.74	40.46	65.98	67.11	82.18
BRD-K13544237	CP	r(-)-propylnorapomorphine	dopamine receptor agonist, antiamyloidogenic agent	DRD2, DRD1, DRD3		3.08, 1.92	55.30	0.68, 0.19	96.37	21.91	72.58	27.00	54.99	43.03	20.81	83.68	63.30	42.26	49.58	66.89	16.71	54.80	70.70	58.16	17.00	62.97	48.89	79.29	19.75	78.28	35.96	0.51	56.88	66.55	83.84	85.29	55.30
BRD-A25569250	CP	KI-16425	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3		3.46, 2.31	55.24	1.16, 0.22	72.96	92.81	42.36	62.28	97.21	73.18	52.26	30.85	39.02	41.61	61.80	87.38	2.96	37.74	94.31	41.57	84.26	14.26	33.51	55.24	87.68	58.38	68.56	1.66	77.40	39.40	89.80	53.02	-58.37
BRD-A51393488	CP	noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor	BDKRB2, SIGMAR1		4.62, 2.69	55.24	0.63, 0.10	21.83	-55.45	83.27	36.71	-39.33	57.46	41.03	25.08	21.58	5.39	55.24	76.79	2.82	-6.89	43.37	93.35	72.48	76.90	70.72	91.56	12.49	73.32	33.17	99.15	69.07	55.63	10.61	65.42	74.73
BRD-K87142802	CP	veliparib	PARP inhibitor, DNA repair enzyme inhibitor	PARP1, PARP2	PARP inhibitor	7.31, 4.23	55.22	1.06, 0.25	99.58	36.81	99.79	0.95	77.78	56.88	33.55	41.82	74.92	54.48	19.59	79.76	-79.09	9.90	74.61	5.62	61.63	16.73	99.58	82.08	88.30	43.46	36.10	98.91	82.13	37.32	55.22	62.94	41.29
BRD-K79602928	CP	metformin	insulin sensitizer, AMPK activator, biguanide, gluconeogenesis inhibitor	ACACB, INS, PRKAB1		5.31, 2.04	55.21	1.72, 0.47	55.21	97.57	95.36	52.81	59.03	54.87	3.52	15.96	69.48	50.10	68.16	87.82	22.51	9.58	98.03	87.16	65.43	83.84	41.28	47.73	69.69	67.30	74.00	16.36	-14.62	21.23	32.82	74.16	15.73
BRD-K70281171	CP	U-99194	dopamine receptor antagonist	DRD3		6.92, 3.85	55.20	1.11, 0.27	6.26	90.12	83.08	54.55	89.32	12.86	96.49	7.82	94.45	32.23	97.47	76.68	0.00	8.94	55.20	19.88	48.84	43.68	87.27	38.86	82.74	81.42	31.46	-99.26	71.12	21.89	56.87	95.63	65.73
BRD-K93034159	CP	cladribine	adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor	ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B	Ribonucleotide reductase inhibitor	3.85, 2.31	55.18	1.42, 0.52	99.26	49.37	47.68	64.96	24.15	8.61	42.46	25.77	75.15	87.98	93.62	86.15	78.01	55.18	74.32	99.54	45.51	30.21	61.63	46.77	85.95	36.76	50.56	89.18	15.91	72.60	55.24	54.11	23.01
BRD-K85871428	CP	SC-68376	p38 MAPK inhibitor	MAPK14		6.92, 5.77	55.17	0.84, 0.26	12.61	83.74	77.88	30.17	91.84	40.32	68.10	55.17	19.33	44.73	13.96	82.26	14.28	44.77	45.81	12.88	80.66	77.95	21.08	87.03	35.74	99.61	91.09	1.30	63.75	18.43	86.54	82.25	56.44
BRD-K52989797	CP	clomipramine	serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor	SLC6A4, SLC6A2, CYP2C19, GSTP1, HTR2A, HTR2B, HTR2C, SLC6A3	Tricyclic antidepressant	5.38, 3.46	55.14	0.86, 0.22	61.46	55.14	32.58	64.10	83.91	5.68	14.24	82.34	9.52	50.72	29.99	62.55	65.22	87.83	53.81	23.18	32.87	95.86	42.55	45.65	76.91	67.01	26.80	68.00	91.58	76.78	31.71	54.63	73.36
BRD-K73109821	CP	diazoxide	ATP channel activator, potassium channel activator	ATP1A1, CA1, CA2, KCNJ11, KCNMA1, SLC12A3		5.77, 2.31	55.13	1.05, 0.27	71.05	46.47	96.56	15.39	98.56	25.22	77.02	36.44	96.58	14.77	31.80	45.17	3.14	15.01	42.35	17.38	78.13	35.12	5.71	87.29	55.13	84.02	89.92	-2.22	59.22	61.42	90.46	79.04	96.57
BRD-K22662435	CP	ganciclovir	DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor, DNA synthesis inhibitor		DNA polymerase inhibitor	6.12, 2.45	55.12	1.63, 0.35	0.39	94.14	71.33	49.68	95.71	68.84	53.67	55.12	8.81	21.80	3.15	87.92	20.19	8.26	92.73	59.65	93.53	52.26	94.56	77.66	97.16	45.96	88.30	95.84	31.96	12.57	63.93	6.88	36.07
BRD-K37516142	CP	idebenone	calcium channel modulator, reducing agent			6.67, 3.11	55.10	0.86, 0.18	44.24	17.36	88.94	11.52	24.19	32.15	67.82	88.88	70.72	95.63	75.56	89.35	15.32	22.58	80.81	93.79	94.96	57.39	35.99	27.93	38.65	81.07	8.22	-52.78	23.05	96.43	55.10	43.69	91.79
BRD-K13926615	CP	vardenafil	phosphodiesterase inhibitor	PDE5A, CYP2C19, CYP2C8, CYP3A5, PDE6G, PDE6H		4.62, 3.08	55.01	0.99, 0.28	95.84	22.06	8.95	14.78	72.07	15.65	42.15	72.42	11.14	96.90	50.69	47.14	6.25	24.16	43.62	8.22	59.59	34.05	97.36	65.78	55.10	46.44	68.25	99.47	55.66	90.51	55.01	86.31	58.99
BRD-K67080878	CP	milrinone	phosphodiesterase inhibitor	PDE3A, PDE2A, PDE3B, PDE5A		10.38, 5.77	55.00	0.42, 0.07	70.78	96.50	6.18	22.36	36.77	88.86	99.98	83.46	88.90	78.77	34.08	84.57	-54.58	11.78	66.19	-2.71	55.00	4.43	98.70	76.65	50.74	24.11	83.03	8.32	53.92	91.73	54.00	54.22	95.85
BRD-K54314721	CP	zolmitriptan	serotonin receptor agonist	HTR1B, HTR1D, HTR1A, HTR1F, HTR1E		3.46, 1.92	54.99	0.59, 0.14	83.16	-63.56	18.64	23.69	46.13	54.90	63.86	74.83	17.71	89.91	92.96	82.17	-2.82	-2.04	90.79	-1.48	90.17	14.78	76.52	60.69	54.62	39.29	25.24	4.03	54.99	93.13	74.13	78.61	73.75
BRD-A17453586	CP	MDL-72832	serotonin receptor agonist	HTR1A		8.08, 4.23	54.93	0.91, 0.24	-2.82	97.50	45.48	46.42	77.27	29.60	93.28	51.90	96.20	96.87	54.93	32.27	23.27	61.33	62.81	66.15	99.19	78.47	21.51	54.21	86.05	78.67	38.72	-65.20	72.41	44.60	41.16	97.83	42.14
BRD-A64125466	CP	dehydrocholic-acid	gastrointestinal agent that stimulates bile production or the flow of bile into the duodenum			3.08, 1.15	54.92	0.50, 0.16	89.47	78.46	86.79	10.14	89.44	18.44	5.73	54.92	36.05	81.80	82.11	79.45	2.78	5.28	45.05	16.34	78.89	44.01	23.18	39.17	74.61	90.65	79.70	78.21	67.49	14.60	46.42	92.17	32.28
BRD-K27141178	CP	SB-203186	serotonin receptor antagonist	HTR4		6.94, 3.67	54.92	1.80, 0.59	-31.72	96.09	75.73	8.90	78.69	99.86	10.05	76.23	54.92	98.86	35.17	92.98	0.00	7.95	56.06	30.18	97.22	38.26	36.15	80.42	75.11	62.75	71.54	-1.16	-7.61	43.09	19.10	51.53	93.21
BRD-K63165456	CP	norcyclobenzaprine	adrenergic receptor ligand, serotonin receptor ligand	HTR2A	Serotonin receptor antagonist	6.54, 4.62	54.90	0.90, 0.20	38.56	36.28	61.95	54.90	34.84	18.89	34.59	63.06	16.91	78.93	29.86	63.01	25.30	74.22	7.43	7.86	22.11	96.09	31.72	44.44	71.11	79.99	77.90	64.83	99.93	62.73	28.46	84.36	90.61
BRD-K93480852	CP	KN-93	calcium/calmodulin dependent protein kinase inhibitor	CAMK2A		7.31, 3.46	54.90	0.61, 0.08	96.73	54.90	37.10	89.40	18.47	76.12	8.74	30.48	28.69	49.34	13.84	53.73	79.01	91.58	77.59	90.52	85.65	97.89	27.11	98.17	20.28	56.08	7.47	21.75	83.07	68.94	38.16	50.03	88.82
BRD-K15791587	CP	L-733060	tachykinin antagonist	TACR1	Tachykinin antagonist	6.54, 4.23	54.87	1.56, 0.66	8.05	7.47	37.05	84.59	17.93	5.16	51.33	76.42	17.95	74.02	20.22	26.72	71.15	88.82	45.56	69.29	68.67	98.34	76.87	80.19	82.54	54.87	7.52	-0.53	99.84	16.52	19.10	94.63	80.21
BRD-K89997465	CP	chlorpromazine	dopamine receptor, dopamine receptor antagonist, Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors	DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, ADRA1A, ADRA1B, ADRA1D, CALM1, CHRM1, CHRM3, HRH4, HTR2B, KCNH2, KIF11, ORM1, ORM2, SMPD1, TRPC5	Dopamine receptor antagonist	9.23, 4.23	54.83	1.59, 0.63	23.78	19.09	68.82	91.17	57.71	22.27	15.37	52.68	51.47	56.08	-2.83	53.47	85.69	96.83	95.07	95.11	91.96	97.96	22.21	54.83	75.21	10.26	17.31	21.79	97.54	48.92	45.52	66.23	81.79
BRD-K22227508	CP	targinine	nitric oxide synthase inhibitor	NOS2, NOS3		8.00, 6.22	54.78	2.35, 0.69	52.16	97.89	24.76	41.89	85.82	17.51	97.31	94.41	39.23	99.25	94.87	99.61	0.12	18.00	57.94	16.55	7.89	11.81	82.10	18.02	73.90	77.40	54.78	-39.22	12.77	98.05	98.77	78.02	23.52
BRD-K40619305	CP	larixinic-acid	comopund that interacts with metal centers			6.15, 3.08	54.78	1.18, 0.39	22.29	4.65	90.15	24.44	69.63	10.93	66.70	-71.91	7.07	59.85	72.75	78.72	0.00	29.48	70.67	0.00	50.15	54.78	87.12	69.80	96.46	76.80	23.35	95.72	41.78	69.38	79.07	50.33	23.02
BRD-A14208071	CP	oxyphenonium	acetylcholine receptor antagonist	CHRM1		6.54, 3.08	54.74	1.41, 0.40	11.61	65.23	98.36	47.37	90.16	43.88	55.11	54.74	42.19	96.11	93.68	92.75	7.60	0.00	68.97	7.74	25.51	21.58	19.62	46.14	98.94	79.25	76.40	-21.17	-0.85	22.02	77.69	80.27	89.75
BRD-K75532464	CP	FTI-276	farnesyltransferase inhibitor	FNTA, FNTB		5.00, 1.92	54.65	0.58, 0.22	99.52	46.29	78.14	8.57	79.26	92.50	20.14	78.85	14.96	17.03	31.65	93.36	-82.47	31.28	73.94	-18.11	76.54	21.42	69.54	61.40	80.47	83.42	46.26	81.02	12.86	40.35	44.12	59.46	54.65
BRD-A81402010	CP	KU-C103443N	CDC inhibitor, rho GTPase inhibitor			2.86, 2.04	54.63	0.75, 0.23	18.76	46.17	59.28	92.16	55.17	37.04	57.60	70.51	10.68	54.24	11.65	74.86	64.76	62.49	25.03	86.67	85.68	59.72	14.64	48.61	16.71	-16.87	5.56	71.19	5.32	54.63	75.51	72.44	43.94
BRD-K10843433	CP	phenylbutazone	cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1, PTGIS		4.62, 3.46	54.63	0.66, 0.13	41.84	69.48	43.08	31.11	72.15	63.10	93.62	56.48	54.63	8.03	19.85	50.68	1.97	31.29	98.52	14.72	68.25	38.99	67.37	57.89	69.68	99.54	35.30	-46.39	-38.57	66.00	27.05	64.90	56.89
BRD-K92428232	CP	GSK-461364	PLK inhibitor	PLK1		6.54, 1.15	54.62	1.40, 0.31	10.59	73.36	18.92	80.79	92.57	58.22	23.75	22.50	21.65	7.07	5.38	25.85	83.21	90.26	68.11	60.12	98.06	92.24	92.89	36.82	34.28	54.62	31.99	96.94	96.85	3.24	41.93	20.56	73.01
BRD-A94709349	CP	metaxalone	muscle relaxant			4.62, 1.54	54.61	0.88, 0.30	5.18	81.97	99.86	59.07	88.10	9.45	91.45	54.61	60.93	7.86	32.56	59.05	0.00	9.65	72.58	77.73	98.77	15.48	50.15	3.77	48.63	10.33	67.58	-49.98	-13.43	64.68	22.28	96.30	83.89
BRD-A36217750	CP	sulfinpyrazone	platelet aggregation inhibitor	ABCC1, ABCC2, FPR1, SLC22A12		5.71, 3.67	54.58	0.36, 0.06	58.44	17.88	85.52	2.89	55.15	30.24	65.38	63.99	51.59	43.95	80.03	84.02	-0.92	0.92	80.06	7.47	70.50	19.54	54.58	81.05	86.60	68.12	18.59	-14.36	-7.39	52.85	69.50	49.42	58.65
BRD-K17075857	CP	chloroxine	opioid receptor inhibitor	OPRK1		6.15, 3.08	54.57	1.31, 0.13	97.99	93.36	96.30	86.99	86.72	16.32	17.64	50.33	20.03	80.76	25.37	76.75	95.95	91.95	52.48	99.96	79.28	78.33	31.25	25.87	54.57	22.68	3.84	11.61	77.07	40.91	35.56	74.22	34.77
BRD-K17306061	CP	aprepitant	tachykinin antagonist	TACR1, CYP2C19		4.23, 1.92	54.56	1.22, 0.30	83.91	-32.85	22.68	57.43	54.56	18.79	53.65	84.00	16.54	10.66	53.79	79.49	-20.79	0.92	75.60	-4.58	94.18	63.18	89.68	67.28	9.80	18.11	-10.59	97.33	88.85	77.71	5.82	99.12	80.68
BRD-K39462424	CP	dexchlorpheniramine	histamine receptor antagonist			6.15, 2.69	54.51	1.17, 0.39	8.94	92.49	17.68	31.64	46.56	26.09	94.51	-51.61	6.34	95.99	92.53	46.70	7.69	70.26	54.51	67.14	77.78	57.68	38.51	22.90	97.09	61.52	10.95	-90.43	85.77	51.00	93.22	92.20	87.16
BRD-A60294240	CP	tribenoside	vasoprotective agent			6.12, 3.67	54.50	1.05, 0.33	97.88	34.84	82.73	26.18	46.62	99.89	46.20	53.93	15.59	17.98	91.76	83.66	1.25	57.93	25.39	23.54	74.49	65.63	21.88	53.46	83.15	92.16	68.54	-62.18	-2.49	54.50	65.31	86.62	88.00
BRD-K68065987	CP	MK-2206	AKT inhibitor	AKT1, AKT2, AKT3		7.69, 1.92	54.43	1.82, 0.36	10.37	33.41	84.33	95.89	27.11	6.94	43.18	-17.40	34.52	28.26	7.89	54.43	87.84	96.29	95.52	88.56	37.36	97.39	11.89	61.06	75.15	28.29	63.05	-51.82	97.32	34.41	56.16	54.86	59.58
BRD-K67017579	CP	cilostazol	phosphodiesterase inhibitor, platelet aggregation inhibitor	PDE3A, CYP2C19, CYP3A5, PDE3B		5.00, 3.46	54.41	1.17, 0.38	99.89	44.85	8.46	15.38	93.34	28.15	5.26	69.84	8.54	78.76	15.35	59.68	38.09	17.44	99.05	5.15	98.20	54.41	91.40	95.11	-45.50	53.94	43.28	96.25	77.36	23.21	91.12	89.22	89.73
BRD-A56359832	CP	zileuton	leukotriene synthesis inhibitor, lipoxygenase inhibitor	ALOX5		3.46, 1.15	54.36	0.57, 0.07	34.46	8.20	85.80	31.67	46.42	50.12	54.75	92.37	36.74	37.37	80.00	79.29	-48.51	49.87	90.46	-1.44	59.37	17.47	65.95	89.88	33.84	42.93	68.76	91.78	54.36	90.43	24.18	73.11	59.94
BRD-K92138166	CP	mammea-a	cytotoxic, antibacterial			4.23, 2.31	54.36	0.55, 0.08	83.16	14.42	34.18	74.94	27.93	14.85	54.14	90.11	44.94	54.36	76.11	5.64	85.08	72.59	44.04	98.94	95.55	85.93	61.45	78.10	37.74	14.93	3.28	3.46	77.85	24.39	59.20	75.56	50.83
BRD-K01567962	CP	pyrazolanthrone	JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor	MAPK10, MAPK8, MAPK9, TTK, LRRK2, MAPK8IP1		7.31, 3.46	54.35	0.68, 0.16	94.26	50.30	17.14	92.25	52.22	24.26	10.90	71.86	4.93	1.62	32.08	66.48	68.80	75.13	80.71	97.91	85.42	40.29	54.71	99.89	53.97	53.48	59.74	97.02	54.35	51.99	37.36	82.46	15.21
BRD-K72222507	CP	quinapril	angiotensin converting enzyme inhibitor	ACE		5.77, 3.08	54.29	0.57, 0.11	72.49	39.73	46.66	3.49	57.18	-11.92	54.29	75.90	60.88	98.66	52.88	22.63	1.16	18.77	82.21	10.89	84.86	-2.15	84.56	67.71	78.69	40.05	8.10	0.85	96.16	60.61	42.60	75.17	58.58
BRD-K78959463	CP	FPL-64176	calcium channel agonist, L-type calcium channel activator	CACNA1C, CACNA1S		3.08, 1.54	54.28	0.98, 0.39	82.85	-6.41	-2.18	66.24	-22.00	74.45	62.35	80.92	56.81	21.50	20.20	49.25	12.77	1.48	8.49	-0.83	91.65	54.28	91.54	93.37	52.91	52.63	30.37	90.73	81.54	90.40	59.91	40.69	65.25
BRD-A72988804	CP	tiaprofenic-acid	cyclooxygenase inhibitor	PTGS2, PTGS1		5.31, 2.04	54.27	1.32, 0.48	96.67	73.22	96.90	20.46	69.43	93.96	28.05	-75.37	40.70	81.53	36.31	97.19	3.61	34.26	90.45	6.63	56.54	54.27	59.59	53.13	71.92	91.32	37.44	-0.04	-9.07	20.17	73.82	7.59	60.37
BRD-K14821540	CP	FCCP	mitochondrial oxidative phosphorylation uncoupler			6.92, 4.62	54.25	1.90, 0.72	76.39	81.32	92.48	99.08	92.92	5.74	1.76	37.19	28.16	53.34	5.65	83.42	99.58	95.96	80.33	99.93	54.25	96.23	18.35	73.04	42.60	48.18	8.86	-36.78	58.00	25.26	25.64	55.30	41.22
BRD-K59522102	CP	piperine	monoamine oxidase inhibitor, ACAT inhibitor	MAOA, MAOB, TRPV1		7.31, 3.08	54.21	0.70, 0.17	96.28	34.15	2.29	44.24	88.95	4.98	13.84	55.57	57.35	17.49	54.56	47.91	3.17	37.58	78.88	3.93	76.33	-3.38	65.56	99.30	54.21	24.59	30.15	96.75	25.19	63.91	57.29	92.26	64.78
BRD-K50417881	CP	eticlopride	dopamine receptor antagonist	DRD2, DRD3, DRD4		4.49, 2.04	54.14	1.05, 0.25	93.41	16.59	93.99	41.83	30.31	70.60	38.80	44.62	84.88	39.93	33.92	79.03	56.98	73.40	94.38	10.17	88.57	59.54	75.25	54.14	15.99	51.25	26.72	94.42	89.29	51.56	7.43	64.50	10.31
BRD-K83322645	CP	L-693403	sigma receptor antagonist, sigma receptor ligand	DRD2, SIGMAR1		4.62, 1.92	54.13	1.06, 0.28	54.75	-33.72	62.75	56.58	28.99	32.67	74.01	52.33	41.69	75.73	54.13	64.07	0.00	30.50	40.09	-4.94	73.82	35.69	86.23	97.26	57.16	38.67	82.37	99.86	54.51	72.45	30.24	53.76	45.10
BRD-K65417056	CP	meprylcaine	anesthetic			5.77, 2.31	54.12	0.45, 0.11	48.13	74.79	16.90	25.95	87.84	5.47	96.03	-38.08	21.77	25.59	66.78	81.05	5.82	33.51	82.69	16.84	54.12	77.10	65.56	40.21	54.47	66.11	61.45	89.74	51.10	66.62	39.48	80.50	47.43
BRD-K88759641	CP	EMD-66684	angiotensin receptor antagonist	AGTR1		6.15, 3.46	54.06	1.19, 0.43	99.96	50.63	20.31	63.98	72.68	98.38	76.84	58.68	78.15	50.96	47.58	54.06	0.00	19.17	15.80	16.37	93.56	6.51	89.32	99.54	55.50	26.68	15.09	0.00	36.72	97.40	45.54	89.79	91.95
BRD-K50938786	CP	ropivacaine	membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker	SCN10A, SCN9A		3.46, 1.15	54.00	1.15, 0.35	99.93	92.30	88.99	47.31	6.94	33.74	94.19	54.00	44.23	97.01	92.14	73.16	2.50	18.81	49.51	6.68	80.82	80.94	97.04	40.84	96.23	82.20	12.37	0.78	10.93	89.19	31.72	28.05	62.76
BRD-K37798499	CP	etoposide	topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor	TOP2A, CYP2E1, CYP3A5, TOP2B	Topoisomerase inhibitor	3.11, 1.78	53.99	2.69, 0.78	19.43	73.64	79.59	71.71	29.94	45.32	12.33	53.99	31.44	65.42	76.32	95.07	86.43	57.01	46.36	99.65	87.84	5.32	22.62	80.92	87.59	56.46	35.16	0.00	-48.98	99.33	40.05	26.39	12.95
BRD-K89626439	CP	sirolimus	mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor	MTOR, FKBP1A, CCR5, FGF2	MTOR inhibitor	6.94, 2.86	53.99	1.99, 0.56	9.96	49.73	22.43	97.25	81.48	48.67	6.48	75.29	7.84	37.02	16.94	80.71	82.59	80.59	67.97	99.75	86.23	81.09	-10.92	53.99	30.53	14.62	9.62	-36.31	73.63	91.14	54.00	48.13	69.79
BRD-A06726973	CP	dibutyrylcyclic-gmp	cGMP analog			6.15, 2.31	53.98	0.98, 0.30	66.27	46.55	71.03	1.97	98.01	30.84	0.99	22.12	62.01	86.57	14.79	70.45	0.00	18.31	82.12	24.75	32.10	26.47	78.35	98.47	81.14	40.69	53.98	98.23	88.73	77.92	25.41	89.84	27.46
BRD-K73589491	CP	nizatidine	histamine receptor antagonist	HRH2		3.85, 1.92	53.97	0.59, 0.14	86.13	8.25	11.23	30.82	61.16	90.17	88.15	79.25	44.25	23.24	33.31	95.22	-3.28	-0.39	36.18	4.26	72.63	18.94	59.00	56.18	25.52	59.96	3.21	15.81	58.24	93.33	67.22	71.58	53.97
BRD-K46742498	CP	alosetron	serotonin receptor antagonist	HTR3A		7.56, 5.33	53.93	1.31, 0.35	20.16	52.40	80.92	12.84	83.47	35.89	46.32	99.15	83.42	98.12	97.83	84.36	3.55	30.05	3.04	77.63	86.32	32.73	93.53	60.28	99.33	53.93	40.34	4.75	9.53	48.54	79.93	68.35	27.71
BRD-K90789829	CP	nefazodone	serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor	HTR2A, SLC6A4, HTR2C, SLC6A2, ADRA1A, ADRA1B, ADRA2A, CYP3A4, CYP3A5, CYP3A7, HTR1A, SLC6A3		4.62, 2.31	53.91	0.60, 0.16	85.37	22.35	64.91	41.11	45.71	61.82	36.94	33.44	8.21	83.65	64.11	80.83	44.72	20.63	97.04	90.49	99.78	68.64	47.65	78.97	53.91	63.71	49.08	95.87	76.68	47.71	41.82	53.59	14.19
BRD-K99107520	CP	felbamate	carbonic anhydrase inhibitor, GABA receptor modulator, glutamate receptor blocker	GRIN2A, GRIN2B, GRIN3A		4.62, 1.54	53.91	0.57, 0.11	58.41	40.33	6.00	78.06	47.01	33.23	85.33	-35.22	57.70	86.63	44.81	69.59	-0.63	3.81	86.08	5.61	66.21	22.53	53.47	53.91	45.79	63.99	30.20	90.85	-5.36	83.02	70.54	76.97	70.83
BRD-A31312900	CP	montelukast	leukotriene receptor antagonist	CYSLTR1, ALOX5, CYP2C8		7.76, 4.49	53.90	1.17, 0.31	29.16	53.90	99.25	28.96	75.28	93.56	23.88	99.79	42.54	76.67	3.00	81.56	-3.02	34.73	36.21	-22.74	97.38	67.76	26.94	57.24	12.48	69.95	63.26	18.70	85.89	32.91	46.79	78.58	75.24
BRD-K27710560	CP	splitomycin	SIRT inhibitor	SIRT1, SIRT2		6.12, 3.67	53.90	1.26, 0.49	90.67	77.19	86.35	8.90	45.62	62.68	31.85	49.39	34.93	86.95	41.72	84.59	1.20	41.83	21.42	7.47	78.50	17.61	99.93	73.28	84.51	75.87	53.90	94.29	71.02	95.98	19.70	28.54	11.73
BRD-K68132782	CP	terbinafine	fungal squalene monooxygenase inhibitor, squalene epoxidase inhibitor, steroid sulfatase inhibitor	CYP2C19, CYP2C8, SQLE		5.71, 1.63	53.90	0.82, 0.14	96.27	83.06	19.92	68.46	52.92	26.77	24.78	20.48	7.47	75.22	52.82	95.89	20.90	15.72	60.38	61.51	97.22	63.14	93.27	66.25	53.90	27.62	91.02	20.59	26.13	86.67	69.02	47.67	28.41
BRD-K80396088	CP	gliquidone	sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue	ABCC8, KCNJ10, KCNJ11, KCNJ8	KCNJ11 modulator	3.46, 1.92	53.88	0.72, 0.24	29.35	-37.21	5.02	13.67	52.07	49.22	49.08	80.21	9.78	62.59	94.00	67.82	1.87	-12.17	91.65	87.40	71.50	32.12	89.80	77.95	-41.41	68.55	-14.95	62.56	53.88	68.36	17.67	63.24	95.91
BRD-K21667562	CP	AM-404	FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist	TRPV1, CNR1, CNR2, FAAH		5.38, 3.08	53.87	1.23, 0.27	64.13	39.35	76.51	39.51	89.13	72.07	51.25	31.03	52.96	67.22	21.38	73.98	12.49	42.94	92.24	96.42	79.71	15.16	78.15	98.11	53.87	33.32	90.19	2.95	23.22	28.41	30.32	97.90	80.04
BRD-K71103788	CP	duloxetine	norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, SLC6A3, HTR2A, HTR2C, HTR6		5.77, 3.85	53.85	0.49, 0.14	18.40	-17.42	25.52	88.44	28.98	63.45	35.09	73.47	75.37	7.42	48.00	29.46	58.62	88.92	75.59	30.44	80.53	93.25	37.47	32.20	71.64	28.05	56.48	-6.21	90.24	53.85	41.44	78.10	90.57
BRD-K37561857	CP	zardaverine	phosphodiesterase inhibitor	PDE4D, PDE3A, PDE4A, PDE4B, PDE4C		8.46, 3.08	53.77	0.61, 0.11	46.10	23.98	35.20	47.62	94.08	6.86	18.08	53.77	94.68	63.32	49.52	73.94	0.21	1.76	93.58	14.51	97.32	54.29	47.64	86.84	94.03	77.97	78.81	95.57	66.22	33.56	36.61	79.61	53.35
BRD-K40758068	CP	efavirenz	HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5		6.67, 3.11	53.77	0.74, 0.20	17.16	40.87	43.15	33.00	52.18	23.31	78.62	73.60	-6.30	54.71	71.33	65.03	2.99	0.01	95.79	8.72	99.58	4.90	23.41	72.90	86.25	53.77	62.05	89.82	80.97	42.02	86.54	54.23	0.32
BRD-K86930074	CP	cediranib	VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist	KDR, FLT1, FLT4, KIT, PDGFRB, CSF1R, FLT3, PDGFRA	PDGFR/KIT inhibitor, VEGFR inhibitor	7.69, 4.62	53.73	1.56, 0.56	0.00	54.05	76.78	95.89	67.09	19.60	18.95	50.33	18.51	38.54	26.76	97.18	75.85	99.65	95.69	99.54	2.18	94.12	-6.56	60.77	14.35	54.06	40.13	-48.50	66.47	39.65	78.48	45.05	53.73
BRD-K55127134	CP	fluphenazine	dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist	DRD2, DRD1, CALM1, CHRNA7, DRD5, HRH1, HTR2A, HTR6, HTR7	Dopamine receptor antagonist	6.92, 3.85	53.72	1.40, 0.49	63.28	15.71	83.34	53.72	14.05	47.88	45.34	34.97	20.17	36.91	12.72	47.42	58.21	94.89	88.41	87.22	46.69	96.65	83.66	70.80	77.10	49.82	32.66	87.48	99.37	72.97	30.93	45.66	56.94
BRD-K58299615	CP	RO-90-7501	amyloid precursor protein inhibitor, beta amyloid aggregation inhibitor	APP		7.76, 2.45	53.72	1.18, 0.27	9.03	95.74	97.22	8.73	81.13	24.94	28.81	-38.81	95.22	94.97	53.72	87.62	13.91	63.23	18.43	49.15	92.82	39.57	99.51	61.37	96.78	60.85	86.74	-93.89	22.70	28.34	44.47	75.14	40.66
BRD-K35723520	CP	darinaparsin	apoptosis stimulant, NADPH oxidase stimulant			6.92, 3.85	53.71	1.13, 0.31	90.49	16.68	94.47	0.81	17.90	99.35	81.73	70.48	24.53	23.83	48.01	86.24	-69.39	16.58	91.18	-39.06	69.92	45.04	76.88	78.35	53.71	95.50	33.29	95.22	32.98	93.92	35.28	81.80	43.10
BRD-K56047318	CP	RHC-80267	triacylglycerol lipase inhibitor	DAGLA, DAGLB, LIPC, LIPE, LIPG		5.00, 3.08	53.68	0.72, 0.19	12.01	84.56	31.02	22.81	69.45	56.09	81.07	-64.01	17.32	67.29	60.36	48.42	-1.87	65.51	28.74	2.33	39.37	53.68	99.15	54.77	54.48	67.80	9.30	35.44	64.57	78.87	33.96	56.12	12.12
BRD-K40782193	CP	QX-222	sodium channel blocker			4.49, 2.45	53.67	1.09, 0.33	88.48	54.72	89.28	39.01	42.55	77.05	10.09	69.65	38.77	86.93	55.72	28.83	3.02	56.49	71.42	2.82	68.99	12.49	96.37	77.16	53.67	15.55	59.20	38.68	19.04	81.25	49.88	43.17	42.74
BRD-K53878242	CP	MMPX	phosphodiesterase inhibitor			6.54, 3.08	53.67	0.97, 0.36	12.69	11.84	96.65	18.03	68.36	44.88	88.29	53.67	91.96	18.68	93.58	63.32	2.33	1.16	99.47	8.80	94.03	25.07	25.69	98.03	98.03	22.04	12.03	72.87	-38.72	53.93	82.76	79.74	18.04
BRD-A51714012	CP	venlafaxine	serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine reputake inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A4, CYP2C19, SLC6A3		3.08, 0.77	53.66	0.63, 0.15	95.71	70.75	8.05	30.94	74.09	76.02	57.50	21.96	7.83	66.70	63.89	11.73	-5.78	19.61	91.90	2.82	78.80	20.47	43.56	66.06	68.78	53.66	41.28	0.04	11.67	42.00	60.76	59.82	58.41
BRD-A81866333	CP	CGS-21680	adenosine receptor agonist	ADORA2A, ADORA1, ADORA2B, ADORA3	Adenosine receptor agonist	3.08, 1.54	53.65	0.98, 0.35	46.44	53.65	93.30	60.94	83.98	12.34	95.76	21.74	99.93	57.57	68.43	76.22	1.83	11.71	71.97	2.33	-76.05	17.35	65.72	61.37	88.22	29.32	68.31	-16.43	38.10	29.95	21.39	75.98	21.42
BRD-K67100011	CP	pivmecillinam	cell wall synthesis inhibitor			5.00, 2.31	53.45	1.03, 0.27	99.65	42.11	13.80	44.49	91.29	93.10	15.99	92.95	53.45	65.69	9.62	33.75	6.61	35.44	9.83	11.98	82.35	61.99	65.28	93.02	47.42	87.18	10.65	-0.85	15.69	64.17	74.19	91.54	87.32
BRD-K95609758	CP	BMS-191011	large conductance calcium activated potassium channel opener, large conductance potassium channel activator	KCNMA1	Potassium channel activator	2.69, 0.77	53.43	1.52, 0.33	75.04	42.18	93.64	23.28	84.39	55.64	32.67	85.34	81.81	23.26	30.78	85.48	-81.61	29.31	55.84	-98.79	81.45	19.58	53.43	86.23	28.64	19.77	66.95	-4.99	7.86	98.45	54.20	29.75	71.32
BRD-K33864865	CP	LY-225910	CCK receptor antagonist	CCKBR	CCK receptor antagonist	4.62, 2.31	53.40	0.90, 0.19	99.34	13.09	92.45	65.36	35.00	88.15	47.89	36.73	15.74	59.60	80.37	47.69	37.94	55.73	83.82	94.97	53.11	36.34	49.37	92.49	-68.32	53.40	7.29	18.46	65.80	93.00	17.70	62.58	62.58
BRD-K92000912	CP	AM-251	ACAT inhibitor, cannabinoid receptor antagonist, cannabinoid receptor inverse agonist	CNR1, GPR18, GPR55		6.54, 3.08	53.38	0.55, 0.14	44.45	29.37	60.36	60.40	49.05	66.37	18.41	31.09	8.88	95.83	31.04	56.24	22.94	58.29	52.56	96.25	88.67	48.75	49.23	85.24	98.10	38.52	76.40	7.81	53.38	71.41	44.84	59.12	69.10
BRD-A48430263	CP	pioglitazone	PPAR receptor agonist, insulin sensitizer, adiponectin expression enhancer, thiazolidinedione	PPARG, INS, TRPM3	PPAR receptor agonist	5.00, 2.69	53.36	0.41, 0.10	46.14	14.63	18.82	1.10	59.24	83.55	20.92	55.85	44.39	65.05	79.60	54.94	1.09	10.05	76.73	6.90	74.53	16.53	65.25	53.36	82.08	71.65	46.81	95.75	74.33	76.85	28.25	35.96	41.09
BRD-K05350981	CP	oligomycin-c	ATP synthase inhibitor, regulatory volume decrease inhibitor	ATP5A1	ATP synthase inhibitor, ATPase inhibitor	6.67, 1.78	53.33	1.44, 0.43	71.08	21.15	18.93	84.64	36.05	21.48	3.29	45.09	5.60	57.18	51.49	95.35	88.93	91.01	96.95	99.96	74.68	90.36	11.72	57.95	53.33	28.87	59.97	0.42	3.39	81.48	92.85	29.68	0.11
BRD-K70301876	CP	escitalopram	selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor	SLC6A4, ADRA1A, CHRM1, CYP2C19, HRH1, SLC6A2, SLC6A3		8.85, 3.85	53.28	0.45, 0.13	99.72	9.49	7.38	19.13	36.95	30.65	50.14	73.46	60.10	64.48	31.38	72.71	-0.60	1.76	96.25	4.31	96.23	34.99	53.28	76.98	56.25	34.23	71.21	16.92	47.68	60.37	88.22	88.62	94.03
BRD-K83023055	CP	GR-135531	melatonin receptor agonist			4.08, 2.04	53.28	1.18, 0.34	98.63	12.31	9.80	62.37	35.63	84.28	27.36	80.70	17.70	49.60	46.95	42.97	5.57	-9.14	75.56	21.20	87.18	45.78	96.35	53.28	86.82	88.92	71.01	80.60	33.43	77.42	61.59	18.58	66.20
BRD-A84702196	CP	penicillin	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	5.38, 2.31	53.27	1.33, 0.38	11.51	79.99	96.69	15.68	69.45	93.57	76.97	51.55	76.75	21.34	7.26	83.97	3.17	19.01	43.76	2.68	67.51	67.81	92.76	53.27	92.28	82.11	12.89	-99.30	7.66	6.59	75.17	50.35	60.36
BRD-K91243525	CP	SR-142948	neurotensin receptor antagonist	NTSR1		6.15, 4.23	53.27	1.27, 0.38	76.04	11.73	6.77	6.45	26.96	71.36	75.06	68.85	53.27	96.54	80.95	52.38	-11.22	2.88	-50.25	5.63	91.84	25.08	29.75	90.91	75.23	85.63	11.40	-75.67	99.43	89.02	46.14	57.67	84.57
BRD-K44442813	CP	pidotimod	interferon receptor agonist, interleukin receptor agonist, T cell stimulant			5.33, 2.67	53.21	1.86, 0.65	28.33	26.64	48.11	30.86	78.88	-0.02	27.07	6.39	62.90	53.21	31.72	97.74	47.78	34.40	87.17	92.24	54.16	38.13	89.92	73.99	71.67	93.51	96.93	14.86	26.36	90.67	81.20	60.27	7.08
BRD-K13810148	CP	givinostat	HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor	HDAC2, HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, IL1B, IL1R2, IL6R, TNF	HDAC inhibitor	3.27, 0.41	53.19	1.35, 0.48	28.75	96.79	8.90	63.95	33.32	27.72	38.84	-38.89	26.83	2.47	-3.03	88.29	76.07	83.45	96.26	53.19	76.31	77.71	4.97	74.69	61.85	8.42	22.95	31.61	3.77	63.26	94.18	96.83	78.63
BRD-A25234499	CP	aminoglutethimide	antiglucocorticoid, aromatase inhibitor, corticosteroid antagonist, steroid sulfatase inhibitor	CYP19A1, CYP11A1, NR3C1		6.15, 3.46	53.18	0.45, 0.10	82.55	45.74	71.27	57.83	84.98	25.75	30.02	76.54	21.62	96.19	48.01	83.20	2.40	11.27	72.85	21.19	87.42	13.95	85.10	46.29	51.53	81.44	63.03	0.04	82.62	49.54	17.02	89.78	53.18
BRD-K68392338	CP	ZK-93426	benzodiazepine receptor agonist, benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA5		5.77, 3.08	53.18	1.15, 0.33	90.55	28.71	88.22	57.68	53.12	30.47	44.73	87.08	46.85	67.71	57.42	78.01	7.05	3.76	92.07	99.47	33.56	20.78	83.50	92.06	55.71	73.14	52.10	12.46	-39.68	79.33	53.18	46.67	28.33
BRD-K78084463	CP	W-12	calmodulin antagonist			3.82, 3.05	53.17	1.39, 0.38	2.69	86.47	99.89	35.16	94.86	91.86	2.93	-59.13	24.60	78.81	66.65	49.68	4.19	0.28	90.86	80.92	39.90	64.85	10.74	97.61	94.88	77.03	36.17	NaN	-23.48	18.55	58.11	56.67	-59.20
BRD-K87990216	CP	piretanide	diuretic, glucocorticoid receptor agonist	SLC12A1, SLC12A2		6.54, 2.69	53.14	1.20, 0.41	53.14	96.15	94.24	32.57	90.07	67.30	-1.32	-24.18	48.16	43.11	89.50	34.40	17.39	1.94	99.08	86.64	97.15	23.72	65.54	86.09	86.57	35.54	84.42	99.30	49.04	33.41	46.24	93.29	6.17
BRD-K49481516	CP	galantamine	acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors	ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG		6.22, 2.67	53.13	1.66, 0.57	80.30	84.35	59.15	40.78	91.55	55.97	80.10	53.13	42.27	68.94	93.62	97.33	43.11	27.76	7.06	27.98	44.38	45.51	48.30	80.20	47.76	59.42	91.31	-4.98	23.02	90.28	96.51	48.23	43.72
BRD-K87024524	CP	phenelzine	monoamine oxidase inhibitor	MAOB, AOC3, MAOA, ABAT, GAD2, GPT, GPT2, SLC6A2, SLC6A3, SLC6A4		6.15, 4.23	53.13	0.74, 0.17	35.42	66.22	53.50	49.66	76.95	62.32	9.20	73.30	91.47	90.53	51.33	98.16	10.20	18.15	68.05	1.30	89.46	45.70	30.52	53.97	43.02	53.13	76.31	1.87	35.26	92.15	69.13	44.90	14.29
BRD-A30435184	CP	metergoline	dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor	DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Serotonin receptor antagonist	6.94, 4.08	53.12	1.90, 0.58	43.66	38.62	94.40	92.72	23.51	93.55	11.20	53.12	25.92	41.36	15.24	92.64	88.16	99.47	64.30	99.58	49.43	99.15	44.71	85.24	38.55	32.04	76.59	9.59	98.26	74.62	65.37	32.52	26.65
BRD-A19633847	CP	perhexiline	carnitine palmitoyltransferase binder, carnitine palmitoyltransferase inhibitor	CPT1A, CPT2		8.08, 3.85	53.09	2.63, 0.72	10.04	63.21	53.09	94.69	54.71	13.01	16.01	63.70	27.47	11.54	10.00	60.61	98.77	99.01	85.38	99.44	21.19	97.89	24.14	23.09	53.71	25.44	35.65	76.54	95.38	63.40	21.77	20.06	14.26
BRD-K59753853	CP	MDL-29951	glutamate receptor antagonist, fructose biphosphate inhibitor, UDP/CysLT (GPR17, P2Y-like) Agonists	FBP1, GPR17		4.62, 1.15	53.09	1.28, 0.45	61.58	61.35	90.00	22.82	60.28	56.57	53.09	80.35	18.54	54.51	23.98	71.21	1.55	8.29	82.11	7.49	87.35	48.92	29.31	40.42	98.73	77.83	86.60	-40.53	43.83	2.11	50.61	46.31	94.72
BRD-K32501161	CP	vanoxerine	dopamine reuptake inhibitor, dopamine transporter inhibitor, monoamine oxidase inhibitor	SLC6A3, MAOA, MAOB		3.85, 1.92	53.08	1.47, 0.31	57.42	66.62	34.95	86.96	50.80	21.27	44.73	64.00	25.38	77.28	37.57	58.06	83.98	82.75	96.25	99.58	91.40	71.19	22.49	53.08	39.10	14.95	5.05	-47.85	90.20	33.15	35.45	77.30	5.78
BRD-K20755323	CP	SA-792728	sphingosine kinase inhibitor, ATPase inhibitor	SPHK1, VCP		3.85, 1.54	53.07	1.88, 0.68	53.07	43.97	87.21	84.55	75.94	11.65	3.49	67.99	67.04	46.64	10.70	62.65	91.51	92.10	74.82	99.75	48.51	90.38	57.95	74.60	49.64	31.75	14.14	-89.53	74.89	30.04	16.23	40.51	49.15
BRD-A56675431	CP	altizide	thiazide diuretic		Na-K-Cl transporter inhibitor	4.90, 1.63	52.99	1.28, 0.43	96.49	11.70	31.15	27.17	18.22	87.77	20.77	66.89	52.99	15.34	59.12	82.81	-2.78	-1.96	74.51	1.52	0.32	11.50	78.90	82.22	81.90	78.99	67.60	31.00	19.97	56.51	74.97	72.24	43.11
BRD-K49890030	CP	gavestinel	glutamate receptor antagonist, glycine receptor antagonist	GLRB		4.62, 3.08	52.98	1.19, 0.34	97.63	29.94	60.99	73.78	25.67	19.78	79.04	43.02	77.94	11.22	41.23	67.87	5.21	11.51	62.96	2.38	73.32	27.57	87.31	98.52	9.80	85.85	39.09	96.22	18.17	52.98	16.64	94.89	53.30
BRD-A75769826	CP	SDM25N	opioid receptor antagonist	OPRD1		4.62, 3.08	52.97	0.41, 0.07	13.80	26.56	64.61	20.90	52.35	90.31	52.97	84.71	79.95	76.66	64.27	29.69	5.74	83.92	79.91	66.91	26.53	83.42	99.43	27.02	87.87	63.94	23.72	-2.78	89.42	12.52	9.80	43.60	35.91
BRD-A83892713	CP	rifampicin	DNA directed RNA polymerase inhibitor, enzyme inducer	NR1I2, ABCB1, CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5, SLCO1A2, SLCO1B1, SLCO1B3		7.76, 4.08	52.97	1.26, 0.34	8.04	82.82	94.76	12.94	56.95	33.81	59.47	62.11	17.42	13.89	52.97	90.70	33.36	20.29	11.53	40.17	23.32	16.27	99.65	94.68	98.29	87.84	65.93	-0.49	-11.19	98.45	74.77	54.47	43.77
BRD-K30697463	CP	desoximetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	4.23, 1.54	52.94	1.52, 0.51	13.28	63.46	7.22	75.78	64.24	73.21	88.58	34.68	20.93	68.68	14.24	17.23	5.21	80.97	79.19	52.00	80.69	39.58	23.43	65.27	94.04	65.48	52.94	-7.77	57.50	31.65	46.65	65.14	23.06
BRD-K14200658	CP	syrosingopine	vesicular monoamine transporter inhibitor	SLC18A2, SLC18A1		7.69, 3.85	52.92	0.92, 0.30	98.23	11.01	29.69	89.59	-1.23	32.41	61.61	42.51	14.99	6.36	55.40	52.92	34.58	65.92	97.99	94.91	74.63	86.10	70.60	69.13	6.62	17.47	22.41	37.88	80.33	33.87	27.45	79.85	53.05
BRD-K63945320	CP	dihydrosamidin	nitric oxide production inhibitor, phospholipase inhibitor, platelet activating factor receptor antagonist			5.38, 2.31	52.90	0.44, 0.09	8.69	65.47	72.00	19.39	81.97	8.58	52.90	-34.98	64.45	33.91	50.92	69.42	39.28	4.83	97.57	60.35	90.20	29.68	57.82	96.14	48.03	57.86	9.94	-1.09	15.66	52.97	72.26	66.79	36.67
BRD-K29530284	CP	amlexanox	histamine release inhibitor, mediator release inhibitor	FGF1, IL3, S100A12, S100A13		7.11, 4.00	52.87	1.24, 0.34	33.24	20.53	74.86	38.88	70.58	7.71	5.47	91.55	88.12	7.90	99.33	79.89	6.87	2.10	97.50	97.06	98.77	50.14	47.48	59.04	-30.43	28.94	89.51	0.85	93.84	88.95	52.87	53.35	3.44
BRD-K50891186	CP	GR-103691	dopamine receptor antagonist		Dopamine receptor antagonist	5.31, 3.67	52.87	1.63, 0.51	99.82	19.83	86.84	55.54	38.78	80.91	14.97	-21.03	52.17	40.70	71.16	81.51	52.87	90.36	46.59	52.64	44.29	96.75	53.69	10.47	79.33	75.95	30.47	-43.80	61.83	72.90	10.10	15.57	77.17
BRD-K14536225	CP	piceid	glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor	GAA, XDH		4.49, 2.04	52.85	1.11, 0.41	72.18	9.30	91.36	5.64	78.61	91.42	70.87	33.06	13.22	46.98	63.25	55.04	-2.18	2.11	82.83	60.19	67.52	9.06	33.26	58.28	68.50	43.73	16.71	-98.01	-2.99	57.24	77.66	52.85	-7.96
BRD-M47937986	CP	cefatrizine	cell wall synthesis inhibitor			6.67, 2.67	52.85	0.83, 0.25	34.16	1.76	23.77	3.30	60.48	35.67	6.48	80.09	-8.25	65.61	13.87	42.05	2.04	43.25	74.53	7.11	98.24	17.71	88.33	96.11	58.45	65.89	59.23	60.07	26.59	52.85	85.49	82.31	98.47
BRD-K72783841	CP	tyrphostin-AG-555	CDK inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	CDK2, EGFR		2.69, 0.77	52.83	1.20, 0.32	21.64	43.10	83.42	56.79	16.14	52.99	19.68	-14.16	96.58	14.93	52.83	87.24	81.28	82.29	79.97	73.35	36.79	62.10	41.99	77.71	20.27	59.87	19.65	68.92	42.39	20.05	43.92	27.72	76.99
BRD-K63430059	CP	methoxsalen	acetylcholinesterase inhibitor, cytochrome P450 inhibitor, DNA damaging, DNA synthesis inhibitor, immunosuppressant	ACHE, CYP1A2		4.49, 1.63	52.81	1.16, 0.31	7.08	66.96	93.47	24.16	67.37	67.86	21.30	-62.71	53.70	81.35	91.83	82.92	0.99	12.98	95.77	26.31	60.17	32.85	97.38	52.55	35.83	52.81	49.64	-86.90	16.21	95.60	47.70	59.01	56.88
BRD-A87387433	CP	cefpodoxime	cell wall synthesis inhibitor			8.00, 4.89	52.78	1.22, 0.39	5.97	82.56	68.07	41.37	49.33	92.78	44.51	85.28	23.77	52.78	73.55	97.61	0.07	34.94	74.29	38.51	96.11	12.49	87.79	58.76	82.99	67.09	14.29	12.89	27.65	86.23	97.85	34.28	41.38
BRD-K52020312	CP	metronidazole	DNA inhibitor	CYP2C8, CYP2E1, CYP3A5, CYP3A7		10.67, 7.11	52.77	1.66, 0.42	13.35	94.67	76.25	37.42	91.87	89.31	14.40	30.57	95.06	81.86	76.20	99.98	15.26	18.14	53.33	36.53	52.77	47.44	-16.79	62.93	73.76	21.17	60.64	-1.26	-19.63	93.29	92.00	36.50	5.64
BRD-K92731339	CP	perindopril	angiotensin converting enzyme inhibitor	ACE		5.38, 4.23	52.77	0.61, 0.22	78.02	-4.21	4.26	0.56	13.03	76.55	53.98	91.78	29.74	9.64	9.21	62.59	-5.74	-5.54	74.75	3.99	52.77	14.27	61.19	98.89	4.79	23.93	4.97	70.80	60.07	55.78	65.02	97.12	61.92
BRD-K06593056	CP	LE-135	retinoid receptor agonist	RARB		6.92, 3.46	52.76	0.53, 0.05	66.16	25.10	56.54	90.56	30.90	43.15	25.38	70.65	3.88	52.76	33.28	43.16	97.85	86.54	19.50	99.86	67.15	78.27	18.78	58.58	80.92	29.73	17.03	17.76	7.47	55.31	26.82	55.82	79.80
BRD-K62374253	CP	rufloxacin	topoisomerase inhibitor		Bacterial DNA gyrase inhibitor	11.11, 4.89	52.72	1.00, 0.24	71.35	50.17	75.88	0.64	52.71	78.45	33.61	85.88	15.99	46.78	81.26	80.38	2.67	51.44	99.82	27.84	99.79	43.39	38.68	95.57	88.04	59.66	78.36	-79.22	52.72	80.60	95.17	1.02	11.69
BRD-K76304753	CP	phenazopyridine	unidentified pharmacological activity	SCN1A		4.62, 3.08	52.66	0.52, 0.19	29.55	79.84	88.03	31.50	94.04	10.32	32.60	61.62	42.26	39.75	52.66	48.46	10.63	0.67	99.58	97.96	97.88	72.05	60.19	49.15	72.59	75.70	36.05	-0.07	33.12	20.55	72.06	89.87	70.02
BRD-A80213327	CP	NSC-23766	RAC1 GTPase inhibitor			5.00, 2.69	52.63	0.67, 0.17	80.31	52.63	98.55	18.32	82.66	52.58	15.87	36.86	32.10	73.82	60.85	79.49	2.33	8.10	83.43	10.06	96.92	25.61	23.09	58.91	91.39	63.03	24.76	-45.65	43.85	57.22	46.83	72.62	61.08
BRD-A22256192	CP	terazosin	adrenergic receptor antagonist	ADRA1D, ADRA1A, ADRA1B, KCNH2, KCNH6, KCNH7		5.00, 2.69	52.60	0.55, 0.11	80.23	54.71	3.82	10.00	83.82	45.44	26.28	55.76	62.08	61.33	31.18	90.69	-28.86	19.71	94.28	1.16	89.12	16.68	93.62	33.92	59.10	61.98	81.24	16.76	22.35	93.73	40.43	22.33	52.60
BRD-K56509348	CP	BMS-182874	endothelin receptor antagonist	EDNRA		8.16, 2.86	52.60	1.15, 0.31	65.09	42.45	52.60	3.97	4.84	89.18	70.46	91.57	53.48	78.44	22.76	86.66	-1.44	14.08	71.20	2.59	93.10	7.49	99.89	20.12	68.64	97.89	32.03	99.75	96.97	52.03	51.48	44.87	11.69
BRD-K69688083	CP	mestinon	cholinesterase inhibitor	ACHE, BCHE		9.22, 4.15	52.60	2.26, 0.53	78.77	97.57	97.41	5.62	86.28	74.21	40.42	58.19	69.78	43.69	99.72	96.52	11.57	14.11	98.52	52.60	22.33	27.53	51.11	19.36	41.44	69.14	72.21	1.83	49.60	99.93	33.39	92.51	7.83
BRD-K34820100	CP	tebuthiuron	photosynthesis inhibitor			3.46, 0.38	52.57	0.59, 0.14	28.03	64.26	28.71	32.19	78.06	70.35	57.74	76.51	6.08	25.02	60.54	69.92	0.00	2.04	93.44	90.88	96.97	6.48	46.24	52.57	87.98	95.70	17.96	14.02	6.98	28.51	92.25	91.94	45.17
BRD-A07875874	CP	cilnidipine	calcium channel blocker, L-type calcium channel blocker, N-type calcium channel blocker	CACNA1B, CACNA1C		5.00, 1.15	52.56	0.75, 0.28	81.69	15.90	78.98	78.05	94.01	54.62	-32.49	76.69	24.35	6.14	80.08	66.29	51.05	45.13	86.49	97.87	90.60	33.39	-28.00	68.51	24.79	16.72	32.85	-27.19	50.43	39.51	52.56	82.16	53.23
BRD-A39290993	CP	cyproterone	androgen receptor antagonist, DNA directed DNA polymerase stimunlant, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant, progesterone receptor agonist, testosterone receptor antagonist	AR, ADORA1, ESR1	Androgen receptor modulator, Progesterone receptor antagonist	3.85, 2.31	52.56	1.01, 0.23	10.56	68.56	86.83	53.13	97.66	44.21	78.66	80.32	57.98	10.67	51.46	82.02	23.73	24.94	54.14	26.55	23.15	32.35	-20.82	52.56	71.35	36.90	94.14	0.56	-0.53	66.57	57.92	47.32	93.92
BRD-K11163873	CP	phenanthridone	PARP inhibitor	PARP1	PARP inhibitor	3.85, 2.31	52.53	1.27, 0.39	61.51	23.46	65.28	75.56	79.35	22.51	19.58	55.99	26.77	25.57	32.31	62.32	18.16	50.94	81.09	52.53	57.39	16.63	14.00	98.29	36.92	64.33	41.27	72.54	43.65	48.74	56.46	98.63	57.21
BRD-K32164935	CP	tolazamide	ATP channel blocker	KCNJ1, KCNJ10		5.00, 2.31	52.51	0.97, 0.33	44.98	73.92	69.49	37.27	57.02	27.06	76.95	52.51	36.30	55.08	87.85	69.57	5.92	39.14	72.51	12.50	58.59	18.26	9.27	45.31	80.25	72.18	12.43	-89.55	39.06	73.91	41.83	77.24	54.99
BRD-K71731651	CP	PNU-120596	acetylcholine receptor modulator, acetylcholine receptor positive allosteric modulator	CHRNA7		3.08, 1.92	52.51	1.24, 0.47	92.76	26.60	0.00	29.11	31.18	43.35	99.47	53.34	25.27	57.47	11.44	63.78	-12.32	17.52	33.08	-7.11	-23.02	0.00	92.57	52.51	-8.28	78.50	57.11	93.32	83.83	84.74	72.52	66.36	69.08
BRD-K12079898	CP	PD-160170	neuropeptide receptor antagonist	NPY1R		6.54, 4.23	52.50	1.17, 0.32	51.00	22.16	85.33	41.17	29.26	17.73	28.70	89.33	8.27	91.17	99.50	84.65	52.50	73.40	14.06	64.10	87.99	76.43	17.42	35.13	77.04	34.19	8.67	-10.19	99.86	56.08	11.37	80.16	67.96
BRD-K90027355	CP	spironolactone	mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker	NR3C2, AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, KCNA5, KCND3, NR3C1, PGR, SCNN1A, SHBG		6.54, 3.85	52.40	0.53, 0.15	20.03	72.52	63.66	27.50	52.40	20.87	98.98	78.94	32.50	60.89	63.11	39.05	-9.44	36.46	37.41	1.81	87.62	32.15	74.02	72.33	81.93	69.40	34.84	-54.82	35.79	92.83	50.42	92.21	81.12
BRD-K71499074	CP	diclofenamide	carbonic anhydrase inhibitor	CA1, CA2, CA4, CA12, CA7		5.00, 1.92	52.39	0.74, 0.23	44.07	72.82	15.36	51.90	38.21	46.95	88.12	36.12	9.88	99.68	70.10	30.07	-0.60	34.72	97.67	63.33	59.90	18.07	84.52	66.29	85.33	83.49	34.65	91.81	44.61	88.66	75.56	52.39	28.50
BRD-A07440155	CP	labetalol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRA1A, ADRA1D, ADRA1B		6.54, 1.92	52.36	0.61, 0.19	57.97	28.27	33.90	34.30	8.58	44.60	65.71	79.20	84.15	12.46	4.56	56.10	2.26	40.70	90.30	16.26	98.22	24.62	38.29	97.08	6.73	69.48	67.64	46.00	52.36	82.43	66.03	60.56	96.78
BRD-A97730597	CP	hexylcaine	sodium channel blocker	SCN5A, SCN10A		6.15, 1.92	52.28	0.56, 0.14	12.09	85.11	96.25	49.03	99.40	31.46	1.23	-83.36	45.75	52.28	95.25	73.38	9.53	9.83	81.21	18.76	83.62	66.41	77.27	70.48	88.90	90.08	50.30	0.03	21.66	29.74	70.27	44.36	89.90
BRD-K74765201	CP	tomelukast	leukotriene receptor antagonist	CYSLTR1		5.71, 2.45	52.28	0.76, 0.10	60.96	-11.33	89.33	1.13	46.11	30.56	89.42	91.61	60.78	92.41	52.28	30.20	3.34	24.22	-95.86	-24.27	96.93	-31.65	77.65	28.86	-3.45	12.28	61.92	10.26	90.43	91.66	78.28	54.83	65.83
BRD-K26241953	CP	piceatannol	syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor	ATP5A1, ATP5B, ATP5C1, IRF3, PTGS2, SIRT1, SYK, TYR		2.31, 1.15	52.26	1.05, 0.30	54.57	21.02	14.46	77.76	53.30	16.17	12.30	52.26	11.26	25.58	14.83	43.01	77.37	91.75	92.79	84.13	9.86	81.74	23.04	91.02	-46.48	93.98	-0.63	-13.33	75.62	75.61	63.60	51.60	91.19
BRD-A39230911	CP	chlorphensin	muscle relaxant			6.53, 4.08	52.24	0.85, 0.26	95.24	82.84	92.51	49.69	55.54	99.86	6.65	53.60	13.99	15.81	7.51	97.34	2.96	12.52	97.79	59.45	39.37	47.52	85.87	98.68	90.13	52.24	47.50	-0.04	-0.88	95.74	23.21	18.62	58.54
BRD-K06335600	CP	tizanidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, CYP1A2, NISCH		6.12, 3.27	52.17	1.50, 0.47	7.48	64.13	93.49	58.19	52.17	39.46	51.74	-18.12	61.99	92.68	92.27	87.29	2.75	9.66	94.33	13.09	-73.32	16.88	77.38	3.49	75.62	57.08	60.16	24.90	1.59	99.89	41.55	40.01	76.40
BRD-K43330982	CP	JTE-013	lysophospholipid receptor antagonist	S1PR2, P2RY10		7.69, 4.23	52.13	0.72, 0.19	10.10	37.78	52.13	20.34	96.52	10.81	62.85	53.30	7.53	90.05	57.80	29.49	38.01	42.44	84.46	90.39	95.94	24.49	-6.18	71.79	19.09	52.26	18.71	58.17	84.22	6.71	55.29	93.43	20.04
BRD-A99833829	CP	bethanechol	acetylcholine receptor agonist	CHRM2, CHRM1, CHRM3, CHRM4		4.49, 1.22	52.08	1.18, 0.32	77.02	92.66	36.26	25.19	79.15	45.67	18.56	-28.67	8.31	91.46	59.50	81.30	6.65	9.88	90.96	93.21	21.69	19.56	89.38	77.69	52.08	28.43	61.75	95.60	48.34	83.91	38.31	83.14	0.00
BRD-K17743125	CP	belinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	3.46, 0.77	52.08	1.84, 0.53	32.28	97.96	23.76	69.05	46.74	30.82	78.94	-18.29	30.22	9.85	15.68	97.37	81.89	90.28	96.35	98.63	61.42	84.70	11.13	34.50	78.05	29.94	71.06	1.16	5.02	41.05	78.55	52.08	75.70
BRD-K51677086	CP	erythromycin	NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor	CYP3A4, MLNR		4.62, 1.92	52.06	1.31, 0.32	97.91	56.17	76.37	31.12	95.35	73.28	30.88	27.57	20.52	37.08	44.83	79.71	2.89	52.06	54.02	86.99	89.51	67.29	97.08	30.99	45.89	91.62	12.44	2.23	22.75	78.42	8.34	76.80	32.62
BRD-A78360835	CP	cercosporin	photoactivated to produce toxic reactive oxygen species, PKC inhibitor			6.12, 3.27	52.04	2.96, 0.78	71.60	97.82	96.12	89.17	69.49	26.97	1.55	-12.50	53.52	38.44	52.04	85.33	99.30	96.91	-81.67	100.00	86.06	84.93	29.02	33.48	51.11	17.47	78.24	0.00	10.57	21.88	6.15	57.93	27.90
BRD-K16664969	CP	GTP-14564	FLT3 inhibitor, tyrosine kinase receptor inhibitor	FLT3, CSF1R, KIT, PDGFRB		4.23, 1.92	51.96	0.93, 0.17	98.99	15.12	17.31	86.96	2.95	89.60	80.33	38.42	76.08	79.77	56.36	66.85	44.92	22.86	81.74	15.33	51.96	32.35	41.16	92.22	19.23	50.12	8.36	-34.57	66.29	45.45	62.44	90.85	95.57
BRD-K89839824	CP	raltitrexed	thymidylate synthase inhibitor, pyrimidine antagonist	TYMS, FPGS	Thymidylate synthase inhibitor	3.08, 0.38	51.96	0.86, 0.26	58.47	53.45	27.63	50.83	72.01	41.47	93.63	86.29	22.10	84.72	51.66	69.82	65.59	20.22	34.77	79.60	28.31	32.60	44.06	51.96	79.66	67.81	27.69	1.90	33.98	94.25	52.46	73.97	12.26
BRD-A80017228	CP	bendroflumethiazide	sodium/potassium/chloride transporter inhibitor, thiazide diuretic	SLC12A3, CA1, CA2, CA4, KCNMA1, SLC12A1		8.08, 3.46	51.91	0.55, 0.09	76.25	48.51	23.05	10.65	59.55	12.86	8.17	98.00	50.38	26.48	38.23	28.37	6.85	-3.35	90.21	61.35	84.28	38.56	88.22	96.90	24.31	51.91	57.89	91.80	88.27	83.42	34.55	88.97	66.47
BRD-A49358627	CP	ciprofibrate	PPAR receptor agonist, lipase clearing factor inhibitor	PPARA, LPL		5.38, 3.08	51.89	1.09, 0.34	47.94	-20.12	34.28	61.06	54.57	-8.62	22.02	54.47	1.09	-9.40	25.54	76.22	-7.89	1.34	97.94	3.20	76.52	4.20	58.19	98.01	69.11	92.34	54.19	88.72	-7.10	61.79	51.89	99.15	8.87
BRD-K46137903	CP	prednicarbate	corticosteroid agonist, immunosuppressant, phospholipase activator	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	3.08, 1.54	51.87	1.38, 0.64	38.19	65.99	90.11	48.89	52.98	16.82	20.91	51.87	34.99	59.34	44.71	62.26	4.23	72.85	14.51	55.98	7.09	4.93	51.02	72.01	54.94	60.73	86.35	6.08	45.81	34.37	54.38	97.29	86.30
BRD-K28863208	CP	PNU-282987	acetylcholine receptor antagonist	CHRNA7		4.23, 1.92	51.84	0.78, 0.19	51.84	27.00	45.01	18.55	29.16	21.07	48.95	83.31	57.87	57.38	61.79	54.75	0.00	12.77	80.13	9.25	45.31	25.35	75.15	91.46	51.08	67.34	23.41	92.09	52.59	69.21	48.45	92.83	75.18
BRD-K95992530	CP	Cyclo-[Arg-Gly-Asp-D-Phe-Val]	integrin antagonist	ITGAV, ITGB3		3.46, 0.38	51.82	0.75, 0.14	67.02	25.90	51.82	25.34	63.09	6.95	75.92	45.61	57.44	61.18	12.74	9.33	0.00	21.37	63.53	15.08	72.86	82.62	45.13	83.41	17.93	88.01	18.10	2.22	78.37	16.91	58.96	75.48	86.72
BRD-K79145749	CP	dibenzepin	norepinephrine reuptake inhibitor			6.15, 2.69	51.80	0.90, 0.27	85.61	79.95	95.71	38.40	83.31	30.19	99.72	50.05	81.71	18.24	93.36	66.10	12.01	12.80	97.60	4.48	85.74	48.53	51.80	64.59	82.08	34.34	71.38	-82.77	-0.68	33.33	44.56	48.47	91.76
BRD-K81272440	CP	dantrolene	calcium channel antagonist	RYR1, RYR3		5.00, 3.08	51.79	0.70, 0.14	54.28	66.23	46.50	37.08	87.50	4.05	47.55	85.88	41.21	51.79	44.14	27.99	2.36	1.69	86.17	13.06	89.91	75.21	49.69	81.28	36.75	37.42	68.82	5.64	68.10	89.58	59.27	92.50	72.02
BRD-A44448661	CP	pentobarbital	GABA receptor modulator	GABRA1, CHRNA4, CHRNA7, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B		5.71, 2.86	51.77	1.23, 0.52	61.90	51.04	81.40	16.67	81.12	78.05	22.09	36.75	13.19	83.83	82.17	51.77	-2.75	23.27	66.25	7.18	80.49	33.25	91.35	28.12	86.52	38.68	34.49	-0.04	54.92	57.58	52.33	34.87	65.94
BRD-A19736161	CP	ondansetron	serotonin receptor antagonist	HTR3A, CYP2D6, CYP3A5, HTR1A, HTR1B, HTR3B, HTR4, OPRM1		6.92, 3.46	51.75	0.45, 0.02	85.88	34.77	38.42	25.36	51.75	51.05	9.30	35.00	17.69	99.99	51.69	92.89	1.62	26.50	94.00	32.33	96.97	58.68	86.90	68.21	82.60	56.11	55.22	87.11	42.10	80.94	34.79	73.15	34.09
BRD-K46469693	CP	SCH-442416	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3		6.54, 2.69	51.73	0.95, 0.22	3.09	95.46	93.17	20.49	90.78	42.92	-0.95	-32.45	28.72	30.84	27.48	87.41	12.90	61.25	74.85	65.90	93.98	59.84	20.34	90.55	66.07	97.36	51.73	-1.81	18.83	15.82	64.95	23.35	96.58
BRD-K10705233	CP	GW-405833	cannabinoid receptor agonist	CNR2	Cannabinoid receptor agonist	8.08, 4.23	51.71	0.10, 0.01	58.68	46.16	74.85	95.48	17.41	7.76	11.19	31.43	12.99	52.30	27.41	62.79	97.64	93.87	34.73	99.96	35.91	94.68	51.79	70.06	23.91	76.49	12.71	18.11	78.38	32.18	51.71	60.59	24.13
BRD-K73982490	CP	BI-78D3	JNK inhibitor	MAPK8		5.77, 3.08	51.69	1.74, 0.51	43.57	85.69	98.36	37.09	29.14	89.24	16.42	25.52	21.51	60.52	56.94	56.25	65.10	31.18	75.78	74.08	63.39	49.44	25.10	78.22	74.25	39.15	51.69	-62.26	0.32	25.02	84.03	13.49	99.25
BRD-A70407468	CP	PSB-36	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3		5.71, 2.04	51.63	1.01, 0.23	49.00	54.34	46.96	84.70	40.52	71.88	21.41	19.60	69.61	99.81	90.50	92.88	14.52	88.63	39.99	25.43	83.09	83.13	79.79	38.05	16.49	60.38	33.04	-64.27	46.92	80.25	51.63	28.38	64.68
BRD-K61217870	CP	n-(3-acetamidophenyl)-3-chlorobenzamide	glutamate receptor inhibitor	GRM5		6.15, 3.85	51.63	0.99, 0.22	80.40	-4.09	2.61	20.90	-41.24	58.77	73.49	90.24	8.62	83.23	55.02	48.60	-3.88	-7.32	75.76	11.53	65.91	-26.20	99.12	47.67	-88.90	30.53	50.12	58.46	60.83	93.32	51.63	59.69	91.69
BRD-K38615104	CP	A-443644	AKT inhibitor	AKT1, AKT2, AKT3, CDC42BPB, GSK3B, PHKG1, PKIA, PRKACA		7.31, 3.08	51.60	2.41, 0.84	33.31	99.08	23.41	24.44	96.97	42.95	79.55	-36.45	5.51	90.26	60.23	89.12	3.21	66.21	98.59	93.71	85.28	50.83	37.01	79.66	93.76	78.84	84.95	-97.02	-2.70	1.20	30.07	51.60	49.53
BRD-K70914287	CP	BIBX-1382	EGFR inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2	EGFR inhibitor	8.85, 3.46	51.59	1.45, 0.41	26.19	52.85	38.83	96.83	50.78	33.02	2.44	39.31	16.11	7.09	25.98	54.54	83.72	99.05	92.15	98.59	63.50	98.17	9.45	19.65	77.40	67.79	38.56	-1.67	97.02	56.62	51.59	13.50	65.04
BRD-K06712146	CP	YM-90709	IL5 inhibitor, interleukin receptor antagonist	CSF2RB, IL5RA		4.62, 2.69	51.58	1.00, 0.31	98.03	79.61	88.68	65.29	99.58	8.32	7.61	60.04	29.61	58.73	37.67	80.24	57.26	44.45	21.27	93.76	80.52	34.39	17.93	77.76	25.70	33.70	82.55	-0.56	9.53	39.87	26.36	75.40	51.58
BRD-A50764878	CP	MDL-73005EF	serotonin receptor antagonist, serotonin receptor partial agonist	HTR1A		5.31, 2.04	51.52	0.63, 0.07	41.32	10.78	13.81	65.22	51.50	88.52	48.69	82.73	62.46	91.83	39.41	89.59	7.45	15.72	77.00	36.02	97.66	10.55	75.30	32.47	51.52	62.26	33.09	10.42	64.33	76.66	76.22	77.28	29.67
BRD-K04546108	CP	JAK3-inhibitor-VI	JAK inhibitor	JAK3	JAK inhibitor	4.62, 2.69	51.51	1.86, 0.65	5.36	97.92	68.78	83.22	69.69	72.16	3.06	-50.22	3.45	48.30	95.50	87.74	83.39	55.86	12.54	99.82	-14.64	23.54	34.43	36.03	54.09	60.96	51.51	-11.75	-8.63	0.00	83.62	54.16	-3.66
BRD-K99922388	CP	DPO-1	potassium channel blocker	KCNA5	Potassium channel blocker	4.08, 1.22	51.51	1.20, 0.36	96.97	7.63	4.85	38.26	74.20	80.32	9.98	51.51	11.39	74.50	64.72	97.39	16.56	28.46	90.00	5.61	89.14	41.74	64.03	80.98	75.47	35.03	67.35	10.82	8.96	76.71	49.39	86.19	46.74
BRD-K11129031	CP	gemfibrozil	lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist	PPARA, CYP2C8, LPL, SLCO1B1, SLCO1B3, SLCO2B1		2.45, 2.04	51.48	0.83, 0.24	35.95	10.25	94.88	8.95	70.90	85.68	4.79	87.79	85.25	43.05	82.38	51.48	-1.20	1.09	80.35	1.66	75.59	16.55	72.40	42.99	57.54	52.57	45.84	65.18	4.82	91.12	49.72	43.11	78.07
BRD-K15409150	CP	penfluridol	dopamine receptor antagonist, T-type calcium channel blocker	CACNA1G, DRD1, DRD2	T-type calcium channel blocker	8.08, 3.85	51.47	1.57, 0.35	70.73	78.71	95.00	95.92	60.56	-20.43	28.36	21.03	17.09	21.11	21.30	89.09	98.39	96.19	78.12	99.96	79.98	97.99	27.16	52.98	46.62	20.97	6.72	-8.32	59.37	51.47	26.19	22.51	16.02
BRD-K16277217	CP	piperacetazine	antipsychotic			6.54, 4.23	51.45	1.14, 0.31	39.54	23.75	3.10	21.14	37.20	50.51	51.45	79.94	20.53	35.23	90.46	75.86	1.73	58.03	81.96	16.81	47.40	45.27	82.58	89.24	92.28	89.93	22.92	98.63	91.31	96.11	47.80	99.74	79.84
BRD-A73581086	CP	ergometrine	adrenergic receptor stimulatant, serotonin receptor stimulant	ADRA1A, HTR1E, HTR2A		4.23, 0.77	51.44	0.98, 0.39	5.14	35.62	58.69	35.22	75.22	27.67	54.77	82.34	33.61	74.29	78.48	45.35	10.63	1.90	75.04	3.03	93.55	21.42	49.53	69.75	51.44	46.77	58.53	0.85	39.45	67.02	86.56	94.97	58.41
BRD-K28115081	CP	apafant	platelet activating factor receptor antagonist	PTAFR		6.54, 3.46	51.43	1.13, 0.28	83.37	-29.61	5.33	11.72	46.37	51.43	38.63	54.25	5.71	78.78	66.34	88.63	9.01	-0.86	65.71	-5.18	66.72	30.68	40.75	98.45	59.56	30.05	11.38	75.74	92.06	68.60	37.20	68.60	59.40
BRD-K75615183	CP	talipexole	adrenergic receptor agonist, dopamine receptor agonist, dopamine autoreceptor agonist, serotonin receptor antagonist	DRD2, HTR3A		8.85, 2.69	51.40	0.89, 0.22	66.35	11.69	23.58	29.16	56.06	97.26	64.28	49.80	18.47	98.68	98.68	97.00	1.76	40.43	-34.93	25.34	42.47	36.39	98.70	84.16	49.44	83.89	27.35	32.13	51.40	95.75	82.46	92.27	88.03
BRD-K22828899	CP	TUL-XXI039	serine/threonine kinase inhibitor			6.12, 3.27	51.37	1.26, 0.35	28.92	9.34	58.22	19.79	95.18	-3.91	77.10	76.15	6.39	95.42	88.80	73.75	-2.04	-1.66	81.80	5.92	41.72	-4.28	94.79	51.37	83.77	34.29	74.24	92.50	17.29	89.40	86.36	34.72	3.70
BRD-K03670461	CP	tyrphostin-AG-82	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR, LCK		3.08, 2.31	51.36	0.80, 0.15	67.03	-37.39	5.56	31.80	2.78	16.64	93.12	51.36	5.88	92.00	73.38	13.28	28.50	57.92	-29.37	56.63	75.88	14.84	82.52	69.30	36.41	32.31	23.52	85.54	77.41	79.39	69.27	82.00	-30.54
BRD-K15592317	CP	CP466722	ATM kinase inhibitor	ATM		6.54, 2.69	51.34	2.06, 0.59	57.33	53.15	60.22	98.87	89.04	17.68	8.60	-37.92	66.20	49.84	81.70	88.81	83.61	60.65	97.02	99.60	72.04	50.90	26.77	25.35	55.88	51.34	7.01	-88.70	8.39	38.29	26.29	36.03	34.09
BRD-A39415247	CP	norethisterone	ovulation inhibitor	PGR	Progesterone receptor agonist	5.38, 2.31	51.33	0.76, 0.27	42.81	59.51	55.60	14.86	56.01	8.43	10.10	24.19	34.97	5.08	92.80	30.45	3.00	51.33	78.50	85.83	37.47	88.19	75.57	47.10	76.31	94.08	63.61	1.83	19.70	55.53	8.12	54.25	98.67
BRD-K62810658	CP	PD-98059	MEK inhibitor, MAP kinase inhibitor	MAP2K1, AKT1, CHEK1, GSK3B, LCK, MAP2K2, MAPK1, MAPK11, MAPK12, MAPK14, MAPK3, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	MEK inhibitor	2.31, 0.00	51.32	0.90, 0.23	20.23	31.95	67.58	1.46	68.66	30.21	76.66	59.15	11.84	77.08	26.34	54.81	-67.89	72.97	77.37	2.64	32.86	49.44	64.98	26.58	86.53	61.66	33.37	72.16	16.67	66.36	38.28	51.32	60.25
BRD-A87479750	CP	tenidap	cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist	ALOX5, KCNJ4, PTGS1		5.00, 1.92	51.30	0.78, 0.24	49.56	61.56	90.27	26.91	87.38	64.77	40.53	68.01	72.89	8.58	66.47	86.34	3.57	-9.05	87.26	-83.70	-51.24	17.27	17.91	83.12	15.53	57.74	51.30	1.02	39.62	76.08	85.55	66.01	47.49
BRD-K04111260	CP	raclopride	dopamine receptor antagonist	DRD2, DRD3, HTR1A		4.62, 3.08	51.29	0.45, 0.08	34.60	-8.89	59.55	23.53	69.69	30.82	-11.08	69.69	61.68	65.24	3.57	51.29	1.57	4.27	87.67	7.37	91.91	21.72	55.73	73.04	77.61	46.19	81.65	55.39	68.98	49.50	32.08	86.70	49.31
BRD-A65767837	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	4.08, 2.45	51.28	1.58, 0.39	57.98	92.94	93.80	31.05	82.16	86.54	5.71	-51.88	44.11	80.99	4.58	69.15	7.12	67.29	-92.52	93.68	67.67	20.45	84.49	26.12	97.57	51.28	79.05	-29.35	5.04	-23.09	20.15	22.93	62.51
BRD-K11373525	CP	ZD-7155	angiotensin receptor antagonist	AGTR1	Angiotensin receptor antagonist	4.23, 1.15	51.23	1.28, 0.45	13.15	84.24	99.12	35.71	95.08	-7.51	92.96	-82.64	51.23	28.51	88.49	90.59	0.00	1.62	92.92	29.84	92.23	11.40	12.54	38.93	89.86	71.12	56.95	-37.35	-15.16	3.96	63.95	79.90	75.63
BRD-K16444452	CP	ibudilast	phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor	PDE4A, PDE4B, PDE4C, MIF, PDE10A, PDE3A, PDE4D, TLR4, CYSLTR1, IL1B, IL6, PDE11A, PDE5A		7.31, 3.08	51.20	0.76, 0.13	95.75	51.53	0.02	49.05	30.98	74.88	82.54	64.44	57.56	94.03	46.43	37.05	-2.43	1.41	68.06	-1.41	51.20	21.24	25.12	86.76	73.96	88.87	15.10	-86.92	46.42	65.14	15.80	80.50	72.44
BRD-K42098891	CP	protriptyline	tricyclic antidepressant (TCA)	SLC6A2, SLC6A4	Tricyclic antidepressant	5.38, 3.08	51.20	1.17, 0.33	39.48	12.94	78.91	64.43	98.84	45.89	3.56	73.39	36.66	10.20	13.92	51.20	3.53	65.36	90.79	5.14	99.12	91.27	12.62	89.44	54.98	23.26	56.35	1.94	75.60	14.62	38.04	91.93	84.81
BRD-K05104363	CP	PD-184352	MEK inhibitor, MAP kinase inhibitor	MAP2K1, MAP2K2, MAP3K1, MAP3K2	MEK inhibitor	4.62, 1.15	51.19	1.43, 0.49	36.96	67.73	5.29	60.28	31.69	14.88	52.64	4.12	31.89	93.58	20.02	82.72	32.26	95.38	93.45	94.83	66.64	22.10	82.43	35.46	19.15	21.04	67.90	70.53	40.70	72.85	44.50	51.19	58.35
BRD-K93461745	CP	buspirone	serotonin receptor agonist, serotonin receptor partial agonist	HTR1A, DRD2		3.85, 1.15	51.19	0.68, 0.15	58.01	6.73	51.91	12.09	51.19	24.53	30.81	79.53	81.90	13.37	32.60	33.73	1.30	24.27	94.72	2.64	95.68	15.68	90.36	81.40	7.61	43.49	42.07	82.28	81.10	79.14	73.12	85.73	68.40
BRD-K03842655	CP	penitrem-a	potassium channel blocker	KCNMA1		5.77, 3.08	51.18	0.89, 0.24	51.18	45.32	38.62	75.28	80.70	33.57	9.14	27.14	45.21	5.77	3.63	38.36	93.34	83.89	49.00	99.54	68.53	91.11	30.76	69.23	89.60	88.05	15.20	0.88	95.38	46.56	60.44	88.91	73.27
BRD-A47598013	CP	citalopram	serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, SLC6A2		6.92, 3.85	51.17	1.09, 0.23	45.60	76.64	67.90	20.31	97.21	90.72	51.17	69.30	33.55	82.51	58.44	35.04	0.11	22.45	33.83	18.15	97.12	85.71	34.48	27.52	87.84	53.69	3.59	-33.30	23.28	46.42	54.42	78.71	87.46
BRD-K48869804	CP	icilin	TRPA1 agonist, TRPM8 agonist	TRPA1, TRPM8		4.23, 1.92	51.17	0.57, 0.14	77.13	71.76	32.67	23.67	94.79	53.25	84.32	49.09	24.26	58.85	32.07	67.60	8.13	64.56	39.14	31.47	50.80	24.49	92.04	19.46	74.24	86.59	26.44	-0.49	51.17	89.20	48.20	73.24	79.64
BRD-A90311807	CP	cilastatin	dehydropeptidase inhibitor	DPEP1		5.77, 3.08	51.16	0.95, 0.34	7.05	33.30	98.11	18.21	55.19	62.89	51.16	94.44	38.68	18.43	13.75	36.57	-56.45	2.57	93.37	-3.79	88.07	29.73	27.17	99.45	24.17	69.37	76.57	58.54	64.36	81.87	62.77	85.05	51.12
BRD-K54665485	CP	R-59022	diacylglycerol kinase inhibitor, protein kinase inhibitor	DGKA		7.76, 4.90	51.14	1.57, 0.51	51.14	51.44	97.85	53.12	86.77	99.75	5.46	26.74	11.95	99.68	8.23	89.22	34.62	29.35	90.42	33.86	95.59	48.63	23.26	76.69	62.50	99.28	24.30	-50.40	17.33	32.66	64.82	20.18	69.23
BRD-K83144676	CP	olmesartan	angiotensin receptor antagonist, angiotensin antagonist	AGTR1		8.44, 4.89	51.14	1.99, 0.48	24.72	15.56	7.14	27.48	27.15	91.05	48.05	18.17	20.36	98.15	92.29	98.12	5.71	23.06	29.30	67.22	96.80	0.14	99.71	79.23	34.70	72.08	77.90	59.58	51.14	98.59	95.75	65.35	22.23
BRD-A89175223	CP	bisoprolol	adrenergic receptor antagonist	ADRB1, ADRB2		3.85, 1.92	51.11	0.41, 0.05	72.53	17.42	53.06	13.67	90.03	31.15	30.63	59.80	19.11	95.68	83.06	97.78	4.19	15.69	71.65	4.76	75.59	52.11	9.05	54.65	49.06	65.59	56.17	-59.62	51.11	66.95	51.01	45.52	36.16
BRD-K64157027	CP	ZD-2079	adrenergic receptor agonist, insulin sensitizer	ADRB3		7.69, 4.23	51.08	1.17, 0.34	35.32	11.04	83.15	52.20	62.48	18.22	-23.78	82.52	50.30	11.90	13.36	53.09	0.00	0.00	98.30	2.04	89.92	20.46	-77.75	98.84	96.86	90.62	74.51	99.86	32.92	60.52	76.55	21.68	51.08
BRD-K97764662	CP	PD-173074	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR3, FGFR2, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	FGFR inhibitor, VEGFR inhibitor	6.54, 1.92	51.07	1.28, 0.40	10.71	48.77	32.28	95.91	62.81	56.23	-22.67	47.36	11.91	7.51	5.11	60.61	83.37	96.37	65.46	93.77	53.88	84.65	26.09	82.30	41.25	22.84	46.85	95.61	89.81	51.07	23.05	29.27	72.96
BRD-A07765530	CP	epinephrine	carbonic anhydrase activator, hormone, neurotransmitter	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF		2.86, 1.63	51.01	1.24, 0.66	9.77	87.61	20.87	63.84	90.76	26.82	56.12	80.96	18.11	41.50	21.73	30.33	51.01	58.47	75.81	87.87	67.79	49.98	84.47	17.87	46.77	29.06	86.80	84.09	0.00	75.39	27.13	0.49	69.12
BRD-A00758722	CP	noretynodrel	progestogen steroid hormone	PGR		5.38, 2.69	51.00	0.88, 0.28	9.49	94.06	89.10	14.79	96.18	15.54	95.44	-94.86	34.10	5.00	19.93	66.11	3.18	53.55	75.16	90.38	18.99	63.69	64.08	25.61	81.80	50.42	69.09	-5.78	-8.84	-24.10	51.00	57.08	55.01
BRD-A19195498	CP	trimipramine	adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)	SLC6A2, SLC6A4, SLC6A3, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A	Norepinephrine reuptake inhibitor, Tricyclic antidepressant	6.54, 5.00	50.89	1.33, 0.50	50.89	26.44	86.44	82.33	28.25	25.06	59.79	83.72	45.11	35.24	35.37	42.47	74.00	92.18	-57.58	26.77	78.43	98.63	27.34	22.87	57.80	0.00	30.44	-7.02	99.68	64.69	86.33	54.01	93.77
BRD-K11911061	CP	GR-127935	serotonin receptor antagonist	HTR1B, HTR1D, HTR1A, HTR2A, HTR2C, HTR1E, HTR1F, HTR2B, HTR6	Serotonin receptor antagonist	10.38, 5.77	50.88	1.34, 0.19	17.75	36.97	50.88	97.50	66.41	10.61	-8.42	-22.55	-2.22	41.01	8.42	51.11	97.85	97.89	95.06	99.86	76.79	98.17	14.41	96.51	58.88	27.52	25.49	0.00	83.85	6.87	66.96	98.16	22.16
BRD-K77695569	CP	tiabendazole	quinol-fumarate reductase inhibitor			3.08, 1.54	50.87	0.77, 0.14	50.87	47.37	3.16	25.96	7.34	14.96	76.17	64.64	1.59	90.30	28.72	42.95	2.79	6.78	74.84	37.74	50.20	33.97	70.54	67.53	70.65	94.38	60.44	91.74	60.25	69.01	58.86	94.95	39.63
BRD-K92817986	CP	BJM-CSC-19	compound cytotoxic to breast cancer stem cells			2.69, 1.15	50.87	0.58, 0.14	66.66	21.15	21.27	68.67	28.78	82.65	38.21	75.33	7.53	40.94	20.99	59.28	19.15	65.29	87.25	19.55	68.35	50.87	74.06	34.37	55.05	70.99	25.45	-0.03	31.77	81.24	77.52	81.34	41.61
BRD-K21520694	CP	sulfacetamide	antibiotic			8.98, 4.90	50.86	1.20, 0.33	54.43	61.62	0.42	8.73	26.14	49.86	70.56	99.07	46.14	39.63	39.17	65.37	0.78	0.35	90.94	-0.46	74.44	11.54	48.43	99.51	50.86	62.89	8.10	95.88	84.22	97.37	14.85	96.93	93.70
BRD-K86204871	CP	terconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor		Sterol demethylase inhibitor	5.38, 1.92	50.85	0.58, 0.15	17.41	49.51	49.78	65.83	61.89	50.66	63.57	78.17	28.22	78.71	9.75	36.88	10.62	33.51	79.32	29.29	97.32	87.18	80.25	86.32	83.67	50.85	44.56	4.55	73.46	32.33	34.77	94.12	87.01
BRD-K26979635	CP	NS-3694	glutamate receptor antagonist	GRIK1		2.04, 0.41	50.84	1.36, 0.32	92.57	8.54	27.85	18.71	6.20	67.67	36.77	71.81	23.47	14.83	6.26	36.68	4.88	22.27	75.52	3.41	50.84	-2.54	82.38	62.85	-61.37	85.39	67.05	71.16	69.39	78.15	52.55	65.09	65.35
BRD-K59637651	CP	NSC-119889	botulin neurotoxin inhibitor, mur synthetase inhibitor			5.71, 4.08	50.83	1.03, 0.30	19.57	80.14	96.06	38.61	85.74	98.39	20.01	-19.27	49.27	42.04	93.49	96.97	19.95	50.83	76.43	26.79	89.25	35.44	78.19	77.58	75.47	73.55	29.65	0.00	15.16	82.27	19.76	58.75	34.74
BRD-K82036761	CP	sertraline	serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor	SLC6A4, CYP2C19, SLC6A3	Serotonin receptor antagonist	5.38, 4.23	50.80	1.59, 0.59	87.63	48.15	13.37	93.94	50.80	13.11	15.03	37.18	44.87	12.82	25.89	84.95	89.25	98.24	70.70	83.46	71.62	99.40	79.06	47.03	44.74	21.14	28.57	1.83	98.24	35.17	72.01	67.13	70.38
BRD-K61192372	CP	capecitabine	dihydropyrimidine dehydrogenase inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, RNA synthesis inhibitor, thymidylate synthase inhibitor	TYMS, DPYD	Thymidylate synthase inhibitor	2.69, 1.15	50.78	1.72, 0.45	46.72	31.32	14.38	35.18	-14.45	89.19	78.17	50.78	83.87	11.08	73.75	73.05	-21.10	3.45	-41.03	-0.60	89.07	48.68	89.26	98.45	39.09	71.46	40.21	99.93	75.06	87.16	94.49	47.28	89.46
BRD-U97083655	CP	teicoplanin	bacterial cell wall synthesis inhibitor			4.23, 1.15	50.78	1.33, 0.49	12.36	65.06	95.40	8.61	64.16	56.63	47.84	55.96	72.76	92.37	28.73	80.30	-1.66	8.09	84.60	-2.04	96.53	19.51	20.22	66.33	27.36	96.14	38.52	49.68	29.51	41.91	50.78	68.40	71.96
BRD-K02283807	CP	GR-32191	thromboxane receptor antagonist, prostanoid receptor antagonist	TBXA2R	Thromboxane receptor antagonist	3.46, 1.54	50.75	0.80, 0.28	76.03	8.75	93.78	28.13	18.74	50.75	83.21	25.87	42.55	72.37	51.01	84.43	2.15	0.80	91.70	24.73	93.47	26.89	88.24	87.93	85.31	29.60	40.96	96.86	14.36	16.03	86.86	75.02	38.33
BRD-K81128206	CP	edrophonium	acetylcholinesterase inhibitor	ACHE, BCHE		5.31, 2.04	50.75	0.90, 0.33	29.30	75.13	93.59	50.75	88.07	17.71	81.52	97.38	16.25	42.81	14.29	32.32	1.87	30.21	98.45	54.76	96.79	30.58	89.74	73.53	69.42	33.13	39.11	98.11	14.53	42.17	40.49	67.92	64.74
BRD-K49865102	CP	PD-0325901	MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor	MAP2K1, MAP2K2	MEK inhibitor	3.46, 1.54	50.71	1.34, 0.64	18.96	50.71	5.97	41.10	22.73	50.46	7.22	56.66	10.80	95.10	21.77	74.92	-10.52	89.32	97.73	-96.42	87.16	2.54	55.94	64.28	54.09	14.23	77.61	85.35	57.83	86.32	57.79	24.85	12.26
BRD-K03384561	CP	roquinimex	T cell inhibitor, T cell stimulant, tumor necrosis factor receptor antagonist			4.23, 1.54	50.70	0.91, 0.33	66.58	70.70	23.44	20.65	80.87	47.25	39.96	-38.68	20.11	96.94	67.08	48.44	-31.91	28.42	37.62	9.25	76.83	55.05	85.37	12.69	82.05	87.12	54.78	-98.24	50.70	89.76	79.62	82.00	28.63
BRD-K15502390	CP	nevirapine	non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	CYP2B6, CYP2C19, CYP3A4	Reverse transcriptase inhibitor	7.76, 5.71	50.69	0.91, 0.23	53.07	20.76	-2.43	12.76	46.83	52.79	86.94	96.16	16.81	49.57	50.69	78.09	1.94	19.13	85.02	-48.11	96.48	22.36	64.73	53.25	58.76	6.82	70.62	24.91	5.98	99.97	64.67	73.18	45.81
BRD-A85472596	CP	L-670596	prostanoid receptor antagonist			5.71, 2.45	50.68	1.40, 0.35	62.10	3.28	47.99	46.46	48.26	62.87	86.09	68.58	58.79	99.93	96.96	88.31	2.96	22.25	32.45	15.13	53.23	4.23	90.55	54.27	31.95	55.47	57.07	-89.74	15.10	64.36	7.29	50.68	49.68
BRD-K95202259	CP	ML-3163	p38 MAPK inhibitor	CYP2D6, CYP3A4, MAPK11, MAPK12, MAPK14	P38 MAPK inhibitor	3.46, 1.54	50.68	0.93, 0.22	37.77	45.61	58.35	65.68	80.51	31.67	67.20	76.97	89.91	91.73	20.13	38.84	0.00	34.38	45.26	62.82	41.16	29.61	39.83	84.09	50.68	31.81	63.41	29.80	87.10	20.62	59.94	88.00	85.14
BRD-A54236247	CP	racephedrine	adrenergic receptor agonist			3.67, 2.45	50.67	1.25, 0.33	85.44	-2.29	44.47	38.23	13.08	85.87	50.67	82.37	88.34	94.62	24.69	82.32	2.78	44.25	69.84	-10.25	26.64	25.01	86.22	75.69	37.31	64.33	44.43	98.20	76.74	21.44	1.92	55.28	54.32
BRD-A84481105	CP	thioridazine	acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor	DRD1, DRD2, HTR2A, ADRA1A, ADRA1B, CHRNA7, DRD5, HRH1, HTR1A, HTR2C, HTR6, HTR7, KCNH2, MALT1	Dopamine receptor antagonist	10.00, 5.38	50.66	1.84, 0.60	16.93	44.68	96.86	89.50	54.50	7.92	24.93	63.15	17.24	16.67	12.23	33.43	89.75	99.15	83.64	86.46	80.18	98.00	66.92	50.43	47.54	10.43	44.89	96.81	97.32	62.10	38.32	49.82	50.66
BRD-A93255169	CP	thalidomide	angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor	TNF, CRBN, CYP1A2, CYP2B6, CYP2C19, CYP3A5, FGFR2, NFKB1, ORM1, ORM2, PTGS2		3.85, 1.54	50.64	1.03, 0.41	77.09	-6.67	17.48	50.64	29.29	16.05	93.44	56.01	22.77	16.41	21.13	74.92	-12.96	51.57	73.67	0.46	78.89	10.46	88.23	54.02	29.76	75.13	39.12	97.65	44.31	50.84	38.20	74.39	83.53
BRD-K94841585	CP	emodic-acid	laxative, free radical generator			2.31, 0.77	50.63	0.76, 0.18	67.78	32.25	84.45	65.79	64.23	50.63	7.51	31.70	5.60	57.37	81.10	60.92	8.14	45.58	85.01	64.20	-33.26	24.35	23.42	67.63	42.88	52.38	15.12	0.85	62.70	85.12	13.07	82.27	27.93
BRD-K51816706	CP	oxindole-I	protein kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor	AKT1, KDR, PDPK1, RET		6.92, 3.08	50.61	1.02, 0.25	15.52	53.53	95.04	91.04	84.81	53.28	40.16	-35.73	75.88	3.28	99.68	64.49	44.69	42.12	57.40	99.44	86.90	44.80	17.46	50.61	95.44	82.91	47.55	2.43	-0.32	-7.51	48.20	65.28	38.37
BRD-K66175015	CP	afatinib	EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4	EGFR inhibitor	8.85, 6.15	50.61	1.34, 0.32	86.64	36.44	64.38	97.38	28.01	15.92	12.10	38.41	10.71	56.82	4.58	76.50	92.24	99.89	81.99	99.82	45.50	96.62	81.03	46.85	30.65	22.68	50.61	99.05	99.37	4.79	48.37	47.93	71.88
BRD-K30189597	CP	SYK-inhibitor	syk inhibitor	SYK		3.85, 2.31	50.58	0.99, 0.24	-3.03	52.64	8.49	93.94	52.14	5.26	31.68	55.27	31.54	48.37	27.61	37.97	68.93	86.78	86.67	59.90	39.36	4.35	23.14	64.89	34.76	52.40	50.58	0.00	56.83	12.59	77.95	64.80	79.85
BRD-A25067867	CP	benzatropine	anticholinergic	CHRM1, HRH1, SLC6A3		4.90, 1.63	50.53	1.56, 0.44	-11.98	84.33	67.47	37.48	95.80	21.46	95.81	58.51	41.44	86.26	99.14	73.66	8.54	40.22	-39.65	29.33	12.07	50.53	22.90	10.89	70.89	24.62	49.77	-62.96	79.36	94.70	84.00	81.37	87.78
BRD-K68190965	CP	GR-46611	serotonin receptor agonist	HTR1D		3.46, 1.54	50.51	0.63, 0.13	35.30	21.97	5.41	29.79	59.04	31.73	8.31	51.42	4.41	81.36	27.30	42.20	4.29	70.97	56.80	20.85	64.36	65.05	59.91	84.88	50.51	72.00	54.55	42.77	78.98	46.62	33.46	66.00	68.05
BRD-A96897502	CP	U-74389F	lipid peroxidase inhibitor			5.00, 2.31	50.48	0.85, 0.34	95.65	27.18	22.06	32.10	50.48	54.89	48.14	82.10	9.65	89.55	13.48	28.03	17.56	68.52	41.62	3.14	18.18	62.48	52.41	84.30	71.16	29.73	70.43	90.55	91.59	87.24	27.03	80.91	34.68
BRD-K96862998	CP	pirfenidone	FGFR antagonist, p38 MAPK inhibitor, TGF beta receptor antagonist, TGF beta receptor inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist	TNF, FURIN, MAPK14, TNFRSF1A		6.15, 2.31	50.44	1.26, 0.27	79.11	37.49	1.68	8.16	82.91	32.44	96.55	97.48	81.86	18.11	26.82	8.98	-2.26	3.28	-20.95	-8.01	98.88	30.71	54.38	50.44	53.92	67.55	11.79	-29.65	96.69	53.13	84.87	87.28	91.51
BRD-K82865713	CP	prostaglandin-b2	cAMP inhibitor			3.46, 1.15	50.43	0.77, 0.26	86.71	50.43	61.28	26.14	58.78	14.41	93.46	-32.40	92.00	60.79	16.08	82.12	1.76	11.61	-25.48	25.69	34.84	30.24	93.95	86.81	63.38	89.97	37.77	97.04	89.67	91.69	42.71	49.69	25.22
BRD-A52193669	CP	withaferin-a	acetylcholinesterase inhibitor, butyrylcholinesterase inhibitors, IKK inhibitor, NFkB pathway inhibitor, PKC inhibitor	ACHE, BCHE, IKBKB	IKK inhibitor	3.46, 1.54	50.42	1.85, 0.40	93.17	84.90	17.57	9.61	69.10	28.46	9.56	62.04	13.62	50.36	50.42	90.21	90.70	91.62	37.03	99.44	26.61	71.36	86.40	81.29	28.17	67.91	86.37	5.97	23.19	42.39	67.78	23.27	44.47
BRD-K32292990	CP	CGP-53353	EGFR inhibitor, PKC inhibitor	EGFR, PRKCB	PKC inhibitor	5.00, 1.92	50.42	0.67, 0.11	68.86	31.95	16.74	95.28	82.90	65.50	7.85	-24.12	11.86	12.21	21.84	88.94	80.20	57.97	50.42	99.65	77.71	79.11	41.56	76.62	40.60	85.01	11.03	0.00	6.94	56.44	34.04	82.67	10.53
BRD-K11801786	CP	trimidox	antimetabolite, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor	RRM1		8.16, 4.90	50.40	1.60, 0.43	5.14	97.92	65.70	32.06	94.73	56.31	70.32	-85.66	21.78	49.61	97.76	95.04	4.44	9.81	93.43	74.37	23.58	22.94	98.95	7.63	69.49	69.89	30.41	-81.20	25.49	98.59	57.02	50.40	38.38
BRD-K44094599	CP	tacrolimus	calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor	FKBP1A, CYP3A5, CYP3A7		4.00, 2.67	50.32	1.22, 0.44	74.91	-60.36	-0.03	41.30	-29.29	4.05	48.79	94.86	78.84	92.41	20.13	7.49	0.67	86.84	90.21	76.20	22.44	2.15	81.76	52.53	-95.88	-58.81	50.32	0.00	88.02	90.25	81.54	76.28	89.73
BRD-A95869247	CP	indapamide	carbonic anhydrase inhibitor, thiazide diuretic	KCNQ1, CA7, KCNE1, SLC12A3	Na-K-Cl transporter inhibitor	4.49, 2.04	50.29	1.00, 0.23	51.72	6.81	92.47	32.61	80.69	4.02	35.30	73.23	36.04	89.12	18.50	51.72	8.88	25.60	96.10	4.34	58.49	27.43	85.96	82.75	50.29	73.42	37.36	86.58	33.45	84.60	69.33	40.56	16.74
BRD-K46142322	CP	RS-67333	serotonin receptor partial agonist	HTR4		4.23, 0.77	50.28	1.17, 0.35	23.24	12.72	35.87	58.93	50.28	9.51	65.37	74.11	10.63	36.83	73.91	54.71	1.83	3.67	27.55	1.20	96.92	83.67	81.68	40.65	65.68	69.99	14.88	-7.54	90.14	15.90	78.05	98.63	91.41
BRD-K20141153	CP	atomoxetine	norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor	SLC6A2, SLC6A3, SLC6A4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B		6.92, 3.46	50.26	0.63, 0.11	97.92	45.89	53.85	41.42	60.68	47.38	39.69	54.72	32.67	41.18	73.97	92.49	5.78	31.30	97.60	8.97	45.04	45.30	96.84	32.14	38.91	86.58	48.57	50.26	88.86	87.51	84.50	76.13	52.04
BRD-K68103045	CP	CGS-20625	benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA5		5.38, 2.31	50.25	0.89, 0.23	16.58	79.40	50.25	32.58	94.05	36.36	88.79	38.53	5.32	32.29	92.94	70.50	-11.89	15.15	96.40	32.07	68.32	18.97	72.84	90.24	89.79	80.91	12.40	21.02	-23.36	97.88	57.61	91.71	26.42
BRD-K62289640	CP	lylamine	cannabinoid receptor agonist	CNR1		9.23, 6.54	50.24	1.65, 0.63	9.58	50.24	51.72	96.62	2.26	6.67	56.51	91.02	35.99	14.89	4.02	79.08	99.37	99.68	75.21	99.93	46.37	97.64	33.67	37.45	29.21	61.56	10.35	-53.70	99.89	3.70	19.02	90.84	79.64
BRD-K25875056	CP	SC-9	protein kinase C activator			3.08, 0.77	50.23	1.23, 0.36	65.22	15.63	51.59	30.17	91.01	31.32	89.37	58.71	57.83	81.78	18.16	60.87	2.75	40.76	50.23	0.00	51.05	21.82	73.39	30.54	9.85	32.21	56.12	99.37	42.42	80.70	9.58	72.52	12.74
BRD-A44008656	CP	doxylamine	histamine receptor antagonist	HRH1, CHRM1		6.15, 2.69	50.21	0.36, 0.09	78.71	13.18	37.89	4.01	50.21	25.88	41.13	62.92	61.60	16.37	70.95	86.20	-24.21	5.13	94.16	4.58	76.85	16.31	39.17	69.78	91.97	54.35	31.65	84.76	23.65	71.43	85.14	83.87	27.60
BRD-A68589262	CP	troxipide	glucosamine synthetase stimulant			8.44, 4.89	50.19	1.55, 0.52	52.90	90.81	53.91	9.38	79.64	80.22	4.55	43.12	-14.27	99.96	50.19	99.47	46.00	19.46	98.01	94.77	90.84	59.86	34.83	45.72	78.93	28.71	98.54	49.80	35.51	7.29	4.29	88.70	0.15
BRD-K40624912	CP	ZM-39923	JAK inhibitor	JAK1, JAK3		4.90, 2.04	50.19	1.75, 0.43	25.15	39.48	93.04	-5.41	79.45	46.34	16.32	13.79	17.68	92.55	83.51	51.67	72.76	81.70	64.59	79.16	50.19	23.19	92.39	45.74	47.20	30.71	14.68	89.03	97.50	74.83	64.72	47.49	9.06
BRD-K80725821	CP	RS-16566	(R)-zacopride ligand			6.92, 4.62	50.18	1.03, 0.33	67.85	-18.48	50.18	38.41	76.92	15.15	13.48	76.58	6.20	28.02	75.63	11.21	-1.87	4.19	61.28	32.87	38.46	16.58	72.71	98.03	56.33	67.16	6.83	93.68	99.93	68.50	20.97	70.34	76.91
BRD-A02189320	CP	met-leu-phe	in touchstone			6.94, 3.67	50.16	1.18, 0.31	94.53	50.16	98.77	25.50	91.07	98.90	43.83	29.82	22.09	95.39	8.25	89.58	2.26	49.11	99.58	22.57	77.24	16.17	99.93	49.05	54.55	46.60	86.30	99.40	25.34	83.15	48.74	58.32	14.39
BRD-K78637815	CP	LY-320135	cannabinoid receptor antagonist	CNR1		4.23, 2.31	50.16	1.63, 0.51	19.42	-36.85	83.84	39.71	76.38	-8.62	89.71	67.40	24.52	-0.46	17.95	40.42	0.00	0.63	92.30	-81.64	61.30	15.53	85.19	97.46	17.40	58.04	18.28	82.30	93.34	50.16	71.88	94.26	74.27
BRD-A47494775	CP	dipivefrine	adrenergic receptor agonist	ADRA1A, ACHE, ADRA2A, ADRB2, BCHE		4.49, 2.04	50.13	0.67, 0.17	51.49	30.99	57.22	37.68	44.62	24.14	16.86	61.12	97.13	69.32	38.22	77.91	5.58	43.20	90.01	3.14	96.85	50.75	16.51	27.31	87.84	51.87	79.47	1.37	59.35	50.13	51.62	29.39	24.87
BRD-A89434049	CP	sarmentogenin	ATPase inhibitor	ATP1A1	ATPase inhibitor	1.53, 1.53	50.13	2.40, 0.72	37.94	66.82	17.27	56.94	91.93	15.88	66.75	49.81	76.75	2.47	6.67	20.47	92.17	61.37	91.61	93.68	56.35	12.50	36.89	65.51	62.13	50.45	44.22	NaN	5.32	6.54	22.40	99.12	47.07
BRD-K50140147	CP	NVP-TAE684	ALK tyrosine kinase receptor inhibitor, ALK tyrosine kinase receptor mutant inhibitor, leucine rich repeat kinase inhibitor	ALK, INSR		7.31, 3.46	50.12	1.82, 0.51	11.02	88.93	82.76	99.33	73.48	27.10	16.82	27.77	47.03	50.12	44.17	65.63	83.72	89.06	75.36	99.58	23.84	95.04	21.66	29.22	90.13	50.92	37.46	-93.01	93.41	10.38	27.48	34.72	63.98
BRD-K64755930	CP	etazolate	phosphodiesterase inhibitor, alpha secretase activator, GABA receptor modulator	GABRB3, PDE4A		4.90, 2.04	50.12	1.39, 0.44	94.03	16.49	20.21	86.75	28.74	19.55	51.72	29.65	99.93	55.92	22.30	62.72	8.91	3.60	50.12	9.75	90.72	32.09	89.69	59.66	34.22	17.83	55.91	99.37	57.08	81.43	57.81	22.15	14.78
BRD-K96319534	CP	phentermine	adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor	MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4		4.62, 2.31	50.11	0.49, 0.08	97.56	41.97	57.01	22.61	87.31	94.56	6.31	43.07	22.29	50.11	23.70	83.77	2.82	16.62	86.82	10.25	67.32	14.31	44.05	59.90	79.66	89.02	71.47	99.12	24.23	42.86	83.47	75.43	26.80
BRD-K32696739	CP	noreleagnine	imidazoline receptor ligand, serotonin receptor ligand	ADRA2A, ADRA2B, ADRA2C, HTR2A, MAOA, MAOB		7.31, 3.46	50.09	1.11, 0.23	96.66	31.62	7.55	50.09	0.60	51.78	51.25	43.83	2.26	99.68	96.95	75.69	3.92	22.91	42.60	2.04	29.00	34.20	95.13	61.29	82.87	73.88	-12.38	28.34	65.73	64.76	59.44	93.77	6.27
BRD-K45988865	CP	tetramethylsilane	organosilicon compound used as an internal standard in NMR spectroscopy			5.77, 2.69	50.09	1.18, 0.18	30.69	62.97	91.19	45.80	80.08	14.90	50.09	49.62	17.86	74.18	96.24	95.27	-15.89	1.59	88.85	26.71	62.68	5.80	32.75	98.03	53.93	96.76	10.90	-60.55	21.31	90.89	82.68	90.84	44.80
BRD-A89337244	CP	PD-102807	acetylcholine receptor antagonist	CHRM4		8.08, 3.46	50.06	1.00, 0.10	14.08	69.43	95.01	96.02	39.21	85.46	5.19	52.37	16.52	15.63	15.70	35.74	88.07	70.64	95.18	99.58	41.51	96.79	6.37	29.43	25.90	53.75	29.99	50.06	76.07	42.44	64.00	50.15	38.04
BRD-K09397065	CP	SR-57227A	serotonin receptor agonist, serotonin release enhancer	HTR3A		5.38, 3.46	50.05	0.53, 0.13	53.83	61.22	40.24	14.79	75.89	17.00	96.32	12.41	71.81	57.11	31.36	90.47	1.41	-1.16	93.38	9.02	93.36	21.25	13.10	97.24	80.06	68.03	72.84	-0.04	17.51	39.00	27.83	97.71	50.05
BRD-K54771420	CP	glycocholic-acid	cholesterol inhibitor	FABP6		5.00, 2.31	50.04	0.50, 0.11	43.64	80.85	29.43	24.73	98.90	95.10	16.44	-46.20	45.90	6.07	45.40	77.61	-1.44	37.69	93.96	60.56	89.77	32.77	83.47	98.09	50.04	98.24	40.90	93.69	7.82	32.24	83.08	97.44	73.75
BRD-K60690191	CP	MPEP	glutamate receptor antagonist	GRM5, GRM1, GRM4		10.19, 6.37	50.04	1.56, 0.49	58.53	19.06	1.37	10.25	88.49	0.03	25.22	72.87	28.06	72.41	48.89	15.51	-0.21	61.48	53.09	50.04	87.30	84.95	34.67	64.35	98.43	99.93	5.01	0.00	95.42	1.59	2.63	99.08	77.59
BRD-K04170657	CP	psoromic-acid	Rab-Prenylation Inhibitor			3.82, 1.53	50.02	1.73, 0.28	95.75	-45.17	93.48	47.67	47.15	10.12	81.38	86.11	6.47	99.93	95.42	52.38	6.10	74.93	7.36	9.33	80.67	52.39	99.68	47.29	43.80	33.79	-2.33	NaN	72.55	86.41	14.82	46.77	94.61
BRD-A20131130	CP	2',5'-dideoxyadenosine	adenylyl cyclase inhibitor			1.92, 0.77	50.02	1.40, 0.35	93.15	11.86	93.00	17.66	79.07	37.45	88.44	92.11	59.77	28.74	73.40	50.02	-79.80	29.85	31.50	2.92	64.29	17.73	55.34	34.84	52.64	58.81	23.85	2.96	11.24	87.28	53.16	85.94	49.41
BRD-A28856712	CP	tetryzoline	adrenergic receptor agonist			4.90, 1.63	50.00	1.32, 0.22	96.90	-23.84	63.96	17.59	94.02	35.20	11.87	60.47	69.72	96.61	94.27	15.62	1.87	42.46	98.96	3.76	71.49	19.06	71.11	50.00	18.57	2.74	70.93	52.97	36.33	25.90	29.46	73.31	89.25
BRD-K21971034	CP	OM-137	Aurora kinase inhibitor		Aurora kinase inhibitor	3.27, 0.82	49.90	0.95, 0.15	10.01	-2.54	1.55	56.64	49.90	52.05	55.31	71.00	52.69	65.71	86.05	94.48	1.90	4.81	73.24	6.34	56.33	4.27	67.41	18.85	24.28	25.64	15.21	0.00	78.67	85.78	40.87	49.41	55.36
BRD-A35033682	CP	eriodictyol	cytochrome P450 inhibitor, TRPM3 antagonist, xanthine oxidase inhibitor	CYP1B1, NFE2L2, XDH		5.00, 2.69	49.87	1.48, 0.51	85.61	10.98	6.59	25.23	56.07	4.77	11.82	20.75	65.88	10.18	17.52	70.51	23.46	70.10	49.87	95.17	30.29	49.94	91.92	99.30	11.24	55.39	62.11	49.33	32.14	62.81	64.42	65.45	24.39
BRD-K66412701	CP	pazufloxacin	topoisomerase inhibitor			6.67, 4.00	49.84	1.58, 0.75	5.11	64.11	41.55	10.83	23.52	22.25	70.23	24.63	-15.61	96.89	99.03	99.58	2.78	15.72	90.37	75.08	2.68	68.92	51.40	66.56	35.34	16.90	98.11	89.69	49.84	89.06	68.48	21.64	7.77
BRD-K81855038	CP	roxatidine	histamine receptor antagonist	HRH2		8.00, 4.44	49.84	0.94, 0.23	15.03	64.28	71.87	60.94	98.01	62.52	23.88	86.58	26.55	98.78	26.97	97.25	4.72	-1.69	90.34	7.70	99.37	49.84	13.85	61.11	18.60	16.31	83.58	-0.04	-39.55	88.91	38.29	76.62	9.61
BRD-K85985071	CP	ellipticine	topoisomerase inhibitor, DNA intercalating drug	TOP2A, TOP2B	Topoisomerase inhibitor	4.62, 2.69	49.84	1.99, 0.44	58.11	97.99	35.90	49.84	73.27	47.12	37.67	-14.65	7.93	86.77	69.11	64.45	79.02	0.00	66.57	97.98	41.62	62.21	5.94	36.29	81.93	51.32	36.04	-56.17	-0.56	31.82	75.44	50.22	49.72
BRD-A85025557	CP	NCS-382	GABA receptor antagonist	GABBR1, GABBR2, SLC52A2	GABA receptor antagonist	5.77, 3.46	49.83	0.59, 0.10	39.90	23.63	90.90	42.14	89.52	24.75	13.60	43.46	81.76	9.89	6.69	72.59	-18.16	10.91	91.82	-10.92	86.96	62.56	46.84	99.51	40.42	98.45	49.83	97.11	71.30	12.23	88.96	94.36	92.80
BRD-A39646320	CP	HC-toxin	HDAC inhibitor	HDAC1	HDAC inhibitor	3.08, 0.77	49.82	1.55, 0.53	65.21	97.92	72.89	51.94	25.67	26.18	8.77	-18.10	16.76	32.78	13.07	69.55	84.79	88.11	99.33	97.07	51.96	78.60	0.10	49.82	33.41	35.36	68.09	12.83	15.24	49.39	72.69	7.54	51.96
BRD-K68997413	CP	PF-3845	FAAH inhibitor	FAAH		3.85, 2.31	49.73	0.69, 0.28	89.15	58.96	96.83	49.73	40.65	86.16	13.63	55.31	52.61	5.21	13.95	74.65	11.21	39.39	91.25	7.44	62.81	31.39	91.04	88.73	24.44	80.86	22.08	-0.90	14.65	74.64	16.24	35.19	65.13
BRD-A85587465	CP	bemesetron	serotonin receptor antagonist	HTR3A, HTR3B	Serotonin receptor antagonist	6.92, 2.31	49.68	0.69, 0.13	9.82	48.12	93.27	30.86	49.68	17.07	-9.18	86.11	41.27	13.09	56.25	94.71	6.57	23.18	78.28	2.55	67.03	89.93	30.63	97.45	74.28	66.06	35.68	92.94	76.35	28.09	8.57	85.01	73.89
BRD-K93280214	CP	gabazine	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2		6.92, 3.85	49.62	0.88, 0.17	70.32	-30.53	17.62	3.59	49.62	0.03	59.12	82.98	31.96	42.86	17.52	50.25	-2.22	-7.17	89.14	2.18	69.81	5.69	88.28	99.89	70.22	46.46	32.16	91.51	69.49	78.42	40.30	97.92	73.81
BRD-K17868609	CP	BRL-54443	serotonin receptor agonist	HTR1E, HTR1F		4.23, 1.92	49.61	0.97, 0.26	14.48	51.48	82.62	48.20	52.20	93.52	-68.14	20.61	18.55	-11.56	49.61	66.16	-2.11	1.20	98.48	-3.66	95.94	57.55	-37.44	97.82	77.85	63.17	58.95	0.00	-28.07	24.41	46.52	89.04	74.40
BRD-K70557564	CP	zosuquidar	P glycoprotein inhibitor, P glycoprotein modulator	ABCB1, ABCB4		4.23, 1.92	49.59	0.98, 0.31	77.08	-39.71	14.90	85.69	79.02	0.03	49.35	94.48	34.69	29.99	3.62	80.80	69.42	49.59	74.41	32.07	98.85	90.38	36.62	1.13	13.30	38.37	22.64	6.48	96.55	74.68	52.29	74.36	68.62
BRD-A41451487	CP	PK-11195	benzodiazepine receptor antagonist, constitutive androstane receptor (CAR) antagonist, PXR agonist, translocator protein antagonist	TSPO, NR1I2, NR1I3		1.54, 0.77	49.55	0.45, 0.03	82.44	61.72	56.24	49.55	61.66	47.15	53.81	51.80	42.77	10.98	18.34	37.57	72.64	72.36	30.14	80.58	8.24	39.99	90.43	87.34	42.44	37.41	8.00	0.07	52.77	86.82	10.54	47.42	55.94
BRD-K33308633	CP	INCA-6	calcineurin inhibitor, Inhibitor of interaction between calcineurin and its substrate nuclear factor of activated T cells (NFAT)	NFATC1		5.00, 3.08	49.54	0.63, 0.18	26.15	13.96	72.12	28.87	62.24	16.38	27.73	49.54	6.38	33.89	67.64	76.92	78.10	45.18	70.17	83.98	34.14	45.23	41.98	77.97	61.26	98.13	29.09	93.54	39.23	75.80	87.17	75.05	46.71
BRD-K74212935	CP	ergocryptine	dopamine agonist			5.77, 3.08	49.54	0.64, 0.14	59.24	74.21	51.21	18.41	99.15	15.61	40.48	79.75	60.40	26.61	79.73	28.06	1.44	10.69	58.70	23.61	91.65	15.14	9.55	84.94	82.01	16.65	-18.74	2.78	67.61	7.86	49.54	87.19	78.91
BRD-K93460210	CP	lamotrigine	glutamate release inhibitor, serotonin receptor inhibitor, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker	SCN1A, SCN2A, SCN3A		5.00, 1.54	49.51	0.76, 0.11	41.94	49.51	95.73	38.30	64.94	-1.34	20.40	41.84	74.88	31.26	95.27	86.35	2.57	-0.91	89.01	5.14	96.02	16.26	20.94	79.51	76.34	93.51	84.93	9.12	58.11	42.12	84.74	24.17	60.79
BRD-A55913614	CP	primaquine	antimalarial agent, DNA inhibitor	KRT7, NQO2		4.23, 1.54	49.48	0.57, 0.14	49.48	59.19	96.43	24.56	72.49	10.62	-34.40	55.69	21.42	12.92	49.57	90.30	82.01	40.06	98.91	69.18	96.76	47.53	12.74	77.95	74.54	91.42	40.21	-0.88	15.63	9.36	39.41	49.15	91.35
BRD-K32645441	CP	dipropyl-5ct	serotonin receptor agonist	HTR1B, HTR1D, HTR1F, HTR7		8.85, 5.77	49.48	0.89, 0.16	2.47	59.32	78.83	1.39	98.28	-5.54	90.09	91.93	31.28	97.95	99.65	78.66	-31.59	16.35	-22.39	0.78	49.48	44.67	96.44	74.51	40.13	77.48	23.26	-6.69	36.14	94.57	-29.88	95.03	79.34
BRD-K24201553	CP	SB-269970	serotonin receptor antagonist	HTR7		3.85, 0.77	49.46	0.86, 0.31	9.73	31.27	95.11	25.54	90.96	49.46	50.57	-79.04	55.40	8.04	79.07	32.67	0.00	24.01	95.95	7.40	95.71	59.50	20.99	53.99	67.05	71.09	28.13	2.55	-26.34	67.17	28.63	53.59	81.57
BRD-K88551539	CP	CAY-10585	hypoxia inducible factor inhibitor	HIF1A		6.54, 1.54	49.45	1.76, 0.75	69.24	64.37	84.62	87.62	11.21	84.65	14.95	57.04	8.88	54.46	46.53	95.17	3.28	8.99	91.07	96.27	85.15	0.74	35.17	97.22	76.21	27.35	35.74	11.87	0.00	67.00	5.42	30.19	49.45
BRD-A22143024	CP	estropipate	estrogen receptor agonist	ESR1, ESR2	Estrogen receptor agonist	3.46, 2.31	49.40	0.61, 0.10	70.73	10.77	2.47	16.36	80.09	49.40	41.77	64.45	30.58	75.70	3.72	66.59	1.83	-1.80	91.23	2.50	90.90	6.92	68.20	73.48	89.03	42.09	32.58	99.26	54.35	88.78	65.20	11.35	24.16
BRD-A98299281	CP	velnacrine	calcium channel activator	ACHE		5.71, 2.86	49.32	0.89, 0.18	45.65	68.45	55.65	36.15	49.32	75.39	22.08	53.63	9.78	61.08	56.51	77.41	6.34	2.57	93.38	18.27	96.58	55.04	96.71	40.02	83.96	37.42	34.44	-15.25	0.18	47.22	77.15	51.17	48.38
BRD-K07403598	CP	CAY-10470	NFKB pathway inhibitor	NFKB1, TNF		4.49, 3.27	49.32	0.98, 0.16	76.20	73.84	49.32	91.57	66.40	9.49	31.36	74.42	4.13	43.86	70.85	97.96	81.99	86.92	43.74	99.47	0.59	87.62	50.73	15.54	24.26	23.61	22.64	-2.13	39.50	84.36	69.55	21.64	1.30
BRD-K18787491	CP	U-0126	MEK inhibitor, JAK inhibitor, MAP kinase inhibitor	AKT1, CHEK1, GSK3B, JAK2, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	MEK inhibitor	4.23, 1.54	49.32	1.06, 0.43	10.53	59.52	77.77	87.87	62.18	49.32	0.00	-20.95	69.71	16.10	20.60	97.15	17.58	92.70	91.10	98.82	33.02	89.77	-17.44	33.81	85.11	60.27	17.01	-21.62	41.75	4.83	19.44	55.44	58.14
BRD-K14765469	CP	vesamicol	acetylcholine transport inhibitor	SLC18A3		5.38, 2.69	49.31	0.59, 0.17	49.31	95.01	86.53	39.89	89.69	3.14	31.66	61.31	33.88	67.31	88.40	53.89	9.45	12.62	99.03	55.96	96.97	40.53	39.07	11.92	48.94	88.96	90.72	0.81	15.50	6.03	56.76	49.27	59.54
BRD-K81916719	CP	triclabendazole	acetylcholinesterase inhibitor, DNA methyltransferase inhibitor, microtubule inhibitor	DNMT1		6.67, 3.11	49.26	0.83, 0.25	97.35	24.94	49.26	10.25	-3.66	11.64	68.55	49.77	67.19	23.38	53.98	72.87	13.48	49.91	98.96	-90.87	87.90	31.14	59.30	35.74	-2.26	22.10	54.41	0.88	72.46	53.09	81.25	40.95	9.82
BRD-A20697603	CP	thiostrepton	downregulates FOXM1 expression, FOXM1 expression inhibitor, protein synthesis inhibitor	FOXM1	Protein synthesis inhibitor	6.54, 2.69	49.25	1.86, 0.31	48.75	97.15	49.25	94.71	80.51	21.14	-1.59	35.38	34.92	20.29	9.20	88.66	94.31	99.40	91.53	99.68	37.11	91.61	29.44	7.97	73.20	47.13	93.34	-10.32	58.22	7.27	68.20	1.02	49.43
BRD-A85234536	CP	N6-cyclopentyladenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1	Adenosine receptor agonist	7.35, 3.67	49.22	1.27, 0.39	99.96	33.35	92.67	51.02	58.40	39.84	41.50	73.48	96.20	99.93	82.56	67.66	3.96	33.80	92.25	21.67	53.54	3.91	49.48	67.18	49.22	33.35	47.62	-99.33	28.23	85.11	27.69	38.71	14.36
BRD-K08998509	CP	fananserin	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A, DRD4		5.38, 3.85	49.19	1.20, 0.42	27.34	-20.71	37.48	23.58	35.47	41.78	49.43	24.23	9.61	91.15	31.19	86.57	0.00	19.88	80.07	6.04	80.77	49.19	56.82	91.24	86.35	98.09	11.68	93.71	74.83	80.10	34.14	73.32	59.25
BRD-K24675965	CP	LY-288513	CCK receptor antagonist	CCKBR		4.23, 2.31	49.11	0.94, 0.19	78.60	30.88	96.13	83.05	94.12	99.19	96.39	-74.19	20.98	27.57	42.21	86.16	2.22	29.41	78.58	2.54	44.28	10.58	49.19	49.64	64.40	35.10	58.93	99.86	49.11	43.11	81.43	16.52	10.95
BRD-K94270326	CP	ecopipam	dopamine receptor antagonist	DRD1, DRD5, DRD2		6.15, 3.08	49.10	0.76, 0.11	22.83	-8.18	23.21	70.88	58.38	33.00	4.37	50.39	56.70	21.26	7.17	86.74	20.80	16.30	98.52	55.67	75.99	52.42	13.86	95.16	49.10	46.56	41.76	60.08	87.56	13.39	46.24	97.46	61.83
BRD-A37837077	CP	cyclazosin	adrenergic receptor antagonist	ADRA1B, ADRA1A, ADRA1D		4.23, 1.15	49.09	0.94, 0.30	9.73	44.23	37.68	72.01	30.58	37.67	44.98	41.67	8.39	21.50	41.90	51.50	49.09	88.05	96.70	65.23	61.03	64.13	91.89	25.05	26.03	63.73	70.12	73.93	95.11	56.55	37.90	1.83	52.67
BRD-A31007383	CP	SDZ-WAG-994	adenosine receptor agonist	ADORA1		7.69, 4.23	49.08	1.30, 0.43	71.31	87.73	95.12	8.74	99.58	27.58	22.19	-16.94	85.61	32.12	29.02	68.98	12.75	0.53	70.37	26.90	96.76	40.64	59.64	92.29	49.08	41.04	61.41	4.98	3.88	90.75	62.40	98.06	15.11
BRD-K35430135	CP	SR-59230A	adrenergic receptor antagonist	ADRB3, ADRB1, ADRB2		3.85, 1.92	49.07	0.66, 0.16	11.23	17.09	49.07	77.81	40.05	-15.59	59.55	47.24	25.53	24.02	6.13	57.92	4.30	57.83	85.29	34.72	74.02	77.17	58.32	87.40	33.57	13.07	62.39	64.25	97.09	94.98	29.14	83.91	28.48
BRD-K13646352	CP	midostaurin	FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor	FLT3, KIT, CCNB1, FLT1, KDR, PDGFRB, PRKCA, PRKCG, VEGFA	FLT3 inhibitor, PDGFR/KIT inhibitor, PKC inhibitor, VEGFR inhibitor	8.85, 5.00	49.03	1.35, 0.26	44.91	86.35	67.60	99.98	70.03	86.46	49.03	-12.58	83.82	14.05	9.76	82.29	87.14	85.85	97.19	99.87	72.24	95.53	-14.62	23.77	74.09	31.52	12.93	-40.14	13.50	1.92	32.81	14.49	45.16
BRD-A71657825	CP	2-(biphenyl-4-ylsulfonamido)pentanedioic-acid	matrix metalloprotease inhibitor	MMP13, MMP8, MMP9		5.71, 1.63	49.01	0.60, 0.11	35.09	-23.30	78.07	22.59	79.14	26.06	38.03	95.13	25.19	17.95	76.30	58.57	4.53	49.01	74.37	4.78	77.37	22.94	91.02	86.32	59.70	61.32	28.95	-7.87	96.26	33.25	93.50	82.80	24.65
BRD-A03816571	CP	CP-55940	cannabinoid receptor agonist, CC chemokine receptor antagonist	CNR1, CNR2, CXCR4, GPR55		5.38, 1.54	49.00	1.01, 0.33	51.07	-9.80	14.34	61.33	-7.11	-9.46	96.39	83.24	5.25	9.17	44.09	24.68	87.10	49.00	92.55	96.29	81.41	29.81	9.80	96.25	8.25	54.40	9.07	89.64	41.82	78.27	61.56	73.02	26.66
BRD-K55301415	CP	abiraterone	17,20 lyase inhibitor, androgen biosynthesis inhibitor, cytochrome P450 inhibitor, steroid sulfatase inhibitor	CYP17A1, CYP11B1		3.27, 2.04	48.98	1.34, 0.45	15.98	23.76	26.84	19.82	48.98	19.76	59.79	87.22	32.19	22.05	85.41	58.82	0.00	-27.43	88.36	85.54	85.70	20.82	64.45	77.81	12.79	40.75	82.01	74.11	25.89	94.58	50.68	70.94	24.58
BRD-A09722536	CP	cyclophosphamide	alkylating agrent, BCL inhibitor, galectin inhibitor	BCL2, CYP2B6, CYP2C19, CYP3A5, LGALS1		7.35, 4.49	48.96	1.06, 0.41	55.23	89.85	93.98	13.72	89.47	25.22	21.44	95.23	3.28	59.55	40.52	88.61	3.15	2.04	57.25	84.76	84.32	24.02	69.29	40.89	43.88	22.18	48.96	-46.87	8.20	98.91	40.50	69.54	53.76
BRD-K17796732	CP	JWH-015	cannabinoid receptor agonist	CNR2, GPR55	Cannabinoid receptor agonist	5.00, 3.85	48.95	1.25, 0.41	35.19	32.13	84.96	29.11	80.64	48.95	47.74	68.55	7.02	42.53	20.00	81.55	-1.37	10.42	44.91	66.15	57.14	61.03	38.24	62.91	57.11	99.26	7.46	74.30	51.12	23.63	43.66	85.77	53.43
BRD-K09132007	CP	D-4476	casein kinase inhibitor, TGF beta receptor inhibitor	CSNK1A1, CSNK1D, TGFB1	TGF beta receptor inhibitor	4.23, 2.31	48.93	1.18, 0.35	45.91	12.72	83.05	82.97	26.16	48.93	61.33	22.50	62.95	20.07	25.85	40.00	3.49	48.12	61.72	87.53	92.58	88.71	64.03	98.38	68.79	43.69	10.83	-4.58	11.09	89.70	41.27	84.37	93.29
BRD-A05186015	CP	bupropion	dopamine reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine transporter inhibitor, norepinephrine transporter inhibitor, norepinephrine/dopamine dual reuptake inhibitor	SLC6A2, SLC6A3, CHRNA3, CYP2B6		5.00, 3.08	48.89	0.61, 0.08	39.98	64.00	76.40	5.92	64.87	23.16	52.55	55.17	33.98	61.94	48.89	42.82	0.63	15.26	91.06	14.51	96.14	50.77	48.68	44.91	33.47	63.28	33.70	51.61	92.36	46.85	68.33	43.42	74.81
BRD-A41941932	CP	vitexin	antioxidant			3.08, 1.92	48.88	1.34, 0.58	48.76	51.44	48.88	18.25	97.34	72.78	48.41	56.98	76.50	37.32	1.16	71.38	4.39	4.07	82.57	20.54	94.84	76.26	-6.18	87.12	28.24	47.42	61.46	0.00	4.67	-18.27	79.23	96.76	78.53
BRD-A96456596	CP	FPL-55712	leukotriene receptor antagonist, leukotriene synthesis inhibitor			5.38, 3.46	48.86	1.09, 0.26	63.47	34.53	46.93	51.28	45.44	8.02	12.11	74.01	30.17	3.52	62.22	55.84	-2.22	-21.80	70.47	4.76	89.19	8.42	26.53	97.25	55.46	93.94	28.85	0.85	81.11	48.86	77.67	99.30	49.52
BRD-K72093121	CP	vidarabine	adenylyl cyclase inhibitor, DNA directed DNA polymerase inhibitor, viral DNA synthesis inhibitor	ADCY5	Ribonucleotide reductase inhibitor	4.90, 1.63	48.82	0.84, 0.34	8.98	60.13	52.68	49.69	50.33	36.67	35.85	77.70	24.85	89.09	59.39	48.82	6.23	0.42	90.17	32.80	87.31	12.16	43.94	23.69	12.67	27.15	59.16	79.50	61.19	94.59	80.44	41.74	40.26
BRD-A81177136	CP	KN-62	calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist	AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1		5.00, 1.54	48.81	0.81, 0.14	67.33	39.30	83.12	88.32	29.37	38.15	17.26	33.95	66.45	11.27	71.41	29.55	62.31	85.38	16.66	91.05	29.33	85.34	27.04	56.60	69.47	48.81	40.51	-24.35	97.29	45.73	21.83	73.63	85.71
BRD-A87719232	CP	naproxen	cyclooxygenase inhibitor	PTGS2, PTGS1		4.62, 3.46	48.78	1.25, 0.35	23.05	54.83	28.64	6.64	29.99	94.48	58.00	46.11	32.10	98.21	55.71	81.57	0.00	69.51	17.53	2.01	-9.82	4.72	92.31	48.78	85.34	62.02	45.57	28.52	57.18	83.78	40.38	79.60	81.14
BRD-K15601958	CP	SEW-2871	lysophospholipid receptor agonist	S1PR1		5.00, 2.31	48.76	1.19, 0.39	98.61	36.42	63.87	21.13	96.19	46.42	43.14	51.85	38.57	93.96	76.25	90.18	0.00	15.28	53.98	3.00	63.21	10.43	48.76	90.98	34.17	98.45	14.03	-99.19	12.22	36.65	56.95	98.79	84.64
BRD-K06388322	CP	pramipexole	dopamine receptor agonist	DRD3, DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C		9.33, 6.22	48.74	1.11, 0.22	48.16	94.56	66.47	38.38	91.62	48.74	61.95	-52.19	26.88	88.43	77.73	99.26	6.07	56.09	90.76	24.43	97.99	40.05	-42.21	72.23	98.13	35.92	97.99	19.96	34.80	-61.71	33.60	36.53	58.19
BRD-K42748308	CP	XE-991	acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker	KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5		5.38, 2.31	48.74	0.73, 0.24	20.79	-24.43	48.74	18.45	81.91	72.41	18.10	57.90	0.85	4.93	53.81	49.47	7.26	54.68	93.55	61.74	70.82	71.42	23.55	22.90	81.10	16.22	3.93	0.21	44.45	78.44	50.95	72.36	10.70
BRD-K67506692	CP	tyrphostin-AG-126	ERK1 and ERK2 phosphorylation inhibitor, tyrosine kinase inhibitor			3.46, 1.54	48.74	1.78, 0.40	32.37	41.79	21.67	78.90	83.81	89.59	7.10	82.33	9.22	73.28	38.30	86.17	87.17	15.54	90.69	97.51	87.96	6.41	15.57	70.34	48.74	81.92	3.28	0.35	-37.70	79.05	32.39	42.58	59.80
BRD-A08187463	CP	racecadotril	enkephalinase inhibitor, membrane metalloendopeptidase inhibitor, neprilysin inhibitor	MME		6.92, 3.85	48.73	0.98, 0.31	33.35	37.45	98.94	15.09	88.15	7.35	51.99	91.98	31.17	77.95	27.63	96.49	23.45	4.86	94.96	5.86	97.05	5.67	47.89	90.29	44.05	47.76	57.03	91.34	44.67	94.19	48.73	71.76	87.55
BRD-K29458283	CP	chlorambucil	DNA damaging, DNA inhibitor			2.69, 1.92	48.71	0.51, 0.16	70.17	94.71	70.01	18.27	90.23	43.88	46.11	22.52	37.55	48.71	64.82	81.69	7.93	48.65	67.17	91.84	69.52	19.05	61.82	72.71	41.16	57.30	55.99	0.03	39.77	29.51	48.50	76.86	10.00
BRD-K64614248	CP	salicin	antiinflammatory agent			4.62, 1.54	48.71	1.13, 0.30	73.23	50.11	22.09	12.68	57.65	78.91	48.71	84.46	42.13	50.31	15.89	59.32	3.21	10.23	81.10	18.86	75.58	41.25	34.40	87.68	31.71	48.08	34.13	86.46	52.59	88.76	45.03	96.94	28.76
BRD-A24514565	CP	warfarin	cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor	VKORC1, CYP2C19, CYP2C8, CYP4F2		6.53, 3.27	48.69	0.85, 0.22	41.70	61.59	48.69	5.98	70.76	80.47	33.92	96.76	42.52	12.76	84.16	74.06	-1.09	5.98	92.56	3.02	89.98	15.13	83.05	83.66	-16.17	65.68	23.28	3.99	22.85	89.73	25.55	60.33	57.95
BRD-K24681473	CP	YM-155	survivin inhibitor, XIAP expression inhibitor	BIRC5		5.38, 1.54	48.69	2.30, 0.64	5.78	96.34	48.90	88.79	76.54	20.49	0.99	-17.97	17.24	24.03	6.78	83.67	93.06	49.46	59.18	99.84	85.79	66.54	37.86	20.91	82.31	75.91	12.11	0.00	-1.23	4.19	48.69	33.19	74.25
BRD-K24538644	CP	KUC104502N	opioid receptor antagonist	OPRK1		3.85, 3.46	48.68	0.95, 0.19	90.08	-22.49	6.33	-6.62	36.64	27.95	49.64	94.74	38.09	90.44	67.01	48.68	-12.26	11.45	47.86	-0.95	71.17	17.70	92.54	66.42	52.14	7.03	59.13	99.30	79.43	98.27	25.62	18.37	86.31
BRD-A78377521	CP	monastrol	kinesin-like spindle protein inhibitor	KIF11		5.77, 1.92	48.63	0.77, 0.18	17.13	75.21	49.93	22.71	54.68	22.37	35.30	43.59	73.08	79.40	9.74	53.02	4.67	24.52	48.63	1.30	37.13	37.31	79.91	96.74	82.76	87.53	16.10	35.09	62.61	75.60	9.76	68.56	96.72
BRD-K99291625	CP	SB-203580	p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor	MAPK14, MAPK1, MAPK11, AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK10, MAPK12, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF	P38 MAPK inhibitor	3.08, 1.15	48.63	1.74, 0.34	30.98	86.33	3.68	61.64	49.71	65.51	88.75	48.63	34.03	51.01	86.83	86.00	2.85	45.12	8.99	91.71	-1.72	6.51	65.04	10.53	11.05	65.60	42.55	1.30	33.12	70.95	86.51	86.52	26.87
BRD-M16762496	CP	PIK-75	DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	PI3K inhibitor	6.15, 3.08	48.63	1.86, 0.69	2.29	98.84	2.92	1.69	84.34	63.92	54.33	42.64	27.81	71.73	53.51	89.31	0.00	48.63	-67.66	91.30	0.00	0.00	51.53	72.78	78.05	13.85	7.81	-2.18	-1.87	57.05	14.22	68.88	69.53
BRD-A72066420	CP	mifobate	cholesterol inhibitor, PPAR receptor antagonist, renin inhibitor	PPARG, REN		7.35, 4.49	48.59	1.33, 0.49	99.89	31.88	45.11	7.47	75.72	98.71	16.59	60.88	13.26	75.08	96.81	97.24	-2.93	7.20	48.59	7.25	77.93	21.66	67.53	69.74	76.44	93.11	38.28	-92.11	6.48	41.95	40.74	79.37	91.86
BRD-K48735772	CP	PD-158780	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR	EGFR inhibitor	6.12, 2.86	48.58	1.63, 0.51	95.76	13.12	21.00	94.01	17.05	55.12	31.66	74.13	14.24	17.22	60.21	63.42	81.65	83.74	78.14	95.76	75.24	69.80	41.29	61.88	-23.41	-30.94	15.66	48.58	47.38	38.23	25.46	51.92	3.35
BRD-K93618743	CP	ipriflavone	bone resorption inhibitor			7.11, 3.56	48.58	1.25, 0.25	21.97	15.50	90.90	3.71	29.37	-0.03	99.09	48.58	3.88	52.68	98.27	95.17	0.49	69.62	60.73	93.01	86.83	0.25	17.79	19.58	44.06	57.68	45.47	0.00	0.21	81.26	93.46	97.37	63.27
BRD-A29082194	CP	gitoxigenin	ATPase inhibitor	ATP1A1	ATPase inhibitor	3.46, 1.92	48.56	0.82, 0.30	5.56	48.60	83.05	35.59	60.36	4.33	24.26	41.99	91.89	6.41	35.40	36.65	80.40	6.96	48.56	87.47	62.81	82.81	19.24	79.04	87.47	56.03	28.22	-87.95	3.88	15.38	78.36	76.76	95.74
BRD-K33882852	CP	ZK-93423	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2		3.85, 1.15	48.56	0.83, 0.20	69.49	69.39	92.32	79.89	34.33	40.25	-18.14	-17.12	17.42	44.63	57.46	61.74	48.56	31.52	73.05	98.77	53.66	70.15	44.40	49.50	91.06	88.88	8.10	0.99	38.16	-11.35	6.17	81.89	11.32
BRD-K92413528	CP	thiazolidinecarboxylic-acid	glutathione synthase stimulant, reducing agent			8.44, 4.00	48.56	2.32, 0.82	37.87	56.19	16.42	64.28	3.43	7.12	59.55	70.04	5.22	97.04	96.65	99.75	15.98	7.58	98.06	79.44	-81.92	17.34	65.27	64.54	55.88	26.39	43.01	0.00	34.98	99.75	96.67	48.56	-0.18
BRD-K90733503	CP	cefalexin	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	8.00, 4.44	48.54	1.35, 0.28	7.45	97.45	93.61	12.78	97.45	28.93	82.53	89.95	51.78	83.38	64.56	96.93	25.25	4.46	87.11	55.74	98.28	31.63	34.52	17.17	48.54	9.96	97.56	13.74	33.29	-31.09	17.53	47.15	74.32
BRD-K32795028	CP	1-benzylimidazole	thromboxane synthase inhibitor	CYP11B1, QPCT		6.54, 2.31	48.51	1.14, 0.38	11.80	-97.64	2.82	25.31	-85.11	3.10	92.43	48.51	-41.03	73.01	70.45	41.90	31.55	22.90	95.67	1.48	87.12	62.10	97.29	56.48	83.05	52.37	93.75	92.12	74.68	34.27	30.93	98.79	38.98
BRD-K01663662	CP	diphenidol	acetylcholine receptor ligand	CHRM1, CHRM3, CHRM4, CHRM2		7.69, 2.69	48.50	1.07, 0.27	33.19	-5.88	69.75	25.20	57.18	71.26	51.22	98.39	16.59	79.79	66.70	17.93	-6.95	-0.03	43.14	-84.45	12.59	13.73	48.50	95.21	71.18	68.63	45.44	95.51	18.59	76.95	9.41	90.85	98.87
BRD-K41731458	CP	triclosan	DNA methyltransferase inhibitor, enoyl-(acyl-carrier protein) reductase Fabl inhibitor, enoyl-[acyl-carrier-protein] reductase [NADH] inhibitor	DNMT1		4.62, 3.08	48.50	1.36, 0.30	87.70	69.41	78.21	96.32	87.06	48.50	-8.32	83.10	22.39	14.99	25.98	54.83	95.50	78.87	38.71	99.75	59.66	83.73	18.05	40.24	10.24	28.04	37.13	42.76	73.42	8.26	27.42	51.77	16.00
BRD-K63913457	CP	eicosatrienoic-acid	vasodilator			4.23, 2.69	48.50	1.28, 0.47	16.02	9.27	6.78	26.66	71.05	49.06	34.07	68.01	9.88	94.50	80.20	79.79	-3.95	8.20	-11.85	2.50	34.56	14.48	90.20	68.09	50.26	95.55	42.01	0.00	50.48	64.46	58.91	83.31	48.50
BRD-A48261811	CP	argatroban	thrombin inhibitor, peptidase inhibitor, protease inhibitor	F2, CYP3A5		5.33, 2.22	48.49	0.98, 0.25	79.30	57.07	23.73	85.66	55.14	48.49	72.48	56.04	22.60	12.37	21.32	75.14	-0.88	28.80	46.74	23.68	93.24	48.99	24.32	55.79	28.72	89.54	32.54	17.04	39.60	55.77	95.17	71.60	17.49
BRD-K16478699	CP	PLX-4720	RAF inhibitor	BRAF, KDR	RAF inhibitor	3.46, 0.77	48.46	0.86, 0.30	63.45	51.43	79.85	66.47	35.28	20.57	33.93	71.79	26.80	3.59	1.41	61.92	73.96	45.87	90.22	98.66	65.59	17.18	48.46	38.35	41.52	14.16	70.22	92.48	23.62	28.52	63.52	53.98	30.53
BRD-K72029282	CP	probucol	atherogenesis inhibitor, cholesterol inhibitor, reducing agent	ABCA1, ABCB11, CES1		3.46, 1.54	48.46	1.40, 0.43	42.49	87.68	41.92	0.00	49.58	14.79	80.73	81.50	62.59	48.46	91.13	94.96	1.06	-1.69	-79.24	15.47	72.44	5.14	64.08	65.43	52.14	38.50	50.42	-95.76	23.32	92.60	41.24	42.01	93.87
BRD-A00993607	CP	alprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A		5.77, 3.46	48.43	0.57, 0.13	37.33	21.45	67.20	5.37	89.96	20.29	66.38	90.01	98.66	19.89	55.45	48.43	2.40	9.37	55.45	41.58	54.44	21.81	16.77	87.31	44.25	59.15	22.23	98.78	64.31	42.94	23.42	96.58	88.26
BRD-K11399644	CP	phenformin	AMPK activator	KCNJ8, PRKAA1		1.92, 1.54	48.43	0.83, 0.18	25.03	73.92	49.33	25.99	52.07	85.11	56.72	58.87	52.70	5.01	59.30	48.43	4.21	1.30	33.73	62.74	52.65	14.06	-76.42	62.74	35.00	47.25	18.75	0.07	65.56	56.32	40.10	11.23	86.63
BRD-K70401845	CP	erlotinib	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR, NR1I2	EGFR inhibitor	5.77, 3.08	48.41	1.18, 0.40	9.67	75.07	48.41	93.33	83.28	24.72	24.62	56.34	22.51	32.12	-6.44	82.42	77.11	75.66	74.74	98.37	89.90	38.30	48.68	57.88	4.86	57.21	-8.88	0.00	37.80	47.01	26.03	65.98	1.44
BRD-K83597974	CP	pargyline	monoamine oxidase inhibitor	MAOB, MAOA		2.31, 0.77	48.38	0.91, 0.28	19.70	25.51	68.87	14.48	54.79	12.79	67.80	87.09	27.79	12.25	74.09	73.31	0.00	9.29	95.56	2.61	56.79	32.68	83.47	70.49	48.31	76.56	48.80	48.38	45.93	94.50	41.79	92.79	33.18
BRD-A65615053	CP	zacopride	serotonin receptor antagonist, serotonin receptor agonist	HTR3A, HTR4, HTR3B, HTR5A		3.67, 3.27	48.35	0.26, 0.05	77.11	49.46	52.18	5.45	51.64	37.15	25.57	48.35	25.85	98.10	12.88	87.69	-2.29	14.91	91.79	2.48	81.54	35.62	49.82	60.19	44.61	51.99	53.10	17.96	32.40	61.44	56.15	8.21	3.66
BRD-A28422058	CP	L-689560	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D		4.23, 2.31	48.31	0.76, 0.18	44.49	35.62	61.49	19.46	87.92	57.72	26.78	-28.02	26.42	95.00	10.09	59.31	2.71	6.32	47.95	16.92	41.64	86.37	72.64	70.50	50.00	79.14	57.12	46.06	78.70	19.85	62.58	53.84	48.31
BRD-K54094468	CP	remoxipride	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR2A, SIGMAR1		5.38, 3.08	48.30	0.72, 0.16	6.87	78.02	97.89	19.49	57.25	24.53	1.94	91.20	25.96	96.97	85.04	29.79	-4.44	-13.99	92.93	48.30	87.25	13.20	31.16	90.86	63.99	72.27	69.37	0.04	19.10	17.00	39.64	98.40	89.55
BRD-K46424862	CP	hymecromone	monoamine oxidase inhibitor	MAOA		5.31, 3.67	48.28	0.81, 0.25	64.69	51.33	99.51	-21.14	32.81	98.48	6.24	46.42	17.34	82.70	27.68	93.58	3.90	25.73	97.21	2.01	82.60	22.19	68.58	92.90	48.28	9.88	45.77	87.45	17.99	55.25	23.64	54.12	65.25
BRD-K46317332	CP	proadifen	nitric oxide synthase inhibitor, cytochrome P450 inhibitor, potassium channel blocker	NOS1		5.38, 3.08	48.27	0.60, 0.16	57.56	43.22	16.60	21.17	32.45	41.99	40.55	73.62	77.45	93.35	69.29	58.31	7.85	15.08	21.15	6.25	68.73	30.89	58.03	56.49	34.43	48.27	21.43	-1.87	72.50	58.29	65.51	85.13	67.73
BRD-A90131694	CP	alclometasone	glucocorticoid receptor agonist, immunosuppressant	NR3C1, SERPINA6	Glucocorticoid receptor agonist	3.46, 1.54	48.26	1.36, 0.61	14.44	48.26	8.46	61.35	41.06	50.73	51.90	44.82	22.54	85.22	45.44	83.74	15.23	55.60	-60.81	18.97	67.61	11.99	52.32	70.55	91.82	52.37	40.99	61.93	32.29	72.49	22.52	81.36	11.14
BRD-K16336526	CP	capsaicin	TRPV agonist, NFkB pathway inhibitor, tumor NADH oxidase inhibitor	TRPV1, CFTR, ENOX2		7.11, 5.33	48.25	1.43, 0.47	47.24	65.47	21.03	59.10	-7.46	18.16	46.80	67.81	-17.74	79.45	31.41	92.43	54.89	17.52	94.35	10.79	62.01	71.18	44.01	36.14	62.36	59.76	99.58	48.25	26.71	8.01	92.14	80.27	23.22
BRD-A19661776	CP	mianserin	serotonin receptor antagonist, tetracyclic antidepressant	HTR2A, HTR2C, ADRA1A, ADRA1B, ADRA1D, HRH1, HTR2B, HTR6, HTR7, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH2, HRH4, HTR1A, HTR1F, OPRK1, SLC6A2, SLC6A3, SLC6A4		2.69, 1.92	48.20	1.14, 0.30	8.13	86.44	92.19	57.23	78.66	15.23	77.80	41.50	40.52	67.18	58.78	52.05	1.34	44.99	41.04	8.75	47.87	48.20	66.66	69.97	83.84	42.71	24.54	0.04	74.06	95.98	42.13	50.66	43.74
BRD-K01612348	CP	meropenem	cell wall synthesis inhibitor			8.57, 4.08	48.20	0.94, 0.31	81.62	35.95	17.65	12.41	21.01	27.95	65.92	89.65	11.91	81.48	41.36	95.61	2.26	13.01	99.26	28.44	99.61	17.55	48.20	39.01	36.39	47.10	76.98	81.17	49.07	99.50	76.81	70.88	55.62
BRD-K06895174	CP	cisapride	acetylcholine receptor agonist, serotonin receptor agonist	HTR4, KCNH2, CYP2B6, CYP2C8, CYP3A5, CYP3A7, HTR2A, HTR3A	Serotonin receptor agonist	4.62, 1.54	48.18	0.73, 0.13	72.31	24.77	48.18	10.17	82.02	11.66	29.15	-22.70	42.28	17.95	20.37	76.16	3.08	46.61	96.03	31.52	77.28	73.07	85.90	70.89	52.75	75.16	41.81	2.89	28.60	70.33	81.28	56.61	60.64
BRD-A97674275	CP	ranolazine	fatty acid oxidation partial inhibitor, Sodium Channel  Blockers, sodium channel blocker	SCN9A, SCN10A, SCN5A, SLC22A2		3.08, 2.31	48.16	0.36, 0.02	22.69	66.10	51.00	5.00	82.28	12.43	41.72	7.68	27.34	70.57	33.55	69.38	7.53	8.76	95.87	18.60	90.85	48.16	60.06	73.43	60.83	39.61	57.29	0.74	-0.88	48.82	50.68	36.68	58.54
BRD-K88871508	CP	lisuride	dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand	DRD2, HTR2B, HTR2C, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, ADRA1A, HRH1, HTR6		8.08, 3.85	48.16	1.01, 0.27	99.76	14.61	85.03	35.21	13.92	93.72	57.68	52.35	56.01	29.50	2.68	66.98	3.65	0.88	15.05	7.00	98.91	48.16	76.04	98.03	17.61	73.64	36.71	4.49	49.28	50.38	24.20	31.93	95.56
BRD-A28746609	CP	paclitaxel	tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane	TUBB, NR1I2, ABCB1, BCL2, CYP2C8, MAP2, MAP4, MAPT, TLR4, TUBB1	Tubulin inhibitor	3.46, 1.15	48.14	0.64, 0.27	80.85	63.97	48.14	64.38	86.27	81.00	61.51	32.49	61.27	5.68	16.18	60.76	16.59	5.76	77.92	9.19	72.17	37.60	48.31	44.37	12.41	41.47	6.55	-65.44	70.24	25.02	12.89	59.35	69.25
BRD-K54142781	CP	cirazoline	alpha receptor agonist	ADRA1A		8.08, 5.38	48.13	1.07, 0.28	28.99	75.15	61.36	18.02	83.34	4.90	51.24	27.70	90.41	73.54	9.28	47.07	0.00	36.80	79.03	6.64	26.46	48.13	85.41	85.24	58.19	96.22	-10.81	-96.86	14.56	62.87	13.08	96.78	55.61
BRD-K06854232	CP	AM-580	RAR agonist, retinoid receptor agonist	RARA	Retinoid receptor agonist	5.38, 1.92	48.12	0.38, 0.13	81.32	67.85	96.93	32.20	79.82	32.93	24.85	39.32	43.65	57.69	38.64	68.02	2.08	25.39	83.69	97.43	78.75	48.12	41.97	57.22	89.23	51.31	38.65	34.88	4.09	86.78	34.24	61.87	45.43
BRD-K64052750	CP	gefitinib	EGFR inhibitor	EGFR, CYP2C19	EGFR inhibitor	4.62, 2.31	48.11	1.10, 0.50	8.14	75.02	62.51	93.39	48.11	9.35	23.13	75.85	10.54	3.88	48.34	77.48	22.52	79.92	72.07	96.55	70.84	72.99	12.54	49.54	21.41	23.14	5.67	-65.79	57.57	19.18	29.91	59.92	19.41
BRD-A20126139	CP	medrysone	corticosteroid hormone receptor agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	4.23, 3.08	48.09	1.15, 0.48	6.85	84.92	12.22	50.46	67.39	53.79	50.12	-30.23	15.47	46.73	15.20	20.53	50.93	48.09	49.72	79.50	41.83	37.36	77.77	17.74	54.31	88.89	21.61	85.72	13.43	86.95	65.66	35.07	27.96
BRD-A96485169	CP	EBPC	aldose reductase inhibitor	AKR1B1		5.38, 2.31	48.04	0.77, 0.24	70.03	24.06	75.39	38.40	79.82	48.04	58.25	43.38	41.52	19.09	42.04	85.14	30.41	4.00	44.07	24.19	31.48	45.66	66.97	52.65	35.01	73.25	29.60	82.86	75.68	93.48	55.22	98.45	83.19
BRD-A30815329	CP	felodipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2		4.62, 1.92	48.03	0.97, 0.16	94.07	-55.71	25.22	22.06	47.61	19.21	20.82	76.47	24.11	5.31	73.36	44.67	3.46	1.62	77.46	66.55	48.03	34.07	95.52	89.56	-4.26	72.35	84.71	87.90	48.09	68.97	42.18	84.36	77.90
BRD-K68620903	CP	dydrogesterone	progesterone receptor agonist	PGR		2.69, 1.15	47.99	0.98, 0.32	91.05	17.57	48.03	47.99	6.39	20.49	40.52	49.80	12.68	11.87	19.58	92.37	-1.55	6.80	96.19	9.13	95.75	6.41	87.50	72.92	28.36	93.88	15.11	92.64	52.47	67.07	77.73	65.34	29.89
BRD-K99174507	CP	cardiogenol-c	pyrimidine compound, induces embryonic stem cell ifferentiation into cardiomyocytes			3.85, 2.31	47.93	0.99, 0.17	63.85	24.80	90.79	13.56	76.89	31.66	88.35	82.41	44.22	41.58	38.69	62.67	3.51	5.43	17.22	2.85	56.96	37.31	47.93	80.92	66.96	73.58	35.40	-14.58	61.83	78.84	44.69	93.40	78.30
BRD-K08547377	CP	irinotecan	topoisomerase inhibitor	TOP1, CYP3A5, TOP1MT	Topoisomerase inhibitor	2.31, 1.92	47.92	1.91, 0.52	14.00	89.38	12.37	47.92	48.07	42.73	78.61	52.66	35.21	93.51	59.20	41.32	87.00	76.80	10.54	98.63	90.15	13.29	17.38	41.25	38.54	30.44	56.83	1.30	33.44	35.81	52.37	52.75	50.05
BRD-K00206590	CP	P-1075	ATP channel activator, potassium channel agonist	KCNJ8	KCNJ11 modulator, Potassium channel activator	5.38, 1.15	47.91	1.06, 0.25	54.60	80.88	81.64	7.45	93.97	58.77	35.54	47.91	29.30	30.61	34.84	22.33	0.00	11.69	96.45	68.05	69.37	71.11	-14.04	76.87	51.92	92.13	25.35	-23.87	-0.85	45.56	10.99	75.05	57.02
BRD-K06234293	CP	LY-364947	TGF beta receptor inhibitor, p38 MAPK inhibitor	TGFBR1	P38 MAPK inhibitor, TGF beta receptor inhibitor	3.46, 1.15	47.88	1.06, 0.28	35.03	43.57	93.19	18.16	93.14	14.21	94.30	47.88	52.19	50.21	70.80	27.52	-63.96	21.56	-26.98	48.19	12.68	67.00	44.41	61.49	42.44	76.02	32.62	-8.53	92.51	69.38	37.51	75.80	67.46
BRD-K59597909	CP	phenothiazine	dopamine receptor antagonist			3.85, 1.92	47.88	0.60, 0.10	21.86	29.04	79.70	10.13	46.37	61.51	67.98	50.96	23.71	62.57	57.54	64.85	-72.56	4.30	28.46	1.97	71.88	6.39	48.15	87.23	76.11	47.88	29.60	0.85	39.73	56.78	30.09	58.62	55.52
BRD-K28029915	CP	dolasetron	serotonin receptor antagonist	HTR3A		5.38, 1.54	47.87	1.38, 0.42	22.78	87.23	43.26	15.23	66.23	28.47	41.73	51.26	4.72	92.70	74.69	65.65	2.26	47.87	51.91	1.08	83.68	16.12	52.34	26.73	98.98	84.65	34.68	-35.79	95.14	27.95	26.33	73.72	82.27
BRD-K80672993	CP	M2-PK-activator	pyruvate kinase isozyme activator	PKM		3.46, 2.31	47.84	0.49, 0.08	67.41	19.65	83.69	21.84	66.99	50.38	62.31	48.90	48.53	47.84	27.86	62.65	-8.46	25.28	26.80	34.55	46.44	0.88	82.00	72.45	15.15	51.33	15.31	-0.04	47.22	86.59	57.56	78.92	5.88
BRD-K40175214	CP	torin-1	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	MTOR inhibitor, PI3K inhibitor	5.77, 3.08	47.83	1.67, 0.61	2.08	47.83	59.48	96.75	39.87	57.67	-20.89	79.95	9.39	51.47	30.26	65.01	90.66	71.73	92.56	99.59	67.17	69.32	6.95	26.51	43.17	4.02	21.66	-72.65	47.30	39.71	78.76	50.11	25.79
BRD-K40892394	CP	AR-C133057XX	nitric oxide synthase inhibitor	NOS2, NOS1		4.62, 2.31	47.83	1.27, 0.33	78.10	12.18	80.90	1.37	33.86	37.03	8.50	93.23	91.42	5.95	7.43	66.10	-87.98	4.19	67.91	-99.26	85.82	31.38	91.02	99.40	34.46	81.79	28.38	79.87	95.13	98.52	48.64	30.10	47.83
BRD-A33447119	CP	oxfendazole	anthelmintic agent			2.31, 0.77	47.80	0.48, 0.13	72.87	82.49	52.31	25.58	87.51	60.63	60.05	76.54	54.03	15.65	22.50	73.42	24.03	16.69	65.86	7.10	47.80	3.37	45.14	-30.82	9.42	17.71	62.12	93.09	18.02	86.40	25.64	7.56	70.36
BRD-K50388907	CP	fenofibrate	PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor	PPARA, APOA1, CYP2C19, CYP2C8, MMP25		4.62, 3.46	47.78	1.01, 0.25	91.20	30.90	63.55	28.55	84.22	11.21	12.00	49.51	67.38	8.72	59.03	76.40	1.20	11.83	92.50	9.09	67.25	71.39	31.61	71.10	36.75	99.72	25.80	0.07	91.00	47.78	10.56	42.79	64.60
BRD-K62200014	CP	anagrelide	phosphodiesterase inhibitor	PDE3A		5.38, 3.46	47.77	0.98, 0.31	18.32	7.98	85.93	74.94	87.51	88.25	40.16	61.63	22.27	24.94	66.68	92.52	1.59	9.57	95.07	6.96	88.65	21.30	32.88	49.23	33.00	46.85	2.61	53.46	22.21	78.89	47.77	77.30	89.72
BRD-A33084410	CP	5'-guanidinonaltrindole	opioid receptor antagonist			6.53, 4.08	47.76	1.44, 0.57	90.75	-11.51	6.74	2.82	-19.94	99.22	40.08	89.97	37.54	23.50	94.88	79.31	-2.26	0.00	90.74	5.57	49.62	19.56	98.83	47.76	77.98	81.81	67.61	99.86	65.81	72.33	20.93	25.64	26.52
BRD-A16478930	CP	amcinonide	corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant	NR3C1, ANXA1	Glucocorticoid receptor agonist	4.90, 2.86	47.74	1.53, 0.59	3.62	83.94	14.37	76.52	27.73	8.89	55.03	93.17	22.27	56.45	99.40	78.53	19.22	47.74	56.82	10.28	21.63	9.06	17.29	50.80	54.40	70.42	33.26	-27.85	32.26	99.86	16.20	91.71	87.13
BRD-K74195153	CP	irsogladine	diuretic, phosphodiesterase inhibitor	PDE4A		7.31, 3.85	47.74	0.74, 0.16	29.73	30.52	12.59	15.81	47.74	45.98	33.73	82.38	90.94	80.51	91.80	60.97	1.06	-1.16	98.19	-6.58	95.99	16.12	54.12	83.89	45.47	51.90	41.63	-28.57	77.96	67.24	28.92	99.82	53.55
BRD-K79366068	CP	PSB-069	NTPDase inhibitor	ENTPD1, ENTPD2, ENTPD3		4.62, 0.77	47.71	0.90, 0.22	15.38	83.91	58.82	37.74	90.45	88.84	52.18	-39.84	34.19	56.15	48.81	66.74	-3.14	16.22	53.18	4.09	47.71	62.25	27.39	40.89	95.67	89.40	29.37	28.35	1.99	50.71	31.72	92.64	39.89
BRD-K47323024	CP	methapyrilene	histamine receptor antagonist		HRH1 antagonist	5.31, 3.67	47.69	1.35, 0.44	87.61	85.37	72.55	37.44	98.20	22.30	86.35	47.69	33.04	60.27	15.11	55.76	33.35	17.41	99.08	96.77	95.56	30.55	46.89	94.65	42.62	43.43	35.69	0.04	13.26	95.42	68.89	92.46	46.63
BRD-K92093830	CP	doxorubicin	topoisomerase inhibitor, DNA intercalating drug	TOP2A	Topoisomerase inhibitor	6.92, 3.85	47.67	1.56, 0.65	8.82	98.94	71.00	59.11	99.01	56.79	37.46	-79.63	14.97	74.82	50.47	92.44	33.34	57.98	36.55	97.11	86.85	47.67	24.67	85.47	88.26	38.34	43.20	15.62	-31.88	39.53	54.41	46.56	35.15
BRD-A65449987	CP	flunisolide	cytochrome P450 inhibitor, corticosteroid agonist, corticosteroid hormone receptor agonist, glucocorticoid receptor agonist, immunosuppressant	NR3C1	Glucocorticoid receptor agonist	3.08, 1.15	47.61	1.23, 0.76	57.40	62.85	44.15	81.80	45.30	7.76	12.60	45.70	8.62	5.35	63.63	57.47	52.88	48.96	97.71	31.02	69.78	15.15	17.95	68.99	17.86	83.49	14.17	-14.24	-11.17	90.35	52.65	47.61	69.45
BRD-K96084870	CP	DMBI	platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor	PDGFRB		4.23, 1.54	47.58	0.66, 0.17	37.92	12.24	79.05	83.40	75.19	24.25	52.56	48.77	27.41	21.75	13.58	73.05	68.70	37.73	82.56	45.62	81.72	89.08	28.94	41.61	64.27	87.91	20.72	0.78	43.52	23.58	48.08	47.58	69.71
BRD-A62025033	CP	temsirolimus	mTOR inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor	MTOR, PTEN	MTOR inhibitor	3.46, 1.92	47.57	1.08, 0.38	32.13	89.80	83.34	91.17	47.10	53.59	39.86	-31.45	8.35	7.31	18.18	58.58	90.58	86.23	85.91	99.65	78.43	82.22	55.25	42.77	63.38	50.59	8.91	0.00	3.68	47.57	37.48	29.87	10.52
BRD-A67799922	CP	phenoxybenzamine	adrenergic receptor antagonist	ADRA2B, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2C, ADRB2, CALM1		3.46, 1.54	47.53	0.77, 0.15	14.26	79.70	28.82	55.24	81.89	11.06	2.17	47.22	54.16	32.23	72.15	61.62	72.17	80.51	41.30	98.73	42.05	20.45	14.68	75.57	47.53	54.61	11.47	0.78	13.47	16.26	74.35	85.80	49.94
BRD-A12560204	CP	nitrendipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, CACNA1H, CACNA1S, CACNA2D2, CACNB2, CACNG1, KCNN4	Calcium channel blocker	7.11, 4.89	47.50	1.74, 0.41	6.60	68.75	42.20	30.08	94.13	7.60	21.03	48.55	6.40	58.33	96.29	98.70	6.07	39.71	47.50	86.11	-70.37	5.94	34.57	32.44	65.66	-12.19	82.57	78.37	50.51	89.09	96.37	82.06	34.35
BRD-K68341547	CP	W-9	calmodulin antagonist	CALM2	Calmodulin antagonist	8.08, 4.62	47.50	0.93, 0.22	98.85	42.07	2.75	65.14	30.72	61.95	99.72	58.20	20.97	98.66	25.54	19.10	3.79	56.37	48.67	11.16	97.71	64.49	40.81	92.50	22.55	27.21	8.91	79.45	86.15	47.50	23.08	67.17	9.76
BRD-K42221274	CP	NNC-711	GAT inhibitor	SLC6A1, SIGMAR1		6.15, 3.08	47.49	0.90, 0.24	56.24	18.71	20.11	52.90	57.66	9.67	96.77	32.05	46.42	17.55	97.81	66.71	0.00	1.52	80.55	2.71	47.49	5.14	73.27	18.75	53.40	96.76	18.52	-75.11	53.51	97.74	45.73	73.32	73.42
BRD-K63151507	CP	MNITMT	lymphocyte inhibitor			2.31, 1.54	47.49	1.07, 0.26	11.00	-11.17	53.58	12.92	98.93	0.03	16.05	68.52	9.71	72.84	68.57	53.66	-5.61	10.52	57.29	14.77	51.17	16.69	76.86	70.55	47.49	16.25	13.91	6.08	31.89	60.14	49.66	63.70	89.62
BRD-K69600043	CP	thiethylperazine	dopamine receptor antagonist	DRD1, DRD2, DRD4	Dopamine receptor antagonist	7.31, 1.92	47.49	0.92, 0.26	88.91	4.12	3.52	27.28	97.17	60.52	49.41	86.96	18.81	21.76	35.89	34.88	8.02	31.95	90.27	36.12	92.37	65.94	21.24	95.53	93.41	7.45	-14.33	0.88	54.60	83.89	77.25	94.08	47.49
BRD-A01320529	CP	salmeterol	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	5.38, 1.92	47.47	0.56, 0.09	40.16	45.75	92.14	84.69	88.57	7.24	6.66	70.77	86.12	45.19	18.22	54.77	55.86	90.08	36.20	94.78	36.94	96.23	15.34	30.84	47.47	50.05	91.28	0.49	97.15	55.08	27.73	22.71	33.22
BRD-A95445494	CP	maackiain	interleukin synthesis inhibitor, sodium/glucose cotransporter inhibitor	SLC5A2		5.77, 1.54	47.47	1.69, 0.55	51.94	64.85	29.26	22.83	69.84	79.97	94.46	95.89	33.16	28.77	47.47	84.22	-1.83	4.33	34.12	-3.66	12.68	6.17	48.45	75.13	79.67	48.50	1.16	-2.43	10.58	84.28	6.44	85.85	86.91
BRD-K50422030	CP	clomethiazole	GABA receptor agonist, GABA receptor antagonist, GABA receptor modulator, p38 MAPK inhibitor	GABRA1		5.00, 1.54	47.47	0.74, 0.19	17.15	63.89	85.53	25.53	95.18	95.06	94.47	-26.05	85.30	95.32	6.66	21.55	6.48	29.68	-13.26	13.52	50.31	47.47	48.49	11.92	89.02	70.12	7.29	-89.42	71.81	45.98	46.98	85.45	94.18
BRD-A17655518	CP	ibuprofen	cyclooxygenase inhibitor, NFkB pathway inhibitor	PTGS2, PTGS1, ASIC1, BCL2, CFTR, CYP2C8, FABP2, PLAT, PPARG, SLC5A8, THBD		6.53, 2.04	47.46	0.92, 0.19	83.22	10.45	43.05	6.59	15.41	40.86	49.35	93.62	56.14	95.09	27.29	29.05	3.03	20.76	82.10	47.46	91.50	36.15	63.60	89.94	28.26	6.28	18.73	91.13	40.73	89.22	70.70	75.23	53.15
BRD-K30649484	CP	mafenide	carbonic anhydrase inhibitor, unidentified pharmacological activity	CA6, CA12, CA14, CA2, CA4, CA9		5.00, 3.08	47.41	1.82, 0.47	57.91	96.68	44.07	36.20	87.52	47.41	55.89	58.21	2.47	85.65	59.89	60.95	5.27	51.55	10.53	33.42	17.81	66.82	92.33	32.56	92.24	19.95	63.48	-99.37	7.87	4.56	20.96	56.28	27.08
BRD-K06014311	CP	DH-97	melatonin receptor antagonist	MTNR1B		5.00, 1.92	47.39	1.31, 0.50	41.08	10.29	27.65	65.34	85.63	10.05	15.92	51.55	14.95	96.51	72.74	40.23	5.88	55.14	15.29	44.97	37.05	81.33	47.39	89.45	50.83	98.70	15.12	71.26	41.75	49.08	45.49	84.63	69.20
BRD-K09186807	CP	KIN001-244	phosphoinositide dependent kinase inhibitor	PDPK1		3.46, 2.69	47.35	1.56, 0.55	58.61	52.80	53.73	85.92	31.55	47.35	25.56	19.94	11.37	84.36	15.81	66.00	4.24	33.78	88.39	41.14	87.96	74.58	48.88	78.64	41.10	27.77	29.02	18.05	36.98	9.39	73.09	65.07	51.27
BRD-K00312224	CP	PPT	estrogen receptor agonist	ESR1	Estrogen receptor agonist	6.92, 3.85	47.34	0.85, 0.16	15.43	21.44	72.68	53.05	59.12	6.43	-7.43	47.56	27.72	6.12	9.16	30.33	2.53	79.74	63.43	36.56	59.31	95.13	12.39	82.23	80.48	90.82	18.72	47.34	71.59	9.37	29.16	50.57	55.45
BRD-K10467831	CP	tibolone	estrogen receptor agonist, androgen receptor agonist, progesterone receptor agonist, selective estrogen receptor modulator (SERM), steryl sulfatase inhibitor	AR, ESR1, PGR, STS	Androgen receptor modulator	6.15, 3.46	47.34	1.91, 0.58	10.94	84.15	46.74	17.33	85.77	80.47	32.96	38.96	24.78	69.69	64.87	41.09	26.78	33.15	47.34	53.71	56.70	50.24	86.06	34.75	99.93	83.99	96.70	-12.01	-19.37	84.86	81.35	25.09	18.54
BRD-K03642198	CP	AY-9944	hedgehog pathway inhibitor			6.15, 3.08	47.33	1.05, 0.19	43.78	22.99	93.55	90.20	27.36	0.03	80.01	-29.83	34.05	47.33	26.94	79.31	64.27	95.88	-38.93	10.54	93.15	96.71	45.18	53.26	67.81	17.71	24.55	26.12	98.38	88.31	39.88	55.11	56.41
BRD-A29426959	CP	carbinoxamine	histamine receptor antagonist, L-type calcium channel blocker	HRH1		6.92, 4.23	47.31	1.30, 0.38	91.97	-56.16	2.04	4.23	-53.46	30.12	77.95	96.73	64.62	16.27	6.26	25.26	1.13	-1.48	91.61	10.14	91.41	47.31	99.58	85.96	23.82	27.59	85.98	99.30	99.30	80.36	79.98	96.72	36.77
BRD-A84174393	CP	meloxicam	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		6.54, 4.23	47.29	1.10, 0.35	7.42	59.04	61.93	47.29	59.12	99.75	65.14	71.37	29.38	91.98	58.71	39.54	-1.09	18.14	-62.60	7.93	54.31	19.66	55.35	39.59	86.56	23.56	12.38	-11.62	42.31	63.66	52.62	44.79	90.61
BRD-K73838513	CP	cinacalcet	calcimimetic that activates calcium-sensing receptors	CASR		5.00, 1.92	47.29	1.19, 0.41	17.93	-11.89	1.34	8.04	0.60	45.78	90.60	97.58	33.61	58.91	97.40	62.61	-19.06	0.99	78.86	-23.00	32.13	76.25	56.88	57.93	38.57	13.75	56.38	0.00	94.75	62.15	85.21	99.15	47.29
BRD-K55044200	CP	amoxicillin	cell wall synthesis inhibitor, PBPA inhibitor	SLC15A1		6.12, 2.04	47.28	1.64, 0.45	1.09	97.08	99.61	30.21	95.36	47.28	23.78	95.31	69.45	34.51	81.42	71.17	18.70	1.59	-92.22	87.86	41.66	15.99	-3.59	32.66	95.46	22.93	54.68	-99.12	-43.52	88.99	77.68	82.30	62.59
BRD-K17008822	CP	BD-1008	sigma receptor antagonist		Sigma receptor antagonist	6.15, 3.85	47.27	1.15, 0.38	26.27	11.87	57.52	57.70	12.08	94.55	21.80	47.27	54.67	96.48	7.67	63.05	5.22	29.41	72.79	2.58	59.56	68.86	20.31	25.16	29.07	35.11	40.59	-8.69	96.33	89.49	61.62	84.24	99.74
BRD-A81233518	CP	glycopyrrolate	acetylcholine receptor antagonist	CHRM1, CHRM3, CHRM2, CHRM4, CHRM5		4.62, 2.31	47.24	0.88, 0.26	76.25	51.44	42.54	26.14	47.50	19.45	54.16	13.19	18.07	96.99	72.39	57.14	31.96	8.06	90.23	14.96	77.04	8.38	66.99	54.13	78.91	47.24	37.62	-0.35	27.02	24.98	63.04	64.08	22.32
BRD-K21853356	CP	RG-14620	EGFR inhibitor	EGFR		2.69, 2.31	47.22	1.09, 0.33	10.99	89.96	94.81	1.34	98.63	7.68	-0.95	-38.16	42.27	61.30	8.29	34.78	6.72	61.76	95.45	83.45	58.93	71.20	-32.73	49.31	90.12	72.05	32.55	15.20	-0.60	-14.62	47.22	74.45	86.73
BRD-K06926592	CP	tretinoin	RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand	RARG, RORB, ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARRES1, RORC, RXRB, RXRG	Retinoid receptor agonist	3.46, 1.92	47.21	0.84, 0.17	87.39	31.64	72.17	27.11	37.96	15.58	48.32	53.18	22.24	47.21	1.68	52.04	35.32	42.38	40.90	99.30	52.38	36.53	1.06	79.74	51.29	21.30	68.76	7.83	78.30	48.23	22.42	89.82	66.50
BRD-K45446451	CP	JZL-184	monoacylglucerol lipase inhibitor	MGLL		4.62, 1.15	47.16	1.31, 0.39	31.22	22.26	37.59	10.21	15.14	74.64	27.28	71.23	66.84	53.82	27.21	47.16	-29.46	17.42	84.93	-60.85	92.94	16.95	53.80	73.77	52.55	86.67	76.61	17.05	78.77	93.16	40.68	70.07	9.07
BRD-K97365803	CP	PI-828	PI3K inhibitor		PI3K inhibitor	4.62, 1.15	47.15	1.73, 0.70	11.75	94.54	20.56	98.91	52.20	46.93	14.12	-29.43	12.42	68.34	55.84	81.99	76.17	73.60	98.06	90.12	76.73	91.83	13.24	47.15	70.21	27.61	21.31	-86.60	31.20	30.08	11.84	43.66	47.44
BRD-A70514680	CP	articaine	local anesthetic			2.86, 1.22	47.12	1.18, 0.34	7.49	50.31	93.55	4.51	47.12	54.42	26.93	50.17	12.68	82.35	18.94	86.66	2.78	1.80	61.97	27.18	92.87	21.92	71.99	61.29	71.26	96.16	33.30	-83.27	28.02	10.60	64.07	47.94	2.43
BRD-K71799949	CP	carbamazepine	potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker	ABCB1, CYP1A2, CYP3A4, SCN1A, SCN3A, SCN5A		4.62, 2.31	47.09	0.68, 0.16	60.56	24.05	64.55	26.42	72.20	9.63	29.55	75.42	37.83	64.95	52.19	59.21	-11.32	56.39	68.02	-14.86	46.97	6.11	39.74	77.17	21.37	21.90	82.47	4.11	42.19	68.32	49.20	79.00	47.09
BRD-A55369275	CP	CGP-54626	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8		4.08, 1.63	47.08	1.74, 0.64	9.51	32.13	16.94	38.71	55.80	95.53	25.19	48.79	48.93	39.38	27.26	92.73	1.16	28.36	84.53	7.95	60.11	39.14	83.19	80.46	72.01	90.38	61.63	22.33	86.41	47.08	22.14	64.02	16.84
BRD-K36153907	CP	KU-C103885	cystic fibrosis transmembrane conductance regulator inhibitor			5.60, 2.59	47.08	1.35, 0.26	-37.85	82.20	82.70	67.07	62.66	12.25	8.53	56.00	16.37	32.79	74.07	43.23	64.36	22.83	60.74	60.67	47.08	10.43	10.27	43.80	97.25	86.65	49.12	-55.82	4.38	9.37	44.42	63.65	99.26
BRD-K76907295	CP	VU-0418947-2	hypoxia inducible factor activator		HIF activator	4.74, 3.02	47.08	1.82, 0.63	98.35	90.47	53.52	93.94	20.70	72.14	0.00	-74.53	9.74	47.08	78.61	95.14	98.49	90.89	18.73	100.00	6.62	92.87	27.02	34.21	57.89	12.90	18.74	1.83	11.27	78.42	73.67	33.32	25.33
BRD-K55468218	CP	spiperone	dopamine receptor antagonist	ADRA1A, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR7, ADRA1B, ADRA1D, DRD1, DRD5, HTR1D, HTR2B, HTR2C, HTR6		5.38, 2.31	47.07	0.64, 0.16	90.21	15.13	20.39	45.88	-1.55	53.77	20.42	71.98	17.78	14.21	42.19	60.20	84.44	56.24	81.47	93.84	45.05	71.51	47.07	67.14	10.04	67.38	29.63	43.53	50.99	64.02	65.18	-39.09	29.49
BRD-K82216340	CP	medroxyprogesterone	progesterone receptor agonist	PGR, ESR1	Progesterone receptor agonist	6.94, 2.45	47.07	1.81, 0.60	1.30	97.89	85.26	44.66	98.77	5.71	33.66	-70.58	55.15	32.19	91.58	63.56	37.76	86.91	-65.89	24.21	74.04	71.37	-18.67	30.71	43.80	7.25	95.89	-85.51	85.21	98.39	64.51	50.54	47.07
BRD-K80738081	CP	resveratrol	apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor	PTGS1, PTGS2, SIRT1, APOA1, BACE1, CSNK2A1, MAOA, NQO2, SCN5A, TXNRD1, TXNRD2, XDH		5.38, 1.54	47.06	0.95, 0.20	92.13	21.64	23.77	59.71	64.99	44.60	79.86	77.84	16.53	20.72	87.17	53.32	-1.97	47.47	85.24	16.11	76.75	37.59	46.98	89.92	44.41	46.50	13.82	33.21	13.78	96.50	87.43	87.00	47.06
BRD-A42759514	CP	ornidazole	antiprotozoal agent			6.15, 3.46	47.05	0.88, 0.17	81.81	31.33	28.29	13.41	70.55	95.35	36.57	93.76	58.36	7.95	11.24	62.38	3.96	1.92	77.82	3.46	94.53	15.12	41.32	94.91	45.37	74.38	47.05	99.08	43.34	94.35	92.87	90.56	39.11
BRD-A64933752	CP	CV-1808	adenosine receptor agonist	ADORA2A, ADORA2B	Adenosine receptor agonist	5.71, 3.67	47.03	1.07, 0.36	94.24	32.25	99.49	23.90	93.76	43.83	51.28	-18.30	94.65	85.76	44.10	47.03	2.82	2.04	77.27	2.15	92.85	20.93	82.02	70.70	86.44	33.76	18.53	-76.99	64.28	34.96	44.13	77.63	50.04
BRD-K10042277	CP	desmethylclozapine	acetylcholine receptor agonist, dopamine receptor agonist, dopamine receptor antagonist, dopamine receptor partial agonist, serotonin receptor antagonist, serotonin receptor inverse agonist	CHRM1, DRD2, DRD3, HTR2A		8.08, 5.00	47.02	0.95, 0.25	61.22	7.97	9.98	61.65	29.31	20.62	-13.54	55.69	17.27	5.36	15.00	-8.01	69.36	84.69	66.33	0.60	75.34	97.58	36.40	98.31	-6.17	55.10	13.80	47.02	99.68	9.02	59.47	86.32	93.99
BRD-A37347161	CP	BRL-52537	opioid receptor agonist	OPRK1		3.67, 1.22	47.01	1.23, 0.41	67.36	25.73	72.04	13.23	24.99	47.34	9.41	54.69	47.01	78.43	88.19	70.18	2.43	25.40	76.37	-4.09	71.48	16.15	67.02	15.82	65.93	86.67	39.07	0.00	6.22	87.06	30.57	67.71	12.62
BRD-K97799481	CP	theophylline	adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, CHIA, CYP2E1, CYP3A4, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A		8.57, 5.31	47.01	1.84, 0.49	44.45	79.05	51.94	28.83	47.94	32.87	96.58	68.54	6.79	97.72	90.72	85.63	2.96	7.25	96.84	0.00	56.04	12.30	24.02	68.43	47.01	8.21	10.17	-91.94	14.98	99.93	79.92	84.37	19.31
BRD-A74500471	CP	ethambutol	bacterial arabinosyl transferase inhibitor		Bacterial cell wall synthesis inhibitor	6.15, 3.46	47.00	1.17, 0.41	35.59	33.34	15.59	20.94	24.41	92.82	80.95	87.38	16.11	91.14	71.26	73.11	-9.44	9.61	-2.29	-2.96	47.00	25.62	89.34	52.82	75.18	54.95	10.68	-17.04	57.66	57.02	74.21	66.38	19.12
BRD-A64092382	CP	mexiletine	sodium channel blocker, potassium channel blocker	SCN5A, AHR, CYP2B6, CYP2E1, KCNK2, KCNK3, SCN4A	Sodium channel blocker	7.69, 3.85	46.99	0.61, 0.13	63.19	-9.60	40.76	42.44	95.79	9.09	10.87	93.26	25.58	17.97	33.50	85.24	5.88	-2.85	82.32	18.31	97.39	8.32	68.87	98.10	45.09	88.95	49.03	98.63	19.29	64.73	60.73	84.79	46.99
BRD-K68867920	CP	quetiapine	dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist	DRD2, HTR1A, HTR2A, DRD1, HRH1, HTR1D, HTR1E, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD3, DRD4, DRD5, HTR1B, HTR1F, HTR2C, HTR3A, HTR6, HTR7, SLC6A2		5.38, 5.00	46.99	1.34, 0.48	83.68	38.94	76.64	46.99	85.42	98.38	8.28	85.03	19.68	93.66	7.43	69.60	4.58	4.30	34.36	68.12	89.40	41.84	0.67	72.60	54.26	34.90	14.58	-54.29	25.11	2.22	71.92	94.98	99.82
BRD-A17448384	CP	beclometasone	glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant	NR3C1, CYP3A5, GPR97, SERPINA6	Glucocorticoid receptor agonist	4.23, 2.31	46.95	1.57, 0.56	2.71	-96.95	7.91	28.32	-2.18	9.94	82.36	83.45	6.38	88.24	37.33	36.81	-6.67	78.75	31.66	81.62	85.40	15.42	84.95	46.95	79.19	71.72	31.05	76.73	88.19	60.26	40.74	83.52	92.95
BRD-A39969961	CP	eplerenone	cytochrome P450 antagonist, mineralocorticoid receptor antagonist	NR3C2, CYP3A5		5.38, 2.69	46.95	1.35, 0.40	9.80	93.86	76.66	25.59	90.54	33.47	67.69	73.12	95.59	99.49	70.27	49.31	-2.85	8.82	60.81	25.01	95.57	41.72	-23.27	46.95	32.52	94.03	36.41	-77.77	34.22	-61.60	31.19	58.65	92.97
BRD-A71765365	CP	mepireserpate	catecholamine depleting sympatholytic	SLC18A2, SLC18A1		6.12, 4.49	46.95	1.89, 0.67	99.89	58.12	97.99	77.90	20.04	99.93	10.06	72.62	9.88	35.59	2.54	92.86	24.82	77.25	8.66	79.01	79.61	91.02	62.80	28.00	46.95	6.17	4.37	-6.03	35.50	69.85	9.41	6.87	97.36
BRD-K97509413	CP	coumestrol	AGE inhibitor, estrogen receptor agonist, estrogen receptor ligand	ESR1, ESR2	Estrogen receptor agonist	5.00, 2.31	46.94	1.31, 0.35	5.04	96.66	93.65	8.50	70.84	12.69	16.03	29.56	51.37	92.86	48.84	3.03	-21.44	1.09	95.07	-9.22	82.23	9.72	10.53	89.22	-4.70	98.85	46.94	-0.74	65.25	59.45	5.29	72.58	48.28
BRD-K05434375	CP	HA-1004	calcium channel blocker			6.92, 3.46	46.92	0.84, 0.19	5.55	87.39	79.29	18.79	68.87	97.23	20.77	49.80	12.93	87.40	82.79	50.49	-1.76	0.88	51.52	3.17	78.89	40.16	25.84	17.66	46.92	61.49	41.03	1.37	79.93	19.11	38.54	51.72	95.70
BRD-K35941380	CP	methysergide	serotonin receptor antagonist	HTR2C, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR7, HTR1A, HTR1D, HTR5A, HTR6		5.77, 3.46	46.91	0.81, 0.24	46.91	62.77	79.49	19.96	99.09	7.72	18.73	-26.11	36.87	53.49	14.43	46.09	-2.82	11.34	90.28	7.47	95.37	16.43	67.16	75.67	90.77	75.58	34.64	95.23	51.24	80.10	27.02	49.71	12.01
BRD-K71003802	CP	hippeastrine	plant alkaloid with cytotoxic effects on some human tumor cell lines			6.15, 5.00	46.86	0.90, 0.28	46.86	94.24	92.05	58.97	99.82	20.00	89.59	26.58	99.65	21.02	26.04	94.27	0.00	11.28	85.34	28.38	96.55	4.12	48.53	98.81	89.38	27.14	29.33	0.00	11.25	7.48	78.93	81.90	39.00
BRD-K32710582	CP	EI-247	insulin growth factor receptor inhibitor	INSR		4.62, 1.15	46.84	1.22, 0.30	65.87	87.98	4.26	27.45	54.82	29.25	15.40	46.16	18.33	69.61	11.91	65.29	2.57	19.56	88.86	31.17	31.27	16.95	38.65	98.63	82.74	46.84	50.76	96.98	37.39	65.27	53.56	95.11	60.41
BRD-A42831637	CP	tetrahydrocannabinol-7-oic-acid	analgesic, anti-inflammatory			5.31, 3.67	46.83	1.08, 0.25	99.37	49.65	86.88	25.88	82.20	90.57	4.79	31.97	22.07	21.04	8.26	61.98	-31.96	18.61	60.43	24.53	85.47	13.19	88.27	45.34	61.60	74.55	49.04	-22.05	24.49	92.77	10.08	46.83	47.43
BRD-K38197229	CP	bumetanide	diuretic, solute carrier family member inhibitor	SLC12A1, SLC12A2, CFTR, GPR35, SLC12A4, SLC12A5		7.31, 5.00	46.80	1.00, 0.23	7.35	69.79	16.80	23.50	85.98	88.39	61.10	46.80	11.41	55.81	99.12	88.83	1.41	0.88	55.58	9.50	92.51	34.97	38.89	35.76	59.59	94.54	31.94	32.89	6.84	80.04	31.76	80.78	87.32
BRD-K27305650	CP	LY-294002	PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor	MTOR, PIK3CD, PIK3CG, PIK3CA, PIK3CB, PLK1, PRKDC, AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PDE2A, PRKCA, ROCK1, RPS6KB1, SGK1	Bromodomain Inhibitor, MTOR inhibitor, PI3K inhibitor	4.90, 0.41	46.76	1.16, 0.51	8.68	78.16	18.78	90.05	39.45	59.27	29.28	22.64	6.38	69.85	36.45	69.44	2.82	15.28	96.21	79.29	40.02	87.92	91.02	66.57	56.91	71.49	58.25	63.36	20.18	44.48	34.00	46.76	32.35
BRD-K82143716	CP	flucytosine	pyrimidine analog, inhibits fungal DNA synthesis	DNMT1		10.22, 5.33	46.76	0.98, 0.39	20.19	5.66	5.64	21.52	15.63	86.49	3.80	63.33	22.52	92.13	85.22	97.18	6.90	-0.63	75.74	11.68	99.89	70.93	21.26	88.72	33.89	71.77	55.52	9.81	18.93	57.04	90.35	46.76	84.29
BRD-A49370193	CP	RO-60-0175	serotonin receptor agonist	HTR2C, HTR2A, HTR2B	Serotonin receptor agonist	6.92, 3.46	46.75	0.97, 0.23	42.46	10.87	20.76	75.17	34.47	5.94	7.52	75.31	91.43	17.44	1.44	51.73	14.12	22.03	80.41	40.31	75.55	90.12	15.78	94.75	74.63	91.15	60.13	99.82	71.57	13.18	78.61	46.75	32.08
BRD-A92670106	CP	tocainide	sodium channel blocker, voltage-gated sodium channel blocker	SCN5A		3.67, 0.82	46.69	0.43, 0.11	95.58	75.73	90.94	24.80	28.78	74.75	56.18	66.25	39.33	91.90	24.80	49.93	-2.43	8.85	75.69	17.38	81.09	39.08	23.02	46.69	12.59	22.43	52.75	-90.68	3.88	23.61	64.43	48.49	71.13
BRD-K14993104	CP	bemegride	chemoreceptor agonist	GABRA1		6.54, 3.85	46.69	0.85, 0.27	92.27	80.42	65.83	39.78	79.97	5.46	59.94	46.81	39.87	99.89	46.10	50.63	1.97	58.17	13.29	10.10	46.69	38.71	96.21	12.93	91.92	46.22	3.30	-32.33	37.70	78.06	17.46	77.55	97.57
BRD-K39670393	CP	amthamine	histamine receptor agonist	HRH2		3.08, 1.92	46.66	0.82, 0.24	84.17	15.71	16.07	29.81	59.92	86.88	31.00	15.85	21.31	69.25	46.66	67.03	-2.82	4.28	68.40	44.70	2.73	19.00	82.94	94.47	43.23	88.24	62.53	32.56	40.10	64.61	65.86	92.77	58.84
BRD-A79903587	CP	tegafur	DNA synthesis inhibitor, thymidylate synthase inhibitor	TYMS		7.11, 3.56	46.64	0.58, 0.20	8.38	14.38	5.32	14.32	73.44	5.77	5.51	55.53	51.36	59.61	16.85	97.66	0.63	56.74	99.05	-42.82	96.03	62.25	55.16	43.48	-37.01	46.64	99.08	83.81	-4.58	12.18	77.62	29.26	72.46
BRD-K39111395	CP	BCL2-inhibitor	BCL inhibitor	BCL2	BCL inhibitor	5.38, 2.31	46.63	1.31, 0.45	83.79	58.39	16.02	55.78	70.82	45.64	52.41	46.63	13.14	44.45	50.66	88.58	94.05	78.46	41.90	99.44	38.29	40.51	49.45	71.86	37.02	77.81	21.08	6.18	31.68	10.41	52.51	29.30	34.28
BRD-K93658967	CP	aloisine	CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor	CDK2, CDK5, CDK1, CDK5R1, CFTR, PTK2B, ZAP70	CDK inhibitor, Glycogen synthase kinase inhibitor	4.23, 1.54	46.62	0.94, 0.31	27.35	63.80	64.09	60.69	63.16	25.60	80.42	-34.87	43.08	94.90	34.85	57.18	13.50	7.04	74.46	23.80	70.26	17.18	61.48	96.12	46.62	25.52	9.94	8.87	33.16	72.02	49.05	13.67	59.40
BRD-A73741725	CP	exemestane	aromatase inhibitor	CYP19A1	Aromatase inhibitor	1.54, 0.77	46.59	1.02, 0.35	79.77	37.10	4.04	26.12	68.48	13.36	17.43	35.57	52.68	16.94	9.20	78.73	52.77	82.28	69.38	46.59	66.98	64.16	41.98	61.98	14.61	20.87	67.79	49.02	44.17	31.88	20.96	60.77	79.08
BRD-A85280935	CP	quinpirole	dopamine receptor agonist	DRD2, DRD3, DRD4, DRD1, HTR1A, HTR2A, HTR2B, HTR2C		3.27, 1.22	46.59	1.22, 0.32	80.07	20.96	77.14	4.55	62.10	97.78	20.37	51.14	63.37	14.62	81.09	73.45	4.47	24.55	71.68	-2.18	83.91	8.88	93.09	46.59	69.19	51.45	30.14	4.55	15.18	71.13	21.25	43.03	4.57
BRD-K04010869	CP	prostaglandin-a1	HSP inducer, NFKB pathway inhibitor			2.31, 0.77	46.57	0.63, 0.16	35.25	-38.62	76.77	6.82	46.57	28.16	75.97	82.00	86.66	32.66	15.16	47.70	-83.69	-3.10	79.30	-13.07	59.07	4.27	72.61	89.69	50.71	12.84	26.09	-70.47	62.30	89.61	44.67	76.79	83.15
BRD-A02759312	CP	betaxolol	adrenergic receptor antagonist	ADRB1, ADRB2		3.08, 0.77	46.56	0.85, 0.17	5.81	24.02	88.22	26.10	70.44	11.93	42.98	55.09	20.38	57.84	58.03	74.36	-0.11	5.83	79.93	8.92	84.27	5.69	47.50	44.93	89.67	38.98	75.42	0.00	34.63	70.80	46.56	67.90	55.50
BRD-K04185004	CP	oxybuprocaine	anesthetic	SCN10A		6.15, 3.46	46.56	0.92, 0.35	77.94	84.95	16.69	15.02	27.18	91.46	95.76	35.47	56.96	12.62	-2.78	28.47	2.40	10.56	14.70	9.13	62.51	12.33	56.96	82.36	46.56	62.73	50.01	99.93	36.28	60.50	42.85	61.76	60.87
BRD-K15616905	CP	CCCP	mitochondrial oxidative phosphorylation uncoupler			6.15, 4.62	46.54	2.15, 0.60	6.04	81.21	91.01	98.98	64.86	53.04	0.71	22.54	13.12	29.90	22.89	58.34	99.58	82.24	46.54	99.86	95.22	94.79	24.97	56.71	39.99	11.98	10.92	2.26	41.42	12.80	48.08	11.19	75.23
BRD-K43468059	CP	byssochlamic-acid	mycotoxin			2.45, 2.04	46.53	1.36, 0.40	90.13	85.21	35.85	11.72	89.12	45.43	22.69	-40.39	78.40	28.54	41.72	84.15	2.82	46.53	98.27	78.25	85.84	54.30	91.43	5.71	75.11	84.11	59.95	-96.56	-26.73	-6.54	86.50	15.95	34.66
BRD-K54704028	CP	BAY-36-7620	glutamate receptor antagonist	GRM1		3.85, 1.92	46.52	1.14, 0.31	38.41	24.27	72.43	52.93	55.63	7.71	86.78	45.38	38.77	46.52	83.49	8.27	6.34	16.67	46.31	11.00	14.24	68.64	81.34	95.00	70.64	47.10	4.25	98.22	64.06	97.04	26.95	91.99	22.84
BRD-K99411983	CP	lumicolchicine	colchicine isomer, non-binder of microtubules			5.00, 3.46	46.47	0.51, 0.16	79.20	9.10	11.20	12.44	8.96	22.30	16.10	82.54	8.40	78.95	68.42	61.77	-20.85	56.20	98.25	2.18	56.90	43.29	79.60	67.50	51.61	83.58	12.70	0.00	44.97	46.47	29.01	97.92	86.40
BRD-A82371568	CP	clofarabine	ribonucleoside reductase inhibitor, DNA polymerase inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor	RRM1, POLA1, RRM2, SLC22A8	Ribonucleotide reductase inhibitor	3.85, 3.08	46.45	2.16, 0.52	96.95	46.45	41.38	85.86	61.75	37.44	32.70	45.88	81.25	25.22	87.46	62.54	90.57	26.35	43.37	99.72	-46.07	22.16	48.59	65.58	31.21	68.21	67.88	63.62	42.70	42.48	11.63	70.67	17.98
BRD-K48367671	CP	febuxostat	xanthine oxidase inhibitor	XDH		3.85, 2.31	46.44	0.91, 0.20	43.64	7.76	25.77	26.34	38.87	97.92	33.89	75.39	32.20	95.25	52.06	72.36	2.75	23.89	88.06	20.31	99.07	73.23	43.08	10.22	39.98	73.19	22.18	83.79	46.44	62.32	91.19	90.89	94.57
BRD-K59570838	CP	homoveratrylamine	dopamine analog			7.69, 2.69	46.43	1.41, 0.34	36.35	51.06	21.54	17.92	0.00	90.73	36.66	86.62	10.69	88.59	93.13	94.43	2.26	4.30	0.84	0.70	46.43	17.62	73.82	49.17	57.50	56.18	9.52	-87.79	12.63	84.90	90.57	63.88	90.49
BRD-A35989968	CP	megestrol	progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor	PGR	Progesterone receptor agonist	7.63, 3.05	46.30	1.46, 0.42	6.12	27.01	88.25	66.39	80.79	97.28	-8.95	-48.22	43.04	13.65	-83.43	89.83	58.45	46.29	98.52	99.47	46.30	68.14	9.41	32.24	88.17	90.89	97.16	NaN	-18.48	0.46	30.43	33.60	48.26
BRD-K86600316	CP	RS-79948	adrenoreceptor antagonist			5.31, 2.86	46.26	0.88, 0.23	8.93	29.97	68.95	25.88	23.26	46.26	14.91	67.25	13.71	99.19	64.74	87.80	2.78	11.75	55.72	28.70	54.67	17.87	98.13	85.38	90.12	81.30	-18.34	0.00	41.62	77.96	58.09	96.97	3.10
BRD-K03816923	CP	rottlerin	large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor	KCNH2, PRKCD, TGM2		7.31, 4.23	46.23	2.56, 0.93	76.15	64.09	32.25	97.05	36.16	12.79	12.35	46.23	14.24	12.22	7.32	29.61	99.37	95.91	51.98	99.96	52.92	83.46	33.09	36.35	14.23	25.18	8.51	63.08	73.66	76.30	35.64	61.74	46.97
BRD-A69960130	CP	bromocriptine	dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor	DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, HTR6, HTR7, PRL		5.77, 2.69	46.21	1.01, 0.19	13.51	34.80	3.14	86.23	61.68	24.71	-5.57	46.13	65.92	8.28	46.91	20.64	79.28	86.83	90.79	88.58	94.56	84.72	-32.29	69.53	35.93	46.21	15.21	-2.43	80.74	-7.82	23.70	72.57	92.60
BRD-K60219430	CP	serdemetan	MDM inhibitor, angiogenesis stimulant, apoptosis stimulant, oncogene inhibitor	MDM2		4.23, 1.54	46.21	1.31, 0.38	14.46	59.41	34.39	93.22	14.25	19.99	13.50	14.24	16.04	14.58	25.22	67.85	87.89	95.29	50.46	98.61	53.14	88.62	21.09	53.51	11.03	23.59	18.31	86.71	83.95	58.08	46.21	56.58	20.21
BRD-K54316499	CP	tolterodine	acetylcholine receptor antagonist	CHRM2, CHRM3, CHRM1, CHRM4, CHRM5		10.67, 4.89	46.20	1.59, 0.44	97.06	21.97	20.01	32.10	48.06	67.06	98.87	44.24	13.01	9.76	59.21	84.34	7.57	46.20	99.08	-0.28	87.91	0.07	91.52	36.46	29.47	37.25	93.50	-13.89	30.65	99.75	76.40	51.39	69.15
BRD-K43245338	CP	MDL-28170	calpain inhibitor, cathepsin inhibitor	CAPN1, CTSB, CTSL		5.00, 3.46	46.19	1.06, 0.32	15.27	10.97	91.61	16.86	65.47	-9.02	46.19	66.44	99.34	73.53	44.49	40.30	1.48	0.74	53.23	2.01	80.11	49.40	20.07	82.25	36.23	74.76	12.15	-96.29	68.92	9.88	70.64	92.52	82.17
BRD-A11605036	CP	thiocolchicoside	GABA receptor antagonist	GABRA1, GABRB2, GABRG2, GLRA1, GLRB		5.00, 2.69	46.18	1.44, 0.57	88.48	46.18	63.56	22.56	99.08	40.27	72.38	51.36	20.99	96.41	34.36	77.93	2.52	16.20	2.83	33.23	75.21	12.97	10.33	96.76	94.65	90.61	8.25	-3.37	66.43	42.74	30.73	94.63	67.16
BRD-K53972329	CP	ruxolitinib	JAK inhibitor, tyrosine kinase inhibitor	JAK1, JAK2, TYK2, JAK3		5.00, 1.92	46.18	0.56, 0.17	51.83	15.07	87.35	79.07	79.10	-14.31	43.79	41.13	22.38	12.88	20.03	75.67	38.52	15.37	60.76	21.42	77.36	37.69	69.69	46.73	54.05	61.16	34.18	96.86	68.99	25.96	46.63	46.18	-6.77
BRD-K62982419	CP	cilomilast	phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor	PDE4A, PDE4B, PDE4D, IL12A, IL12B, IL1B, PDE4C, TNF		3.46, 0.38	46.18	1.22, 0.35	26.35	2.05	43.74	38.57	68.44	0.03	82.17	66.65	90.68	56.33	46.18	67.28	-3.89	0.80	-41.39	-95.38	86.87	0.85	79.03	62.43	79.16	44.77	4.37	-62.81	61.39	59.54	69.26	32.91	77.70
BRD-K20655524	CP	mefexamide	psychostimulant			7.31, 4.62	46.17	0.80, 0.31	11.43	55.09	20.81	7.80	66.15	95.05	16.10	-11.19	4.36	92.71	68.74	89.28	5.88	32.95	76.46	7.58	81.59	48.54	64.30	28.46	93.81	90.07	32.70	-0.04	25.30	98.29	46.17	91.87	27.44
BRD-A27887842	CP	prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	Glucocorticoid receptor agonist	4.62, 2.31	46.15	1.15, 0.44	87.40	56.35	90.89	74.24	57.19	20.38	4.32	46.15	9.71	35.84	13.95	90.79	6.38	28.72	99.30	32.96	83.57	28.32	33.88	36.08	29.35	72.33	64.89	99.12	14.66	-5.29	57.71	71.84	65.99
BRD-K15164005	CP	apoptosis-activator-II	carboxylesterase inhibitor	BCHE, CES1		10.38, 5.77	46.15	1.08, 0.40	10.39	10.78	84.45	9.91	67.42	4.72	7.61	78.34	46.15	42.56	21.00	38.08	-2.78	1.76	48.68	10.87	53.81	62.18	97.11	98.09	71.46	97.04	30.66	93.88	99.93	9.21	36.58	77.09	97.51
BRD-A49734948	CP	foliosidine	anticonvulsant			8.46, 5.00	46.13	0.94, 0.30	74.47	-25.89	98.78	24.60	67.78	43.96	12.13	78.26	90.75	15.03	4.55	46.13	1.59	0.78	98.51	4.37	98.48	18.39	-98.01	99.51	94.42	95.54	96.37	75.74	17.56	7.58	82.81	92.01	19.95
BRD-A78877355	CP	nefopam	cyclooxygenase inhibitor, prostanoid receptor inhibitor			5.38, 3.85	46.13	1.00, 0.24	31.43	38.61	78.43	26.94	98.83	9.51	59.71	43.98	17.93	98.80	91.53	67.74	8.75	37.96	25.44	4.45	65.39	58.29	18.43	41.67	71.59	90.05	85.88	-79.67	23.87	60.61	46.13	70.41	98.09
BRD-K22878149	CP	SB-205607	delta 1 opioid receptor agonist, opioid receptor agonist	OPRD1, OPRK1, OPRM1		9.62, 4.62	46.09	1.65, 0.52	5.91	97.18	99.89	46.09	99.40	23.75	33.42	49.34	96.62	99.68	43.26	97.29	7.52	53.46	-63.37	91.60	20.71	62.10	96.99	12.02	93.25	11.77	20.53	-1.87	23.64	33.64	59.48	78.97	2.91
BRD-K25311561	CP	KU-55933	ATM kinase inhibitor	ATM, PRKDC		3.08, 1.92	46.07	0.84, 0.26	11.21	41.75	37.92	61.50	39.90	60.17	21.88	84.65	6.45	44.27	3.21	50.47	20.69	75.39	93.61	70.85	86.99	81.10	46.07	40.97	17.31	49.51	22.55	78.71	73.42	35.45	46.31	32.32	61.50
BRD-K64835161	CP	BRD-K64835161	CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor	CLK1, CLK4, DYRK1B		3.85, 1.15	46.07	1.14, 0.42	90.30	8.87	10.27	83.82	42.77	66.76	12.18	32.02	53.42	96.49	12.92	37.27	17.66	-0.78	98.27	94.09	66.08	62.40	68.02	32.25	63.08	1.23	31.47	11.70	93.39	80.77	86.55	46.07	10.79
BRD-K58772419	CP	AZD-6482	PI3K inhibitor	PIK3CD, PIK3CG, PIK3CA, PIK3CB	PI3K inhibitor	5.38, 3.08	46.05	1.38, 0.60	62.83	21.17	56.21	90.96	40.14	60.56	33.71	35.79	15.11	44.80	34.74	86.67	-1.30	27.78	97.78	83.40	86.80	83.17	20.73	73.51	46.05	31.07	41.70	0.42	72.50	68.25	21.55	74.43	95.75
BRD-A92826379	CP	lupanine	ATP channel blocker, insulin secretagogue, Sodium Channel  Blockers, sodium channel blocker	INS	Sodium channel blocker	5.77, 2.69	46.03	0.91, 0.24	96.60	-9.39	8.48	11.23	82.85	63.34	93.62	86.53	98.46	14.04	-4.88	22.84	-16.46	4.40	96.93	-78.23	89.21	3.52	99.08	85.87	-58.10	78.34	5.57	96.86	46.03	81.74	3.93	9.96	78.15
BRD-K23623876	CP	decafluorobutane	ultrasound contrast agent	GRM5		7.69, 5.00	46.03	1.15, 0.30	97.77	15.91	63.76	31.33	-67.43	74.71	97.72	98.48	9.54	80.91	59.24	7.15	-6.46	9.29	34.62	3.44	46.03	9.72	96.96	96.25	75.46	66.02	-10.89	0.00	-0.36	60.49	22.49	91.97	65.53
BRD-K81209512	CP	AG-494	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		4.62, 1.92	46.03	0.85, 0.26	15.04	24.06	41.59	55.69	76.56	22.24	13.50	59.53	10.78	35.62	28.67	75.76	42.29	88.03	75.13	61.57	63.95	36.22	31.76	98.63	46.03	24.03	60.99	12.25	73.79	43.20	49.32	90.43	96.12
BRD-K53790871	CP	triamcinolone	antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent	NR3C1, CYP3A5, CYP3A7, SERPINA6	Glucocorticoid receptor agonist	5.71, 1.63	45.99	1.48, 0.52	7.35	83.87	43.51	57.10	90.16	34.90	92.59	48.08	79.07	32.44	-2.58	19.69	1.87	37.84	11.49	59.34	45.99	3.47	87.28	75.77	53.60	6.11	59.21	80.72	53.34	96.77	16.67	-23.01	22.05
BRD-K19309090	CP	SR-95639A	acetylcholine receptor agonist	CHRM1		4.23, 2.69	45.95	0.89, 0.15	48.23	45.95	94.41	19.17	90.33	28.39	84.55	90.11	36.09	44.48	82.66	67.87	5.74	12.49	14.94	28.48	81.64	51.48	71.29	84.05	-42.76	45.64	5.00	-97.48	82.06	93.70	7.89	55.63	20.13
BRD-A62525898	CP	prednisone	glucocorticoid receptor agonist	NR3C1, HSD11B1		4.23, 1.54	45.93	0.74, 0.22	43.10	37.11	97.58	4.51	96.19	33.42	45.93	33.20	40.32	38.14	29.25	84.50	3.95	33.28	95.77	21.39	14.62	57.29	43.02	70.22	61.81	71.80	32.35	92.62	54.98	55.43	72.60	66.02	47.58
BRD-A72441487	CP	stiripentol	GABA aminotransferase inhibitor, GABA reuptake inhibitor, sodium channel blocker	ABAT, SCN1A, SCN3A		3.85, 1.92	45.89	1.07, 0.35	47.45	10.25	45.89	34.01	58.62	32.96	62.29	58.76	35.64	9.55	99.33	48.04	6.87	22.90	64.34	0.00	45.63	41.74	98.67	39.60	83.84	34.41	82.03	13.83	35.47	95.91	73.11	92.84	76.77
BRD-K10176267	CP	L-701252	glutamate receptor antagonist	GRIN1		7.31, 4.62	45.88	1.18, 0.38	78.31	25.80	12.38	40.16	90.87	20.34	45.88	87.64	55.42	78.69	11.33	34.72	1.16	23.88	66.62	-2.57	96.43	58.01	41.37	56.65	69.60	56.16	65.53	27.99	0.81	28.57	21.29	96.62	74.42
BRD-K08619838	CP	tremorine	acetylcholine receptor agonist			5.77, 3.08	45.86	1.05, 0.24	93.98	53.24	34.40	32.35	16.50	37.95	96.18	29.59	14.72	67.33	72.24	73.24	1.76	18.12	68.00	0.63	22.78	42.92	99.15	66.30	16.65	45.86	15.01	46.51	54.45	73.14	15.79	80.30	68.28
BRD-K10670311	CP	sulfasalazine	cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist	PTGS1, PTGS2, ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, SLC46A1, SLC7A11, TBXAS1		8.00, 2.67	45.86	1.00, 0.25	43.14	8.56	21.49	66.84	96.19	94.28	83.84	85.52	54.07	14.76	47.30	78.37	23.75	34.90	99.82	-7.53	96.74	21.98	14.62	16.63	37.93	45.86	70.51	-86.39	19.73	93.26	96.55	15.79	59.13
BRD-K63504947	CP	semaxanib	VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist	KDR, FLT1, KIT, PDGFRB, FGFR1, FLT3, MET, PDGFRA, RET		6.54, 3.85	45.84	1.01, 0.31	28.29	82.18	86.90	45.84	95.13	24.30	6.99	44.52	57.70	24.14	52.07	40.17	33.01	23.54	74.06	13.78	96.58	66.61	26.82	99.79	79.65	96.77	31.19	27.88	47.71	6.38	52.77	99.89	19.48
BRD-K05151076	CP	ZK-164015	estrogen receptor antagonist	ESR1, ESR2	Estrogen receptor antagonist	7.69, 3.08	45.83	1.38, 0.18	61.23	86.36	57.32	95.21	29.88	11.93	24.11	36.95	18.56	30.09	38.54	45.83	94.66	79.56	47.14	99.75	42.44	73.42	13.53	45.13	48.38	65.29	8.77	0.78	74.22	82.55	29.65	56.29	14.47
BRD-K56343971	CP	vemurafenib	RAF inhibitor, protein kinase inhibitor	BRAF, CYP2C19, CYP3A4, CYP3A5, RAF1	RAF inhibitor	3.85, 2.69	45.83	1.58, 0.60	45.80	77.19	69.05	92.24	44.64	55.67	9.74	23.88	28.94	50.41	8.31	48.25	76.11	91.14	87.26	99.54	73.10	19.48	33.01	55.52	25.41	22.12	32.82	-18.38	56.85	40.92	45.83	47.91	13.40
BRD-A84389091	CP	L-655708	GABA receptor inverse agonist	GABRA5, GABRA1, GABRA2, GABRA3, GABRG2		4.08, 3.27	45.82	0.99, 0.30	97.73	45.82	56.87	30.57	24.07	91.28	19.78	52.41	6.88	99.93	64.82	85.40	4.45	4.99	-15.42	11.12	41.90	4.85	56.85	24.86	85.63	73.92	9.34	-30.67	19.29	84.21	51.63	71.36	65.12
BRD-K54529596	CP	captopril	angiotensin converting enzyme inhibitor	ACE, LTA4H, MMP2, MMP9		6.53, 5.31	45.79	1.42, 0.42	17.56	47.49	92.37	29.57	40.33	45.79	45.67	99.89	11.28	23.24	41.66	89.60	0.00	-2.01	98.17	2.99	91.62	2.85	20.56	92.64	74.97	82.11	58.83	2.28	36.25	82.05	66.71	87.61	71.67
BRD-K71035033	CP	masitinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor	KIT, FGFR3, LYN, PDGFRA, PDGFRB	PDGFR/KIT inhibitor	3.46, 1.92	45.76	0.80, 0.24	18.20	52.52	11.96	37.16	73.38	-18.72	1.52	49.50	-9.52	85.53	83.03	40.18	34.49	67.90	12.51	98.03	84.33	46.26	17.26	61.68	45.76	69.46	15.16	27.83	81.23	31.49	58.57	88.72	44.90
BRD-K96354014	CP	nifedipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA1F, CACNA1H, CACNB2, CALM1, CYP3A5, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3		3.85, 2.31	45.72	0.86, 0.28	92.31	27.89	48.23	26.11	64.58	33.69	58.09	45.94	39.13	24.97	51.49	41.60	-1.13	16.61	61.04	1.62	94.19	10.48	45.72	89.68	31.65	61.92	21.66	0.43	52.15	78.73	31.56	92.05	80.06
BRD-A52172093	CP	VU-0413807-2	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I		4.74, 3.45	45.71	1.13, 0.25	58.93	-49.20	76.38	48.45	73.56	45.71	13.31	85.98	55.19	9.55	18.09	57.14	0.53	1.66	97.82	-10.71	95.77	61.02	24.09	71.79	21.81	32.08	11.97	-0.88	31.08	68.26	92.59	27.36	91.08
BRD-K01624546	CP	docosatrienoic-acid	inhibitor of LTB4 binding to neutrophils			8.46, 4.62	45.71	1.52, 0.59	31.77	-91.97	18.43	5.57	-73.15	37.97	87.35	79.19	45.71	98.98	-40.49	62.25	-2.82	4.92	67.52	2.84	35.63	5.23	98.47	99.68	50.86	57.91	5.53	55.05	36.07	96.63	46.42	95.56	95.55
BRD-K66788707	CP	fludarabine	DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor	ADA, DCK, POLA1, RRM1, RRM2	DNA synthesis inhibitor, Ribonucleotide reductase inhibitor	6.94, 1.63	45.70	0.98, 0.33	67.65	41.83	68.70	20.27	48.91	5.11	21.07	67.27	90.62	25.15	25.80	44.01	3.88	27.14	98.60	11.34	92.27	45.14	70.15	59.26	45.70	58.64	29.64	83.64	28.68	33.30	88.88	46.17	62.81
BRD-K29668683	CP	BD-1063	sigma receptor antagonist	SIGMAR1	Sigma receptor antagonist	4.62, 3.08	45.69	1.31, 0.28	5.13	45.69	81.45	32.89	76.09	28.55	5.85	86.40	46.66	16.08	86.16	67.80	1.44	13.55	90.98	15.30	93.98	23.73	19.86	97.48	80.25	91.12	3.00	0.00	17.54	33.19	78.06	98.03	89.96
BRD-K37691127	CP	hinokitiol	tyrosinase inhibitor	TYR		3.85, 2.31	45.69	1.36, 0.45	41.38	97.30	59.08	90.28	21.73	7.08	45.06	-32.42	45.69	53.15	27.87	62.47	85.95	86.03	40.38	99.54	93.15	78.64	17.90	40.78	55.19	39.51	39.09	79.19	40.37	47.35	49.21	20.02	42.71
BRD-K43290182	CP	Ro-04-6790	serotonin receptor antagonist, serotonin receptor inhibitor	HTR6		3.85, 0.77	45.69	0.85, 0.27	95.40	16.86	87.12	15.75	90.45	66.88	13.52	-41.13	61.01	48.38	31.15	90.57	-1.25	1.69	33.16	28.55	83.73	45.69	85.66	53.45	90.72	55.30	82.05	-65.95	-18.16	8.24	15.73	83.88	44.90
BRD-K46211610	CP	tolazoline	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, ADRA1A, HRH1, HRH2		4.90, 2.45	45.68	0.48, 0.09	36.15	17.17	64.87	11.63	41.57	54.51	23.02	79.09	45.68	62.54	45.96	88.75	0.11	10.95	78.58	6.74	97.36	41.35	58.97	46.19	11.67	56.44	30.31	4.58	28.66	84.78	92.66	34.15	79.01
BRD-K13725475	CP	rhodomyrtoxin	cytotoxic, DNA intercalator			7.35, 3.67	45.66	1.24, 0.32	62.35	-17.57	7.68	76.42	6.33	23.12	8.89	76.64	2.01	26.21	6.01	62.46	83.12	70.54	-26.02	93.06	75.85	85.60	79.47	45.66	-34.44	4.55	27.42	99.51	95.42	94.29	2.68	7.97	55.47
BRD-K12102668	CP	nialamide	monoamine oxidase inhibitor	COMT, MAOA, MAOB		6.92, 4.62	45.65	1.83, 0.55	-58.35	40.90	90.98	26.05	82.16	81.63	18.45	17.96	6.17	78.69	85.46	49.72	0.00	71.90	71.11	51.01	92.48	40.15	27.62	31.39	99.47	69.27	57.16	-92.87	45.40	51.56	21.13	45.65	26.55
BRD-K46068882	CP	eugenitol	androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator	AR, MAOA		1.92, 0.77	45.64	1.18, 0.30	45.64	-20.41	2.37	26.29	-17.26	3.17	23.86	51.18	57.45	81.47	91.62	54.10	-2.08	0.92	50.90	2.18	-40.89	14.13	79.13	77.20	47.57	75.53	16.80	59.86	71.16	88.32	48.93	32.72	4.95
BRD-A51410489	CP	yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2C, ADRA2B, HTR1A, HTR1B, HTR1D, HTR2B, DRD2, DRD3, HTR1E, HTR1F, HTR2A, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8		6.15, 3.46	45.61	1.49, 0.53	33.46	56.83	92.58	44.49	45.61	98.48	23.98	74.71	36.92	88.07	95.00	93.40	-6.04	28.43	42.70	22.22	53.93	18.71	10.52	96.37	93.94	83.32	9.97	-90.05	30.39	81.33	6.20	93.84	91.58
BRD-A37492983	CP	iocetamic-acid	molecule used as a contrast medium			6.94, 3.67	45.60	0.77, 0.35	75.60	39.46	92.72	10.44	69.14	98.11	1.97	31.89	50.36	82.05	32.09	45.60	0.07	1.97	99.05	74.46	99.40	16.52	72.40	66.04	59.69	28.18	19.45	0.07	6.40	45.35	78.63	33.53	61.98
BRD-K11636097	CP	JNJ-7706621	CDK inhibitor, Aurora kinase inhibitor	CDK1, CDK2, AURKA, AURKB	CDK inhibitor	7.69, 5.00	45.60	4.50, 1.56	5.69	99.12	86.31	79.24	98.93	33.29	44.14	-42.54	51.30	59.40	95.95	97.36	5.78	12.40	98.09	98.91	29.79	31.89	45.60	71.78	94.20	51.74	25.21	-98.20	-39.40	11.62	37.05	82.19	19.40
BRD-A42553870	CP	L-152804	neuropeptide receptor antagonist	NPY5R		4.23, 1.92	45.57	0.95, 0.26	6.17	9.70	33.70	13.07	63.53	45.57	34.51	27.37	6.63	85.22	53.09	36.99	1.44	27.29	65.87	-0.88	97.29	31.31	99.19	66.52	55.70	85.94	54.18	4.03	46.33	24.35	66.11	96.03	59.80
BRD-K05906022	CP	limonin	HIV protease inhibitor			3.85, 1.54	45.56	0.82, 0.22	62.81	51.23	39.17	32.26	81.69	84.97	34.97	37.26	24.44	51.74	70.02	79.71	1.68	17.98	43.57	1.13	96.76	45.56	60.47	72.99	74.20	72.09	41.54	0.00	19.03	76.86	37.74	76.66	23.12
BRD-K87573634	CP	propylpyrazole	estrogen receptor agonist	ESR1		6.53, 3.27	45.56	1.33, 0.36	16.18	45.56	46.10	42.66	72.32	-11.07	1.66	52.61	34.11	6.59	12.91	47.45	29.15	89.92	79.22	98.79	96.76	68.43	56.14	30.35	63.29	74.29	84.69	6.27	4.61	9.70	88.68	30.45	-39.14
BRD-K11634954	CP	GBR-13069	dopamine uptake inhibitor	SLC6A3		5.38, 2.69	45.55	0.97, 0.26	75.08	38.27	15.81	71.33	8.42	12.37	82.53	77.62	32.98	5.51	42.92	81.48	33.41	87.88	11.16	77.92	-75.97	92.85	53.36	47.30	-44.59	45.55	7.15	69.75	99.58	42.89	-31.45	53.69	95.74
BRD-K37447567	CP	hydrocotarnine	non-narcotic opium alkaloid used in cancer pain treatment			2.86, 1.63	45.53	1.43, 0.45	89.87	44.37	42.71	6.45	53.27	45.96	12.19	71.10	18.49	63.24	50.56	82.28	1.76	45.53	85.60	2.71	44.30	0.00	23.16	77.53	81.11	27.01	62.09	-97.40	-27.53	64.71	35.41	68.38	64.06
BRD-A31204924	CP	mitotane	antineoplastic agent	CYP11B1, CYP11A1, CYP3A4, ESR1, FDX1		6.54, 3.46	45.50	0.66, 0.11	95.74	15.82	25.67	54.53	42.77	42.28	7.15	93.34	9.78	23.15	23.51	48.83	74.02	48.52	98.10	99.05	90.75	28.37	54.63	67.78	35.83	27.62	45.50	0.00	5.27	80.99	10.10	86.86	67.19
BRD-K66876909	CP	linezolid	50S ribosomal subunit inhibitor, protein synthesis inhibitor, monoamine oxidase inhibitor	MAOA		5.77, 2.31	45.48	1.05, 0.20	73.18	9.85	14.97	18.25	8.72	11.37	39.63	82.98	46.66	70.44	76.46	51.78	-9.04	6.76	73.17	-47.01	45.48	-9.34	85.73	28.71	57.94	5.74	42.79	99.72	61.73	89.72	57.25	37.86	81.14
BRD-A34255068	CP	rolipram	phosphodiesterase inhibitor, interleukin receptor antagonist	PDE4A, PDE4B, PDE4D, PDE4C, PDE5A		3.46, 1.92	45.46	0.74, 0.10	67.36	11.73	41.26	15.39	28.80	45.46	45.50	76.91	73.43	41.99	41.52	73.09	-3.30	0.56	91.23	-1.66	55.19	9.61	85.41	69.07	45.61	63.97	24.30	38.28	17.91	73.55	72.22	73.61	24.32
BRD-K29582677	CP	flunarizine	calcium channel blocker, T-type calcium channel blocker	CACNA1G, CACNA1H, CACNA1I, CALM1, CYP2J2, HRH1		4.23, 3.08	45.40	0.92, 0.23	86.56	-16.53	3.18	39.10	42.76	-9.96	58.35	63.02	74.26	48.13	60.55	35.76	0.00	32.50	65.91	5.43	15.48	6.96	93.12	81.48	-30.37	35.49	61.11	99.44	45.40	78.86	29.26	77.04	47.47
BRD-A44090213	CP	indoprofen	cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor	PTGS1, PTGS2, CXCR1, CXCR2	Cyclooxygenase inhibitor	4.49, 2.04	45.39	0.86, 0.19	58.13	37.49	8.13	18.25	14.83	58.39	77.11	93.20	29.94	89.65	92.21	79.51	1.83	-2.66	93.10	7.75	-57.30	5.71	78.07	25.07	-9.69	-16.21	82.26	84.25	45.39	67.33	37.02	54.85	56.58
BRD-A56012032	CP	thiorphan	membrane metalloendopeptidase inhibitor	MME		6.92, 2.31	45.39	1.03, 0.25	98.31	40.35	92.44	5.68	99.37	20.46	17.98	25.20	22.49	63.84	79.96	54.16	0.00	12.62	97.89	27.52	41.34	22.70	43.05	65.81	84.12	92.00	14.40	4.32	45.39	85.73	57.10	97.43	70.33
BRD-A93477898	CP	PETCM	caspase activator	CASP3		4.90, 2.04	45.37	0.94, 0.27	9.76	65.14	97.53	7.94	66.50	14.47	70.38	45.37	43.37	69.74	76.30	97.22	4.62	13.56	74.27	10.56	75.32	16.57	92.32	72.37	60.30	45.31	43.17	-96.89	9.63	28.42	79.40	29.19	67.42
BRD-K50168500	CP	canertinib	EGFR inhibitor, EGFR antagonist, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4, AKT1	EGFR inhibitor	6.92, 3.46	45.35	1.59, 0.39	60.23	58.63	45.35	96.48	32.39	38.18	3.74	25.68	6.53	19.02	8.63	49.44	78.68	99.15	92.81	99.93	43.37	96.02	33.43	43.54	24.28	60.35	67.37	16.27	53.40	58.48	18.08	37.95	57.05
BRD-K92049597	CP	triamterene	sodium channel blocker	SCNN1A, SCNN1B, SCNN1G, SCNN1D	Sodium channel blocker	4.23, 2.31	45.32	0.78, 0.23	78.13	-69.41	84.45	73.84	19.75	25.89	48.87	33.11	54.55	36.05	17.00	86.48	5.92	3.72	90.24	70.90	84.91	16.28	36.39	98.60	40.04	61.06	43.33	99.33	40.03	51.65	45.32	93.82	26.59
BRD-K92446736	CP	zatebradine	HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker	HCN1, HCN2, HCN3, HCN4		5.38, 2.69	45.32	0.68, 0.17	87.23	13.30	8.56	22.14	29.30	81.48	88.82	43.15	9.73	55.49	69.38	49.49	2.18	12.56	10.18	8.65	1.62	34.16	95.54	86.08	59.80	86.22	31.80	-0.88	90.15	80.57	45.32	96.28	97.57
BRD-K25741894	CP	skimmianine	acetylcholinesterase inhibitor			3.46, 0.77	45.28	0.93, 0.18	96.13	41.62	79.37	54.40	94.79	26.03	27.08	70.72	15.17	88.58	81.16	78.94	-8.90	15.73	32.17	22.43	32.12	10.82	86.40	84.77	27.46	46.17	44.39	-9.15	5.36	84.41	45.28	97.40	67.78
BRD-K31792052	CP	pifithrin	interleukin receptor antagonist			6.54, 5.00	45.24	0.73, 0.20	51.26	-8.53	99.26	74.06	16.48	6.94	30.82	94.32	53.29	46.13	21.86	44.71	6.97	0.63	78.00	17.43	80.73	91.48	38.02	25.20	30.12	98.73	16.00	-27.23	76.23	45.24	68.58	78.58	84.45
BRD-K81225797	CP	SCH-58261	adenosine receptor antagonist	ADORA2A, ADORA1, ADORA2B, ADORA3		4.23, 1.92	45.24	1.01, 0.42	10.38	52.36	59.53	47.92	76.90	30.06	-1.59	74.87	69.17	14.32	20.59	70.99	2.04	9.58	74.53	70.69	43.99	47.93	-81.69	74.68	92.50	84.57	40.86	17.43	-19.33	45.24	40.85	9.13	94.93
BRD-K86434416	CP	selegiline	monoamine oxidase inhibitor, superoxide dismutase stimulant	MAOB, MAOA, CYP2B6, CYP2C19		10.20, 7.35	45.24	0.80, 0.26	9.53	47.07	62.07	6.78	76.23	22.73	79.44	99.30	34.81	73.41	29.88	77.30	2.26	0.00	93.80	0.92	33.29	2.50	83.49	27.39	68.91	34.55	56.08	9.65	6.84	99.54	81.06	45.24	79.00
BRD-K67043667	CP	altretamine	DNA synthesis inhibitor			3.85, 2.31	45.23	0.41, 0.07	99.08	24.36	42.90	17.19	42.75	35.14	14.39	50.25	9.99	17.22	77.03	51.13	1.97	9.32	56.77	1.16	79.56	14.12	50.59	77.68	30.94	73.29	53.43	75.65	86.25	88.86	45.23	73.10	22.43
BRD-K75699339	CP	rizatriptan	serotonin receptor agonist	HTR1D, HTR1B, HTR1F, HTR1A, HTR1E		4.62, 3.08	45.23	0.34, 0.08	23.47	23.30	5.45	27.12	85.33	51.13	34.39	65.77	22.01	64.06	58.57	51.32	1.02	10.32	95.89	4.46	96.11	45.23	46.70	52.45	31.14	17.92	58.58	1.76	17.13	60.57	25.68	86.56	81.74
BRD-A44551378	CP	LFM-A12	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR		6.87, 3.05	45.23	1.40, 0.35	2.04	28.75	97.64	88.11	26.88	99.79	96.78	79.53	79.58	4.58	-33.20	87.42	-5.99	8.66	50.01	2.71	81.31	21.38	43.22	39.71	60.11	47.23	47.96	NaN	4.64	11.69	76.78	21.94	96.79
BRD-K37289225	CP	clozapine	serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist	DRD2, DRD4, ADRA1A, ADRA1B, CHRM1, DRD1, DRD3, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD5, HTR1F, HTR2B, HTR3A, HTR5A	Dopamine receptor antagonist, Serotonin receptor antagonist	4.23, 1.15	45.22	0.73, 0.14	45.22	15.78	27.81	70.10	52.20	43.58	39.94	32.86	8.39	39.35	83.01	93.49	6.07	31.86	93.00	29.29	82.86	89.11	69.86	39.71	86.75	78.75	27.60	0.04	94.08	93.15	41.18	77.86	49.74
BRD-K85603128	CP	resorcinol	phosphodiesterase inhibitor	CA12, CA14, CA2, PTGS1		5.00, 2.69	45.22	1.27, 0.31	36.30	-13.50	-4.16	6.79	67.26	14.26	83.26	80.44	57.12	57.85	67.35	45.22	2.26	3.73	56.22	4.09	78.53	-5.55	83.53	89.81	-33.83	43.53	2.75	6.26	1.02	46.72	86.56	94.36	61.14
BRD-A22713669	CP	BVT-948	tyrosine phosphatase inhibitor	PTPN1, PTPN11, PTPN2		3.27, 2.04	45.21	2.32, 0.45	49.53	96.35	93.97	77.60	45.21	82.59	16.57	-47.35	9.47	38.34	76.10	87.45	91.72	89.26	34.11	99.86	42.35	40.52	82.76	7.48	62.20	41.16	49.94	-11.15	-12.68	15.75	35.29	47.74	33.50
BRD-A65671304	CP	candesartan	angiotensin receptor antagonist	AGTR1, AGTR2	Angiotensin receptor antagonist	1.54, 1.15	45.19	0.53, 0.10	94.43	25.11	60.35	32.02	75.47	78.20	3.42	-23.13	5.50	67.98	46.02	28.11	16.44	9.81	75.51	62.74	74.92	14.69	46.73	77.57	60.48	19.74	21.05	45.19	23.53	7.40	46.08	49.55	35.00
BRD-K79124250	CP	ioxaglic-acid	iodine contrast agent			10.38, 6.15	45.19	1.26, 0.44	63.17	11.39	93.30	55.41	69.64	99.72	42.01	22.07	9.73	24.98	18.39	48.51	-2.33	4.33	92.13	3.20	45.19	29.73	38.72	98.87	66.20	70.09	62.25	12.90	35.07	14.60	77.07	98.86	98.56
BRD-K82135108	CP	elesclomol	apoptosis stimulant, HSP agonist, HSP inducer, oxidative stress inducer, topoisomerase inhibitor	TOP2A		1.92, 0.38	45.19	1.14, 0.13	88.12	56.01	43.44	8.63	37.59	16.96	78.42	56.73	34.30	33.52	52.68	83.50	86.96	89.90	45.19	90.26	15.10	38.89	31.73	61.50	24.24	46.17	55.12	7.33	21.24	27.25	76.89	28.86	67.67
BRD-K42142750	CP	retrorsine	mutagenic, antimitotic, cytotoxic			4.49, 2.45	45.11	0.97, 0.31	72.30	41.08	91.39	12.71	55.59	97.76	43.21	-18.05	45.11	83.99	79.90	84.61	6.87	9.46	49.26	19.68	34.64	19.91	92.43	73.83	55.23	33.30	67.64	3.10	3.52	84.93	74.27	34.89	13.83
BRD-K78838262	CP	austricine	hypolipidemic			6.11, 3.05	45.09	1.58, 0.44	-5.89	11.43	49.18	41.03	67.74	8.62	29.15	49.15	-45.76	5.83	13.39	88.45	-73.96	15.84	9.27	69.86	-94.19	77.82	98.01	94.97	60.20	95.38	29.31	NaN	11.51	81.94	86.75	68.57	98.48
BRD-A67862938	CP	naftidrofuryl	adrenergic receptor antagonist			4.23, 2.31	45.08	1.30, 0.57	99.75	8.25	19.74	68.86	28.13	33.63	71.33	82.81	45.08	4.15	2.26	14.55	-1.87	22.37	81.45	10.56	91.62	8.18	91.46	76.83	17.33	16.84	36.19	72.02	71.53	95.81	51.49	51.17	77.01
BRD-K82846253	CP	repaglinide	insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide	ABCC8, CYP2C8, CYP3A5, INS, KCNJ11, PPARG		4.90, 2.86	45.08	0.43, 0.09	39.62	13.39	16.73	10.96	29.96	29.88	46.92	82.96	45.99	72.23	45.08	83.89	1.44	33.46	80.00	-50.00	80.82	9.03	93.83	87.87	8.28	46.60	25.84	57.45	74.58	72.63	8.41	38.41	84.46
BRD-K15891719	CP	tenofovir	reverse transcriptase inhibitor, nucleoside reverse transcriptase inhibitor, nucleotide reverse transcriptase inhibitor			6.92, 3.46	45.02	3.25, 0.93	2.22	97.38	28.48	5.25	98.59	54.89	59.88	87.27	-0.25	45.02	64.77	92.04	2.96	8.68	9.87	70.70	45.30	1.30	-15.34	72.86	98.34	83.11	-10.95	-99.93	25.29	11.24	28.28	57.57	59.44
BRD-U37049823	CP	HG-6-64-01	RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor	ABL1, BRAF, CSF1R, EGFR, FGFR1, FLT3, KIT, MAPK11, PDGFRB, RET	PDGFR/KIT inhibitor, RAF inhibitor	7.69, 5.77	45.00	1.82, 0.35	31.16	84.24	39.74	95.50	52.19	40.13	1.34	48.18	19.66	45.00	10.92	76.86	94.86	98.52	43.41	99.96	39.77	96.62	29.99	33.80	71.19	25.40	24.50	0.00	92.49	63.34	91.52	51.45	27.15
BRD-A23072235	CP	pheniramine	acetylcholine receptor antagonist	HRH1		5.00, 3.08	44.99	0.61, 0.11	65.17	86.45	47.55	6.74	88.98	48.97	0.32	-19.16	16.73	4.62	14.29	89.24	2.04	5.49	96.53	8.87	87.62	66.27	-40.90	92.84	44.99	83.15	65.70	98.27	-21.35	35.00	34.29	12.85	49.28
BRD-K09764130	CP	mead-ethanolamide	cannabinoid receptor agonist			5.00, 3.08	44.99	0.76, 0.18	94.74	-8.25	52.40	63.89	58.92	44.99	69.94	70.75	33.03	16.40	89.89	54.80	-10.35	22.88	32.89	-5.87	32.78	22.23	86.97	22.99	34.43	48.55	27.65	-27.15	91.60	69.79	16.20	56.02	70.92
BRD-K64517075	CP	heliomycin	antibiotic, bacterial RNA synthesis inhibitor			8.16, 5.71	44.97	2.15, 0.80	30.37	69.73	16.86	98.66	84.34	10.09	0.00	85.80	56.48	14.76	74.38	74.51	99.47	98.52	88.24	99.96	-89.38	95.70	4.36	45.65	44.97	-2.54	19.65	0.00	0.00	64.70	11.94	2.08	34.65
BRD-A97437073	CP	rosiglitazone	PPAR receptor agonist, insulin sensitizer, thiazolidinedione	PPARG, ACSL4, CYP2C8, FFAR1, INS, TRPC5, TRPM3	PPAR receptor agonist	3.46, 1.92	44.95	0.39, 0.11	30.31	13.64	44.95	34.59	56.59	41.96	36.36	66.03	30.02	10.61	25.80	63.14	8.95	53.51	82.79	70.16	92.07	31.10	49.05	52.48	63.27	61.24	71.17	0.07	31.91	36.23	45.72	78.70	26.83
BRD-K30197592	CP	5-methoxytryptamine	serotonin receptor agonist	HTR2A, HTR6, HTR1B, HTR1D, HTR1E, HTR1F, HTR2C, HTR4, HTR7, TRPM8		7.31, 3.85	44.95	1.44, 0.44	68.01	10.42	50.81	28.80	19.73	6.79	88.11	44.95	17.76	92.62	35.64	60.00	-2.11	10.92	43.35	-20.29	34.99	22.22	94.60	81.02	87.96	86.13	-5.64	85.82	96.00	54.92	38.59	66.02	89.79
BRD-K15108141	CP	gemcitabine	cell cycle inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor	RRM1, CMPK1, RRM2, TYMS	Ribonucleotide reductase inhibitor	4.23, 3.08	44.94	1.97, 0.58	21.86	97.96	99.58	31.92	33.68	96.60	10.63	38.41	27.86	68.28	51.33	82.70	77.55	53.67	69.05	99.47	18.81	17.51	28.22	44.53	44.94	13.12	27.71	61.24	20.33	54.40	62.32	17.40	91.47
BRD-K60298136	CP	ITE	aryl hydrocarbon receptor agonist, aryl hydrocarbon receptor ligand	AHR		6.54, 3.46	44.89	1.24, 0.36	42.14	41.36	87.12	83.31	83.57	23.60	76.63	63.63	91.82	33.17	7.37	52.66	41.60	69.65	-23.01	15.01	68.25	52.52	38.37	96.69	43.39	75.70	43.41	29.32	44.89	18.75	23.40	96.45	70.71
BRD-K00662280	CP	CL-218872	GABA receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2		5.38, 1.92	44.84	1.31, 0.27	96.22	63.84	9.37	17.09	56.21	83.46	43.02	-31.39	6.81	51.95	73.32	73.11	1.23	0.78	45.67	36.36	45.81	20.12	44.84	74.56	37.22	81.94	23.31	0.00	19.21	89.52	70.84	77.88	34.81
BRD-K02867583	CP	minaprine	serotonin uptake inhibitor	HTR2B, SLC6A4, ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2C, MAOA		3.67, 1.63	44.83	1.11, 0.28	81.85	30.40	44.83	4.32	29.83	26.23	67.61	59.40	43.06	79.22	47.54	44.49	2.99	12.05	84.31	7.45	66.70	26.51	93.30	84.04	-25.09	81.92	59.52	99.01	53.80	15.03	34.44	55.34	31.97
BRD-K77925998	CP	quipazine	serotonin receptor agonist	HTR2A, HTR3A, HTR3B, HTR1A, HTR1D, HTR2B, HTR2C, HTR6, SLC6A4		3.85, 1.92	44.83	0.84, 0.26	77.90	23.67	16.78	25.93	30.09	83.23	58.45	44.83	26.88	67.27	38.44	40.23	1.83	12.59	96.84	2.92	67.21	28.10	97.56	18.78	45.51	74.03	82.55	76.33	27.03	58.54	35.05	66.89	79.16
BRD-A11702965	CP	chromomycin-a3	DNA binding			7.31, 3.46	44.81	1.43, 0.64	3.66	99.12	51.79	18.39	95.72	54.15	72.33	-60.15	10.30	42.47	77.18	95.28	0.00	1.73	62.63	62.78	1.06	5.10	71.04	62.85	83.72	44.81	6.77	-15.45	-7.61	21.62	20.57	52.90	76.94
BRD-K68873215	CP	phosphodiesterase-V-inhibitor-II	phosphodiesterase inhibitor	PDE5A		3.08, 1.54	44.81	0.68, 0.23	9.53	54.42	68.82	60.44	65.82	9.06	22.05	55.67	12.76	6.81	84.26	54.88	3.17	71.66	52.40	88.55	48.86	41.29	16.69	71.29	44.81	30.04	75.03	-57.34	43.32	23.88	11.92	82.24	32.06
BRD-K71860425	CP	CDK2-5-inhibitor	inhibitor of CDK2/cyclin E and CDK5/p25	CDK2, CDK5		9.23, 3.85	44.81	1.09, 0.31	29.14	76.37	14.07	84.70	81.41	40.05	87.71	60.40	93.54	25.32	44.40	36.15	-1.95	21.10	60.70	-1.23	58.64	30.59	88.61	98.13	44.81	96.86	38.21	2.61	23.24	53.44	79.89	99.58	42.98
BRD-A41301928	CP	bongkrek-acid	mitochondrial ADP, ATP translocase inhibitor	SLC25A4		4.62, 0.77	44.80	1.39, 0.41	54.65	89.63	94.66	-8.73	82.89	77.30	37.86	-64.41	37.25	84.32	44.80	62.07	0.00	4.87	63.70	73.68	97.22	36.37	17.40	17.58	66.29	36.91	57.91	-24.62	8.72	77.85	23.21	33.40	89.65
BRD-A81795050	CP	U-18666A	oxidosqualene cyclase inhibitor			6.92, 4.62	44.80	1.19, 0.26	32.98	-2.36	25.44	75.24	61.88	23.75	0.81	73.04	32.75	18.09	14.30	44.80	79.39	85.95	62.05	-6.21	27.23	98.31	29.72	63.49	17.75	28.54	61.52	63.92	99.72	60.43	40.04	51.06	98.91
BRD-K93441486	CP	diphemanil	acetylcholine receptor antagonist	CHRM3		5.31, 3.27	44.80	0.84, 0.31	96.36	36.21	86.29	44.80	28.46	79.42	18.75	20.61	11.75	72.54	17.42	56.24	3.31	48.19	46.35	38.57	78.32	7.88	52.49	35.95	61.13	67.58	18.42	0.04	4.80	59.17	22.39	47.73	78.47
BRD-K36927236	CP	glibenclamide	sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist	KCNJ11, ABCC8, CFTR, KCNJ5, KCNJ8, ABCA1, ABCB11, ABCC9, CPT1A, KCNJ1, SLCO2B1, TRPA1		3.08, 1.92	44.79	0.88, 0.11	7.13	-31.16	57.11	26.83	78.72	24.01	71.17	90.72	32.75	84.33	84.78	65.94	0.18	5.55	-45.28	21.22	77.88	21.32	44.28	54.32	44.79	84.45	30.89	-25.39	94.23	82.40	16.84	75.86	85.58
BRD-K18194590	CP	mephentermine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3		2.69, 0.77	44.77	0.98, 0.26	13.33	75.09	56.01	22.45	68.21	72.15	-9.82	-29.17	12.70	-13.20	46.30	77.32	0.00	1.80	93.87	21.62	69.53	3.14	30.82	62.84	79.24	44.77	44.98	91.36	-31.75	-71.08	28.00	51.33	68.57
BRD-K25079130	CP	avrainvillamide-analog-4	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	2.15, 0.86	44.75	0.49, 0.15	44.11	31.92	59.97	32.84	44.75	3.49	15.05	11.63	19.31	48.09	3.95	61.53	58.24	71.71	51.36	99.47	86.64	10.55	50.69	58.18	51.29	58.47	3.70	46.49	39.66	19.89	42.84	32.34	64.50
BRD-K79425933	CP	benperidol	dopamine receptor antagonist	DRD2		5.00, 2.31	44.73	1.01, 0.39	25.92	37.44	98.10	81.73	83.11	44.73	7.58	64.02	22.17	32.19	65.97	79.74	50.69	39.90	83.12	88.28	35.21	27.55	16.09	94.90	5.64	98.77	35.89	63.73	26.25	11.71	37.31	55.65	76.07
BRD-K93176058	CP	AC-55649	RAR agonist, retinoid receptor agonist	RARB, RARA	Retinoid receptor agonist	3.46, 1.92	44.73	1.35, 0.26	98.26	-48.83	6.79	5.94	-8.59	34.84	93.82	80.72	17.12	33.78	44.73	-12.31	-86.61	-2.11	50.59	-68.03	40.97	-6.13	74.01	71.36	68.21	29.32	66.25	76.22	73.74	63.50	50.01	62.66	62.57
BRD-K55454768	CP	TAS-301	voltage-independent calcium influx blocker	CAMK2A		1.22, 0.41	44.72	1.10, 0.27	80.75	-7.15	69.62	52.43	11.54	30.15	15.85	51.59	92.51	65.35	67.14	44.60	8.10	55.86	77.08	2.54	57.50	25.47	47.36	18.83	36.74	17.65	18.84	44.72	68.92	36.77	75.87	20.82	45.08
BRD-K44432556	CP	VU-0418946-1	hypoxia inducible factor activator	HIF1A	HIF activator	5.00, 1.92	44.69	1.80, 0.63	88.42	94.54	32.15	96.31	75.69	44.69	-29.65	19.91	1.47	80.28	59.17	94.26	98.78	93.78	13.95	100.00	-76.65	91.59	37.55	39.79	21.92	23.51	55.59	6.65	11.70	84.59	49.70	36.78	8.00
BRD-A51382177	CP	fosinopril	angiotensin converting enzyme inhibitor, breast cancer resistance protein inhibitor	ACE, ABCG2		4.49, 2.86	44.63	1.51, 0.53	44.23	19.08	85.27	44.63	25.74	89.23	4.37	79.15	19.11	97.58	26.25	82.70	3.56	2.57	92.80	23.11	39.16	12.36	43.97	85.28	6.91	20.98	77.30	71.50	51.72	97.37	72.90	93.11	91.16
BRD-A61793559	CP	metolazone	carbonic anhydrase inhibitor, quinazoline diuretic, inhibitor of sodium chloride symporters	SLC12A3, CA2, CA7		5.00, 2.31	44.61	0.48, 0.10	96.80	12.74	3.39	10.28	14.89	79.15	32.38	63.54	36.39	4.12	19.86	81.84	-2.57	23.31	96.17	15.25	36.29	54.57	80.21	50.68	26.56	80.22	-16.91	62.22	48.07	74.98	44.61	79.16	82.24
BRD-K02123250	CP	JNJ-38877605	hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	MET		7.35, 2.45	44.60	1.05, 0.27	7.22	70.09	67.80	40.89	84.03	40.98	86.53	94.25	46.33	10.66	98.31	76.61	0.07	5.62	85.43	38.40	89.18	15.17	11.10	88.28	96.28	29.89	44.60	38.84	-59.07	91.25	23.58	51.63	19.66
BRD-K45296539	CP	ZD-7114	adrenergic receptor agonist	ADRB3		5.77, 2.69	44.59	0.56, 0.18	38.12	76.84	57.49	25.70	94.86	16.00	48.85	52.74	74.74	33.09	44.71	71.65	3.31	23.66	39.93	3.07	-24.58	5.32	37.62	93.69	73.43	41.56	44.59	-88.95	4.79	63.31	67.11	96.61	89.62
BRD-K20742498	CP	RS-39604	serotonin receptor antagonist	HTR4	Serotonin receptor antagonist	5.77, 4.62	44.58	1.50, 0.55	41.35	22.60	25.90	80.15	39.29	44.46	22.74	52.94	20.59	44.58	81.82	94.28	66.46	97.39	22.50	98.31	-26.70	97.67	15.47	76.59	45.23	6.20	31.35	-0.88	91.33	28.94	67.97	83.39	90.11
BRD-K82091397	CP	SB-239063	p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor	MAPK11, MAPK14, PTGS2, TNF	P38 MAPK inhibitor	3.08, 0.38	44.58	0.83, 0.35	14.99	52.15	53.08	-1.48	45.98	40.79	59.76	49.92	5.18	69.50	1.27	7.23	0.00	33.30	64.01	8.29	81.67	10.76	48.23	16.02	36.71	68.80	26.96	44.58	65.40	78.85	54.72	9.70	73.72
BRD-K28453807	CP	nitrocaramiphen	acetylcholine receptor antagonist			4.62, 1.92	44.56	0.66, 0.20	55.18	4.44	89.09	7.34	82.00	15.49	80.13	30.23	93.81	57.40	74.87	50.08	0.00	9.78	6.62	3.95	44.56	9.38	66.61	66.13	25.67	11.46	47.46	-0.07	51.46	75.21	14.86	53.96	21.86
BRD-A41692738	CP	TGX-221	PI3K inhibitor	PIK3CB, PIK3CD	PI3K inhibitor	5.38, 2.31	44.50	0.98, 0.31	67.68	82.86	42.38	87.78	28.55	30.61	44.50	37.24	37.77	22.14	51.56	25.30	65.97	32.78	87.87	98.29	32.85	66.38	9.05	54.74	47.40	48.61	37.56	97.36	32.80	37.22	60.58	85.46	36.78
BRD-K68437527	CP	EMF-bca1-60	caspase inhibitor			4.23, 1.92	44.50	0.66, 0.17	42.82	12.30	43.17	57.73	42.74	71.35	9.49	37.76	29.18	13.37	14.15	93.48	29.12	30.31	88.06	34.50	84.23	70.93	41.38	67.76	72.01	53.88	44.50	41.07	73.77	93.94	58.96	76.40	76.71
BRD-A36066264	CP	estradiol-benzoate	contraceptive agent	ESR1	Estrogen receptor agonist	3.46, 0.77	44.48	0.39, 0.10	39.71	50.96	4.77	89.55	54.72	44.48	63.64	44.94	18.14	91.91	12.15	71.29	63.12	24.04	11.41	93.76	74.55	32.97	40.46	93.35	28.48	18.48	95.41	22.80	15.88	77.82	76.74	8.51	22.53
BRD-A03623303	CP	metoprolol	adrenergic receptor antagonist	ADRB1, ADRB2		8.85, 7.69	44.45	0.89, 0.38	63.62	21.08	61.65	25.62	47.33	7.08	19.67	63.52	7.99	65.14	56.65	21.10	2.22	19.78	79.79	10.01	42.37	86.40	28.22	91.83	53.95	99.97	24.39	2.47	44.45	3.84	65.82	99.07	89.73
BRD-K68407802	CP	KIN001-055	EGFR inhibitor, JAK inhibitor, leukotriene synthesis inhibitor, mediator release inhibitor	EGFR, JAK3		2.31, 1.54	44.44	1.02, 0.31	58.18	53.18	8.08	47.51	26.08	33.60	84.10	-28.17	44.44	81.45	25.33	80.83	0.07	48.15	91.05	-0.70	79.48	20.90	93.19	22.82	-8.25	8.96	61.57	-99.58	26.34	71.15	15.36	55.47	78.64
BRD-A38030642	CP	cyclosporin-a	calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor	PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3		7.31, 4.23	44.39	2.28, 0.90	73.70	33.67	32.55	95.77	42.55	33.18	-8.46	42.11	21.00	26.57	2.50	85.93	97.50	89.52	86.06	99.96	67.05	89.11	11.05	51.10	44.68	17.19	57.21	4.08	48.33	70.67	31.90	26.85	44.39
BRD-K99616396	CP	motesanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist	FLT1, FLT4, KDR, KIT, PDGFRA, RET	PDGFR/KIT inhibitor	5.38, 1.54	44.39	0.64, 0.17	72.24	55.26	23.13	79.89	13.62	18.43	30.81	33.98	8.10	59.66	85.64	82.73	36.45	41.09	98.72	75.07	53.90	6.31	49.68	82.86	43.64	51.79	29.13	32.88	25.89	44.39	48.04	86.30	35.43
BRD-A33711280	CP	metixene	acetylcholine receptor antagonist	CHRM5, CHRM1, CHRM2, CHRM3, CHRM4		5.71, 3.67	44.34	0.91, 0.25	90.84	36.44	65.10	74.50	18.51	93.55	-4.01	34.15	6.19	79.36	3.62	10.24	36.74	52.96	98.36	5.62	44.34	89.61	19.70	62.42	27.44	-4.23	56.47	99.15	84.33	67.62	11.01	53.05	40.16
BRD-K61323504	CP	SB-225002	CC chemokine receptor antagonist, Chemokine CXCR2  (IL-8 beta Receptor) Antagonists	CXCR2		2.31, 0.38	44.34	1.27, 0.60	64.52	60.18	87.84	55.34	44.34	44.10	67.97	64.07	50.77	25.20	10.00	29.86	80.20	66.28	7.61	91.52	67.88	8.10	80.58	2.89	44.28	36.33	30.61	-62.69	-21.38	34.05	30.16	79.31	71.41
BRD-K55344148	CP	BU-224	imidazoline receptor ligand	MAOA, MAOB	Imidazoline ligand	4.49, 2.45	44.30	1.20, 0.35	85.46	19.79	94.37	8.54	57.79	92.80	27.79	74.44	32.31	38.51	17.89	97.18	-2.78	49.89	92.37	9.26	81.86	49.00	51.47	44.20	44.30	69.52	16.07	24.50	32.90	94.19	19.72	86.25	38.27
BRD-K81839095	CP	estrone	estrogen receptor agonist, estrogenic hormone	ESR1, ESR2	Estrogen receptor agonist	1.15, 0.38	44.30	0.52, 0.35	81.67	65.48	85.98	27.62	77.56	27.20	20.60	-12.51	24.58	44.30	39.30	93.09	0.00	24.48	60.38	96.07	67.33	19.52	8.97	63.62	47.90	66.59	52.02	0.00	16.98	20.15	37.76	79.18	44.98
BRD-A29289453	CP	PCA-4248	platelet activating factor receptor antagonist	PTAFR		7.31, 4.62	44.28	0.76, 0.15	54.40	0.00	14.35	70.67	27.53	7.11	42.16	62.33	27.73	23.24	5.21	52.41	17.55	44.28	97.60	83.73	1.24	88.50	88.54	98.67	25.73	76.91	14.37	99.65	54.77	62.38	17.63	85.61	41.36
BRD-A73368467	CP	fexofenadine	histamine receptor antagonist	HRH1		4.23, 2.31	44.24	0.72, 0.16	56.93	30.67	22.65	18.51	96.67	16.34	28.20	78.38	14.80	62.06	43.94	87.61	0.00	12.67	47.80	2.04	82.41	12.50	57.01	85.35	44.24	48.61	80.15	69.61	33.84	27.81	74.97	75.48	42.17
BRD-K28183345	CP	proguanil	dihydrofolate reductase inhibitor	CYP2C19, DHFR		5.00, 1.92	44.24	0.90, 0.27	11.17	47.70	64.76	57.70	44.24	52.42	26.00	94.94	19.49	68.21	15.53	47.37	3.44	7.03	99.19	22.57	97.36	18.20	35.42	95.56	49.55	46.52	10.67	14.86	37.26	79.24	40.62	80.17	18.23
BRD-K31611373	CP	fluprostenol	prostaglandin F receptor agonist	PTGER3, PTGFR, TBXA2R		3.08, 1.15	44.22	0.72, 0.15	36.55	38.54	88.36	83.71	45.89	26.86	87.45	24.46	68.30	44.22	3.56	90.89	8.36	56.79	11.01	90.32	63.42	70.99	48.48	56.30	34.57	29.58	82.44	14.88	37.42	24.62	26.68	36.74	65.19
BRD-K36638830	CP	anabasine	acetylcholine receptor agonist			5.38, 3.08	44.19	1.10, 0.19	29.12	4.12	2.92	31.58	29.96	73.59	22.45	78.59	44.19	99.79	28.79	13.06	2.26	2.04	92.26	2.70	73.10	47.50	72.59	91.52	43.37	99.61	20.71	41.05	83.80	98.94	89.52	86.54	50.09
BRD-K06467078	CP	corynanthine	alpha adrenergic receptor antagonist			4.49, 2.45	44.16	1.27, 0.38	29.32	53.23	72.97	15.96	59.39	73.25	25.32	35.12	35.48	97.51	92.29	94.40	2.17	18.47	77.64	9.22	23.76	29.47	41.66	76.60	73.77	91.21	44.16	-5.93	61.27	43.24	85.47	34.68	60.67
BRD-K88358234	CP	xaliproden	serotonin receptor agonist, nerve growth factor agonist, neurotrophic factor enhancer	HTR1A		5.38, 2.69	44.15	0.72, 0.27	7.84	50.64	44.15	0.78	30.90	77.11	92.51	79.53	46.14	69.32	72.62	49.75	2.01	15.81	13.88	60.37	48.91	36.54	87.28	21.04	79.58	31.83	28.73	42.86	27.79	10.28	46.47	15.01	46.36
BRD-A16311756	CP	profenamine	butyrylcholinesterase inhibitors, cholinergic receptor antagonist, glutamate receptor antagonist	CHRM1, BCHE, CHRM2, GRIN3A		4.08, 2.45	44.13	1.26, 0.40	33.84	29.07	26.28	72.95	41.92	14.39	14.10	72.33	12.38	14.67	45.07	19.36	52.00	87.82	76.44	44.13	59.70	95.84	9.16	51.08	31.06	61.60	11.72	-99.19	79.94	14.83	44.18	67.76	81.80
BRD-A50311610	CP	meclozine	constitutive androstane receptor (CAR) agonist	NR1I3, HRH1		2.69, 1.15	44.11	0.80, 0.23	85.02	70.64	49.27	30.62	73.80	33.98	63.28	39.18	35.41	24.94	32.04	82.89	2.82	20.05	75.09	2.61	92.95	56.14	47.53	70.85	44.11	40.78	25.33	20.45	13.96	86.38	74.72	50.28	27.81
BRD-K83794624	CP	pirarubicin	topoisomerase inhibitor	TOP2A	Topoisomerase inhibitor	5.77, 3.85	44.09	3.16, 0.95	42.50	99.12	70.44	66.16	98.63	30.29	94.96	-57.11	24.55	94.33	73.58	89.29	0.00	19.78	91.69	97.58	87.38	39.57	-5.95	44.09	80.98	33.90	33.99	-20.32	-13.75	7.42	42.10	61.70	57.07
BRD-A90799790	CP	isradipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1D, CACNA2D1, CACNA1F, CACNA1H, CACNA1S, CACNA2D2, CACNB2		6.94, 3.67	44.07	1.30, 0.35	31.98	47.20	90.87	28.05	58.46	99.86	8.49	70.35	17.97	85.65	8.42	91.97	4.32	30.76	88.15	25.83	99.37	17.99	94.95	18.80	44.07	51.86	18.71	74.88	21.06	93.74	21.61	30.09	67.73
BRD-K00656370	CP	6-aminochrysene	inhibitor of transferase activity			3.67, 1.63	44.07	0.65, 0.15	42.27	62.59	50.58	35.42	79.96	31.39	29.05	79.80	44.07	37.90	68.52	67.09	4.38	5.27	78.15	21.53	45.84	27.20	51.85	61.52	53.49	11.20	20.24	0.85	54.31	98.75	38.20	75.62	15.85
BRD-A08003242	CP	rhodomyrtoxin-b	cytotoxic, DNA intercalator			9.39, 6.53	44.05	1.80, 0.58	56.19	93.85	93.47	98.37	27.28	79.24	-0.95	10.29	6.38	44.05	3.63	60.23	99.89	99.65	63.43	100.00	30.91	97.22	9.33	30.49	12.89	12.93	3.88	-0.85	52.50	48.38	13.75	-29.47	89.72
BRD-K06080977	CP	eicosatetraynoic-acid	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX12, PPARA, PPARG, PTGS1		3.46, 1.15	44.03	0.90, 0.25	61.21	6.73	72.00	-0.78	73.48	-0.04	23.15	63.44	-5.75	28.74	56.44	29.11	-54.85	1.41	47.73	-4.52	86.28	51.22	85.77	30.44	66.35	51.97	24.32	19.24	83.05	51.74	44.03	35.95	72.24
BRD-K67680372	CP	CI-966	GABA uptake inhibitor, GAT inhibitor	SLC6A1		4.62, 3.08	43.87	0.90, 0.19	13.75	-8.25	41.51	18.81	71.13	23.57	23.33	59.31	71.84	14.62	90.91	89.25	0.00	-1.34	80.56	18.39	15.76	71.37	83.54	89.53	58.41	43.87	18.50	52.02	26.65	93.92	13.94	50.93	74.93
BRD-A58048407	CP	nimodipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, NR3C2, AHR, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR		7.69, 3.85	43.86	0.64, 0.13	99.98	41.73	61.21	37.47	80.29	52.89	26.52	45.32	29.88	30.22	63.43	66.19	-0.78	18.27	87.74	32.94	91.56	19.06	68.39	94.20	41.03	54.83	18.97	-0.04	8.18	43.86	59.33	59.95	35.02
BRD-A39255369	CP	DCPIB	chloride channel blocker, gap junction modulator, glutamate transporter inhibitor, membrane permeability inhibitor	SLC1A2		5.00, 1.54	43.85	0.65, 0.24	31.99	43.85	46.60	7.73	83.99	13.32	21.09	37.93	69.67	12.68	63.73	57.65	4.65	23.48	79.59	33.41	96.39	42.19	13.92	58.70	90.93	81.76	77.08	70.74	7.58	26.07	12.83	56.26	78.19
BRD-K56558538	CP	ambroxol	glucosylceramidase inhibitor, mucolytic agent, sodium channel blocker	GBA		7.69, 3.46	43.85	0.84, 0.24	43.85	-37.15	95.46	9.93	67.75	12.01	21.07	96.92	78.45	5.47	-3.03	5.54	-6.54	6.80	98.28	-1.66	97.36	30.90	41.63	88.08	31.55	82.35	81.50	65.81	13.84	63.75	48.59	98.64	97.37
BRD-K71430621	CP	clobenpropit	histamine receptor antagonist, histamine receptor inverse agonist	HRH3, HRH4, HRH1, HRH2		5.38, 2.31	43.84	0.63, 0.18	43.84	51.76	89.01	60.28	16.18	52.83	90.97	43.14	52.20	32.43	8.21	17.82	2.82	2.08	55.38	21.60	68.41	42.18	37.98	62.46	87.44	31.80	24.02	6.29	96.37	24.04	46.63	63.21	57.49
BRD-A13084692	CP	troglitazone	PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant	PPARG, ACSL4, AKR1B1, CCL2, CYP3A4, ESRRA, ESRRG, INS, SERPINE1, SLC29A1, TRPM3	PPAR receptor agonist	1.54, 1.15	43.81	0.83, 0.27	63.37	39.14	11.81	53.19	25.76	37.66	55.40	51.89	8.88	5.18	13.83	47.26	5.17	48.02	69.91	6.33	61.30	34.78	18.53	83.12	60.47	48.40	3.56	43.81	68.89	32.27	44.59	74.85	3.07
BRD-K05528470	CP	L-745870	dopamine receptor antagonist	DRD4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR6, HTR7		5.77, 3.08	43.76	0.74, 0.18	18.17	70.98	61.07	17.94	88.34	8.33	82.74	51.07	56.58	72.50	98.31	32.99	4.58	6.84	93.72	5.41	34.64	36.98	43.76	93.94	78.95	47.03	27.36	-99.93	41.67	-7.71	52.55	61.98	27.61
BRD-K77008974	CP	WYE-354	mTOR inhibitor	MTOR	MTOR inhibitor	2.31, 0.77	43.76	1.44, 0.57	9.26	43.76	9.88	92.22	3.35	26.65	17.79	48.54	5.46	41.30	24.79	48.25	80.47	45.41	50.19	98.11	75.79	65.26	8.63	89.89	31.00	34.08	48.81	0.81	27.44	29.98	45.18	65.95	59.61
BRD-A43849199	CP	karakoline	phytotoxin			5.31, 2.86	43.75	1.60, 0.55	8.95	43.75	72.55	59.66	95.18	98.16	49.45	-45.25	18.05	17.74	17.59	69.38	-3.97	5.98	52.88	2.18	28.73	67.07	93.36	45.16	97.08	78.98	6.87	-99.15	-20.81	35.09	68.94	21.88	81.16
BRD-A15530910	CP	carpindolol	adrenergic receptor antagonist, serotonin receptor antagonist		Serotonin receptor antagonist	4.62, 1.92	43.74	1.11, 0.32	12.36	14.45	25.91	72.99	30.49	63.74	83.15	61.07	68.40	72.99	7.30	29.32	30.91	89.05	61.87	0.00	32.13	94.19	39.65	24.32	43.74	48.36	39.72	-41.20	95.81	65.34	27.65	84.37	96.59
BRD-K12219985	CP	glipizide	sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue	ABCC8, KCNJ10, KCNJ11, PPARG	KCNJ11 modulator	1.54, 0.38	43.72	0.94, 0.19	56.76	28.43	67.39	38.32	93.36	71.96	10.82	-58.13	9.50	27.73	46.68	55.56	1.62	23.49	95.69	43.72	11.59	13.31	34.73	78.90	78.46	85.60	27.70	60.13	-14.43	48.85	40.85	69.80	60.87
BRD-K70976396	CP	cefoxitin	cell wall synthesis inhibitor			8.98, 3.27	43.72	1.06, 0.36	27.32	87.23	22.15	-0.26	4.36	78.49	79.11	63.98	26.86	16.90	52.07	54.46	3.35	24.55	99.72	6.81	96.76	6.19	94.12	9.04	43.72	78.61	54.09	84.86	60.71	95.45	34.30	37.67	32.42
BRD-K73395020	CP	SA-1478088	metalloproteinase inhibitor	MMP12, MMP14, MMP2, MMP8, MMP9		7.31, 4.62	43.70	2.35, 0.81	11.46	84.90	51.62	95.56	15.78	12.58	24.41	32.96	24.42	29.62	13.00	79.50	99.37	99.79	43.70	99.72	57.67	94.37	48.72	54.78	28.26	40.80	11.79	-1.90	53.35	65.16	30.59	36.21	85.01
BRD-K24859147	CP	KIN001-242	protein kinase inhiibor	RPS6KA3		5.38, 1.92	43.67	0.97, 0.26	1.50	74.35	85.32	5.92	58.99	8.32	43.67	47.03	34.84	81.24	44.80	89.78	0.00	5.28	87.33	3.33	96.41	30.48	7.20	25.74	46.15	27.62	45.16	-98.77	6.96	57.06	67.42	64.34	38.35
BRD-K11927976	CP	ER-27319	mediator release inhibitor, syk inhibitor	SYK		8.08, 5.77	43.66	3.42, 1.16	9.25	99.19	41.03	2.08	98.58	36.37	94.54	-66.16	42.38	90.96	67.61	89.29	0.00	58.12	97.92	98.56	7.96	64.04	27.43	43.66	90.90	80.00	5.36	-44.44	-1.23	4.06	74.51	31.70	58.34
BRD-A71459254	CP	cymarin	ATPase inhibitor	ATP1A1	ATPase inhibitor	5.00, 1.54	43.65	1.97, 0.57	18.24	90.63	43.65	92.59	70.86	62.50	38.83	38.29	37.47	3.04	7.81	29.21	93.09	79.32	90.24	99.08	50.30	23.99	41.98	94.99	63.31	58.48	9.25	0.00	11.07	20.38	24.98	47.20	45.58
BRD-K85925969	CP	zalcitabine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor		Nucleoside reverse transcriptase inhibitor	7.11, 4.44	43.63	0.81, 0.27	82.75	16.31	11.88	9.19	23.24	18.30	43.63	35.08	5.92	59.42	65.53	86.16	-35.75	13.67	99.51	1.44	97.20	6.48	83.94	40.73	70.59	56.51	77.02	-0.04	-12.48	89.99	94.07	75.68	54.62
BRD-K94830329	CP	ataluren	CFTR channel agonist, coagulation stimulant, dystrophin stimulant	CFTR, DMD, F8, F9		2.45, 1.22	43.62	1.92, 0.58	12.65	68.50	8.34	6.75	22.38	71.97	54.33	54.61	5.50	35.20	21.18	82.27	1.97	27.52	74.73	12.54	73.85	2.08	87.18	56.64	68.42	39.56	64.90	99.30	64.50	84.40	43.62	6.29	2.61
BRD-K67868012	CP	PI-103	PI3K inhibitor, mTOR inhibitor	PIK3CA, PIK3CG, MTOR, PIK3CB, PIK3CD, PRKDC	MTOR inhibitor, PI3K inhibitor	3.46, 0.77	43.57	1.93, 0.66	8.06	71.09	77.90	89.15	64.97	12.87	25.28	-11.90	15.60	17.96	19.84	45.35	81.29	67.95	98.01	90.44	74.40	58.72	-14.38	43.57	72.91	65.58	19.88	-8.55	16.46	9.34	25.60	46.93	12.98
BRD-K84639753	CP	safinamide	dopamine reuptake inhibitor, glutamate release inhibitor, monoamine oxidase inhibitor, calcium channel antagonist, calcium channel modulator, Sodium Channel  Blockers, sodium channel blocker	MAOB, SLC6A3		3.08, 0.77	43.56	1.69, 0.50	34.22	-13.17	2.18	-1.65	5.17	64.77	44.72	66.69	24.67	70.31	43.56	48.34	-17.57	0.70	68.67	0.60	32.74	20.38	78.86	80.37	7.65	48.15	-6.18	99.01	80.64	13.01	84.64	64.22	46.20
BRD-K78373679	CP	RO-3306	CDK inhibitor	CDK1	CDK inhibitor	4.49, 1.63	43.54	1.35, 0.31	38.57	91.19	86.14	93.35	17.79	83.44	17.19	18.50	5.60	91.15	14.80	80.32	80.37	72.11	48.53	92.81	23.27	45.96	23.81	2.47	68.28	46.88	52.53	0.00	2.01	37.26	18.20	43.54	18.16
BRD-K95785537	CP	PP-2	src inhibitor	SRC, LCK, ABL1, LYN, RIPK2	SRC inhibitor	3.46, 2.69	43.54	1.60, 0.53	11.51	40.62	72.30	99.15	56.08	67.23	51.60	51.49	33.80	78.75	21.16	70.40	5.68	0.98	84.04	98.29	61.93	83.85	-8.89	29.72	54.98	18.25	10.55	-11.62	43.54	14.91	34.67	73.92	26.31
BRD-K01493881	CP	apigenin	casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor	AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1A2, CYP1B1, HSD17B1, MAOA, ODC1, XDH		2.31, 1.92	43.53	0.91, 0.41	76.48	95.70	38.14	15.08	60.63	35.57	58.70	45.01	4.81	81.32	43.53	65.49	3.28	9.43	52.04	37.32	-4.55	3.37	19.00	79.21	47.08	54.87	64.71	-81.55	11.60	22.42	14.85	50.78	50.51
BRD-A27489425	CP	rolitetracycline	antibiotic			5.38, 3.46	43.51	1.91, 0.49	8.71	94.05	95.65	33.73	92.92	55.63	49.84	14.71	27.33	17.30	45.16	81.69	2.92	18.29	90.62	91.86	73.75	26.62	63.77	15.85	99.58	47.79	43.99	-99.65	-1.23	8.85	20.95	41.75	43.51
BRD-K49456190	CP	prima-1-met	thioredoxin inhibitor, TP53 activator	TP53		2.31, 1.92	43.50	1.36, 0.39	87.40	8.12	43.50	-8.13	49.22	87.87	52.07	35.61	20.53	39.28	67.56	82.24	-75.90	10.99	24.11	-69.61	-8.61	5.84	54.37	69.36	82.51	51.70	9.33	14.28	45.48	89.75	72.17	51.76	31.80
BRD-K03600606	CP	catechin	beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker	BACE1, CA1, CA12, CA14, CA2, CA4, CA6, CA9, FASN, PTGS1, SCN5A		2.69, 1.54	43.46	1.31, 0.36	97.49	22.72	29.80	43.46	58.68	60.20	86.08	19.68	10.81	66.47	70.32	58.00	1.73	9.00	71.49	1.97	40.09	71.18	82.67	42.70	54.74	46.64	15.71	-1.86	0.00	90.36	19.34	37.50	51.23
BRD-A35511923	CP	L-803087	somatostatin receptor agonist	SSTR4		5.77, 3.46	43.44	1.28, 0.50	18.12	43.44	79.33	24.30	92.77	18.34	13.93	48.61	35.58	69.76	8.69	93.16	4.62	2.71	96.44	6.02	90.62	16.69	13.15	99.47	32.21	96.53	28.06	94.87	52.64	-16.45	48.93	93.96	71.67
BRD-K68095457	CP	palmitoylethanolamide	cannabinoid receptor agonist, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, unidentified pharmacological activity	CNR2, GPR119, GPR55	Cannabinoid receptor agonist	5.00, 3.85	43.44	0.83, 0.24	54.77	-10.27	17.60	2.64	2.78	7.96	59.53	24.47	75.97	43.44	44.45	36.51	-3.88	4.13	54.80	-2.04	45.10	10.68	58.27	71.85	51.70	89.19	42.38	99.19	90.19	22.14	57.14	54.13	28.05
BRD-K57080016	CP	selumetinib	MEK inhibitor, MAP kinase inhibitor	MAP2K1, MAP2K2	MEK inhibitor	5.00, 2.69	43.41	0.89, 0.32	39.88	92.98	9.95	84.15	33.30	15.86	53.90	38.41	51.21	57.19	7.43	29.73	27.91	98.56	44.38	-50.21	51.87	52.26	57.70	43.41	72.61	7.35	15.90	-53.87	62.54	56.20	5.56	47.52	39.35
BRD-K19462402	CP	buflomedil	adrenergic receptor antagonist, calcium channel antagonist	CACNA1C		9.33, 5.78	43.40	1.24, 0.35	42.90	88.86	25.77	15.19	79.60	49.81	0.85	36.87	43.04	99.67	79.77	97.00	0.82	26.50	97.89	77.01	99.61	41.56	43.40	81.03	15.55	12.30	73.74	4.57	23.12	42.10	73.76	47.80	58.11
BRD-K66093087	CP	FGIN-1-43	benzodiazepine receptor ligand	TSPO		4.49, 2.86	43.39	1.50, 0.53	38.37	-21.56	43.39	11.58	19.72	98.41	49.43	73.71	25.00	55.52	69.57	44.70	3.20	-5.49	83.85	-8.69	89.57	17.43	67.99	91.14	37.12	28.45	34.77	99.72	79.92	59.94	24.96	20.10	48.70
BRD-K17896185	CP	FIT	opioid receptor agonist	OPRD1		9.62, 3.46	43.33	1.44, 0.51	12.73	27.09	3.27	90.79	76.56	23.35	79.93	43.33	5.66	9.42	61.48	89.35	84.67	99.10	-22.87	99.61	-76.09	96.62	37.14	35.49	29.28	35.00	9.71	45.84	99.89	55.19	47.39	32.48	47.37
BRD-K80778372	CP	RO-19-4605	GABA benzodiazepine site receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5		3.85, 1.92	43.32	0.72, 0.19	19.89	25.83	69.67	47.89	19.36	54.37	60.46	47.14	35.64	69.78	62.54	35.29	-2.96	17.44	97.99	2.57	62.17	27.15	38.56	96.58	43.32	52.09	13.23	-1.27	60.60	96.81	37.49	55.94	18.17
BRD-K28346421	CP	rifapentine	DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor	CYP2C8, CYP3A4		5.00, 2.31	43.30	1.13, 0.32	54.63	39.43	18.26	49.71	47.74	25.39	0.67	55.84	25.11	97.04	84.98	74.52	42.80	43.30	24.55	63.28	27.90	87.16	40.19	74.36	48.93	95.15	39.08	-6.23	65.51	42.77	66.78	21.25	28.47
BRD-K34437622	CP	BRD-K34437622	thymidylate synthase inhibitor	TYMS		6.67, 4.00	43.28	1.73, 0.50	16.16	52.64	37.14	29.03	69.56	4.40	35.73	-24.52	13.15	24.15	69.86	87.18	21.59	22.46	98.91	34.38	88.77	2.85	50.59	43.28	47.70	79.77	95.59	15.94	-7.67	68.19	97.85	78.23	85.44
BRD-A35623999	CP	CGP-37157	L-type calcium channel blocker, mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor	SLC8A1		3.85, 1.92	43.27	0.78, 0.25	2.33	41.13	13.95	43.27	44.29	-66.75	5.29	-30.35	69.44	18.31	85.93	66.81	1.76	-25.41	98.83	15.27	66.52	15.92	92.79	84.11	7.89	56.03	33.67	99.51	80.64	83.36	5.71	46.68	96.02
BRD-A35588707	CP	teniposide	topoisomerase inhibitor, DNA inhibitor, DNA repair enzyme inhibitor, mitotic inhibitor	TOP2A, CYP3A5	Topoisomerase inhibitor	1.92, 1.15	43.22	2.61, 0.64	14.46	97.11	59.38	65.74	75.15	19.54	20.70	-12.76	36.10	61.96	82.71	73.24	83.72	85.87	32.38	99.54	57.51	10.70	28.96	56.32	38.85	43.22	33.44	6.22	-3.18	44.31	49.72	20.81	26.34
BRD-A47829399	CP	artesunate	DNA synthesis inhibitor			4.62, 1.54	43.22	1.72, 0.51	12.28	18.78	14.34	63.15	44.61	89.40	11.61	52.14	22.26	37.38	16.31	66.95	96.16	27.80	87.04	83.93	62.68	17.98	71.73	35.69	35.41	33.78	61.84	94.90	35.83	57.37	81.37	37.25	43.22
BRD-K78294846	CP	osthol	ACAT inhibitor, GABA receptor modulator			4.62, 2.69	43.17	0.73, 0.13	96.14	15.75	18.08	36.11	-0.95	27.24	50.53	77.22	78.98	92.55	21.85	53.67	16.51	3.79	59.02	2.75	40.21	17.44	88.30	43.17	12.12	72.32	74.93	99.37	51.03	25.00	79.55	97.29	-28.62
BRD-K30020243	CP	aliskiren	renin inhibitor, peptidase inhibitor, protease inhibitor	REN		4.62, 1.54	43.15	0.56, 0.11	45.28	21.15	60.91	13.74	74.70	29.87	63.89	-22.55	19.15	44.25	12.02	94.24	3.28	11.76	93.84	5.08	79.70	40.20	15.44	89.57	95.22	77.50	43.65	8.19	43.09	61.84	43.15	96.55	27.28
BRD-K28761384	CP	zuclopenthixol	dopamine receptor antagonist	DRD2, DRD1, ADRA1A, ADRA2A, DRD5, HRH1, HTR2A		6.15, 3.46	43.14	0.95, 0.25	14.42	6.77	83.57	64.08	15.72	19.98	-37.25	43.14	5.81	4.12	21.36	55.47	13.35	63.27	97.54	27.66	76.68	91.23	15.94	89.25	43.12	77.81	64.43	99.19	97.65	7.47	73.53	26.38	49.79
BRD-K21672174	CP	RO-28-1675	glucokinase activator	GCK		5.00, 2.31	43.11	0.66, 0.01	40.63	55.34	23.68	93.47	36.95	33.03	20.23	40.46	8.65	33.61	54.95	66.07	99.37	94.04	96.62	99.79	90.14	27.37	59.79	47.56	43.11	19.72	19.45	84.19	49.92	40.79	61.93	11.37	23.36
BRD-A22769835	CP	homochlorcyclizine	antihistamine	HRH1		4.90, 1.63	43.08	0.95, 0.22	89.14	5.88	7.08	34.56	43.03	43.08	37.74	72.92	25.40	96.86	8.17	60.84	8.18	43.99	96.92	56.78	96.79	52.55	12.37	36.16	43.98	-25.56	12.12	22.82	61.47	86.21	68.09	15.30	82.87
BRD-A75402480	CP	desoxycorticosterone	mineralocorticoid receptor agonist			4.23, 1.92	43.07	1.09, 0.35	6.09	2.96	85.93	22.70	38.19	46.84	17.30	18.31	3.80	45.13	3.91	75.26	5.78	68.94	57.20	89.56	74.68	36.57	23.77	98.48	70.27	32.20	65.53	96.22	69.06	43.07	41.01	61.78	39.31
BRD-K44876623	CP	zolpidem	benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist, non-benzodiazepine hypnotic	GABRA1, GABRA2, GABRA3	Benzodiazepine receptor agonist	3.67, 1.22	43.06	0.75, 0.16	70.50	24.06	2.26	7.56	8.14	55.59	32.47	57.85	7.71	12.16	63.35	92.00	0.22	0.92	93.37	20.43	73.91	10.57	73.61	56.60	43.06	33.93	61.79	76.81	-5.07	95.67	66.12	66.16	-0.81
BRD-K83972459	CP	JWE-035	Aurora kinase inhibitor	AURKA	Aurora kinase inhibitor	4.62, 1.15	43.06	1.50, 0.56	10.94	96.98	71.78	83.40	71.39	59.55	14.34	38.79	18.43	17.11	41.80	89.97	81.25	92.59	88.22	91.86	88.74	93.33	-0.39	56.57	24.23	18.53	36.32	-82.77	24.10	43.06	31.23	46.64	43.04
BRD-K78633253	CP	EXO-1	ARF inhibitor			6.54, 3.46	43.05	0.30, 0.06	43.44	18.09	80.07	22.83	89.62	26.95	17.02	33.37	37.50	82.65	43.57	29.11	4.99	28.50	94.75	49.81	93.91	31.00	43.05	72.14	-71.54	93.94	20.35	9.88	5.74	83.46	68.49	94.84	71.08
BRD-K59369769	CP	tozasertib	Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor	AURKA, AURKB, ABL1, AURKC, BCR, FLT3, JAK2, DDR2, LCK	Aurora kinase inhibitor	5.77, 3.08	43.04	0.77, 0.23	5.47	75.41	19.57	86.26	47.49	12.79	10.43	25.98	6.34	46.06	25.04	56.91	27.38	88.23	73.51	99.86	65.20	80.95	34.72	43.07	60.42	43.04	41.05	-27.24	58.53	-13.45	35.96	55.56	35.08
BRD-K97158071	CP	droperidol	dopamine receptor antagonist, dopamine receptor	DRD2, ADRA1A	Dopamine receptor antagonist	4.62, 1.15	43.02	0.52, 0.11	13.86	76.09	69.95	2.08	86.28	27.23	8.53	80.36	35.37	30.82	33.38	74.38	6.92	1.52	96.31	22.76	96.41	16.33	43.02	57.89	82.22	37.77	55.98	3.63	25.98	55.90	70.56	81.13	85.80
BRD-K18619710	CP	digoxigenin	ATPase inhibitor	ATP1A1		3.85, 1.15	43.00	1.19, 0.38	14.53	84.54	86.11	31.09	95.78	10.99	59.37	45.88	10.64	7.31	-2.26	50.80	83.48	56.78	77.53	9.93	24.74	20.81	43.00	43.28	65.41	54.46	43.58	-95.21	21.50	7.88	1.83	88.85	28.32
BRD-K96263742	CP	GW-7647	PPAR receptor agonist	PPARA	PPAR receptor agonist	4.23, 1.15	42.98	0.85, 0.20	5.92	37.54	83.51	5.94	96.03	25.34	-21.93	44.24	76.04	12.82	40.15	44.90	0.00	10.85	87.79	12.58	97.18	42.98	31.91	50.88	73.50	97.15	69.39	81.12	-16.93	16.53	51.35	23.99	51.93
BRD-A50928468	CP	norgestrel	progesterone receptor agonist	CYP2E1, PGR	Progesterone receptor agonist	4.62, 2.31	42.95	1.06, 0.30	7.35	95.77	90.40	27.24	92.71	4.37	16.27	-62.73	42.95	19.44	32.46	40.71	3.91	55.91	38.82	10.79	18.76	83.29	67.40	59.83	80.18	92.82	81.86	-2.98	47.68	22.29	67.42	64.00	69.20
BRD-K41895714	CP	AS-605240	Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	MAOB, PIK3CA, PIK3CB, PIK3CD, PIK3CG	PI3K inhibitor	3.46, 1.54	42.94	1.70, 0.61	11.63	57.72	3.37	62.44	7.85	42.94	94.94	66.19	38.56	24.41	24.77	70.26	26.97	95.89	40.24	-98.73	63.86	59.41	96.78	20.17	24.22	9.54	44.57	-99.15	59.71	56.96	25.87	57.91	48.48
BRD-K94353609	CP	fluocinolone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1, SERPINA6	Glucocorticoid receptor agonist	5.71, 2.86	42.94	1.72, 0.78	58.18	68.76	12.83	52.81	52.91	53.01	19.54	99.27	77.24	22.97	4.85	43.96	3.98	42.60	79.48	0.00	80.86	2.10	42.94	84.87	-21.37	30.56	30.83	6.84	30.96	70.45	25.67	52.78	66.36
BRD-K08556791	CP	ethoprop	acetylcholinesterase inhibitor	ACHE		4.08, 2.45	42.91	1.47, 0.39	65.30	47.73	83.48	43.58	29.19	42.91	18.55	49.81	9.46	86.54	89.81	46.24	2.11	6.77	22.89	1.62	73.43	59.51	-15.73	63.08	35.75	42.11	21.21	-93.06	21.93	31.97	44.89	65.97	61.68
BRD-K50836978	CP	purvalanol-a	CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor	CDK1, CDK2, CDK4, CDK5, CCND1, CCNE1, CSNK1G3, RPS6KA1, SRC	CDK inhibitor	5.71, 3.27	42.91	2.88, 0.41	9.44	97.99	58.47	88.50	45.88	11.07	27.52	-31.89	35.72	21.66	76.27	42.91	82.56	75.64	85.63	99.72	30.45	77.40	79.02	48.58	92.83	68.66	25.40	-98.80	15.22	8.92	33.32	29.32	16.02
BRD-K94512704	CP	spiramide	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR1A, HTR2A, HTR2B, HTR2C	Serotonin receptor antagonist	6.92, 3.08	42.89	0.69, 0.23	36.48	26.53	66.35	17.03	42.89	37.89	28.79	33.16	51.57	25.55	18.28	48.28	58.67	61.47	34.68	31.07	71.64	77.39	18.11	78.39	98.24	55.19	32.03	-38.58	92.20	16.23	57.62	65.24	51.10
BRD-A65145453	CP	ATPA	glutamate receptor agonist	GRIK1, GRIA2		3.27, 1.63	42.88	1.16, 0.27	87.66	42.19	89.98	4.05	17.34	96.86	24.45	55.68	47.83	94.21	7.82	39.13	1.16	42.88	94.65	0.92	40.27	49.38	84.85	90.42	42.94	38.92	18.45	74.36	41.96	72.34	47.99	37.68	40.20
BRD-A98283014	CP	calmidazolium	calcium channel blocker, calmodulin antagonist	ATP2B1, PDE1A		8.33, 3.92	42.88	2.63, 0.69	38.04	59.92	29.45	96.48	96.65	8.82	-11.91	-43.62	4.29	38.87	81.19	96.28	97.57	92.21	29.13	99.96	28.88	96.72	6.75	57.96	76.17	23.97	66.45	-6.58	52.59	42.88	50.12	33.88	18.23
BRD-K31471398	CP	dihydrexidine	dopamine receptor agonist	DRD1, DRD2, DRD3, DRD4, DRD5		7.69, 3.85	42.88	1.32, 0.43	9.59	46.74	95.02	34.60	95.74	56.51	40.32	42.88	36.73	38.38	59.51	75.70	6.89	65.30	91.14	19.70	97.31	8.60	-8.63	33.72	99.65	77.41	27.11	-4.97	-16.47	4.23	95.39	87.81	45.07
BRD-A16444946	CP	acarbose	glucosidase inhibitor	GAA, MGAM, AMY2A, SI		4.17, 2.50	42.84	0.84, 0.13	45.76	27.67	11.33	28.27	27.83	9.02	37.31	-44.26	4.76	56.77	50.48	41.79	1.48	4.33	50.05	42.84	94.19	66.07	85.27	47.63	31.75	63.36	30.31	66.73	70.65	71.97	81.51	88.48	23.77
BRD-K90574421	CP	ipsapirone	serotonin receptor agonist	HTR1A		2.45, 1.22	42.83	1.03, 0.32	42.83	25.41	26.07	26.67	35.70	96.20	16.11	37.38	54.73	80.28	28.71	77.90	1.09	14.33	57.29	22.85	79.11	49.43	95.94	60.31	84.65	69.25	15.92	-0.04	-18.95	53.41	6.70	58.45	94.35
BRD-A67373739	CP	AICA-ribonucleotide	adenosine release stimulant, AMPK stimulant	ATIC, PRKAA1		1.54, 0.77	42.81	2.41, 0.59	42.81	11.16	22.47	-4.23	66.58	87.64	73.48	83.43	17.06	13.66	84.87	17.78	-87.90	5.29	12.52	-91.32	-53.13	2.36	84.48	87.23	79.33	58.64	27.73	0.00	77.07	86.27	81.06	74.74	58.64
BRD-K93080877	CP	Ala-Ala-Phe-CMK	tripeptidyl peptidase inhibitor	TPP2		4.08, 2.45	42.81	1.13, 0.43	12.73	76.43	48.50	15.88	6.13	92.38	36.58	37.20	77.27	52.80	7.34	66.99	55.86	42.81	-84.92	41.99	22.12	50.65	90.79	6.62	96.95	16.58	43.85	-5.90	58.17	84.93	15.64	7.96	55.84
BRD-A20239487	CP	atenolol	adrenergic receptor antagonist	ADRB1, ADRB2		4.49, 2.45	42.80	1.47, 0.41	19.05	23.05	27.00	43.35	42.80	85.61	95.62	84.64	11.12	33.08	53.08	62.42	3.31	1.55	60.77	4.72	11.59	2.78	48.84	47.36	83.66	81.79	40.66	40.72	20.83	99.58	66.56	90.18	22.69
BRD-K09907482	CP	PRL-3-inhibitor-I	PRL phosphatase inhibitor, tyrosine phosphatase inhibitor	PTP4A3		7.31, 1.54	42.80	0.49, 0.07	67.90	-2.76	17.82	13.89	11.61	59.25	28.15	93.21	23.99	6.35	4.02	80.30	-10.59	-20.07	95.88	-6.47	43.94	11.57	67.25	97.60	22.35	95.93	14.13	97.11	51.48	70.05	75.13	95.63	42.80
BRD-A32349859	CP	methyl-angolensate	apoptosis inhibitor	HTR2B		6.87, 2.29	42.80	1.50, 0.33	45.49	65.75	99.23	37.43	98.68	77.17	17.18	-63.84	20.34	71.50	59.06	78.94	4.23	42.51	94.93	4.74	96.79	30.43	3.48	74.62	15.84	96.90	78.52	NaN	43.08	-54.98	38.01	-58.85	23.15
BRD-A95096829	CP	PNU-96415E	dopamine receptor antagonist			3.46, 1.15	42.79	0.91, 0.20	36.64	33.01	35.71	47.38	75.52	17.66	92.85	-74.01	9.48	25.52	61.71	48.17	3.33	22.86	95.05	90.51	95.92	35.24	42.79	71.30	6.24	81.55	45.71	81.73	13.62	29.81	48.69	83.82	28.63
BRD-K52930707	CP	rescinnamine	angiotensin converting enzyme inhibitor	ACE		4.23, 2.69	42.75	1.10, 0.27	64.19	10.72	28.76	77.76	26.23	20.40	42.60	42.83	9.80	11.92	47.20	75.25	10.70	77.84	56.65	41.12	42.75	82.74	81.70	69.51	25.59	7.05	19.47	35.61	99.40	96.26	37.59	89.61	50.03
BRD-K68202742	CP	trichostatin-a	HDAC inhibitor, CDK expression enhancer, ID1 expression inhibitor	HDAC7, HDAC8, HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9	HDAC inhibitor	4.62, 0.77	42.75	1.69, 0.59	20.44	98.17	63.88	75.42	42.75	29.39	45.98	-36.17	18.56	27.32	35.08	96.44	82.72	89.03	71.02	99.32	27.97	82.32	8.58	39.77	64.57	9.33	79.89	-0.07	9.39	33.26	95.14	28.53	68.49
BRD-K94379058	CP	BML-190	cannabinoid receptor inverse agonist	CNR2		6.54, 4.23	42.75	0.73, 0.10	65.80	-15.75	70.45	33.76	80.84	0.02	-7.64	61.50	6.45	8.16	18.76	47.73	2.40	66.00	53.97	29.02	43.53	10.53	49.83	88.02	25.63	57.43	70.48	21.58	66.10	6.62	42.75	97.84	26.68
BRD-K22031190	CP	diflunisal	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		3.08, 0.77	42.72	1.05, 0.19	79.44	92.42	44.26	40.81	94.23	87.74	50.76	68.64	22.18	70.16	81.84	42.72	2.15	30.36	-45.73	22.91	10.75	8.70	26.91	70.17	90.31	48.71	34.62	-36.35	74.96	33.71	29.84	87.61	39.01
BRD-A15079084	CP	phorbol-12-myristate-13-acetate	PKC activator, CD antagonist	CD4, KCNT2, PRKCA, TRPV4	PKC activator	6.92, 3.85	42.71	2.48, 0.49	23.84	64.78	76.43	97.50	46.30	34.91	-19.79	37.99	13.44	67.91	3.59	71.16	98.04	82.79	76.90	99.93	90.58	93.73	18.64	67.18	22.57	34.33	26.93	26.05	6.02	35.47	28.32	42.71	45.97
BRD-K47192521	CP	icosapent	fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties	PTGS1, PTGS2, ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, SLC8A1, TRPV1		5.71, 2.86	42.71	1.13, 0.30	42.71	39.35	54.00	19.08	72.73	89.72	38.50	29.17	41.21	7.84	30.22	66.82	-2.26	3.50	89.29	2.54	62.24	7.26	45.60	80.16	69.73	81.49	45.14	53.15	24.31	79.53	67.91	9.34	31.97
BRD-K84709232	CP	caffeic-acid	lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor	ALOX5, MIF, RELA, TNF		2.31, 0.77	42.71	1.24, 0.43	42.71	38.36	37.89	66.59	49.40	-0.03	-15.69	-52.73	40.32	7.05	38.08	79.62	85.60	85.73	42.93	79.95	85.81	75.10	9.54	89.52	6.59	46.79	40.73	-46.81	41.65	86.82	43.99	24.72	76.70
BRD-A09094913	CP	strychnine	acetylcholine receptor antagonist	GLRA1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA2, GLRA3, GLRB		5.38, 3.08	42.68	0.85, 0.19	96.99	-30.05	7.39	18.45	47.46	6.76	16.12	62.42	28.66	66.15	38.49	66.99	1.41	5.92	98.52	-1.66	-90.74	11.22	96.66	95.83	42.68	75.52	19.92	89.17	72.59	98.46	92.35	86.89	28.45
BRD-A17428743	CP	BW-723C86	serotonin receptor agonist	HTR2B, HTR2A, HTR2C		7.69, 4.23	42.65	0.78, 0.22	74.44	-82.36	95.36	83.75	19.29	37.88	34.57	95.63	80.42	9.78	59.20	38.35	3.63	29.43	42.65	-12.44	97.72	87.57	58.84	95.80	-16.47	39.04	4.13	-9.28	97.60	52.43	30.36	91.24	98.91
BRD-A49046702	CP	SKF-89976A	GABA uptake inhibitor	SLC6A1		4.62, 1.92	42.64	0.89, 0.27	30.63	74.09	95.21	73.47	42.64	27.44	62.06	59.12	63.08	24.78	-13.05	95.17	0.00	26.07	94.07	10.88	93.32	31.42	14.97	90.18	97.89	34.32	20.23	3.60	5.50	94.94	22.45	76.05	94.93
BRD-K78599730	CP	manumycin-a	farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor	FNTA, IKBKB	NFkB pathway inhibitor	3.85, 1.92	42.58	2.32, 0.57	91.81	97.53	69.53	48.38	46.43	26.09	4.72	7.33	8.86	13.98	11.26	71.54	96.79	96.19	86.90	99.75	39.14	47.14	53.46	62.73	51.61	19.77	42.58	16.95	-48.72	10.68	41.78	0.00	35.61
BRD-A75455249	CP	kavain	calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers	MTOR		2.31, 0.38	42.55	0.56, 0.16	27.20	25.03	22.08	42.73	56.08	24.20	57.99	32.40	25.22	63.39	61.54	55.05	3.19	42.55	64.06	3.70	95.75	11.41	16.73	61.03	85.26	87.94	17.52	91.26	12.14	74.26	13.45	85.59	21.99
BRD-A77722753	CP	hydralazine	smooth muscle relaxant	AOC3, P4HA1		5.38, 2.69	42.54	0.98, 0.30	15.25	3.19	79.41	42.54	19.78	8.85	10.50	58.14	23.97	50.57	63.02	66.37	0.00	10.42	92.52	5.63	41.65	29.52	50.60	98.58	17.87	20.03	23.60	48.46	82.75	74.14	47.80	98.13	70.57
BRD-A55416093	CP	colforsin	adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant	ADCY2, ADCY5, GNAS		6.92, 4.23	42.53	0.95, 0.47	11.43	54.36	80.34	93.23	46.86	12.68	82.95	43.86	99.93	20.56	39.39	55.98	7.43	-56.36	40.83	17.17	62.46	42.53	61.25	48.51	86.44	51.13	34.16	-10.18	22.89	17.08	12.62	40.10	78.90
BRD-A65550283	CP	ginsenoside	steroidal receptor agonist			4.62, 2.31	42.51	1.13, 0.31	33.04	85.86	37.02	35.13	59.85	81.92	87.14	-52.28	78.02	21.04	34.97	52.58	0.00	21.02	-34.32	7.07	30.43	10.73	53.09	42.51	82.81	95.36	31.50	60.15	50.52	71.07	37.98	67.66	50.77
BRD-K12867552	CP	THM-I-94	HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor	HDAC1, HDAC10, HDAC2, HDAC3, HDAC6, HDAC8	HDAC inhibitor	3.85, 1.15	42.51	1.81, 0.57	37.01	97.99	64.10	78.08	33.63	28.43	40.43	18.00	32.70	13.44	18.43	84.59	89.71	90.47	75.95	98.59	14.90	83.53	8.39	42.51	45.68	33.20	45.24	0.88	44.64	9.75	72.64	39.31	53.19
BRD-K14888893	CP	minoxidil	antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant	KCNJ8, ABCC9, KCNJ1, KCNJ10, KCNJ11, PTGS1, REN		6.15, 4.23	42.51	1.34, 0.35	29.42	61.94	37.26	2.89	77.54	84.90	84.07	76.26	-2.29	62.88	85.75	42.51	-83.17	53.55	-97.89	4.54	55.13	2.88	39.35	61.65	96.13	80.97	29.15	-26.77	39.02	78.17	23.23	85.00	3.95
BRD-K64746805	CP	MBCQ	phosphodiesterase inhibitor	PDE5A		2.86, 0.82	42.49	1.13, 0.39	71.01	17.87	29.21	57.00	21.62	55.69	28.09	44.13	7.53	84.43	30.00	42.86	82.19	11.84	76.08	98.68	32.15	8.60	91.88	72.12	24.15	65.74	5.69	-2.43	38.82	68.72	42.49	60.93	12.71
BRD-A54880345	CP	etomidate	membrane integrity inhibitor, membrane permeability inhibitor	GABRA1, ADRA2B, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		3.08, 1.15	42.48	0.56, 0.16	52.05	17.92	52.54	20.22	37.48	47.20	30.96	80.66	52.36	12.56	-13.18	42.48	2.09	4.34	84.20	11.20	96.76	29.67	32.26	83.58	43.21	21.76	29.54	61.00	37.93	75.05	75.37	93.32	51.03
BRD-K64610608	CP	EMF-bca1-57	caspase inhibitor	CASP3		2.69, 1.15	42.48	0.90, 0.17	78.09	-92.35	19.45	10.23	29.90	-17.73	20.44	55.66	12.19	29.47	14.42	32.31	2.71	18.59	85.37	-8.98	91.38	59.15	58.87	90.35	68.83	43.84	42.48	99.40	95.34	62.87	31.76	43.35	69.85
BRD-A91699651	CP	chloroquine	antimalarial agent	CYP2C8, GSTA2, MRGPRX1, TLR9, TNF		6.92, 2.31	42.47	0.83, 0.11	97.38	8.76	16.31	19.99	23.74	29.09	77.05	81.46	48.72	13.01	59.65	44.54	-8.90	10.51	52.47	-2.55	65.69	20.37	98.55	35.24	39.21	37.31	42.47	44.98	83.96	90.68	24.57	77.60	81.29
BRD-K82795137	CP	loratadine	histamine receptor antagonist	HRH1, CYP2C19, CYP3A5	HRH1 antagonist	3.56, 2.22	42.47	1.14, 0.22	88.92	73.23	38.91	48.16	11.32	25.84	82.75	42.92	34.15	3.06	42.47	76.78	63.70	67.90	87.25	51.78	12.33	69.37	93.16	12.16	3.28	11.68	58.80	-0.04	21.26	75.03	-12.37	0.88	38.62
BRD-A79672927	CP	tropicamide	acetylcholine receptor antagonist, anticholinergic	CHRM3, CHRM4, CHRM1, CHRM2		4.49, 0.82	42.44	1.06, 0.39	74.07	78.15	95.00	13.67	60.89	55.82	11.06	82.97	57.34	56.79	29.10	64.14	-1.44	1.69	93.06	4.50	87.48	19.08	17.38	64.74	15.70	42.44	23.04	-0.78	32.82	64.25	40.26	15.86	92.66
BRD-A49225603	CP	alimemazine	histamine receptor ligand	HRH1		8.57, 3.67	42.43	1.67, 0.66	88.49	15.80	5.67	86.33	6.27	62.87	7.10	48.04	20.26	8.07	27.03	80.43	87.39	96.41	58.28	96.67	57.62	98.63	67.72	45.79	7.67	3.35	27.62	40.27	99.93	42.43	15.04	34.21	11.63
BRD-K82562631	CP	tolmetin	cyclooxygenase inhibitor	PTGS2, PTGS1	Cyclooxygenase inhibitor	5.77, 3.85	42.41	0.64, 0.18	41.22	16.23	45.77	3.62	42.41	46.40	50.10	53.28	20.34	45.15	48.99	52.49	1.83	3.81	97.95	2.89	33.79	32.33	54.16	29.22	34.43	72.30	37.11	63.61	32.83	83.16	80.24	97.93	34.99
BRD-K81169441	CP	cerivastatin	HMGCR inhibitor	HMGCR, CYP2C8, CYP3A5	HMGCR inhibitor	9.33, 3.56	42.39	0.95, 0.18	33.60	5.61	2.30	88.59	16.31	12.79	21.17	16.90	40.16	93.34	96.87	95.03	83.24	96.16	98.27	98.83	88.61	91.25	29.04	65.25	-9.87	21.12	22.41	7.22	68.92	98.72	82.80	25.91	42.39
BRD-A70268693	CP	PG-9	presynaptic cholinergic modulator			6.54, 1.15	42.38	0.75, 0.31	18.11	62.88	75.35	24.34	50.81	4.90	86.76	-29.54	90.08	89.75	65.61	43.36	0.00	14.91	20.63	40.42	40.25	37.14	95.73	49.11	48.54	43.63	65.47	-3.63	26.76	97.47	42.38	35.04	22.26
BRD-K40919711	CP	BAPTA-AM	potassium channel blocker	KCNA3, KCNA5, KCNH2		3.46, 1.54	42.38	1.31, 0.26	7.05	70.15	42.47	89.70	59.19	5.50	-6.35	35.13	11.16	71.11	17.85	36.42	77.97	83.38	51.62	98.65	19.76	66.61	12.48	48.39	18.37	28.92	20.57	73.07	25.49	20.61	60.35	50.64	42.38
BRD-A50737080	CP	CGK-733	ATM kinase inhibitor, ATR kinase inhibitor	ATM, ATR		6.54, 4.62	42.37	2.44, 0.64	80.72	49.32	48.92	99.19	46.95	68.18	0.99	44.79	7.65	10.80	43.63	84.12	99.44	87.05	51.57	100.00	26.99	76.14	20.11	20.48	17.57	8.74	5.67	6.25	28.98	42.37	12.37	12.86	1.90
BRD-A10969569	CP	ambelline	plant alkaloid			4.90, 2.04	42.35	0.69, 0.16	54.50	19.02	91.61	58.94	13.12	88.16	8.30	61.58	44.02	32.45	42.35	78.98	1.44	14.57	85.66	2.54	27.55	11.30	68.94	22.86	50.24	59.19	43.12	0.00	11.08	26.53	23.39	63.60	59.53
BRD-K63195589	CP	tipifarnib	farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant	FNTA, FNTB		5.00, 3.46	42.35	0.66, 0.16	61.80	14.59	93.28	3.17	56.23	28.06	7.38	58.23	20.01	25.03	6.06	8.28	-3.98	43.19	89.02	5.06	54.08	42.35	91.32	48.73	10.94	79.04	36.67	93.34	76.04	66.54	18.27	11.35	74.64
BRD-K33312228	CP	halometasone	cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant	NR3C1	Glucocorticoid receptor agonist	5.78, 4.00	42.30	1.69, 0.53	19.03	80.93	17.69	40.25	38.71	60.08	15.77	21.16	27.34	98.98	76.67	99.30	70.92	46.74	52.66	86.88	40.28	40.99	34.84	33.86	50.77	42.30	97.55	38.03	7.15	99.58	71.40	90.62	17.70
BRD-A61856038	CP	tremulacin	5-lipoxygenase inhibitor			5.77, 3.08	42.29	1.53, 0.52	5.34	95.20	45.17	65.25	84.05	39.25	33.93	0.00	17.92	90.04	55.45	45.75	17.04	39.30	50.20	23.08	48.45	55.05	25.61	62.02	99.60	34.37	33.74	-85.87	42.29	33.72	37.81	48.34	87.68
BRD-K20287671	CP	SU-4312	platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor	KDR, PDGFRB	VEGFR inhibitor	8.08, 3.46	42.28	0.88, 0.31	42.09	33.21	95.24	73.35	50.69	7.29	73.35	77.90	73.76	86.56	93.24	74.40	4.02	9.19	-44.95	-10.83	1.57	42.28	66.73	99.89	35.88	34.23	10.55	-1.34	56.05	40.33	26.64	94.60	98.92
BRD-A83326220	CP	brazilin	nitric oxide production inhibitor, nitric oxide synthase expression inhibitor, telomerase inhibitor			4.62, 2.31	42.25	1.50, 0.50	87.89	15.75	34.72	68.21	10.35	22.37	4.76	20.91	7.46	37.90	14.96	63.93	94.61	98.10	85.07	99.68	29.24	59.65	80.99	57.88	63.67	42.25	14.03	2.44	42.36	18.84	17.27	45.05	50.31
BRD-K39520573	CP	GW-5074	RAF inhibitor, leucine rich repeat kinase inhibitor	LRRK1, LRRK2, NTRK1, RAF1	RAF inhibitor	4.49, 2.45	42.23	0.77, 0.22	12.31	60.63	27.90	33.26	35.65	91.05	29.08	25.95	8.16	46.85	14.89	68.76	67.19	1.90	62.92	98.31	94.24	68.83	53.15	42.23	48.59	2.50	18.99	75.21	48.33	34.52	53.27	24.90	11.85
BRD-A28970875	CP	puromycin	adenosine receptor agonist, protein synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1	Protein synthesis inhibitor	6.54, 3.85	42.21	2.40, 0.51	90.48	85.44	38.14	97.07	89.19	26.85	22.32	17.14	7.97	26.38	14.27	73.74	97.78	94.41	-10.50	100.00	49.38	68.49	35.71	44.02	64.55	77.90	43.90	0.00	21.51	26.64	12.11	42.21	17.95
BRD-K27184429	CP	levocetirizine	histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor	HRH1, CXCL8		6.67, 5.78	42.15	1.36, 0.36	19.24	42.95	27.24	41.01	33.55	43.29	7.17	78.08	6.52	46.70	70.17	89.23	12.13	2.09	82.71	38.40	97.12	4.42	15.01	70.87	98.03	98.06	9.65	8.11	42.15	41.70	99.29	84.39	76.66
BRD-K25905511	CP	buddleoflavonoloside	acetylcholinesterase inhibitor			2.69, 1.92	42.14	1.34, 0.43	81.39	55.91	17.39	76.74	85.82	29.87	29.14	71.93	36.57	14.63	42.14	19.30	-2.18	49.88	78.83	6.60	84.93	60.89	20.42	85.36	35.86	95.48	9.34	0.00	76.84	16.19	9.82	94.95	62.94
BRD-K77908580	CP	entinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC9	HDAC inhibitor	2.69, 0.77	42.14	1.00, 0.38	7.58	82.00	44.40	70.34	64.35	13.94	11.31	-4.05	15.35	15.66	14.21	52.56	78.62	73.78	70.31	99.65	49.61	77.44	15.33	50.31	58.97	30.82	42.14	3.88	6.77	34.73	41.59	24.28	48.76
BRD-K94176593	CP	TWS-119	glycogen synthase kinase inhibitor	GSK3B, JUN, MYC	Glycogen synthase kinase inhibitor	5.77, 3.08	42.14	1.14, 0.41	22.83	95.74	16.58	93.67	83.51	25.59	41.34	-52.31	58.44	15.69	5.21	51.99	0.00	78.92	63.39	99.40	92.02	49.57	51.18	48.98	7.52	31.08	3.82	43.63	56.56	-20.00	22.35	13.11	42.14
BRD-K39965020	CP	doconexent	PPAR receptor agonist, unidentified pharmacological activity	FFAR1, PPARA, PTGS1, PTGS2	PPAR receptor agonist	2.69, 1.54	42.13	0.77, 0.27	87.72	15.09	17.78	4.55	21.80	38.83	82.00	24.99	27.41	54.77	35.49	63.62	5.75	61.35	57.56	0.56	48.56	42.13	76.10	94.23	87.84	97.91	23.12	27.75	26.91	71.60	74.33	87.42	32.76
BRD-K96670504	CP	lonidamine	glucokinase inhibitor, protein synthesis inhibitor	GCK		6.15, 3.85	42.12	0.76, 0.18	17.27	14.61	35.80	26.14	57.36	29.73	91.49	62.25	20.89	38.91	0.85	-17.69	-6.30	-3.53	93.30	28.39	32.28	46.53	73.63	76.41	68.87	57.70	47.85	97.61	88.13	22.61	42.12	97.65	54.72
BRD-A01826957	CP	xanthinol	vasodilator			5.38, 3.46	42.10	1.31, 0.44	89.09	34.48	6.29	31.79	59.92	40.02	67.23	43.50	4.48	93.51	96.70	73.37	6.87	14.10	42.10	-24.77	75.85	5.48	99.93	70.21	83.45	22.80	20.97	-16.83	-10.75	91.69	74.72	60.09	15.72
BRD-K81473089	CP	tacrine	acetylcholinesterase inhibitor, acetylcholine release stimulant, butyrylcholinesterase inhibitors, potassium channel antagonist	ACHE, BCHE		5.31, 2.86	42.10	0.77, 0.17	17.64	40.59	15.90	54.10	96.13	80.20	27.72	74.97	32.79	30.64	86.24	76.56	6.89	8.63	90.68	69.67	42.10	13.33	82.09	42.69	73.75	27.79	72.99	39.76	7.97	93.68	49.38	15.28	28.67
BRD-K05977355	CP	fluconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor	CYP3A5, CYP3A7		3.46, 2.31	42.07	0.53, 0.09	22.20	-5.41	58.35	22.74	41.03	5.53	10.74	47.44	11.16	15.71	29.82	62.58	0.07	0.53	98.77	41.12	47.10	39.94	55.53	77.31	69.08	76.92	42.07	88.91	57.04	93.36	63.30	83.87	25.70
BRD-K31843556	CP	T-0070907	PPAR receptor anatagonist, PPAR receptor antagonist	PPARG		5.38, 1.92	41.97	0.45, 0.10	41.97	11.87	11.40	82.43	55.33	21.48	20.63	54.77	36.54	8.53	15.49	48.99	2.85	80.97	39.55	88.65	84.46	92.31	44.05	92.37	32.17	48.53	9.78	83.20	69.77	16.75	-6.99	33.07	54.76
BRD-K09631521	CP	thiotepa	cytochrome P450 inhibitor	CYP2B6		2.69, 1.54	41.96	1.48, 0.39	60.56	56.23	6.07	25.93	19.75	56.67	33.83	94.38	91.90	38.35	8.46	73.64	4.20	2.38	17.77	-5.15	48.61	12.05	58.90	90.13	63.02	15.09	53.14	0.88	77.06	60.23	41.96	52.50	13.71
BRD-A09533288	CP	verapamil	calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist	CACNA1C, CACNA1D, CACNA1G, CACNA1S, CACNA1A, CACNA1B, CACNA1F, CACNA1I, CACNB1, CACNB2, CACNB3, CACNB4, CYP2C8, CYP2E1, CYP3A4, CYP3A5, CYP3A7, DRD2, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4		4.23, 1.92	41.94	0.84, 0.11	40.69	-3.77	17.77	11.96	11.10	15.79	84.10	79.57	37.62	48.29	21.00	79.55	2.92	27.01	96.79	-9.24	75.55	47.24	74.68	86.59	32.19	19.96	41.94	55.56	68.22	81.46	42.30	87.99	41.03
BRD-A15435692	CP	BMY-14802	sigma receptor antagonist, glutamate receptor antagonist, serotonin receptor agonist	HTR1A, SIGMAR1	Sigma receptor antagonist	6.54, 5.00	41.94	0.85, 0.31	18.32	22.08	33.48	1.09	70.72	98.94	61.84	98.10	34.98	68.20	1.52	5.74	-3.12	20.85	79.35	38.11	46.14	4.90	88.35	90.44	21.91	26.35	74.09	31.80	91.65	41.94	46.65	99.12	84.69
BRD-K06543683	CP	bisindolylmaleimide-ix	PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor	SIRT1, AKT1, GSK3B, LCK, LRRK2, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT2		8.85, 3.85	41.92	2.49, 0.91	4.16	99.26	41.92	34.57	99.54	62.22	58.66	-67.12	19.07	79.49	87.11	95.97	5.51	1.34	-8.32	98.30	0.92	39.89	-32.03	66.02	91.76	49.83	21.66	-69.95	-52.35	0.74	69.39	71.33	80.15
BRD-A80641450	CP	FR-139317	endothelin receptor antagonist	EDNRA		5.38, 3.46	41.90	1.18, 0.40	41.24	91.35	89.57	32.08	83.04	96.95	16.99	18.82	94.39	5.69	44.73	75.05	-2.50	8.79	69.37	0.56	67.08	59.89	19.24	97.59	36.96	76.45	41.90	-97.43	43.43	46.08	40.65	40.49	14.81
BRD-K24240364	CP	GYKI-52466	glutamate receptor antagonist, kainate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4		3.85, 3.08	41.89	1.10, 0.34	8.90	20.69	8.03	41.89	87.79	66.32	73.41	49.86	99.93	81.29	21.47	56.47	-2.11	11.76	47.96	3.15	83.47	66.94	50.15	18.68	34.48	34.69	32.81	1.41	29.24	64.36	19.77	83.63	78.88
BRD-K01649396	CP	indatraline	norepinephrine transporter inhibitor, dopamine transporter inhibitor, dopamine uptake inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor	SLC6A2, SLC6A3, SLC6A4		11.11, 3.11	41.88	1.58, 0.47	40.26	11.75	16.04	96.56	44.94	-6.09	-0.35	22.52	7.10	16.64	34.76	79.41	84.93	95.88	95.67	98.34	93.20	95.83	10.01	21.45	29.45	36.28	27.78	95.15	96.05	92.84	96.12	41.88	58.55
BRD-K02715688	CP	hydrastine	GABA receptor antagonist			1.92, 1.15	41.85	1.48, 0.45	78.14	-5.60	3.98	12.85	70.46	31.57	93.65	41.85	26.01	12.78	4.69	58.12	1.83	1.87	75.81	-3.95	59.15	0.95	44.86	76.99	9.73	39.71	0.56	73.84	64.18	93.26	54.38	73.11	78.92
BRD-A99411506	CP	esculin	antioxidant, unidentified pharmacological activity			4.62, 2.69	41.79	0.77, 0.30	41.79	15.84	70.29	14.09	87.55	9.63	93.98	27.89	45.24	85.22	37.64	88.33	2.08	0.60	81.21	16.33	72.47	54.79	13.29	56.59	86.60	92.96	38.30	-3.07	-16.29	4.23	58.75	99.75	25.69
BRD-A16700644	CP	isoxsuprine	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	6.12, 4.49	41.76	0.77, 0.20	41.76	29.35	3.34	48.26	23.98	62.71	24.66	36.87	99.47	49.24	35.44	86.88	2.69	42.37	68.14	7.79	32.06	19.21	99.93	42.87	66.13	35.41	45.64	93.39	37.41	86.31	67.72	14.24	8.91
BRD-K47207162	CP	zimelidine	serotonin uptake inhibitor	SLC6A4, MAOA, MAOB		6.53, 3.27	41.76	0.98, 0.25	93.85	27.66	95.70	65.59	64.92	93.26	6.31	70.86	17.74	26.23	59.37	40.07	16.13	30.75	45.10	29.58	99.37	14.39	10.00	76.39	92.96	29.21	40.02	21.66	-20.36	76.83	41.76	47.51	96.76
BRD-K52397688	CP	amperozide	dopamine receptor antagonist, FAAH inhibitor, serotonin receptor antagonist	HTR2A, DRD2, FAAH		6.15, 3.08	41.76	0.45, 0.09	29.05	41.76	99.30	55.26	97.47	52.77	8.15	40.13	37.94	6.63	36.87	27.92	54.72	55.54	97.41	93.34	87.19	56.05	52.58	40.36	22.05	78.81	24.88	-27.80	39.66	35.26	36.46	71.21	86.18
BRD-A67438293	CP	treprostinil	prostacyclin analog	PTGIR, CYP2C8, P2RY12, PPARD, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4		7.76, 3.27	41.74	0.99, 0.23	10.83	1.83	86.44	-3.21	42.76	12.81	35.79	93.03	75.81	-2.18	54.63	-10.62	-1.44	-13.92	99.37	-2.54	73.33	2.33	91.47	41.74	3.42	92.18	96.52	99.47	95.74	38.27	56.46	10.56	85.16
BRD-K70330367	CP	amantadine	glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist	DRD2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A		4.23, 1.92	41.73	0.81, 0.13	16.32	41.28	77.73	17.71	82.92	30.35	5.70	41.73	67.53	8.60	41.05	46.61	4.46	-1.66	90.57	57.96	93.93	41.82	-50.09	74.77	89.31	85.34	11.51	6.65	9.40	12.15	52.57	58.17	90.13
BRD-A19500257	CP	geldanamycin	HSP inhibitor	HSP90AA1, HSP90AB1	HSP inhibitor	2.69, 1.15	41.70	0.99, 0.30	2.33	66.16	43.07	58.56	19.96	8.67	11.40	46.35	13.92	23.09	5.45	41.70	77.39	88.05	60.44	99.44	53.41	85.98	18.93	29.33	70.99	23.59	51.36	-22.21	59.35	14.74	22.64	29.69	61.91
BRD-K87991767	CP	umbelliferone	carbonic anhydrase inhibitor, cyclooxygenase inhibitor	CA9, CA12, PTGS2		8.08, 4.62	41.69	0.61, 0.16	63.90	63.85	17.55	21.07	89.70	25.12	79.22	-29.90	50.37	6.34	7.29	17.42	-13.93	8.28	20.93	6.37	41.69	37.52	99.82	96.54	33.85	88.64	68.61	76.56	88.24	84.88	57.13	19.27	50.28
BRD-A15131297	CP	benazepril	angiotensin converting enzyme inhibitor	ACE		5.38, 3.08	41.56	0.78, 0.15	88.02	-26.22	82.41	3.70	92.81	46.56	-7.67	95.07	5.32	23.13	14.70	78.75	1.55	-0.70	68.41	18.66	98.73	44.77	41.56	69.85	56.08	8.20	40.58	0.35	32.04	44.73	64.86	90.71	39.35
BRD-K02965346	CP	SU-11274	hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	MET		4.23, 2.31	41.56	1.42, 0.56	14.14	25.21	7.12	89.99	4.70	74.17	5.53	34.85	14.24	41.56	67.34	62.40	23.02	85.14	59.87	40.71	72.84	64.69	15.51	61.04	20.35	14.74	39.55	1.13	62.06	69.17	73.49	50.65	97.70
BRD-K09255212	CP	clioquinol	chelating agent, antiamyloidogenic agent, beta amyloid antagonist, carbonic anhydrase inhibitor	OPRK1		3.27, 2.86	41.56	0.92, 0.15	93.03	23.62	67.80	38.33	32.42	80.51	59.60	87.86	42.16	98.17	41.56	36.82	20.81	24.43	15.42	84.22	61.48	16.88	67.70	17.45	31.51	36.30	15.46	21.15	68.31	74.85	19.06	52.75	79.04
BRD-K08287586	CP	butylparaben	antimicrobial preservative			5.77, 3.08	41.55	0.50, 0.10	68.30	56.93	30.28	57.08	90.12	18.92	37.76	29.17	41.55	25.01	93.57	73.74	4.89	16.13	73.45	30.94	89.65	22.13	24.95	93.87	75.69	46.25	29.44	-0.88	-36.25	74.37	52.06	70.72	-29.51
BRD-K12002134	CP	megestrol	progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor	PGR	Progesterone receptor agonist	6.53, 2.04	41.54	1.36, 0.45	65.32	69.18	31.33	49.55	48.29	11.35	-11.31	31.09	6.17	84.88	13.55	9.90	20.65	34.58	99.37	90.39	89.34	84.71	17.50	25.87	-16.73	51.91	96.97	76.58	41.54	22.20	77.25	3.29	51.56
BRD-A26845397	CP	isamoltan	adrenergic receptor antagonist	ADRB1, ADRB2		3.85, 1.92	41.53	0.98, 0.34	74.37	-25.86	16.80	16.47	-8.54	32.48	15.78	75.36	19.10	-6.47	5.91	43.26	-1.35	-1.20	96.88	1.44	84.22	16.33	59.57	76.30	6.07	41.53	67.59	99.82	90.98	89.48	79.23	63.90	48.36
BRD-A18579359	CP	wiskostatin	neural Wiskott-Aldrich syndrome protein inhibitor	WAS, WASL		7.69, 5.77	41.52	1.68, 0.72	41.52	31.43	77.76	95.60	48.23	7.12	32.41	14.65	20.09	1.09	4.33	51.10	82.09	97.98	9.97	52.67	22.62	99.08	67.91	85.08	33.41	53.46	20.13	-2.43	94.82	42.34	34.01	20.24	60.43
BRD-A42346008	CP	metanephrine	epinephrine metabolite, levels are diagnostic for the neoplasm pheochromocytoma			6.53, 4.08	41.50	1.57, 0.50	98.84	17.39	76.29	12.38	-3.10	46.09	25.83	87.87	99.82	99.27	15.05	85.02	-1.48	18.12	80.90	-3.71	31.98	-3.78	90.99	92.79	41.50	10.61	21.81	28.32	68.53	98.52	53.76	18.02	61.75
BRD-K62965247	CP	tipifarnib-P2	farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant	FNTA, FNTB		5.00, 3.85	41.50	1.40, 0.33	80.97	37.61	99.54	40.96	10.08	99.60	21.04	49.53	8.97	66.41	4.10	80.34	6.60	78.35	52.37	38.62	75.66	75.74	31.33	67.84	37.36	10.07	17.70	41.50	77.96	92.34	19.66	27.65	94.61
BRD-A80502530	CP	cinobufagin	ATPase inhibitor, chloride channel activator	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2	ATPase inhibitor	5.38, 1.92	41.49	2.39, 0.55	3.45	95.61	91.69	97.46	68.67	14.05	37.02	16.84	41.49	82.37	54.44	50.96	87.14	80.46	-43.66	98.06	34.44	55.89	27.07	64.62	40.70	39.38	18.08	-3.95	39.01	12.22	7.83	63.09	61.77
BRD-K00486786	CP	RO-08-2750	nerve growth factor receptor ligand, NGF binding inhibitor	NGFR, NGF		6.15, 2.69	41.47	1.11, 0.30	20.12	20.60	94.44	43.10	53.45	6.11	41.47	64.52	47.64	26.40	65.82	45.50	86.46	9.58	14.07	61.33	14.54	10.92	15.15	88.98	24.29	98.98	14.20	-0.81	21.27	41.91	42.77	55.75	17.96
BRD-K90333595	CP	phentolamine	adrenergic receptor antagonist	ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C		3.08, 1.15	41.46	0.94, 0.23	77.95	16.32	58.76	41.46	23.51	5.98	15.95	76.53	39.07	15.38	24.04	32.45	4.52	28.85	55.72	-0.60	89.42	32.58	53.56	43.24	45.18	52.77	34.54	0.04	74.22	61.01	51.15	92.47	61.69
BRD-A79237180	CP	ascorbic-acid	vitamin C, antioxidant	AKR1B1		6.94, 5.71	41.45	1.89, 0.52	4.16	97.92	26.57	66.81	98.48	32.89	98.73	-66.95	7.32	89.91	25.59	72.65	6.44	3.44	56.79	77.45	41.45	2.40	78.19	36.71	93.68	3.96	81.06	6.57	-47.93	99.44	50.21	65.98	0.00
BRD-K78122587	CP	NNC-55-0396	T-type calcium channel blocker	CATSPER1, CATSPER2, CATSPER3, CATSPER4	T-type calcium channel blocker	10.00, 5.77	41.41	1.65, 0.48	12.60	86.13	92.46	99.35	46.12	11.13	-9.83	16.20	41.45	62.99	28.41	85.37	98.91	99.75	89.87	99.96	70.69	99.30	11.37	41.41	21.63	26.52	13.13	-33.70	98.83	-2.57	28.35	21.19	22.13
BRD-K67261995	CP	adipiodone	serum albumin binder	ALB		5.38, 3.08	41.40	0.93, 0.32	83.52	41.40	36.73	21.51	62.95	12.38	89.36	95.33	35.27	75.16	67.17	32.71	-4.23	-0.63	91.04	2.04	51.68	21.94	57.56	96.03	27.95	27.80	6.40	8.38	47.53	82.91	17.77	94.98	67.97
BRD-K95237249	CP	probenecid	MRP inhibitor, TRPV agonist, uricosuric blocker	SLC22A6, ABCC1, PANX1, SLC22A11, SLC22A8, SLCO1C1, TRPV2		7.69, 5.38	41.40	1.38, 0.33	29.22	-4.39	78.90	4.57	38.12	-1.34	71.30	99.79	29.47	16.76	31.71	7.99	-1.55	-5.85	97.82	-50.65	85.23	9.01	92.94	73.39	72.85	52.13	65.20	89.00	62.44	94.88	20.30	75.48	41.40
BRD-K84595254	CP	strophanthidin	ATPase inhibitor	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2	ATPase inhibitor	4.62, 1.15	41.37	1.91, 0.48	28.03	92.81	27.35	89.93	93.37	74.18	0.92	38.78	17.87	5.38	7.68	65.28	92.60	41.37	92.21	99.03	21.66	50.12	16.88	76.31	64.93	81.01	28.94	-0.81	-20.25	5.81	60.78	55.17	20.45
BRD-K08115555	CP	tyrphostin-AG-1288	catechol O methyltransferase inhibitor, tumor necrosis factor inhibitor	COMT		3.85, 1.92	41.36	1.44, 0.39	34.66	76.18	41.36	14.96	50.28	74.23	25.04	86.99	27.77	12.56	54.95	81.43	-7.34	-23.21	85.48	16.74	28.37	13.21	27.14	83.39	87.48	54.36	40.37	-23.88	21.37	59.79	75.81	58.64	82.91
BRD-K08619574	CP	thioproperazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Dopamine receptor antagonist	8.08, 3.85	41.34	0.81, 0.30	60.30	21.39	98.05	11.90	52.96	11.35	22.80	66.68	12.77	1.80	-32.22	27.35	5.00	38.30	96.83	3.66	94.29	84.17	66.57	41.34	88.50	94.15	7.26	-0.04	93.92	57.58	27.46	86.49	96.35
BRD-A75479906	CP	rimantadine	acetylcholine channel inhibitor, unidentified pharmacological activity			5.71, 1.63	41.33	1.86, 0.53	58.53	82.43	86.34	8.72	55.40	28.04	42.36	87.82	16.59	10.52	6.94	17.98	27.03	71.53	61.18	18.75	88.24	13.00	81.01	96.72	41.92	39.74	25.85	-12.33	14.46	76.52	63.96	41.33	16.22
BRD-K48115423	CP	2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol	matrix metalloprotease inhibitor	MMP13		3.08, 1.15	41.32	0.84, 0.20	74.25	95.63	3.24	24.20	54.69	40.76	24.80	9.23	25.32	91.14	51.51	90.22	-1.84	1.16	93.12	41.32	62.52	43.06	50.93	14.42	16.69	68.59	40.58	91.76	37.75	77.79	8.11	89.68	1.30
BRD-K47328134	CP	lysylphenylalanyl-tyrosine	heparin activation inhibitor			1.53, 1.53	41.31	1.41, 0.44	65.75	-67.03	11.74	41.16	20.48	12.03	87.11	69.71	6.06	85.66	50.07	76.22	3.49	-3.94	85.47	89.20	29.09	-4.90	36.41	62.67	79.01	4.97	9.07	NaN	88.80	88.24	6.52	41.45	98.45
BRD-K89046952	CP	ciclacillin	cell wall synthesis inhibitor			3.08, 1.92	41.26	1.22, 0.27	51.00	27.83	66.32	42.85	3.35	45.20	94.41	86.06	27.67	39.16	56.90	67.14	0.00	2.01	30.65	4.12	15.40	44.77	65.29	32.41	-13.59	15.04	12.00	-8.32	59.32	41.26	59.43	53.58	85.60
BRD-K46937689	CP	phenazone	cyclooxygenase inhibitor	PTGS1, PTGS2		5.38, 1.92	41.25	0.56, 0.14	98.94	45.60	20.12	13.87	74.10	41.25	32.35	62.73	10.64	8.07	47.97	72.01	2.50	5.05	73.74	4.51	59.43	6.41	76.09	64.28	-13.25	24.59	81.97	32.61	40.61	78.95	17.04	59.26	58.47
BRD-K86191271	CP	cytosporone-b	HMR receptor agonist	NR4A1		6.54, 3.85	41.24	0.92, 0.31	99.93	23.85	96.66	-1.16	51.62	95.04	32.80	80.68	18.11	30.72	17.96	70.59	-34.61	4.12	56.84	-15.85	81.50	10.51	87.36	74.75	49.40	92.37	7.63	87.31	41.24	73.35	13.69	40.77	25.72
BRD-K05396879	CP	15-delta-prostaglandin-j2	PPAR receptor agonist, FXR antagonist	PPARG, NR1H4	PPAR receptor agonist	0.77, 0.00	41.23	1.39, 0.63	44.49	6.93	8.47	0.67	35.38	47.18	45.53	71.49	18.19	65.83	8.77	41.23	73.22	75.65	76.52	94.41	52.66	26.59	62.16	15.88	28.42	22.27	27.28	-10.00	77.10	40.22	72.64	2.96	56.99
BRD-K82577285	CP	dipropyl-dopamine	dopamine receptor agonist			6.53, 3.27	41.21	2.07, 0.69	41.21	89.93	97.79	11.95	78.52	38.22	10.19	36.86	96.58	78.77	3.21	66.45	-10.60	18.39	43.96	60.16	59.98	15.17	99.22	48.80	98.45	46.49	34.92	-99.47	-49.85	0.00	6.27	10.34	89.51
BRD-K46018455	CP	bezafibrate	PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor	PPARA, PPARD, PPARG, HSD11B1, LPL	PPAR receptor agonist	4.23, 1.92	41.19	0.83, 0.24	83.31	52.92	28.07	10.88	79.31	41.19	74.22	88.35	47.64	23.21	49.90	15.16	1.37	1.66	46.61	21.30	13.27	2.71	62.25	65.55	38.42	37.08	7.89	-0.07	50.11	95.25	39.33	73.11	69.13
BRD-K50398167	CP	meclofenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist	PTGS1, PTGS2, ALOX5, CNR1, KCNQ2, KCNQ3		5.00, 2.69	41.19	0.53, 0.06	19.87	25.79	96.86	4.37	82.74	8.37	26.08	-61.44	46.87	11.99	68.01	48.88	2.11	50.00	92.25	4.09	92.36	41.19	33.68	60.04	76.18	81.01	37.64	-86.04	43.54	18.85	40.07	77.74	73.30
BRD-K32610195	CP	androstenedione	cytochrome P450 inhibitor	AKR1C3, HSD17B1, HSD3B1		2.69, 1.15	41.15	1.32, 0.38	42.69	-25.51	45.19	8.47	80.65	75.87	32.45	53.28	0.00	46.25	33.17	20.81	-10.32	36.09	72.31	-86.75	93.58	5.46	60.48	29.65	-3.91	41.15	47.64	0.00	26.94	51.61	59.68	49.76	49.28
BRD-K63979671	CP	etifenin	compound used in hepatobiliary scans of the liver			3.85, 1.92	41.13	0.73, 0.20	34.39	13.62	46.70	38.63	-4.12	83.37	63.36	82.16	54.49	30.26	30.63	40.12	-3.95	-39.79	91.93	6.51	76.53	15.34	41.13	91.19	68.53	68.49	29.55	79.00	0.21	95.78	69.05	57.02	35.58
BRD-K17705806	CP	JTC-801	opioid receptor antagonist	OPRL1		7.69, 2.96	41.11	2.92, 0.63	32.32	75.86	31.69	95.67	97.16	32.72	-27.96	-39.21	0.00	21.66	94.68	89.95	96.83	89.75	15.69	99.96	86.90	91.61	-4.97	60.30	95.28	46.92	31.64	0.00	-19.19	41.11	26.68	29.38	45.23
BRD-K36627727	CP	tamibarotene	retinoid receptor agonist, RAR agonist	RARA, RARB	Retinoid receptor agonist	4.62, 1.54	41.09	0.98, 0.31	18.37	77.22	87.34	86.36	66.73	12.69	47.21	31.02	41.09	15.30	22.51	88.61	54.37	19.90	70.70	97.21	-11.54	18.61	11.65	50.41	31.92	44.50	29.07	-44.72	0.78	51.91	39.76	94.00	74.52
BRD-A78295502	CP	hydroquinine	anti-arrhythmia agent			5.31, 0.82	41.03	1.10, 0.39	9.90	20.38	93.16	5.94	86.70	44.69	8.74	25.79	11.89	54.49	39.50	54.57	41.13	39.12	78.20	88.14	95.82	62.35	66.80	38.91	87.84	97.00	20.85	0.88	2.62	41.03	51.22	26.54	5.84
BRD-K24526313	CP	levcromakalim	potassium channel activator, potassium channel agonist	KCNJ8, ABCC9, KCNJ5	Potassium channel activator	5.00, 2.31	40.99	0.81, 0.26	13.09	49.56	35.71	49.56	73.59	40.99	85.83	-38.09	53.96	12.16	96.26	28.71	3.63	3.43	77.54	5.60	68.63	5.32	31.36	42.98	65.27	61.03	4.67	-74.26	9.61	61.79	71.95	34.04	54.92
BRD-K37865504	CP	LY-2183240	FAAH inhibitor, FAAH reuptake inhibitor	FAAH		3.46, 0.77	40.89	1.76, 0.63	24.40	56.37	89.92	53.14	23.45	45.08	7.22	33.21	52.18	54.56	16.84	23.81	78.06	91.53	13.20	98.77	41.67	52.09	40.89	71.79	18.53	31.42	11.00	-32.07	29.55	28.74	21.30	51.58	57.19
BRD-A31800922	CP	procyclidine	anticholinergic	CHRM1, CHRM2, CHRM3, CHRM4		7.76, 4.90	40.88	1.05, 0.30	37.79	20.56	47.66	6.45	54.65	0.01	62.38	97.50	40.88	16.36	7.14	6.82	2.85	4.33	97.89	3.14	93.14	46.82	94.12	16.00	25.67	9.75	63.39	98.63	69.00	77.06	73.59	38.27	79.65
BRD-K88568253	CP	iproniazid	monoamine oxidase inhibitor	MAOA, MAOB		5.71, 2.04	40.88	0.60, 0.25	1.80	53.78	55.96	28.64	93.15	12.39	60.55	72.39	15.70	56.55	97.92	67.60	1.34	1.69	83.40	23.80	4.18	11.98	39.46	28.62	70.96	63.91	17.50	61.71	-44.17	94.91	58.50	40.88	20.40
BRD-A06352418	CP	terfenadine	histamine receptor antagonist	HRH1, KCNH2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, KCNH1		10.38, 7.69	40.87	1.94, 0.60	81.81	19.22	88.38	92.93	85.95	24.52	-30.81	32.97	38.88	10.68	8.40	49.70	97.92	99.65	78.00	99.89	28.26	99.68	39.28	44.70	52.04	16.25	25.35	98.77	99.93	9.02	17.41	16.48	40.87
BRD-A18763547	CP	BAX-channel-blocker	cytochrome C release inhibitor	BAX		7.69, 5.38	40.87	2.48, 0.57	10.25	87.61	66.59	95.21	56.42	10.40	66.20	35.29	41.95	5.45	7.29	40.87	96.69	98.20	33.45	99.41	9.70	97.89	32.37	53.27	21.96	32.37	24.28	-41.27	94.65	72.93	31.83	34.75	50.71
BRD-A62809825	CP	thapsigargin	ATPase inhibitor, calcium channel blocker, PKC activator	ATP2A1	ATPase inhibitor	4.23, 3.08	40.81	1.76, 0.47	2.33	82.13	41.58	90.98	64.55	8.35	-3.56	24.28	64.75	86.12	18.16	45.55	99.05	40.96	9.94	99.93	29.14	21.74	40.81	32.81	18.71	45.76	12.69	-75.09	11.28	50.73	17.21	56.36	56.26
BRD-K18855837	CP	varenicline	acetylcholine receptor partial agonist	CHRNA4, CHRNA3, CHRNA6, CHRNA7, CHRNB2		6.12, 3.27	40.80	1.34, 0.34	33.51	63.21	40.80	1.98	62.88	4.65	80.04	76.54	54.97	62.25	54.40	65.89	-1.73	14.97	19.19	2.15	64.51	30.76	14.66	67.99	98.37	25.58	56.36	-0.88	-4.70	8.95	12.64	82.60	50.34
BRD-K63641886	CP	cefuroxime	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	7.35, 4.90	40.79	1.75, 0.41	8.85	82.13	77.85	29.02	92.85	75.23	81.43	54.76	22.64	37.04	99.30	78.29	1.48	40.79	-34.83	97.84	9.09	21.02	67.41	30.95	85.32	6.84	23.40	-42.74	15.89	99.93	49.67	79.69	-46.43
BRD-K63874012	CP	thioperamide	histamine receptor antagonist, histamine receptor inverse agonist	HRH3, HRH4		4.23, 1.92	40.79	0.66, 0.16	61.04	-18.37	70.12	27.12	69.89	11.54	93.99	38.27	9.98	25.46	33.49	30.37	-8.21	38.28	91.71	-2.01	96.01	17.92	49.01	57.19	58.01	71.52	40.79	68.47	59.02	24.11	83.76	72.04	33.99
BRD-K02265150	CP	amoxapine	adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant	SLC6A2, SLC6A4, HTR2A, HTR6, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2B, HTR2C, HTR3A, HTR7, SLC6A3	Norepinephrine reuptake inhibitor	7.31, 3.85	40.78	1.20, 0.32	16.53	11.19	5.47	83.76	4.09	10.51	90.79	98.00	30.50	5.14	40.78	45.22	62.45	86.70	15.49	5.14	70.12	95.56	22.67	43.45	29.68	26.31	19.05	4.54	98.98	57.02	61.30	76.20	85.28
BRD-K01253243	CP	SB-590885	RAF inhibitor	BRAF	RAF inhibitor	4.62, 2.31	40.77	0.90, 0.41	18.09	73.07	26.05	75.15	47.94	15.81	26.84	-16.73	27.24	17.64	4.80	93.05	41.79	97.92	49.26	92.77	65.38	62.40	25.06	26.71	17.87	27.79	81.17	43.91	59.31	38.19	65.00	40.77	17.84
BRD-K53414658	CP	tivozanib	VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor	FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB	PDGFR/KIT inhibitor, VEGFR inhibitor	4.23, 1.15	40.76	1.91, 0.52	32.57	72.86	66.42	94.60	24.18	20.95	38.17	-49.56	17.57	36.90	16.25	48.11	20.77	90.11	62.27	98.59	32.87	89.36	40.66	30.55	52.20	66.92	20.20	86.44	74.98	65.52	42.73	40.76	8.92
BRD-K80451230	CP	zamifenacin	acetylcholine receptor antagonist	CHRM3		5.31, 2.45	40.76	1.13, 0.31	15.24	33.66	94.43	40.76	43.78	75.59	16.87	52.79	6.34	96.17	29.09	91.13	3.00	75.61	86.48	20.10	73.90	35.86	69.38	38.51	38.04	4.23	71.15	0.00	32.80	91.01	75.13	54.16	13.30
BRD-A23290232	CP	westcort	corticosteroid		Glucocorticoid receptor agonist	4.49, 3.67	40.71	1.26, 0.47	69.71	67.19	17.63	40.81	10.40	45.33	58.47	97.77	22.59	8.41	21.94	33.74	3.14	69.70	71.99	2.54	22.98	60.13	37.16	69.75	-37.58	46.53	20.31	39.28	51.70	85.96	13.29	56.25	40.71
BRD-K74501079	CP	azithromycin	50S ribosomal subunit inhibitor, protein synthesis inhibitor	MLNR		7.69, 5.38	40.71	1.00, 0.33	14.60	11.16	47.60	11.33	8.25	82.91	38.92	25.30	6.57	81.08	40.71	57.11	4.19	55.20	64.63	20.09	88.60	39.80	47.36	52.82	98.06	41.42	6.51	3.00	68.92	46.67	23.03	46.53	37.79
BRD-M45964048	CP	verteporfin	apoptosis stimulant, photosensitizing agent, radical formation stimulant			3.46, 1.54	40.70	0.91, 0.30	23.35	68.13	70.17	25.49	53.29	54.38	43.63	93.76	83.51	76.68	51.17	74.99	8.36	4.02	-55.97	8.77	46.02	16.43	42.36	40.70	35.96	30.20	21.54	-1.62	23.50	19.82	24.13	53.53	90.18
BRD-K31987754	CP	oleylethanolamide	Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker	GPR119, CNR1, GPR55, KCND3, PPARA		3.27, 2.04	40.66	0.98, 0.31	39.42	58.69	98.57	20.91	83.70	80.27	7.02	14.06	41.57	50.54	41.49	83.17	-5.31	16.27	87.89	10.33	18.97	16.61	42.20	77.95	8.03	59.54	78.83	0.85	2.02	57.04	14.33	38.15	40.66
BRD-K96720755	CP	relcovaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR		5.00, 2.31	40.65	1.09, 0.28	23.37	93.10	96.93	36.90	58.98	77.06	61.43	82.97	37.97	43.94	92.42	84.28	9.89	27.77	10.46	31.67	32.99	49.56	74.86	84.80	94.77	28.34	19.66	-68.54	28.22	63.21	18.50	18.45	40.65
BRD-K60640630	CP	mometasone	glucocorticoid receptor agonist, immunosuppressant	NR3C1	Glucocorticoid receptor agonist	3.85, 1.92	40.62	1.19, 0.64	23.16	21.56	98.08	90.78	12.88	14.44	78.63	18.70	11.10	10.93	3.14	21.76	54.68	74.17	89.88	92.37	84.82	17.31	62.19	53.24	38.50	69.61	28.35	40.62	13.71	68.34	46.40	49.04	14.45
BRD-K74733595	CP	APHA-compound-8	HDAC inhibitor	HDAC8	HDAC inhibitor	2.69, 0.38	40.62	1.50, 0.48	28.75	74.05	57.18	64.82	35.30	97.64	18.20	26.77	13.05	41.56	33.74	50.45	68.81	14.79	45.81	49.39	36.62	53.80	8.92	54.85	47.45	39.48	36.41	2.04	10.59	35.29	40.62	62.96	80.34
BRD-K87919739	CP	tyrphostin-AG-825	receptor tyrosine protein kinase inhibitor	ERBB2		4.23, 1.54	40.61	1.22, 0.33	21.32	42.83	36.26	58.97	24.21	69.73	80.58	-59.96	14.38	13.30	3.38	31.71	4.63	10.08	89.29	64.65	40.61	16.09	52.36	65.64	81.67	65.60	49.81	0.00	-33.19	-9.32	53.67	67.16	82.64
BRD-A72596465	CP	GW-6471	PPAR receptor antagonist	PPARA		2.69, 1.15	40.58	0.81, 0.17	32.25	-30.66	41.54	70.10	9.86	21.83	11.30	44.88	8.33	11.66	73.36	52.72	45.10	52.32	81.06	98.80	34.12	75.32	46.92	40.58	36.02	25.55	51.42	4.02	12.76	87.73	10.32	40.97	33.66
BRD-K16621777	CP	enobosarm	androgen receptor modulator, androgen receptor agonist	AR	Androgen receptor modulator, Progesterone receptor antagonist	6.15, 3.46	40.56	0.81, 0.18	23.28	68.80	-2.79	30.60	96.37	23.26	32.89	14.58	19.20	40.56	38.65	92.26	-5.55	57.12	49.74	8.89	96.58	10.95	74.79	69.78	24.00	69.82	82.28	99.05	54.50	85.04	76.51	19.81	16.16
BRD-K28907958	CP	CD-437	RAR agonist, retinoid receptor agonist	RARG		4.23, 2.31	40.55	3.42, 0.89	41.00	94.85	54.14	84.55	58.84	15.64	9.72	-17.10	61.08	23.04	78.29	72.87	96.41	89.30	40.55	99.72	13.47	31.27	33.38	58.66	19.46	7.89	45.97	0.53	5.36	52.03	14.95	-32.34	34.05
BRD-K15933101	CP	ropinirole	dopamine receptor agonist, dopamine receptor modulator	DRD2, DRD3, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C		4.62, 3.08	40.54	0.89, 0.31	24.71	35.70	63.94	9.16	57.78	39.58	9.82	75.81	47.82	84.18	34.27	65.92	2.01	6.68	77.56	10.14	98.73	39.98	40.06	49.73	73.25	37.09	61.78	38.00	76.08	38.96	40.54	78.08	97.74
BRD-A80793822	CP	pemoline	non-narcotic dopaminergic compound			7.35, 2.86	40.53	0.68, 0.18	9.14	30.64	70.35	14.69	75.49	4.83	40.53	62.63	20.31	87.73	62.16	88.63	2.33	2.04	86.01	1.69	91.90	31.14	12.88	45.81	3.28	70.79	60.32	-0.04	13.62	95.21	54.14	75.98	2.29
BRD-K17140735	CP	SCH-79797	proteinase activated receptor antagonist	F2R		9.48, 5.17	40.53	3.38, 0.63	6.42	85.76	53.95	87.22	47.33	13.21	-4.51	17.32	-10.63	71.01	25.81	65.18	99.05	98.38	22.71	99.93	20.82	95.58	52.36	40.53	86.67	9.76	17.61	-0.81	40.58	23.58	14.03	4.65	71.42
BRD-K64514229	CP	toltrazuril	anti-protozoal			5.77, 3.08	40.53	0.67, 0.16	72.84	-20.33	51.54	-8.62	50.32	12.38	77.11	67.22	19.59	25.21	40.53	45.93	-4.45	-15.01	98.52	-1.20	76.96	8.60	70.19	57.42	-13.53	25.33	62.66	11.88	38.89	88.05	58.71	16.15	68.91
BRD-A43882281	CP	pinacidil	ATP channel activator, potassium channel agonist	ABCC9, KCNJ8		3.46, 1.15	40.52	0.66, 0.19	50.35	40.52	54.98	32.51	92.02	17.74	87.07	71.12	12.09	64.41	5.14	52.12	0.00	23.82	29.74	19.40	80.58	37.43	18.17	33.23	65.50	34.00	64.83	-0.07	46.16	24.41	78.05	60.19	57.71
BRD-K12260308	CP	xanthoxyline	plant-derived antifungal			3.85, 2.31	40.51	0.93, 0.28	60.81	36.63	41.54	6.45	98.66	35.23	49.58	-32.20	5.92	15.58	61.56	59.35	-2.78	40.53	97.82	-38.94	47.15	-0.74	-40.49	51.54	26.80	67.28	-16.12	-62.97	-0.32	45.80	51.97	78.45	40.51
BRD-K73391359	CP	quinisocaine	anesthetic			4.62, 2.31	40.50	0.63, 0.11	76.56	58.39	44.78	52.92	32.92	63.25	62.83	80.22	39.58	33.41	3.35	28.49	1.67	-14.23	68.45	1.83	44.91	45.81	11.14	87.39	29.71	35.88	24.16	-0.04	71.54	40.50	36.19	65.27	63.52
BRD-A10523515	CP	GSK-429286A	ROCK inhibitor	ROCK1		3.46, 1.92	40.49	0.80, 0.28	19.00	8.58	41.64	57.62	21.26	20.12	65.15	62.54	25.56	15.69	13.41	20.25	-3.59	12.90	49.68	-30.88	53.19	64.27	86.67	48.86	40.49	51.83	12.92	37.86	91.25	13.00	57.41	62.56	77.80
BRD-A01593789	CP	chlormadinone	progesterone receptor agonist	PGR		4.62, 1.92	40.47	0.64, 0.23	16.60	35.33	40.47	16.61	56.67	2.35	24.43	29.99	88.15	25.44	53.16	40.99	31.69	16.71	52.23	12.86	46.64	83.70	45.79	81.02	25.17	36.46	24.57	-98.60	84.39	41.66	40.60	59.22	94.39
BRD-K94832621	CP	Y-134	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1, ESR2	Estrogen receptor antagonist	6.54, 5.00	40.46	1.28, 0.23	5.59	30.81	66.60	89.01	13.30	3.17	4.40	39.59	17.72	12.20	61.32	40.46	89.18	98.87	32.63	97.43	51.80	98.06	-0.25	58.24	48.37	23.41	40.94	-15.01	95.38	28.50	53.39	40.12	47.14
BRD-K30867024	CP	SB-216641	serotonin receptor antagonist	HTR1B, HTR1D, HTR1A, HTR2A, HTR2B, HTR2C	Serotonin receptor antagonist	6.92, 4.23	40.45	0.78, 0.13	12.66	20.33	63.47	68.77	4.62	26.11	29.85	70.58	5.97	18.76	76.69	7.95	84.19	89.61	36.22	96.43	51.26	95.13	24.08	21.57	43.75	17.63	56.41	0.49	99.93	69.47	11.12	58.72	40.45
BRD-K47278471	CP	diphenhydramine	histamine receptor antagonist	HRH1		6.22, 4.00	40.40	1.67, 0.52	87.50	85.30	38.63	22.58	36.97	43.99	37.27	84.92	20.32	81.20	61.87	79.76	6.87	15.29	66.51	10.90	64.78	37.29	82.06	3.88	8.77	42.71	99.64	4.88	31.66	94.91	88.92	34.74	40.40
BRD-A52588987	CP	SKF-83566	dopamine receptor antagonist	DRD1, DRD5		8.57, 4.08	40.38	0.19, 0.01	45.15	49.69	78.44	38.20	90.14	20.38	4.55	40.38	22.50	93.44	26.63	96.35	12.26	22.33	95.67	84.89	98.03	39.55	39.54	61.66	53.71	89.92	33.28	23.85	35.24	33.59	80.59	63.83	28.00
BRD-A74771556	CP	nikkomycin	chitinase inhibitor			7.35, 2.04	40.38	1.15, 0.34	51.19	-10.48	11.92	3.08	-17.84	61.00	65.80	95.63	31.25	39.45	3.79	51.73	-17.94	3.58	68.29	-95.40	93.07	6.98	28.87	60.23	22.24	54.65	79.70	99.68	77.33	94.54	40.38	6.81	99.22
BRD-K62736196	CP	guanabenz	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C		4.23, 1.92	40.35	0.53, 0.08	16.53	88.27	15.66	34.12	44.32	13.70	67.67	74.18	65.81	3.28	83.14	75.11	0.00	9.62	94.37	2.02	65.81	37.93	68.55	40.35	16.99	47.17	11.99	-89.73	38.24	90.67	63.08	70.10	21.21
BRD-A53576514	CP	orphenadrine	acetylcholine receptor antagonist	CYP2B6, GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2		8.46, 6.15	40.32	0.95, 0.28	16.96	36.20	72.74	10.86	21.84	57.34	91.57	83.93	62.30	9.00	-1.16	30.06	3.00	29.10	13.80	-3.14	93.55	65.35	58.83	73.02	10.91	98.45	9.51	-98.64	66.20	40.32	46.19	46.55	99.97
BRD-K88701661	CP	dimercaptosuccinic-acid	chelating agent, DNA methyltransferase inhibitor	DNMT1	HIF activator	4.46, 1.27	40.31	1.56, 0.50	40.31	18.98	56.75	21.45	66.51	79.39	9.14	63.85	22.67	21.75	82.38	62.51	7.31	1.66	44.38	0.00	97.46	72.20	54.50	96.54	94.71	6.86	2.71	0.00	1.59	79.38	37.13	15.34	62.71
BRD-A35912562	CP	pregnenolone	acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1	CYP17A1, PGR, SULT2B1		4.23, 2.31	40.30	1.01, 0.36	83.82	79.72	91.96	34.05	89.82	43.40	-6.48	37.46	49.08	90.07	17.58	63.35	2.57	15.05	94.93	2.96	33.59	29.10	40.30	75.93	98.77	90.12	53.87	-0.73	37.99	31.76	17.25	52.05	33.49
BRD-A54487287	CP	cortisone	glucocorticoid receptor agonist	NR3C1		3.46, 1.92	40.30	0.72, 0.15	93.97	39.62	18.64	22.34	83.43	30.30	45.74	82.34	71.90	5.70	21.49	29.75	-4.98	6.16	36.26	7.44	73.09	14.24	83.33	72.70	49.83	59.25	17.37	40.30	81.04	57.67	37.56	82.46	62.35
BRD-K10870738	CP	CDC	lipoxygenase inhibitor	ALOX12, ALOX5		3.85, 2.69	40.30	1.05, 0.38	87.86	37.14	85.18	40.37	39.02	16.89	36.36	36.95	40.30	22.43	55.93	53.71	4.23	63.23	-33.36	9.41	60.24	31.45	18.06	61.92	79.06	92.96	64.82	-7.11	49.33	-51.54	54.33	99.79	39.74
BRD-K10573841	CP	tunicamycin	GLCNAC phosphotransferase inhibitor	GNPTAB		6.53, 4.08	40.29	2.39, 0.75	92.34	52.06	68.41	92.88	58.55	4.70	0.00	19.51	23.58	62.03	12.14	76.70	97.71	59.07	37.24	100.00	-16.17	82.30	9.55	43.59	10.30	6.35	24.40	5.84	40.29	87.68	52.46	2.85	2.01
BRD-K49810818	CP	sorafenib	RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist	RET, BRAF, FLT3, KDR, RAF1, FLT1, FLT4, KIT, DDR2, FGFR1, PDGFRB, CYP2B6, CYP2C8, CYP3A5, PDGFB, SLCO1B3	FLT3 inhibitor, PDGFR/KIT inhibitor, RAF inhibitor, VEGFR inhibitor	5.77, 3.85	40.29	1.83, 0.52	14.13	87.07	40.29	94.28	79.79	87.03	0.88	-11.33	25.16	12.46	1.30	75.75	95.92	92.70	52.49	100.00	67.08	58.51	13.12	53.61	22.97	11.79	22.14	-32.80	25.48	73.40	47.17	16.56	1.30
BRD-K17743697	CP	KB-R7943	sodium/calcium exchange inhibitor	SLC8A1, TRPC3, TRPC5, TRPC6	T-type calcium channel blocker	5.77, 3.85	40.25	1.43, 0.42	11.17	19.82	56.03	92.42	84.90	9.22	9.30	37.43	7.10	70.10	14.15	58.48	88.23	90.86	87.29	41.39	57.06	99.65	27.11	67.08	11.34	23.57	37.79	2.55	98.64	15.56	28.28	40.25	70.06
BRD-A02990301	CP	lofexidine	adrenergic receptor agonist	ADRA2A		5.38, 4.23	40.19	1.19, 0.33	5.18	25.89	25.67	34.78	52.54	45.75	21.10	35.03	6.86	94.98	49.96	33.55	-5.88	30.09	97.99	73.28	78.50	40.19	23.56	44.37	99.61	67.61	41.51	89.81	91.92	59.48	36.43	25.55	0.85
BRD-K59331372	CP	SB-366791	TRPV antagonist	TRPV1		4.23, 2.31	40.10	0.92, 0.26	28.98	63.27	10.41	25.94	66.77	60.36	-21.42	-25.50	38.40	40.10	56.43	77.97	-2.74	12.77	78.61	61.18	89.90	18.70	-7.21	80.60	84.22	53.30	4.22	0.85	-61.06	2.85	77.28	75.27	90.52
BRD-K36862742	CP	hydroflumethiazide	sodium/potassium/chloride transporter inhibitor	SLC12A1, ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1		4.49, 1.22	40.07	1.64, 0.39	-8.88	30.99	76.09	37.97	21.10	40.07	2.47	92.51	22.78	62.05	82.67	85.08	5.61	16.26	63.99	1.52	94.41	25.62	55.84	87.99	82.33	57.13	48.39	0.04	14.74	34.46	34.02	64.04	89.45
BRD-K45861246	CP	azaperone	dopamine receptor antagonist	DRD2, DRD3		5.38, 2.69	40.07	0.59, 0.11	40.47	74.02	74.56	8.66	85.67	25.14	49.97	79.15	87.18	7.46	22.91	84.44	4.44	4.12	68.78	31.73	82.55	6.45	49.69	42.61	40.07	36.43	30.34	-96.40	61.24	7.43	14.80	74.10	32.03
BRD-K52911425	CP	GDC-0941	PI3K inhibitor	PIK3CG, PIK3CA, PIK3CB, PIK3CD	PI3K inhibitor	6.54, 1.15	40.03	1.49, 0.70	2.82	82.29	23.26	95.07	61.88	32.71	14.41	-35.29	24.42	49.33	44.76	89.28	74.74	83.43	96.83	99.37	84.42	95.24	-27.00	36.43	45.44	24.71	13.81	-25.38	39.16	40.03	37.16	50.53	6.70
BRD-K27450477	CP	EHNA	adenosine deaminase inhibitor	ADA, PDE2A, ADORA2A		4.23, 1.54	39.99	0.70, 0.22	98.63	31.84	17.66	58.46	26.99	94.48	87.07	16.96	16.80	75.72	23.27	71.17	18.90	13.19	21.61	10.68	39.99	29.15	58.16	69.82	44.06	16.81	73.56	21.26	14.61	92.29	78.41	45.20	75.15
BRD-A41112154	CP	oleanolic-acid	antitumor agent			3.82, 1.53	39.98	2.12, 0.63	16.15	75.83	28.62	82.48	42.09	4.83	21.87	54.83	37.87	99.22	91.00	74.26	-0.56	1.83	61.88	4.48	70.39	18.67	23.88	82.60	57.83	69.67	17.41	NaN	-36.90	0.53	51.57	99.08	-7.55
BRD-K50938287	CP	sumatriptan	serotonin receptor agonist	HTR1D, HTR1B, HTR1A, HTR1F, HTR1E, HTR5A, HTR6, HTR7		5.33, 3.11	39.98	0.84, 0.25	92.36	18.44	15.82	18.25	9.91	39.99	27.11	90.02	28.62	39.98	4.62	35.29	1.94	-0.60	75.72	-0.18	99.93	5.11	78.12	60.21	8.42	85.39	43.40	96.98	39.21	67.64	81.05	95.88	89.56
BRD-K57631554	CP	aminolevulinic-acid	oxidizing agent	ALAD		4.90, 3.67	39.93	1.47, 0.42	11.69	19.07	16.68	56.54	39.93	8.32	17.34	81.22	59.27	23.68	15.57	52.85	65.99	66.44	89.74	40.14	0.42	10.50	13.90	57.48	29.40	71.18	8.00	21.62	4.01	79.11	54.34	55.35	70.83
BRD-K82823076	CP	RO-15-4513	GABA benzodiazepine site receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB2, GABRG2		6.15, 2.69	39.92	0.78, 0.16	38.96	34.65	3.10	61.76	31.14	52.05	29.47	-24.09	12.02	12.99	76.13	78.66	3.21	9.46	96.24	58.15	60.42	39.92	52.46	95.15	35.11	75.59	72.38	67.06	26.06	98.03	25.16	83.14	30.50
BRD-A45664787	CP	iloprost	platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog	PTGIR, PTGER1, PTGER2, PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER3, PTGER4, PTGFR, TBXA2R		1.92, 1.92	39.90	0.84, 0.25	5.07	42.08	11.87	6.63	27.46	36.39	79.61	58.73	71.54	55.72	35.82	66.86	2.08	12.81	40.17	39.29	86.62	9.32	39.08	70.88	81.03	94.55	7.78	0.78	0.56	39.90	61.88	85.43	61.91
BRD-A65280694	CP	molindone	dopamine receptor antagonist	DRD2, HTR2A, CHRM1, DRD5, HRH1, HTR1A		8.98, 4.90	39.90	1.01, 0.30	56.90	86.43	39.35	23.68	20.67	99.98	5.79	39.90	30.46	97.96	13.87	81.58	1.62	31.75	95.91	26.60	88.92	6.96	80.72	70.58	9.22	53.42	59.20	0.85	32.00	73.07	66.42	37.80	93.93
BRD-K09499853	CP	KU-0060648	DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	DNA dependent protein kinase inhibitor, PI3K inhibitor	5.77, 1.92	39.90	1.84, 0.56	9.39	97.74	57.37	93.69	67.10	39.90	-26.22	-38.41	29.45	0.70	25.50	75.79	88.32	97.79	82.65	98.82	28.30	96.62	-17.53	42.32	63.58	4.05	55.88	-50.02	1.94	37.51	24.38	6.19	51.30
BRD-A90515964	CP	guaifenesin	expectorant			4.08, 2.45	39.89	1.19, 0.38	90.42	17.35	75.17	13.31	19.28	32.53	6.35	95.38	22.34	90.50	77.77	47.79	3.73	11.77	82.68	0.85	86.84	44.89	30.17	88.07	27.30	23.28	20.56	71.38	77.39	30.14	48.74	44.50	39.89
BRD-K05804044	CP	AZ-628	RAF inhibitor	BRAF, RAF1	RAF inhibitor	3.46, 2.31	39.89	1.76, 0.56	33.62	91.35	9.76	89.29	39.89	42.59	29.75	35.62	11.88	9.35	5.60	90.22	5.50	89.92	85.72	92.97	66.47	32.15	83.50	26.18	44.67	23.50	86.15	65.95	25.71	41.59	19.05	42.27	20.48
BRD-K07325606	CP	hispidin	beta secretase inhibitor, cyclooxygenase inhibitor, HIV integrase inhibitor, PKC inhibitor, prolyl endopeptidase inhibitor, xanthine oxidase inhibitor	PREP, PRKCB, PTGS2, XDH		3.46, 1.15	39.89	1.05, 0.34	38.09	-59.94	2.61	39.89	14.39	0.03	20.24	92.88	63.79	58.93	60.45	55.70	-2.78	43.72	85.18	-0.56	53.00	14.19	41.96	63.92	15.79	49.50	6.55	19.80	35.15	79.27	31.62	85.21	70.97
BRD-K78692225	CP	leflunomide	dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor	DHODH, AHR, CYP2C19, JAK3, PTK2B, STAT6		3.85, 1.92	39.89	0.52, 0.18	11.73	65.90	32.61	50.45	95.17	22.55	20.36	77.61	33.83	39.89	25.71	65.56	0.11	4.03	97.46	32.23	69.56	32.70	32.96	87.68	48.25	63.26	38.75	-52.57	72.71	5.53	68.12	64.96	81.43
BRD-K02130563	CP	panobinostat	HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	3.85, 1.15	39.88	1.89, 0.52	28.95	97.92	30.72	52.45	47.11	59.39	23.95	-40.77	10.55	39.88	18.34	80.41	82.01	91.69	66.27	99.47	61.25	62.04	14.84	27.04	71.42	16.25	22.42	-0.04	0.88	33.11	48.43	24.58	50.39
BRD-K28143534	CP	cyproheptadine	histamine receptor antagonist, serotonin receptor antagonist	HRH1, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HTR2A, HTR2B, HTR2C, HTR6, HTR7		2.31, 1.54	39.88	1.19, 0.47	25.15	25.70	36.54	3.52	46.09	42.59	46.67	20.60	8.97	30.31	64.51	72.65	78.07	-0.04	-2.74	94.77	44.03	15.18	39.88	41.32	98.10	45.39	10.80	-99.19	-0.60	20.36	68.91	53.53	67.36
BRD-A45333398	CP	periplocymarin	apoptosis inducer			2.45, 1.22	39.87	2.74, 0.73	7.67	86.70	75.73	87.61	17.92	47.18	6.24	23.31	25.14	69.98	14.51	80.18	93.34	66.36	59.72	98.77	15.30	39.87	18.47	42.50	12.15	46.81	35.20	-5.06	-4.74	18.24	16.05	42.97	44.97
BRD-K08132273	CP	tyrphostin	epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor	ERBB2		3.46, 1.92	39.82	1.00, 0.28	88.87	33.27	66.40	28.98	35.40	81.02	76.61	71.45	12.26	39.82	50.03	73.15	-14.68	16.13	-24.06	6.22	-13.89	9.34	80.26	53.43	22.33	78.69	38.22	0.88	43.05	60.18	55.32	86.87	22.34
BRD-K98548675	CP	parthenolide	NFkB pathway inhibitor, adiponectin receptor agonist	ADIPOR2, IKBKB, RELA	NFkB pathway inhibitor	4.62, 1.92	39.82	2.27, 0.65	46.69	58.33	36.07	24.42	47.65	19.28	29.22	26.30	25.71	53.59	23.51	59.36	87.14	98.24	6.38	99.30	76.61	68.01	12.54	49.98	40.16	51.88	33.29	-1.33	29.30	39.82	20.18	15.23	59.33
BRD-K10860596	CP	granisetron	serotonin receptor antagonist	HTR3A, CYP3A5		6.54, 3.08	39.80	1.49, 0.36	11.18	83.64	97.65	30.68	85.65	26.40	16.70	66.76	33.96	31.01	2.75	41.60	3.06	46.61	68.73	19.91	71.59	43.14	15.22	84.58	99.01	58.94	13.00	-9.50	21.13	39.80	31.82	96.99	96.12
BRD-K97810537	CP	beclometasone	glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant	NR3C1, CYP3A5, GPR97, SERPINA6	Glucocorticoid receptor agonist	3.85, 2.31	39.75	1.28, 0.67	39.75	9.30	51.60	68.81	11.94	33.46	28.40	47.42	-5.50	8.99	33.26	38.13	13.44	63.74	88.97	62.16	87.17	32.42	45.27	93.82	5.46	32.28	17.27	99.54	61.91	95.12	66.20	26.73	67.76
BRD-K88849294	CP	lobaric-acid	tyrosine phosphatase inhibitor	PTPN1		5.31, 3.27	39.74	1.53, 0.39	71.90	28.15	47.82	23.51	42.77	16.00	4.37	36.65	11.91	12.04	73.27	27.25	1.83	53.45	65.55	-2.75	42.09	10.32	95.80	67.77	31.43	39.74	36.00	98.40	64.10	54.37	25.55	40.93	43.45
BRD-A26384407	CP	chlortalidone	carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor	CA7, CA1, CA12, CA14, CA4, SLC12A1		3.08, 1.54	39.71	0.86, 0.15	38.10	21.06	14.16	33.73	24.54	47.69	76.33	91.58	26.51	94.96	22.80	81.50	1.62	14.51	71.02	-1.77	95.06	17.01	80.32	81.95	9.23	39.71	10.92	35.70	85.98	65.11	81.18	91.67	60.89
BRD-K62792802	CP	LY-83583	inhibitor of soluble guanylyl cyclase, leukotriene synthesis inhibitor	GUCY1A2		5.60, 3.88	39.71	2.01, 0.45	89.34	97.82	82.03	8.77	99.72	30.86	7.61	56.84	99.72	66.44	37.05	64.92	2.78	9.35	-20.83	8.05	63.77	11.54	18.12	39.71	74.10	95.48	80.52	-22.84	-12.13	26.82	64.60	70.44	24.55
BRD-K17497770	CP	butein	angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor	ACE, CXCL8, IL6, SIRT1, SRD5A1, SRD5A2, TNF		2.69, 1.54	39.69	1.52, 0.56	58.71	63.73	20.80	61.77	37.65	4.04	12.06	18.27	41.02	63.35	6.69	55.69	83.88	94.96	30.82	99.61	84.93	82.60	-10.95	57.15	33.28	34.78	20.29	-92.48	31.02	6.11	39.69	63.74	94.48
BRD-K99964838	CP	bosutinib	src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor	ABL1, SRC, BCR, CAMK2G, LYN, CAMK1D, CDK2, FRK, FYN, HCK, MAP2K1, MAP2K2, MAP3K2, MAP4K5, STK10, STK24, STK4, TNK2, TXK	SRC inhibitor	8.46, 4.62	39.67	1.28, 0.45	19.22	88.33	32.18	96.33	35.41	51.21	31.18	49.80	41.53	31.83	5.92	57.97	39.67	99.79	39.58	72.23	68.96	95.15	28.51	16.87	35.85	21.44	99.40	-96.62	62.73	30.64	77.30	18.89	79.61
BRD-K61177364	CP	NBI-27914	CRF receptor antagonist	CRHR1		5.38, 2.31	39.63	0.73, 0.13	55.67	-1.90	46.60	49.92	-2.04	33.63	23.40	63.26	-0.48	81.82	72.51	39.63	2.52	3.10	41.58	4.05	-8.16	6.24	38.97	93.29	39.83	94.80	9.77	79.36	24.23	53.50	58.12	95.91	24.99
BRD-K85266041	CP	DNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B		2.69, 1.54	39.63	1.00, 0.22	13.83	35.19	67.96	39.63	56.70	21.31	43.82	50.96	62.76	3.63	11.38	49.00	1.44	17.13	43.27	2.75	76.18	11.56	28.28	81.08	19.07	11.29	90.48	99.93	31.73	40.39	19.46	50.68	55.65
BRD-K85383046	CP	IAA-94	chloride channel blocker			8.08, 5.77	39.63	1.01, 0.19	67.79	-45.52	8.76	25.40	25.59	20.56	75.81	87.89	39.63	92.34	8.07	13.41	-4.76	28.26	36.27	-10.97	57.53	11.17	99.54	91.53	9.26	70.60	79.56	99.86	97.56	85.05	18.46	98.54	97.46
BRD-K88611939	CP	aniracetam	glutamate receptor agonist	DRD2, GRIA1, GRIA2, GRIA3, HTR2A, GRIA4		3.08, 1.15	39.61	0.52, 0.08	40.45	34.19	26.17	9.93	28.74	26.37	86.50	76.63	4.44	83.92	58.30	24.86	-2.26	-1.76	71.56	6.97	72.66	50.93	96.71	39.61	39.10	95.14	58.80	0.07	14.64	34.19	45.86	50.01	85.37
BRD-K85402309	CP	dovitinib	EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist	EGFR, FGFR3, PDGFRB, CSF1R, FGFR1, FGFR2, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA	EGFR inhibitor, FGFR inhibitor, VEGFR inhibitor	5.38, 1.92	39.60	0.99, 0.19	4.61	27.50	18.63	93.03	43.47	17.51	17.90	92.29	8.43	14.09	6.72	9.33	66.82	61.08	37.38	85.18	23.62	66.86	20.36	28.03	52.62	42.01	61.73	97.18	91.20	39.60	36.58	40.87	43.51
BRD-K26117720	CP	gingerol	nitric oxide synthase inhibitor			3.67, 2.04	39.59	0.75, 0.14	66.82	15.43	3.90	25.93	51.99	22.51	7.27	46.14	7.06	79.42	53.87	79.52	8.71	28.61	63.40	49.33	61.72	25.41	57.01	39.59	17.60	-12.47	54.82	-0.78	15.87	79.39	41.31	60.86	7.43
BRD-K72816382	CP	cinalukast	leukotriene receptor antagonist	CYSLTR1		6.15, 2.31	39.59	1.88, 0.63	96.35	-55.79	2.73	22.76	-24.21	40.23	22.98	88.96	12.33	94.96	64.08	12.09	-2.71	0.56	70.06	2.08	96.50	16.18	44.09	95.37	-16.29	92.28	-11.15	-68.92	43.54	57.00	39.59	96.75	86.53
BRD-K76274772	CP	MAPP-D-erythro	ceramidase inhibitor			6.92, 3.85	39.57	1.14, 0.49	56.55	44.35	81.08	22.49	97.13	-7.30	8.60	62.39	17.33	39.57	53.14	49.63	-2.26	4.13	35.19	2.67	13.15	10.77	60.09	98.28	63.07	97.36	14.54	0.00	32.03	2.77	42.23	99.79	69.49
BRD-K95901403	CP	XL-147	Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	PIK3CA, PIK3CD, PIK3CG		5.00, 2.31	39.57	2.02, 0.58	58.41	87.34	39.56	92.38	76.92	62.87	22.27	77.37	19.28	24.76	87.01	76.06	94.50	54.03	10.14	99.86	1.85	39.57	77.42	58.32	39.79	5.47	12.69	-0.81	5.36	23.37	26.37	35.65	15.87
BRD-A30590053	CP	MR-16728	acetylcholine release enhancer			2.69, 0.77	39.56	0.59, 0.23	44.78	7.01	38.39	31.88	44.88	5.85	52.00	47.02	83.80	39.56	55.41	37.49	12.42	32.84	20.99	5.62	84.95	79.99	49.04	54.84	25.18	65.17	7.47	39.20	81.01	64.31	8.30	86.86	23.80
BRD-K17674993	CP	diflorasone	corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	1.54, 0.38	39.56	1.47, 0.31	26.34	79.41	92.45	57.04	92.62	22.29	8.74	-71.54	8.17	39.56	17.87	21.38	24.97	74.27	19.20	91.57	96.21	40.35	42.82	41.80	73.08	26.87	35.23	-36.88	-28.93	88.95	25.09	54.86	46.04
BRD-K41143549	CP	BRD-K41143549	glutamate receptor antagonist			7.35, 3.27	39.56	1.34, 0.43	79.10	-9.94	8.30	4.74	-77.78	99.75	88.16	46.45	28.05	97.14	82.84	57.08	1.06	9.25	12.47	2.01	41.46	10.66	99.68	9.07	42.92	51.09	6.77	39.56	96.95	56.96	33.99	48.87	-14.49
BRD-K16233984	CP	eriochrome-black-t	azo dye used in titrations to detect metal ions			5.77, 2.69	39.49	1.23, 0.38	99.75	25.84	46.33	83.25	3.17	18.73	23.03	28.52	75.78	6.78	32.05	39.24	11.07	6.96	93.35	-28.96	72.42	15.68	96.27	94.33	-3.74	60.50	49.03	99.54	48.13	13.84	39.49	68.82	43.68
BRD-K23566484	CP	nilutamide	androgen receptor antagonist, RNA directed RNA polymerase inhibitor	AR, CYP2C19		4.62, 1.15	39.48	0.66, 0.20	85.37	34.04	31.80	48.29	72.99	8.57	77.13	85.27	76.87	25.43	40.63	45.90	-16.57	18.43	66.85	10.39	71.55	0.07	42.17	26.83	32.98	23.57	20.32	17.87	39.48	74.90	22.03	74.83	76.37
BRD-A48720949	CP	testosterone	androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist	AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5	Androgen receptor modulator	5.00, 1.92	39.47	0.82, 0.19	18.27	63.32	71.99	38.99	94.06	25.97	14.24	38.01	33.17	75.53	73.63	93.70	4.68	65.24	70.93	98.66	34.05	34.98	23.79	65.26	76.20	39.47	43.43	11.70	-0.53	96.33	13.23	52.69	34.90
BRD-A84389633	CP	tropanyl-3,5-dimethylbenzoate	serotonin receptor antagonist			3.08, 1.54	39.43	0.81, 0.18	7.89	-67.94	54.14	18.91	81.80	5.88	7.57	78.11	1.13	14.88	13.98	71.82	-2.85	-23.63	93.55	10.37	83.09	64.00	14.76	80.25	33.05	44.27	66.64	83.97	72.36	10.88	39.43	83.96	62.89
BRD-K08109516	CP	L-701324	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D		3.46, 2.31	39.40	0.68, 0.17	51.49	-70.90	44.49	39.40	-27.19	3.00	49.81	84.58	31.23	14.06	52.98	10.59	-2.82	-13.22	79.29	-2.96	46.13	11.57	57.30	65.88	-10.75	12.84	32.08	86.84	22.92	83.81	49.65	98.34	79.64
BRD-A92537424	CP	danazol	estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator	ESR1, GNRHR, AR, CCL2, CYP2C8, GNRHR2, PGR, TNF		4.62, 2.31	39.39	1.02, 0.32	25.13	-4.90	1.37	22.27	26.12	16.01	63.31	81.46	45.13	39.39	75.11	63.87	3.43	-17.00	97.59	92.48	63.59	54.05	14.43	79.02	36.51	47.77	-64.33	34.65	41.73	24.09	30.95	81.56	55.76
BRD-K49669041	CP	BX-912	AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor	PDPK1, AKT2, CDK2, CHEK1, GSK3B, KDR, PDK1		6.15, 2.31	39.39	0.92, 0.26	4.43	88.72	39.39	95.56	87.47	21.44	7.84	-8.90	14.41	7.86	67.80	54.33	83.66	15.38	63.24	97.77	63.55	33.76	-16.61	39.79	77.15	60.85	76.55	-99.86	-0.56	10.41	7.42	72.55	16.25
BRD-K54987996	CP	CAY-10578	casein kinase inhibitor			4.49, 2.45	39.39	1.03, 0.23	29.71	-9.69	79.60	38.33	82.83	9.62	24.68	39.04	25.83	73.48	53.81	66.61	3.95	16.85	89.74	22.90	69.33	0.00	97.96	63.01	77.44	38.91	52.62	99.93	87.48	39.39	90.00	18.34	0.00
BRD-K85119730	CP	tolbutamide	ATP channel blocker	ABCC8, CYP2B6, CYP2C19, CYP2C8, KCNJ1, KCNJ11, KCNJ8		6.54, 2.31	39.36	1.03, 0.28	93.10	15.75	88.92	34.89	39.46	58.95	19.74	93.43	31.97	65.20	16.89	39.36	2.32	8.44	79.88	2.56	97.18	21.22	76.15	95.81	19.44	37.17	31.37	-0.46	17.23	97.38	52.44	97.29	98.91
BRD-K82164249	CP	andarine	androgen receptor modulator	AR	Androgen receptor modulator	1.92, 1.15	39.34	1.08, 0.30	23.34	12.93	6.40	36.11	16.28	39.82	86.87	46.58	34.47	60.11	97.93	67.21	2.22	72.05	47.26	6.81	86.70	17.61	59.78	21.68	6.34	39.34	50.04	16.54	9.49	61.94	74.35	63.91	1.06
BRD-K99545815	CP	PF-562271	focal adhesion kinase inhibitor, angiogenesis inhibitor, apoptosis stimulant	PTK2, PTK2B		4.72, 3.00	39.32	2.69, 1.02	0.56	99.08	51.30	33.81	95.18	85.63	38.95	-50.85	26.64	43.24	65.22	83.10	-0.53	36.85	87.28	88.84	34.85	6.17	69.67	59.42	86.78	39.93	19.05	16.63	-4.55	44.46	0.85	27.70	39.32
BRD-K99447003	CP	enalaprilat	angiotensin converting enzyme inhibitor	ACE		4.00, 2.67	39.31	1.80, 0.55	56.56	5.44	46.76	7.10	24.17	4.96	18.73	30.38	6.64	65.68	98.32	46.78	-3.48	24.88	68.94	-18.25	86.43	13.52	99.68	39.31	77.60	36.22	28.42	9.04	43.87	71.86	75.49	86.19	55.84
BRD-A94669766	CP	naringenin	aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist	CYP19A1, ESR2, CYP1B1, GLO1, HSD17B1		2.31, 1.15	39.30	1.16, 0.26	98.65	94.21	29.48	35.21	75.63	74.40	32.43	26.83	9.47	39.46	70.59	84.95	-3.00	25.65	63.11	16.97	91.47	31.56	84.03	78.87	29.35	75.42	-43.42	-0.70	37.23	23.41	94.04	74.10	39.30
BRD-K34014345	CP	naproxol	antiinflammatory agent	PTGS1, PTGS2		5.00, 2.31	39.29	0.80, 0.20	30.23	24.94	5.37	48.96	42.88	11.21	73.57	39.29	63.33	83.37	87.20	35.98	8.91	-35.15	82.84	-25.42	18.83	7.96	95.12	93.03	43.36	45.20	32.84	96.53	32.72	99.19	34.14	82.03	22.24
BRD-K40656405	CP	L-165041	PPAR receptor agonist	PPARD	PPAR receptor agonist	4.23, 2.31	39.29	0.86, 0.30	8.14	54.36	65.16	11.50	91.22	4.46	48.61	39.29	42.90	38.38	6.44	46.98	9.68	12.98	-70.60	9.25	56.58	13.50	33.06	91.71	80.25	82.72	9.02	-74.03	7.71	66.59	73.13	95.66	61.77
BRD-K08806317	CP	timolol	adrenergic receptor antagonist	ADRB2, ADRB1		4.62, 1.92	39.28	0.59, 0.10	10.89	14.93	45.80	25.60	43.04	6.28	81.15	86.36	39.28	2.47	-10.25	64.82	2.82	6.07	71.42	-1.34	87.90	24.13	89.24	87.52	-36.65	19.13	59.25	0.18	50.21	83.60	47.55	31.84	89.54
BRD-A94756469	CP	digoxin	ATPase inhibitor, ROR antagonist	ATP1A1, ABCB1, RORC, SLCO1B3	ATPase inhibitor	3.85, 1.54	39.27	2.18, 0.59	15.28	86.66	72.10	90.45	56.17	10.97	14.46	14.70	65.26	4.66	43.62	61.75	93.18	77.56	39.27	96.76	40.03	66.98	29.08	27.34	32.51	71.07	20.09	-0.21	10.32	16.12	15.85	51.84	32.02
BRD-K67860401	CP	AR-A014418	glycogen synthase kinase inhibitor	GSK3B	Glycogen synthase kinase inhibitor	4.23, 2.69	39.27	0.88, 0.19	49.64	72.76	53.05	18.06	42.20	82.43	37.24	43.71	82.17	12.50	25.79	42.72	0.00	-24.61	20.62	33.08	51.90	-27.95	39.27	77.88	77.96	71.82	8.97	37.48	-33.60	15.32	16.22	97.13	45.57
BRD-K07888107	CP	depudecin	HDAC inhibitor	HDAC1, HDAC2	HDAC inhibitor	1.92, 1.15	39.18	2.21, 0.53	41.38	24.41	24.20	57.45	42.21	30.82	2.47	39.18	21.05	20.77	19.79	57.14	5.79	7.61	63.79	2.01	20.09	21.54	47.19	93.51	58.53	57.29	51.13	21.65	31.06	75.44	53.34	87.74	49.98
BRD-K76723084	CP	isotretinoin	retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist	CYP2B6, CYP2C19, CYP2C8, CYP3A5, CYP3A7, NR2C2, PPARD, RARA, RARB, RARG, RORB, RORC	Retinoid receptor agonist	3.85, 0.77	39.17	0.82, 0.27	81.40	20.15	2.26	2.89	4.58	39.17	59.06	48.14	11.14	42.86	53.32	59.50	29.66	11.49	91.22	90.83	91.06	31.36	24.15	49.86	-17.64	41.23	17.56	20.27	35.25	96.78	45.26	54.18	22.60
BRD-A79981887	CP	midodrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D		5.00, 2.69	39.14	0.78, 0.14	22.29	30.26	77.29	10.22	84.88	25.43	89.62	87.12	37.38	39.14	80.10	75.85	-1.16	8.64	-54.35	18.87	33.83	8.24	98.29	30.91	59.63	7.05	67.04	39.79	75.82	86.91	37.50	63.68	70.37
BRD-U01690642	CP	acetyl-geranyl-cysteine	Ras carboxyl methylation inhibitor			6.15, 4.62	39.14	1.15, 0.40	64.13	-11.03	31.66	4.97	9.98	28.11	74.17	93.29	86.61	77.01	11.91	11.12	-2.11	-0.78	97.04	-10.28	98.24	13.25	94.07	44.80	8.88	48.05	39.14	99.86	44.00	9.04	47.98	3.21	97.81
BRD-A24429032	CP	HEAT	adrenergic receptor antagonist	ADRA1A		2.69, 1.54	39.11	1.06, 0.27	26.23	-33.74	7.35	44.13	5.03	56.65	27.91	81.62	26.47	41.15	66.57	50.35	2.78	37.55	54.72	4.67	98.24	17.64	18.59	71.68	77.70	39.11	-16.49	10.31	70.88	19.88	42.14	90.89	96.77
BRD-A43150328	CP	penicillic-acid	bacterial quorum sensing inhibitor, caspase inhibitor			2.04, 1.22	39.11	1.40, 0.55	88.80	32.66	68.08	8.42	33.41	85.06	40.62	9.86	21.02	78.83	19.98	62.24	64.75	84.78	-22.28	28.10	39.43	49.66	24.41	44.86	17.60	79.22	37.64	1.87	83.20	35.57	39.11	47.75	6.23
BRD-K36737713	CP	AG-957	Abl kinase inhibitor, protein tyrosine kinase inhibitor	ABL1, EGFR		6.15, 2.69	39.11	1.59, 0.56	54.92	18.56	39.11	22.83	27.22	12.82	-2.47	67.91	19.71	19.93	14.49	26.09	94.03	98.38	68.17	99.02	57.75	73.62	14.98	65.73	39.35	73.31	12.62	83.54	98.75	33.33	35.61	60.78	10.30
BRD-K76810206	CP	nicergoline	adrenergic receptor antagonist	ADRA1A		9.62, 6.54	39.09	0.76, 0.16	94.36	-13.76	7.54	32.15	34.69	12.81	35.33	95.74	58.23	60.89	19.87	21.52	4.88	24.40	73.13	49.47	42.10	89.16	37.71	36.98	39.09	32.40	3.55	85.57	99.98	56.09	72.36	51.59	85.67
BRD-K73293050	CP	WZ-3146	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR		6.15, 1.54	39.05	1.74, 0.50	4.32	17.21	59.07	96.51	72.70	6.36	5.25	34.00	62.08	63.43	31.04	23.43	33.04	88.84	94.66	64.09	39.05	97.55	14.61	74.41	38.04	0.00	77.90	33.04	83.68	25.46	14.99	40.66	80.31
BRD-K81847782	CP	scandenin	plant compound with antimicrobiial activity			1.53, 0.00	39.03	0.79, 0.17	88.73	2.54	86.24	40.63	37.40	47.37	37.43	20.09	36.73	0.32	-73.23	83.42	7.85	71.37	96.86	6.01	92.02	26.22	33.08	25.24	31.20	80.76	54.84	NaN	56.57	76.39	4.72	94.82	83.68
BRD-K31542390	CP	mycophenolic-acid	dehydrogenase inhibitor, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2	IMPDH inhibitor	3.46, 2.31	38.96	0.92, 0.33	27.41	97.64	71.34	38.96	87.93	13.64	81.00	27.93	9.88	43.03	19.93	76.08	31.47	15.27	48.25	69.69	41.08	30.84	41.60	38.33	53.68	89.14	18.08	0.81	15.53	25.70	77.77	78.43	25.66
BRD-K54233340	CP	dorsomorphin	AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor	ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC		6.92, 3.46	38.95	1.16, 0.24	38.95	98.41	95.99	90.12	87.07	26.35	48.47	-70.17	74.34	21.46	31.76	82.09	90.31	75.93	-43.05	98.94	22.16	88.16	35.24	29.08	82.17	54.15	36.35	-79.83	5.36	10.23	23.06	35.52	44.41
BRD-A18620900	CP	estriol	estrogen receptor agonist, estrogen receptor antagonist	ESR1, ESR2	Estrogen receptor agonist	4.08, 1.22	38.93	1.24, 0.34	89.91	56.78	38.93	55.76	43.38	42.58	7.61	61.83	81.59	33.58	6.37	39.32	3.21	2.01	85.42	23.14	90.80	21.23	83.94	29.92	15.04	68.27	36.57	4.19	35.24	68.28	28.92	-7.99	96.09
BRD-A68930007	CP	ouabain	ATPase inhibitor, alpha subunit binder	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2	ATPase inhibitor	3.46, 1.54	38.92	2.09, 0.56	18.33	89.01	93.03	89.44	45.47	31.11	5.71	16.75	48.98	3.02	6.57	48.33	93.98	80.97	38.92	98.84	33.53	48.77	18.27	30.41	50.78	48.55	20.58	-0.49	-15.92	2.22	31.40	81.99	58.22
BRD-A99449986	CP	MT-21	adenine nucleotide translocase inhibitor, caspase activator, neurotrophic agent	CYCS, SLC25A4		3.08, 1.54	38.91	0.67, 0.20	20.59	31.33	32.20	47.19	52.20	79.98	-20.11	56.86	11.33	42.40	36.75	28.31	69.14	22.50	84.76	91.98	69.89	77.36	26.19	24.48	38.91	56.08	12.00	62.29	32.64	-11.60	44.60	8.21	44.55
BRD-K34995470	CP	SU-1498	receptor tyrosine protein kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor	ERBB2, KDR		3.46, 1.92	38.91	0.81, 0.25	65.73	4.33	7.32	80.56	2.86	40.68	65.32	38.91	10.63	23.25	14.13	34.36	81.43	37.48	39.02	99.54	1.43	71.71	53.00	82.34	20.43	29.04	14.69	91.09	58.49	87.54	38.28	53.86	16.45
BRD-K11663430	CP	pyroxamide	HDAC inhibitor, cell cycle inhibitor	HDAC1	HDAC inhibitor	0.77, 0.00	38.89	1.53, 0.64	5.81	66.40	43.80	37.09	17.48	26.18	31.73	7.40	11.76	14.76	38.89	80.78	67.74	62.02	61.66	80.14	73.12	71.40	14.48	38.19	59.24	45.32	24.54	-59.04	9.83	17.13	57.22	65.29	41.66
BRD-K51967704	CP	BIIB021	HSP inhibitor	AOX1, HSP90AA1	HSP inhibitor	3.85, 1.92	38.89	1.28, 0.52	11.66	73.63	30.43	23.98	69.44	-2.43	34.61	-26.04	3.39	42.26	10.01	60.12	65.16	95.94	45.34	98.59	53.83	30.84	41.43	56.63	45.64	5.21	42.53	3.89	38.89	2.78	52.46	1.60	7.75
BRD-A09472452	CP	flecainide	sodium channel blocker, sodium channel inhibitor, voltage-gated sodium channel blocker	SCN5A, KCNA5, KCNA7, SCN4A		2.31, 1.92	38.86	0.55, 0.09	89.38	-10.47	2.44	18.96	14.05	12.79	54.08	81.97	42.65	50.65	40.34	50.19	0.00	1.94	38.86	19.04	86.71	24.30	67.35	85.93	6.55	3.96	44.63	77.21	75.09	34.96	16.24	62.17	30.16
BRD-A82656074	CP	naltrindole	opioid receptor antagonist	OPRD1, OPRK1, OPRM1		5.00, 3.46	38.86	0.94, 0.36	9.13	59.71	41.91	38.86	38.22	44.84	30.57	87.49	13.01	33.99	54.73	52.14	10.60	41.17	-72.45	-0.63	52.03	62.90	14.74	48.50	64.32	36.30	-16.15	-99.89	99.93	35.09	8.36	72.99	60.52
BRD-K89162000	CP	tandutinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	FLT3, KIT, PDGFRA, PDGFRB, CSF1R, PDGFD	PDGFR/KIT inhibitor	3.85, 2.69	38.86	0.97, 0.28	14.45	15.88	68.75	47.34	43.48	3.80	16.39	25.97	8.12	45.39	14.19	38.67	-8.91	74.95	53.54	2.18	50.50	82.07	38.86	51.39	38.94	63.14	22.94	-15.59	59.83	49.04	27.20	62.69	34.84
BRD-K53913732	CP	SB-408124	orexin receptor antagonist, orexin type 1 receptor antagonist	HCRTR1, HCRTR2		5.00, 2.31	38.84	0.93, 0.22	74.29	-5.36	93.53	64.39	80.84	42.06	47.90	38.84	-53.10	12.82	8.76	34.73	21.30	9.78	99.00	21.42	99.30	26.93	0.25	95.87	3.70	91.83	31.62	99.68	77.05	27.64	41.78	18.91	53.32
BRD-A43671941	CP	oxprenolol	adrenergic receptor antagonist	ADRB1, ADRB2		6.53, 4.08	38.83	0.88, 0.22	98.38	27.82	90.95	6.41	45.99	3.87	38.83	38.20	52.74	44.57	56.56	32.25	4.23	4.30	96.42	2.64	81.07	23.59	31.09	44.83	15.92	22.04	30.40	62.79	65.31	77.61	25.92	43.68	50.91
BRD-K40578143	CP	GR-79236	adenosine receptor agonist	ADORA1, ADORA2A	Adenosine receptor agonist	6.54, 3.08	38.81	1.09, 0.34	26.49	13.26	-4.28	20.23	4.83	91.66	83.44	70.61	38.81	4.15	24.69	69.08	-2.82	33.53	78.47	-3.20	61.15	40.14	93.95	96.04	-13.10	98.87	26.52	94.06	23.29	67.17	32.56	66.77	97.53
BRD-A43331270	CP	niguldipine	adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor	ADRA1A, CACNA1C, ADRA1B, ADRA1D		8.85, 4.23	38.80	2.22, 0.72	38.80	41.80	75.47	91.30	10.58	4.05	14.37	46.97	8.63	6.41	3.63	48.68	96.76	99.12	74.93	99.93	42.79	96.06	35.50	21.69	8.15	3.76	4.00	37.55	81.35	69.17	24.38	10.99	44.49
BRD-K47943470	CP	tyrphostin-51	EGFR inhibitor			4.62, 2.69	38.76	1.35, 0.39	40.45	30.10	6.61	46.08	0.63	88.35	67.49	98.56	98.69	4.58	10.47	30.23	-77.60	0.95	2.85	-74.90	22.82	39.43	38.76	36.65	-3.84	39.75	45.77	-78.45	95.78	45.81	74.91	81.60	87.69
BRD-K79930101	CP	GW-583340	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, ErbB2 tyrosine kinase inhibitor, receptor tyrosine protein kinase inhibitor	EGFR, ERBB2		6.54, 4.23	38.76	0.94, 0.33	26.19	10.83	17.67	38.76	14.80	24.74	99.40	73.45	37.08	8.74	11.46	63.91	2.26	48.33	45.71	2.71	72.38	8.21	46.48	85.42	60.58	60.11	3.84	53.46	69.15	18.77	18.20	98.40	75.52
BRD-A45498368	CP	WYE-125132	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	MTOR inhibitor	7.31, 1.54	38.74	1.59, 0.50	8.96	48.23	63.79	93.03	39.72	12.49	3.49	31.28	6.74	19.51	38.74	95.58	90.10	75.92	88.64	99.54	94.43	92.95	5.85	43.13	12.69	45.89	8.10	-34.40	0.00	20.82	32.41	36.37	52.58
BRD-K47693913	CP	evoxine	antagonist of strychnine and pentylenetrazole; enhances effects of narcotics			1.54, 0.77	38.73	0.94, 0.32	15.31	-11.59	10.51	42.20	80.69	-12.69	18.72	49.03	3.59	39.24	38.73	16.48	-5.88	3.70	61.20	24.29	50.30	19.06	88.59	12.35	55.02	40.47	39.72	0.85	89.12	78.12	21.16	91.40	55.35
BRD-K34415467	CP	trimethobenzamide	histamine receptor antagonist	DRD2		3.08, 1.54	38.67	0.81, 0.31	4.85	23.93	49.40	8.10	80.57	10.61	21.10	74.14	9.80	38.67	73.77	58.45	1.48	9.44	65.06	0.53	86.54	32.76	68.34	68.24	47.13	50.02	11.85	-4.23	-26.34	73.05	22.98	84.40	49.77
BRD-K78485176	CP	olmesartan	angiotensin receptor antagonist, angiotensin antagonist	AGTR1	Angiotensin receptor antagonist	9.62, 6.54	38.67	0.98, 0.26	48.38	96.96	80.95	18.84	99.99	12.79	9.48	34.73	29.00	14.21	15.39	67.15	2.08	38.67	83.66	29.25	93.47	17.90	13.24	93.73	87.29	69.64	52.01	-65.84	-80.46	8.87	85.70	85.94	84.07
BRD-K34608650	CP	BRD-K34608650	cannabinoid receptor agonist	CNR2		5.38, 2.69	38.64	1.24, 0.35	76.84	14.46	91.27	6.03	82.67	88.88	20.11	70.10	57.39	4.12	6.21	15.72	1.30	7.33	99.47	18.06	96.08	4.06	52.99	97.60	38.54	92.83	38.64	-26.26	-0.46	41.01	37.17	74.36	63.10
BRD-K19796430	CP	erismodegib	hedgehog pathway inhibitor, smoothened receptor antagonist	SMO		3.08, 2.31	38.61	2.52, 0.73	9.55	84.36	99.89	10.54	74.19	27.51	29.46	-25.00	43.68	24.77	34.06	52.73	-10.60	46.06	45.36	6.51	74.45	30.76	-76.54	42.61	90.05	38.61	61.13	-99.93	18.17	6.07	49.39	49.11	96.08
BRD-K35960502	CP	niclosamide	DNA replication inhibitor, STAT inhibitor	STAT3		8.46, 5.38	38.61	2.25, 0.74	38.71	85.05	53.70	99.12	82.46	16.14	-20.00	-32.49	15.79	32.42	22.41	67.32	99.97	99.15	85.76	99.93	76.64	97.85	25.86	38.61	26.02	24.78	36.50	29.58	81.36	52.48	23.33	12.49	33.76
BRD-A20968261	CP	WAY-213613	glutamate transporter inhibitor	SLC1A2		2.69, 0.77	38.60	0.76, 0.27	36.71	10.31	2.11	38.69	4.62	62.74	86.98	72.72	5.88	90.70	21.51	9.78	0.00	17.64	63.67	2.54	53.82	13.28	60.29	55.82	57.95	44.40	12.12	38.60	68.28	83.82	25.94	85.34	0.53
BRD-K89930444	CP	AG-592	tyrosine kinase inhibitor			5.77, 3.08	38.59	1.82, 0.48	38.59	81.76	6.79	94.83	60.16	7.68	3.46	42.01	30.81	1.42	55.52	25.77	99.01	96.84	26.72	99.96	19.89	86.41	34.58	78.26	20.40	39.92	17.63	-0.85	50.50	0.00	15.80	62.79	64.18
BRD-K18757346	CP	U-46619	thromboxane receptor agonist	PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R		3.85, 2.31	38.57	0.91, 0.20	29.62	14.92	47.45	37.79	28.26	5.95	17.98	52.75	38.57	5.73	8.50	46.91	0.00	1.97	68.20	2.71	51.65	58.40	43.65	90.06	9.08	49.10	94.03	15.28	36.26	79.25	71.46	57.00	76.74
BRD-A36318220	CP	necrostatin-1	RIPK inhibitor, indoleamine 2,3-dioxygenase inhibitor	IDO1, KRR1, RIPK1		2.69, 1.15	38.56	0.58, 0.11	82.84	-22.14	31.76	57.52	31.69	3.81	59.42	81.90	38.56	75.19	67.37	34.40	15.80	34.62	30.67	15.84	89.40	53.65	28.12	76.85	33.46	33.77	43.52	-0.04	74.29	77.93	21.35	88.98	70.68
BRD-K90524085	CP	MY-5445	phosphodiesterase inhibitor, platelet aggregation inhibitor	PDE5A		4.23, 2.31	38.56	0.70, 0.18	10.35	38.56	74.66	71.33	47.59	41.98	25.37	25.74	91.19	88.08	4.66	27.21	37.68	41.93	84.27	30.25	84.53	35.91	27.71	59.70	61.50	92.22	15.07	-95.11	30.16	6.03	33.70	99.40	90.87
BRD-A53952395	CP	prilocaine	anesthetic	SCN5A		6.53, 3.67	38.54	1.05, 0.44	11.85	16.61	70.72	7.76	8.70	36.23	74.80	99.65	10.29	89.64	17.84	85.66	0.99	1.76	84.55	3.14	68.50	0.99	61.89	81.06	46.77	38.54	27.75	99.08	-44.64	64.49	6.23	59.86	95.46
BRD-K90543092	CP	levonorgestrel	estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist	PGR, AR, CYP2E1, ESR1, SRD5A1	Progesterone receptor agonist	4.49, 2.04	38.54	1.13, 0.44	1.50	46.47	13.37	57.71	37.03	32.96	95.82	62.29	29.97	13.50	32.03	45.72	20.71	46.31	92.94	10.82	50.24	11.37	52.99	11.19	61.02	38.54	65.24	-42.35	5.89	81.18	27.14	47.09	70.37
BRD-K12244279	CP	MEK1-2-inhibitor	MEK inhibitor	MAP2K1, MAP2K2	MEK inhibitor	3.08, 1.15	38.53	1.14, 0.49	11.31	22.02	5.18	79.26	20.49	51.27	30.26	53.61	24.92	45.49	13.88	69.27	0.00	88.21	85.59	12.15	40.44	83.38	8.15	65.81	45.76	39.14	38.53	1.49	19.40	35.99	59.41	29.38	89.58
BRD-K49328571	CP	dasatinib	KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor	ABL1, FYN, LCK, SRC, KIT, YES1, BCR, EPHA2, LYN, PDGFRB, ABL2, BTK, DDR1, DDR2, PDGFRA, STAT5B	SRC inhibitor	5.77, 3.08	38.53	1.44, 0.53	50.02	73.79	36.70	99.19	19.98	35.98	0.95	-11.42	77.18	17.44	0.74	92.49	61.70	92.32	98.11	86.69	37.18	94.43	21.45	88.28	38.53	12.63	13.36	-61.50	35.78	48.49	29.66	39.36	96.09
BRD-A15034104	CP	bergenin	anti-arthritic compound that modulates Th1/Th2 cytokine balance	PTPN1		6.12, 4.08	38.52	1.19, 0.32	63.91	20.12	70.27	8.48	47.92	90.51	22.61	24.17	35.07	55.34	71.85	72.83	1.20	33.76	45.92	3.07	56.62	21.25	99.19	69.67	38.52	90.84	96.30	-6.95	-6.29	35.19	24.32	40.67	4.53
BRD-K79404599	CP	enzastaurin	PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor	PRKCB, AKT1, GSK3B, PRKCA, PRKCD, PRKCG	PKC inhibitor	2.69, 0.77	38.49	0.86, 0.27	16.83	75.51	63.58	61.65	33.55	41.86	8.84	38.62	12.62	71.43	18.26	48.43	36.43	92.18	47.33	90.71	84.80	72.12	19.96	23.80	34.46	38.49	1.83	17.93	77.81	26.03	30.66	34.72	61.07
BRD-A02333338	CP	cyclopamine	smoothened receptor antagonist, hedgehog pathway inhibitor	SMO, DHH, IHH, PTCH1		4.62, 1.54	38.47	1.39, 0.55	29.35	98.34	27.00	34.55	85.55	92.72	43.68	96.66	21.50	38.47	0.00	46.98	0.00	28.55	36.33	6.72	64.07	71.36	26.26	61.24	51.37	25.60	68.92	-76.69	0.67	5.89	73.45	65.74	96.90
BRD-A46179541	CP	doxapram	potassium channel blocker	KCNK3, KCNK9	Potassium channel blocker	3.46, 2.31	38.47	1.13, 0.48	14.42	-3.77	7.99	40.83	44.57	22.47	5.57	53.46	-0.99	75.23	7.84	55.84	8.71	54.48	90.85	20.33	88.43	73.92	27.43	50.49	59.59	72.82	38.47	2.22	37.07	67.29	19.56	50.50	15.78
BRD-K68332390	CP	ponalrestat	aldose reductase inhibitor, reductase inhibitor	AKR1B1		3.08, 1.54	38.43	1.34, 0.30	35.67	8.28	28.26	24.83	59.52	3.59	64.87	46.37	11.91	49.70	43.79	38.43	2.82	5.29	42.33	6.83	60.48	13.83	39.00	91.81	42.77	31.63	71.93	86.80	62.48	12.13	26.50	80.81	3.07
BRD-K07881437	CP	danusertib	Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor	AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, BCR, SLK	Aurora kinase inhibitor	4.62, 1.92	38.42	2.02, 0.48	34.41	87.39	47.75	94.95	83.69	22.07	13.27	38.42	54.98	28.32	5.84	31.30	31.18	15.27	95.69	3.27	72.72	78.90	57.52	54.33	71.72	19.99	58.40	4.54	77.13	6.59	34.43	16.73	58.24
BRD-K65285700	CP	BRD-K65285700	cannabinoid receptor agonist	CNR2	Cannabinoid receptor agonist	3.08, 1.92	38.40	0.86, 0.26	54.41	9.13	8.50	75.47	8.85	69.05	12.08	38.40	61.91	15.00	27.62	59.51	57.43	39.98	29.99	94.94	90.16	85.75	18.79	94.98	38.32	81.63	-6.69	0.78	48.88	7.14	8.83	66.19	37.81
BRD-K40965114	CP	cyanopindolol	adrenergic receptor antagonist	HTR1D		3.27, 2.04	38.38	1.40, 0.47	38.38	19.05	77.27	25.51	27.35	25.83	9.21	37.22	53.70	92.07	65.03	89.59	-2.71	22.58	99.08	6.76	46.74	40.61	73.02	57.18	25.48	50.75	73.98	16.40	31.82	77.07	7.19	24.89	50.07
BRD-K57304726	CP	PRE-084	alpha receptor agonist, sigma receptor agonist	SIGMAR1		5.38, 2.69	38.36	0.73, 0.20	77.35	19.13	99.40	13.30	56.04	18.95	21.63	63.12	22.21	42.83	13.49	52.39	1.48	3.70	99.19	17.44	91.16	30.04	22.93	65.10	82.27	82.51	40.29	1.87	28.12	28.66	38.36	91.54	63.56
BRD-A03216249	CP	mepivacaine	potassium channel antagonist, voltage-gated sodium channel blocker	SCN10A, SCN9A		5.00, 2.31	38.35	1.41, 0.36	66.34	84.99	84.03	22.45	68.96	66.68	0.99	20.53	20.56	41.21	61.79	49.94	5.19	31.31	52.63	0.00	35.31	14.59	45.06	75.41	89.25	26.41	83.43	30.71	38.35	91.67	34.95	8.49	20.15
BRD-K85606544	CP	neratinib	EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4, KDR	EGFR inhibitor	9.62, 6.92	38.35	1.48, 0.31	15.81	63.99	32.58	94.86	59.96	30.67	7.55	-68.25	8.88	96.00	2.85	68.43	92.39	99.99	37.69	99.93	22.48	95.53	65.62	26.10	57.58	48.64	33.77	39.53	81.70	16.03	38.35	7.60	27.25
BRD-A66199457	CP	asiaticoside	possible antitumor agent			5.71, 3.27	38.34	1.50, 0.44	99.47	39.45	99.23	30.69	2.53	99.54	25.41	27.93	45.22	67.88	87.64	88.58	0.00	23.10	9.53	5.89	74.31	46.25	98.07	84.21	9.07	70.69	29.65	-4.23	38.34	35.91	11.06	9.91	90.92
BRD-K88625236	CP	nonoxynol-9	interacts with the lipids in the membranes of the acrosome and the midpiece of the sperm			5.00, 2.31	38.32	1.23, 0.22	71.79	61.77	66.44	94.71	68.82	18.89	28.77	56.53	17.98	38.32	47.41	93.49	91.98	81.43	36.40	99.93	12.35	75.46	23.86	32.02	74.96	67.40	-0.75	-27.85	20.32	22.77	29.19	27.19	10.86
BRD-U94846492	CP	quinine	cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor	KCNN4, ABCB1, CYP2D6, GP9, KCNB2, SLC29A4		3.08, 1.15	38.32	2.16, 0.49	65.69	-10.18	93.24	7.89	34.54	12.79	78.92	70.96	38.32	20.06	84.75	79.34	3.34	77.12	85.38	-26.07	89.98	10.66	20.07	55.37	26.88	68.35	15.19	7.76	7.61	87.61	82.01	85.87	30.24
BRD-K32318651	CP	acyclovir	DNA polymerase inhibitor, DNA directed DNA polymerase inhibitor	PNP		8.46, 4.62	38.31	1.99, 0.50	19.64	61.77	83.98	18.18	39.14	7.12	66.13	-31.84	12.55	99.89	71.57	52.13	8.36	10.89	76.92	26.02	76.85	32.24	97.59	-26.25	96.86	48.37	33.49	-20.68	0.78	72.52	27.15	62.91	38.31
BRD-A73605923	CP	mocimycin	protein synthesis inhibitor			5.38, 3.46	38.28	0.90, 0.30	11.33	-40.60	38.28	20.64	17.53	29.61	13.47	51.35	11.93	45.11	25.58	49.19	2.82	14.55	70.33	1.90	97.89	43.04	14.41	65.71	12.29	91.97	63.32	99.86	54.62	69.66	21.91	63.22	50.98
BRD-K85015012	CP	NNC-05-2090	GABA uptake inhibitor, GAT inhibitor	SLC6A11, SLC6A12, SLC6A13		9.62, 6.54	38.25	1.48, 0.51	23.38	20.61	95.72	94.53	11.44	10.67	33.93	43.51	68.30	10.83	31.93	50.98	88.61	98.52	62.90	98.97	46.09	99.40	17.31	31.94	32.90	7.48	2.57	-2.47	99.19	38.25	56.50	27.95	90.65
BRD-K08219523	CP	5-nonyloxytryptamine	serotonin receptor agonist	HTR1B, HTR1D		8.46, 4.62	38.24	1.58, 0.38	54.04	24.05	90.49	97.02	29.09	75.43	11.99	53.20	63.14	16.41	69.62	71.98	97.28	99.79	74.89	99.93	25.84	98.20	34.61	22.05	13.29	27.99	-6.84	-14.00	77.14	30.40	38.24	7.01	22.04
BRD-K82381502	CP	acetylcholine	neurotransmitter of the peripheral and central nervous systems	ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2		4.90, 2.45	38.24	2.52, 0.67	30.16	92.83	55.16	35.97	77.08	74.24	82.55	-79.55	17.07	27.12	17.13	57.58	1.16	31.00	96.50	81.95	81.85	14.00	83.17	8.89	55.89	39.46	27.49	7.61	29.56	86.82	38.24	43.48	20.90
BRD-K69837166	CP	trap-101	nociceptin/orphanin FQ (NOP) receptor antagonist, opioid receptor antagonist	OPRL1		6.54, 2.69	38.23	0.89, 0.22	-2.57	17.16	44.82	7.87	98.10	14.14	-3.87	17.71	35.84	38.21	58.45	38.23	10.66	44.25	91.52	97.33	63.51	33.29	-25.68	94.38	78.42	85.36	-15.15	0.00	14.90	49.01	58.53	99.72	75.22
BRD-K64402243	CP	ivachtin	caspase inhibitor	CASP3		4.23, 2.69	38.20	1.60, 0.39	41.99	-34.90	6.76	30.95	42.77	32.43	96.62	51.64	80.68	35.91	99.72	75.48	1.87	14.17	26.16	-91.24	-35.92	5.54	75.56	93.18	8.95	46.77	12.15	69.83	48.33	96.83	38.20	90.08	3.17
BRD-A97739905	CP	ketoprofen	cyclooxygenase inhibitor	PTGS2, PTGS1, CXCR1, SLC5A8		6.92, 2.69	38.19	1.07, 0.39	3.35	24.92	97.44	3.77	73.58	38.19	7.82	96.42	52.68	65.36	91.66	5.53	2.29	2.36	98.87	5.94	99.31	30.59	54.50	95.54	38.05	37.41	58.52	62.04	-19.23	52.11	38.11	3.96	92.96
BRD-A87606379	CP	nadolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3		5.00, 2.31	38.18	0.72, 0.11	40.42	35.18	1.23	26.04	38.18	19.30	74.00	92.24	23.35	37.12	58.51	69.18	-1.09	22.14	82.65	1.83	49.56	2.62	27.80	84.16	51.88	72.78	38.57	16.21	18.55	63.00	10.79	69.63	64.62
BRD-K68756823	CP	FR-180204	MAP kinase inhibitor	MAPK1, MAPK3		6.54, 4.62	38.18	0.89, 0.24	10.36	47.23	10.01	38.18	71.08	0.03	16.74	17.24	13.89	97.99	85.75	30.39	10.67	75.83	65.09	94.98	86.78	63.87	32.00	71.90	89.65	77.85	29.58	33.54	60.20	27.70	80.59	2.04	16.74
BRD-A13946108	CP	sulindac	ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor	AKR1B1, PTGS1, PTGS2, MAPK3, PPARD, PTGDR2		5.31, 1.22	38.17	1.27, 0.35	5.58	38.17	37.02	52.85	50.35	5.78	6.74	74.26	20.29	20.18	47.32	81.71	2.82	-10.12	81.02	2.75	97.25	41.58	45.89	51.42	-9.34	4.33	57.73	99.19	11.35	94.77	17.78	22.74	67.26
BRD-K98157055	CP	SIB-1757	glutamate receptor antagonist	GRM5		6.92, 4.23	38.16	1.11, 0.28	-24.43	95.48	99.51	14.71	97.68	40.33	18.29	27.42	10.64	38.16	26.92	36.04	-3.14	57.09	-8.95	52.11	93.29	24.95	63.19	90.86	83.07	89.40	63.58	-0.88	20.30	26.32	67.25	73.50	21.76
BRD-K31912990	CP	CGP-71683	neuropeptide receptor antagonist	NPY5R		8.46, 5.00	38.09	1.72, 0.61	67.06	57.83	82.72	98.62	73.72	2.85	-26.35	29.90	13.07	13.50	15.37	75.01	99.37	99.12	54.99	99.96	73.68	98.48	9.13	21.45	22.16	5.30	6.20	14.45	81.03	38.09	47.55	32.31	17.79
BRD-A48809242	CP	IB-MECA	adenosine receptor agonist, granulocyte colony stimulating factor agonist	ADORA3, ADORA1, ADORA2A, ADORA2B	Adenosine receptor agonist	5.71, 2.45	38.03	0.89, 0.24	96.24	-10.68	71.05	8.53	-29.23	93.34	8.30	61.87	99.68	49.92	3.00	29.55	1.83	19.75	67.05	2.64	49.63	62.16	57.88	84.52	38.35	14.07	-8.97	63.13	35.24	14.32	16.44	38.03	45.68
BRD-K49294207	CP	BIBU-1361	EGFR inhibitor	EGFR	EGFR inhibitor	9.39, 4.90	38.03	1.69, 0.69	3.77	38.03	78.43	95.48	13.59	3.04	10.27	13.92	19.99	63.26	25.83	85.14	95.88	99.89	69.32	99.47	46.26	98.99	15.82	64.08	34.92	4.72	32.38	0.00	58.23	46.45	70.57	7.20	15.94
BRD-A64227845	CP	SKF-77434	dopamine receptor agonist, dopamine receptor partial agonist	DRD1		3.46, 2.69	37.94	0.84, 0.34	6.75	94.56	53.89	29.43	89.14	3.88	96.56	37.94	99.24	25.29	77.95	87.81	-5.87	32.20	35.39	-6.36	-15.21	14.75	91.01	44.62	55.76	19.71	67.65	-86.35	81.17	65.52	62.89	34.66	37.22
BRD-K71289571	CP	zafirlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2		4.90, 2.86	37.94	0.97, 0.27	76.56	26.82	8.05	17.18	23.65	21.59	95.86	49.35	8.88	39.24	6.09	76.45	4.98	37.94	93.94	53.09	81.35	34.65	92.98	6.13	24.60	94.81	61.32	7.10	37.02	87.73	82.68	76.89	32.87
BRD-A34205397	CP	suloctidil	adrenergic receptor antagonist, platelet aggregation inhibitor, vasodilator			9.91, 7.33	37.91	2.07, 0.56	7.58	61.96	54.00	98.41	40.28	17.75	-17.12	39.22	8.19	30.74	15.70	37.91	99.33	98.73	-7.19	99.93	76.57	99.15	10.94	4.02	40.55	8.15	33.01	-10.39	87.34	19.43	54.20	2.57	62.92
BRD-K53263234	CP	CITCO	constitutive androstane receptor (CAR) agonist	NR1I3		5.31, 3.27	37.91	1.18, 0.35	69.53	25.39	16.73	18.84	18.19	99.00	55.86	42.49	21.13	49.71	27.63	37.91	13.39	-16.81	14.59	2.15	71.14	22.37	93.51	75.74	72.64	26.37	11.45	60.82	24.92	45.61	47.34	55.29	76.67
BRD-K47598052	CP	PP-1	src inhibitor, Abl kinase inhibitor	HCK, RET, SRC	SRC inhibitor	6.92, 3.85	37.89	1.75, 0.64	15.30	56.76	78.69	97.70	41.16	28.39	1.13	31.71	88.31	60.02	1.27	73.06	3.48	15.07	97.50	93.32	86.89	94.70	-22.34	76.63	32.31	-5.70	14.58	-12.92	37.89	20.12	21.77	41.18	57.44
BRD-A39747742	CP	estradiol-valerate	estrogen receptor agonist	ESR1	Estrogen receptor agonist	1.92, 1.54	37.88	1.16, 0.43	75.94	70.89	87.99	27.54	75.61	35.62	6.24	-40.99	28.92	6.08	24.73	70.29	8.91	4.16	97.99	64.19	53.81	8.26	-17.80	84.82	89.74	71.47	41.26	37.88	-27.32	42.29	13.52	82.37	12.38
BRD-K77175907	CP	calcifediol	vitamin D receptor agonist	VDR	Vitamin D receptor agonist	4.62, 1.92	37.84	0.88, 0.28	90.10	36.69	7.17	72.74	88.30	0.02	12.52	26.20	9.34	92.45	72.87	96.13	24.65	56.23	71.53	80.09	60.45	19.56	0.14	59.45	80.88	27.48	25.18	86.80	14.05	90.90	24.36	37.84	-13.79
BRD-A67981824	CP	cefotaxime	cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	6.54, 4.62	37.83	1.38, 0.35	41.66	76.70	33.47	3.17	59.28	24.33	49.19	65.97	34.83	99.89	60.94	15.75	0.00	23.81	3.02	4.25	84.08	11.94	93.70	49.19	97.92	39.22	36.29	2.61	16.81	44.31	12.66	63.28	37.83
BRD-K05673000	CP	dicloxacillin	bacterial cell wall synthesis inhibitor		Bacterial cell wall synthesis inhibitor	7.31, 3.08	37.80	0.85, 0.26	68.27	-88.42	1.59	16.01	38.75	27.01	27.64	98.98	42.27	96.49	94.07	37.80	-3.17	2.04	90.17	-0.99	76.79	9.02	99.29	50.25	38.34	8.21	7.48	-74.91	22.38	82.73	14.99	55.29	94.25
BRD-K32828673	CP	chelidonine	tubulin polymerization inhibitor		Tubulin inhibitor	2.86, 0.82	37.80	1.86, 0.72	26.90	72.43	87.61	69.99	17.75	84.64	12.69	32.46	15.17	74.59	6.05	50.62	37.80	8.26	-23.00	93.80	84.27	56.41	96.56	7.57	40.54	45.04	36.67	-8.42	-20.89	43.39	14.81	25.91	75.89
BRD-K78431006	CP	crizotinib	ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	ALK, MET, CYP2B6, CYP3A5, MST1R, ROS1		3.85, 3.46	37.75	0.97, 0.19	3.41	83.90	68.69	87.80	74.40	19.54	-14.94	-21.36	8.07	54.72	66.46	50.66	81.61	74.76	47.62	99.96	-46.32	86.08	9.03	34.19	93.66	37.75	35.06	12.91	55.79	32.37	35.03	28.74	30.68
BRD-K72024482	CP	MRS-1754	adenosine receptor antagonist	ADORA2B, ADORA1, ADORA2A, ADORA3		5.77, 2.69	37.70	0.80, 0.20	28.79	10.77	3.52	11.74	23.56	11.72	97.70	34.74	12.85	39.42	37.70	49.00	0.00	5.29	72.46	0.00	82.32	0.74	81.40	59.45	66.59	79.11	26.08	89.63	60.17	57.70	92.00	99.08	30.37
BRD-A32164164	CP	methyllycaconitine	acetylcholine receptor antagonist	CHRNA7		4.23, 0.77	37.67	1.06, 0.31	70.53	-14.56	4.86	27.13	42.56	4.61	-8.56	47.53	5.64	3.71	65.01	65.36	0.00	3.65	88.67	-2.33	97.17	37.67	68.21	78.58	-64.81	86.65	77.00	31.26	-10.25	-9.03	74.88	46.53	50.86
BRD-K26669427	CP	WR-216174	CDK inhibitor, PFMRK inhibitor			5.38, 2.69	37.62	1.34, 0.45	16.38	81.32	33.26	74.54	31.72	9.69	17.30	29.34	42.79	33.12	80.64	36.48	85.41	83.04	65.36	99.68	66.78	43.88	16.12	49.66	45.99	37.19	37.62	-22.23	82.89	-4.04	25.66	63.64	27.34
BRD-K59851896	CP	calycanthine	GABA release inhibitor			2.69, 0.38	37.61	0.83, 0.23	13.72	38.27	8.32	45.00	-4.55	11.28	95.18	50.46	3.13	79.05	95.54	46.50	-1.87	3.56	47.58	2.89	77.98	21.44	37.61	25.65	64.58	23.42	5.53	-0.78	51.29	84.35	72.37	91.08	10.71
BRD-A75478957	CP	PD-166793	collagenase inhibitor, metalloproteinase inhibitor, stromelysin inhibitor	MMP13, MMP2, MMP3		3.46, 2.31	37.59	1.16, 0.31	3.21	37.59	83.42	31.68	16.05	65.27	11.83	78.35	42.35	7.86	63.38	13.95	-6.98	0.00	20.87	2.26	98.73	59.08	-17.08	63.47	66.15	85.99	28.06	-58.58	54.94	12.38	91.42	75.67	64.37
BRD-K04046242	CP	equilin	estrogen receptor agonist	HSD17B1	Estrogen receptor agonist	2.31, 0.38	37.57	0.45, 0.36	33.66	38.84	9.22	11.79	37.57	20.43	40.67	15.33	10.86	24.98	37.19	86.54	2.22	46.46	45.60	97.14	43.03	9.54	45.64	43.42	37.39	53.18	32.62	6.71	51.34	39.97	48.06	70.71	28.36
BRD-K26134695	CP	calpeptin	calpain inhibitor, proteasome inhibitor, tyrosine phosphatase inhibitor			5.00, 2.31	37.57	1.59, 0.51	19.05	63.71	24.33	41.15	37.57	27.42	93.43	88.51	33.45	49.43	27.07	73.75	0.00	42.49	60.86	-4.05	32.02	16.34	89.29	50.92	93.96	22.92	24.16	-28.12	88.08	10.44	16.63	94.92	89.75
BRD-K77641333	CP	naphazoline	adrenergic receptor agonist, peptide agonist	ADRA1A, ADRA2A		6.92, 3.08	37.56	1.15, 0.33	7.51	24.52	92.49	71.95	80.52	21.75	42.96	97.32	19.78	-0.67	80.61	37.56	1.62	-8.25	97.18	9.61	98.85	13.22	-57.32	92.86	15.94	60.12	81.69	49.95	57.46	-12.86	29.04	32.19	95.70
BRD-K08554278	CP	bisbenzimide	BCL inhibitor, DNA binding, topoisomerase inhibitor	BCL2L1, TOP1		6.15, 2.69	37.55	0.94, 0.38	11.77	84.27	85.98	7.92	78.20	63.43	11.31	28.36	20.80	40.95	53.66	94.26	19.00	34.53	68.09	1.97	28.70	19.58	25.00	61.24	68.27	98.38	5.36	0.00	-6.92	50.59	37.55	89.04	65.75
BRD-K76775527	CP	nimesulide	cyclooxygenase inhibitor, matrix metalloprotease inhibitor, prostanoid receptor inhibitor	PTGS2, LTF, PLA2G2E, PTGS1		10.77, 6.92	37.54	1.30, 0.38	64.13	24.35	83.78	24.75	-45.07	44.44	0.78	76.46	18.04	2.57	-0.42	25.21	2.73	5.03	97.19	0.78	96.52	15.14	42.14	100.00	38.68	66.38	48.26	99.44	29.80	96.69	37.54	99.15	31.61
BRD-A10303790	CP	talampicillin	antibiotic			2.31, 1.54	37.53	0.80, 0.17	44.78	6.99	32.14	13.16	37.53	30.88	83.61	58.95	8.21	96.01	94.99	86.40	-6.54	19.87	65.71	7.69	25.94	11.30	98.35	56.45	25.13	38.07	20.69	84.49	28.83	39.87	36.44	93.70	43.54
BRD-K81876028	CP	CP-93129	serotonin receptor agonist	HTR1A, HTR1B		3.85, 3.08	37.49	1.17, 0.32	45.93	74.29	85.75	23.94	68.29	11.21	77.11	57.69	91.89	4.43	11.36	66.74	-9.45	5.65	64.47	8.11	50.99	35.12	36.77	89.91	30.46	87.14	64.34	-3.82	0.83	-7.67	23.93	93.74	37.49
BRD-K91733562	CP	secoisolariciresinol	antioxidant			4.62, 2.31	37.47	1.17, 0.33	58.53	31.80	30.90	4.53	59.75	-20.98	88.66	61.40	41.34	93.48	27.16	82.78	-9.80	4.19	81.49	24.28	96.97	36.28	28.22	37.47	69.58	29.78	9.17	-59.04	18.85	41.67	64.52	80.25	49.36
BRD-K14681867	CP	somatostatin	somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand	SSTR1, SSTR2, SSTR3, SSTR4, SSTR5, GH1, GHR, OPRD1, OPRM1		4.62, 0.77	37.46	0.93, 0.34	83.44	21.47	8.29	25.20	45.54	11.51	37.54	65.56	56.94	3.21	37.46	37.98	3.97	9.32	86.13	1.30	32.77	14.36	19.12	95.12	61.22	62.60	18.13	-99.08	21.24	46.80	64.14	85.86	69.38
BRD-K06198550	CP	isorotenone	mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor	MT-ND1		5.77, 1.54	37.45	1.10, 0.23	62.58	-23.85	2.85	80.72	3.52	8.83	33.67	65.37	35.07	60.09	75.08	46.06	37.45	9.58	44.66	95.59	28.69	10.89	65.61	91.40	4.38	4.09	-5.96	-1.87	46.84	96.75	5.29	85.66	61.18
BRD-K64044582	CP	linoleamide	ACAT inhibitor	SOAT1, SOAT2		5.77, 3.46	37.45	1.16, 0.32	27.89	12.35	29.83	22.22	44.38	28.10	57.04	37.45	6.17	67.16	73.22	97.00	0.00	12.08	48.69	2.29	-51.58	9.90	77.36	61.19	94.61	39.35	51.23	14.77	10.10	99.54	49.34	99.08	19.29
BRD-K76205745	CP	losartan	angiotensin receptor antagonist	AGTR1		1.92, 1.15	37.45	0.31, 0.02	78.19	8.28	56.39	16.27	55.45	32.91	22.27	77.38	13.20	24.01	47.90	45.15	-0.60	17.27	45.42	1.48	91.39	19.39	37.45	35.62	37.60	68.83	11.48	37.84	52.75	27.72	28.29	74.18	82.15
BRD-A69917777	CP	aminopentamide	anticholinergic agent			5.38, 2.31	37.44	0.72, 0.16	24.23	30.73	35.21	25.72	96.87	1.34	-35.27	58.21	32.95	31.18	29.94	41.04	-11.59	37.44	79.32	5.47	79.82	50.24	16.28	63.87	79.20	76.62	63.96	48.81	39.35	2.22	52.59	93.13	32.21
BRD-K14441456	CP	tyrphostin-AG-556	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		4.23, 2.31	37.41	1.13, 0.40	5.88	25.64	19.43	79.00	13.67	7.80	87.80	37.96	11.45	30.83	9.26	37.41	81.81	61.98	59.90	85.50	94.68	73.32	40.91	82.21	27.13	22.85	-7.96	-2.64	76.40	10.67	52.55	97.00	33.89
BRD-A63836183	CP	PD-123319	angiotensin antagonist	AGTR2		2.69, 1.54	37.37	0.80, 0.24	-3.91	93.81	49.42	39.15	37.37	27.94	57.60	51.30	72.44	8.07	65.22	70.70	-2.33	6.93	-57.41	2.62	-86.50	4.93	79.17	86.12	34.88	49.32	46.46	0.00	35.17	75.58	10.12	43.17	8.68
BRD-A75517195	CP	thiazolopyrimidine	CDC inhibitor			3.85, 3.08	37.37	0.32, 0.08	16.98	39.77	46.68	30.97	27.21	20.34	26.39	45.33	35.80	5.28	8.25	54.37	92.37	68.24	81.96	92.63	18.47	42.13	48.34	26.84	33.73	49.04	21.93	88.19	37.37	20.43	38.63	51.13	19.39
BRD-K51730347	CP	diphencyprone	immunostimulant			4.44, 2.22	37.37	1.84, 0.66	6.03	72.49	-4.02	65.39	17.26	13.34	45.94	70.77	5.47	-25.80	6.30	78.73	90.39	96.97	45.96	86.23	87.26	37.37	89.30	6.50	8.95	26.29	36.46	31.43	17.96	84.85	57.87	36.07	51.24
BRD-K20920669	CP	cromoglicic-acid	immunosuppressant	KCNMA1, S100P		8.16, 3.67	37.30	1.11, 0.34	37.30	3.61	23.06	16.62	20.52	92.62	42.75	83.38	2.82	69.89	96.25	58.56	2.76	17.00	98.52	2.01	78.20	33.92	32.44	96.03	23.92	78.31	9.50	23.62	60.92	99.82	73.40	35.14	77.96
BRD-K47869605	CP	podophyllotoxin	caspase activator, insulin growth factor receptor inhibitor, microtubule inhibitor, tubulin inhibitor	IGF1R, CASP3, TOP2A, TUBA4A, TUBB	Tubulin inhibitor	3.08, 1.15	37.28	1.50, 0.43	9.13	89.93	37.28	75.29	85.69	13.63	60.19	26.32	70.77	70.64	20.17	14.29	75.78	76.20	8.35	98.91	94.50	30.96	40.68	11.00	35.83	46.75	5.34	-0.07	2.11	42.64	30.42	14.13	69.63
BRD-K68336408	CP	tyrphostin-AG-1478	EGFR inhibitor	EGFR, MAPK14	EGFR inhibitor	10.00, 5.38	37.25	1.60, 0.51	16.55	64.49	53.23	98.48	20.49	42.65	19.30	18.72	21.98	23.11	5.18	81.72	98.24	95.10	76.58	100.00	57.75	86.37	16.65	29.25	13.85	25.45	21.36	66.00	2.78	39.08	37.25	54.75	26.69
BRD-K32412559	CP	morphothebaine	adrenergic receptor inhibitor			5.38, 2.31	37.23	0.58, 0.15	56.43	8.06	2.92	37.23	17.66	16.03	0.00	60.78	-0.18	84.29	39.72	60.05	1.76	0.70	99.03	56.17	97.29	33.01	0.21	83.70	74.23	61.01	25.92	2.44	30.10	51.99	79.07	81.10	11.17
BRD-K56115039	CP	BU-226	imidazoline 2 receptor ligand		Imidazoline ligand	7.35, 3.67	37.21	1.64, 0.49	98.98	25.79	19.04	31.70	9.65	79.62	59.83	37.21	41.49	99.75	73.81	90.27	0.00	41.61	96.97	8.17	-11.25	23.90	36.76	62.18	28.59	60.14	7.03	-99.93	1.59	94.51	61.66	94.06	13.89
BRD-K75641298	CP	metoclopramide	dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist	DRD2, HTR3A, HTR4, CHRM1, HTR3B		7.31, 5.00	37.21	0.95, 0.27	36.32	4.12	85.04	55.06	99.40	36.19	37.54	37.21	8.63	15.13	31.13	36.95	11.94	72.66	71.91	11.91	43.06	56.51	31.17	95.42	96.65	98.06	22.73	71.33	28.20	30.05	21.83	98.24	67.40
BRD-K91315211	CP	betahistine	histamine receptor agonist, histamine receptor antagonist	HRH3, HRH1		3.85, 1.15	37.18	1.58, 0.39	41.83	-42.62	3.52	25.45	56.03	5.37	55.72	87.20	50.59	21.06	12.54	37.18	2.82	-1.59	98.52	45.77	93.40	2.29	37.44	95.19	6.13	47.46	84.40	84.19	35.76	64.75	6.18	35.97	4.92
BRD-A13122391	CP	triptolide	RNA polymerase inhibitor	CYP2C19, RELA		5.77, 2.69	37.16	1.92, 0.68	2.50	98.98	95.96	0.63	87.44	50.55	86.89	-48.05	24.36	54.33	39.10	79.27	2.57	36.61	-88.83	64.51	37.16	7.17	25.19	38.15	43.39	67.50	36.21	-62.76	-55.39	15.07	44.57	40.49	26.43
BRD-A26032986	CP	zaldaride	calmodulin antagonist, calmodulin inhibitor	CALM1		3.85, 1.92	37.16	0.61, 0.16	37.16	36.04	39.82	76.56	80.33	78.64	21.32	20.03	11.12	5.99	28.73	88.44	4.78	4.79	89.67	17.47	63.20	91.72	21.94	27.06	63.87	73.30	58.41	0.00	74.32	32.07	28.60	48.61	75.20
BRD-K18250272	CP	propoxycaine	anesthetic			2.31, 0.77	37.15	0.56, 0.15	93.14	15.50	3.71	5.99	29.41	18.22	60.93	85.79	11.13	41.28	78.99	71.18	0.11	7.46	88.71	58.69	36.52	2.31	84.16	54.14	35.13	45.72	12.19	0.04	37.15	94.86	17.38	47.93	39.40
BRD-K89375097	CP	pirenzepine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		4.23, 1.54	37.14	1.38, 0.34	69.89	32.39	3.77	28.96	10.86	29.94	21.09	21.41	40.59	72.77	37.14	84.26	-2.39	1.87	92.09	1.97	76.40	13.34	97.33	62.41	8.28	45.33	20.99	91.48	76.69	21.05	42.11	93.90	81.41
BRD-K26657438	CP	imiquimod	interferon inducer, toll-like receptor agonist, immunostimulant	TLR7, TLR8		2.31, 1.15	37.10	1.31, 0.49	83.90	5.11	93.24	11.61	66.16	77.67	47.76	81.31	25.19	37.35	91.27	81.36	-82.95	8.07	10.99	-72.30	76.87	32.41	37.10	57.19	66.53	21.94	29.93	1.16	20.48	90.29	33.43	34.88	41.28
BRD-K04833372	CP	GSK-1904529A	insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, INSR		4.23, 2.69	37.07	1.94, 0.52	15.27	-18.66	23.57	25.68	0.92	11.29	74.16	93.47	9.53	92.38	44.71	9.48	0.07	64.09	34.61	-6.58	92.86	46.34	30.66	49.47	37.07	5.39	3.59	45.31	61.23	71.75	72.61	45.25	97.57
BRD-K12184916	CP	NVP-BEZ235	mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor	MTOR, PIK3CA, PIK3CG, PIK3CD, ATR, PIK3CB	MTOR inhibitor, PI3K inhibitor	4.23, 1.54	37.06	2.02, 0.53	3.40	42.31	39.77	96.48	21.59	25.37	8.49	-15.28	37.06	14.32	20.86	25.52	87.48	42.49	79.82	98.34	54.55	64.68	13.46	41.34	42.42	38.51	10.28	-96.35	12.89	13.03	45.17	38.05	8.81
BRD-A22684332	CP	procaterol	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	6.15, 3.08	37.02	0.94, 0.36	24.78	82.22	35.57	55.89	70.83	28.51	89.86	-58.61	94.98	34.26	81.14	63.83	3.00	8.48	69.07	4.17	37.13	8.18	78.11	98.64	11.38	41.01	12.71	-18.75	4.83	37.02	11.52	53.01	61.99
BRD-A78391468	CP	prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	Glucocorticoid receptor agonist	3.08, 1.92	37.02	1.53, 0.75	87.53	5.77	4.23	47.69	49.73	8.05	8.76	74.11	8.07	29.38	6.20	19.88	-2.78	47.56	47.50	17.07	97.71	11.29	47.18	47.08	-12.12	6.55	37.02	0.85	46.11	59.02	39.64	37.88	69.04
BRD-K66707493	CP	lawsone	coloring agent			2.69, 1.15	37.02	0.91, 0.26	11.69	15.85	66.38	85.13	70.37	19.03	72.54	42.63	82.72	3.31	37.02	59.07	47.87	17.83	29.91	16.39	31.06	43.69	6.26	66.76	18.86	38.63	68.43	0.00	66.97	6.72	26.54	98.46	15.74
BRD-A88282067	CP	delcorine	ganglioblocking, antiarrhythmic			5.00, 1.92	36.99	1.53, 0.42	19.69	25.06	79.29	15.46	73.49	63.32	85.39	35.99	16.62	95.55	82.66	86.28	-52.78	31.61	-86.73	8.96	32.87	34.17	88.99	40.09	87.82	82.57	50.35	34.21	36.99	81.19	5.65	84.19	16.09
BRD-K61829047	CP	7b-cis	exportin antagonist	XPO1		2.31, 0.77	36.98	2.61, 0.70	15.49	87.18	19.63	45.97	58.38	12.61	5.57	18.13	8.23	30.47	7.29	48.33	92.35	88.72	58.24	99.12	49.58	85.47	-12.36	31.58	37.52	36.98	10.33	5.98	90.19	2.53	48.63	40.43	13.77
BRD-K66956375	CP	oleoylethanolamide	Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist	CNR1, GPR119, GPR55, KCND3, PPARA		4.62, 1.92	36.95	1.34, 0.52	13.31	-45.57	44.53	-65.66	73.98	5.38	18.71	91.42	13.39	89.85	93.16	37.86	13.34	24.12	14.09	88.36	96.55	-38.86	36.95	40.13	39.84	41.01	4.76	4.65	57.57	34.73	81.53	75.42	14.84
BRD-K93918653	CP	quizartinib	FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor	FLT3, CSF1R, KIT, RET, PDGFRA, PDGFRB		3.85, 1.92	36.94	0.72, 0.17	11.58	80.55	95.10	36.98	74.24	8.57	11.40	54.50	20.04	12.20	55.30	23.75	19.14	1.73	67.30	16.28	73.80	29.63	58.26	10.50	52.64	36.94	34.25	86.19	33.17	64.83	27.83	43.10	77.75
BRD-A96882008	CP	L-732138	tachykinin antagonist	TACR1, TACR2		3.46, 1.92	36.92	1.41, 0.35	73.41	55.83	86.19	55.63	93.64	22.55	91.36	-35.82	91.93	0.35	12.13	26.81	2.78	4.05	89.37	15.31	91.96	36.92	10.22	95.17	7.89	64.36	26.34	27.01	20.82	9.18	61.23	78.50	87.06
BRD-K50387473	CP	XMD-892	MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor	MAPK7, DCLK2, LRRK2, PLK4, TNK1	Bromodomain Inhibitor, Leucine rich repeat kinase inhibitor	4.23, 0.38	36.91	1.06, 0.53	25.25	90.12	19.52	29.26	38.71	36.91	19.72	16.18	10.45	34.17	43.73	88.01	57.17	39.29	68.09	65.48	54.22	49.74	10.08	35.10	13.11	44.61	44.17	0.00	0.00	32.67	49.60	28.54	60.05
BRD-K77286328	CP	reversine	Aurora kinase inhibitor, adenosine receptor antagonist	AURKB, ADORA3, AURKA, INCENP, MAP2K1	Aurora kinase inhibitor	6.15, 3.08	36.90	1.58, 0.56	11.87	44.39	70.23	98.80	80.81	27.55	53.86	-70.59	11.25	18.04	13.68	91.11	81.16	66.32	42.29	99.54	36.24	71.26	25.68	53.25	36.90	6.82	13.68	1.09	14.06	15.13	36.00	40.12	52.37
BRD-A19053259	CP	pseudopelletierine	stimulant reflex trigger used as an anthelmintic and anti-amoeboid			5.00, 1.92	36.85	0.86, 0.25	36.85	56.31	95.63	3.38	92.52	19.06	35.26	61.32	-15.16	5.97	-3.91	14.31	-24.41	-40.56	99.22	-31.64	92.89	0.74	12.31	83.05	94.32	10.94	40.59	94.50	30.22	76.24	53.88	80.14	79.27
BRD-A31227688	CP	kynuramine	aryl hydrocarbon receptor activator			5.38, 2.69	36.85	0.94, 0.28	92.43	-10.17	15.83	9.93	-13.01	4.01	76.63	72.43	97.62	14.40	4.80	11.36	-6.38	3.74	49.00	1.80	49.16	10.71	96.34	88.88	-28.30	36.85	77.34	99.54	79.83	45.25	33.02	51.39	50.20
BRD-K73290745	CP	ICI-199441	opioid receptor agonist	OPRK1, CYP2D6, OPRD1, OPRM1, UTS2R		5.38, 3.85	36.82	1.42, 0.38	1.09	36.82	97.53	90.92	66.74	0.02	24.89	44.26	7.61	35.97	44.92	23.11	49.65	89.59	45.62	29.40	-18.74	98.98	67.35	4.62	31.02	11.99	44.54	-0.85	96.65	86.20	14.63	23.64	50.06
BRD-A82238138	CP	budesonide	glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant	NR3C1, CYP3A5, CYP3A7	Glucocorticoid receptor agonist	1.63, 0.82	36.81	1.40, 0.83	16.50	29.93	36.81	88.43	12.15	26.86	71.41	24.52	11.90	33.35	26.56	55.64	61.63	87.68	17.53	50.83	60.65	49.47	28.09	64.59	27.86	49.84	51.67	0.00	12.02	63.52	63.95	41.80	22.22
BRD-K34330170	CP	rotenonic-acid	RAR antagonist			3.85, 1.15	36.79	0.84, 0.23	11.79	44.86	95.13	23.62	65.29	7.85	23.63	28.66	64.69	11.42	94.76	89.67	5.25	14.41	55.58	24.42	93.18	23.30	42.22	61.40	36.79	76.81	86.07	0.78	82.48	13.55	11.60	46.11	11.08
BRD-K45479396	CP	BP-554	serotonin receptor agonist	HTR1A		6.54, 2.69	36.79	1.53, 0.40	17.11	33.87	75.26	74.00	51.89	78.06	14.25	27.96	86.67	12.67	3.91	53.63	2.78	0.00	98.52	2.83	95.50	65.45	-19.78	96.62	36.79	7.83	75.96	94.20	23.32	60.30	28.24	27.52	98.59
BRD-K62012036	CP	acitretin	retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor	RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3	Retinoid receptor agonist	3.46, 1.54	36.75	1.64, 0.48	95.25	5.99	3.06	1.27	50.75	54.24	20.80	80.46	7.92	33.52	29.83	8.42	13.25	19.50	64.50	84.77	67.09	17.05	71.40	80.00	44.43	67.40	16.26	98.01	38.30	21.77	36.75	49.35	17.81
BRD-K30296925	CP	flavokavain-b	carcinoma cell growth inhibitor, hypoxia inducible factor inhibitor	HIF1A		2.31, 1.92	36.74	1.49, 0.66	74.11	76.85	29.68	25.50	79.58	25.87	33.94	-28.11	5.57	41.63	11.64	37.52	81.28	91.72	67.44	98.91	12.44	53.41	-66.35	62.83	59.07	26.76	36.74	-2.73	-1.20	33.91	11.53	71.49	56.43
BRD-A18043272	CP	phensuximide	anticonvulsant			2.45, 1.63	36.73	0.60, 0.25	85.67	6.65	17.31	-3.85	1.71	80.03	79.09	86.45	6.20	75.01	4.34	5.43	-3.46	-31.85	37.44	-11.03	78.12	29.32	68.04	86.35	41.96	50.17	5.46	74.09	36.73	16.29	-7.14	40.90	70.27
BRD-A38913120	CP	BH3I-1	BCL inhibitor	BCL2		3.46, 1.15	36.70	0.98, 0.30	62.84	24.62	1.35	0.63	2.71	4.97	94.67	70.98	10.31	50.01	55.16	24.24	-24.72	22.15	49.21	11.13	84.34	-58.95	83.59	27.65	82.91	36.70	-7.63	93.29	84.57	91.13	53.11	98.59	14.57
BRD-K13087974	CP	4,5-dianilinophthalimide	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR	EGFR inhibitor	5.77, 2.31	36.69	0.84, 0.35	99.26	56.12	15.60	64.82	43.10	0.04	16.59	-62.09	5.57	3.77	8.99	81.59	24.11	11.71	99.72	97.78	64.70	32.09	49.54	39.91	23.25	69.37	42.03	98.52	36.69	87.43	36.32	10.90	33.57
BRD-K00959089	CP	thenoyltrifluoroacetone	PPAR receptor ligand	CES1, PPARA, SDHA		5.00, 3.08	36.67	1.36, 0.39	20.29	77.53	18.80	71.71	85.68	9.49	26.79	86.98	17.34	18.23	6.24	25.71	-2.27	22.26	36.67	42.24	45.08	6.91	68.39	99.33	13.28	37.85	53.92	98.28	39.01	91.19	18.93	83.04	33.76
BRD-K14618467	CP	IKK-16	IKK inhibitor	IKBKB	IKK inhibitor	10.38, 5.77	36.67	1.49, 0.32	19.19	97.43	78.94	99.65	52.82	-10.06	-0.95	-12.22	16.56	25.22	13.63	60.93	97.55	99.82	36.67	99.93	36.70	98.20	48.60	12.81	60.64	28.40	29.83	-8.28	60.19	23.33	39.39	32.10	16.95
BRD-A35519318	CP	benidipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C, CACNA1G, CYP3A5		8.44, 4.44	36.66	0.88, 0.27	79.28	34.91	94.79	9.73	20.93	42.11	46.12	67.49	43.23	-12.79	7.32	26.71	36.66	22.21	99.82	69.98	99.72	3.86	52.19	35.31	-76.50	4.71	72.87	51.16	0.28	68.76	83.09	0.60	-62.71
BRD-K35240538	CP	methylprednisolone	glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	5.77, 3.08	36.64	1.44, 0.60	12.37	33.63	82.68	36.64	67.13	47.84	62.50	27.39	16.54	99.68	30.09	29.42	3.26	76.60	13.38	17.83	93.44	44.91	89.98	28.73	93.73	25.00	21.37	0.00	83.82	91.98	41.43	14.94	73.02
BRD-K84663978	CP	trequinsin	phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker	PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PTGIR		3.08, 0.38	36.62	0.55, 0.36	50.12	19.09	54.49	44.94	69.47	21.39	19.52	48.60	73.56	58.57	36.62	47.10	8.26	16.67	56.72	76.37	31.34	27.65	63.78	28.88	77.33	22.19	12.68	-86.88	31.38	19.22	21.71	45.19	86.26
BRD-A01295252	CP	trans-7-hydroxy-pipat	dopamine receptor ligand			4.62, 3.46	36.61	0.77, 0.33	76.49	10.08	2.15	44.92	21.85	78.97	78.70	74.56	6.82	54.91	25.00	30.51	-17.12	1.97	78.40	20.67	94.30	16.12	50.86	41.78	39.51	36.61	10.29	0.85	20.04	79.49	16.89	97.85	71.33
BRD-A26097136	CP	bulleyaconitine-a	non-opiod analgesic			6.92, 5.00	36.60	1.14, 0.45	99.22	24.40	33.23	29.11	21.01	36.11	98.48	-18.29	73.78	37.07	22.88	51.16	-19.12	22.12	68.39	14.48	11.51	75.11	36.60	99.51	29.34	91.29	53.39	-49.28	27.91	52.32	41.18	92.77	60.75
BRD-K59058766	CP	chlorprothixene	dopamine receptor, dopamine receptor antagonist	DRD2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, HRH1, HTR2A, HTR2B, HTR2C	Dopamine receptor antagonist	10.38, 4.62	36.60	1.59, 0.57	12.45	16.44	25.56	95.21	26.06	32.45	29.10	-76.53	41.68	12.78	75.85	97.00	86.22	96.95	78.13	96.61	54.22	98.87	11.52	86.80	36.60	31.85	6.48	-0.39	98.94	26.17	33.62	86.78	80.93
BRD-K82941592	CP	rosuvastatin	HMGCR inhibitor	HMGCR	HMGCR inhibitor	6.15, 2.69	36.60	0.58, 0.19	21.79	22.11	-3.52	70.47	26.15	54.72	19.96	63.64	6.37	4.51	7.67	34.64	12.34	82.58	47.69	8.22	80.78	96.23	55.00	43.81	28.25	43.56	71.28	99.68	83.64	13.80	36.60	68.28	11.40
BRD-K19284129	CP	salvinorin-a	opioid receptor agonist	OPRK1, OPRD1, OPRM1		5.38, 2.69	36.58	0.56, 0.23	13.34	8.95	36.58	40.22	34.78	25.96	62.17	-61.58	41.92	28.27	56.71	58.75	1.30	0.56	59.23	3.11	66.35	62.81	17.32	95.90	78.98	98.10	40.33	27.78	-9.03	23.36	34.91	80.67	96.58
BRD-K90382497	CP	GW-843682X	PLK inhibitor	PLK1, PLK3		3.08, 1.92	36.58	0.77, 0.28	74.99	11.18	41.62	6.05	20.11	90.43	34.54	91.80	36.58	25.15	4.73	38.22	39.49	51.06	30.85	59.67	75.90	6.93	41.72	85.94	15.58	27.69	6.87	70.69	31.90	48.37	5.76	25.46	80.74
BRD-A80638690	CP	floxuridine	DNA synthesis inhibitor, MDCK inhibitor, PEPT1 inhibitor, pyrimidine antagonist	TYMS	DNA synthesis inhibitor	3.67, 2.45	36.56	1.23, 0.32	36.43	85.53	42.54	67.06	37.05	7.99	11.84	58.37	48.64	11.04	75.90	87.65	84.92	34.63	34.69	99.47	19.93	87.39	24.13	26.63	52.57	36.56	32.23	8.67	6.01	97.61	41.69	34.16	30.89
BRD-K92678294	CP	irilin-a	isoflavone			10.77, 8.08	36.56	0.70, 0.23	16.16	7.80	36.56	16.92	79.06	9.68	2.18	53.22	12.13	68.83	59.71	61.38	4.23	3.52	68.86	6.24	48.92	5.32	24.97	98.79	63.70	93.62	21.54	95.07	99.93	68.70	23.23	98.63	32.05
BRD-K87048468	CP	RS-102221	serotonin receptor antagonist	HTR2C, HTR2A, HTR2B		6.15, 1.92	36.54	1.13, 0.25	77.90	25.18	49.96	50.61	36.54	24.21	65.75	90.53	47.74	30.61	17.61	25.27	-15.30	35.32	29.96	22.46	63.09	2.96	68.75	99.68	25.64	25.64	18.83	45.05	70.52	97.20	55.09	49.56	19.07
BRD-A34208323	CP	VU-0404997-2	glutamate receptor modulator	GRM4		3.08, 1.54	36.50	0.95, 0.26	72.75	12.14	2.08	64.87	9.72	31.57	7.95	57.77	36.50	6.41	13.42	9.19	55.81	10.37	96.69	80.69	56.53	62.00	44.11	32.63	-8.78	2.50	55.18	65.96	37.07	34.00	49.89	49.47	13.83
BRD-K64670467	CP	JNJ-16259685	glutamate receptor antagonist	GRM1		3.85, 1.15	36.49	1.05, 0.33	24.51	27.41	16.92	38.13	21.45	16.44	88.70	36.49	9.80	26.10	33.90	62.40	-5.24	41.96	49.78	3.87	14.79	4.92	69.72	86.13	42.04	92.09	16.65	5.99	56.61	75.24	55.83	98.73	43.94
BRD-K67298865	CP	SB-431542	TGF beta receptor inhibitor, ALK inhibitor	TGFBR1, ACVR1C, ACVR1B	TGF beta receptor inhibitor	5.77, 2.69	36.49	1.23, 0.48	34.21	33.06	73.57	70.76	9.43	99.74	49.91	77.40	17.01	49.89	20.07	42.00	22.41	31.78	-40.03	22.99	36.49	53.56	15.15	54.00	36.36	18.58	0.78	-36.44	91.53	84.71	58.38	92.50	88.68
BRD-K56403959	CP	ZK-756326	CC chemokine receptor ligand	CCR8		3.67, 1.63	36.48	1.11, 0.35	53.71	13.55	78.85	24.96	42.33	94.20	17.24	26.81	25.29	68.92	32.93	42.72	4.38	42.51	35.14	29.19	15.92	3.50	79.80	47.47	72.97	62.03	26.31	6.28	36.48	59.50	31.91	69.98	72.88
BRD-A59215453	CP	lobelanidine	acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand	SLC18A2, CHRNA10, CHRNA4, CHRNA9, CHRNB2, OPRM1		8.46, 4.62	36.45	1.27, 0.51	41.29	47.27	18.31	61.04	25.57	97.76	17.01	70.49	4.20	97.02	32.62	24.15	2.04	-2.01	78.37	4.05	97.31	15.62	36.45	84.51	54.40	21.26	12.10	99.19	7.39	73.76	36.35	99.82	94.82
BRD-A66927094	CP	nemonapride	dopamine receptor antagonist, serotonin receptor agonist	DRD2, DRD3, DRD4		5.38, 3.46	36.45	0.98, 0.38	36.45	9.30	93.59	11.52	73.49	61.91	12.06	63.27	-28.75	15.12	11.66	84.90	1.09	-1.06	88.45	5.06	91.47	26.80	17.34	97.77	97.25	72.25	59.05	4.75	31.23	13.00	90.61	97.81	95.25
BRD-K55430733	CP	WAY-629	serotonin receptor agonist	HTR2C		3.27, 1.63	36.41	1.16, 0.34	36.39	11.00	14.50	15.18	35.95	44.04	37.24	60.59	16.98	68.02	11.40	94.17	2.08	54.52	-41.27	2.71	76.90	33.86	13.72	43.57	62.93	42.61	8.23	-9.62	36.41	60.49	55.85	49.45	81.14
BRD-K35573744	CP	erbstatin-analog	EGFR inhibitor, tyrosine kinase inhibitor	EGFR		2.86, 1.63	36.40	1.30, 0.33	15.98	91.92	37.81	16.08	46.23	37.52	37.66	35.01	32.57	32.70	64.77	68.70	78.03	88.07	36.40	96.30	0.35	30.59	16.92	18.83	7.89	34.28	29.61	-89.29	80.22	52.20	36.37	64.49	60.78
BRD-A02710418	CP	meptazinol	opioid receptor agonist	BCHE		4.62, 2.69	36.39	1.05, 0.41	72.87	-11.23	31.29	16.93	71.46	14.84	51.46	77.42	9.57	14.84	65.68	36.39	3.52	11.10	95.95	5.62	98.50	24.32	82.20	93.26	6.13	60.34	76.04	-90.57	54.65	25.75	27.42	81.70	62.69
BRD-A42167015	CP	carteolol	adrenergic receptor antagonist	ADRB1, ADRB2		3.46, 1.92	36.39	0.70, 0.17	35.52	79.12	7.51	31.09	96.40	27.96	50.46	80.85	22.29	83.90	59.20	48.49	2.04	3.07	85.40	5.82	86.80	10.64	12.31	43.48	82.63	36.39	5.39	-97.32	41.81	27.92	48.98	93.85	23.08
BRD-K11742128	CP	triprolidine	histamine receptor antagonist	HRH1		0.82, 0.00	36.38	1.49, 0.60	30.68	-11.68	80.58	49.99	39.45	11.22	7.57	57.91	17.27	23.01	34.64	58.35	16.48	55.87	85.43	2.90	48.73	5.14	36.38	64.82	7.51	63.55	28.80	84.39	31.20	83.23	31.72	63.01	76.39
BRD-K07762753	CP	aminopurvalanol-a	CDK inhibitor, tyrosine kinase inhibitor	CDK1, CDK2, CDK5, CDK6	CDK inhibitor	4.23, 2.69	36.37	1.91, 0.49	8.88	98.20	55.52	95.00	51.04	-10.86	32.12	-25.60	18.71	24.10	73.24	82.28	88.76	55.98	36.30	99.44	47.16	68.27	33.24	79.87	75.65	84.03	34.02	-84.89	15.89	12.11	36.37	27.79	9.48
BRD-K61951118	CP	FG-7142	GABA benzodiazepine site receptor inverse agonist			4.49, 2.04	36.35	0.82, 0.26	81.93	13.81	27.29	31.67	42.75	93.25	-54.73	26.19	-25.55	84.33	40.52	73.12	0.00	0.00	37.17	2.54	40.13	3.13	66.80	70.92	32.11	36.35	29.71	96.18	-3.52	51.20	42.59	44.91	21.26
BRD-K83963101	CP	MLN-8054	Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKA		4.23, 2.69	36.35	1.11, 0.33	14.72	27.29	26.31	20.14	57.18	-11.48	68.80	58.70	70.73	47.11	41.98	62.00	2.40	11.04	75.78	-30.69	68.75	78.27	28.10	10.32	28.12	17.78	51.56	-97.60	77.36	36.35	34.97	78.91	59.00
BRD-K17294426	CP	clebopride	dopamine receptor antagonist	DRD2, ACHE		3.67, 1.63	36.32	1.03, 0.31	37.33	-12.17	85.25	7.30	20.18	81.53	12.90	38.40	22.14	65.15	3.56	28.12	2.57	17.72	70.76	1.80	85.12	36.32	82.06	76.69	40.33	39.63	26.63	87.92	57.47	50.17	7.20	11.76	31.17
BRD-A87125127	CP	3-matida	glutamate receptor antagonist	GRM1		4.46, 3.18	36.29	1.87, 0.60	6.74	6.77	0.03	47.01	4.89	18.36	79.39	53.63	32.88	32.80	65.17	36.29	-3.31	-15.18	94.51	-4.29	97.71	85.90	64.30	79.03	5.81	4.26	11.98	-12.21	59.84	72.85	63.69	73.54	99.68
BRD-K49945136	CP	GR-113808	serotonin receptor antagonist	HTR4		3.85, 1.92	36.26	0.91, 0.32	42.72	78.00	73.86	17.42	46.20	94.33	78.41	-24.30	82.32	2.61	62.36	56.10	2.00	11.11	76.85	27.10	-11.03	33.97	18.73	51.67	36.44	43.73	27.10	-63.19	4.70	4.63	17.93	36.26	93.76
BRD-K74761218	CP	WT-171	HDAC inhibitor	HDAC6		2.04, 0.41	36.26	1.70, 0.59	25.83	97.57	36.26	67.23	8.17	36.53	9.91	31.15	35.43	42.53	43.31	27.93	84.65	79.80	63.18	70.01	34.16	78.05	9.55	44.46	11.40	5.78	20.11	1.80	68.96	30.74	39.44	32.32	70.27
BRD-K46384212	CP	o-3M3FBS	phospholipase activator			3.08, 1.54	36.24	0.64, 0.14	21.68	5.76	89.16	8.57	90.09	21.40	14.64	87.41	30.33	13.15	-1.09	51.30	-1.68	-11.01	92.55	36.24	98.34	17.59	25.66	67.89	75.42	36.69	42.54	48.59	5.91	-5.01	66.22	96.47	76.31
BRD-A09467419	CP	mebeverine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		5.38, 3.46	36.22	0.85, 0.23	87.74	10.62	2.92	46.12	-7.53	80.89	33.40	36.22	38.21	4.51	14.39	84.14	18.56	64.44	17.15	2.54	15.12	63.66	83.62	64.39	7.75	71.64	57.59	0.85	97.42	29.06	66.09	69.82	-4.71
BRD-K28912512	CP	nicotinamide	oxidoreductase stimulant, protein synthesis stimulant	PARP1, AOX1, BST1, CYP2E1, LDHA, SIRT5		8.46, 5.77	36.22	2.00, 0.57	-63.69	92.47	54.65	3.91	87.48	7.32	36.88	79.58	8.11	96.56	96.20	50.44	6.91	8.54	-97.96	66.70	97.33	19.55	22.95	36.27	99.99	64.18	26.98	-29.13	-41.98	47.85	36.22	34.26	5.80
BRD-K57930253	CP	nitrazepam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, SCN1A	Benzodiazepine receptor agonist	8.00, 5.78	36.22	1.19, 0.33	85.37	-22.27	9.22	13.04	94.15	19.73	97.31	88.36	83.11	75.13	99.93	71.35	22.17	43.03	9.93	-82.59	0.74	25.90	99.05	36.22	2.32	3.49	99.10	-1.42	26.00	88.68	92.08	27.60	56.85
BRD-K02590140	CP	O-2050	cannabinoid receptor antagonist	CNR1		5.77, 3.08	36.18	1.14, 0.42	86.20	81.38	55.38	69.02	12.43	98.95	97.73	41.66	42.12	13.01	33.89	19.99	21.98	8.19	14.64	36.18	41.35	23.59	19.95	52.04	49.71	31.56	18.56	18.89	0.63	22.27	42.13	58.68	73.76
BRD-K62221994	CP	T-98475	gonadotropin releasing factor hormone receptor antagonist	GNRH1, GNRHR		7.69, 6.15	36.18	1.59, 0.49	36.46	10.18	5.62	94.06	21.54	-3.31	46.44	61.23	31.83	7.33	5.40	66.73	95.07	99.59	70.99	99.47	10.64	99.64	9.94	80.91	26.00	33.30	24.79	-3.39	99.23	49.48	36.18	97.71	33.84
BRD-K63150726	CP	JTE-907	cannabinoid receptor inverse agonist	CNR2	Cannabinoid receptor agonist	3.46, 1.54	36.17	1.17, 0.34	21.71	14.83	8.75	74.10	36.17	12.79	14.19	54.59	7.92	0.35	1.34	57.59	73.18	69.95	50.63	98.91	51.80	78.37	31.72	90.90	9.34	54.71	16.52	22.41	68.67	10.97	64.36	95.07	0.72
BRD-K52620403	CP	STO-609	calcium/calmodulin dependent protein kinase inhibitor, calmodulin inhibitor	CAMKK1, CAMKK2		3.85, 1.92	36.16	1.22, 0.38	61.07	1.80	21.48	57.80	-8.31	36.16	1.83	76.50	83.08	14.07	18.13	16.43	13.90	14.24	57.78	24.19	37.29	23.94	99.65	55.26	-56.39	74.71	-4.73	91.63	49.03	41.04	23.31	55.43	87.77
BRD-K34441861	CP	moexipril	angiotensin converting enzyme inhibitor, phosphodiesterase inhibitor	ACE, ACE2		5.38, 2.69	36.15	1.23, 0.51	66.32	17.67	-5.71	27.88	59.55	18.40	96.25	49.52	10.32	19.61	85.97	52.84	-11.24	44.93	81.32	14.14	76.63	0.88	36.15	98.63	23.48	78.50	6.78	0.00	41.61	92.64	24.24	86.67	-19.51
BRD-K76587808	CP	fraxetin	anti-oxidative and anti-apoptotic agent			2.69, 1.54	36.12	0.65, 0.08	36.12	9.24	55.77	7.87	87.04	78.01	23.19	75.97	43.50	16.24	8.91	90.62	-2.85	11.11	86.38	5.14	81.24	17.18	31.47	33.76	57.86	75.54	47.08	4.16	27.90	10.91	58.41	84.98	62.27
BRD-A92161634	CP	scopoline	acetylcholine receptor antagonist			3.67, 2.04	36.11	0.73, 0.14	85.60	55.73	38.12	32.53	79.02	24.77	14.34	11.35	33.88	20.85	24.81	38.54	3.17	28.53	76.63	9.64	64.15	15.37	75.40	69.88	87.84	80.28	12.08	-38.57	3.66	36.11	67.14	71.97	46.53
BRD-A76279427	CP	myriocin	sphingolipid biosynthesis inhibitor	AKT1, SPTLC1, SPTLC2, SPTLC3		6.54, 3.08	36.10	0.90, 0.24	99.79	24.06	63.57	-6.45	85.15	41.61	53.68	36.10	60.34	89.41	57.80	82.60	-80.02	24.77	20.77	1.73	17.82	5.52	35.20	29.49	96.65	87.44	11.90	-96.90	20.91	87.15	46.81	85.60	9.20
BRD-K66944906	CP	fraxidin	carbonic anhydrase inhibitor	CA1		7.31, 3.46	36.10	1.30, 0.40	11.53	11.60	39.55	6.66	56.53	39.14	36.10	67.42	35.71	3.88	-6.66	38.84	-3.00	2.04	97.51	-92.66	80.49	27.40	27.16	98.58	-25.57	96.80	-0.63	61.80	43.14	50.77	22.00	92.93	74.09
BRD-K51485625	CP	ritonavir	HIV protease inhibitor, cytochrome P450 inhibitor	CYP3A4, CYP1A2, CYP2B6, CYP2C19, CYP3A5, CYP3A7	HIV protease inhibitor	4.89, 3.11	36.09	0.77, 0.18	2.89	20.72	94.96	49.13	40.86	-7.73	5.78	36.09	47.44	31.26	-32.13	89.50	40.29	55.60	98.48	80.33	99.89	89.77	-28.18	25.34	22.77	26.52	86.37	-33.35	30.10	4.78	37.73	11.18	40.34
BRD-A76093993	CP	cromakalim	ATP channel activator, potassium channel agonist	KCNJ8, ABCC9, KCNJ5		6.92, 6.15	36.08	1.11, 0.28	34.28	44.89	7.67	14.24	83.74	19.13	99.86	-56.15	12.83	74.82	70.02	69.90	-5.92	12.42	23.98	10.99	45.60	6.42	81.57	37.04	69.72	95.28	36.15	-5.74	19.34	57.22	36.08	97.79	0.70
BRD-A52326238	CP	isogedunin	HSP inhibitor			6.53, 3.27	36.07	1.13, 0.20	99.93	26.50	43.59	3.42	44.01	71.28	36.07	74.25	25.58	12.93	79.51	90.59	10.83	66.25	26.20	1.48	14.36	20.67	99.51	25.46	31.82	40.02	73.29	99.93	36.31	90.39	23.63	13.67	19.64
BRD-A80574334	CP	oxalomalic-acid	isocitrate dehydrogenase inhibitor	ACO1, IDH1		6.15, 2.69	36.07	1.95, 0.58	42.78	19.16	9.95	1.27	56.75	58.37	54.93	96.97	7.89	56.49	99.12	28.38	-27.51	14.03	-90.19	5.32	39.64	53.28	34.87	36.07	97.35	70.24	5.25	-98.96	16.48	67.00	22.02	85.74	60.86
BRD-K74402642	CP	NSC-632839	ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor	USP2, USP7, SENP2, USP1		5.00, 1.92	36.06	3.01, 0.78	41.57	79.51	19.64	36.06	54.30	15.38	-4.69	26.77	14.39	10.11	3.19	57.11	95.55	98.04	44.85	99.54	30.73	76.95	44.91	47.52	29.33	63.10	53.17	66.32	35.28	-23.69	30.79	6.15	14.48
BRD-K23913458	CP	coumarin	vitamin antagonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6		4.23, 2.69	36.04	0.68, 0.25	99.75	4.86	55.61	7.89	26.67	63.37	28.77	36.04	-32.40	61.99	31.29	51.05	-5.88	4.68	48.23	2.61	-53.14	11.22	67.78	40.84	51.28	90.24	40.75	94.92	73.56	12.55	22.05	37.83	0.85
BRD-A33168282	CP	sotalol	adrenergic receptor antagonist, polarization inhibitor, potassium channel antagonist	ADRB1, ADRB2, KCNH2		5.31, 3.67	36.03	0.82, 0.20	95.65	36.03	56.88	18.82	31.97	86.19	32.55	85.38	11.54	96.82	64.36	85.07	-3.32	7.00	84.88	28.57	80.73	11.82	19.83	86.90	34.02	14.60	79.73	17.06	9.83	86.96	78.47	69.68	33.99
BRD-K12762134	CP	XAV-939	PARP inhibitor, TNKS inhibitor	TNKS, TNKS2		4.23, 1.92	36.03	0.88, 0.30	41.55	-41.35	76.38	31.05	-11.97	24.21	-13.48	84.02	33.56	82.34	26.99	36.03	-3.40	4.25	72.97	-12.27	85.72	37.28	85.57	85.34	83.57	22.62	18.12	99.15	69.55	41.10	29.72	24.46	50.84
BRD-A62057054	CP	MDL-11939	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C		5.71, 4.49	36.00	1.39, 0.53	40.28	36.00	44.23	24.62	39.01	99.96	-4.79	48.78	36.89	72.74	7.40	29.16	-3.42	8.10	14.62	6.18	31.53	29.93	88.17	46.01	54.43	10.75	3.95	13.24	50.87	70.89	11.17	51.57	99.08
BRD-A96799240	CP	4-hydroxyretinoic-acid	retinoic acid metabolite			3.85, 1.54	36.00	1.15, 0.31	58.10	45.70	84.82	7.96	60.74	-0.03	60.56	-14.31	7.57	72.14	89.51	66.65	69.61	9.86	25.50	58.03	22.46	9.51	5.92	-5.04	32.21	84.80	43.52	-21.23	23.53	36.00	93.44	76.45	4.26
BRD-K41445866	CP	alfaxalone	11-beta hydroxysteroid dehydrogenase inhibitor, chloride channel agonist, general pump inhibitor	HSD11B1		4.90, 3.27	35.98	1.35, 0.51	23.85	12.72	25.93	10.89	40.85	47.70	63.88	32.45	51.99	98.77	39.21	39.39	4.17	44.72	34.36	1.66	17.83	46.64	99.75	28.63	43.10	53.78	30.78	0.86	3.00	35.98	35.44	71.75	36.89
BRD-A84493640	CP	atovaquone	cytochrome b-c1 complex inhibitor, dihydroorotate dehydrogenase inhibitor, mitochondrial electron transport inhibitor	DHODH		3.67, 2.04	35.97	1.27, 0.34	86.78	26.03	24.84	-6.45	7.18	36.91	55.03	68.32	60.27	84.87	40.20	51.82	-32.40	1.52	87.98	-5.15	17.00	5.39	85.63	77.82	9.99	18.13	29.14	15.27	88.66	85.73	35.97	73.31	20.94
BRD-K63089472	CP	farnesylthioacetic-acid	inhibitor of methyl esterification of farnesylated proteins			4.62, 2.69	35.97	1.24, 0.35	10.43	-85.23	-8.54	12.48	-74.76	-5.53	51.57	83.71	45.24	26.29	50.22	-9.80	-2.50	-14.42	80.09	-10.98	64.87	38.25	35.75	92.06	-28.44	25.09	35.97	95.96	69.03	84.66	48.08	94.90	69.80
BRD-A15415227	CP	GW-1929	PPAR receptor agonist, insulin sensitizer	INS, PPARG	PPAR receptor agonist	3.08, 0.38	35.95	1.10, 0.28	67.32	78.66	95.41	24.30	82.91	14.16	5.53	42.39	83.65	19.16	22.75	71.37	2.82	2.42	81.83	20.95	94.47	16.34	20.06	77.72	96.46	93.54	24.63	-33.56	31.55	12.61	35.95	90.18	82.28
BRD-K63630713	CP	etacrynic-acid	not applicable, sodium/potassium/chloride transporter inhibitor	SLC12A1, ATP1A1, SLC12A2		2.86, 1.63	35.93	0.82, 0.19	52.74	30.82	80.37	10.07	51.82	79.13	-7.65	85.98	42.84	35.93	28.76	29.12	12.61	30.03	85.45	0.56	56.07	39.10	23.26	28.65	40.14	90.74	49.95	4.86	-22.80	65.60	35.42	19.03	67.30
BRD-K41564320	CP	purvalanol-b	tyrosine kinase inhibitor	CDK2, CDK4, MAPK1, MAPK3, CDK5, SRPK2		4.08, 2.04	35.92	1.24, 0.31	87.47	72.69	9.48	13.47	48.21	9.09	8.83	46.86	58.09	87.24	96.58	40.37	5.57	38.13	8.60	15.08	65.77	9.40	27.10	18.73	57.87	53.48	12.04	-6.23	44.62	65.75	28.94	9.81	35.92
BRD-A42423104	CP	benproperine	anti-tussive			7.11, 5.78	35.91	1.26, 0.35	4.56	24.51	5.29	52.41	19.84	70.99	62.40	54.76	-26.13	97.63	38.86	99.72	2.22	20.60	71.38	5.30	97.91	35.91	19.45	32.05	41.40	50.07	8.04	-1.76	15.22	80.13	92.59	54.58	27.48
BRD-K51223576	CP	AG-99	tyrosine kinase inhibitor	EGFR		4.49, 1.22	35.86	1.05, 0.27	52.59	11.85	13.45	21.37	50.69	21.93	30.90	31.42	21.02	56.54	47.52	65.19	5.57	57.33	67.60	28.59	34.67	32.15	96.94	83.61	39.85	60.36	9.49	-87.80	35.86	64.00	46.46	83.23	10.32
BRD-K49657628	CP	tyrphostin-AG-18	epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor	EGFR		4.23, 3.08	35.82	0.65, 0.17	35.37	29.49	12.40	12.32	12.83	43.66	42.75	79.69	15.61	77.94	13.61	41.85	16.42	33.95	-17.49	70.85	19.71	79.93	47.02	43.26	35.82	89.33	9.73	0.00	90.01	78.07	55.88	14.62	99.26
BRD-A41145729	CP	methoprene-acid	RXR agonist	NCOA2, NR1H3, RXRA, RXRB		5.77, 2.31	35.81	1.06, 0.35	2.50	65.99	73.51	6.97	89.72	22.55	12.42	81.90	14.97	82.76	69.60	31.43	-4.86	-26.32	14.65	4.52	85.09	40.82	35.81	53.98	68.51	50.49	-6.34	-13.14	56.47	-46.10	26.75	71.11	82.14
BRD-A88254928	CP	salbutamol	adrenergic receptor agonist	ADRB2, ADRB1		9.33, 4.89	35.80	1.44, 0.41	26.40	95.08	95.71	15.62	35.80	12.97	1.83	15.23	99.93	94.54	25.69	96.03	9.02	27.76	97.54	26.64	87.02	2.08	22.00	58.15	36.97	41.72	75.29	0.04	1.33	91.31	42.29	19.55	65.17
BRD-K76064317	CP	tyrphostin-AG-1296	FLT3 inhibitor	FLT3		2.31, 1.92	35.78	0.65, 0.23	35.78	27.42	48.00	55.09	81.22	74.21	17.72	21.76	45.58	9.64	19.32	43.14	3.28	57.78	87.45	2.50	39.22	10.38	12.82	64.24	29.77	59.34	9.94	99.30	54.50	18.85	21.76	60.34	-12.81
BRD-A61392169	CP	eliprodil	glutamate receptor antagonist	GRIN1, GRIN2B		3.27, 1.63	35.77	0.95, 0.35	6.50	29.85	91.01	4.90	49.36	15.92	49.05	56.90	32.58	32.55	12.71	89.59	10.65	30.10	87.65	19.50	35.77	36.67	85.20	65.55	62.76	84.54	18.56	17.67	39.55	21.58	48.86	65.52	0.00
BRD-A15010982	CP	HU-211	glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent	CNR1, CNR2, GLRA1, GLRA2, GLRA3, GPR55, GRIN1, NFKB1		4.90, 3.27	35.73	2.10, 0.49	35.79	60.34	75.28	59.04	69.00	13.34	18.85	34.86	-2.22	44.21	66.71	62.18	93.38	28.11	-83.54	99.30	66.67	19.81	16.11	5.56	29.15	13.21	7.48	-7.38	-1.34	64.08	52.63	35.73	62.94
BRD-A29901043	CP	KIN001-127	ITK inhibitor	ITK		4.23, 2.31	35.68	1.63, 0.50	-12.12	33.46	21.82	95.20	52.91	11.52	5.13	43.86	26.47	32.06	47.31	43.60	17.35	89.32	93.33	13.32	82.65	92.30	-15.94	28.73	44.44	9.81	31.74	-78.48	85.48	82.38	52.25	35.68	63.10
BRD-K35377380	CP	I-OMe-AG-538	inhibitor of insulin growth factor 1 receptor protein tyrosine kinase			5.31, 3.27	35.68	1.02, 0.26	65.37	35.68	95.04	29.08	32.60	52.74	-17.98	57.90	15.79	51.11	40.54	87.47	2.20	29.39	-32.37	1.83	20.13	23.51	77.97	79.63	62.70	53.81	22.91	0.00	82.15	44.61	26.39	12.61	60.80
BRD-K50866992	CP	tropisetron	serotonin receptor antagonist, polarization inhibitor, sodium channel blocker	HTR3A, GLRA1, GLRA2, GLRB, HTR4		2.67, 1.78	35.68	1.88, 0.47	27.24	95.47	76.90	27.62	39.15	20.37	35.68	67.84	62.76	98.57	62.13	74.72	16.54	47.51	-52.09	63.98	12.96	22.42	26.65	30.41	70.09	5.69	61.48	-2.82	17.42	60.51	80.14	24.57	3.93
BRD-K32836707	CP	CAY-10577	casein kinase inhibitor			6.92, 3.46	35.66	1.09, 0.41	93.82	86.10	28.47	7.19	26.90	20.24	84.74	-22.33	16.03	15.40	52.44	79.40	-4.49	11.19	98.87	-2.96	16.16	0.67	98.70	65.98	-4.19	73.27	64.04	98.69	35.66	91.01	39.18	10.43	72.07
BRD-A36471396	CP	biperiden	anticholinergic	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2		5.38, 2.69	35.65	0.88, 0.26	-62.98	76.91	35.65	3.53	95.02	16.52	-34.22	92.20	86.33	48.32	74.72	74.96	-28.61	4.13	86.31	9.24	96.59	20.84	-85.83	82.41	57.06	34.22	14.31	-16.18	49.46	21.79	27.09	98.21	94.78
BRD-K26664453	CP	cytochalasin-b	microtubule inhibitor, phagocytosis inhibitor	ACTB		3.85, 1.92	35.65	2.51, 0.58	23.40	36.02	47.22	95.60	35.65	6.94	1.52	24.19	18.03	27.51	2.43	57.47	83.41	74.61	84.05	99.58	93.87	92.95	-13.87	70.49	23.18	19.53	5.50	0.00	74.45	5.31	43.21	75.91	27.48
BRD-K74133369	CP	oligomycin-a	ATP synthase inhibitor, ATPase inhibitor	ATP5A1	ATP synthase inhibitor, ATPase inhibitor	8.85, 3.85	35.65	1.85, 0.44	47.93	81.47	96.71	99.01	75.49	27.20	34.40	24.29	4.31	18.24	57.89	98.70	95.98	87.84	19.51	99.96	63.09	76.83	21.45	11.27	7.46	27.25	8.14	0.95	35.65	28.46	41.99	48.61	6.68
BRD-K09549677	CP	mibefradil	T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker	CACNA1G, CACNA1H, CACNA1C, CACNA1I, ANO1, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP3A5, CYP3A7, SCN2A, SCN4A, SCN5A, SCN9A	T-type calcium channel blocker	9.62, 5.77	35.64	1.64, 0.48	44.66	58.46	4.59	96.48	12.00	5.50	20.84	31.36	19.25	11.02	16.36	48.04	93.06	98.70	37.52	99.72	-15.39	99.89	18.12	4.95	50.52	3.00	6.46	0.00	99.93	50.07	35.64	44.52	67.20
BRD-A84189516	CP	baccatin-III	paclitaxel precursor			3.08, 1.54	35.63	1.48, 0.32	7.85	86.46	8.46	47.82	91.13	32.68	42.16	45.37	11.37	5.59	3.63	24.67	77.71	40.19	43.78	11.81	62.76	35.63	18.04	96.69	29.45	75.63	22.70	-82.25	3.88	31.18	38.21	84.99	62.70
BRD-K29653726	CP	topiramate	carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker	CA2, CA4, GRIK1, CA1, CA12, CA7, CYP2C19, CYP3A4, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, SCN1A, SCN5A		9.33, 3.56	35.62	0.97, 0.22	90.19	-2.59	27.38	15.79	29.82	49.81	6.71	38.41	71.01	5.35	93.63	78.64	2.36	0.56	99.33	3.03	96.88	6.08	91.43	22.09	54.56	97.41	84.82	89.17	32.62	97.47	31.59	-34.47	35.62
BRD-K75089421	CP	procainamide	sodium channel blocker, voltage-gated sodium channel blocker	SCN5A, DNMT1		4.62, 1.15	35.61	0.63, 0.13	49.34	17.77	35.30	35.61	35.64	14.12	57.68	90.49	35.23	26.67	23.91	9.97	-1.90	9.83	65.65	2.15	47.39	21.44	74.74	38.14	50.40	73.93	15.70	24.80	27.70	93.94	44.05	57.89	61.91
BRD-A75368507	CP	demeclocycline	30S ribosomal subunit inhibitor		Bacterial 30S ribosomal subunit inhibitor	6.12, 4.08	35.58	1.13, 0.25	3.00	26.39	66.85	74.58	84.59	9.92	64.87	99.30	8.05	31.15	91.91	60.26	5.78	4.12	45.03	4.17	66.68	6.10	70.88	28.16	5.64	46.24	17.23	1.80	-91.71	61.98	35.58	80.64	42.01
BRD-K63923597	CP	barasertib	Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKB, AURKC	Aurora kinase inhibitor	2.31, 0.77	35.56	0.64, 0.41	41.39	48.26	18.46	53.13	22.65	34.24	35.56	76.92	15.87	8.07	29.92	35.02	3.03	28.88	69.73	98.78	45.44	20.37	47.07	44.37	25.99	31.99	46.12	38.44	43.89	27.99	44.88	27.75	48.25
BRD-A26095496	CP	clobetasol	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	5.00, 3.08	35.54	1.44, 0.73	44.16	29.16	10.06	67.73	59.17	13.30	45.94	23.54	3.31	13.24	-9.04	35.54	53.50	74.83	-27.53	50.78	18.24	48.61	90.44	43.31	19.74	35.68	45.27	98.41	77.43	17.13	31.37	20.06	32.19
BRD-K60174629	CP	z-prolyl-prolinal	prolyl endopeptidase inhibitor	PREP		3.46, 1.54	35.50	0.88, 0.26	2.08	22.71	32.42	14.38	16.34	34.46	61.18	-45.37	2.45	85.56	95.21	69.35	2.47	30.04	43.54	32.15	42.09	35.50	38.63	29.30	95.35	63.15	44.26	0.00	35.70	4.85	48.84	96.44	68.13
BRD-K48168960	CP	propylthiouracil	thyroperoxidase inhibitor	TPO, DIO1		6.53, 3.67	35.48	1.72, 0.64	7.08	-3.91	18.48	8.86	42.87	86.52	7.51	95.00	8.39	63.76	66.27	94.13	0.26	5.43	94.43	1.48	94.33	6.39	31.67	98.45	71.48	16.92	7.90	54.68	35.48	98.77	90.23	54.66	17.31
BRD-K04414442	CP	SB-222200	tachykinin antagonist	TACR3		4.62, 3.08	35.47	1.33, 0.55	94.53	30.21	15.18	70.80	21.13	98.38	77.85	63.48	33.16	64.04	79.24	63.76	2.75	10.83	8.07	2.96	85.69	22.49	84.43	28.65	21.18	35.47	24.58	-39.80	78.58	50.44	24.58	49.96	99.12
BRD-K26863634	CP	BIX-01338	histone methyltransferase inhibitor			3.67, 2.04	35.47	1.50, 0.34	8.00	11.93	20.21	24.86	60.75	4.23	64.98	83.72	8.39	17.44	58.98	81.07	57.19	9.16	60.35	96.58	86.54	25.72	17.37	21.18	41.82	64.42	10.19	-0.78	35.47	84.22	40.34	75.46	23.90
BRD-K81418486	CP	vorinostat	HDAC inhibitor, cell cycle inhibitor	HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, HDAC11, HDAC5, HDAC9	HDAC inhibitor	3.08, 0.00	35.47	1.66, 0.57	29.29	97.11	45.12	77.48	45.23	29.55	27.96	-21.87	24.48	16.20	17.76	70.95	87.36	84.14	90.45	96.79	35.47	80.01	11.17	26.04	43.15	20.59	50.56	2.47	19.03	29.81	52.69	24.67	56.64
BRD-K00337317	CP	NU-7441	DNA dependent protein kinase, DNA dependent protein kinase inhibitor, P glycoprotein inhibitor	PRKDC, ABCB1	DNA dependent protein kinase inhibitor	1.92, 0.77	35.46	1.41, 0.63	13.64	85.10	11.63	93.45	35.46	81.69	-12.43	29.01	7.72	17.83	10.11	46.06	78.95	88.74	71.84	98.94	21.35	90.09	13.23	34.26	28.53	4.80	60.86	21.46	53.27	79.14	23.29	51.96	42.83
BRD-A11007541	CP	BCI-hydrochloride	MAP kinase phosphatase inhibitor, protein phosphatase inhibitor	DUSP1, DUSP6		3.85, 1.15	35.44	2.47, 0.52	32.84	45.18	5.60	40.64	51.69	8.76	-3.28	69.41	7.66	31.93	9.97	66.92	96.76	91.09	22.07	98.77	63.00	71.21	16.49	70.64	30.12	48.41	35.44	2.15	60.59	16.95	51.69	0.00	25.35
BRD-K42452249	CP	EO-1428	p38 MAPK inhibitor	MAPK11, MAPK14		3.85, 2.31	35.42	1.26, 0.32	35.42	47.50	26.12	67.52	44.39	15.09	-8.38	57.10	50.16	17.25	16.88	36.23	6.53	22.23	80.58	54.01	97.25	10.49	17.91	87.26	21.30	98.13	10.26	88.16	13.61	16.36	54.28	90.17	28.00
BRD-K75181824	CP	acetyl-geranygeranyl-cysteine	inhibitor of methyl esterification of geranylgeranylated proteins			4.23, 1.92	35.39	1.10, 0.38	35.39	-20.65	7.27	-0.95	47.20	80.28	87.42	76.90	6.20	57.79	25.71	9.73	-87.14	4.62	67.51	-81.88	33.53	5.12	80.25	20.41	-50.21	68.84	43.50	75.82	89.24	65.65	4.90	65.87	63.71
BRD-A65013509	CP	oxybutynin	acetylcholine receptor antagonist	CHRM3, CHRM1, CHRM2, CHRM4		6.12, 3.27	35.37	1.14, 0.34	76.69	5.88	46.68	30.95	84.91	-23.25	15.83	97.11	15.01	2.16	12.89	27.44	1.06	41.99	1.52	0.00	70.98	29.54	92.97	44.87	-26.84	73.25	35.37	67.93	74.33	98.31	25.70	54.72	54.89
BRD-K56700933	CP	phenethyl-isothiocyanate	cancer cell growth inhibitor, unidentified pharmacological activity	CYP2E1		3.85, 0.77	35.37	0.93, 0.19	60.45	16.56	6.88	19.85	25.60	5.85	8.62	59.09	42.06	2.40	3.63	17.82	59.91	89.57	75.72	95.52	95.71	16.14	26.23	43.90	8.92	61.82	79.66	73.86	29.03	72.95	89.42	32.32	35.37
BRD-M64432851	CP	sunitinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist	FLT3, KDR, KIT, FLT4, FLT1, PDGFRA, PDGFRB, RET, CSF1R, FGFR1	FLT3 inhibitor, PDGFR/KIT inhibitor, RAF inhibitor, VEGFR inhibitor	9.23, 4.23	35.36	1.50, 0.52	0.00	53.78	8.56	99.58	51.74	2.92	17.97	35.36	8.88	29.92	19.59	72.31	87.89	94.86	35.95	99.61	71.36	95.84	14.23	14.39	39.81	76.29	67.70	-34.87	86.34	32.32	27.52	18.52	21.09
BRD-A61470182	CP	n-formylmethionylalanine	macrophage activator			4.90, 2.04	35.33	1.38, 0.47	8.05	29.07	97.88	26.78	72.80	43.83	88.10	41.23	77.79	90.25	80.20	34.64	2.11	2.36	-49.41	1.82	31.77	52.26	99.08	35.33	84.20	65.93	45.23	-99.51	8.23	7.82	20.79	18.88	91.68
BRD-A43940795	CP	tetrahydropalmatine	serotonin release inhibitor			3.85, 1.15	35.32	0.50, 0.14	48.73	39.32	83.08	20.51	96.10	5.13	30.58	21.51	39.67	24.63	18.03	70.29	4.58	1.71	68.06	8.79	65.86	51.04	10.08	35.32	67.30	96.89	49.50	0.67	19.86	16.18	85.13	91.01	24.81
BRD-K69690935	CP	curcumin	cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity	PTGS1, PTGS2, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CCND1, CYP3A4, DNMT1, DNMT3B, EP300, G6PC, MAPT, MMP13, MMP9, NOS2, XDH		1.54, 0.38	35.32	1.56, 0.32	94.96	13.25	31.26	12.76	45.37	77.98	29.57	76.30	4.90	57.81	34.55	65.22	-79.74	24.33	-41.77	4.37	77.36	17.34	89.05	58.19	62.94	91.51	21.56	1.20	50.38	25.82	60.20	54.61	35.32
BRD-K30097969	CP	pitavastatin	HMGCR inhibitor, apolipoprotein expression enhancer, osteopontin expression inhibitor	HMGCR, APOA1, CYP2C8	HMGCR inhibitor	7.31, 4.62	35.31	2.19, 0.43	7.89	97.92	93.54	24.30	89.96	13.21	37.89	26.18	8.88	76.19	4.47	52.96	74.87	92.25	16.72	98.38	52.21	72.61	-13.73	44.64	99.93	35.31	18.67	-89.72	-54.84	-24.36	18.77	29.14	97.55
BRD-K05464208	CP	JX-401	p38 MAPK inhibitor	MAPK14		5.77, 3.08	35.27	1.08, 0.38	89.67	-6.89	35.27	30.78	-32.04	9.73	27.56	71.37	37.26	95.39	7.90	-1.66	3.97	15.65	94.99	2.22	45.01	13.73	60.64	98.05	11.26	37.46	12.08	99.75	78.44	51.24	61.66	99.00	18.57
BRD-K78280988	CP	anandamide	cannabinoid receptor agonist, potassium channel blocker, TRPV agonist	CNR1, CNR2, TRPV1, CACNA1G, CACNA1H, CACNA1I, GLRA1, GPR119, GPR18, GPR55, KCNA2, KCND3, KCNK3, KCNK9, TRPM8	Cannabinoid receptor agonist	6.92, 3.46	35.26	0.77, 0.25	43.26	8.58	0.00	3.39	16.86	40.43	82.99	91.65	39.95	9.75	16.26	35.26	-11.98	-2.04	-21.13	-7.74	17.44	46.38	89.30	16.09	86.50	99.75	-22.64	-16.52	90.88	62.34	45.25	99.44	75.58
BRD-K60923938	CP	veratridine	sodium channel activator	SCN1A, SCN3A, SCN8A, SCN9A		6.15, 4.62	35.25	1.07, 0.30	35.25	53.24	80.41	82.95	33.56	42.65	7.81	-15.04	-8.70	5.56	12.70	60.14	-5.46	28.81	65.72	6.77	69.92	22.97	20.37	99.86	22.40	42.36	66.23	99.82	20.40	41.01	88.26	62.50	8.60
BRD-K12516989	CP	zaprinast	phosphodiesterase inhibitor, histamine release inhibitor	PDE5A, GPR35, PDE1A, PDE4D, PDE9A		3.85, 0.77	35.23	1.01, 0.34	-1.90	-21.16	40.38	2.51	28.54	12.59	70.38	44.42	65.18	4.12	32.10	88.48	0.00	1.69	42.41	-35.74	66.28	2.85	35.23	64.09	3.96	8.66	61.07	27.11	57.54	69.39	68.12	37.55	60.98
BRD-A54596827	CP	solifenacin	acetylcholine receptor antagonist	CHRM3, CHRM1, CHRM2, CHRM4, CHRM5		5.31, 1.63	35.22	1.32, 0.39	99.65	16.74	41.59	25.18	52.99	16.34	17.31	33.20	33.08	57.14	31.92	55.04	2.82	64.04	81.63	10.91	7.54	43.60	35.22	68.09	24.55	55.70	13.85	23.79	75.38	75.90	40.09	52.48	22.57
BRD-A71157293	CP	fursultiamine	thiamine deriviative			4.90, 2.86	35.22	1.40, 0.47	19.13	11.59	71.81	30.00	72.11	22.87	2.18	42.04	27.28	48.59	73.16	51.06	5.92	10.13	40.87	3.00	74.28	29.17	61.48	33.53	40.82	70.66	35.22	1.30	33.56	35.89	36.31	72.47	19.78
BRD-K24656285	CP	farnesol	amine oxidase B inhibitor, FXR agonist	MAOB, MVK, NR1H4		4.23, 2.69	35.19	2.13, 0.48	49.98	-79.45	34.44	8.02	69.50	9.85	76.58	76.47	91.76	75.69	12.34	54.81	-21.09	19.16	36.11	-74.98	22.78	-6.45	15.96	92.08	-4.37	35.19	17.53	98.11	27.89	97.99	71.41	77.00	83.67
BRD-K89055274	CP	alverine	smooth muscle relaxant	HTR1A		2.69, 1.54	35.17	0.90, 0.28	55.81	-8.71	89.73	50.25	52.05	31.92	21.44	70.72	0.49	21.63	13.43	75.60	1.07	40.70	89.79	2.82	84.76	46.76	11.04	53.46	49.69	35.17	-5.71	13.89	17.84	24.35	49.93	94.93	21.11
BRD-K09635134	CP	l-erythro-MAPP	ceramidase inhibitor, negative control for D-erythro-MAPP			6.54, 4.23	35.13	0.80, 0.34	36.00	-17.11	41.53	17.68	34.56	0.03	12.98	55.51	33.85	14.47	37.77	13.35	-1.64	-10.24	95.05	2.89	84.24	-5.15	39.70	58.90	11.19	42.46	59.23	-30.58	92.69	61.60	35.13	99.93	45.63
BRD-K13049116	CP	BMS-754807	insulin growth factor receptor inhibitor	IGF1R, AKT1	IGF-1 inhibitor	5.38, 2.31	35.13	2.85, 0.90	15.13	67.86	79.23	99.04	33.42	15.97	-0.63	16.84	32.69	14.03	13.88	21.12	88.16	75.62	91.38	99.00	48.23	85.82	26.69	66.27	16.92	44.79	36.32	0.70	83.20	27.40	40.90	35.13	17.89
BRD-K26573499	CP	DMAB-anabaseine	alpha receptor partial agonist	CHRNA7		3.08, 1.54	35.13	0.98, 0.41	10.80	13.61	84.01	25.82	61.46	9.06	13.27	87.75	24.39	21.33	48.49	64.34	1.94	13.71	51.68	3.07	85.70	68.00	21.35	77.89	39.22	90.66	29.63	10.40	14.82	35.13	57.78	71.62	82.67
BRD-K77987382	CP	mebendazole	acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor	TUBA1A, TUBB, TUBB4B	Tubulin inhibitor	3.46, 1.54	35.13	1.63, 0.59	12.70	53.11	78.75	86.01	50.75	22.37	13.64	52.24	17.16	13.98	13.34	55.53	79.81	61.07	21.67	99.65	25.93	39.20	23.81	22.09	29.18	45.66	26.90	-93.61	-51.35	44.01	35.13	46.09	66.24
BRD-A20589515	CP	dihydroxyphenylglycine	glutamate receptor agonist	GRM1		5.73, 1.27	35.10	1.77, 0.52	90.09	19.07	-0.02	30.85	19.29	73.43	76.89	82.46	89.29	5.41	98.38	82.68	2.04	29.05	21.60	10.40	90.92	31.39	34.88	63.20	94.40	88.83	-7.43	-89.62	7.09	91.74	35.10	72.67	89.76
BRD-K14693417	CP	cinchonine	antimalarial agent	CYP2D6		3.85, 1.54	35.10	0.74, 0.19	98.92	21.17	13.17	57.89	62.10	28.17	46.96	37.97	52.83	56.46	84.24	61.01	9.54	44.22	35.10	16.29	66.65	6.41	60.67	96.43	8.65	13.69	22.38	14.35	11.27	23.71	31.99	69.76	12.66
BRD-K65910366	CP	KUC103904N	opioid receptor antagonist			4.23, 0.77	35.09	0.86, 0.15	10.84	30.54	23.35	80.71	19.48	55.26	-0.88	30.49	35.09	30.02	9.90	88.42	38.87	88.35	45.82	94.73	-54.34	91.50	15.65	40.60	78.09	2.61	73.51	1.13	95.38	76.18	44.35	10.48	24.41
BRD-A77349281	CP	RK-682	heparanase inhibitor, tyrosine phosphatase inhibitor	HPSE, PTPN1		5.77, 3.85	35.08	0.58, 0.30	87.36	33.48	87.87	12.39	55.23	8.32	63.13	25.40	44.52	35.08	35.21	32.49	1.73	-18.13	87.31	6.21	36.81	9.04	17.85	87.85	81.65	83.99	46.02	-99.61	-13.71	23.21	70.62	34.63	96.72
BRD-A18202423	CP	CPCCOEt	glutamate receptor antagonist	GRM1		5.00, 1.15	35.07	0.74, 0.25	4.86	25.14	80.68	20.23	87.00	11.04	24.80	70.36	19.85	64.60	35.07	9.26	-12.72	1.34	19.46	-0.70	71.79	19.03	92.01	60.18	55.49	67.37	87.51	99.12	49.54	29.53	58.73	85.98	18.25
BRD-A28105619	CP	cucurbitacin-i	inhibitor of STAT3/JAK2 signaling, JAK inhbitor, lipocortin synthesis stimulant, STAT inhibitor	JAK2, STAT3		8.46, 5.38	35.07	2.92, 0.80	15.93	77.03	23.28	96.48	40.58	28.89	-20.77	24.08	17.90	46.69	8.77	35.07	98.34	99.75	55.32	100.00	82.05	88.46	7.06	43.53	37.23	37.72	28.88	1.70	30.50	19.05	36.03	23.67	19.51
BRD-K46862739	CP	metyrapone	cytochrome P450 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, mineralocorticoid receptor antagonist	CYP11B1, HSD11B1, NR3C2		6.94, 3.67	35.06	0.67, 0.19	72.66	-28.77	57.07	2.11	26.17	20.50	54.42	88.55	29.38	31.21	62.56	30.94	-8.38	-7.69	99.31	-3.36	35.10	22.92	50.03	46.69	20.31	35.06	50.71	26.05	80.59	98.59	41.25	25.78	47.43
BRD-A34751532	CP	homosalate	HSP activator			4.23, 2.31	35.04	0.73, 0.31	13.96	8.73	24.51	21.88	81.27	-16.95	51.30	53.51	80.36	82.79	3.66	36.61	0.07	4.33	3.88	5.24	46.41	1.87	64.24	42.67	35.04	34.84	21.52	96.56	90.86	59.97	8.08	63.67	50.82
BRD-K92492521	CP	LY-255283	leukotriene receptor antagonist	LTB4R, LTB4R2		6.92, 3.08	35.02	1.02, 0.32	3.00	3.81	14.70	10.54	35.02	7.14	70.59	55.14	54.65	74.52	96.65	21.78	2.22	2.12	9.85	-3.70	58.40	-3.42	29.96	78.14	73.66	85.50	-11.14	-61.92	92.18	35.19	50.94	99.72	88.62
BRD-A74904029	CP	EI-231	casein kinase inhibitor	CSNK2A1, CSNK2A2, CSNK2B		2.69, 1.92	34.95	1.39, 0.43	8.14	85.50	34.95	44.57	42.70	65.04	22.72	59.93	14.02	18.12	47.10	78.57	0.00	1.09	36.06	32.63	89.15	13.96	8.77	83.93	88.77	35.87	11.97	-57.58	-3.31	3.35	16.27	66.13	90.89
BRD-A00100033	CP	nifurtimox	DNA inhibitor			1.92, 1.15	34.93	0.97, 0.34	85.26	42.16	57.61	9.22	83.01	9.90	51.66	65.89	12.54	43.36	11.00	61.41	4.58	1.16	62.67	2.60	93.83	3.95	13.03	60.68	31.32	46.23	18.08	-6.24	34.93	28.36	10.61	50.07	48.81
BRD-K18895904	CP	olanzapine	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HTR2C, DRD1, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR6, HTR7, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C8, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH2, HRH4, HTR1F, HTR2B, HTR3A, HTR5A		7.56, 6.67	34.90	0.57, 0.17	11.42	-6.08	8.88	13.30	6.30	42.96	24.88	56.74	-18.52	98.91	4.25	77.91	2.04	0.56	98.27	3.07	99.98	66.64	37.02	37.62	53.62	34.90	21.17	55.16	40.14	50.27	13.47	32.63	41.04
BRD-K67847053	CP	guanabenz	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C		6.15, 3.46	34.89	0.84, 0.23	25.16	28.86	8.60	27.03	37.62	89.24	9.31	80.12	59.59	59.93	23.02	73.66	-1.76	14.15	55.12	14.35	95.71	41.47	16.39	87.74	83.49	4.51	18.31	0.81	79.08	15.72	34.89	69.28	98.65
BRD-A65597028	CP	RX-821002	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D		5.31, 2.04	34.87	1.51, 0.50	98.34	56.34	99.86	6.42	51.73	97.11	40.79	43.40	39.63	34.87	40.08	29.58	1.37	5.20	51.56	3.14	96.79	28.60	40.61	20.35	19.50	32.53	18.00	-75.79	32.82	77.37	25.11	-5.30	88.40
BRD-K05181463	CP	L-741626	dopamine receptor, dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR2A, HTR2B	Dopamine receptor antagonist	9.62, 3.85	34.85	1.27, 0.42	10.73	16.32	97.85	88.48	78.73	-11.14	30.79	-41.81	27.80	4.59	14.29	16.14	23.18	77.21	86.93	63.65	70.63	96.62	11.01	15.96	35.18	7.89	57.22	97.12	98.20	9.00	34.85	70.01	84.73
BRD-A22844106	CP	tenoxicam	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		3.46, 1.54	34.83	0.67, 0.11	44.90	14.76	6.11	6.59	84.79	63.37	67.83	74.87	5.18	60.22	18.92	60.76	-3.03	12.77	92.05	3.10	97.18	7.32	78.39	34.83	66.57	45.83	16.23	-0.92	26.78	92.75	37.60	33.45	6.13
BRD-K41170226	CP	deoxycholic-acid	biliverdin reductase A activator, G protein coupled receptor agonist, unidentified pharmacological activity	GPBAR1, EFTUD1, FPR1		5.38, 3.08	34.82	0.91, 0.28	43.68	48.15	54.13	3.50	82.35	17.40	29.75	27.81	19.73	69.18	81.44	86.57	-15.20	0.53	76.89	-24.20	36.76	33.33	51.90	27.24	71.60	68.72	33.79	48.37	23.76	98.46	19.39	34.82	32.90
BRD-K53523901	CP	arctigenin	adiponectin receptor agonist, AP inhibitor, aryl hydrocarbon receptor antagonist, HIV integrase inhibitor, MEK inhibitor, NFkB pathway inhibitor, topoisomerase inhibitor	ADIPOR1, AHR, CHUK, MAP2K1		5.77, 3.08	34.80	0.69, 0.15	95.13	27.47	3.73	89.35	4.33	33.93	9.01	74.10	30.17	68.04	35.66	25.38	20.96	7.79	55.03	2.50	53.65	62.28	47.26	5.59	-68.08	47.76	-4.40	-84.15	87.84	84.89	47.99	34.80	95.98
BRD-K29313308	CP	HDAC3-selective	HDAC inhibitor	HDAC3		1.72, 0.86	34.78	0.56, 0.36	57.20	19.89	68.95	25.53	69.64	13.15	13.01	48.25	18.11	61.92	36.80	59.37	10.74	29.10	70.55	97.81	40.58	11.10	34.78	33.02	59.13	31.67	19.43	7.66	15.11	54.29	26.66	37.69	44.95
BRD-K47679368	CP	bromfenac	cyclooxygenase inhibitor	PTGS1, PTGS2		5.71, 2.86	34.77	1.44, 0.48	34.77	18.58	34.17	13.03	12.90	46.79	70.52	25.26	1.59	9.95	49.30	76.24	2.26	53.43	68.63	15.77	56.01	16.87	49.77	50.42	81.64	85.80	27.52	31.22	25.11	99.86	54.56	95.88	-17.60
BRD-K36740062	CP	GSK-1070916	Aurora kinase inhibitor	AURKB, AURKC, AURKA, CYP2D6, CYP3A4	Aurora kinase inhibitor	6.92, 2.69	34.74	1.24, 0.53	41.42	61.63	32.35	97.70	55.14	25.23	12.97	-25.97	10.30	88.73	14.44	28.84	70.64	96.41	97.54	99.10	31.88	95.53	34.74	24.35	74.81	18.86	50.72	18.74	65.34	42.36	20.93	13.40	29.01
BRD-K01779529	CP	fluoropyruvate	PDH inhibitor			5.38, 0.77	34.71	1.27, 0.24	89.92	-55.60	-10.42	3.44	-16.22	95.19	88.72	96.37	50.31	4.77	36.56	34.71	-69.33	2.71	76.54	-98.87	45.24	2.15	92.28	96.28	39.92	28.44	17.54	99.08	40.32	87.07	31.13	26.44	12.47
BRD-K23204545	CP	busulfan	DNA damaging, DNA inhibitor			7.35, 4.08	34.71	1.14, 0.38	65.16	96.47	96.34	29.54	98.66	11.10	65.73	80.90	5.71	95.79	50.52	92.52	-0.07	6.76	12.50	16.47	85.78	6.66	34.71	22.83	96.10	59.72	11.02	-56.27	15.07	98.14	58.19	-22.33	0.00
BRD-A53131506	CP	epitestosterone	inactive testosterone analog	AKR1C1, AKR1C2, AR		4.23, 1.92	34.69	0.63, 0.11	46.16	10.70	62.94	18.86	3.48	40.56	17.99	34.69	5.40	11.63	12.70	77.54	-2.18	19.75	89.74	3.01	82.46	21.46	4.90	43.38	24.18	57.47	71.62	99.30	44.66	25.03	37.94	56.69	57.66
BRD-K00627859	CP	tubastatin-a	HDAC inhibitor	HDAC6	HDAC inhibitor	2.31, 0.38	34.69	0.35, 0.25	15.46	37.01	56.39	9.89	29.04	18.18	15.09	51.74	14.64	42.25	36.38	33.59	36.25	30.74	57.76	80.64	84.17	14.44	19.21	29.07	44.89	20.61	34.69	44.93	17.75	47.25	29.06	37.70	74.97
BRD-K49671696	CP	ketanserin	serotonin receptor antagonist, collagen stimulant	HTR2A, HTR2C, ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2B, HTR5A, HTR7, SLC18A1, SLC18A2		7.31, 3.85	34.66	0.76, 0.25	6.09	75.13	94.79	-1.52	76.09	7.68	33.98	98.36	36.02	-7.51	77.24	40.64	4.67	-13.77	34.66	-2.23	33.16	54.68	30.40	48.02	53.47	76.42	3.91	-19.38	24.92	45.69	23.72	81.83	92.22
BRD-K14696368	CP	9-methyl-5H-6-thia-4,5-diaza-chrysene-6,6-dioxide	NFkB pathway inhibitor	RELA		3.85, 1.92	34.65	0.85, 0.25	94.70	34.65	75.91	-10.86	47.16	49.90	68.65	59.33	16.91	4.58	58.77	24.89	-11.27	1.94	52.12	-0.60	15.33	6.53	76.01	31.98	63.35	81.77	15.09	-81.08	-5.56	48.27	38.66	74.08	10.45
BRD-K64890080	CP	BI-2536	PLK inhibitor, apoptosis stimulant, cell cycle inhibitor, protein kinase inhibitor	PLK1, BRD4, PLK2, PLK3	Bromodomain Inhibitor	5.00, 0.77	34.65	1.49, 0.56	12.97	96.07	57.12	43.89	53.39	42.60	7.28	-37.41	11.42	37.81	10.69	46.89	82.75	96.37	34.84	69.43	14.18	94.71	7.44	11.70	32.24	19.79	61.03	-0.04	41.56	31.34	34.65	14.93	30.20
BRD-K77793136	CP	hydroxyfasudil	ROCK inhibitor	ROCK1, PKIA, PRKACA, ROCK2	Rho associated kinase inhibitor	6.12, 2.86	34.64	1.35, 0.39	11.51	49.24	98.63	31.11	24.85	99.89	16.60	38.30	70.65	56.92	37.94	97.74	2.45	7.57	34.64	29.02	48.17	5.14	17.05	24.92	43.32	68.33	14.28	0.53	4.46	46.73	26.91	41.75	71.81
BRD-K79877282	CP	PF-543	sphingosine kinase inhibitor	SPHK1		1.72, 0.00	34.60	0.60, 0.36	47.92	23.22	34.60	24.75	30.14	5.13	43.68	46.04	20.88	47.19	40.35	59.05	7.99	33.56	31.33	96.85	19.47	46.01	41.88	10.61	52.05	15.69	9.14	84.36	39.99	32.58	23.99	44.34	64.84
BRD-K84987553	CP	MDM2-inhibitor	MDM inhibitor	MDM2	MDM inhibitor	5.00, 2.31	34.58	1.22, 0.52	12.62	49.46	9.78	33.22	15.21	9.52	79.04	70.06	24.98	2.54	-1.20	9.73	30.72	70.83	97.99	16.32	41.03	30.64	71.57	95.61	34.58	25.38	41.28	2.22	70.70	48.02	77.94	98.70	45.90
BRD-K00184207	CP	GR-206	aryl hydrocarbon receptor ligand			3.46, 2.31	34.57	0.97, 0.31	6.54	18.61	81.05	65.37	8.17	29.17	58.21	70.09	22.76	26.72	22.53	-43.96	-42.18	-11.32	97.89	2.57	88.97	34.57	52.97	39.73	74.65	60.07	1.59	11.63	74.17	37.92	30.49	77.28	58.61
BRD-K43887077	CP	dopamine	dopamine receptor agonist	DRD2, DRD1, DRD3, DRD4, DRD5, DBH, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4		5.00, 3.08	34.57	0.88, 0.34	30.97	-38.81	8.38	27.09	73.10	12.14	92.03	80.11	42.25	12.90	10.88	38.79	1.51	-0.76	98.45	1.62	66.25	13.53	83.88	34.36	-54.19	34.57	78.86	78.11	93.97	83.91	66.03	32.77	61.52
BRD-K87049188	CP	fusaric-acid	chelating agent, dopamine beta hydroxylase inhibitor	DBH		5.00, 4.23	34.57	1.02, 0.35	22.82	-24.61	8.46	5.01	52.94	55.06	77.30	68.19	40.56	43.79	13.64	34.57	-27.12	16.20	18.00	-0.53	84.18	6.48	99.68	22.14	89.87	87.82	-18.47	-89.76	88.72	24.02	64.06	88.82	60.03
BRD-A07780951	CP	orciprenaline	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	6.12, 4.49	34.55	1.14, 0.48	34.55	23.57	9.63	66.99	40.96	14.28	33.81	68.24	99.96	59.65	10.37	31.16	-4.82	4.31	97.89	2.89	40.74	76.24	51.99	31.18	36.46	21.02	23.29	96.56	67.67	14.08	42.47	30.19	53.59
BRD-K96778649	CP	tyrphostin-47	EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor	EGFR		3.46, 1.54	34.53	1.05, 0.30	-8.14	68.82	56.05	70.82	60.40	59.81	34.53	15.91	52.77	14.34	57.01	75.24	15.35	22.95	26.66	61.61	62.72	65.70	33.69	29.77	85.24	66.71	9.55	1.20	12.36	8.11	28.33	54.68	24.43
BRD-U68942961	CP	JW-7-24-1	LCK Inhibitor	LCK		9.23, 3.85	34.49	2.46, 0.67	34.40	75.59	97.40	98.55	74.80	38.06	-16.98	-13.54	15.13	30.87	24.83	94.82	96.87	91.44	90.81	99.96	34.49	96.65	18.90	13.29	35.14	10.18	31.45	0.46	30.45	44.80	52.97	22.65	28.14
BRD-A41995253	CP	brucine	glycine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5		3.08, 1.54	34.48	0.60, 0.14	93.36	-65.32	3.98	17.10	79.17	66.04	27.12	64.63	13.16	8.64	81.87	6.48	4.91	4.59	63.09	16.14	97.43	11.68	56.18	81.28	14.89	45.51	5.43	89.78	65.64	34.48	75.03	65.90	14.78
BRD-K25906698	CP	immepip	histamine receptor agonist	HRH3, HRH4		5.38, 2.69	34.47	1.00, 0.33	3.49	-20.36	87.88	0.53	86.79	6.09	87.11	57.61	14.31	86.42	71.28	34.47	-4.34	-0.78	-53.27	4.72	-53.07	49.72	90.98	7.47	79.03	98.77	36.90	-74.16	77.07	3.07	17.39	41.11	58.27
BRD-K99063460	CP	didanosine	nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor	PNP	Nucleoside reverse transcriptase inhibitor	7.56, 6.22	34.44	0.86, 0.24	26.46	74.30	2.96	34.44	26.03	65.84	56.71	26.11	32.19	2.87	60.53	98.40	2.18	3.19	99.72	20.26	80.47	9.03	34.27	60.74	69.53	33.96	31.35	55.99	-0.32	89.46	58.46	84.26	70.41
BRD-K23192422	CP	lestaurtinib	FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant	FLT3, NTRK1, JAK2, NTRK2, NTRK3	FLT3 inhibitor, JAK inhibitor	6.92, 3.46	34.42	3.09, 0.86	-3.91	98.24	41.67	89.71	74.82	17.52	22.73	-28.63	74.52	30.44	52.50	86.37	0.00	33.81	57.86	99.47	11.03	14.60	32.89	34.42	56.70	66.78	15.54	-95.56	11.96	15.24	43.37	67.91	80.75
BRD-A84327315	CP	calcitriol	vitamin D receptor agonist, hypercalcaemic agent	VDR, CYP3A5	Vitamin D receptor agonist	4.62, 1.15	34.40	0.84, 0.27	5.78	75.96	86.34	23.87	97.46	12.23	26.77	70.33	24.61	11.31	38.10	80.69	3.00	27.54	43.44	2.04	80.68	66.11	34.40	65.14	93.68	48.04	8.15	-1.98	0.35	77.83	27.00	77.09	19.44
BRD-K30570479	CP	VU-0400195-3	glutamate receptor modulator	GRM4		4.23, 1.92	34.40	1.07, 0.27	66.58	35.65	0.00	25.54	40.52	32.13	65.78	55.35	74.01	68.06	21.57	34.40	0.00	0.63	82.49	2.22	87.00	30.28	69.42	57.90	0.00	17.74	26.41	1.08	39.34	20.60	30.46	93.10	75.24
BRD-U08759356	CP	EI-346-erlotinib-analog	epidermal growth factor receptor (EGFR) inhibitor	EGFR		4.62, 1.54	34.35	1.74, 0.51	34.35	90.08	2.96	80.09	47.80	22.45	33.97	21.58	16.34	6.70	14.21	88.52	91.37	97.34	64.10	99.51	14.93	54.46	51.58	28.86	21.15	35.97	28.10	-33.52	34.86	72.72	30.50	16.15	59.85
BRD-K12502280	CP	TG-101348	JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor	JAK2, FLT3, BRD4, JAK1, JAK3, RET, TYK2	Bromodomain Inhibitor, FLT3 inhibitor, JAK inhibitor	2.69, 0.00	34.33	1.65, 0.56	6.62	92.37	53.89	92.50	47.27	14.38	9.92	-19.95	25.70	35.91	11.61	54.14	80.33	96.16	64.00	97.39	15.49	93.37	4.90	15.26	10.34	5.46	34.33	-21.19	39.38	48.98	11.00	4.60	40.87
BRD-K68488863	CP	ENMD-2076	Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor	AURKA, FLT3, KDR, PDGFRA, SRC, CSF1R, EPHA1, FGFR1, FGFR2, FGFR3, FLT4, KIT, PTK2	Aurora kinase inhibitor	3.86, 2.15	34.32	1.09, 0.32	25.21	52.33	67.70	54.33	38.57	74.16	4.41	3.98	12.91	4.02	7.43	43.18	76.69	50.31	42.63	99.89	31.41	61.41	-23.33	48.38	51.26	34.32	9.79	-0.46	26.37	21.75	25.56	10.43	67.77
BRD-K31054881	CP	BMY-7378	serotonin receptor antagonist, adrenergic receptor antagonist	HTR1A, ADRA1D, ADRA1A, ADRA1B		2.31, 1.54	34.30	1.25, 0.47	18.96	42.92	31.22	39.11	-14.61	19.18	86.21	69.82	92.96	48.97	89.36	55.61	-3.49	6.12	1.86	-3.07	33.95	-50.38	99.59	34.30	-26.03	20.55	37.65	-77.15	37.14	89.37	14.68	42.40	61.57
BRD-K72895815	CP	SSR-69071	leukocyte elastase inhibitor	ELANE		6.54, 3.46	34.30	2.18, 0.52	23.75	85.09	34.30	62.68	64.66	7.44	18.72	61.18	24.04	38.12	7.95	27.92	91.19	83.14	-68.05	99.93	34.82	88.52	32.99	26.42	35.10	48.21	17.04	-0.49	74.33	15.61	31.40	14.79	97.84
BRD-K15196155	CP	IBC-293	hydroxycarboxylic acid receptor agonist	HCAR3		8.85, 5.77	34.27	1.02, 0.26	8.13	47.79	51.78	18.25	87.28	15.16	60.81	34.27	56.46	88.78	6.00	73.10	0.00	7.54	16.92	3.04	15.17	82.81	18.28	23.10	97.96	96.37	43.94	1.14	31.41	46.04	16.81	85.86	89.71
BRD-K59419204	CP	AM-281	cannabinoid receptor antagonist, cannabinoid receptor inhibitor	CNR1, CNR2, GPR55		3.27, 2.04	34.26	0.94, 0.30	80.22	13.38	39.93	40.23	38.19	91.93	10.36	34.26	9.27	44.26	11.61	24.58	41.35	24.95	46.54	76.50	67.27	38.55	30.86	49.01	79.29	21.02	8.14	0.00	1.97	27.02	5.15	18.61	69.06
BRD-A74907996	CP	equol	estrogen receptor agonist	ESR2, ESR1		1.72, 0.00	34.25	0.52, 0.39	51.89	23.49	3.27	20.06	50.81	7.68	44.82	31.06	20.22	18.99	25.16	68.88	1.17	46.08	20.50	94.94	65.72	24.31	34.25	19.97	51.45	40.39	41.68	12.39	73.73	19.89	49.74	74.53	37.51
BRD-K73589401	CP	corticosterone	mineralocorticoid receptor agonist	HSD11B1, NR3C2, NCOA1		6.92, 4.62	34.23	1.63, 0.55	4.51	34.23	42.31	43.02	94.46	26.00	61.11	27.27	10.88	45.29	15.40	75.74	5.00	74.98	-96.20	23.02	99.15	25.65	10.01	87.14	99.93	75.96	30.13	-5.85	54.37	19.69	62.40	93.76	5.09
BRD-A14574269	CP	UB-165	acetylcholine receptor agonist	CHRNA3, CHRNA4, CHRNB2		5.38, 3.46	34.21	1.14, 0.43	75.13	54.89	17.72	28.07	29.30	70.99	97.58	49.80	53.69	29.74	6.73	50.64	0.00	14.81	64.17	4.76	82.45	3.52	25.93	55.18	68.75	66.53	11.97	-48.79	34.21	-10.07	73.64	98.59	32.23
BRD-A97479839	CP	piperidolate	acetylcholine receptor antagonist	CHRM1		6.15, 4.62	34.21	1.19, 0.31	99.33	24.64	2.83	8.68	26.65	50.73	38.41	82.98	34.21	31.18	64.76	15.74	3.14	2.11	88.19	1.34	91.87	25.35	66.86	95.00	-10.09	24.08	31.17	99.44	84.13	87.70	79.63	71.52	34.17
BRD-A95513702	CP	androsta-1,4-dien-3,17-dione	aromatase inhibitor	CYP19A1	Aromatase inhibitor	2.31, 0.38	34.20	0.66, 0.23	10.95	56.13	78.86	67.01	63.60	20.01	20.78	45.93	14.92	74.71	24.13	17.37	2.78	72.51	-33.91	29.24	36.10	66.64	20.36	29.83	91.85	44.68	13.34	-37.34	85.52	34.20	19.92	69.93	90.52
BRD-K19533706	CP	tranilast	angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor	HPGDS, HRH1, IDO1, IFNG, IL10, IL2, IL4, SLC22A12, TGFB1, TNF, TRPV2		8.85, 3.08	34.17	0.76, 0.17	23.31	-2.61	71.87	11.19	65.43	15.34	5.29	85.97	49.98	25.38	12.33	17.93	0.07	1.80	89.72	86.32	97.22	43.69	17.48	90.22	16.11	60.24	34.17	67.13	13.04	63.10	26.62	72.65	71.15
BRD-K83637872	CP	SANT-1	smoothened receptor antagonist	DHH, IHH, PTCH1, SMO		5.00, 3.08	34.13	0.78, 0.17	21.79	47.61	7.24	27.50	21.53	29.34	96.85	64.03	54.90	47.62	98.32	80.06	6.17	9.83	-34.92	2.76	33.82	25.45	83.62	96.55	47.47	34.13	33.79	0.00	59.20	98.77	58.11	94.58	0.88
BRD-A43974575	CP	tranylcypromine	cytochrome P450 inhibitor, histone lysine demethylase inhibitor, monoamine oxidase inhibitor	MAOA, MAOB, KDM1A, CYP2A6		6.94, 4.49	34.09	1.14, 0.30	95.19	7.91	31.39	8.68	9.23	99.54	18.87	62.15	13.18	93.28	19.96	63.30	5.78	4.71	93.32	3.95	46.01	55.18	92.08	72.89	20.31	17.67	34.09	95.12	94.48	33.99	46.15	83.62	31.32
BRD-K21450440	CP	benzthiazide	carbonic anhydrase inhibitor	CA2, CA1, CA12, CA4, CA9, SLC12A3		3.85, 2.31	34.09	1.08, 0.26	82.67	16.83	3.10	23.65	14.07	67.83	71.06	62.23	82.45	8.79	31.81	52.31	-14.70	-17.31	95.05	-15.45	93.81	-6.19	75.27	39.99	38.62	63.13	3.63	0.00	38.04	22.98	21.57	76.59	34.09
BRD-K16406336	CP	methylene-blue	guanylate cyclase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, tau aggregation inhibitor	ACHE, MAPT		5.00, 2.31	34.08	2.94, 0.64	24.80	88.45	67.95	65.79	43.21	16.75	-1.34	-36.18	20.28	81.56	22.10	93.55	95.51	80.86	29.46	98.91	38.82	14.70	56.54	84.60	30.99	17.39	76.43	17.18	5.92	14.45	21.14	44.26	34.08
BRD-K16977723	CP	PP-3	EGFR kinase inhibitor			5.00, 3.08	34.08	0.85, 0.35	99.06	21.55	21.07	38.10	-8.16	10.71	87.87	71.82	45.25	34.08	13.83	24.60	-14.50	14.16	88.78	-81.94	64.18	8.55	46.07	61.26	21.02	45.59	-12.59	-74.39	90.93	68.95	19.55	87.12	88.00
BRD-K84141129	CP	VU-0400193-3	glutamate receptor modulator	GRM4		4.62, 3.85	34.06	0.83, 0.27	8.06	-4.65	1.41	0.00	70.58	33.59	67.00	83.45	38.89	93.48	47.13	34.68	-3.95	-11.50	-38.38	3.19	98.01	62.09	79.99	25.05	6.61	35.37	1.14	0.88	28.08	75.30	53.39	62.30	34.06
BRD-K02404261	CP	caffeine	adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor	ADORA1, ADORA2A, ADORA2B, ATM, ITPR1, RYR1, ADORA3, ATR, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR2, RYR3		5.00, 3.46	34.03	0.43, 0.13	88.95	34.03	8.89	28.09	63.09	20.87	8.54	76.54	6.17	22.46	31.54	47.41	-6.44	7.12	73.89	3.82	59.65	10.49	79.14	72.73	79.33	59.73	69.78	1.10	68.81	31.73	28.55	54.55	38.30
BRD-K81528515	CP	nilotinib	Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, KIT, BCR, CYP2B6, CYP2C8, DDR1, DDR2, PDGFRA	FLT3 inhibitor	5.38, 3.08	34.02	0.60, 0.17	52.98	40.96	19.40	40.59	66.90	15.39	41.68	34.55	14.60	29.73	8.68	83.17	77.38	66.69	51.22	99.99	62.52	3.59	12.98	25.94	27.55	34.02	39.47	0.03	12.53	22.64	38.25	30.22	18.06
BRD-A00267231	CP	hemado	adenosine receptor agonist	ADORA3, ADORA1, ADORA2A, ADORA2B		7.31, 4.62	34.01	0.85, 0.32	67.78	39.67	93.05	25.12	17.18	77.72	48.77	38.14	45.37	8.32	12.50	24.36	1.39	8.28	18.66	-4.26	87.95	9.35	13.56	62.55	76.86	95.52	3.70	-40.78	89.58	20.18	34.01	99.79	92.30
BRD-K47659338	CP	EMD-386088	serotonin receptor agonist	HTR6	Serotonin receptor agonist	3.85, 1.15	34.01	0.47, 0.09	34.01	5.29	10.52	39.47	36.16	36.92	7.78	64.16	47.91	5.72	9.15	33.67	6.58	27.41	91.32	16.71	74.95	86.81	28.77	79.12	24.58	53.00	36.35	98.78	75.35	9.41	5.76	24.93	90.19
BRD-K79353516	CP	indolophenanthridine	CALY activator, dopamine receptor agonist	CALY, DRD1		3.46, 0.77	33.99	1.11, 0.25	65.97	51.27	9.35	95.39	9.27	11.78	4.76	22.54	10.47	23.55	29.36	35.29	68.78	33.99	61.24	92.61	49.97	86.39	11.52	31.81	39.20	46.77	48.81	-0.81	92.26	22.80	11.93	36.40	33.67
BRD-A35108200	CP	dexamethasone	glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant	ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2	Glucocorticoid receptor agonist	1.15, 0.38	33.98	1.30, 0.85	85.39	14.76	17.60	35.41	18.69	6.55	71.08	70.63	25.61	72.78	46.28	84.37	-15.01	62.40	-76.60	-34.40	42.32	19.28	41.70	33.98	37.86	67.42	6.20	-6.06	26.49	47.68	28.28	13.91	38.78
BRD-K36864847	CP	BD-1047	alpha receptor antagonist, sigma receptor antagonist	SIGMAR1		3.46, 1.92	33.97	0.76, 0.19	25.74	14.51	11.36	14.49	71.09	38.31	7.65	55.82	54.45	25.15	52.95	69.49	2.40	16.80	97.64	20.70	30.43	80.35	16.91	66.64	38.59	21.42	7.26	-96.46	53.01	80.35	33.97	94.80	89.50
BRD-A21723284	CP	naltriben	opioid receptor antagonist	OPRD1, OPRK1, OPRM1		5.00, 3.08	33.93	1.01, 0.31	48.54	-15.89	0.00	31.01	14.44	26.14	88.42	88.39	39.02	16.45	17.09	22.84	19.36	7.59	46.78	0.56	46.04	29.15	58.31	79.54	44.05	33.39	28.16	33.93	97.64	72.63	67.37	99.68	83.13
BRD-A68929948	CP	DAPT-GSI-IX	antiamyloidogenic agent, gamma secretase inhibitor		Gamma secretase inhibitor	3.85, 1.54	33.90	0.84, 0.23	7.99	33.90	22.39	60.24	81.79	10.41	33.83	-61.05	24.56	37.61	62.25	82.68	1.48	16.68	81.19	13.06	80.00	59.80	36.86	85.46	69.89	66.11	12.78	2.01	31.84	54.98	27.40	93.12	22.30
BRD-K05653692	CP	DL-PDMP	ceramide glucosyltransferase inhibitor, glucosyltransferase inhibitor	ASAH1, UGCG		5.77, 1.92	33.90	0.67, 0.05	8.95	29.82	43.89	97.36	6.41	10.55	-2.47	67.37	26.09	13.23	3.63	48.30	96.66	96.41	83.76	99.72	62.38	98.23	44.80	23.89	26.17	8.42	58.19	80.85	93.38	18.38	33.50	20.10	33.90
BRD-K61993165	CP	niacin	vitamin agonist	HCAR2, HCAR3, ACHE, DGAT2, HCAR1, NNMT, PTGDR, QPRT		5.38, 1.15	33.86	1.23, 0.31	83.09	46.29	13.48	22.10	33.86	33.03	37.20	38.69	33.04	14.63	22.39	59.56	-2.85	69.52	98.24	-0.67	21.14	17.43	49.46	96.55	69.81	52.59	18.21	1.16	-0.35	47.15	84.78	81.87	32.95
BRD-A95696820	CP	acadesine	adenosine release stimulant, AMPK activator, AMPK stimulant			7.64, 5.10	33.83	2.15, 0.51	20.40	96.79	34.86	4.02	98.20	98.44	20.83	-84.03	44.26	98.98	18.31	38.37	-0.18	75.68	-62.69	5.76	32.80	33.71	82.69	5.53	85.67	43.60	57.08	0.00	16.68	99.19	77.93	7.76	33.83
BRD-K54416256	CP	methimazole	antithyroid Drugs	TPO		4.08, 1.63	33.81	0.90, 0.34	13.20	18.38	47.42	7.79	75.23	13.35	43.78	95.37	70.92	10.61	2.26	46.04	12.31	4.21	60.19	0.00	85.45	0.00	37.08	55.45	8.99	45.56	81.54	-4.59	2.33	99.54	33.81	24.01	92.11
BRD-U82589721	CP	HG-5-113-01	protein kinase inhibitor	ABL1, LTK, STK10		3.85, 2.31	33.79	1.97, 0.53	0.00	97.92	20.79	90.43	37.52	21.08	1.34	36.93	32.26	61.25	21.25	77.87	56.03	34.56	-48.35	89.43	7.12	33.79	54.22	22.89	83.27	50.86	17.68	-85.57	0.32	1.06	27.87	41.77	37.54
BRD-K56064827	CP	EI-273	PKC inhibitor	PRKCA, PRKCG		8.08, 4.23	33.74	2.13, 0.88	45.23	66.24	8.14	7.28	0.95	99.72	18.00	87.81	27.24	10.05	92.73	75.44	-22.30	-1.30	34.02	17.48	45.76	9.29	-30.64	95.92	13.96	74.70	33.74	-6.98	8.98	76.19	89.80	58.29	98.84
BRD-A02481876	CP	importazole	importin-beta transport receptor inhibitor	KPNB1		6.15, 3.08	33.72	1.51, 0.24	17.92	33.72	17.31	87.39	47.07	22.79	-12.60	-73.61	43.11	19.84	7.90	82.25	94.86	95.86	74.38	99.61	86.53	67.90	39.09	26.00	46.71	0.95	18.65	50.76	0.78	32.24	36.16	24.32	30.38
BRD-K32330832	CP	VER-155008	HSP inhibitor	HSPA1A		4.62, 1.54	33.71	0.98, 0.36	21.84	29.64	67.94	73.87	21.13	97.10	3.00	-22.20	8.90	8.89	40.32	27.32	13.73	85.77	79.36	76.81	37.16	46.87	3.39	11.02	33.71	54.27	24.12	-2.39	23.83	42.17	38.75	47.72	82.24
BRD-A49906757	CP	scopolamine	acetylcholine receptor antagonist	CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI		3.08, 1.54	33.70	0.82, 0.25	14.03	42.64	-2.48	12.98	58.59	10.88	55.08	-19.35	41.83	59.23	90.66	63.83	-13.93	15.19	30.25	2.54	19.41	3.51	64.05	65.75	25.69	63.43	33.70	-0.85	35.30	64.10	36.28	50.98	3.03
BRD-K12120659	CP	GR-144053	integrin antagonist	ITGB3, ITGA2B		5.77, 1.92	33.70	1.01, 0.33	61.98	-4.05	-18.60	56.12	23.71	6.98	97.47	60.88	22.56	9.98	58.54	50.70	0.00	6.11	69.31	2.85	50.20	4.31	36.67	86.45	-8.40	90.67	17.95	-9.85	33.70	35.39	25.24	99.32	52.22
BRD-A36630025	CP	SN-38	topoisomerase inhibitor	TOP1	Topoisomerase inhibitor	3.08, 1.54	33.69	3.27, 1.09	13.56	97.60	38.47	41.42	66.78	26.11	19.20	-64.29	8.32	41.71	16.57	62.81	79.05	81.08	39.70	96.58	16.34	5.20	49.07	16.14	61.29	13.44	58.98	3.97	13.71	14.57	30.82	36.72	33.69
BRD-K07507905	CP	BRL-37344	adrenergic receptor agonist	ADRB3, ADRB1, ADRB2		3.85, 2.69	33.69	0.76, 0.25	40.52	4.81	66.99	9.30	93.32	31.08	81.25	66.67	76.12	42.63	48.86	57.79	0.00	17.41	8.88	4.51	14.86	39.93	63.25	4.65	33.69	50.16	11.12	1.32	86.28	7.32	15.69	48.57	18.66
BRD-K11853856	CP	PJ-34	PARP inhibitor	EEF2, PARP1, PARP15, PARP3	PARP inhibitor	5.77, 3.85	33.66	0.83, 0.23	32.07	33.66	95.18	7.71	78.59	23.99	11.83	25.13	40.39	7.57	86.97	24.30	0.00	-21.47	48.73	28.51	42.43	20.70	91.61	50.43	98.06	71.73	29.71	96.67	22.90	72.99	20.89	50.04	37.88
BRD-K27737647	CP	H-89	AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker	PRKACA, GSG2, KCNA2, KCNA3, KCNA5, KCNAB2, KCNC1, KCNC2, KCNC3, KCNE1, KCNE2, KCNE3, KCNE4, KCNH1, KCNH2, KCNQ1, KCNQ2, KCNQ3, KCNQ5, KCNS3, PKIA	PKA inhibitor	6.54, 2.69	33.66	1.58, 0.55	5.61	35.64	17.57	96.51	78.60	10.84	-26.35	-38.79	24.17	2.74	30.38	64.61	74.01	91.01	62.95	86.44	24.76	96.26	-31.07	47.10	19.39	33.66	19.29	8.46	99.93	82.57	23.40	77.85	38.99
BRD-K13571841	CP	pepstatin	aspartic protease inhibitor	CTSB, CTSD, CTSL, REN		4.90, 2.86	33.65	2.32, 0.85	71.84	92.59	75.77	11.76	33.65	99.54	38.54	82.23	16.43	83.39	26.41	91.57	-5.79	1.62	-48.38	1.66	97.74	71.79	79.61	40.60	94.71	33.26	18.78	-77.35	6.62	24.45	12.32	19.98	75.66
BRD-A96255180	CP	ribavirin	antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor	IMPDH1, ADK, ENPP1, IMPDH2, NT5C2		4.62, 1.54	33.60	1.03, 0.22	33.60	59.14	26.84	16.74	82.31	24.81	34.65	65.94	96.14	86.43	15.36	23.60	-11.73	54.45	-24.93	-14.20	21.17	66.79	15.77	47.08	47.20	26.88	3.66	-19.45	-53.58	50.27	38.09	55.27	89.24
BRD-K53318339	CP	vinpocetine	phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor	PDE1A, PDE1C, SCN10A		5.00, 2.69	33.59	0.94, 0.25	65.78	30.06	1.60	20.88	-8.42	74.21	55.37	56.53	17.03	51.59	45.83	36.09	-2.22	2.01	88.77	2.82	26.79	1.23	52.56	73.59	19.26	33.59	10.21	-1.87	72.24	80.48	45.80	95.91	14.88
BRD-K08502430	CP	angiogenesis-inhibitor	angiogenesis inhibitor	EGFR		3.85, 1.92	33.58	1.67, 0.48	9.77	76.14	88.99	46.87	79.70	-40.88	-0.99	14.06	3.59	8.10	34.60	45.64	86.55	79.65	33.58	99.70	-65.74	10.74	39.61	64.19	33.54	63.39	35.31	4.55	16.37	18.30	25.55	43.56	-53.35
BRD-K60230970	CP	MG-132	proteasome inhibitor	PSMB1	Proteasome inhibitor	4.62, 2.31	33.56	2.30, 0.69	55.55	69.39	13.88	92.97	57.83	18.00	7.69	52.15	33.60	25.49	17.08	47.17	96.93	93.25	2.51	99.82	30.15	43.12	28.98	60.81	28.26	9.43	67.78	38.16	33.56	3.63	30.57	1.55	8.74
BRD-K37792168	CP	denbufylline	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4D		6.15, 4.62	33.54	0.76, 0.24	48.70	-44.64	99.58	27.38	92.52	6.94	11.14	51.20	95.77	0.39	22.37	74.04	3.00	0.56	81.14	24.51	65.38	10.19	39.22	82.75	33.54	14.16	80.51	99.01	6.99	88.75	23.70	91.31	23.81
BRD-K20285085	CP	fostamatinib	syk inhibitor, FLT3 inhibitor	SYK, FLT3, RET		4.62, 3.08	33.53	2.07, 0.75	16.13	44.79	30.44	98.91	6.01	97.64	8.74	-22.45	71.29	12.71	3.00	33.53	-32.11	0.00	98.81	5.11	73.79	87.95	51.71	64.56	34.63	35.09	22.93	30.40	54.93	42.99	8.75	13.26	85.97
BRD-K46212057	CP	voriconazole	cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor	CYP2C19, CYP51A1		6.54, 4.23	33.53	1.43, 0.45	70.43	-46.44	4.64	7.06	-43.96	94.22	80.10	93.36	5.92	91.89	29.36	33.53	-29.14	10.75	-52.37	-18.43	87.23	1.23	98.69	58.43	15.98	2.22	75.78	60.17	59.66	95.14	96.82	16.57	98.38
BRD-K62310379	CP	fluticasone	glucocorticoid receptor agonist	NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A	Glucocorticoid receptor agonist	1.92, 0.77	33.53	1.31, 0.69	23.28	22.00	37.79	71.35	32.74	65.95	63.25	63.03	8.45	18.84	44.19	66.77	29.32	72.91	4.59	33.53	81.01	1.34	32.57	4.95	21.41	78.34	21.37	0.07	22.84	50.28	81.02	92.16	68.25
BRD-K97309399	CP	thiothixene	dopamine receptor, dopamine receptor antagonist	HTR2A, DRD1, DRD2, HRH1	Dopamine receptor antagonist	7.69, 3.85	33.47	1.48, 0.45	-27.56	56.74	18.51	94.32	19.31	-0.03	59.17	52.48	35.59	87.53	24.40	20.63	93.23	98.96	22.86	99.07	13.88	98.84	33.47	17.24	50.88	28.97	16.45	-34.73	99.93	32.30	31.45	90.71	94.59
BRD-K13566078	CP	BMS-345541	IKK inhibitor	IKBKB, CHUK		5.00, 2.31	33.46	0.90, 0.55	3.09	98.38	39.12	17.51	38.63	63.12	9.00	-60.85	6.17	54.64	19.51	87.16	14.20	3.02	31.49	67.58	15.76	25.48	18.59	57.69	44.63	41.39	46.50	89.62	-41.35	33.46	42.23	37.59	16.52
BRD-K15563106	CP	phloretin	VCAM expression inhibitor, ICAM1 expression inhibitor	AQP9, CLCN3, SLC23A1		5.00, 2.69	33.44	0.17, 0.02	35.53	97.86	7.93	91.33	26.41	63.01	11.78	44.07	8.83	4.79	20.28	48.77	88.34	86.04	47.30	99.50	30.83	39.94	48.73	48.97	33.44	28.68	9.10	92.99	16.59	29.29	25.57	22.98	27.05
BRD-K26674531	CP	GR-235	FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist	ESR1, IKBKB, NR1H4, NR1I2, PGR	FXR antagonist	3.46, 1.54	33.42	1.27, 0.40	25.89	20.30	39.40	26.33	53.84	76.92	56.36	46.43	17.99	13.29	38.74	96.97	22.54	57.83	39.83	2.29	2.48	27.89	41.47	79.75	18.71	27.22	21.56	-0.85	33.42	76.47	12.96	66.97	89.88
BRD-K40990712	CP	hexamethyleneamiloride	gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor	GNRHR, ADRA2A, GNRH1, PLAU, SLC9A1		6.54, 2.69	33.42	0.89, 0.19	-7.36	65.47	34.44	9.64	33.42	26.54	26.48	27.53	26.68	86.08	39.84	27.20	3.14	23.03	42.90	3.95	99.08	83.46	72.13	52.12	93.60	94.96	35.10	14.30	72.79	-8.22	11.67	89.52	0.00
BRD-A38898897	CP	GW-311616	leukocyte elastase inhibitor	ELANE		3.46, 1.92	33.37	1.43, 0.49	30.40	1.83	2.92	65.70	34.10	33.66	62.04	74.74	59.04	10.61	21.27	9.80	3.14	-6.79	88.86	-3.24	67.29	-0.60	38.94	90.86	4.65	34.12	7.29	1.34	33.37	54.65	46.63	82.60	24.37
BRD-K95851186	CP	CGP-13501	GABA receptor modulator	GABBR1		2.69, 0.77	33.37	1.01, 0.28	60.26	27.92	76.24	24.58	43.11	-0.03	43.64	76.03	57.60	5.35	1.13	31.70	1.30	17.37	85.51	0.78	84.72	16.81	23.13	92.00	72.41	55.12	19.24	31.10	33.37	53.26	5.39	94.51	38.17
BRD-K04853698	CP	LDN-193189	ALK inhibitor, serine/threonine protein kinase inhibitor	ACVR1, BMPR1A		2.94, 1.96	33.35	4.48, 1.43	18.36	94.03	13.16	86.01	89.98	33.35	12.08	-35.58	9.80	32.18	32.70	88.80	94.83	45.37	34.92	99.75	36.53	45.25	62.92	-6.69	80.25	28.25	9.45	80.46	-3.88	74.73	18.47	10.77	-9.44
BRD-K09668667	CP	benzo(a)pyrene	pro carcinogen that is metabolized to the DNA intercalating agent benzo(a)pyrene diol epoxide			5.34, 2.29	33.33	1.40, 0.43	46.08	11.98	6.84	31.16	91.28	33.41	23.50	47.86	12.63	11.49	8.90	27.58	47.22	12.69	95.08	1.97	7.12	33.26	85.87	96.69	6.98	67.37	8.96	NaN	45.41	66.57	53.23	83.45	79.51
BRD-K93433262	CP	alfacalcidol	hypercalcaemic agent, vitamin D receptor agonist	VDR, CYP27B1, CYP3A5	Vitamin D receptor agonist	5.71, 2.86	33.29	1.53, 0.51	89.71	-3.52	5.60	23.66	25.47	18.74	34.47	90.86	4.12	40.60	94.73	36.07	15.24	17.39	96.51	3.89	94.34	33.29	18.23	89.80	8.40	15.62	29.58	54.61	3.31	99.75	80.10	47.91	60.07
BRD-K02113016	CP	olaparib	PARP inhibitor, DNA repair enzyme inhibitor	PARP1, PARP2, PARP3	PARP inhibitor	3.85, 3.08	33.28	0.59, 0.13	55.65	61.58	93.34	65.96	8.89	52.22	30.70	43.56	55.62	37.61	12.90	29.47	30.47	1.16	55.31	48.33	15.50	11.69	24.67	48.22	29.60	19.75	3.64	99.58	35.57	33.28	14.96	25.56	46.28
BRD-K48722833	CP	iloperidone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HTR1A, HTR6, HTR7, ADRA1A, ADRA2C, DRD1, DRD3, DRD4, HRH1		5.77, 2.69	33.28	1.19, 0.39	13.01	-58.40	41.48	23.94	1.27	19.01	33.28	97.36	10.67	2.47	34.67	-60.42	-72.02	12.39	45.15	-73.03	49.37	54.48	52.77	74.46	17.46	-30.87	43.22	99.15	95.74	50.40	27.47	97.35	77.19
BRD-K18518344	CP	digitoxigenin	ATPase inhibitor	ATP1A1	ATPase inhibitor	3.27, 1.22	33.26	2.61, 0.56	6.48	95.02	82.47	79.99	71.02	56.38	15.41	0.00	21.06	12.91	7.07	79.66	94.04	88.23	-62.08	99.09	27.97	46.88	33.26	24.21	57.05	37.62	27.94	-1.75	-1.83	0.00	39.38	34.61	28.13
BRD-K87696786	CP	LY-456236	glutamate receptor antagonist	GRM1		3.08, 1.15	33.23	0.98, 0.27	-2.43	19.07	34.41	31.00	7.79	16.04	13.25	43.87	37.32	35.40	16.23	33.23	0.00	15.94	53.51	-87.86	89.91	15.66	8.10	91.35	35.83	33.54	14.38	-24.55	49.93	45.84	43.65	92.48	57.24
BRD-K01815685	CP	indole	aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor	AHR, IDO1		6.15, 3.46	33.21	0.92, 0.18	64.01	24.57	29.02	26.23	39.40	35.29	24.03	28.42	8.25	75.24	18.33	61.58	39.28	26.74	-48.30	14.90	51.13	20.82	46.74	46.78	75.75	85.59	20.81	6.24	88.83	33.21	38.34	96.05	5.86
BRD-K33211335	CP	dextromethorphan	glutamate receptor antagonist, sigma receptor agonist	SIGMAR1, CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, CYP3A5, GRIN1, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SLC6A2, SLC6A4		4.62, 2.31	33.21	0.61, 0.14	65.95	25.08	24.58	27.12	15.45	15.35	76.08	60.90	18.07	33.65	60.83	69.08	3.17	4.23	94.95	28.48	72.54	10.93	59.84	91.73	-4.55	46.11	33.21	4.83	32.87	86.72	34.75	60.49	27.04
BRD-K97354755	CP	SU-6656	src inhibitor	LYN, AURKB, AURKC, BRSK2, CALM1, CAMK2D, LCK, RET, SRC, YES1		6.11, 5.34	33.21	1.23, 0.32	46.99	33.28	86.20	18.82	83.53	0.69	35.48	33.14	56.19	8.27	-29.95	26.97	2.04	22.31	76.32	26.62	79.83	9.57	18.54	83.03	39.42	99.58	8.79	NaN	7.61	42.53	29.57	97.94	92.51
BRD-K50325075	CP	UCL-2077	potassium channel blocker, slow afterhyperpolarization channel blocker			5.77, 2.69	33.20	0.83, 0.24	6.08	12.38	95.15	10.62	47.74	59.47	22.02	79.54	39.15	71.50	15.32	52.50	3.03	-31.55	92.60	0.56	31.51	10.88	99.40	98.65	47.48	78.65	29.85	1.19	19.01	90.61	25.05	87.70	33.20
BRD-K51662849	CP	ilomastat	matrix metalloprotease inhibitor	ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9		4.23, 1.92	33.20	0.91, 0.33	25.74	20.77	11.73	21.49	22.79	58.16	14.38	23.92	54.71	64.62	78.88	80.03	7.57	2.04	-85.37	8.01	32.86	33.35	66.91	53.14	87.26	84.88	33.20	-27.71	40.41	25.07	44.37	71.33	61.82
BRD-A29644307	CP	nomifensine	norepinephrine-dopamine reuptake inhibitor	SLC6A2, SLC6A3, DRD2, MAOA, MAOB, MPO		5.31, 3.67	33.18	1.27, 0.43	81.77	-4.69	9.20	0.00	-6.85	42.52	17.48	78.89	8.08	13.81	10.86	70.51	-4.20	6.56	56.83	1.58	33.18	6.58	47.94	77.12	-34.71	73.15	-13.34	98.80	74.92	77.42	80.96	60.17	67.81
BRD-K73978287	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	3.67, 1.63	33.18	1.49, 0.48	15.34	25.17	33.76	51.14	3.17	1.02	68.90	75.42	57.46	6.41	20.05	17.12	0.00	22.30	92.37	8.53	75.37	51.66	69.63	6.69	25.54	45.93	33.18	99.12	13.71	95.46	38.28	24.01	85.98
BRD-A02180903	CP	betamethasone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	2.31, 1.54	33.16	1.63, 0.90	60.61	-27.48	8.49	80.54	10.93	33.20	52.24	79.57	8.08	27.56	11.04	13.89	11.19	45.60	-56.53	-2.50	49.55	0.99	98.10	87.61	-10.36	32.20	41.81	98.27	51.03	55.61	15.04	49.42	33.16
BRD-A07395371	CP	esmolol	adrenergic receptor antagonist	ADRB1		4.00, 2.22	33.16	0.56, 0.15	45.28	14.79	0.78	14.96	23.33	28.38	65.21	62.44	37.83	93.29	18.42	81.74	-7.56	0.42	36.73	0.35	36.65	0.11	33.16	13.01	50.06	-1.09	36.75	-52.12	51.62	89.45	89.24	24.57	37.25
BRD-A54927599	CP	KF-38789	P selectin inhibitor	SELP		4.23, 0.77	33.12	2.00, 0.59	49.21	83.07	26.87	79.67	14.32	5.86	22.27	35.15	33.12	46.66	25.55	32.22	87.14	82.81	-31.55	98.91	42.15	33.71	58.16	50.50	2.92	24.27	13.43	-14.40	14.52	21.28	33.98	19.51	86.07
BRD-A74667430	CP	etodolac	cyclooxygenase inhibitor, TRPV agonist	PTGS2, PTGS1, RXRA, TRPV1	Cyclooxygenase inhibitor	3.46, 1.92	33.10	0.91, 0.24	49.79	-25.77	25.95	4.24	33.10	18.26	40.43	97.36	57.38	10.88	8.42	13.26	1.87	-12.33	90.31	3.14	47.09	8.55	51.18	92.26	19.73	4.97	41.23	88.44	73.18	40.07	33.70	32.59	93.76
BRD-K26548821	CP	quinpirole	dopamine receptor agonist	DRD2, DRD3, DRD4, DRD1, HTR1A, HTR2A, HTR2B, HTR2C		7.69, 3.08	33.10	0.86, 0.13	14.07	83.16	6.53	23.67	86.66	53.99	65.85	18.79	38.05	86.95	0.60	21.45	2.08	14.83	61.28	2.29	81.51	31.12	33.10	88.01	32.47	59.86	67.28	87.17	0.85	-3.95	27.81	74.77	70.39
BRD-K84996949	CP	sinensetin	cyclooxygenase inhibitor			5.38, 3.85	33.09	1.10, 0.38	3.45	52.63	3.10	53.10	29.87	94.15	15.33	31.33	33.09	62.45	36.58	46.90	3.00	15.05	62.62	7.10	91.47	41.08	11.66	96.33	40.02	63.23	28.06	-43.43	10.88	29.66	13.92	40.87	92.72
BRD-A55756846	CP	H-7	PKA inhibitor	PKIA, PRKACA, PRKAR1A	PKA inhibitor	6.15, 2.69	33.08	1.09, 0.32	23.37	95.67	66.41	30.58	92.11	28.47	35.12	16.30	52.82	18.30	99.68	96.90	1.55	-42.52	91.31	60.53	45.68	33.08	-6.29	28.67	53.67	58.84	8.27	-1.20	31.60	-25.12	72.33	40.08	12.15
BRD-A57457122	CP	VU-0400071-3	glutamate receptor modulator	GRM4		5.00, 1.92	33.07	1.52, 0.31	44.76	13.36	0.00	9.40	-15.31	32.44	32.35	87.06	41.12	37.25	6.36	80.22	0.00	3.49	48.52	-7.62	96.53	-36.33	49.63	94.17	-29.48	39.29	3.91	-1.30	77.79	90.51	80.87	36.76	33.07
BRD-K20995441	CP	U-54494A	kappa opioid agonist			5.71, 3.27	33.04	1.33, 0.44	34.18	29.92	15.71	78.72	27.85	99.37	17.23	26.12	93.11	99.79	33.04	84.97	-2.40	18.01	31.20	3.35	63.44	6.45	80.02	90.53	6.17	62.62	12.73	-1.87	34.79	60.68	61.73	11.50	57.64
BRD-K41051431	CP	mecillinam	cell wall synthesis inhibitor			8.44, 4.00	33.04	1.16, 0.34	10.94	27.36	29.46	6.59	82.40	10.37	14.42	82.13	48.70	33.04	99.15	53.96	5.90	4.83	94.08	-0.32	96.49	29.16	88.35	82.92	-1.55	-8.21	90.00	96.71	59.02	97.41	51.69	28.40	26.33
BRD-K76568384	CP	PHTPP	estrogen receptor antagonist	ESR2		6.92, 4.23	33.04	1.22, 0.45	39.01	9.48	78.72	15.84	15.64	37.76	22.73	90.97	31.25	27.85	-3.88	-64.04	1.14	45.89	93.12	24.78	95.84	4.32	24.97	96.51	24.16	64.85	43.90	33.04	22.53	50.58	44.02	99.37	51.50
BRD-A41722204	CP	sulmazole	calcium sensitizer, phosphodiesterase inhibitor			3.08, 1.92	33.02	0.52, 0.11	18.71	50.34	28.62	11.34	86.73	41.74	8.52	-18.13	8.91	12.44	33.02	64.34	-3.27	1.80	60.59	2.11	76.72	29.82	61.87	36.37	75.98	71.93	11.13	84.85	-19.93	41.74	27.45	57.49	91.48
BRD-A62071884	CP	siguazodan	histamine receptor antagonist, phosphodiesterase inhibitor	PDE3A		3.46, 1.54	33.02	1.00, 0.30	17.79	35.02	86.18	6.33	68.07	63.32	8.62	27.30	22.58	55.71	65.71	48.57	-3.60	0.63	51.59	32.99	86.72	33.02	49.27	28.54	93.67	40.73	38.86	-0.85	13.42	-23.79	12.98	86.55	18.95
BRD-K69932463	CP	AZD-8055	mTOR inhibitor	MTOR	MTOR inhibitor	3.08, 0.77	33.02	2.34, 0.75	3.31	45.59	57.02	90.77	14.73	41.44	8.71	11.01	16.73	51.62	40.23	55.99	89.75	69.23	86.91	98.91	93.95	71.36	13.09	33.02	40.69	17.25	27.87	-10.16	5.78	7.22	30.57	6.27	7.49
BRD-A54490543	CP	pirlindole	monoamine oxidase inhibitor	MAOA, SLC6A2, SLC6A4		2.86, 1.63	32.99	0.98, 0.24	67.47	25.82	21.52	36.40	47.37	51.71	26.36	-25.73	25.50	91.21	16.19	23.23	21.62	82.13	82.06	19.12	40.25	57.60	84.21	70.61	24.80	32.99	18.50	37.29	87.49	70.70	19.35	22.34	21.59
BRD-K08640512	CP	RS-100329	adrenoceptor antagonist	ADRA1A, ADRA1D		5.38, 3.85	32.98	0.98, 0.36	55.86	-28.72	14.25	10.26	35.73	59.54	22.60	79.55	48.33	16.41	21.76	32.98	-7.78	14.32	77.12	-3.17	41.55	42.08	28.67	98.03	28.31	59.62	21.33	5.50	57.99	34.31	31.48	84.19	57.58
BRD-K13927029	CP	retinol	RAR receptor binder	ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG		5.38, 2.31	32.95	1.06, 0.43	4.37	32.95	48.92	73.57	11.02	47.94	40.09	96.53	6.77	12.75	71.76	49.55	5.64	10.61	14.59	79.43	-24.08	29.67	9.06	49.12	65.83	50.30	41.75	-10.91	7.85	48.74	32.28	11.33	34.76
BRD-A89672324	CP	CGP-55845	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8		5.38, 3.46	32.93	1.06, 0.30	5.63	-75.70	87.41	-9.02	87.98	0.02	-1.20	97.85	12.90	43.81	54.97	46.65	-12.79	0.63	92.98	4.72	60.03	22.21	30.62	90.49	54.66	73.78	13.07	7.67	31.54	52.00	67.06	96.46	32.93
BRD-K54330070	CP	SB-202190	p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor	MAPK14, AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1	Bromodomain Inhibitor, P38 MAPK inhibitor	4.23, 2.31	32.93	1.02, 0.23	9.73	93.26	18.14	64.37	51.72	37.41	97.32	-31.34	48.72	3.49	6.48	64.11	20.70	88.05	27.15	69.75	13.61	70.37	31.80	49.18	26.14	40.37	8.07	-94.15	57.53	30.23	19.35	32.93	85.86
BRD-K01648091	CP	LE-300	dopamine receptor antagonist, dopamine receptor ligand, serotonin receptor ligand	DRD5, DRD1, HTR2A		6.15, 1.92	32.90	0.65, 0.20	6.66	10.37	42.30	10.14	31.78	-20.46	36.98	64.46	15.01	66.69	26.34	42.67	1.82	9.48	-46.94	5.81	13.12	78.84	53.61	65.75	32.90	99.79	13.25	0.85	91.20	53.55	53.62	97.04	48.02
BRD-K21806131	CP	tegaserod	serotonin receptor partial agonist, serotonin receptor agonist	HTR4, HTR2B, HTR2A, HTR2C		9.14, 6.60	32.90	1.69, 0.63	65.94	54.70	96.64	98.68	68.10	-22.81	20.94	-36.94	8.90	4.98	16.59	92.26	99.30	98.52	61.57	100.00	32.90	96.93	37.35	19.64	13.95	28.14	34.80	-0.78	15.23	28.88	84.58	23.50	19.97
BRD-A22707317	CP	SB-205384	GABA receptor modulator	GABRA3, GABRA5, GABRA6		4.62, 2.69	32.89	0.75, 0.10	96.32	29.98	2.01	44.66	16.14	12.20	94.01	61.18	3.39	76.70	98.84	44.91	5.63	31.34	78.48	21.60	-19.49	5.46	54.35	37.53	32.89	40.13	-12.14	-61.42	40.35	38.57	29.14	56.61	4.17
BRD-K62056274	CP	quipazine	serotonin receptor agonist	HTR2A, HTR3A, HTR3B, HTR1A, HTR1D, HTR2B, HTR2C, HTR6, SLC6A4		1.63, 0.41	32.87	1.32, 0.41	77.62	10.40	82.04	21.66	63.31	57.61	32.87	47.81	24.76	60.08	18.32	90.59	-2.82	9.08	75.74	-4.37	16.96	18.28	87.60	29.29	14.67	57.09	37.90	24.95	18.19	82.06	65.76	38.70	6.73
BRD-A09539288	CP	homatropine	acetylcholine receptor antagonist	CES1, CHRM1		6.12, 1.63	32.80	1.42, 0.52	91.13	87.29	96.65	11.73	84.92	56.80	28.00	-22.31	29.11	32.80	45.91	74.74	-5.88	4.34	82.67	4.51	82.93	16.94	97.03	19.66	96.47	81.35	35.73	-99.47	-61.13	2.56	16.04	82.37	5.56
BRD-A43930669	CP	L-368899	oxytocin receptor antagonist	OXTR, AVPR1A, AVPR2, OXT		5.77, 1.92	32.79	1.28, 0.47	8.93	-2.26	11.60	41.00	-17.50	5.60	94.32	53.70	46.43	6.10	32.79	15.62	4.79	41.47	2.64	0.50	43.93	55.70	85.04	78.51	3.45	21.18	62.74	95.48	98.31	77.28	30.17	99.36	25.66
BRD-A69512159	CP	carbidopa	aromatic L-amino acid decarboxylase inhibitor, dopa decarboxylase (aromatic L-amino acid decarboxylase) inhibitor	DDC		6.92, 3.46	32.79	2.07, 0.67	33.58	95.94	70.37	18.56	99.89	22.18	53.41	-60.87	12.86	26.50	1.37	32.79	2.78	2.71	-90.01	71.63	60.51	30.87	89.63	79.73	95.38	55.30	38.40	-99.15	-79.94	14.53	28.86	42.13	63.93
BRD-K70883034	CP	nimetazepam	chloride channel agonist, GABA receptor agonist, potassium channel agonist	GABRA1, GABRA2, GABRA3, GABRA5		8.89, 4.00	32.76	0.99, 0.27	18.13	22.72	46.95	15.02	27.54	14.69	47.40	59.68	61.94	40.07	93.09	95.92	7.88	5.58	12.18	2.01	96.76	12.43	32.76	18.54	26.83	61.41	94.58	-10.32	-0.14	99.37	88.09	39.58	68.23
BRD-K03557653	CP	sappanone-a	melanogenesis inhibitor, tyrosinase inhibitor			2.31, 1.15	32.73	1.13, 0.48	85.32	10.65	1.58	7.89	9.68	25.23	4.62	-24.30	5.49	60.40	53.77	39.72	54.71	43.09	81.10	97.09	60.37	3.18	32.73	14.07	44.67	27.59	25.08	0.70	41.18	72.63	38.15	50.77	15.18
BRD-A36267905	CP	buphenine	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	6.15, 3.46	32.72	0.68, 0.27	25.19	10.96	91.53	7.07	52.94	-4.72	16.48	72.37	89.25	10.95	36.84	24.45	2.15	0.32	86.16	-27.48	-76.69	62.12	32.72	79.46	18.47	98.66	51.70	91.24	64.19	14.82	19.93	61.09	92.25
BRD-K42679050	CP	Y-27152	potassium channel activator, potassium channel agonist	ABCC9, KCNJ8		3.08, 1.15	32.69	0.83, 0.25	61.32	-40.04	8.06	11.71	13.50	83.03	77.48	16.59	25.68	78.05	18.90	67.71	-2.22	3.32	56.99	8.40	90.92	8.99	82.81	73.93	32.69	51.72	5.67	45.90	15.40	69.64	5.41	89.08	77.60
BRD-A09161221	CP	nomilin	HSP inhibitor			7.63, 5.34	32.68	2.02, 0.62	49.03	30.40	98.57	27.37	87.93	8.91	73.02	34.95	79.43	15.60	8.32	85.45	4.21	19.09	85.90	6.27	24.57	9.58	20.34	99.89	28.47	73.01	50.05	NaN	0.25	16.54	95.90	90.69	68.32
BRD-K40227168	CP	vinburnine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		5.71, 1.22	32.51	0.76, 0.22	86.56	-6.38	-2.15	35.58	-4.62	90.66	21.77	54.09	7.87	10.77	21.03	28.39	2.83	2.70	85.42	-9.56	36.58	36.25	78.29	74.67	-12.12	26.36	32.51	97.35	12.12	90.19	67.52	37.76	60.45
BRD-K82983861	CP	GW-0742	PPAR receptor agonist, insulin sensitizer	INS, PPARD	PPAR receptor agonist	6.92, 5.38	32.44	1.32, 0.43	33.86	-76.47	51.79	8.55	27.04	5.31	13.49	74.97	8.85	65.25	7.77	67.07	-2.28	5.54	43.10	21.49	94.39	9.07	44.47	99.89	44.51	99.40	-3.21	12.07	77.48	56.39	32.44	99.72	19.40
BRD-K98684188	CP	GSK-0660	PPAR receptor inhibitor	PPARD		3.46, 2.69	32.44	1.11, 0.32	53.96	26.51	7.23	24.46	1.48	0.03	32.44	92.93	1.09	43.56	86.37	71.52	-4.72	59.27	2.81	5.62	21.56	18.45	11.00	68.03	81.64	48.98	8.25	-25.26	79.89	57.48	40.25	76.09	62.01
BRD-K57886322	CP	fluocinonide	corticosteroid agonist, corticosteroid hormone receptor agonist	NR3C1, SERPINA6, SMO	Glucocorticoid receptor agonist	3.27, 1.22	32.43	1.57, 0.53	11.37	-96.97	50.37	34.42	23.65	-3.45	56.09	93.00	15.29	51.55	73.36	14.74	4.23	2.84	94.03	-15.19	62.65	4.26	32.43	84.17	6.90	11.66	14.91	0.70	38.60	99.58	66.08	65.95	74.25
BRD-A50675702	CP	fipronil	GABA gated chloride channel blocker, glutamate gated chloride channel blocker			2.69, 1.92	32.42	0.72, 0.19	32.42	26.49	40.43	67.92	88.38	17.79	52.10	60.09	33.87	26.54	6.97	56.06	25.22	3.85	11.99	45.49	32.65	34.38	43.73	39.36	61.67	3.74	7.92	-0.74	-6.69	54.13	10.08	23.24	23.37
BRD-A56892734	CP	esomeprazole	ATPase inhibitor, ABC transporter expression enhancer	ATP4A, CYP2C19, CYP3A4		4.44, 3.11	32.38	1.60, 0.34	18.21	10.47	32.38	20.33	52.13	7.62	34.66	75.76	22.30	81.83	55.47	96.52	17.02	4.05	20.49	8.06	91.37	10.70	64.26	16.08	-73.70	13.21	34.87	43.00	52.80	66.30	92.65	21.62	73.77
BRD-K74305673	CP	IKK-2-inhibitor-V	IKK inhibitor, NFkB pathway inhibitor, protein kinase inhibitor	IKBKB	IKK inhibitor, NFkB pathway inhibitor	8.46, 6.15	32.33	1.99, 0.72	9.64	95.05	82.27	98.90	83.67	1.83	-10.92	-33.20	17.08	33.34	10.57	77.24	100.00	98.91	64.86	99.96	83.19	97.85	9.50	32.33	17.10	20.98	16.09	4.72	46.46	15.11	34.17	7.42	31.64
BRD-K79254416	CP	decitabine	DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor	DNMT1		5.77, 0.77	32.27	0.89, 0.24	16.89	72.97	7.36	80.41	24.20	69.58	26.41	25.15	9.42	23.15	95.05	96.43	2.14	23.94	80.75	-10.85	14.96	31.14	81.67	38.33	92.93	32.27	31.64	99.47	25.87	40.19	87.48	50.26	44.74
BRD-A48570745	CP	ivermectin	GABA receptor agonist, acetylcholine receptor allosteric modulator, GABA release stimulant, purinergic receptor allosteric modulator	CHRNA7, GABRB3, GLRA3, P2RX7		5.38, 2.31	32.24	1.89, 0.43	10.00	32.24	27.76	97.25	72.45	-9.99	-9.45	57.73	8.60	7.38	19.96	37.33	95.07	88.18	87.91	99.89	92.48	89.76	-12.28	50.83	36.34	8.61	7.23	0.88	19.46	4.74	36.87	21.85	40.04
BRD-K77677632	CP	SB-200646	serotonin receptor antagonist	HTR2B, HTR2C		2.69, 0.77	32.21	0.74, 0.20	-2.85	61.82	53.82	32.21	47.90	24.89	54.19	28.00	5.81	-17.27	90.45	75.13	-1.20	0.78	45.82	0.42	9.26	18.47	22.94	8.63	71.04	75.03	52.73	0.00	37.16	58.08	21.29	55.18	61.58
BRD-A14966924	CP	alaproclate	serotonin receptor antagonist, serotonin reuptake inhibitor	SLC6A4		5.38, 3.08	32.19	0.58, 0.13	23.72	26.60	47.04	5.15	99.65	-24.00	85.46	74.35	28.79	26.67	77.93	24.76	-1.02	7.86	-24.14	56.43	89.89	6.13	44.34	69.75	80.50	32.19	14.88	-87.42	15.87	33.70	60.02	96.17	59.63
BRD-K04976539	CP	aminogenistein	PKC inhibitor, src inhibitor	LCK		5.38, 3.46	32.19	1.01, 0.20	77.51	67.75	-28.80	16.43	56.58	22.26	97.08	80.92	17.04	28.53	82.52	51.73	-2.96	2.01	-24.68	33.89	-95.83	-58.89	85.66	92.80	91.89	89.79	0.81	-57.06	32.19	65.34	19.42	99.12	10.85
BRD-K98493452	CP	honokiol	AKT inhibitor, neurotrophic agent	ALOX5, PTGS1, PTGS2		6.67, 3.11	32.19	1.67, 0.49	22.27	95.08	58.36	32.19	71.52	24.94	7.24	36.14	26.96	27.22	95.78	95.17	8.15	63.77	99.55	3.07	93.13	7.22	47.67	84.17	-27.04	3.14	91.27	-1.16	3.91	96.26	82.03	25.15	4.51
BRD-A97104540	CP	fenoterol	adrenergic receptor agonist	ADRB2, ADRB1, ADRB3	Beta-adrenergic receptor agonist	3.85, 3.08	32.18	0.97, 0.36	36.50	-39.42	2.85	32.18	64.33	11.34	78.87	92.16	99.93	18.35	39.33	3.42	-2.27	-30.01	55.52	7.04	81.85	17.55	24.26	79.98	-18.25	10.04	41.85	40.68	94.53	13.88	9.49	97.67	76.36
BRD-A09925278	CP	etilefrine	adrenergic receptor agonist	ADRA1A, ADRB1		4.08, 2.04	32.17	0.82, 0.22	41.06	30.97	61.37	31.76	25.21	98.13	27.37	78.83	99.68	59.74	79.28	62.25	1.84	0.00	97.34	6.81	26.62	17.97	15.34	25.10	32.17	53.30	49.37	-97.58	-20.16	34.28	28.27	34.74	81.41
BRD-K88742110	CP	BRD-K88742110	HDAC inhibitor, interleukin synthesis inhibitor	HDAC8, IL1B		1.15, 0.77	32.17	0.26, 0.17	67.21	19.24	14.67	0.00	18.98	11.49	41.70	42.54	6.20	42.95	32.76	32.17	5.69	31.81	46.41	52.89	23.03	23.48	26.01	45.00	45.68	39.89	16.20	48.21	49.48	38.76	31.77	31.80	50.84
BRD-K73824630	CP	skatole	thrombin inhibitor	F2		3.85, 3.08	32.16	0.92, 0.19	-2.71	-21.02	32.16	49.15	48.17	9.89	26.78	67.97	66.69	19.90	52.63	6.87	4.00	-2.08	36.50	2.18	98.15	72.22	-30.56	35.64	31.84	44.61	34.94	-99.86	12.04	-4.55	36.34	76.26	71.59
BRD-K95885906	CP	quercetagetin	Pim kinase inhibitor	PIM1		4.62, 1.54	32.11	0.70, 0.18	3.00	32.11	97.57	28.39	27.15	48.14	17.02	65.88	33.83	17.93	74.18	25.89	1.90	55.92	36.33	25.11	85.93	20.31	16.54	51.37	36.95	72.50	64.23	-1.18	9.83	41.88	11.04	22.86	80.42
BRD-K26521938	CP	dinoprostone	prostanoid receptor agonist	PTGER2, PTGER1, PTGER3, PTGER4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGFR, TBXA2R		2.31, 1.54	32.07	0.90, 0.27	21.29	-21.59	84.20	37.18	67.05	11.36	28.88	38.88	82.37	12.08	32.07	32.95	6.51	-29.43	2.45	5.65	53.40	4.93	17.84	77.19	42.94	56.67	10.91	0.00	59.31	21.71	39.11	76.31	56.37
BRD-K43405658	CP	tyrphostin-AG-527	protein tyrosine kinase inhibitor	EGFR		2.45, 0.41	32.05	1.23, 0.41	59.48	62.59	17.16	20.79	22.13	21.71	32.05	20.49	12.40	6.41	21.37	79.88	65.11	85.06	70.54	12.77	74.44	34.17	96.37	46.78	23.73	79.71	5.64	-32.77	32.12	29.64	36.04	56.17	10.51
BRD-K26818574	CP	BIX-01294	DNA methyltransferase inhibitor, histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor	EHMT1, EHMT2		8.16, 4.08	32.04	0.95, 0.15	2.33	42.75	10.42	78.18	2.82	30.06	-1.76	65.61	4.02	56.31	22.50	65.45	75.83	82.91	81.35	97.71	13.57	96.83	-18.75	10.02	9.13	0.00	14.43	32.04	57.43	81.34	77.91	58.47	22.65
BRD-K54790157	CP	trioxsalen	DNA synthesis inhibitor			3.85, 1.92	32.03	1.02, 0.31	42.09	-23.79	6.13	20.96	96.19	-10.95	92.70	73.66	47.87	32.43	15.75	32.03	-28.85	1.76	93.18	15.30	96.79	31.88	85.40	60.08	24.55	85.52	10.78	24.93	33.66	20.01	14.13	61.18	89.11
BRD-K28578425	CP	cilostamide	phosphodiesterase inhibitor	PDE3A, PDE3B		1.92, 0.77	32.01	0.36, 0.30	53.55	22.49	29.81	30.96	66.08	42.57	22.03	-16.84	11.41	14.26	21.89	60.75	0.07	22.69	40.32	99.10	73.09	22.02	9.13	53.91	53.32	50.01	32.01	53.52	-2.36	45.01	65.10	73.36	3.31
BRD-A43974499	CP	reboxetine	adrenergic receptor antagonist, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine transporter inhibitor	SLC6A2		4.23, 2.31	31.99	1.36, 0.47	18.71	-1.83	3.57	44.44	-21.12	8.20	80.88	92.60	23.47	81.93	31.99	-40.91	1.83	5.29	84.94	-15.74	84.94	2.92	34.96	90.47	16.72	77.28	16.65	92.66	73.55	63.28	70.34	99.04	5.89
BRD-K43860855	CP	iobenguane	radiopharmaceutical and antineoplastic agent			5.38, 4.23	31.98	1.20, 0.38	11.01	93.37	55.10	3.88	90.72	68.23	-47.77	89.91	93.96	2.36	13.40	33.31	3.29	1.90	98.82	23.20	97.71	25.60	-27.79	52.06	22.55	31.98	38.66	-89.66	-49.63	50.78	55.74	-16.36	99.65
BRD-K99595596	CP	salsolinol	monoamine oxidase inhibitor, tyrosine hydroxylase inhibitor	DRD2		4.23, 1.54	31.95	1.18, 0.36	7.27	76.07	94.92	20.01	74.18	3.56	48.39	36.66	70.86	-1.94	90.91	32.79	2.11	-32.78	22.77	2.22	61.57	11.00	-10.91	31.89	89.77	31.95	77.15	-98.87	23.57	6.59	38.71	57.29	73.70
BRD-K06792661	CP	narciclasine	coflilin signaling pathway activator, LIM kinase activator, ROCK activator	RHOA		5.77, 2.69	31.93	3.52, 0.82	9.55	84.27	68.99	92.27	80.87	20.44	8.32	22.65	12.62	57.79	7.69	59.54	96.07	31.93	96.44	99.05	34.12	32.82	10.22	13.17	51.33	40.95	45.19	0.00	0.39	13.56	22.72	24.02	26.49
BRD-K96799727	CP	pifithrin-mu	HSP inhibitor	HSPA1A, TP53		2.31, 0.38	31.92	1.05, 0.24	44.01	36.45	25.02	20.08	49.72	29.44	15.29	29.72	7.33	38.97	18.45	52.70	77.94	80.57	49.12	97.64	4.33	30.27	28.35	34.46	55.36	43.58	26.95	0.00	15.03	23.60	31.92	62.08	69.05
BRD-K67277431	CP	picotamide	prostanoid receptor antagonist, thromboxane receptor antagonist, thromboxane synthase inhibitor	TBXA2R, TBXAS1	Thromboxane receptor antagonist	4.62, 3.08	31.91	0.80, 0.22	31.91	13.61	26.93	53.07	31.70	26.93	99.62	26.58	13.59	84.57	47.65	61.67	-2.78	46.34	84.58	2.33	68.99	16.78	17.46	70.88	76.28	68.61	13.81	-26.43	1.87	54.29	25.47	86.57	71.24
BRD-A07000685	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	2.04, 2.04	31.90	1.55, 0.57	58.91	23.90	46.25	50.82	11.59	93.45	38.19	66.79	14.71	23.62	3.63	31.90	33.37	15.86	62.42	1.97	67.94	10.61	38.23	50.23	24.07	44.99	26.99	1.30	11.18	43.97	5.91	6.62	89.06
BRD-A99177642	CP	deltaline	acetylcholine receptor antagonist	CHRNA7		3.46, 2.69	31.89	0.77, 0.28	36.92	-16.71	2.83	10.17	39.53	26.44	83.22	47.89	3.06	22.15	7.13	10.68	-7.53	2.57	96.92	-1.69	75.58	31.60	71.84	31.97	22.70	51.15	33.83	61.28	23.93	56.66	31.89	89.88	49.92
BRD-A61858259	CP	CAY-10415	insulin sensitizer	INS	PPAR receptor agonist	4.90, 2.45	31.87	0.77, 0.24	6.60	-21.14	-6.98	5.64	-2.04	3.07	85.54	82.12	31.87	90.77	7.97	26.41	-1.44	33.40	19.89	-38.32	98.04	2.04	89.82	33.45	8.25	45.80	86.98	99.54	94.54	46.06	72.52	20.52	80.13
BRD-K87932577	CP	CDK1-5-inhibitor	CDK inhibitor	CDK1, CDK5, GSK3B	CDK inhibitor, Glycogen synthase kinase inhibitor	3.08, 1.54	31.86	0.94, 0.28	28.76	17.19	5.65	47.35	34.08	66.60	35.42	46.79	38.62	3.34	11.64	39.75	5.12	-1.30	63.05	-5.66	79.92	7.11	15.90	76.88	3.70	57.24	22.94	-1.04	55.18	75.13	25.59	87.06	31.86
BRD-A83431637	CP	resmethrin	cytochrome P450 inhibitor			3.67, 1.22	31.84	0.97, 0.31	55.99	38.43	62.44	30.94	19.41	15.15	14.12	70.21	10.71	97.04	13.88	34.71	9.46	30.10	75.26	18.40	68.46	16.42	58.01	66.05	78.80	44.50	32.37	-37.77	90.90	26.21	7.86	31.84	1.27
BRD-K47761761	CP	PD-168077	dopamine receptor agonist	DRD2, DRD4		4.90, 2.86	31.83	1.06, 0.20	13.97	15.76	25.92	5.64	38.43	31.83	50.38	55.04	22.61	13.37	73.61	76.81	14.89	2.36	63.37	2.08	-76.60	-16.39	60.59	58.28	20.06	44.12	28.60	-0.88	58.43	98.37	72.45	81.96	79.10
BRD-K61269089	CP	daphnetin	protein kinase inhibitor			4.49, 1.63	31.78	1.07, 0.32	77.49	23.57	41.20	23.95	68.09	49.99	9.49	31.06	9.66	60.38	17.52	79.43	4.82	72.96	51.93	14.47	90.74	15.60	37.39	42.27	29.79	31.78	39.19	-0.46	44.55	84.22	25.93	12.87	22.98
BRD-K56301217	CP	ABT-737	BCL inhibitor	BCL2, BCL2L1, BCL2L2	BCL inhibitor	5.00, 1.92	31.72	1.83, 0.67	26.49	17.59	83.22	31.10	32.68	-0.03	15.52	41.08	8.19	5.73	37.39	14.54	90.73	87.70	45.70	99.64	36.61	63.32	24.43	12.79	31.72	17.60	5.64	30.56	62.67	42.19	27.75	34.32	44.74
BRD-K50495309	CP	SRC-kinase-inhibitor-I	src inhibitor	CSK, LCK, RIPK2		3.27, 2.04	31.70	0.85, 0.39	20.79	50.83	53.47	4.97	66.41	52.91	43.08	-21.07	14.23	79.39	43.76	85.04	-7.06	7.98	50.11	27.48	17.38	15.40	94.50	66.42	74.75	44.36	31.70	16.76	6.98	27.88	55.28	16.71	7.72
BRD-K73319509	CP	PF-04217903	c-Met inhibitor, hepatocyte growth factor receptor inhibitor	MET		3.08, 1.54	31.70	0.63, 0.16	45.47	11.47	34.37	0.78	66.29	43.97	14.34	27.47	33.99	24.20	41.67	57.91	-87.89	23.40	20.94	28.02	84.27	18.92	71.42	44.68	95.46	40.82	8.17	-71.61	8.88	23.79	31.70	47.32	59.81
BRD-A29437505	CP	RWJ-21757	toll-like receptor ligand	TLR7		3.85, 3.08	31.69	0.69, 0.20	49.65	16.32	13.44	41.58	11.71	33.28	49.91	57.86	31.69	7.76	73.76	60.51	0.00	-14.38	94.61	3.07	46.35	-3.38	34.29	65.69	51.42	22.88	17.54	10.13	3.66	64.84	27.40	61.14	4.24
BRD-A04352665	CP	maraviroc	CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist, reverse transcriptase inhibitor	CCR5, CYP3A5		2.69, 0.38	31.68	1.38, 0.50	61.00	10.27	14.41	13.02	47.02	40.78	29.01	63.21	25.28	18.00	90.96	75.90	-82.26	4.01	9.97	-90.83	46.24	6.28	48.11	65.71	25.44	53.74	15.21	18.75	37.17	91.32	60.97	77.29	31.68
BRD-K96037667	CP	norethindrone	ovulation inhibitor, progesterone receptor agonist	PGR	Progesterone receptor agonist	4.90, 2.04	31.68	1.01, 0.34	22.00	29.17	3.51	51.13	54.31	7.47	71.47	54.97	13.51	8.03	10.77	45.72	9.87	5.52	80.87	24.78	18.20	83.81	90.44	15.53	61.93	43.32	64.82	98.63	31.68	94.32	52.45	-2.61	27.52
BRD-A45499626	CP	UBP-302	glutamate receptor antagonist	GRIK1		5.00, 3.08	31.67	0.94, 0.34	22.89	24.99	88.03	25.81	49.23	19.01	28.11	49.81	5.81	87.72	55.19	65.14	-4.95	11.75	-55.39	3.07	12.57	48.18	68.50	41.40	91.80	98.96	31.67	-1.37	30.52	77.60	53.88	98.42	22.80
BRD-K64857848	CP	XMD-885	leucine rich repeat kinase inhibitor, MAP kinase inhibitor	LRRK2, MAPK7	Leucine rich repeat kinase inhibitor	3.08, 0.38	31.63	1.08, 0.56	7.78	83.10	11.37	31.63	61.26	25.73	23.06	53.88	54.36	19.78	31.69	37.97	46.91	73.58	24.76	1.16	68.90	89.76	14.77	24.57	0.00	15.30	25.20	-40.30	37.65	47.85	22.39	37.84	59.18
BRD-K35483542	CP	alitretinoin	RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist	RARG, RARA, RARB, RXRA, RXRG, ABCA1, CYP2C8, CYP3A7, RXRB, VKORC1	Retinoid receptor agonist	3.08, 1.92	31.60	0.57, 0.24	56.16	45.72	48.03	22.16	20.75	30.56	36.08	23.88	18.73	87.80	47.14	95.10	1.09	8.01	72.83	31.60	-22.73	19.77	24.48	42.94	61.95	28.28	50.53	2.62	22.42	84.86	44.42	57.73	20.53
BRD-K38055836	CP	etamivan	respiratory stimulant			6.92, 2.69	31.58	1.30, 0.49	10.64	-43.92	36.31	7.71	87.66	0.03	35.94	95.02	10.77	30.68	15.67	-80.62	-6.71	1.59	90.55	11.07	99.68	7.46	56.21	54.34	29.72	33.89	75.57	-1.87	46.02	31.58	38.81	68.47	62.94
BRD-K33572481	CP	taurodeoxycholic-acid	bile acid		Bile acid	4.62, 1.54	31.57	1.15, 0.38	97.71	21.23	8.49	0.56	22.84	21.35	13.52	51.31	67.88	12.05	39.93	44.91	-31.14	29.53	93.88	-3.88	83.96	61.59	31.57	19.37	27.21	66.30	21.44	2.43	39.57	91.17	97.36	57.31	72.85
BRD-K40255344	CP	tyrphostin-A9	protein tyrosine kinase inhibitor, tyrosine kinase inhibitor			6.92, 6.54	31.55	2.16, 0.70	98.49	54.75	13.93	98.13	77.04	9.52	-10.11	30.10	0.00	3.88	8.44	89.88	99.47	90.41	52.73	100.00	75.12	95.70	11.48	35.60	49.18	0.00	9.39	4.23	31.55	42.30	21.19	14.37	29.01
BRD-K54411430	CP	robustic-acid	cAMP inhibitor			3.88, 2.16	31.53	0.97, 0.15	88.13	84.78	49.57	11.34	98.14	9.06	48.36	-34.73	50.67	31.28	31.53	35.96	-0.11	37.89	-86.14	12.67	26.48	3.17	60.40	66.42	15.08	27.60	80.12	-79.51	19.87	80.57	50.13	75.82	6.04
BRD-K80325895	CP	eicosadienoic-acid	in touchstone			6.53, 3.27	31.52	1.49, 0.41	99.61	14.30	63.55	23.55	15.81	86.65	7.22	31.52	11.53	55.40	29.85	82.07	3.00	1.69	96.51	1.77	13.94	10.94	97.68	57.73	66.22	19.38	78.15	95.00	41.81	98.56	14.88	37.92	10.56
BRD-K95921201	CP	reserpine	vesicular monoamine transporter inhibitor	SLC18A2, SLC18A1		8.08, 3.85	31.52	1.59, 0.30	81.68	-10.66	9.85	93.40	31.52	-18.09	19.66	32.07	33.88	3.84	13.62	68.24	93.16	96.97	50.37	99.54	-36.68	96.72	20.61	55.24	11.29	2.15	-3.91	5.06	99.93	54.40	-15.50	8.21	31.90
BRD-A09062839	CP	amylocaine	local anesthetic			4.08, 1.22	31.50	1.07, 0.43	13.81	67.17	97.21	4.33	3.51	96.90	22.81	70.76	6.17	42.49	13.34	53.14	-15.13	26.50	79.47	-4.36	89.86	31.50	15.64	83.20	53.76	41.64	33.29	0.07	61.01	8.84	12.74	23.95	76.62
BRD-K17378184	CP	prestwick-559	dopamine receptor agonist	DRD3, ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD4, HTR1A, HTR2B		10.00, 5.77	31.40	0.68, 0.16	18.21	6.59	40.54	9.39	51.75	80.38	58.09	60.99	22.54	29.49	8.42	27.62	2.92	6.08	98.52	7.00	97.25	77.12	23.12	76.70	31.40	12.04	8.48	-50.44	96.48	77.87	50.58	64.82	99.91
BRD-K35458079	CP	edaravone	free radical scavenger	BCL2		7.35, 3.27	31.40	1.28, 0.38	24.50	41.78	91.62	29.37	36.41	-8.05	17.52	96.68	5.89	40.29	48.67	86.69	2.31	1.66	46.00	10.89	96.13	18.42	13.83	31.40	18.37	55.52	22.60	-84.92	-9.51	99.37	83.62	77.23	34.92
BRD-A39268308	CP	epibatidine	acetylcholine receptor agonist	CHRFAM7A, CHRNA2, CHRNA3, CHRNA4, CHRNA7		5.31, 1.63	31.38	1.85, 0.45	96.84	-12.92	34.54	14.29	33.88	4.90	-22.55	92.69	15.40	24.92	10.79	-4.79	1.44	15.80	95.30	-18.32	39.83	60.07	30.17	89.65	22.51	47.45	49.21	98.07	92.92	57.80	19.68	31.38	45.78
BRD-A92439610	CP	triamcinolone	antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent	NR3C1, CYP3A5, CYP3A7, SERPINA6	Glucocorticoid receptor agonist	2.45, 1.22	31.38	1.18, 0.77	29.10	16.70	32.87	72.10	14.61	99.51	25.07	26.56	38.61	59.70	17.07	61.78	4.82	64.58	77.04	3.24	33.44	7.41	55.71	91.20	10.10	6.47	31.38	55.14	33.21	29.14	21.60	-16.99	62.79
BRD-A98431941	CP	ephedrine	adrenergic receptor agonist	ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2		4.49, 2.45	31.35	1.33, 0.41	98.08	26.60	6.96	18.66	22.79	93.49	24.04	31.35	80.10	54.30	16.88	85.32	-2.08	30.52	47.08	13.44	-13.88	17.46	51.82	27.00	68.43	73.20	12.03	6.48	66.87	85.03	34.97	70.37	85.30
BRD-K98521173	CP	desoxycortone	mineralocorticoid receptor agonist	NR3C1, NR3C2		4.23, 2.31	31.32	1.17, 0.31	4.54	-96.44	3.10	1.06	73.92	4.76	-31.91	93.96	-8.38	-15.32	15.69	-81.98	1.62	-41.73	87.19	10.72	94.18	61.56	58.74	72.70	-77.04	50.90	55.78	97.18	72.25	66.47	31.32	50.14	63.42
BRD-K71512533	CP	SNS-314	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Aurora kinase inhibitor	4.62, 3.08	31.30	0.99, 0.30	15.20	77.06	5.29	90.40	45.59	32.40	50.96	-14.31	31.30	12.97	17.97	23.77	22.67	13.85	97.93	78.30	53.72	31.61	9.45	38.16	56.39	10.26	24.74	12.79	22.22	71.59	34.99	40.27	5.96
BRD-K08206212	CP	entecavir	DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor, DNA replication inhibitor, reverse transcription inhibitor, transcription inhibitor		Reverse transcriptase inhibitor	3.08, 1.92	31.29	0.91, 0.33	44.84	-7.87	78.49	0.00	25.67	-0.03	19.29	42.32	13.54	69.02	55.36	70.09	-3.22	-17.47	93.82	-1.13	85.93	-6.17	21.91	88.46	31.29	34.24	44.93	99.47	-0.39	56.02	23.29	37.42	11.49
BRD-K38305202	CP	domperidone	dopamine receptor antagonist, breast cancer resistance protein inhibitor	DRD2, DRD3, ABCG2, CYP3A5		5.00, 2.31	31.29	0.81, 0.09	91.14	-23.54	-2.29	22.08	89.25	20.42	19.63	79.15	37.86	12.46	9.92	24.56	12.35	7.14	99.58	81.58	95.05	31.43	4.26	39.53	7.51	30.38	31.29	-0.85	37.34	48.71	44.21	98.80	80.10
BRD-K69763916	CP	LY-341495	glutamate receptor antagonist	GRM2, GRM3		5.38, 3.08	31.29	1.00, 0.32	51.26	-4.11	59.91	21.51	20.22	48.08	-15.38	96.02	11.66	6.71	21.19	32.22	1.94	9.62	31.29	-3.39	84.77	15.06	10.48	98.41	47.07	79.92	75.22	79.14	22.25	95.55	15.76	91.80	97.84
BRD-K55191674	CP	benzylpenicillin	PBP3 inhibitor			5.38, 2.31	31.28	2.00, 0.72	21.32	61.10	96.83	31.28	74.37	97.25	20.54	28.70	18.95	51.96	61.80	61.25	-2.18	27.36	31.94	15.91	50.89	6.13	28.58	14.87	86.60	36.53	60.54	-99.37	-9.53	27.59	5.03	38.93	98.73
BRD-K09991945	CP	GSK-3-inhibitor-II	glycogen synthase kinase inhibitor, PKC inhibitor, superoxide dismutase expression inhibitor	GSK3B	Glycogen synthase kinase inhibitor, PKC inhibitor	3.67, 2.04	31.26	1.24, 0.44	86.74	15.26	9.76	78.42	21.68	51.37	16.09	26.64	44.47	5.98	12.14	41.87	88.41	92.96	27.18	90.33	56.22	11.17	51.17	71.76	16.60	31.26	12.69	1.10	54.44	40.00	27.41	50.23	6.34
BRD-K14807180	CP	SB-221284	serotonin receptor antagonist	HTR2B, HTR2C, HTR2A		3.85, 3.08	31.25	0.81, 0.22	14.19	20.51	27.62	6.48	64.98	37.84	47.94	56.94	68.39	29.01	31.25	82.42	-4.79	-15.03	71.13	35.52	9.30	7.48	17.49	66.34	66.57	99.22	-8.10	-0.78	1.01	20.45	37.83	90.04	60.96
BRD-K26160755	CP	RS-45041-190	imidazoline receptor agonist			3.85, 1.54	31.24	0.84, 0.15	69.48	10.94	40.01	39.98	20.16	20.01	80.99	52.75	35.62	90.83	31.24	52.13	-3.21	27.78	82.14	7.65	23.91	24.91	44.09	55.30	-9.80	72.53	28.02	-0.88	18.05	23.56	3.71	71.48	95.69
BRD-A49765801	CP	fludroxycortide	corticosteroid, glucocorticoid receptor agonist	NR3C1, SERPINA6	Glucocorticoid receptor agonist	2.31, 0.77	31.23	1.34, 0.80	1.13	44.30	31.23	40.40	30.45	14.14	64.46	43.96	3.88	44.31	94.69	39.90	1.57	64.62	51.86	4.73	51.77	3.07	32.88	15.62	29.21	65.67	21.09	0.00	-10.44	63.55	53.92	19.48	28.71
BRD-K44849676	CP	capsazepine	TRPV agonist, TRPV antagonist	TRPV1, TRPV4		5.00, 2.31	31.23	1.49, 0.49	90.35	2.54	1.73	73.62	52.98	22.61	18.76	20.51	7.60	6.06	7.16	13.94	87.91	89.92	36.09	99.36	16.98	75.99	18.55	95.81	24.34	68.11	5.60	65.26	85.92	31.23	18.55	55.15	72.67
BRD-K33583600	CP	isoliquiritigenin	guanylate cyclase activator, aldose reductase inhibitor, glutamate receptor antagonist, histamine receptor antagonist, SIRT activator	AKR1B1, HRH2, SIRT1		3.08, 1.54	31.22	1.63, 0.59	49.01	13.37	9.55	19.98	33.36	4.08	16.83	32.15	24.33	6.41	16.87	38.82	73.91	95.10	31.22	98.52	20.01	55.14	19.18	57.88	14.03	42.81	9.49	0.88	39.38	59.78	22.88	48.58	33.66
BRD-K63606607	CP	bufalin	ATPase inhibitor, chloride channel activator	ATP1A1	ATPase inhibitor	4.23, 1.15	31.16	2.18, 0.60	29.36	75.55	81.98	95.56	45.29	27.55	0.70	11.28	15.17	31.16	20.13	25.90	91.58	57.98	85.32	96.02	41.66	50.88	11.87	10.19	48.72	55.19	33.53	0.00	-14.05	0.00	23.02	46.74	25.45
BRD-K63828191	CP	raloxifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM), ALK expression enhancer, cholesterol inhibitor, endoglin expression enhancer, estrogen receptor agonist	ESR1, ESR2, ACVRL1, ENG	Estrogen receptor antagonist	1.54, 0.77	31.16	0.43, 0.34	44.29	25.76	31.70	18.52	37.80	21.66	13.04	29.43	9.22	17.63	16.12	42.46	9.06	36.37	31.16	92.61	59.16	38.08	20.22	40.15	33.70	14.06	19.99	2.61	29.03	31.92	34.97	34.92	45.71
BRD-K08973992	CP	linoleic-acid	oxidative stress inducer	FABP4, FFAR1, FFAR4, HNF4A, KCNB1, PPARG, TRPM8		6.94, 2.04	31.15	1.27, 0.38	96.13	7.97	6.64	17.83	19.94	94.51	68.85	15.36	38.60	89.75	48.01	57.92	-13.12	1.87	58.41	-1.41	19.39	9.54	98.66	79.09	-35.08	87.33	31.15	8.07	6.43	49.23	28.27	67.48	42.05
BRD-K49027941	CP	PSB-1115	adenosine receptor antagonist	ADORA2B, ADORA1, ADORA3		4.49, 2.86	31.15	1.13, 0.34	3.56	8.57	12.65	13.70	48.36	19.69	66.38	31.82	7.81	31.15	35.23	73.97	2.22	9.51	48.53	2.36	29.02	13.46	99.47	61.90	58.27	92.82	14.95	35.36	21.37	48.39	73.91	67.19	20.32
BRD-K57718010	CP	pentylenetetrazol	GABA receptor antagonist		GABA receptor antagonist	3.46, 0.77	31.15	1.01, 0.26	60.29	18.41	69.66	11.29	66.55	22.75	83.71	47.45	65.61	18.92	11.99	28.19	0.70	-1.34	70.16	5.11	97.32	31.15	33.35	21.94	62.07	65.52	47.80	15.47	14.91	31.20	30.59	28.55	34.16
BRD-K84566043	CP	fenpiverinium	acetylcholine receptor antagonist			4.89, 3.56	31.12	1.18, 0.35	26.43	13.24	4.56	23.65	17.57	3.10	57.45	25.47	-11.88	86.71	31.12	85.45	0.39	9.57	94.92	66.80	98.20	34.53	56.86	36.52	9.16	64.86	20.70	99.47	37.86	6.03	63.92	83.62	16.98
BRD-K68174511	CP	torin-2	mTOR inhibitor	MTOR	MTOR inhibitor	7.31, 3.85	31.08	1.56, 0.48	0.03	53.33	81.24	95.91	35.23	19.06	7.43	-12.22	5.56	13.79	31.08	81.79	87.53	80.48	75.11	99.58	87.77	86.48	-0.14	57.95	33.59	27.78	10.67	-20.80	22.49	16.04	67.52	22.16	0.99
BRD-K10466330	CP	AVA	nucleophosmin inhibitor		Nucleophosmin inhibitor	1.72, 0.43	31.05	0.59, 0.35	1.62	33.07	68.93	12.05	75.39	9.85	10.70	45.05	49.35	61.30	59.90	78.85	1.21	25.76	8.98	84.03	-21.72	4.02	14.97	31.05	81.31	15.04	8.42	-87.97	42.36	26.34	45.83	42.06	75.55
BRD-K83010055	CP	VU-0415374-1	glutamate receptor modulator	GRM4		4.23, 2.31	31.04	1.07, 0.32	77.96	24.12	4.16	31.04	26.17	22.71	77.02	26.64	36.25	71.84	52.23	45.66	0.00	16.19	24.21	54.81	98.24	22.43	52.46	36.39	55.07	22.45	5.25	19.70	60.26	25.81	22.30	59.51	39.65
BRD-A16934955	CP	nalbuphine	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1		7.11, 5.33	31.01	1.34, 0.40	5.79	84.40	41.37	31.01	99.75	13.32	9.22	39.95	18.62	29.91	28.59	67.12	-2.82	16.83	45.82	37.06	89.06	14.53	62.13	26.70	86.00	19.21	95.34	91.11	68.24	26.43	71.54	-51.66	2.04
BRD-A34806832	CP	proscillaridin	ATPase inhibitor	ATP1A1	ATPase inhibitor	4.23, 1.92	31.01	2.23, 0.53	19.02	95.57	62.97	91.45	75.51	65.57	27.06	70.35	27.93	3.81	5.21	69.81	92.43	87.65	18.66	99.47	31.01	30.44	38.17	12.69	8.42	60.43	20.39	0.49	2.89	13.59	25.06	38.96	59.22
BRD-A74980173	CP	gatifloxacin	topoisomerase inhibitor, DNA gyrase inhibitor		Bacterial DNA gyrase inhibitor	6.54, 3.08	31.01	1.95, 0.56	13.06	87.71	53.49	43.48	98.56	22.48	18.71	16.59	10.30	98.54	31.01	80.52	17.18	0.81	-94.49	90.22	47.48	28.68	54.25	2.01	95.44	66.84	64.29	-66.78	-29.16	-13.43	38.32	41.53	16.47
BRD-K97056771	CP	HY-11007	Abl kinase inhibitor, Bcr-Abl kinase inhibitor	ABL1, BCR		4.62, 0.77	31.01	1.40, 0.35	95.37	96.51	4.85	33.80	63.85	57.19	38.17	50.40	77.17	1.76	1.74	74.78	29.99	-1.34	15.47	49.15	31.01	1.04	27.28	20.37	20.63	45.09	19.19	-99.19	-83.07	63.72	23.06	64.72	64.32
BRD-K70881766	CP	solanine	acetylcholinesterase inhibitor			5.38, 1.92	31.00	0.63, 0.15	1.13	9.17	36.67	5.17	69.55	11.20	-12.27	31.00	44.08	8.65	22.23	5.87	-1.76	-8.22	73.96	62.08	80.58	36.33	-11.13	88.94	50.85	54.05	33.30	-4.44	32.93	-8.41	23.40	90.41	92.33
BRD-A64228451	CP	terreic-acid	Bruton's tyrosine kinase (BTK) inhibitor	BTK		3.46, 1.54	30.99	1.56, 0.52	17.39	15.23	30.99	15.37	6.78	85.40	6.41	90.98	5.25	12.75	34.97	19.30	56.39	73.63	60.56	71.85	49.04	30.76	36.32	59.23	12.83	30.65	13.75	0.85	42.81	1.37	85.30	75.14	92.36
BRD-K55677650	CP	CO-101244	ionotropic glutamate receptor antagonist	GRIN2B		1.63, 0.82	30.99	0.97, 0.23	22.23	9.38	2.92	7.89	3.44	13.92	30.99	38.40	49.75	84.02	60.40	42.98	3.31	11.50	43.00	31.72	7.51	8.50	58.62	8.72	29.53	54.83	22.73	25.49	50.07	56.90	57.50	59.34	64.04
BRD-K52075715	CP	oxibendazole	DNA polymerase inhibitor, tubulin inhibitor	TUBB, TUBB4B	Tubulin inhibitor	4.23, 0.00	30.98	1.08, 0.47	92.29	21.57	6.09	30.98	38.02	34.39	79.81	81.25	12.03	13.01	14.73	15.07	72.59	29.97	33.36	93.37	40.24	-0.72	56.59	62.22	9.75	37.82	-13.10	-32.67	-52.79	11.00	25.40	91.50	50.20
BRD-K44067360	CP	flufenamic-acid	calcium activated chloride channel inhibitor	AKR1C3, AR, PTGS1, PTGS2, ANO1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, TRPC5, TRPM2, TRPM5		8.46, 3.46	30.95	1.31, 0.34	17.57	30.46	16.69	25.66	29.11	22.89	15.29	79.53	4.02	4.79	14.21	88.02	0.70	0.53	67.67	10.08	80.05	30.95	36.93	78.36	96.11	98.66	82.15	81.27	59.69	88.03	13.63	58.89	98.84
BRD-K36395411	CP	SB-206553	serotonin receptor antagonist, serotonin receptor partial agonist	HTR2B, HTR2C, HTR1A, HTR2A		4.90, 2.86	30.94	1.20, 0.42	52.86	33.21	78.60	38.08	12.94	99.01	-18.56	16.34	35.71	10.69	22.49	75.77	-11.59	26.87	64.57	8.76	28.61	2.36	49.01	81.89	30.94	37.77	56.24	-99.12	-38.13	6.03	14.90	98.77	70.02
BRD-K36258877	CP	AZ-10417808	caspase inhibitor	CASP3		5.00, 2.31	30.92	1.42, 0.40	26.85	65.44	92.89	67.03	16.21	93.16	14.29	77.83	42.18	-21.74	51.90	30.92	2.01	22.24	97.35	2.98	22.24	43.42	38.09	73.55	27.32	19.76	69.45	0.85	18.57	83.66	26.69	16.14	40.38
BRD-A52282606	CP	lacidipine	calcium channel blocker, L-type calcium channel blocker	CACNA1C	Calcium channel blocker	2.67, 1.78	30.90	0.85, 0.20	8.95	-10.04	32.37	58.43	35.46	86.02	21.20	97.78	25.01	21.20	8.24	57.21	84.93	28.34	72.54	30.90	60.05	20.70	10.65	0.53	92.68	-9.08	56.31	-9.63	19.95	59.52	85.38	9.91	81.28
BRD-K84085265	CP	CG-930	JNK inhibitor	MAPK8		2.69, 0.38	30.90	0.86, 0.28	42.25	-1.80	11.01	1.23	-4.79	58.94	53.79	80.93	59.21	41.65	4.05	41.12	-90.13	4.04	38.20	-96.55	64.73	11.21	30.90	58.25	3.70	1.55	7.28	42.98	42.90	29.01	53.04	30.24	78.46
BRD-K34098590	CP	tienilic-acid	sodium/potassium/chloride transporter inhibitor, uric acid diuretic	CYP2C9, SLC12A1, SLC22A12		5.71, 4.08	30.89	1.44, 0.52	43.70	3.88	11.84	5.49	42.68	16.64	41.96	99.89	13.11	30.89	66.27	45.34	0.00	0.00	79.49	2.92	16.50	0.99	-33.57	74.70	32.53	51.31	0.53	-83.29	89.98	90.14	9.70	86.54	79.42
BRD-K35629949	CP	SR-27897	CCK receptor antagonist	CCKAR	CCK receptor antagonist	1.92, 1.15	30.88	0.99, 0.31	30.88	20.37	26.89	45.82	86.60	14.76	42.88	55.68	30.06	-28.61	32.39	20.60	-4.18	-1.30	36.33	2.22	92.87	31.84	14.18	87.32	5.39	36.82	34.78	1.76	9.07	72.58	54.15	75.74	6.73
BRD-K54256913	CP	MK-1775	wee1 kinase inhibitor	WEE1		3.46, 2.31	30.88	1.75, 0.60	21.70	58.38	28.22	86.75	46.08	18.75	4.26	-19.28	8.06	37.76	1.09	25.41	68.56	75.65	81.26	4.12	27.21	68.85	27.38	30.88	40.11	44.14	23.27	79.84	46.50	40.09	20.16	18.41	56.01
BRD-K37848908	CP	ceforanide	cell wall synthesis inhibitor, penicillin binding protein inhibitor			3.08, 1.92	30.85	0.76, 0.32	10.18	30.85	34.81	11.95	6.16	9.08	95.92	76.56	59.77	8.42	33.97	55.47	4.00	6.51	60.75	-10.44	85.80	26.04	14.59	37.04	-14.04	55.14	37.60	-93.88	56.89	14.59	31.14	76.72	20.19
BRD-K46441700	CP	GR-55562	serotonin receptor antagonist	HTR1B, HTR1D	Serotonin receptor antagonist	6.92, 5.38	30.85	0.80, 0.25	7.31	31.81	98.09	25.80	14.94	3.14	23.85	29.30	54.96	9.74	44.14	6.29	30.85	75.69	-70.08	9.26	28.71	87.40	18.22	82.97	63.71	38.23	-27.63	-36.19	99.65	44.08	46.40	87.31	92.13
BRD-K65503129	CP	HSP90-inhibitor	HSP inhibitor, HSP antagonist	HSP90AA1, HSP90AB1	HSP inhibitor	2.31, 1.15	30.85	0.94, 0.23	12.05	92.36	64.45	30.85	86.98	0.03	7.27	-57.05	29.29	6.98	7.45	33.43	21.99	65.69	63.90	90.50	61.21	39.18	-13.85	75.98	74.68	48.55	10.96	-86.40	0.39	-68.36	52.73	24.35	50.89
BRD-A13650332	CP	flucloxacillin	antibiotic of the penicillin class			5.00, 1.15	30.83	1.03, 0.22	9.74	97.15	95.77	39.90	95.98	15.95	11.31	75.45	24.93	39.33	77.39	21.17	-13.00	18.56	93.38	86.93	97.36	17.56	-5.43	28.97	-15.67	86.74	30.83	-77.55	-39.00	-51.47	41.11	66.47	90.65
BRD-K67831364	CP	ZM-323881	vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor	KDR	VEGFR inhibitor	2.69, 1.54	30.83	0.82, 0.20	23.44	-33.78	24.37	58.26	59.18	30.83	8.95	54.60	25.32	13.64	99.68	48.46	-3.09	26.50	80.06	4.50	13.40	-62.09	12.03	68.19	74.93	13.45	8.50	98.80	66.74	78.81	55.11	42.79	55.35
BRD-A04308630	CP	genipin	aglycone, nitric oxide production inhibitor			5.71, 2.45	30.81	2.50, 0.86	19.65	96.21	17.71	44.75	99.40	84.78	22.06	88.04	30.81	79.22	14.23	88.55	7.86	0.00	10.28	6.06	33.73	13.68	54.79	43.49	97.73	13.09	10.32	-59.12	-14.60	66.37	13.64	88.89	39.03
BRD-A14798026	CP	mestranol	estrogen receptor agonist	ESR1	Estrogen receptor agonist	5.77, 4.23	30.79	0.83, 0.28	42.10	32.06	57.68	38.21	17.62	14.03	81.58	-19.25	16.95	66.95	43.34	30.79	0.00	0.79	24.30	9.15	14.67	25.94	42.63	81.33	83.70	99.19	-6.61	0.00	14.36	63.88	23.17	75.53	96.41
BRD-A50157456	CP	terbutaline	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	4.08, 2.86	30.79	1.10, 0.42	10.31	-4.69	1.17	30.79	3.10	90.58	33.55	85.77	99.93	29.81	5.14	25.82	-12.67	-41.22	82.15	-3.37	93.09	-11.99	83.53	39.56	-7.24	37.81	9.40	49.78	73.65	99.19	55.32	29.17	53.95
BRD-A06352508	CP	SB-218078	CHK inhibitor, PKC inhibitor	CHEK1		5.38, 1.92	30.77	1.43, 0.60	16.54	97.89	76.92	83.09	89.17	6.60	15.02	-20.01	83.47	3.37	9.46	79.24	83.62	61.10	56.71	99.58	80.64	10.43	-6.37	49.83	27.71	47.69	23.53	-95.88	-69.40	3.28	20.50	40.73	30.77
BRD-K19295594	CP	gossypol	BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor	BCL2, BCL2L1, MCL1, BCL2L2, CTGF, EGF	BCL inhibitor	5.38, 1.92	30.74	1.26, 0.22	65.11	46.94	63.48	92.95	42.50	30.05	7.19	22.61	20.55	13.65	14.45	53.65	83.24	86.81	-38.57	99.93	65.48	30.74	16.56	21.31	59.83	8.81	19.79	2.03	-0.56	43.24	39.55	38.61	1.97
BRD-A94793051	CP	gestrinone	progesterone receptor antagonist, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant	PGR, AR, ESR1	Androgen receptor modulator, Progesterone receptor antagonist	4.08, 2.04	30.70	1.31, 0.41	19.19	24.21	1.48	67.56	16.32	6.59	5.30	85.69	4.55	5.98	9.92	30.70	2.01	11.49	72.52	90.67	93.22	84.54	31.23	80.16	9.73	68.35	17.61	49.68	1.48	62.64	53.74	38.05	86.31
BRD-K38477985	CP	malonoben	protein tyrosine kinase inhibitor, tyrosine kinase inhibitor	EGFR		6.92, 4.62	30.69	1.84, 0.60	85.81	63.09	15.18	99.54	27.87	21.56	10.40	30.69	35.99	9.03	6.48	47.42	99.79	96.07	14.09	99.96	-24.14	95.45	10.70	53.16	12.13	39.73	10.29	0.00	65.33	50.28	29.26	37.61	28.73
BRD-A51820102	CP	econazole	cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor	CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5	Sterol demethylase inhibitor	3.85, 1.92	30.68	0.51, 0.15	30.68	11.23	3.41	83.76	24.17	27.96	5.74	58.28	0.18	41.12	32.71	52.14	5.71	64.65	68.80	88.15	18.72	88.57	52.93	29.05	-6.98	31.77	29.51	97.14	77.42	36.95	30.53	1.06	25.02
BRD-K86465814	CP	HO-013	PPAR receptor agonist	PPARG	PPAR receptor agonist	3.85, 2.31	30.66	1.10, 0.34	57.97	-10.75	-1.37	2.47	5.21	30.66	13.61	34.47	0.81	39.77	60.98	55.56	-40.50	-1.61	57.79	1.87	70.03	28.00	-0.18	85.17	91.59	22.71	36.94	2.26	62.00	91.17	36.58	44.50	22.23
BRD-K02607075	CP	tubocurarine	acetylcholine receptor antagonist	CHRNA2, HTR3A, ACHE, HTR3B, KCNN1, KCNN2, KCNN3, ZACN		6.54, 2.31	30.65	1.13, 0.40	36.99	10.33	4.90	4.02	-20.38	30.65	95.76	85.39	84.50	38.59	12.97	69.08	-2.11	10.67	15.15	-27.74	53.99	2.70	72.17	96.55	29.18	76.80	-8.10	-75.02	94.79	43.22	9.24	99.15	78.08
BRD-M00539986	CP	formoterol	adrenergic receptor agonist	ADRB2, CYP2C19	Beta-adrenergic receptor agonist	5.38, 3.08	30.61	0.57, 0.16	15.68	15.34	24.34	10.27	58.59	17.81	-10.21	69.01	97.64	23.17	39.44	11.98	-2.82	-27.00	60.28	25.18	79.59	31.53	30.61	74.30	46.62	40.90	-11.65	88.60	82.27	4.27	9.02	84.20	79.54
BRD-K15600710	CP	obatoclax	BCL inhibitor, MCL1 inhibitor	BCL2, BCL2L1, MCL1	BCL inhibitor	6.54, 4.23	30.57	2.15, 0.70	41.41	30.57	1.52	97.30	9.60	10.81	-20.62	36.43	2.82	24.71	21.47	54.68	98.17	91.29	45.43	99.96	62.21	95.45	8.53	16.91	8.81	10.66	20.80	30.88	57.52	22.27	49.49	37.17	8.60
BRD-K51575138	CP	TPCA-1	IKK inhibitor	IKBKB	IKK inhibitor	5.77, 2.31	30.54	1.81, 0.59	10.24	84.82	26.72	95.91	57.40	13.93	12.02	19.88	43.09	22.59	20.03	50.48	90.34	74.88	39.71	99.26	17.30	42.38	8.70	23.99	42.04	10.11	12.10	-22.19	8.81	33.53	30.54	32.93	39.34
BRD-A46186775	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	1.63, 1.22	30.52	1.44, 0.70	42.84	25.82	9.54	28.03	-2.64	63.67	31.38	52.35	10.18	66.41	4.05	18.52	2.36	78.48	36.20	17.06	68.23	-8.68	39.69	60.44	21.62	40.75	30.28	99.54	22.48	32.70	30.52	20.90	61.53
BRD-A59808129	CP	guggulsterone	estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist	NR1H4, PGR, AR, ESR1, IKBKB, NR1I2, NR3C1, NR3C2	FXR antagonist	3.85, 2.31	30.49	1.39, 0.27	87.69	-2.61	7.24	-20.01	19.78	-37.21	31.34	93.26	60.77	7.44	49.60	70.67	-4.58	12.14	33.37	-94.89	2.68	17.62	19.00	36.15	-32.74	-1.30	43.61	95.14	44.87	72.60	30.49	86.11	81.15
BRD-K50214219	CP	CS-1657	PARP inhibitor	PARP1		3.67, 2.04	30.47	0.98, 0.32	74.98	61.80	20.21	39.14	71.41	26.91	66.85	30.47	29.29	83.42	55.52	16.93	-3.04	14.92	71.19	3.80	13.86	36.99	41.88	49.56	45.72	14.87	68.60	-90.67	3.56	25.58	19.60	89.00	17.80
BRD-A01346607	CP	flumetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	1.54, 0.38	30.45	1.31, 0.76	40.15	24.45	8.95	79.86	15.96	41.14	30.45	-22.69	5.08	89.45	23.11	66.35	2.85	38.20	57.35	3.17	45.20	18.25	16.64	42.60	41.10	42.41	14.05	46.93	17.36	81.26	4.36	48.00	16.92
BRD-K46766488	CP	S-14506	serotonin receptor agonist	HTR1A, DRD2, HTR2C	Serotonin receptor agonist	6.12, 2.86	30.44	0.92, 0.26	35.03	13.08	37.91	46.74	28.68	98.10	61.68	35.71	53.14	42.95	6.76	27.62	-3.48	10.67	72.95	10.33	84.36	26.62	15.28	22.72	10.41	64.29	27.80	30.44	68.20	67.75	28.90	-14.66	53.63
BRD-A33833419	CP	TER-14687	inhibitor of translocation of PKCq in T cells	PRKCQ		4.62, 1.92	30.43	1.09, 0.28	15.01	-28.90	26.60	17.05	16.26	66.61	-14.56	35.20	13.84	40.66	11.11	60.88	75.06	30.43	0.00	22.46	72.63	10.92	34.70	90.87	31.72	87.48	21.94	33.13	62.97	26.84	2.75	39.07	90.17
BRD-K89152108	CP	liothyronine	thyroid hormone function stimulant	THRA, THRB		5.71, 2.86	30.43	0.84, 0.28	23.88	6.92	42.04	31.90	30.43	34.96	39.20	64.30	68.73	33.59	7.70	25.02	10.68	7.74	57.09	24.37	81.49	30.26	20.81	3.70	0.00	27.60	5.57	79.00	84.69	85.73	31.55	32.63	17.56
BRD-A43082555	CP	loxoprofen	cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor	PTGS2		8.89, 4.44	30.38	0.88, 0.30	2.08	94.54	55.23	3.98	92.97	86.27	56.43	21.73	90.88	12.68	93.79	96.71	-0.07	15.72	99.51	-4.02	96.48	6.46	30.38	-17.97	59.43	8.01	44.86	-11.59	-1.59	95.18	97.46	9.23	4.80
BRD-U44700465	CP	HG-5-88-01	protein kinase inhibitor	ADCK4, EGFR		1.54, 0.77	30.32	2.00, 0.63	2.29	-9.91	92.05	76.08	-16.05	91.65	18.09	83.32	10.14	59.96	30.32	15.23	2.68	-1.34	72.06	69.31	65.62	63.23	33.05	18.66	29.48	32.79	26.38	0.81	95.53	46.21	15.93	4.24	72.45
BRD-A93236127	CP	digitoxin	ATPase inhibitor	ATP1A1	ATPase inhibitor	4.23, 1.54	30.31	2.18, 0.56	6.90	94.64	79.72	90.77	54.73	18.74	7.43	19.60	29.83	0.95	13.47	32.57	94.71	86.58	39.99	98.94	33.51	44.48	22.54	18.66	30.31	78.61	54.78	-0.21	10.42	1.83	22.00	61.95	20.03
BRD-A42628519	CP	iopanoic-acid	radiopaque medium			4.23, 2.31	30.30	1.26, 0.73	64.39	-10.27	6.12	48.54	15.93	25.12	84.20	61.71	12.49	86.26	6.40	41.03	2.99	56.48	69.13	7.07	90.16	8.83	68.14	17.34	25.71	7.97	25.10	86.13	77.72	52.19	20.23	30.30	54.87
BRD-A62434282	CP	goserelin	gonadotropin releasing factor hormone receptor agonist, luteinizing hormone releasing hormone agonist	GNRHR, GNRH1, LHCGR		0.77, 0.38	30.29	1.14, 0.35	8.89	-19.89	-1.99	8.45	27.35	12.69	32.87	40.41	38.74	27.42	40.82	45.35	-2.78	17.60	90.01	0.67	12.76	21.43	88.38	64.53	93.89	54.21	6.48	94.36	-15.10	66.96	76.74	30.29	73.11
BRD-K00675675	CP	CL-82198	metalloproteinase inhibitor	MMP13		5.38, 3.46	30.28	1.17, 0.40	61.04	-33.34	4.43	7.46	30.28	9.71	29.19	59.15	93.09	68.35	31.11	6.91	-1.87	13.54	83.33	8.71	98.77	35.83	15.31	89.83	40.35	81.47	10.72	-4.00	28.15	83.54	15.81	85.53	38.00
BRD-K04466929	CP	Merck60	HDAC inhibitor	HDAC1, HDAC2		1.15, 0.38	30.28	0.11, 0.02	35.06	45.74	34.63	24.05	21.77	30.14	13.69	38.57	20.41	29.11	12.11	34.56	24.89	30.28	61.30	97.86	41.62	10.42	24.38	58.13	36.98	14.68	35.23	3.97	32.62	22.24	20.59	40.78	66.08
BRD-K05977823	CP	tenovins	SIRT inhibitor, TP53 activator	SIRT1, SIRT2		2.31, 0.77	30.27	1.14, 0.36	28.76	29.46	9.19	46.30	5.73	-48.92	43.90	55.75	63.61	53.60	24.63	78.72	54.61	3.07	38.96	90.22	49.47	17.85	29.25	19.21	50.24	14.08	8.98	0.74	55.39	96.00	88.43	30.24	30.27
BRD-K31238592	CP	devazepide	CCK receptor antagonist, gastrin inhibitor	CCKAR, CCKBR, GAST	CCK receptor antagonist	5.38, 1.92	30.26	1.43, 0.45	98.03	12.45	33.12	51.47	10.41	46.84	-9.23	81.06	30.26	11.61	15.62	15.47	90.87	54.61	25.55	97.37	20.59	44.35	17.44	70.15	15.36	15.30	14.30	99.51	89.97	21.67	31.44	46.65	18.85
BRD-K07888196	CP	tyrphostin-AG-538	insulin growth factor receptor inhibitor, tyrosine kinase inhibitor	EGFR		3.85, 1.92	30.25	0.94, 0.26	58.94	25.40	17.06	33.24	-7.07	25.08	95.75	61.63	29.17	29.65	11.90	29.07	1.44	61.39	80.45	-2.71	94.23	30.25	84.02	65.67	11.70	19.51	25.47	27.02	85.36	87.13	30.95	57.65	71.20
BRD-K55748775	CP	SCH-28080	ATPase inhibitor, potassium-competitive acid antagonist	ATP4A		2.86, 0.82	30.24	0.70, 0.25	6.48	16.88	0.00	30.96	9.67	26.74	9.32	29.60	66.93	74.31	21.72	82.55	5.71	30.24	65.81	41.03	84.16	14.53	41.38	65.99	75.68	80.92	14.18	3.96	6.51	47.72	55.23	77.31	-4.30
BRD-K63516691	CP	T-0156	phosphodiesterase inhibitor	PDE5A		7.69, 3.85	30.24	1.10, 0.40	8.90	72.81	24.87	25.15	99.01	51.15	97.08	-28.56	99.93	26.33	14.29	82.89	3.94	45.16	-43.66	4.35	-76.90	21.09	88.81	83.24	48.59	64.02	19.13	-99.47	69.15	57.88	5.38	57.61	30.24
BRD-K64935403	CP	ebelactone-b	pancreatic lipase inhibitor	PNLIP		3.08, 1.54	30.23	1.40, 0.40	11.42	-76.87	0.00	10.32	-12.05	8.60	31.08	30.23	8.35	6.74	34.11	23.54	20.81	42.50	99.08	4.73	51.47	72.12	44.98	79.88	16.96	49.92	66.39	55.94	75.57	89.76	72.53	10.30	1.94
BRD-U25771771	CP	WZ-4-145	EGFR inhibitor	CSF1R, DDR1, EGFR, PDGFRA, TIE1	EGFR inhibitor	8.08, 3.85	30.23	1.70, 0.58	9.77	84.05	74.26	99.12	75.55	0.02	-5.32	23.37	-10.23	10.61	13.88	71.13	90.79	99.61	81.34	99.93	46.91	88.80	10.73	33.02	23.92	30.23	25.31	-53.22	28.27	15.23	50.82	50.19	10.84
BRD-U88459701	CP	atorvastatin	HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor	HMGCR, DPP4, AHR, CYP3A5, FASLG	HMGCR inhibitor	8.46, 5.38	30.21	1.50, 0.41	13.32	15.09	6.58	84.85	14.39	75.09	10.94	82.33	32.86	11.96	3.07	48.85	-62.43	91.78	91.48	7.47	98.67	93.94	19.40	57.71	23.86	20.48	41.01	96.04	92.44	55.01	18.96	30.21	24.90
BRD-K16551401	CP	PNU-22394	serotonin receptor agonist	MAOA, MAOB		1.54, 1.54	30.20	0.97, 0.28	14.47	-11.10	7.18	13.15	51.97	36.57	76.98	76.53	52.69	28.16	72.94	75.37	4.00	7.08	-13.71	7.49	67.11	14.08	47.12	72.55	55.18	30.20	6.91	0.00	26.39	63.43	26.57	66.73	84.32
BRD-K38903228	CP	hesperidin	free radical scavenger	CACNA1B		3.08, 1.54	30.19	1.34, 0.50	35.30	28.13	11.78	3.75	30.19	18.60	16.53	30.07	8.71	81.09	87.94	65.37	1.83	23.97	73.37	3.07	95.13	25.92	71.79	33.15	69.42	33.43	65.12	-0.88	15.83	77.39	24.12	41.20	68.74
BRD-K62206109	CP	VUF-5681	histamine receptor antagonist	HRH3		4.62, 3.08	30.19	0.89, 0.35	76.36	28.54	2.92	14.75	21.64	21.39	94.36	73.14	13.17	8.74	34.35	28.85	-32.23	14.10	81.25	0.53	94.14	-13.73	57.17	63.54	58.92	39.92	40.68	11.46	83.93	44.11	30.19	99.75	20.04
BRD-K37618799	CP	MRS-1220	adenosine receptor antagonist	ADORA2B, ADORA3		3.08, 1.54	30.18	0.77, 0.31	45.53	33.90	27.84	71.14	79.51	3.10	90.19	56.81	25.69	78.64	92.84	33.08	82.98	24.18	-72.12	12.34	7.82	18.68	98.18	-9.39	29.12	23.93	30.18	-35.45	15.79	41.31	54.97	35.26	25.93
BRD-K43796186	CP	benzyl-quinazolin-4-yl-amine	epidermal growth factor receptor (EGFR) inhibitor	EGFR		1.22, 0.82	30.17	0.90, 0.36	30.17	16.31	79.64	40.93	13.87	27.97	17.34	70.41	49.02	75.15	45.31	44.07	70.29	44.21	24.05	17.05	22.10	33.53	22.36	23.99	42.02	25.58	4.47	-4.08	44.82	24.54	13.94	79.77	39.58
BRD-K70327191	CP	benzoxiquine	topical anti-infective			2.31, 1.54	30.16	0.22, 0.07	22.10	12.79	33.27	27.64	67.35	21.63	7.49	85.16	5.81	30.81	24.79	37.03	10.53	74.90	15.14	17.87	47.98	30.16	18.10	44.12	49.10	69.61	32.31	-2.63	53.36	14.98	21.78	62.84	73.58
BRD-A55484088	CP	BNTX	opioid receptor antagonist	OPRD1, OPRK1, OPRM1		4.49, 1.22	30.15	2.36, 0.59	3.45	76.78	9.23	40.32	37.89	49.38	0.00	64.54	10.10	9.53	4.55	27.33	95.07	95.10	42.55	98.56	45.95	61.11	19.31	68.96	35.67	11.59	39.09	-4.24	2.50	17.80	30.15	-2.43	22.45
BRD-K47539947	CP	tetradecylthioacetic-acid	lipid peroxidase inhibitor			2.31, 1.15	30.14	0.93, 0.40	16.82	23.93	70.50	0.85	52.35	85.23	23.97	80.94	17.34	25.06	51.86	63.93	-3.98	12.71	15.16	30.14	53.72	21.36	65.42	-1.76	31.51	53.73	73.00	20.77	23.60	75.13	22.98	50.93	79.16
BRD-A64479082	CP	quinidine	cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker	SCN5A, ABCB1, CYP2D6, KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SLC29A4	Sodium channel blocker	6.94, 4.08	30.11	1.06, 0.36	14.17	8.23	11.80	46.16	11.27	13.68	40.21	98.21	19.97	56.49	8.73	53.75	5.37	30.05	93.55	15.73	61.61	82.10	25.79	89.60	30.11	60.65	40.00	6.70	28.35	98.71	36.29	6.29	90.62
BRD-K19111024	CP	clofibric-acid	PPAR receptor agonist	PPARA		8.08, 6.54	30.04	1.40, 0.38	6.09	-12.33	37.06	7.07	-1.87	5.06	-42.50	97.64	79.01	-9.01	30.04	10.56	2.29	0.02	99.12	15.26	99.75	16.67	-85.84	91.66	46.89	46.77	32.28	99.06	74.71	28.95	56.72	82.23	61.85
BRD-A87848830	CP	bimatoprost	prostanoid receptor agonist	PTGFR, AKR1C3, PTGER1, PTGER3		7.35, 4.49	30.02	1.51, 0.40	0.85	6.31	67.78	30.02	90.06	4.64	54.66	92.61	9.65	58.71	57.27	76.24	8.12	24.79	-57.24	80.26	-1.77	14.29	27.12	42.10	95.35	95.94	23.14	0.00	-18.64	99.93	55.84	91.60	14.82
BRD-K52662033	CP	lidocaine	histamine receptor agonist, voltage-gated sodium channel modulator	SCN5A, EGFR, SCN10A, SCN9A		5.38, 3.46	30.02	0.90, 0.19	52.86	-39.38	32.08	2.61	6.59	2.33	42.24	93.54	30.02	4.69	52.46	86.79	-0.34	-1.80	87.40	0.42	87.79	16.68	75.99	29.98	25.63	24.52	3.03	-10.16	81.31	75.63	55.24	54.23	37.22
BRD-K89210380	CP	biotin	vitamin cofactor for many metabolic reactions	ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6		6.15, 3.08	30.01	1.50, 0.53	72.14	8.42	54.33	16.28	42.77	16.16	79.06	37.72	15.26	69.25	54.29	21.85	1.73	2.04	58.37	-6.84	96.51	6.13	24.09	94.97	28.80	60.51	1.24	-1.99	27.37	38.00	30.01	97.19	69.50
BRD-A04756508	CP	norgestimate	progesterone receptor agonist	PGR, ESR1	Progesterone receptor agonist	3.08, 1.92	30.00	0.41, 0.15	29.52	8.16	24.60	49.06	50.85	-9.98	17.69	29.53	27.00	43.44	14.13	50.84	53.81	30.00	40.02	96.18	52.72	90.39	10.92	24.86	94.29	25.63	10.09	-4.95	76.79	67.04	11.80	31.10	92.26
BRD-A63998256	CP	helveticoside	ATPase inhibitor	ATP1A1	ATPase inhibitor	3.27, 1.22	29.98	2.44, 0.81	5.16	78.97	57.42	91.24	64.26	27.02	25.35	63.97	31.54	6.34	12.28	70.15	93.38	1.73	82.30	76.38	72.81	41.62	21.54	29.98	63.29	24.77	18.40	-16.18	-72.47	6.46	23.74	39.93	13.44
BRD-A25004090	CP	erastin	anion channel modulator, ion channel antagonist	VDAC2		2.69, 1.15	29.92	0.59, 0.35	63.06	9.67	21.68	27.02	33.45	38.13	15.16	14.98	19.05	25.35	35.36	58.62	31.48	80.13	30.66	99.53	32.16	9.05	30.51	44.42	9.16	53.54	19.49	3.72	49.27	12.54	27.77	14.40	29.92
BRD-K04210847	CP	tamoxifen	estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor	ESR1, ESR2, CYP3A5, EBP, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ	Estrogen receptor antagonist	6.94, 2.86	29.91	1.98, 0.59	39.75	8.64	3.24	92.00	2.50	-10.36	3.05	29.48	7.05	29.91	8.70	59.77	91.09	97.44	69.48	99.89	72.33	97.38	10.68	43.90	17.61	15.63	20.13	1.51	94.78	32.27	54.61	43.67	8.60
BRD-K79437791	CP	acetyl-farnesyl-cysteine	inhibitor of methylation of endogenous isoprenylated proteins	PPARG		3.08, 1.54	29.88	1.23, 0.43	3.45	6.20	96.94	15.38	69.18	48.91	46.05	94.95	57.45	38.83	18.32	-25.89	-36.31	0.00	57.65	-46.67	86.87	0.42	-8.39	4.05	46.46	54.75	24.39	-36.26	42.68	-33.77	29.88	56.04	98.48
BRD-K00615600	CP	AG-14361	PARP inhibitor	PARP1	PARP inhibitor	3.08, 1.54	29.87	0.64, 0.20	61.46	93.59	39.86	24.10	32.50	71.88	29.87	-53.94	15.42	42.54	12.63	60.59	1.41	9.81	73.19	8.90	38.39	2.22	43.06	51.24	17.90	27.11	29.53	94.13	24.41	45.80	27.50	38.33	22.58
BRD-A56020723	CP	CA-074-Me	cathepsin inhibitor, antiamyloidogenic agent	CTSB		3.27, 0.82	29.86	2.63, 0.91	38.76	32.64	23.11	4.55	23.40	6.49	4.51	73.42	32.69	33.46	29.86	87.77	86.39	86.91	42.90	41.22	18.62	57.20	16.62	12.16	8.83	13.38	70.93	-0.42	36.28	14.15	58.00	20.76	22.46
BRD-A98702003	CP	carbenoxolone	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3		4.62, 1.54	29.86	0.97, 0.31	7.85	-38.38	38.18	0.60	50.74	-0.03	7.82	47.69	5.88	79.74	3.69	51.86	0.00	-23.67	32.24	0.78	99.15	3.59	80.51	67.38	18.29	84.07	29.86	1.13	11.76	52.06	33.30	94.08	82.24
BRD-K11630072	CP	carmofur	thymidylate synthase inhibitor, pyrimidine antagonist	TYMS	Thymidylate synthase inhibitor	4.89, 2.22	29.85	1.19, 0.41	94.40	5.05	18.25	19.99	15.16	-45.93	83.74	6.53	18.16	27.99	96.59	93.64	72.07	21.24	83.78	94.94	71.40	0.11	65.61	29.85	15.42	26.84	16.99	88.69	9.62	84.81	79.83	61.84	30.90
BRD-K16508793	CP	diazepam	benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, ADRA1A, CYP2C19, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO		5.71, 2.86	29.80	0.45, 0.10	15.21	26.23	68.45	11.49	25.63	92.56	1.53	35.32	1.59	29.80	21.25	46.40	0.35	13.61	96.30	60.27	97.36	30.90	43.98	46.01	88.36	86.86	6.58	0.88	15.12	25.11	56.75	6.30	48.61
BRD-A60070924	CP	alpha-estradiol	estrogen receptor agonist	ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1		1.72, 0.43	29.79	0.41, 0.33	28.51	23.21	37.58	2.54	36.88	9.38	29.14	38.40	8.25	12.68	13.32	45.26	-1.97	29.77	84.12	95.49	8.25	2.40	67.16	44.23	29.79	59.65	43.41	49.35	76.01	27.96	14.85	71.63	62.53
BRD-K18036262	CP	L-168049	glucagon receptor antagonist, human glucagon receptor antagonist	GCGR		4.49, 2.86	29.79	1.31, 0.35	27.88	36.69	73.20	85.39	9.13	67.06	4.57	90.66	76.43	87.53	10.51	47.32	86.47	42.03	18.69	98.24	29.79	14.52	57.54	11.87	60.39	3.24	12.65	0.88	19.44	89.07	13.91	17.97	20.94
BRD-A69636825	CP	diltiazem	L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker	CACNA1C, CACNA1S, CACNA2D1, CACNG1, CYP3A5, CYP3A7, HTR3A, KCNA5		3.85, 1.54	29.73	0.91, 0.31	20.98	14.46	29.80	53.61	74.14	12.18	29.88	97.38	76.44	26.60	16.11	42.42	2.08	3.07	0.63	2.01	75.32	63.68	51.86	34.28	29.73	20.10	20.60	-71.20	77.96	7.26	15.00	33.38	75.56
BRD-K01436366	CP	XMD-1150	leucine rich repeat kinase inhibitor	LRRK2	Leucine rich repeat kinase inhibitor	1.54, 0.00	29.66	1.33, 0.56	13.34	92.57	61.47	24.61	60.07	7.34	18.03	-49.07	6.17	8.03	18.96	36.66	66.89	86.43	60.03	38.36	45.26	82.59	28.27	14.58	34.20	25.12	94.04	0.03	23.57	37.55	29.66	1.87	32.03
BRD-K70511574	CP	sunitinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist	FLT3, KDR, KIT, FLT4, FLT1, PDGFRA, PDGFRB, RET, CSF1R, FGFR1		3.08, 1.15	29.66	1.27, 0.45	60.01	-73.62	1.90	7.97	28.75	24.59	21.76	95.02	11.68	57.54	29.66	-23.14	6.80	26.50	66.84	10.06	85.02	16.59	99.44	65.15	50.44	10.91	29.92	32.28	57.78	13.34	34.60	40.17	49.13
BRD-K99818283	CP	PIK-90	PI3K inhibitor		PI3K inhibitor	3.46, 0.77	29.65	1.57, 0.61	4.90	29.65	43.97	95.21	12.98	15.09	18.34	21.93	5.17	70.61	9.26	71.30	1.82	29.39	94.36	-31.60	62.54	55.78	9.94	28.97	59.73	27.61	38.07	-0.81	70.58	63.87	45.04	64.10	34.78
BRD-K20338176	CP	cefaclor	cell wall synthesis inhibitor			2.31, 1.15	29.64	0.98, 0.34	11.86	29.64	19.51	34.26	21.12	19.78	81.32	58.96	27.77	15.96	86.51	27.65	-29.39	53.55	47.22	21.37	90.56	9.34	52.13	11.02	93.91	27.38	23.08	-81.14	54.53	68.91	40.43	83.47	59.50
BRD-K67977190	CP	eprosartan	angiotensin receptor antagonist	AGTR1		8.57, 3.67	29.64	1.65, 0.47	41.34	94.59	55.98	14.91	97.65	12.37	19.43	61.82	17.08	43.47	29.64	19.62	-1.98	5.71	61.82	-17.14	67.75	18.17	96.23	13.24	14.25	10.66	98.13	88.15	16.72	99.40	26.30	61.48	37.24
BRD-A15493168	CP	tetracycline	30S ribosomal protein inhibitor, 30S ribosomal subunit inhibitor, protein arginine deiminase inhibitor	PRNP	Bacterial 30S ribosomal subunit inhibitor	6.94, 4.08	29.62	2.18, 0.53	7.49	-90.98	9.99	2.72	73.47	6.94	48.35	97.67	5.18	26.21	73.20	38.76	-2.29	-21.11	71.32	0.00	21.67	13.37	79.28	29.62	64.84	10.22	61.20	85.81	75.40	99.93	16.05	47.62	56.20
BRD-K40742111	CP	baeomycesic-acid	lipoxygenase inhibitor			5.34, 2.29	29.62	2.02, 0.40	18.27	94.20	97.63	17.66	5.39	51.25	9.74	38.23	54.68	2.43	31.28	64.33	-5.88	48.53	73.60	1.02	27.95	0.21	51.92	65.98	-22.25	95.80	3.63	NaN	15.92	-28.83	35.59	10.24	97.84
BRD-A38749782	CP	fludrocortisone	glucocorticoid receptor agonist, mineralocorticoid receptor agonist	NR3C2, AR, NR3C1	Glucocorticoid receptor agonist	2.86, 0.82	29.60	1.64, 0.57	14.82	80.79	22.45	42.92	69.49	35.64	4.60	15.75	25.85	13.43	40.46	45.32	-4.69	79.38	-38.03	30.69	50.79	40.78	81.61	21.03	87.41	89.41	29.60	-93.26	-17.57	6.10	13.03	15.08	30.44
BRD-K39944607	CP	ochratoxin-a	phenylalanyl tRNA synthetase inhibitor	SLC22A6		7.31, 3.85	29.60	1.39, 0.57	3.46	98.24	82.88	27.07	95.17	80.29	40.32	16.81	7.49	71.50	6.26	96.21	17.98	20.75	74.83	47.86	75.11	8.84	25.56	25.06	78.31	49.75	29.60	0.78	-11.26	29.35	42.69	20.63	70.88
BRD-K48722258	CP	dilazep	adenosine reuptake inhibitor, calcium channel antagonist, platelet aggregation inhibitor	SLC29A1, CACNA1C		4.90, 2.45	29.58	1.32, 0.44	2.22	36.13	37.61	83.15	56.06	-10.37	4.55	29.58	20.05	3.81	72.72	80.09	42.26	92.01	70.11	26.87	53.89	92.99	14.63	12.05	16.95	-15.41	25.84	-92.56	19.84	40.04	19.47	35.97	35.08
BRD-K53665955	CP	MK-5108	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Aurora kinase inhibitor	2.15, 0.86	29.53	1.05, 0.53	26.33	29.53	9.43	8.86	50.06	23.19	16.55	38.39	28.19	55.32	33.70	40.38	6.60	4.16	11.21	99.72	60.29	22.18	34.29	30.52	58.96	16.20	4.85	-0.85	41.20	22.40	38.24	63.33	52.70
BRD-K64606589	CP	apicidin	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	HDAC inhibitor	3.46, 0.77	29.53	1.56, 0.50	10.47	95.08	41.73	57.95	30.24	13.90	-33.92	-32.43	13.20	29.53	6.73	69.85	88.23	86.25	68.93	99.86	-2.64	61.27	13.52	37.93	28.63	19.98	45.29	-0.78	0.78	-14.35	39.73	10.76	35.66
BRD-A25576662	CP	streptozotocin	DNA alkylating drug	SLC2A2		6.53, 4.49	29.52	1.32, 0.58	11.70	3.19	1.48	3.88	11.30	33.98	17.96	51.81	11.91	19.54	40.88	29.52	4.73	13.84	93.50	2.57	97.52	5.46	97.18	68.07	45.83	26.79	32.09	96.03	83.40	99.47	98.91	30.06	10.46
BRD-K74141488	CP	naftifine	squalene epoxidase inhibitor, steroid sulfatase inhibitor	SQLE		8.08, 6.15	29.50	0.83, 0.30	8.35	6.20	2.04	39.98	15.39	8.49	50.22	95.13	15.73	76.67	55.41	24.11	-3.49	4.34	60.09	2.15	38.47	5.32	79.64	98.41	46.28	91.12	29.50	71.83	57.37	10.53	25.63	99.97	2.50
BRD-A88774919	CP	doxycycline	metalloproteinase inhibitor, 30S ribosomal protein inhibitor, matrix metalloprotease inhibitor, protein arginine deiminase inhibitor	MMP8, MMP1	Bacterial 30S ribosomal subunit inhibitor	5.71, 2.45	29.45	0.78, 0.23	29.90	4.88	80.86	50.66	19.79	24.46	28.77	89.95	5.43	24.19	-4.27	26.15	22.61	22.97	90.48	12.12	77.85	28.37	12.87	87.19	7.17	29.73	29.45	77.87	39.26	96.41	38.17	46.57	85.58
BRD-K72703948	CP	ZM-447439	Aurora kinase inhibitor	AURKA, AURKB	Aurora kinase inhibitor	2.69, 1.54	29.45	0.55, 0.18	24.75	40.38	19.01	48.14	34.49	24.70	16.05	46.16	4.61	13.50	26.98	44.86	25.25	82.67	31.62	99.72	53.34	67.18	36.23	29.45	16.99	22.36	20.57	2.25	33.39	27.30	23.06	38.10	33.34
BRD-K50311478	CP	tosyl-phenylalanyl-chloromethyl-ketone	chymotrypsin inhibitor, serine protease inhibitor			2.69, 0.77	29.44	1.01, 0.35	90.61	10.43	7.17	18.74	4.22	43.93	8.74	52.12	12.48	30.95	18.85	29.44	7.81	74.25	-8.60	36.06	33.11	63.99	26.99	32.75	-11.81	27.69	66.32	49.05	95.85	35.66	21.28	21.44	59.53
BRD-K94294671	CP	OSI-027	mTOR inhibitor	MTOR	MTOR inhibitor	3.85, 0.77	29.44	1.35, 0.56	3.66	62.10	18.65	94.62	66.22	28.42	15.28	18.40	7.53	70.28	8.71	87.39	84.86	41.27	95.40	98.54	93.22	79.55	10.24	18.36	36.41	29.44	17.49	-0.03	7.05	39.58	47.43	23.32	6.72
BRD-K98490050	CP	amsacrine	topoisomerase inhibitor, DNA intercalating drug	TOP2A, KCNH2	Topoisomerase inhibitor	3.46, 1.92	29.43	2.77, 0.68	7.14	97.57	60.82	74.02	66.68	8.32	64.44	-14.09	51.03	79.27	24.76	61.96	93.34	88.31	-11.54	99.93	7.48	8.99	56.79	24.47	43.50	19.40	31.13	0.00	0.92	14.57	29.30	29.43	0.81
BRD-A98378129	CP	talniflumate	cyclooxygenase inhibitor, calcium channel blocker, calcium-activated chloride channel blocker, mucin production inhibitor	CLCA1		8.46, 4.62	29.42	1.20, 0.51	14.09	13.80	41.00	32.43	4.30	24.08	72.04	62.68	20.56	99.93	22.47	11.02	5.34	54.48	79.11	3.17	78.02	5.56	50.87	85.26	22.33	27.16	22.86	91.17	86.29	98.45	23.04	99.93	29.42
BRD-K98763141	CP	niflumic-acid	cyclooxgenase inhibitor	CLCNKA, PTGS2, ANO1, CLCN1, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, UGT1A9		5.71, 3.27	29.41	1.09, 0.39	56.38	17.50	80.53	20.73	20.54	68.48	58.97	92.33	22.31	4.30	29.41	83.49	0.07	-2.15	99.40	2.71	44.62	0.07	87.50	52.93	18.28	81.84	41.16	0.07	11.15	98.48	28.27	44.92	0.00
BRD-K07220430	CP	cinnarizine	calcium ion channel antagonist, histamine receptor antagonist	HRH1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5		5.77, 3.08	29.39	1.07, 0.45	24.72	9.21	61.95	19.71	64.42	20.69	9.40	82.41	29.97	39.74	96.15	36.03	-2.22	5.26	51.90	6.24	53.55	29.39	20.36	67.21	16.89	86.99	30.84	12.84	29.09	23.76	19.75	92.16	75.10
BRD-K50128260	CP	sildenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3		2.31, 1.15	29.37	0.40, 0.06	40.44	-4.16	9.67	22.85	4.44	34.85	23.82	28.58	16.45	15.49	42.64	58.18	-1.90	20.93	85.40	2.50	59.08	64.60	69.67	93.47	87.81	1.30	5.50	29.37	72.25	81.69	26.55	76.64	93.14
BRD-K03981224	CP	ethisterone	androgen receptor agonist	TYR		4.62, 1.92	29.34	0.73, 0.25	6.66	56.42	64.32	18.81	97.57	21.74	30.10	29.34	4.39	37.58	34.35	16.90	-11.87	30.97	-26.71	6.19	39.82	54.73	88.27	13.04	47.21	22.78	12.06	46.05	9.82	40.36	13.36	18.42	43.46
BRD-K36529613	CP	PU-H71	HSP inhibitor	HSP90AA1	HSP inhibitor	3.46, 0.77	29.33	1.07, 0.36	14.10	52.73	2.82	55.16	37.06	11.37	21.07	52.28	5.46	6.77	3.45	29.33	13.13	77.22	90.61	98.31	40.33	54.71	0.28	44.12	17.85	64.20	31.14	-0.70	47.07	-2.36	23.11	1.52	79.74
BRD-A32949107	CP	MRS-1845	calcium channel blocker	ORAI1		2.31, 0.00	29.32	1.08, 0.34	60.35	29.32	1.59	17.85	52.21	-0.03	-22.37	49.58	25.21	50.11	68.21	65.90	2.22	2.04	31.74	7.18	91.62	13.08	40.53	89.16	-15.09	59.83	5.39	-87.14	43.12	15.77	50.42	63.98	13.11
BRD-K77133231	CP	PD-169316	p38 MAPK inhibitor	ALOX5	P38 MAPK inhibitor	3.82, 1.53	29.31	1.29, 0.28	99.47	14.12	1.70	6.17	-4.60	43.30	45.45	64.64	20.11	31.97	26.66	41.26	-11.10	13.92	-8.90	2.71	12.41	1.62	97.15	53.28	-62.16	9.66	37.07	NaN	78.43	38.29	34.67	85.15	47.70
BRD-K41903098	CP	diphenoxylate	opoid receptor agonist	OPRM1, OPRD1		6.22, 3.56	29.30	0.99, 0.19	8.07	10.61	53.37	81.95	28.16	5.65	45.49	42.28	14.24	29.30	3.07	59.36	4.61	74.83	87.94	15.17	95.16	47.45	18.55	49.47	44.05	43.37	56.23	0.00	13.71	2.11	23.00	77.29	18.54
BRD-K67102207	CP	phenylbutyrate	HDAC inhibitor, cell cycle inhibitor, pharmacological chaperone, pyruvate dehydrogenase kinase inhibitor	CYP3A5, HDAC1		7.76, 3.67	29.27	0.95, 0.33	8.73	92.94	8.53	21.70	94.65	46.58	87.58	96.70	29.27	4.49	60.58	68.15	9.47	23.54	-47.35	12.96	-11.53	0.00	76.69	48.10	61.26	52.95	5.64	-86.75	19.05	98.03	95.47	89.82	2.04
BRD-K08703257	CP	3-amino-benzamide	PARP inhibitor	PARP1		3.85, 1.54	29.23	0.92, 0.16	97.17	-31.51	38.26	9.16	4.42	8.32	70.63	81.72	15.21	16.00	37.64	20.16	-83.83	1.69	32.44	-62.92	35.62	-41.64	83.34	83.12	26.94	19.67	15.61	84.69	35.94	90.22	29.23	35.16	34.45
BRD-K10098805	CP	rhapontin	apoptosis inducer			4.08, 0.00	29.22	1.17, 0.34	46.65	20.15	5.74	14.21	19.32	33.80	36.81	79.60	35.93	47.62	27.44	71.82	1.30	6.39	50.96	1.83	7.51	23.71	90.53	14.83	19.64	76.46	33.48	-0.81	53.74	61.88	29.22	94.37	9.83
BRD-K85242180	CP	beta-CCP	indoleamine 2,3-dioxygenase inhibitor	GABRA1, GABRG2, IDO1		3.08, 0.77	29.13	0.94, 0.25	16.31	-22.03	-1.73	29.17	3.52	13.49	80.34	67.66	8.36	11.22	68.93	40.18	-3.05	6.62	33.93	-8.80	-26.11	19.45	76.26	61.36	17.26	85.28	29.13	67.55	85.59	88.31	9.43	94.72	34.70
BRD-K04146668	CP	GW-441756	growth factor receptor inhibitor, leucine rich repeat kinase inhibitor	LRRK2, NTRK1		5.38, 2.69	29.11	1.23, 0.33	21.95	28.78	-1.59	93.72	-9.66	16.02	22.35	32.21	11.32	3.91	71.32	37.57	85.52	13.78	85.38	92.86	50.35	86.85	89.79	69.23	16.14	63.08	6.30	-2.01	61.92	28.27	29.11	92.12	18.80
BRD-K22385716	CP	LY-303511	casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	CSNK2A1, CSNK2A2, CSNK2B, MTOR	Bromodomain Inhibitor	2.69, 1.15	29.11	0.97, 0.42	29.11	34.85	31.94	66.08	71.07	7.72	0.56	27.79	4.11	17.30	44.57	73.30	7.53	44.31	34.57	61.07	8.91	71.83	-20.87	56.49	24.15	78.49	17.92	-48.57	-43.22	14.68	15.27	62.64	51.20
BRD-K52459643	CP	prostaglandin-e1	prostanoid receptor agonist, prostanoid receptor antagonist	PTGER1, PTGER2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER4, PTGIR		2.69, 2.31	29.08	1.02, 0.34	15.29	57.13	24.30	5.02	38.97	36.28	44.39	38.69	29.08	26.18	15.85	71.14	-38.49	10.24	-50.48	8.84	-7.89	19.44	20.75	36.58	81.69	45.03	9.26	-37.89	89.77	59.00	43.10	93.32	37.69
BRD-A17065207	CP	brefeldin-a	antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor	ARF1, ARFGEF1, ARFGEF2, CYTH2, GBF1, SAR1A	Protein synthesis inhibitor	6.92, 4.62	29.06	2.14, 0.78	8.44	29.06	18.39	98.87	44.32	4.19	-9.21	41.71	25.85	3.70	6.45	38.22	97.92	86.84	93.87	99.93	39.67	91.08	18.82	33.09	15.94	3.56	12.48	28.78	92.79	55.02	10.74	-10.49	57.85
BRD-K02953697	CP	naringin	cytochrome P450 inhibitor	SLCO1A2		2.86, 1.22	28.99	1.26, 0.47	99.89	3.52	20.36	36.75	44.36	61.66	35.30	-30.74	29.30	21.33	8.74	67.70	-1.62	8.78	94.40	4.22	28.99	44.93	25.58	30.79	53.78	25.34	22.12	9.84	18.35	36.78	30.81	64.06	-9.30
BRD-K27499107	CP	carbacyclin	IP receptor activator, PPARbeta receptor activator	PPARD, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R		2.31, 1.54	28.99	0.73, 0.19	28.99	76.33	2.04	21.05	10.43	65.03	29.24	-24.63	18.36	28.63	28.22	36.07	0.00	20.79	20.84	28.39	17.36	1.09	85.70	91.28	33.91	70.50	81.71	97.87	10.63	83.84	46.21	86.91	61.15
BRD-K32584078	CP	BML-257	AKT inhibitor, HCV NS5B RdRp inhibitor	AKT1		4.62, 1.92	28.98	0.93, 0.32	75.18	32.47	89.08	21.22	94.17	0.03	97.43	87.38	86.34	48.92	88.09	26.71	0.00	0.56	13.35	9.09	92.89	27.08	27.23	28.98	10.26	7.35	15.10	-13.79	85.40	42.35	6.36	32.90	67.63
BRD-A26002865	CP	verrucarin-a	protein synthesis inhibitor		Protein synthesis inhibitor	4.23, 2.31	28.88	2.76, 0.81	6.53	63.65	39.43	87.23	58.38	27.44	7.54	76.12	6.31	8.00	19.79	75.80	93.38	14.78	77.88	99.61	92.54	30.28	-0.11	18.35	34.41	72.89	18.39	-1.90	22.74	10.42	28.88	32.24	10.43
BRD-K56450366	CP	NSC-94258	antitumor agent	AKR1B1, CYP19A1, HSD17B1		6.37, 2.55	28.88	1.42, 0.42	16.93	-6.59	-7.23	0.00	8.55	68.36	7.65	92.65	79.76	-48.88	3.03	28.88	-3.95	0.00	81.27	-69.27	89.64	83.32	-19.21	93.34	45.63	34.98	31.03	-0.88	11.24	89.94	40.62	81.70	99.79
BRD-K63915849	CP	AS-604850	Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor	PIK3CG, PIK3CA		4.62, 1.92	28.85	1.13, 0.32	60.60	27.50	83.97	1.84	21.40	10.34	92.47	63.73	38.35	56.77	28.85	-10.23	-21.59	-0.70	47.86	-77.51	22.98	3.43	67.08	37.71	26.04	-3.10	80.65	97.73	92.21	63.27	27.97	1.20	82.45
BRD-K32755366	CP	reserpic-acid	norepinephrine transporter inhibitor			5.38, 4.23	28.81	0.93, 0.38	63.90	28.81	6.84	26.73	89.96	7.33	-1.69	84.00	16.96	41.63	31.98	43.20	-2.57	45.57	-51.23	15.06	20.63	16.64	73.39	99.37	62.48	39.13	25.32	0.00	70.70	75.12	5.64	98.12	27.22
BRD-K74913225	CP	brinzolamide	carbonic anhydrase inhibitor	CA2, CA1, CA7, CA12, CA14, CA4, CA5A, CYP2B6, CYP2C8		2.31, 1.54	28.80	0.66, 0.23	7.75	6.17	3.33	6.78	36.55	-13.71	57.76	35.00	9.45	12.94	28.80	30.83	-1.06	7.28	78.49	-3.70	75.37	17.42	67.03	53.80	39.83	37.06	17.36	1.06	44.26	72.87	1.20	76.26	34.30
BRD-K85133207	CP	HDAC1-selective	HDAC inhibitor			1.29, 0.86	28.78	0.35, 0.22	63.78	27.72	48.58	3.38	16.76	29.46	22.37	67.48	15.40	28.78	12.19	30.09	-1.55	3.91	33.68	61.28	40.87	10.07	26.60	60.26	13.26	16.91	5.00	-0.85	47.18	51.49	30.63	34.22	82.61
BRD-K97330509	CP	SRC-kinase-inhibitor-II	src inhibitor			5.00, 3.46	28.75	0.99, 0.26	60.42	-4.09	-2.14	28.75	-4.62	27.96	62.41	96.27	12.12	47.73	32.26	51.98	-6.86	10.37	45.57	-6.64	14.94	20.89	47.02	96.64	11.23	69.79	9.39	62.84	84.46	33.58	27.43	71.00	25.98
BRD-K03440695	CP	boldine	acetylcholine receptor inhibitor, dopamine receptor antagonist	CHRNA4, CHRNB2, DRD1, DRD2		6.15, 2.69	28.74	0.75, 0.24	15.25	39.01	79.42	26.08	35.86	0.03	23.13	50.32	6.28	95.93	10.50	19.00	2.64	5.27	81.40	44.73	91.34	77.04	-19.87	46.26	28.74	80.27	29.53	0.56	27.32	25.14	17.91	84.71	75.29
BRD-K82688027	CP	RG-13022	EGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor	EGFR, PDGFRA, PDGFRB		1.92, 1.15	28.74	0.88, 0.32	2.15	82.39	86.95	19.94	92.44	17.99	31.89	45.32	94.36	14.68	60.70	71.70	-7.83	0.60	41.48	3.02	21.99	8.57	-17.90	60.55	35.01	38.11	-13.86	-78.08	-36.21	48.32	69.86	15.74	28.74
BRD-K63792901	CP	arecaidine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4		3.85, 2.31	28.73	0.78, 0.23	33.29	12.59	6.81	12.00	40.80	34.19	25.88	69.60	11.35	39.40	60.63	12.61	7.10	42.30	82.32	84.62	85.26	2.54	27.03	96.62	9.64	22.89	28.73	21.17	57.03	86.22	24.36	80.30	22.75
BRD-K97863768	CP	prothionamide	mycobacterium tuberculosis enoyl-[acyl-carrier-protein] reductase [NADH] (inhA) inhibitor			5.77, 3.46	28.67	1.07, 0.39	87.79	93.70	-2.82	44.23	92.26	26.97	-40.92	52.91	18.71	81.87	65.28	41.09	5.88	9.46	33.76	90.16	24.92	28.67	-19.66	95.38	84.64	56.72	9.94	-31.03	0.35	7.09	9.57	98.77	22.45
BRD-A12016240	CP	LY-278584	serotonin receptor antagonist	HTR3A		2.31, 1.15	28.66	0.68, 0.18	32.23	7.84	39.63	67.13	6.86	10.10	78.89	72.14	3.28	3.77	80.56	74.08	1.83	1.97	42.88	3.44	44.97	21.43	37.63	76.82	28.66	92.06	14.60	12.68	0.46	23.49	76.81	65.92	-12.45
BRD-K51751936	CP	alfadolone	GABA receptor agonist			5.77, 2.69	28.63	1.16, 0.34	56.16	9.94	4.17	11.12	42.25	45.94	97.99	45.86	66.92	6.98	18.90	12.94	-8.08	8.64	73.91	-4.43	7.26	0.74	92.86	87.78	-24.98	36.30	7.89	28.63	47.49	95.34	12.88	91.87	82.08
BRD-K78278890	CP	NM-PP1	calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor	CAMK2A, LCK, MAPK8, PRKACA, RIPK2, SRC		4.23, 3.08	28.61	1.14, 0.35	11.66	31.27	77.75	75.32	8.60	99.79	3.15	74.50	44.90	22.13	1.16	28.99	2.71	0.56	28.61	56.04	88.65	45.32	22.90	44.33	40.31	8.08	23.77	-0.88	9.43	43.27	26.63	19.59	86.83
BRD-A38747044	CP	KU-14R	pancreatic β-cell I3 binding site antagonist			5.00, 3.08	28.59	0.89, 0.27	3.17	3.06	42.10	21.12	53.44	4.91	6.81	49.38	14.27	10.07	28.59	65.57	1.44	-6.95	84.29	-3.40	91.52	17.98	50.50	69.27	43.08	94.48	25.80	99.08	36.24	96.28	2.64	98.73	26.21
BRD-A41250306	CP	cyclopenthiazide	diuretic, inhibitor of sodium chloride symporter			5.38, 3.46	28.58	0.52, 0.18	15.78	9.48	6.39	24.87	28.58	41.91	25.94	71.08	8.32	40.52	49.78	61.54	-2.22	5.95	87.09	2.50	92.05	12.07	8.12	54.91	88.33	39.60	30.98	98.77	26.11	-14.45	21.35	59.12	48.41
BRD-U33728988	CP	QL-X-138	mTOR inhibitor	BTK, JAK3, MKNK2, MTOR, PRKDC	MTOR inhibitor	3.85, 1.92	28.56	1.47, 0.68	9.58	11.17	55.38	83.23	30.37	11.83	7.20	35.03	5.46	48.27	15.00	59.14	91.73	-51.60	94.35	97.88	97.17	48.87	28.26	16.00	21.59	73.13	38.88	-0.56	14.64	26.45	12.90	28.56	59.81
BRD-K60184833	CP	tyrphostin-46	tyrosine kinase inhibitor	EGFR		6.54, 3.85	28.51	0.92, 0.27	7.86	24.40	16.95	21.48	56.04	5.00	66.41	42.17	10.64	28.51	33.05	96.08	-2.07	0.60	51.60	-2.85	56.50	8.60	22.41	61.60	35.92	26.65	84.32	0.00	19.70	51.70	74.28	91.77	31.89
BRD-K76698671	CP	HNHA	HDAC inhibitor	HDAC1		3.08, 0.77	28.50	0.94, 0.40	58.49	74.80	55.14	55.20	29.67	67.55	8.10	21.29	4.90	25.14	25.28	51.77	-2.15	59.97	60.03	62.79	45.23	-0.95	4.61	28.50	58.03	63.78	7.93	-21.50	-30.12	18.02	27.92	14.22	79.06
BRD-K31627533	CP	rimexolone	glucocorticoid receptor agonist, immunosuppressant, mineralocorticoid receptor agonist	NR3C1, SERPINA6	Glucocorticoid receptor agonist	3.46, 1.15	28.48	1.19, 0.47	6.66	-57.25	14.93	15.07	-31.17	13.80	22.92	66.40	20.28	39.79	47.51	28.48	7.21	18.36	86.49	18.35	84.34	5.11	41.17	98.31	44.51	62.75	13.27	41.14	87.33	48.80	3.59	29.81	59.54
BRD-K07265709	CP	razoxane	topoisomerase inhibitor, chelating agent	TOP2A, TOP2B		3.85, 1.92	28.47	0.93, 0.33	46.54	-92.44	0.00	20.39	52.62	26.40	16.54	23.69	-19.29	58.07	9.73	18.77	3.00	20.71	63.21	14.94	29.92	28.85	98.88	66.16	62.85	40.91	57.06	99.86	56.73	27.33	63.54	24.30	28.47
BRD-A71009679	CP	KUC103420N	rho GTPase inhibitor, CDC inhibitor			3.85, 1.15	28.45	1.64, 0.38	99.89	18.00	8.81	77.53	25.81	0.02	11.79	18.48	56.37	24.77	18.03	81.10	2.15	48.16	31.48	8.15	71.64	32.96	38.68	85.01	-39.67	22.14	59.16	50.17	86.90	70.89	27.04	8.31	28.45
BRD-K20197062	CP	SA-94315	caspase inhibitor	CASP3		1.15, 0.77	28.41	0.63, 0.11	23.21	38.70	32.49	30.74	87.94	72.25	16.61	28.41	17.40	6.21	3.84	70.37	0.00	-42.51	98.48	-87.36	74.21	10.60	8.75	48.97	19.44	53.86	40.69	-46.78	-15.44	10.51	48.76	37.42	36.90
BRD-K51290057	CP	SA-792709	retinoid receptor agonist	RARA, RARB		3.85, 0.38	28.41	1.50, 0.55	17.51	80.49	21.53	66.25	37.06	3.59	-17.98	-25.83	3.83	6.38	3.56	40.05	90.66	95.26	46.91	99.86	66.35	43.36	14.60	31.23	25.19	19.97	14.35	0.32	79.54	-2.40	77.81	41.28	28.41
BRD-A60197193	CP	amisulpride	dopamine receptor antagonist	DRD2, DRD3, HTR2A, HTR7		3.27, 1.63	28.37	0.55, 0.09	84.84	1.73	10.06	25.63	25.78	4.58	46.20	41.52	13.82	44.88	28.37	29.60	-1.41	14.89	98.03	10.32	71.57	7.89	49.24	56.50	15.62	17.47	56.33	79.70	5.34	84.88	70.47	74.95	-5.10
BRD-K09859624	CP	methantheline	acetylcholine receptor antagonist	CHRM1, HRH2		6.54, 2.31	28.37	1.14, 0.23	95.33	-32.50	4.69	16.36	-49.23	28.37	33.47	83.44	15.04	28.95	53.58	3.07	-33.34	-24.53	32.30	-86.49	46.42	-43.37	83.51	60.66	-82.56	15.10	20.41	4.01	88.71	88.98	77.06	31.33	89.01
BRD-K61737877	CP	VEGF-receptor-2-kinase-inhibitor-IV	VEGFR inhibitor	KDR		7.63, 2.29	28.34	0.90, 0.31	65.61	25.09	-5.66	-8.46	35.96	37.28	95.67	31.58	32.67	23.23	7.40	54.38	-64.13	-13.87	13.27	-15.07	10.07	0.25	76.04	52.37	16.37	71.75	10.74	NaN	47.27	92.60	16.51	99.61	89.93
BRD-A08877921	CP	cephalotaxine	protein synthesis inhibitor			3.05, 2.29	28.32	1.22, 0.17	81.95	28.55	89.85	5.72	96.35	22.84	7.91	79.93	28.09	-4.79	21.21	75.71	7.84	13.63	-11.42	50.63	45.97	4.05	91.38	99.93	10.29	44.40	-2.57	NaN	62.54	13.04	21.40	98.59	43.86
BRD-K69328504	CP	L-690488	nositol monophosphatase inhibitor	IMPA1		6.15, 3.08	28.32	1.00, 0.20	8.97	95.46	97.50	43.53	20.68	76.72	2.91	20.51	21.30	36.85	42.19	48.68	89.53	76.57	-42.93	99.82	68.90	82.08	25.67	24.68	74.04	3.95	24.56	-11.14	18.14	21.30	28.32	1.55	97.44
BRD-K41859756	CP	NVP-AUY922	HSP inhibitor	HSP90AA1, HSP90AA2, HSP90AB1	HSP inhibitor	3.46, 2.31	28.27	1.22, 0.41	4.80	70.18	26.86	60.93	25.62	7.34	-10.56	-17.52	11.39	8.66	2.39	36.93	81.71	94.24	56.85	98.80	35.64	73.45	32.74	66.19	43.41	1.66	42.06	40.74	28.27	8.18	25.84	22.03	11.06
BRD-K31283835	CP	tofacitinib	JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor	JAK3, JAK1, JAK2, CYP2C19, TYK2		4.62, 1.15	28.26	0.80, 0.15	8.80	10.74	83.41	15.81	50.54	2.43	15.37	43.92	7.21	37.14	32.90	91.82	-59.60	-18.39	93.38	0.00	96.02	36.05	49.36	64.04	54.54	28.26	24.31	15.92	22.53	24.35	89.82	44.97	19.95
BRD-K19220233	CP	JNK-9L	JNK inhibitor	MAPK8		5.77, 3.08	28.25	1.32, 0.67	2.11	98.45	96.39	72.06	92.35	26.08	68.73	-42.95	11.05	94.98	46.16	90.22	0.00	3.31	-34.36	75.85	53.23	0.99	14.62	58.06	76.78	24.73	22.94	-1.87	-31.61	15.08	28.25	51.19	81.90
BRD-K05901394	CP	terguride	adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist	DRD2, HTR2A, HTR2B, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2C, PRL		4.62, 1.92	28.09	1.16, 0.42	66.06	13.19	-7.68	38.39	44.01	66.38	70.33	93.80	7.32	8.09	8.67	9.83	-3.14	3.08	97.80	-4.72	98.92	18.17	15.41	90.45	27.58	55.92	28.09	65.54	25.34	16.87	41.03	93.87	37.59
BRD-K36377456	CP	marmesin	precursor in psoralen			7.76, 2.45	28.08	1.34, 0.44	58.23	8.45	43.58	37.58	24.36	19.20	-2.47	71.08	32.47	98.78	77.74	95.77	3.88	10.49	75.22	13.74	54.42	31.95	-9.03	60.49	21.52	5.13	28.08	-63.19	17.39	47.59	23.38	94.11	3.92
BRD-K59469039	CP	AG-879	angiogenesis inhibitor, EGFR inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor	ERBB2, KDR, NTRK1	EGFR inhibitor, VEGFR inhibitor	5.77, 4.23	28.08	2.11, 0.65	74.85	88.23	62.79	99.01	60.68	22.66	33.00	-21.91	8.99	5.99	28.08	60.89	99.37	87.54	73.84	99.93	31.44	81.69	16.84	73.59	7.88	19.08	9.82	3.33	27.72	4.79	14.20	20.74	3.14
BRD-K95655893	CP	MAZ-51	VEGFR inhibitor	FLT4		2.86, 0.82	28.03	2.05, 0.74	34.43	-15.16	24.19	54.64	3.35	8.14	8.81	22.90	4.84	42.63	28.03	38.38	75.36	4.12	30.94	84.38	51.35	7.52	32.51	31.55	13.02	3.29	0.53	46.56	38.13	29.76	29.32	9.05	24.92
BRD-K17415526	CP	tyrphostin-AG-835	protein tyrosine kinase inhibitor	EGFR		1.92, 1.15	28.02	0.81, 0.25	41.48	-11.41	8.12	71.49	5.11	-3.59	9.52	31.45	2.82	28.02	14.37	24.55	72.56	61.45	45.68	41.59	31.48	18.33	26.86	33.08	13.85	42.50	14.91	1.16	20.86	60.44	38.50	42.54	32.23
BRD-K28360340	CP	TW-37	BCL inhibitor, MCL1 inhibitor	BCL2, BCL2L1, MCL1	BCL inhibitor	5.00, 1.92	28.02	2.60, 0.72	9.16	97.48	77.87	89.48	16.15	28.44	-3.48	22.31	6.10	87.30	6.91	62.58	94.48	84.25	23.84	99.82	21.34	88.29	17.85	47.95	25.14	14.11	28.02	48.35	10.44	64.16	18.53	20.59	36.41
BRD-K51805276	CP	temefos	cholinesterase inhibitor			2.31, 1.15	28.01	0.72, 0.23	7.14	19.36	10.45	21.54	28.43	8.32	34.00	41.53	11.15	79.28	31.04	24.76	0.00	28.01	-36.93	15.86	32.03	17.82	33.78	36.05	82.11	50.31	11.03	-23.74	59.02	74.92	5.67	43.80	42.28
BRD-K67013324	CP	luzindole	melatonin receptor antagonist	MTNR1B, MTNR1A		3.46, 1.92	28.00	1.06, 0.34	6.48	14.88	4.08	7.82	18.92	46.31	42.12	89.36	70.43	34.40	6.16	10.60	-1.97	0.00	72.67	10.28	53.66	21.20	29.90	36.13	38.00	68.91	1.34	19.08	70.73	28.00	3.78	76.11	93.17
BRD-K42573370	CP	avrainvillamide-analog-2	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	2.15, 2.15	27.99	0.59, 0.16	55.95	39.30	68.92	19.98	26.16	51.82	10.21	-15.33	17.30	27.99	5.13	50.57	86.36	71.84	47.95	99.93	16.17	44.56	25.18	32.91	34.16	17.70	25.95	15.50	16.57	15.26	21.78	50.35	54.17
BRD-K70505054	CP	ranitidine	histamine receptor antagonist	HRH2, SLC22A2		0.77, 0.38	27.99	1.10, 0.44	8.47	50.90	5.25	8.91	-2.29	41.15	26.52	46.18	66.27	30.11	30.75	32.47	-3.95	10.60	-69.37	15.40	75.79	4.43	33.05	27.99	80.22	67.31	15.12	-99.19	49.97	36.72	-3.56	14.12	72.06
BRD-K63265447	CP	docetaxel	tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane	TUBB, BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB1	Tubulin inhibitor	5.78, 3.56	27.94	1.02, 0.39	2.85	56.21	15.01	7.71	94.79	-3.15	-7.60	26.31	25.92	10.82	3.09	65.18	55.78	49.43	99.86	74.79	90.87	72.32	-12.35	38.37	43.03	53.49	90.45	20.68	-50.43	19.03	48.77	12.66	27.94
BRD-K95309561	CP	dienestrol	estrogen receptor agonist	ESR1	Estrogen receptor agonist	1.54, 0.38	27.91	0.34, 0.25	42.51	33.41	46.97	11.22	27.91	29.71	23.40	37.40	8.43	9.61	15.29	52.29	5.39	20.15	45.00	64.57	74.93	7.36	52.91	29.43	21.50	22.21	15.15	0.18	49.75	11.30	18.94	45.19	47.33
BRD-K37846922	CP	3,3'-diindolylmethane	androgen receptor antagonist, aryl hydrocarbon receptor agonist, beta glucuronidase inhibitor, CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor	AHR, AR, CYP1A2, GUSB, IDO1		3.08, 0.77	27.88	1.33, 0.39	32.18	3.45	27.88	25.53	7.44	96.91	21.79	66.09	51.99	4.43	23.56	63.58	1.30	-11.11	32.66	-52.80	64.41	15.15	51.19	74.59	71.95	19.96	41.26	1.13	64.40	22.85	15.77	61.69	93.35
BRD-A94413429	CP	NTNCB	neuropeptide receptor antagonist	NPY5R		10.00, 6.15	27.87	1.69, 0.73	6.07	12.02	11.70	97.43	11.25	-19.77	-1.37	69.71	53.16	-0.78	-3.91	12.56	88.46	98.52	52.34	98.34	15.05	99.12	-48.95	53.90	27.42	29.64	41.26	-0.88	99.19	66.55	41.17	21.84	27.87
BRD-K40530731	CP	hyoscyamine	acetylcholine receptor inhibitor	CHRM1, CHRM2, CHRM3, CHRM4		4.62, 2.69	27.84	0.85, 0.27	84.69	15.84	9.43	25.93	50.71	16.39	45.82	42.96	27.84	72.24	32.24	41.33	-2.75	7.67	12.86	-24.81	42.33	25.24	32.74	91.47	17.55	58.49	-16.27	-99.86	35.29	26.62	8.71	73.01	96.51
BRD-K53561341	CP	KIN001-220	Aurora kinase inhibitor	AURKA	Aurora kinase inhibitor	3.85, 1.92	27.83	0.97, 0.33	22.14	18.21	2.85	82.86	42.77	27.83	88.18	70.65	5.36	12.90	24.54	36.41	86.05	90.85	-68.86	54.59	89.40	83.59	37.90	21.94	-13.13	9.04	5.32	-62.45	82.14	49.09	-23.88	17.86	77.66
BRD-K04923131	CP	GSK-3-inhibitor-IX	glycogen synthase kinase inhibitor, lipoxygenase inhibitor, PKC inhibitor	ALOX5, GSK3A, GSK3B	Glycogen synthase kinase inhibitor, PKC inhibitor	4.62, 1.54	27.79	1.55, 0.44	50.90	94.78	82.19	78.09	65.49	9.04	8.68	10.80	47.69	2.40	0.90	59.84	90.02	14.57	27.79	98.77	72.62	16.19	10.41	14.90	41.44	65.28	26.51	1.16	11.24	23.40	10.54	52.21	28.30
BRD-K60476892	CP	YC-1	activator of soluble guanylyl cyclase, guanylate cyclase activator, hypoxia inducible factor inhibitor	HIF1A, GUCY1A2, GUCY1A3, GUCY1B3		2.69, 1.92	27.79	0.66, 0.16	34.16	-16.16	29.20	87.36	34.48	21.55	0.92	33.00	55.31	11.57	39.78	65.12	5.24	25.78	-14.64	59.50	74.23	7.13	46.00	57.89	9.16	8.20	11.13	-6.24	-26.25	41.60	27.79	35.60	-23.97
BRD-K19360254	CP	ergocornine	dopamine receptor agonist	DRD2		6.15, 3.85	27.77	1.14, 0.24	75.60	-54.27	2.26	46.31	-22.24	27.12	46.44	94.83	6.96	12.75	13.88	-70.59	-2.78	-2.32	50.68	3.70	95.74	17.75	99.54	99.30	27.77	34.98	9.93	99.86	94.45	78.70	27.41	96.88	74.34
BRD-K02526760	CP	QS-11	ARFGAP inhibitor	ARFGAP1		2.69, 1.92	27.76	1.27, 0.35	32.89	14.40	32.75	80.49	11.55	30.31	30.46	61.73	17.94	25.09	45.82	19.88	86.47	5.11	-19.67	81.30	24.82	13.94	27.76	35.74	30.27	33.75	4.38	0.00	-4.55	59.71	67.21	10.51	17.31
BRD-K65814004	CP	diphenyleneiodonium	nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor	ALDH1A2, ALDH2, ALDH5A1, ALDH7A1, NOX3, XDH		3.46, 1.92	27.74	0.86, 0.14	38.62	92.52	26.27	56.09	68.33	3.07	30.39	-11.26	11.92	27.74	12.20	29.41	82.08	14.44	2.08	94.76	-19.59	71.62	48.63	42.56	23.56	8.20	9.41	6.80	7.29	78.45	53.46	42.91	15.11
BRD-A68281735	CP	REV-5901	leukotriene receptor antagonist, lipoxygenase inhibitor	ALOX5		5.77, 4.23	27.73	0.92, 0.35	44.52	7.90	39.82	52.87	28.76	9.86	27.73	83.39	28.03	23.11	8.39	87.75	11.96	19.63	12.10	5.14	25.84	11.80	11.88	56.73	40.24	85.88	12.65	0.00	98.20	26.90	71.96	97.74	55.74
BRD-K33453211	CP	levocabastine	histamine receptor antagonist	HRH1, NTSR2		5.00, 2.69	27.73	0.60, 0.17	86.29	27.73	8.33	25.93	28.73	92.07	31.08	63.25	11.57	80.57	41.49	34.10	-8.45	3.13	-75.53	3.37	17.64	-13.53	14.17	57.12	89.76	19.88	-2.92	-0.07	91.96	67.01	19.51	54.50	33.09
BRD-K41160163	CP	fenobam	glutamate receptor antagonist	GRM5		6.54, 3.85	27.72	0.82, 0.31	46.99	-51.64	56.03	1.55	89.98	76.37	-95.19	-32.15	-11.38	14.01	99.65	84.26	-12.57	7.07	81.43	27.72	86.43	2.26	-77.27	49.34	60.90	81.22	17.15	98.77	-5.33	20.86	40.62	78.81	-46.03
BRD-K33551950	CP	radicicol	HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor	ACLY, DLAT, HSP90AB1, HSP90B1, MAP3K7, OPRM1, PDK3	HSP inhibitor	5.00, 1.54	27.71	2.09, 0.76	25.24	82.56	18.32	79.36	23.67	1.59	-0.88	15.63	8.10	13.50	28.37	84.50	96.83	97.72	88.94	99.93	42.26	69.31	17.00	27.71	58.55	45.45	24.30	-0.78	89.96	22.65	59.83	0.00	10.64
BRD-A75552914	CP	isoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2		1.92, 0.77	27.70	1.00, 0.19	71.53	41.70	6.85	0.60	27.70	6.39	22.09	70.58	9.90	49.52	14.77	-16.50	0.00	-2.04	72.47	12.36	89.84	15.52	57.68	89.26	-43.20	24.37	21.62	28.27	51.30	44.77	77.83	84.51	45.59
BRD-K93331255	CP	lypressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2		3.46, 1.54	27.70	0.77, 0.24	39.46	59.57	60.42	80.16	34.10	12.69	16.09	27.70	39.02	18.24	42.04	72.81	-3.56	8.21	55.29	12.98	95.52	-22.86	6.59	8.50	28.49	46.75	5.64	0.00	-0.67	9.44	19.16	48.56	84.41
BRD-A80960055	CP	celastrol	anti-inflammatory agent, antioxidant, HSP90 Inhibitor, NFKB pathway inhibitor, topoisomerase inhibitor	IL1B, TNF	Topoisomerase inhibitor	2.69, 1.15	27.66	1.88, 0.49	2.75	94.09	92.16	15.26	95.17	35.83	-22.60	-90.97	-0.99	57.74	70.17	76.15	8.68	22.54	27.65	98.52	27.66	11.30	60.56	57.85	90.28	72.16	29.47	-0.81	-0.63	-1.34	36.58	1.87	26.44
BRD-K92991072	CP	PAC-1	caspase activator	CASP3		2.31, 0.77	27.66	1.80, 0.50	14.71	32.20	67.16	85.02	8.06	97.07	2.22	-22.31	13.45	67.59	4.58	67.00	90.70	88.20	46.35	91.06	27.66	84.94	19.34	36.95	13.33	5.44	29.18	72.38	-17.31	13.04	22.88	7.26	12.05
BRD-K92758126	CP	gibberellic-acid	NFkB pathway modulator	AADACL2		5.00, 1.54	27.65	0.84, 0.18	16.53	20.69	41.52	23.62	87.97	20.33	27.65	-87.25	8.59	57.77	99.04	75.77	1.20	1.20	69.74	2.98	2.24	3.74	85.37	68.44	56.16	93.88	13.51	75.34	10.62	62.99	77.31	95.69	-43.18
BRD-K96119599	CP	leucodin	melanin synthesis inhibitor			3.46, 1.54	27.59	0.83, 0.19	12.61	86.14	79.78	13.67	65.08	2.40	51.75	66.67	27.66	24.17	78.40	27.59	4.23	7.46	23.68	4.12	55.34	20.92	18.98	22.94	54.50	32.11	25.42	-99.47	6.38	29.96	43.70	53.35	84.28
BRD-K62363391	CP	dapsone	dihydrofolate reductase inhibitor, dihydropteroate synthase inhibitor, FOLP inhibitor	DHFR	Dihydrofolate reductase inhibitor	7.76, 4.49	27.58	1.40, 0.41	11.51	15.41	91.07	2.89	13.79	43.59	17.27	95.42	13.20	45.72	39.42	39.98	0.00	4.05	38.60	-75.64	62.17	2.68	11.30	99.10	97.89	-41.73	21.45	27.58	62.85	98.48	17.05	62.42	55.40
BRD-K64881305	CP	ispinesib	kinesin family member inhibitor, kinesin inhibitor, Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors	KIF11		8.08, 5.38	27.58	1.68, 0.51	38.92	13.38	49.48	95.63	4.55	10.49	36.10	79.34	20.76	45.90	6.84	6.88	94.02	98.06	18.84	99.93	93.12	99.61	59.00	11.62	7.51	0.00	21.69	-0.85	99.47	14.61	27.58	21.37	88.74
BRD-K79684402	CP	RO-10-5824	dopamine receptor partial agonist	DRD4		6.54, 3.08	27.58	1.47, 0.36	45.22	-54.02	78.36	27.58	18.88	16.36	1.97	-15.54	79.80	6.32	2.22	28.53	3.57	-0.63	99.82	41.64	99.61	36.93	-14.41	96.58	10.82	46.80	67.62	99.86	27.31	-9.67	22.70	38.68	32.98
BRD-K18316707	CP	O-1918	cannabinoid receptor antagonist			5.00, 2.31	27.57	0.81, 0.30	87.77	25.34	5.22	10.55	49.68	27.57	18.65	70.20	58.03	16.65	10.99	28.42	-6.35	25.69	25.61	9.83	52.42	6.52	85.67	93.54	37.94	58.19	53.57	-4.72	0.53	82.35	10.54	96.92	49.12
BRD-K68191783	CP	ALW-II-38-3	ephrin inhibitor	DDR1, EPHA2, EPHA4, EPHB2, EPHB4, EPHB6		2.31, 1.15	27.56	1.26, 0.52	11.00	43.84	23.71	65.77	23.11	76.27	31.78	63.66	20.35	79.35	3.27	27.56	0.00	23.93	69.95	-10.42	94.66	67.00	21.94	53.48	15.30	37.24	9.38	6.81	72.65	9.52	10.13	32.31	33.15
BRD-K18799075	CP	BAY-59-3074	cannabinoid receptor partial agonist	CNR1, CNR2	Cannabinoid receptor agonist	3.08, 1.54	27.52	0.63, 0.17	99.01	27.74	3.78	42.41	79.36	40.20	14.81	41.63	22.19	66.90	57.10	58.54	5.71	10.38	12.03	4.09	56.91	7.07	16.66	66.97	27.52	22.05	8.14	11.57	31.37	76.96	11.88	43.14	8.70
BRD-K29733039	CP	deforolimus	mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, serine/threonine kinase inhibitor, VEGFR antagonist	MTOR	MTOR inhibitor	3.08, 0.00	27.51	1.78, 0.55	15.45	10.47	19.25	65.07	-1.73	91.84	47.92	50.78	17.27	28.11	6.06	28.61	-1.94	18.94	88.14	1.13	70.18	76.89	10.93	57.90	43.01	6.45	0.53	16.07	49.87	27.51	22.17	70.80	50.78
BRD-K38003476	CP	clocortolone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Glucocorticoid receptor agonist	3.85, 0.77	27.50	1.40, 0.59	27.50	24.70	1.37	34.81	26.53	26.93	17.22	16.92	10.65	89.78	24.90	6.48	49.30	74.94	69.20	91.80	11.43	16.63	79.31	96.55	31.95	51.87	5.53	98.77	80.34	86.95	14.63	50.93	3.80
BRD-K82484965	CP	carmoxirole	dopamine receptor agonist	DRD2		4.62, 2.69	27.42	0.95, 0.26	35.55	-36.45	-12.74	18.26	17.24	57.13	20.24	81.78	6.20	25.08	56.16	27.42	4.78	-55.45	44.15	0.46	98.38	62.56	79.04	94.99	25.61	1.30	19.02	92.14	38.19	62.43	55.42	41.63	15.16
BRD-K26997899	CP	SA-792574	microtubule inhibitor, tubulin inhibitor	TUBB	Tubulin inhibitor	2.69, 0.77	27.36	0.97, 0.43	-5.36	39.07	25.85	16.44	24.93	17.78	10.56	27.72	6.20	17.14	31.85	9.51	65.26	31.71	38.57	96.20	27.36	16.41	-15.81	47.03	50.96	36.57	2.95	-49.69	-47.13	32.05	27.85	66.05	42.47
BRD-K03319035	CP	maprotiline	norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)	SLC6A2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7	Norepinephrine reuptake inhibitor, Tricyclic antidepressant	6.94, 4.08	27.33	1.05, 0.35	9.23	9.80	67.50	39.87	11.33	68.61	27.70	82.04	20.29	27.01	2.54	25.44	15.95	89.24	20.75	14.30	89.60	93.18	76.95	27.39	-8.30	27.33	20.57	-0.04	96.62	51.94	10.89	55.52	98.87
BRD-K55930204	CP	phenytoin	sodium channel blocker	ABCB1, CYP2B6, CYP2C19, CYP3A4, SCN1A, SCN2A, SCN5A		3.67, 3.27	27.26	1.84, 0.61	42.81	-28.20	8.46	14.58	4.59	73.47	15.54	98.06	4.60	17.08	4.39	52.93	0.00	9.18	61.36	9.61	88.60	3.89	43.81	41.38	-20.02	27.26	30.41	88.14	75.38	89.45	57.71	31.24	19.96
BRD-K02275692	CP	cefotiam	cell wall synthesis inhibitor			2.69, 1.54	27.24	1.11, 0.27	94.34	9.21	-1.27	12.35	27.24	68.24	40.16	93.87	3.91	17.96	14.13	65.72	0.00	4.83	31.74	2.12	16.37	13.94	-11.31	79.27	9.99	74.83	33.37	-7.42	93.44	83.90	64.05	93.01	94.95
BRD-K30743633	CP	TCPOBOP	constitutive androstane receptor (CAR) agonist	NR1I3		4.62, 1.92	27.24	1.01, 0.31	38.86	27.67	33.52	25.93	70.23	25.83	27.24	0.00	49.00	-1.83	11.64	77.83	-24.67	3.63	70.71	7.87	94.54	12.17	25.26	70.29	8.83	64.27	65.38	-4.33	-0.88	27.76	57.89	73.42	-24.79
BRD-K19605405	CP	ZM-241385	adenosine receptor antagonist	ADORA2A, ADORA2B, ADORA1, ADORA3		4.23, 1.54	27.23	0.63, 0.23	13.90	-3.25	7.43	8.60	9.96	59.72	49.33	89.66	6.31	90.42	51.38	75.89	2.33	22.24	11.44	78.61	95.65	57.65	27.23	21.04	44.05	67.64	8.45	-3.49	42.54	38.86	7.66	87.64	13.98
BRD-A27554692	CP	altrenogest	progestogen steroid hormone	PGR		3.08, 1.54	27.21	0.70, 0.16	65.96	-6.20	86.39	25.94	73.92	98.54	9.55	54.96	15.20	57.01	79.97	95.16	14.24	17.45	-31.70	11.79	-16.45	16.62	91.37	84.08	27.21	14.13	92.68	-0.88	-5.36	82.61	23.25	30.90	83.22
BRD-K21565985	CP	xylazine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C		0.77, 0.38	27.21	1.05, 0.38	10.90	86.31	6.58	59.13	35.14	39.61	71.98	48.39	6.45	6.77	27.21	74.55	2.01	31.14	83.33	10.86	57.70	9.32	10.96	12.55	35.89	-49.33	14.21	-55.95	-1.55	34.20	41.89	19.19	28.16
BRD-K74514084	CP	pazopanib	VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist	KDR, KIT, FLT1, FLT4, PDGFRB, PDGFRA, BRAF, CSF1R, CYP2B6, CYP2C8, CYP2E1, DDR2, FGF1, FGFR1, FGFR3, ITK, SH2B3	PDGFR/KIT inhibitor, VEGFR inhibitor	5.38, 2.69	27.20	0.81, 0.33	72.59	3.77	16.07	83.91	37.91	7.98	20.77	12.35	9.55	83.87	27.20	24.94	12.59	51.34	95.75	42.30	85.80	84.18	70.32	53.75	-6.99	13.38	16.26	88.72	26.46	26.25	12.68	45.67	28.21
BRD-K65331431	CP	retinyl	vitamin analog			3.85, 2.69	27.18	1.38, 0.39	8.57	20.38	24.79	20.85	24.84	26.72	38.10	76.10	6.77	90.75	27.18	20.22	9.84	3.89	66.72	0.84	50.45	11.10	26.95	77.80	31.29	39.65	77.78	41.08	12.74	51.43	50.41	74.35	76.05
BRD-K39120595	CP	bithionol	autotaxin inhibitor	ESR1, ESR2, MCL1		6.15, 3.46	27.10	1.89, 0.60	19.77	25.99	93.00	97.32	27.30	9.90	-7.58	79.59	10.67	23.91	38.52	84.12	99.44	89.78	8.99	99.72	61.56	93.76	13.06	64.34	23.06	27.10	19.39	1.03	15.57	13.45	10.08	40.15	54.74
BRD-K30990140	CP	FR-122047	cyclooxygenase inhibitor			2.69, 1.15	27.09	0.48, 0.23	2.60	8.25	78.46	19.85	56.14	4.72	67.00	40.73	10.64	27.16	72.44	27.09	4.53	2.43	20.46	6.82	76.45	68.53	-11.33	69.52	40.02	82.09	18.95	87.18	40.66	-3.52	19.78	53.04	-0.92
BRD-K41996876	CP	tyrphostin-1	epidermal growth factor receptor (EGFR) inhibitor	EGFR		5.38, 3.46	27.08	0.55, 0.13	86.83	25.85	99.22	14.76	13.99	50.44	52.08	45.75	23.63	88.56	21.24	25.88	-57.68	9.83	47.77	-15.46	59.67	11.96	50.11	93.69	49.70	25.04	14.60	-57.45	52.69	79.38	9.77	81.45	27.08
BRD-K48935217	CP	epothilone	inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B	Tubulin inhibitor	4.90, 2.86	27.06	1.24, 0.32	49.33	79.72	5.20	31.31	73.22	11.49	36.87	42.57	-7.68	83.54	53.05	64.53	-7.11	40.87	18.57	97.65	43.83	17.99	16.09	27.06	37.62	4.29	-49.36	-86.82	3.91	27.66	20.28	17.17	-19.95
BRD-A47513740	CP	calyculin	protein phosphatase inhibitor	PPP1CA, PPP1CC, PPP2CA		4.08, 0.82	27.02	2.60, 0.66	48.06	95.87	44.50	6.45	55.62	0.03	12.97	27.02	52.28	14.85	6.69	86.04	77.38	15.90	-49.17	84.77	35.02	18.25	31.11	22.14	77.52	30.26	25.55	-96.81	5.92	6.06	38.10	21.59	33.01
BRD-K85013741	CP	auraptene	lipoxygenase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, nitric oxide synthase expression inhibitor	MAOB		4.23, 1.92	27.02	1.27, 0.41	6.60	-74.87	2.32	27.02	-36.93	17.97	81.24	83.86	25.59	25.07	2.50	32.91	1.13	-8.66	86.72	-10.48	96.49	47.59	71.09	88.32	15.23	78.31	15.45	1.83	53.59	88.84	76.58	93.60	94.79
BRD-K57926513	CP	tyrphostin-AG-1295	FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor	FLT3, KDR, PDGFRA, PDGFRB		4.62, 2.69	27.00	1.66, 0.44	27.00	-19.82	1.76	-1.30	-1.52	35.42	61.39	93.73	71.66	6.59	4.44	-1.09	-34.30	-52.47	67.01	-98.31	94.67	-35.16	84.97	65.25	-5.78	32.60	40.72	54.98	19.93	69.34	61.75	24.24	84.84
BRD-A72483914	CP	spiroxatrine	serotonin receptor antagonist	HTR1A, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR2B		3.27, 2.45	26.97	1.03, 0.24	87.61	-2.30	83.78	27.53	23.52	41.08	37.40	11.83	11.37	21.08	59.99	53.98	-3.98	1.90	90.38	1.16	32.80	6.81	77.70	15.42	28.20	26.97	16.01	54.91	24.21	68.76	54.72	-10.67	10.32
BRD-K32977963	CP	eugenol	androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator	AR, MAOA		4.49, 2.86	26.95	0.91, 0.25	29.67	36.44	24.00	15.34	30.64	92.76	-2.50	28.08	51.18	98.18	10.04	64.29	2.96	-2.05	14.22	-1.47	76.86	24.63	22.00	30.62	33.65	39.66	14.45	-4.85	6.74	17.16	26.95	29.63	53.95
BRD-K76872913	CP	benzanthrone	aromatic hydrocarbon derivate with fluorescent and luminescent properties			3.05, 1.53	26.94	1.09, 0.34	41.59	5.56	6.38	10.73	17.96	24.11	60.05	-46.87	29.91	10.72	16.36	39.67	-38.32	-4.23	34.73	2.22	63.02	1.73	78.37	76.81	-10.83	50.79	33.00	NaN	32.88	97.28	4.81	45.76	29.77
BRD-K33396764	CP	alpha-linolenic-acid	omega-3 fatty acid	ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1		5.00, 2.31	26.88	1.28, 0.33	53.79	35.71	4.33	24.85	19.31	9.83	89.41	41.04	60.86	50.43	82.48	12.39	1.06	-0.88	-26.04	-2.07	40.68	0.78	77.86	9.42	64.42	79.64	-4.19	-12.25	84.18	26.88	2.65	32.48	76.11
BRD-K45542189	CP	diethylcarbamazine	lipoxygenase inhibitor	ALOX5, PTGS1		4.23, 2.69	26.82	0.70, 0.16	5.78	16.63	40.91	8.75	42.83	26.82	96.36	96.95	62.36	44.82	59.29	60.16	0.00	-15.72	-69.46	2.79	40.82	-6.68	56.62	11.19	22.28	22.86	11.29	-37.20	56.54	44.77	23.08	51.91	71.68
BRD-K65786282	CP	CGP-7930	GABA receptor modulator, GABA receptor positive allosteric modulator	GABBR1		2.31, 1.54	26.82	1.00, 0.22	17.71	-22.43	2.04	13.24	47.13	15.77	0.70	68.53	4.33	20.37	40.00	12.31	10.08	24.82	72.65	16.43	90.26	10.17	34.70	86.26	40.40	58.67	57.21	99.08	72.54	26.82	39.41	80.65	19.03
BRD-K67174588	CP	toremifene	selective estrogen receptor modulator (SERM), estrogen receptor antagonist	ESR1, CYP3A5	Estrogen receptor antagonist	1.29, 0.43	26.81	0.51, 0.34	39.61	14.14	11.68	9.36	31.18	2.96	20.46	46.14	11.89	22.30	54.74	54.60	1.02	17.44	76.79	98.34	24.71	19.81	32.01	38.32	43.23	26.81	16.13	16.05	45.53	26.76	46.76	46.72	33.36
BRD-K91601245	CP	mercaptopurine	immunosuppressant, protein synthesis inhibitor, purine antagonist	HPRT1, IMPDH1, IMPDH2, PPAT		7.76, 2.86	26.81	1.15, 0.31	25.15	18.34	14.78	73.19	15.62	92.01	24.28	96.90	25.01	18.41	82.05	89.64	5.09	9.09	57.60	42.12	87.90	40.69	28.90	26.81	-6.38	23.12	25.52	0.00	19.93	99.58	58.76	81.21	35.16
BRD-K99946902	CP	hexylresorcinol	polyphenol oxidase inhibitor	TYR		5.71, 2.04	26.80	1.05, 0.36	97.26	30.12	49.73	-2.82	24.10	84.18	7.18	-21.00	22.00	80.40	14.43	62.62	-8.19	34.03	26.80	21.57	52.66	47.50	97.96	63.93	50.84	23.07	32.48	-33.30	11.56	33.32	2.75	8.51	3.56
BRD-K49519144	CP	LY-2140023	glutamate receptor agonist	GRM3, GRM2		3.67, 2.45	26.78	0.95, 0.25	51.56	-4.12	19.71	9.60	40.94	58.50	45.57	83.66	17.20	43.31	13.88	29.09	1.73	1.59	24.28	-9.98	30.77	3.84	87.31	8.02	26.78	8.04	12.65	99.19	31.29	91.65	58.79	1.90	95.38
BRD-K06024458	CP	n-arachidonyl-GABA	arachidonyl amino acid that inhibits pain			4.23, 2.69	26.76	1.06, 0.38	19.01	-15.92	34.88	44.73	-56.78	3.63	15.85	72.59	26.76	2.47	10.78	53.88	-26.49	3.62	84.08	-28.08	30.20	10.80	21.51	49.01	22.59	62.67	45.66	91.03	12.12	52.37	53.29	35.38	44.81
BRD-K96740444	CP	itopride	dopamine receptor antagonist, acetylcholinesterase inhibitor	DRD2, ACHE, CHRM3		8.89, 4.89	26.76	0.83, 0.28	29.05	13.12	18.76	25.52	29.71	21.56	66.08	46.50	26.76	78.54	99.59	63.35	2.05	2.71	99.08	7.57	84.03	8.26	24.10	33.78	17.29	8.76	98.84	0.04	-32.01	73.12	83.08	91.60	9.65
BRD-K52721684	CP	PCO-400	potassium channel activator, potassium channel agonist	ABCC9, KCNJ8	Potassium channel activator	6.92, 3.85	26.75	1.10, 0.33	5.34	8.77	94.61	14.18	62.39	90.94	71.45	67.48	6.20	96.89	-1.23	25.45	2.82	62.01	57.92	5.14	99.11	19.65	54.73	26.75	84.19	50.24	15.91	0.00	23.87	88.27	18.42	97.92	24.00
BRD-K52313696	CP	tacedinaline	HDAC inhibitor, cell cycle inhibitor	HDAC1		3.43, 0.86	26.74	0.49, 0.28	20.16	55.09	23.63	15.02	40.58	19.73	10.77	49.34	4.70	13.38	29.10	49.39	30.89	17.91	77.14	97.64	51.63	12.02	21.11	26.74	56.70	34.99	22.31	-63.46	28.43	25.62	35.57	30.80	14.26
BRD-A93000692	CP	ciglitazone	PPAR receptor agonist, insulin sensitizer	PPARG, INS	PPAR receptor agonist	2.31, 1.92	26.68	0.66, 0.22	33.07	37.27	2.96	41.16	42.57	18.84	23.04	-13.04	3.31	86.48	10.01	26.68	7.87	10.84	93.34	3.26	68.81	47.77	20.44	55.11	19.73	89.57	23.29	51.02	38.63	2.82	10.12	84.17	34.22
BRD-K92428153	CP	mycophenolate-mofetil	dehydrogenase inhibitor, hydroxycarboxylic acid receptor agonist, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2, HCAR2	IMPDH inhibitor	3.08, 1.15	26.67	1.16, 0.33	13.07	94.94	42.50	72.43	33.22	33.09	-0.85	-53.24	10.56	57.30	24.82	40.69	35.57	64.75	55.78	77.19	-56.54	15.15	14.98	10.54	52.23	21.43	73.11	62.11	25.18	26.67	12.32	19.89	17.52
BRD-K32398298	CP	alprazolam	GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, CYP3A5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ		4.00, 3.11	26.66	1.10, 0.50	2.15	91.30	72.93	48.65	55.06	24.32	24.01	29.29	12.39	18.14	21.78	93.79	37.90	0.03	97.99	4.56	26.08	26.66	0.25	89.93	44.78	74.91	79.12	1.78	-50.33	32.79	69.41	15.01	24.42
BRD-K22947005	CP	dexbrompheniramine	histamine receptor antagonist	HRH1		6.22, 3.56	26.64	1.17, 0.30	22.25	66.80	26.64	49.57	86.81	32.41	20.21	-38.33	8.08	17.74	57.08	93.77	21.22	22.86	96.67	10.78	99.19	41.79	12.36	46.26	-68.77	24.64	84.69	0.81	20.64	99.44	49.38	23.82	29.43
BRD-K01902415	CP	pirinixic-acid	PPAR receptor agonist	PPARA	PPAR receptor agonist	4.23, 2.69	26.60	1.06, 0.30	45.57	11.43	54.84	9.16	16.29	3.14	1.80	62.07	58.58	33.75	19.67	18.92	-23.93	11.22	48.19	2.50	23.23	78.75	34.76	86.48	36.43	98.21	12.67	25.25	49.09	26.60	26.46	53.39	74.68
BRD-U86922168	CP	QL-XII-47	BMX inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, bruton's tyrosine kinase inhibitor, cytoplasmic tyrosine protein kinase BMX inhibitor	BMX, BTK		4.23, 2.31	26.45	2.59, 0.67	12.72	33.47	16.88	91.59	26.81	-6.75	-13.58	14.10	6.20	31.12	20.57	85.34	93.01	51.73	81.21	99.54	83.70	51.71	11.92	11.09	29.89	39.42	26.45	0.00	24.91	6.32	59.86	14.17	1.43
BRD-A37817666	CP	picrotoxin	GABA receptor antagonist	GABRA1, GLRA2, GLRA3, GABRR1, GLRA1, GLRB, HTR3A, HTR3B		0.77, 0.00	26.35	1.11, 0.36	36.51	82.77	5.24	4.65	35.57	21.33	55.29	85.55	48.90	5.71	53.54	66.78	-2.29	9.18	55.32	-30.69	22.94	4.86	49.40	80.77	16.70	20.89	18.32	-76.78	22.46	78.01	26.35	59.20	26.77
BRD-K97399794	CP	quercetin	aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor	PIK3CG, AKR1B1, ATP5A1, ATP5B, ATP5C1, CYP2C8, EGFR, GAA, HCK, HIBCH, MAOA, PIM1, PTPN1, SCN5A, SIRT1, STK17B, UGT3A1, XDH		2.69, 1.15	26.33	0.98, 0.30	13.56	57.17	18.91	78.19	27.35	16.01	26.33	-21.89	20.25	68.76	83.66	90.61	76.30	37.46	-15.81	98.34	52.08	6.91	22.26	20.32	4.02	27.86	8.38	-89.31	4.61	62.70	27.41	33.92	3.84
BRD-A82096673	CP	KU-C103428N	CDC inhibitor, rho GTPase inhibitor	NFE2		4.08, 2.86	26.31	0.64, 0.17	99.75	32.32	46.83	46.67	75.25	-7.08	16.56	14.31	4.33	2.36	3.03	24.68	75.03	37.34	47.36	11.02	64.33	35.43	39.57	12.37	-7.58	21.99	26.31	99.44	61.08	22.19	15.55	46.03	21.09
BRD-A06390036	CP	hydroquinidine	anti-arrhythmia agent			4.62, 2.31	26.27	0.61, 0.22	20.63	-14.07	12.98	-9.93	5.19	6.98	86.91	30.16	14.10	13.50	17.37	67.98	30.49	19.04	91.30	5.08	71.55	45.26	99.15	81.31	26.27	24.00	16.63	99.93	56.29	84.42	14.24	67.22	39.41
BRD-K47983010	CP	BX-795	IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor	PDPK1, CDK2, CHEK1, GSK3B, IKBKE, KDR, PDK1, TBK1	IKK inhibitor	6.92, 4.62	26.26	2.16, 0.44	26.26	95.82	10.29	99.93	37.95	78.18	3.59	-15.08	17.46	12.48	14.64	52.14	84.77	77.42	31.82	99.75	26.32	53.42	31.40	49.32	34.45	-7.27	17.43	-0.85	15.66	9.24	9.13	21.77	11.58
BRD-K64785675	CP	TG100-115	PI3K inhibitor	PIK3CG, PIK3CA, PIK3CB, PIK3CD		4.62, 3.46	26.24	1.30, 0.34	12.24	11.98	36.29	13.93	-27.23	65.06	76.86	97.77	69.11	20.38	42.73	51.90	-13.56	-11.29	-50.59	-2.57	61.72	-0.70	87.62	24.31	27.60	36.94	5.70	-4.34	26.24	12.14	55.92	68.41	76.60
BRD-K37130656	CP	rivaroxaban	coagulation factor inhibitor, coagulation inhibitor, serine protease inhibitor	F10, CYP2J2, CYP3A5		4.23, 1.92	26.22	0.91, 0.38	10.35	9.46	13.98	-22.81	26.22	0.02	50.91	87.51	24.10	85.73	59.41	-21.62	-69.48	-27.12	98.52	-97.40	81.89	-1.73	10.92	73.06	-15.52	55.95	42.98	76.55	49.39	5.85	56.92	68.49	68.85
BRD-A47144777	CP	dihydro-7-desacetyldeoxygedunin	HSP90 inhibitor	HSP90AA1		2.45, 1.22	26.20	1.03, 0.27	21.74	14.61	12.69	22.15	29.96	5.71	31.30	18.47	47.28	32.68	57.96	56.36	26.20	48.85	15.46	18.45	42.52	68.76	70.57	39.54	11.23	28.24	37.92	0.00	19.05	5.17	17.03	24.02	70.94
BRD-K99696746	CP	fatostatin	sterol regulatory element binding protein (SREBP) inhibitor	SREBF1, SREBF2		2.31, 1.15	26.19	0.88, 0.24	15.44	27.71	42.03	7.71	36.05	58.05	16.56	27.43	18.70	14.66	23.58	47.06	-33.41	21.21	62.99	-5.11	27.05	24.56	87.23	26.19	27.26	81.50	13.43	12.61	-6.53	41.26	34.37	14.57	30.83
BRD-K50324045	CP	avrainvillamide-analog-6	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	1.29, 0.43	26.15	0.51, 0.22	43.06	17.36	50.00	22.13	54.63	4.25	18.68	56.10	33.83	26.15	10.00	62.13	17.14	29.49	15.62	94.59	11.24	14.08	45.03	21.23	64.78	12.18	27.06	0.21	18.01	22.93	36.01	45.84	89.07
BRD-K52751261	CP	TAK-715	p38 MAPK inhibitor, tumor necrosis factor production inhibitor	MAPK14, TNF	P38 MAPK inhibitor	3.46, 0.77	26.15	0.60, 0.20	87.39	13.18	27.54	4.02	-12.68	26.15	42.88	-21.24	22.30	19.12	2.37	81.60	-8.64	0.00	73.35	21.34	75.61	0.95	54.48	66.00	16.82	27.22	41.23	87.23	-0.92	38.31	13.25	29.97	34.07
BRD-K64800655	CP	PHA-793887	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CCND1, CCNE1, CDK7, CDK9	CDK inhibitor	4.62, 2.69	26.13	1.55, 0.68	2.85	98.59	14.03	26.13	85.18	33.78	40.98	-38.94	16.58	49.44	57.42	84.86	6.05	12.15	80.55	96.15	3.11	51.81	13.45	4.93	58.53	31.26	27.33	-29.05	-0.85	2.85	27.46	23.24	15.01
BRD-K86727142	CP	embelin	HCV inhibitor, XIAP inhibitor	XIAP		4.23, 3.08	26.13	0.69, 0.23	-6.73	5.73	41.53	23.51	26.13	13.67	1.34	85.34	8.29	89.90	69.05	29.82	28.13	34.58	-33.62	13.20	20.75	6.10	10.71	46.73	15.79	46.51	35.65	0.00	99.86	66.04	7.15	78.65	34.11
BRD-K88560311	CP	rucaparib	PARP inhibitor	PARP1, PARP2	PARP inhibitor	1.15, 0.38	26.12	1.41, 0.26	93.73	21.91	13.50	9.23	26.12	7.97	28.86	64.14	7.58	25.12	60.83	47.24	-2.78	-36.77	11.52	-2.15	31.81	-29.81	32.99	72.44	38.09	21.84	43.74	94.96	39.05	70.20	17.70	35.78	17.01
BRD-K43797669	CP	genistein	tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor	CFTR, ESR2, EGFR, ESR1, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5		0.38, 0.38	26.11	0.38, 0.34	26.11	27.33	31.04	10.48	36.51	48.20	14.35	38.30	13.52	12.91	22.93	52.82	0.07	12.27	37.47	84.96	28.13	6.31	14.98	45.79	44.89	16.95	15.26	10.22	46.78	17.05	25.53	49.58	45.84
BRD-K25504083	CP	cytochalasin-d	actin polymerization inhibitor, actin stabilizer	ACTB		4.23, 2.31	26.08	1.82, 0.44	16.77	10.14	54.65	97.09	1.59	22.70	-22.25	49.54	5.01	65.87	16.87	10.90	88.98	92.58	54.64	99.89	10.09	89.53	27.40	60.02	20.95	0.00	0.81	60.84	68.93	18.06	28.29	8.67	26.08
BRD-A17819071	CP	gedunin	HSP inhibitor	HSP90AA1		2.59, 1.72	26.07	1.02, 0.28	10.84	-88.52	1.41	-14.94	-59.03	-18.59	54.28	89.55	6.17	65.57	77.14	78.83	32.33	8.57	47.34	10.61	64.51	26.07	14.67	56.31	0.00	6.65	2.57	64.46	41.93	44.37	20.36	84.87	29.19
BRD-K69840642	CP	ISOX	HDAC inhibitor	HDAC6	HDAC inhibitor	1.92, 0.00	26.07	1.81, 0.60	17.51	93.58	12.35	67.30	19.28	45.84	20.19	-23.53	25.24	46.80	12.67	80.31	79.22	87.28	79.27	23.04	-16.82	83.82	8.94	44.61	38.60	26.07	67.05	1.30	8.15	9.04	31.63	19.40	45.46
BRD-A70449690	CP	forskolin	adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant	ADCY2, ADCY5, GNAS		5.77, 3.46	26.05	1.24, 0.48	12.35	19.35	39.03	91.03	53.50	12.19	74.26	51.32	99.93	42.10	45.69	53.08	-38.60	-54.02	34.71	3.23	29.39	16.81	19.36	20.99	57.17	41.46	10.10	-85.61	23.09	26.05	22.63	40.60	4.26
BRD-K43149758	CP	myricetin	androgen receptor ligand, cytochrome P450 inhibitor	PIK3CG, AR, CYP3A4		3.67, 1.22	26.04	0.74, 0.16	85.14	25.13	66.51	-24.43	53.64	20.39	24.96	68.03	28.74	12.90	8.11	67.06	-3.03	8.26	78.32	-1.83	93.45	16.73	62.17	17.73	-15.83	26.04	41.07	93.13	14.91	35.54	39.40	80.57	22.39
BRD-A85860691	CP	chaetocin	histone lyinse methyltransferase inhibitor, histone lysine N methyltransferase inhibitor	EHMT2, SUV39H1		4.23, 1.15	26.01	0.70, 0.05	3.48	96.13	24.04	57.44	41.18	15.55	16.66	-19.91	18.20	3.74	7.17	68.41	77.82	87.64	15.04	26.01	45.62	52.67	18.08	44.70	28.58	56.16	12.61	56.98	-6.98	21.39	15.32	35.01	45.29
BRD-K34154330	CP	tracazolate	GABA receptor agonist, GABA receptor modulator	GABRA1		5.00, 1.92	26.01	0.61, 0.17	23.17	24.17	8.21	46.03	35.51	51.90	7.22	24.30	47.64	21.00	42.24	46.05	0.00	10.10	95.87	2.22	94.18	26.01	7.35	57.82	8.86	85.86	41.30	29.79	-0.88	6.43	45.53	30.09	20.70
BRD-K39569857	CP	avrainvillamide-analog-3	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	1.72, 0.00	25.99	0.43, 0.32	8.19	-6.48	35.46	5.92	8.55	2.01	5.29	29.78	11.51	37.50	17.15	4.20	5.39	72.29	38.86	96.27	53.39	34.17	25.99	42.61	26.56	52.99	11.13	0.21	45.73	1.44	21.41	43.38	69.98
BRD-K06750613	CP	GSK-1059615	PI3K inhibitor, mTOR inhibitor	PIK3CA, PIK3CG	MTOR inhibitor, PI3K inhibitor	8.57, 4.08	25.94	1.64, 0.68	4.54	72.38	18.91	99.75	15.43	14.72	11.56	68.36	78.01	13.65	65.32	40.14	87.04	93.59	88.39	99.82	76.74	91.76	11.34	48.22	26.71	2.29	25.94	-40.43	11.40	16.11	23.26	4.72	22.56
BRD-K09436313	CP	prostaglandin	prostanoid receptor antagonist	AKR1C3, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER4, PTGFR		3.85, 1.54	25.93	1.19, 0.49	8.13	-24.32	7.11	-40.07	0.70	24.25	16.02	95.15	36.41	3.90	21.08	56.30	4.78	25.87	75.36	0.56	72.14	84.63	23.03	43.67	55.14	43.64	30.50	33.16	63.79	7.22	25.93	31.86	92.07
BRD-K40887525	CP	ritanserin	serotonin receptor antagonist	HTR2A, HTR2C, HTR2B, ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR5A, HTR6, HTR7		1.54, 0.38	25.92	0.77, 0.20	26.64	10.29	29.29	2.15	23.03	-7.12	26.93	75.96	15.14	22.30	37.02	-27.62	3.02	4.92	92.02	2.71	83.03	29.96	54.34	27.19	25.92	35.02	10.93	-0.78	17.14	4.78	30.61	87.95	37.50
BRD-A97701745	CP	pindolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B		5.38, 2.69	25.89	1.35, 0.31	24.11	-10.90	9.23	7.89	41.78	9.73	90.73	96.41	25.89	14.48	92.01	79.44	2.82	1.80	54.25	2.82	18.06	7.96	96.51	90.46	23.20	39.32	-37.94	15.26	85.80	48.06	30.94	86.72	69.51
BRD-K53570330	CP	carbofuran	cholinesterase inhibitor			3.08, 0.77	25.89	0.91, 0.31	91.84	19.93	6.71	26.51	36.84	10.64	65.13	52.33	7.39	25.89	13.47	-9.47	-2.78	26.52	21.04	1.16	81.42	-3.66	44.11	62.31	13.85	94.11	22.95	-11.70	71.28	5.21	39.35	93.46	43.89
BRD-K32906660	CP	bis-tyrphostin	EGFR inhibitor, dynamin GTPase inhibitor	DNM1, EGFR		4.23, 1.54	25.81	0.93, 0.33	78.20	20.46	-1.44	25.69	39.10	9.90	69.97	52.21	10.46	91.40	82.49	49.96	-35.38	12.41	29.11	-15.92	21.85	25.59	82.66	31.08	20.44	54.96	3.56	-42.25	38.62	40.98	22.83	96.32	25.81
BRD-M40783228	CP	mesna	sulfhydryl compound that inactivates toxic metabolites of some chemotherapeutics			4.90, 3.67	25.81	0.85, 0.32	86.93	20.08	8.30	26.57	90.95	0.07	18.19	81.12	14.45	11.20	62.92	44.16	-18.94	4.05	95.78	0.00	94.12	52.36	30.40	2.29	9.31	8.14	79.53	-0.04	-20.31	79.87	25.81	29.39	63.40
BRD-K54095730	CP	CMPD-1	p38 MAPK inhibitor	GNRHR, MAPK14		4.90, 2.04	25.75	2.41, 0.70	59.91	64.21	9.64	76.44	24.96	41.65	2.71	18.16	7.27	56.04	6.99	66.96	93.66	90.63	29.92	99.30	63.53	58.30	9.98	32.04	5.08	16.87	13.03	-65.78	-12.84	25.75	12.19	11.19	35.42
BRD-K40213712	CP	SAL-1	adenosine receptor antagonist	ADORA2B, ADORA2A		5.71, 3.67	25.72	0.72, 0.13	58.06	40.00	6.63	40.25	28.27	62.94	23.56	18.20	6.49	8.29	78.94	24.42	4.85	1.97	61.83	2.71	82.07	47.26	56.39	14.81	12.57	5.88	25.72	99.60	8.57	68.05	28.95	40.25	16.56
BRD-K85503079	CP	perospirone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, DRD3, DRD4, HTR2C		5.78, 3.56	25.72	0.90, 0.18	5.32	-22.32	15.50	3.58	33.50	21.91	10.55	63.59	9.06	93.28	18.06	53.28	12.92	70.99	91.84	57.22	99.61	78.63	15.82	19.91	33.66	20.11	14.92	0.00	28.03	25.72	45.88	85.05	93.24
BRD-K41868777	CP	W-5	calmodulin antagonist			2.04, 1.22	25.71	1.07, 0.31	9.92	20.59	90.72	40.42	70.92	4.02	5.58	-22.46	5.46	9.84	4.25	73.13	3.84	25.71	91.48	13.30	52.66	6.41	22.64	36.32	69.91	34.24	9.00	88.63	71.60	47.47	70.32	80.14	2.04
BRD-K35128472	CP	2-aminopurine	serine/threonine protein kinase inhibitor			4.62, 1.92	25.68	1.43, 0.39	4.02	17.36	1.40	31.00	25.68	24.25	63.92	63.10	35.70	14.83	3.63	90.61	22.47	-37.61	14.33	74.58	81.42	31.65	8.53	60.35	82.50	59.55	5.29	0.00	7.33	86.23	75.13	72.05	17.96
BRD-A27143604	CP	DPN	estrogen receptor agonist	ESR2	Estrogen receptor agonist	3.46, 1.92	25.65	0.81, 0.28	85.32	52.07	40.44	25.54	80.90	9.97	-2.54	15.39	17.72	15.23	12.69	50.63	0.00	1.06	99.15	2.54	97.30	24.89	4.94	85.42	68.26	86.60	62.95	0.78	-10.47	25.65	86.53	54.68	34.57
BRD-K56001384	CP	antimycin-a	antibiotic, electron transfer inhibitor	CYCS	ATP synthase inhibitor	5.31, 1.63	25.65	1.50, 0.24	22.85	44.05	24.19	84.54	6.16	25.65	36.45	-73.59	-23.62	17.36	46.70	82.81	83.44	73.76	73.06	99.47	14.26	17.56	23.17	20.46	43.84	16.02	34.73	0.85	1.23	52.20	88.08	48.49	12.77
BRD-K72034655	CP	peucedanin	apoptosis inducer, antileukemic			3.05, 2.29	25.64	1.21, 0.50	70.50	26.27	98.21	35.99	47.90	98.36	27.12	25.00	39.53	-1.90	6.18	15.70	-6.87	-0.28	9.49	4.55	-19.90	0.11	18.14	79.02	59.43	46.45	32.58	NaN	8.60	15.51	8.25	78.25	68.81
BRD-A54029483	CP	IRL-2500	endothelin receptor antagonist	EDNRB		5.38, 3.08	25.63	1.14, 0.35	41.02	10.39	7.39	19.18	43.59	0.03	68.43	83.64	12.97	31.00	29.87	36.06	-6.44	8.14	20.74	-10.94	-52.15	4.87	25.63	74.75	-27.18	25.04	35.91	1.93	51.22	79.02	56.77	98.84	34.20
BRD-K61480498	CP	epoxycholesterol	LXR agonist	NR1H2, NR1H3		1.15, 0.77	25.61	1.11, 0.42	39.45	31.66	11.61	38.31	36.89	38.24	21.00	16.41	0.28	37.09	13.38	54.28	6.87	25.61	82.62	94.97	94.79	10.63	34.54	15.58	64.26	51.20	15.59	19.90	-16.17	2.15	38.71	16.66	22.23
BRD-K56596464	CP	QX-314	sodium channel blocker	MAPK14, TGFBR1		5.38, 2.31	25.58	1.15, 0.30	1.66	-43.22	5.02	13.87	12.47	4.62	54.19	88.64	3.47	43.23	91.50	11.12	-2.08	2.77	74.12	-90.93	94.53	12.46	18.35	94.31	25.58	66.45	6.34	26.79	44.89	77.15	34.11	49.30	66.17
BRD-K63533170	CP	AM-630	cannabinoid receptor antagonist, cannabinoid receptor inverse agonist	CNR2, CNR1		3.46, 2.31	25.57	1.25, 0.43	8.89	10.68	2.43	16.03	58.53	4.39	66.82	25.83	99.51	25.72	22.81	-24.94	6.96	5.86	50.89	11.84	80.70	25.57	-28.18	82.69	28.05	60.73	15.66	2.08	36.07	5.68	50.86	80.86	79.61
BRD-K56334280	CP	amonafide	topoisomerase inhibitor, DNA intercalating drug	TOP2A, TOP2B	Topoisomerase inhibitor	3.46, 1.92	25.56	1.61, 0.44	4.29	97.00	2.59	38.77	63.96	21.21	59.24	25.61	8.89	29.76	41.02	65.70	4.47	-50.78	26.60	62.91	7.05	62.45	0.00	27.51	44.89	11.69	60.89	0.85	-11.28	22.15	11.13	25.56	24.51
BRD-K70490179	CP	rimcazole	sigma receptor antagonist, dopamine reuptake inhibitor	SIGMAR1		10.00, 4.62	25.56	1.94, 0.53	-3.00	73.63	95.61	75.34	89.68	5.16	14.61	9.90	18.31	12.44	36.66	47.32	67.09	95.14	-88.60	18.03	29.01	95.51	34.78	20.18	98.84	25.56	2.57	-91.39	98.83	13.69	23.77	73.87	25.41
BRD-K14767410	CP	SC-560	cyclooxygenase inhibitor	PTGS1		4.62, 3.08	25.50	0.90, 0.25	2.26	5.65	35.15	25.44	29.31	0.03	52.57	51.01	42.51	11.41	88.26	26.02	8.06	2.04	-84.03	-2.50	81.28	15.35	57.46	30.11	38.99	25.50	-30.35	-98.14	44.28	92.83	11.07	91.09	17.96
BRD-K13390322	CP	AT-7519	CDK inhibitor, cell cycle inhibitor	CDK2, CDK5, CDK1, CDK4, CDK6, CDK9	CDK inhibitor	6.54, 3.85	25.49	2.49, 0.85	10.61	98.94	9.29	60.95	95.96	85.94	61.09	-57.86	2.34	97.57	87.61	96.57	3.28	0.00	18.04	94.68	23.63	21.07	25.49	86.91	91.98	72.69	13.39	-3.51	-1.27	-3.49	53.05	64.38	6.19
BRD-K14880289	CP	GW-501516	PPAR receptor agonist, insulin sensitizer	PPARD, INS, PPARA	PPAR receptor agonist	4.62, 0.77	25.45	0.93, 0.31	3.28	24.74	15.08	65.82	18.13	73.53	43.15	51.16	16.08	-0.70	7.24	70.30	4.54	8.76	92.07	96.58	87.73	3.59	-63.78	61.56	25.45	54.72	-20.21	-99.61	13.83	52.17	69.76	47.98	58.45
BRD-K89014967	CP	AS-703026	MEK inhibitor	MAP2K1, MAP2K2	MEK inhibitor	3.85, 0.77	25.41	1.41, 0.55	26.23	-30.98	10.21	77.41	15.44	51.72	13.12	74.16	9.69	20.42	8.83	25.41	-44.89	94.35	94.79	-97.67	90.76	34.60	98.09	16.12	21.57	8.09	46.00	96.13	86.10	77.53	24.30	8.98	76.88
BRD-A77050075	CP	heraclenol	furocoumarin compound with antiproliferative activity at G2/M phase			1.54, 0.38	25.40	1.02, 0.30	88.51	58.80	0.00	5.71	7.33	15.53	25.60	25.95	29.51	0.35	25.40	55.78	0.00	1.34	93.94	9.06	41.61	-6.51	23.43	20.48	60.25	36.34	26.46	11.59	1.62	63.06	56.96	42.08	17.27
BRD-K14643723	CP	4-(2-Amino-ethyl)-benzenesulfonamide	carbonic anhydrase inhibitor	CA2, CA1, CA9, CA12, CA14, CA4		5.38, 3.46	25.39	1.06, 0.16	40.21	-4.90	11.82	13.75	-7.79	98.13	65.71	88.20	25.71	29.84	30.77	26.03	0.00	-21.05	-2.29	-90.49	16.96	3.00	55.43	68.07	28.32	14.60	3.03	-99.65	15.16	97.97	25.39	49.14	74.25
BRD-K61314889	CP	IWR-1-ENDO	PARP inhibitor	TNKS, TNKS2	PARP inhibitor	2.69, 1.15	25.38	0.58, 0.15	51.81	22.33	57.42	25.16	53.35	80.58	23.80	62.23	5.99	4.88	62.14	75.70	-70.74	9.60	39.59	7.00	20.18	2.70	56.84	40.81	55.27	-8.50	70.83	97.54	9.97	81.25	25.38	24.66	7.67
BRD-K43880410	CP	pregnenolone	acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1	CYP17A1, PGR, SULT2B1		5.38, 4.23	25.30	1.89, 0.58	38.07	-8.04	56.27	0.00	23.83	62.79	25.22	82.70	16.02	84.10	57.25	41.51	-3.06	3.31	36.33	-65.97	56.55	7.68	17.31	64.29	12.69	43.35	11.44	26.11	23.43	55.75	10.03	25.30	98.91
BRD-A41304429	CP	practolol	adrenergic receptor antagonist	ADRB1		4.62, 1.54	25.27	0.95, 0.31	25.13	52.76	3.24	11.20	51.84	6.01	89.37	80.90	78.30	31.89	-6.99	25.27	7.53	2.77	59.98	2.87	64.35	2.64	41.93	83.29	8.98	13.26	7.44	1.04	58.81	95.03	28.18	61.99	13.35
BRD-A55393291	CP	testosterone	androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist	AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5	Androgen receptor modulator	5.77, 2.69	25.23	0.84, 0.31	4.95	-57.26	0.46	8.61	45.30	-31.93	16.07	94.88	22.58	25.23	85.86	25.14	-1.94	49.41	29.65	-3.00	77.49	19.56	41.19	59.33	83.24	47.26	15.58	-0.74	73.45	25.28	10.61	68.00	75.83
BRD-K54708045	CP	nTZDpa	PPAR receptor partial agonist	PPARG	PPAR receptor agonist	5.00, 3.08	25.23	0.97, 0.24	42.17	-11.76	25.23	22.39	20.05	15.41	33.92	44.91	0.66	12.91	13.88	39.22	5.92	19.36	88.62	6.96	74.58	4.93	43.39	64.58	6.98	53.51	80.67	0.88	94.58	84.79	88.73	67.04	6.63
BRD-K03109492	CP	NSC-663284	CDC inhibitor	CDC25A, CDC25B, CDC25C		5.00, 2.31	25.20	1.94, 0.48	2.62	96.34	90.71	88.93	87.18	5.55	-5.35	37.37	22.24	21.67	14.27	84.45	97.82	88.23	-96.01	99.93	40.43	48.34	17.55	12.41	25.20	44.40	20.18	-1.68	0.28	-1.94	35.53	58.08	20.55
BRD-K97564742	CP	mepyramine	histamine receptor antagonist	HRH1		2.69, 1.54	25.18	0.50, 0.14	3.92	10.50	71.58	3.97	46.11	12.98	78.53	51.14	30.03	25.91	69.08	12.95	2.96	-3.57	31.97	3.05	35.67	10.46	11.66	42.25	15.51	39.32	8.47	2.75	25.18	52.04	16.58	62.70	34.70
BRD-K53545112	CP	CNQX	glutamate receptor antagonist, unidentified pharmacological activity	GRIA1, GRIA2, GRIA3, GRIA4		8.57, 4.90	25.13	1.25, 0.32	25.13	9.23	8.46	3.45	23.63	91.85	32.94	35.71	24.99	92.38	99.85	76.24	-22.39	-4.22	65.25	1.71	42.19	17.19	94.04	37.18	12.54	3.14	46.56	98.24	98.20	72.39	24.50	-19.68	22.58
BRD-K99749624	CP	linifanib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist	CSF1R, KDR, PDGFRB, FLT1, FLT3, FLT4, CSF1, KIT, PDGFRA, RET, TEK		5.38, 3.46	25.13	1.02, 0.49	15.23	97.78	5.44	16.94	44.11	90.07	16.21	18.55	7.67	67.92	16.40	34.47	25.28	32.58	34.78	7.38	12.40	10.50	37.85	18.66	71.36	57.72	33.01	99.19	7.55	13.40	7.22	51.36	25.13
BRD-A10715913	CP	sulpiride	carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist	DRD2, CA7, DRD3, CA1, CA12		5.00, 3.08	25.12	2.13, 0.63	-18.35	97.89	99.51	25.18	92.02	91.06	-26.08	-34.02	20.60	34.90	-6.75	71.13	0.00	1.23	-35.87	69.26	71.07	3.14	-10.96	36.50	98.94	25.12	50.05	-4.08	0.92	-22.86	42.57	10.26	69.55
BRD-A47706533	CP	L-BSO	γ-glutamylcysteine synthetase inhibitor	GCLM		5.77, 2.69	25.07	0.60, 0.16	56.35	-35.75	11.72	20.61	-11.10	-0.02	38.36	71.20	35.01	7.85	96.26	18.70	-1.48	-5.29	39.54	-2.26	86.66	0.53	92.13	25.92	12.71	25.28	21.66	99.47	80.01	25.07	1.38	53.02	79.91
BRD-K61691971	CP	avrainvillamide-analog-1	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	1.72, 0.43	25.02	0.49, 0.40	45.96	45.98	38.16	3.49	40.89	15.87	11.27	25.02	29.08	49.66	10.60	48.63	5.75	12.54	45.17	97.22	35.50	50.07	21.32	15.96	68.21	4.53	13.71	-0.39	-0.88	12.21	20.51	44.21	68.35
BRD-K69556541	CP	ryanodine	calcium channel inhibitor	RYR1, RYR2, RYR3		2.69, 0.77	25.01	1.49, 0.45	89.81	-19.91	8.20	38.24	-9.66	6.56	95.37	70.78	67.45	3.28	4.52	26.50	-4.23	1.90	-36.28	4.46	93.35	17.42	27.41	93.18	18.51	52.06	10.55	-20.70	25.01	25.55	61.73	87.59	74.79
BRD-K33204703	CP	AG-370	PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor	PDGFRB		5.77, 2.69	24.99	1.31, 0.40	6.20	-67.00	74.09	9.12	20.09	3.05	8.41	97.00	16.42	31.35	24.99	91.82	1.16	-13.65	91.83	3.49	84.37	35.98	-41.12	89.03	59.63	96.65	32.07	-60.41	51.35	42.38	19.86	94.44	11.32
BRD-K80431395	CP	triciribine	AKT inhibitor	AKT1, AKT2, AKT3		3.85, 1.54	24.98	1.44, 0.15	3.35	-96.34	8.57	78.02	33.04	5.60	-9.48	89.54	6.23	42.25	42.11	18.93	90.58	3.28	92.04	99.44	75.58	83.15	24.98	90.97	20.74	-15.02	6.45	-13.30	51.55	33.78	21.53	18.60	63.91
BRD-A55594068	CP	vinblastine	microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor	TUBB, JUN, TUBA1A, TUBD1, TUBE1, TUBG1	Tubulin inhibitor	5.00, 3.08	24.97	1.43, 0.39	14.53	71.76	63.08	88.23	24.97	15.28	7.01	43.08	5.35	25.73	43.66	55.67	92.35	78.70	-2.17	99.58	87.28	67.73	14.62	15.70	21.65	10.44	7.85	-8.13	28.25	-8.65	9.03	23.57	56.32
BRD-K75478907	CP	GS-39783	GABA receptor modulator, GABA receptor positive allosteric modulator	GABBR1		1.92, 0.00	24.88	0.49, 0.17	34.13	8.21	22.26	55.35	16.12	19.04	73.51	48.62	16.12	19.66	51.49	52.96	7.84	16.84	-13.27	2.54	8.69	68.17	67.43	11.21	-54.16	57.63	24.88	-86.46	47.24	87.51	28.24	34.70	40.68
BRD-K88741031	CP	methyl-2,5-dihydroxycinnamate	EGFR inhibitor, tyrosine kinase inhibitor	EGFR		4.23, 1.92	24.88	1.06, 0.33	20.04	-16.57	4.55	18.78	12.79	8.61	50.68	35.07	-20.27	12.55	88.00	37.98	36.16	59.64	87.86	24.47	66.62	40.09	50.27	93.96	10.62	24.88	9.43	99.47	95.29	24.68	16.69	88.64	21.83
BRD-A10070317	CP	propranolol	adrenergic receptor antagonist	ADRB2, ADRB3, ADRB1, CYP2C19, HTR1A, HTR1B		4.62, 1.92	24.76	1.45, 0.47	11.26	41.50	14.68	3.45	75.92	12.60	56.14	24.76	15.64	93.27	10.62	29.07	0.00	60.81	32.76	4.23	29.49	19.65	6.71	27.28	96.56	44.74	18.09	-48.38	11.24	34.26	57.97	68.57	24.06
BRD-K56614220	CP	clofazimine	GK0582 inhibitor			3.56, 1.78	24.76	0.64, 0.17	4.33	24.75	65.82	23.67	8.31	4.85	31.19	71.33	12.91	33.17	24.76	69.57	69.59	55.47	93.61	18.35	98.12	40.44	13.22	15.84	34.18	23.16	5.39	-51.30	14.98	-7.23	25.15	49.34	94.79
BRD-K16554956	CP	PTB1	AMPK activator, tyrosine phosphatase inhibitor	PTPN1		3.08, 1.54	24.75	0.93, 0.32	57.82	28.74	87.82	8.58	35.97	77.73	10.30	65.11	6.92	12.45	24.75	38.18	-72.99	4.20	60.58	-98.31	69.46	10.87	21.14	84.28	24.52	80.91	19.11	12.31	15.95	59.28	60.51	47.72	3.03
BRD-K26801045	CP	pipamperone	dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A, HRH1, HTR1A, HTR1B, HTR1D	Dopamine receptor antagonist	3.08, 0.77	24.72	1.05, 0.34	-22.32	31.96	53.52	4.42	47.93	32.00	27.09	37.38	42.67	10.61	24.72	73.14	-26.20	-9.17	-69.36	3.49	47.54	18.48	23.95	34.85	69.90	31.25	10.16	-94.07	-43.46	44.53	10.77	21.84	97.43
BRD-K37312348	CP	kenpaullone	CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor	GSK3B, CDK1, CDK5, CCNB1, CDK2, LCK	CDK inhibitor, Glycogen synthase kinase inhibitor	3.46, 1.54	24.72	0.88, 0.39	19.64	87.63	13.56	37.99	46.78	32.40	1.97	-49.03	47.16	6.38	52.68	78.78	24.72	1.09	-37.92	32.24	29.84	6.28	16.58	47.71	89.22	70.42	-8.50	12.04	83.84	16.98	5.53	13.79	49.22
BRD-K33226500	CP	indinavir	HIV protease inhibitor	CYP3A5	HIV protease inhibitor	4.89, 2.22	24.71	1.13, 0.28	21.97	89.18	15.64	21.00	88.15	18.42	22.19	61.22	53.28	10.53	0.18	52.94	0.49	3.60	90.94	60.72	96.05	11.06	-23.59	-4.90	90.67	33.27	24.05	-99.08	27.88	24.71	76.99	29.97	78.84
BRD-K13211965	CP	L-741742	dopamine receptor antagonist	DRD4, DRD3, SCN1A, SCN3A		4.90, 2.04	24.69	1.61, 0.43	60.70	29.75	53.62	32.30	24.69	84.70	15.32	-33.30	16.39	38.15	18.15	47.55	2.78	37.51	-30.45	18.10	48.59	89.93	-22.94	43.67	79.11	57.80	-29.65	-99.47	14.62	10.63	3.70	13.47	98.19
BRD-K90885812	CP	propantheline	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4		10.20, 7.76	24.67	1.42, 0.36	52.29	73.58	-8.28	40.88	58.45	24.67	59.97	99.82	17.46	12.70	9.42	13.69	3.30	-13.75	99.61	-82.80	75.60	0.14	16.26	72.34	2.22	-4.63	18.38	79.62	57.69	98.52	8.71	54.78	38.27
BRD-A59174698	CP	ritodrine	adrenergic receptor agonist	ADRB2	Beta-adrenergic receptor agonist	5.77, 3.08	24.61	1.26, 0.45	4.73	15.78	92.66	30.17	89.04	31.28	0.74	-17.25	95.00	24.61	-3.68	68.47	0.00	8.98	22.58	13.19	38.46	18.68	19.85	31.56	83.10	31.77	20.60	33.16	54.94	8.28	13.15	83.59	33.77
BRD-K71823332	CP	epothilone-a	microtubule stabilizing agent			1.92, 1.54	24.59	1.02, 0.40	11.58	10.10	12.52	38.77	29.42	8.55	-3.63	34.41	0.35	67.24	81.68	60.53	0.00	15.12	20.80	1.16	75.22	10.10	37.23	26.17	30.93	2.89	72.45	81.82	10.20	27.17	49.44	24.59	0.85
BRD-K70577657	CP	H-9	cAMP dependent protein kinase inhibitor, PKA inhibitor	PRKACA	PKA inhibitor	4.23, 2.31	24.58	0.55, 0.11	18.14	30.20	76.89	13.98	30.74	12.69	21.09	-18.42	34.15	-4.72	34.99	33.59	2.78	-1.27	63.63	0.92	86.49	4.72	5.98	77.00	24.58	73.61	28.70	-0.85	18.57	40.13	19.68	69.54	53.77
BRD-A39522003	CP	OMDM-2	FAAH reuptake inhibitor	GPR119		5.00, 1.54	24.52	1.06, 0.41	38.44	2.51	-1.59	65.77	-24.75	10.01	59.75	49.60	22.28	61.69	35.57	32.79	15.84	40.91	58.94	4.05	24.52	24.50	39.31	25.99	9.13	6.76	10.26	21.11	94.47	27.81	14.74	91.87	23.90
BRD-K10065684	CP	dantron	stimulant laxative			2.31, 1.15	24.50	0.89, 0.15	7.05	22.91	43.37	40.99	24.50	55.82	34.94	-15.96	-5.57	11.75	-4.86	68.53	3.20	31.51	86.70	43.50	91.90	36.67	-0.11	64.63	4.65	39.56	-7.96	1.62	-3.25	17.65	20.70	65.35	32.38
BRD-K29113274	CP	ketoconazole	14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor	AR, CYP19A1, CYP21A2, CYP2C19, CYP3A5, CYP3A7, KCNA10	Sterol demethylase inhibitor	5.78, 3.11	24.50	0.83, 0.18	22.73	-67.94	4.91	52.66	44.64	-87.58	-9.98	49.80	-28.89	47.37	25.15	63.69	35.40	88.34	84.69	9.61	75.67	84.02	0.11	19.34	59.57	3.70	12.70	9.98	95.49	24.50	68.61	8.70	-5.89
BRD-K62353524	CP	DY-131	estrogen-related receptor agonist	ESR2, ESRRB, ESRRG		3.08, 1.54	24.47	0.70, 0.22	25.24	15.51	3.03	46.05	24.47	37.57	62.96	16.84	4.90	39.24	45.56	59.76	68.62	-1.16	70.03	46.79	20.56	10.40	19.24	19.14	70.87	1.59	-9.88	-83.27	-12.45	51.78	25.56	47.87	9.32
BRD-K05658747	CP	raltegravir	HIV integrase inhibitor			3.46, 1.15	24.45	0.99, 0.31	16.22	-27.53	28.75	15.82	27.23	8.32	16.05	63.30	-19.37	65.37	-37.29	85.36	-6.62	24.45	69.25	-90.91	71.22	1.04	19.62	45.84	35.92	39.31	69.50	96.33	25.23	9.37	56.59	18.02	14.87
BRD-K77390737	CP	xanthohumol	aromatase inhibitor, diacylglycerol O acyltransferase inhibitor, valosin containing protein inhibitor	CYP19A1, VCP		2.69, 0.77	24.44	1.35, 0.38	89.49	10.68	3.48	23.76	4.61	4.24	0.88	25.08	0.00	35.11	29.85	32.21	76.17	39.25	64.55	90.48	48.64	4.69	24.44	50.40	15.55	22.59	41.97	88.41	32.51	24.05	17.95	-3.35	12.81
BRD-A41555725	CP	chlortetracycline	protein synthesis inhibitor			0.82, 0.82	24.43	1.30, 0.49	39.42	-2.08	41.10	37.99	21.49	24.43	-3.22	49.24	16.09	44.84	-2.33	76.25	-5.88	5.11	88.87	-2.27	50.67	4.72	30.18	12.04	39.09	15.36	49.94	66.17	-20.02	19.76	67.43	38.19	13.62
BRD-A70731303	CP	avrainvillamide-analog-5	nucleophosmin inhibitor	NPM1	Nucleophosmin inhibitor	2.15, 0.43	24.42	0.40, 0.24	14.05	32.31	13.90	-1.80	38.44	11.67	12.72	42.77	15.62	21.22	34.50	22.24	32.07	84.20	18.01	99.51	40.99	12.50	31.20	42.69	76.19	35.05	20.27	0.00	18.85	2.08	24.42	24.91	56.01
BRD-K63784565	CP	BRD-K63784565	beta amyloid synthesis inhibitor, topoisomerase inhibitor	TOP1		5.73, 1.91	24.36	1.88, 0.51	10.88	8.57	17.20	7.21	72.59	9.30	76.71	71.43	53.96	9.80	16.84	75.09	-0.11	18.71	42.14	-5.01	45.34	29.48	24.36	48.17	96.11	65.81	14.95	-0.88	-12.43	55.62	42.37	9.37	93.48
BRD-K74236984	CP	UNC-0321	histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor	EHMT2		0.77, 0.00	24.36	0.76, 0.18	67.91	5.18	59.01	0.95	16.09	12.92	24.36	46.46	14.69	31.25	13.02	44.80	-86.04	15.17	85.40	-83.19	-11.80	6.43	25.68	51.62	28.15	51.11	45.44	1.87	9.87	85.73	18.05	65.93	48.16
BRD-K53123955	CP	niridazole	oogenesis inhibitor, spermatogenesis inhibitor			3.27, 0.82	24.33	0.78, 0.26	37.60	19.55	49.10	16.83	51.74	10.71	39.59	25.83	13.15	28.01	-9.96	17.91	1.75	-12.02	59.42	2.68	35.07	28.91	24.33	42.46	62.27	29.57	6.77	-34.56	11.96	15.25	10.76	28.20	45.07
BRD-K19554809	CP	MK-212	serotonin receptor agonist	HTR2A, HTR2B, HTR2C		4.49, 3.27	24.32	2.21, 0.98	74.84	37.76	70.02	10.07	2.50	99.93	24.32	71.16	24.37	11.88	3.03	37.99	1.41	2.83	34.77	2.73	98.02	18.18	51.05	31.65	7.54	6.49	29.15	-3.59	21.55	23.14	15.01	36.02	95.96
BRD-A72711497	CP	lasalocid	ionophore antibiotic			9.80, 5.71	24.28	2.03, 0.66	11.20	36.90	20.75	96.14	29.38	24.28	6.95	22.27	19.13	5.36	3.03	31.87	98.52	98.56	-13.64	99.96	38.51	97.53	13.53	31.82	53.49	11.11	3.59	-73.62	62.00	54.12	13.70	2.57	89.54
BRD-K13819402	CP	desoxypeganine	acetylcholinesterase inhibitor, monoamine oxidase inhibitor	ACHE, MAOA		4.62, 2.69	24.24	0.45, 0.10	24.24	-46.22	10.46	3.98	-12.12	4.43	48.37	75.78	26.21	7.26	3.03	19.99	-8.03	44.83	49.73	-46.47	60.73	3.42	97.21	34.23	12.28	25.68	67.28	99.47	65.97	62.47	2.68	19.87	28.04
BRD-K37080523	CP	isoreserpine	vesicular monoamine transporter inhibitor	SLC18A2, SLC18A1, SIAH1		3.85, 1.92	24.21	0.78, 0.17	16.78	92.56	4.68	70.83	49.37	15.91	13.50	43.80	71.65	60.10	21.26	-16.88	9.44	23.69	66.90	22.08	91.71	22.07	0.29	56.47	52.47	24.64	35.95	24.21	83.41	-7.42	10.54	22.11	90.51
BRD-A80775386	CP	hyperforin	cyclooxygenase inhibitor, dopamine reuptake inhibitor, interleukin receptor antagonist, lipoxygenase inhibitor, serotonin uptake inhibitor	NR1I2, ALOX5, PTGS1, TRPC6		4.23, 2.31	24.20	1.53, 0.48	41.43	-3.84	50.94	85.12	43.43	91.28	16.28	57.72	7.81	57.05	15.56	64.06	92.60	57.58	18.71	98.43	14.23	62.32	23.80	18.10	24.02	2.34	8.05	0.00	20.20	75.79	6.02	24.20	85.06
BRD-A83937277	CP	mephenytoin	cytochrome P450 substrate	SCN5A, CYP2C19		3.27, 0.82	24.20	1.45, 0.38	11.21	44.35	24.20	26.10	71.39	15.56	20.94	45.68	14.11	49.60	82.80	79.92	-2.33	14.45	95.66	3.22	85.19	8.79	20.01	90.86	20.64	69.76	7.39	-3.62	17.69	28.94	73.74	69.96	18.89
BRD-K45330754	CP	diethylstilbestrol	estrogen receptor agonist, chloride channel blocker	ESR1, ESR2, ESRRG, ESRRB	Estrogen receptor agonist	2.69, 0.77	24.12	0.41, 0.31	23.84	24.12	16.75	16.67	55.57	9.70	18.50	-26.30	26.74	10.13	14.79	75.67	2.96	11.21	46.66	96.12	42.06	10.47	45.73	48.97	40.57	81.43	15.53	38.10	47.28	9.00	63.59	49.72	13.79
BRD-K68558722	CP	deracoxib	cyclooxygenase inhibitor	PTGS2		6.54, 2.31	24.12	0.60, 0.18	75.70	11.89	13.29	38.53	58.79	10.36	24.12	51.08	7.28	78.84	14.52	63.28	15.70	15.58	88.72	9.05	98.20	21.45	17.15	66.13	82.01	64.84	7.99	8.71	56.09	10.45	49.64	49.91	14.61
BRD-A15297126	CP	fluocinonide	corticosteroid agonist, corticosteroid hormone receptor agonist	NR3C1, SERPINA6, SMO	Glucocorticoid receptor agonist	4.49, 1.63	24.02	1.74, 0.78	23.37	55.06	97.20	70.65	20.67	97.30	11.24	24.02	20.81	8.67	16.07	48.80	3.00	41.85	99.33	28.15	13.15	3.56	21.22	65.73	7.95	28.89	37.55	6.24	3.56	59.79	39.12	-2.29	56.89
BRD-A25143711	CP	hydrocortisone	corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist	ANXA1, NOS2, NR3C1, NR3C2	Glucocorticoid receptor agonist	2.69, 0.77	24.02	1.27, 0.64	13.93	-3.59	34.26	82.49	29.54	4.02	16.03	22.36	9.49	74.87	15.67	24.02	7.19	69.77	26.76	30.61	76.10	16.76	12.76	83.36	32.61	65.91	6.34	18.69	36.40	62.59	6.70	16.35	60.99
BRD-A24228527	CP	ofloxacin	antibiotic that inhibits DNA gyrase, topoisomerase inhibitor	TOP2A		10.61, 8.57	23.99	1.72, 0.47	1.62	-71.85	3.98	-11.08	-41.25	0.04	98.91	100.00	69.10	23.99	42.17	-82.59	0.00	-9.83	53.81	-94.95	77.37	1.23	41.61	4.83	94.27	0.00	35.29	-46.16	96.16	99.93	27.25	68.33	85.22
BRD-K39733634	CP	L-161982	prostanoid receptor antagonist, angiotensin receptor antagonist	PTGER4		5.00, 1.54	23.98	0.86, 0.34	-59.19	58.35	48.02	3.84	58.53	4.16	8.36	82.83	21.67	84.55	57.26	23.50	4.01	12.66	16.63	4.76	79.34	18.17	-8.93	23.98	97.08	72.05	43.45	-98.80	73.32	17.23	44.82	67.53	76.80
BRD-K10852020	CP	tolcapone	catechol O methyltransferase inhibitor, transthyretin amyloid inhibitor	COMT, TTR		4.90, 3.27	23.96	1.28, 0.36	23.26	3.91	3.13	10.67	0.00	76.82	82.36	88.03	2.18	20.08	17.29	52.80	1.97	5.03	63.00	0.00	55.66	0.00	90.11	44.77	59.02	93.14	23.96	89.27	84.51	91.22	11.92	64.32	-23.75
BRD-K55703048	CP	latrepirdine	glutamate receptor antagonist, histamine receptor antagonist, serotonin receptor antagonist	HTR6, GRIN2B, HRH1		4.74, 1.72	23.94	1.57, 0.36	58.01	-96.09	21.66	35.01	12.34	9.80	51.27	51.76	21.63	37.01	4.80	3.42	-2.42	10.58	90.99	-4.82	28.33	4.93	98.17	4.75	-8.28	11.87	42.48	99.47	62.89	23.94	75.33	59.19	51.60
BRD-A01317026	CP	7,8-dihydro-L-biopterin	dihydroneopterin aldolase inhibitor	NOS2, TPH1		3.85, 2.31	23.93	0.86, 0.26	34.35	23.93	15.72	8.70	13.95	14.48	28.87	42.81	-0.70	10.61	26.24	73.47	-2.58	0.00	91.57	6.68	77.85	9.93	20.35	76.95	11.15	1.44	71.34	99.47	0.42	40.48	43.61	29.91	39.27
BRD-A77299732	CP	salubrinal	eukaryotic translation initiation factor inhibitor, GlyT-1 inhibitor	EIF2S1, SLC6A9		4.08, 2.04	23.90	1.56, 0.45	85.95	-10.68	15.52	20.71	2.82	89.62	16.53	36.99	33.55	89.98	17.85	28.57	79.80	16.15	88.83	99.47	76.74	15.83	13.69	31.29	-19.96	19.96	-6.86	2.08	49.57	71.62	55.45	22.62	23.90
BRD-K06817181	CP	BRD-K06817181	JAK inhibitor	JAK2		2.55, 1.27	23.90	1.34, 0.46	34.92	9.17	23.78	1.33	23.90	0.04	15.57	83.37	63.76	52.51	91.30	42.12	72.58	6.04	9.93	2.04	17.54	32.14	10.03	46.47	10.06	35.54	29.60	-0.49	-31.59	98.45	13.68	39.01	30.89
BRD-K67844266	CP	MLN-4924	nedd activating enzyme inhibitor	NAE1, UBA3		1.54, 0.38	23.88	2.53, 0.74	7.86	91.45	28.80	18.42	43.36	-1.99	11.11	34.53	15.44	13.32	13.38	12.55	85.16	72.27	-58.39	81.83	7.15	45.23	71.65	23.88	60.32	26.98	41.04	1.87	7.97	11.45	26.90	26.38	13.81
BRD-K10177585	CP	PSB-11	adenosine receptor antagonist	ADORA3, ADORA1, ADORA2A		2.69, 1.54	23.84	1.27, 0.49	13.66	6.80	51.99	55.64	29.74	-3.57	12.98	67.43	15.20	59.92	89.95	18.09	0.00	10.65	-45.81	-0.53	22.04	30.47	51.93	36.58	23.84	55.95	21.56	-64.25	66.33	89.46	29.43	67.14	10.27
BRD-K76840893	CP	RS-17053	adrenergic receptor antagonist	ADRA1A, ADRA1D		10.00, 7.31	23.83	1.68, 0.52	8.35	16.82	42.97	98.66	46.06	13.76	-18.17	-54.66	20.82	9.56	-0.85	43.60	99.26	99.65	63.65	99.75	19.29	99.86	18.07	23.83	15.52	15.50	6.69	-5.19	99.89	41.72	36.45	69.34	54.31
BRD-K59650319	CP	YM-298198	glutamate receptor antagonist	GRM1		3.46, 1.92	23.82	0.99, 0.30	35.77	1.85	7.57	25.55	18.09	0.03	94.74	52.58	10.37	23.82	15.14	11.90	3.14	-0.63	78.12	3.97	86.04	-11.84	93.46	85.89	-4.23	9.90	15.39	90.64	62.30	65.67	38.91	71.11	47.12
BRD-A13807286	CP	HA-14-1	BCL inhibitor	BCL2	BCL inhibitor	3.08, 1.15	23.78	1.30, 0.26	97.02	45.41	13.67	52.67	18.47	29.14	23.78	53.86	18.00	9.61	17.85	54.93	9.99	22.57	12.02	5.03	57.85	8.99	42.07	82.88	3.31	58.86	46.96	52.43	14.00	11.13	53.89	31.10	2.62
BRD-K96527333	CP	dehydroisoandosterone	GABA receptor modulator			3.08, 0.38	23.78	0.83, 0.22	12.30	-32.59	55.81	6.03	25.65	45.67	23.78	87.85	10.31	6.99	91.57	12.54	-14.13	1.20	-27.19	-1.02	37.48	18.13	91.42	57.07	74.69	65.04	8.43	94.12	14.06	28.35	9.99	55.71	60.88
BRD-K11107424	CP	tiotidine	histamine receptor antagonist	HRH2		5.00, 2.31	23.77	0.97, 0.36	6.89	-7.85	23.77	5.53	12.06	-20.57	6.52	83.72	8.80	7.43	7.82	7.53	1.30	0.63	74.92	1.80	44.56	27.11	67.14	92.79	60.97	68.68	29.65	37.46	4.67	67.06	39.60	86.46	98.51
BRD-K80348542	CP	cephaeline	protein synthesis inhibitor	RPS2	Protein synthesis inhibitor	5.15, 2.15	23.76	3.33, 0.78	10.61	46.17	23.76	95.60	46.68	35.68	3.03	27.32	7.24	14.71	4.28	39.23	96.90	0.00	36.18	99.61	34.46	25.96	10.96	16.14	24.27	52.83	10.29	-0.42	1.27	16.28	0.92	24.17	15.52
BRD-K19525698	CP	ozagrel	thromboxane synthase inhibitor, platelet aggregation inhibitor, selective thromboxane synthetase inhibitor	TBXAS1		5.38, 3.08	23.75	1.06, 0.34	93.81	9.87	-2.15	1.27	4.55	23.75	90.17	88.18	-0.78	69.02	92.28	19.11	-0.07	3.23	65.08	3.52	42.65	15.95	96.91	62.40	8.25	51.77	10.16	93.32	67.12	89.45	12.74	94.63	13.50
BRD-K21350491	CP	phenamil	acid sensing ion channel blocker, Sodium Channel  Blockers, TRPP3 channel inhibitor, TRPV modulator	PKD2L1		3.67, 1.63	23.67	0.80, 0.23	54.80	34.82	20.05	18.31	27.78	93.22	12.61	15.30	6.35	37.53	15.35	44.39	39.79	-7.11	36.51	57.63	36.14	17.74	24.98	16.10	-19.14	21.32	12.00	-1.30	23.67	79.31	56.72	13.00	37.86
BRD-K28470988	CP	L-690330	inositol monophophatase inhibitor	IMPA1		2.69, 1.54	23.66	1.70, 0.78	14.66	10.47	69.69	24.39	-22.13	99.93	18.74	31.22	23.66	4.90	2.79	61.69	-13.11	29.10	31.47	2.22	57.22	5.70	8.80	63.72	12.71	51.32	7.21	0.00	9.19	43.99	44.15	34.13	76.96
BRD-A24543851	CP	nornicotine	acetylcholine receptor agonist			2.67, 2.22	23.62	0.83, 0.20	23.04	-2.81	9.19	49.50	34.62	85.85	1.34	-53.24	6.66	3.21	33.39	87.76	-11.21	-24.32	73.88	34.42	89.56	34.95	4.51	41.33	64.85	60.99	20.63	0.00	-3.53	-7.85	50.88	82.60	23.62
BRD-K66206289	CP	lobeline	acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand	SLC18A2, CHRNA10, CHRNA4, CHRNA9, CHRNB2, OPRM1		5.33, 2.22	23.58	0.76, 0.28	15.28	-3.97	8.46	8.76	21.07	15.36	88.86	83.66	12.52	25.17	92.04	88.63	0.00	3.82	97.15	-3.62	92.49	0.06	69.22	23.58	-70.86	11.76	57.13	1.20	42.06	88.09	44.67	58.75	28.57
BRD-A45543382	CP	metrizamide	iodine contrast agent			3.27, 2.04	23.53	0.84, 0.24	41.39	-11.16	7.51	7.95	23.53	49.18	-9.07	33.66	73.88	55.15	55.30	17.47	3.84	7.46	97.71	2.50	22.60	17.79	84.54	43.32	17.63	73.17	25.57	96.60	41.93	11.66	9.16	12.30	52.31
BRD-K92301463	CP	16,16-dimethylprostaglandin-e2	15-hydroxyprostaglandin dehydrogenase inhibitor, unidentified pharmacological activity	HPGD		3.08, 1.15	23.50	1.40, 0.40	97.19	36.58	19.04	12.23	18.70	99.55	22.07	48.71	59.83	7.77	5.20	45.63	30.51	35.28	14.08	43.57	36.93	14.93	21.13	28.09	18.72	13.12	15.66	1.99	9.87	36.19	71.25	23.50	69.30
BRD-K30677119	CP	PP-30	RAF inhibitor	RAF1		2.69, 0.77	23.49	1.25, 0.48	9.36	51.55	39.32	94.32	23.00	52.28	7.80	23.49	8.94	21.46	14.47	48.36	2.85	24.30	67.02	91.13	42.89	33.18	14.94	30.86	53.82	11.77	23.39	-1.76	13.87	26.35	16.13	21.55	71.11
BRD-K67445247	CP	flurofamide	bacterial urease inhibitor			3.08, 1.92	23.42	1.14, 0.33	18.27	17.60	3.16	25.12	36.41	0.03	21.67	54.80	30.84	20.96	-30.93	24.68	-2.82	0.85	81.27	-12.22	38.43	0.60	23.42	78.49	22.50	45.80	55.03	13.75	63.71	22.70	59.14	86.24	44.19
BRD-K18135438	CP	chenodeoxycholic-acid	11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist	HSD11B1, NR1H4		3.08, 1.15	23.41	1.22, 0.45	48.53	23.53	16.79	4.23	52.20	10.18	43.07	77.88	13.67	7.83	6.58	68.34	-30.86	0.63	-1.30	3.90	91.19	6.17	79.59	19.84	23.41	40.56	54.16	-21.12	34.10	-39.10	69.79	71.68	35.53
BRD-K67439147	CP	SIB-1893	glutamate receptor antagonist	GRM5, GRM4		2.31, 0.77	23.35	1.10, 0.41	14.21	59.61	22.24	32.29	87.18	2.57	5.25	-29.91	-17.43	79.83	12.28	37.25	14.05	23.35	21.09	70.65	32.95	15.61	17.43	74.29	79.93	88.91	42.88	0.81	12.69	-5.97	31.70	77.28	63.60
BRD-U73238814	CP	QL-XI-92	DDR1 inhibitor	DDR1		5.00, 2.31	23.28	1.31, 0.35	9.30	18.22	4.16	41.92	16.11	9.09	11.30	40.84	13.92	21.02	14.95	35.39	62.47	95.14	43.55	98.34	62.44	92.31	21.91	18.89	21.92	1.52	23.28	72.25	53.02	56.92	17.04	34.82	29.58
BRD-K82255054	CP	propofol	membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist	CYP2B6, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A, TRPV1		3.85, 1.92	23.27	0.66, 0.17	58.12	16.68	18.50	13.94	71.31	3.57	12.03	83.47	7.33	23.27	2.26	36.81	-0.21	1.27	84.75	0.60	70.40	16.39	25.86	86.64	17.92	43.52	21.44	97.36	41.90	-42.36	52.49	63.08	23.96
BRD-K10016611	CP	pyridine-2-aldoxime	acetylcholinesterase inhibitor	ACHE, BCHE		5.31, 4.08	23.26	1.45, 0.59	29.81	-74.36	0.00	10.87	73.86	22.68	35.40	93.09	0.78	65.55	23.26	68.63	5.80	-11.47	97.57	1.79	82.23	7.31	12.54	71.29	43.00	60.28	-29.55	0.00	-23.99	99.75	88.66	58.82	21.44
BRD-A83237092	CP	fulvestrant	estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor	ESR1, EPHX2, ESR2, GPER1	Estrogen receptor antagonist	2.15, 1.29	23.23	0.74, 0.31	69.40	62.49	16.49	13.67	50.57	62.37	18.27	23.40	5.55	23.23	8.45	46.57	17.55	14.18	54.88	99.44	69.23	0.78	10.44	17.78	28.26	5.05	12.72	-17.61	32.60	17.92	55.79	36.55	64.01
BRD-K48923948	CP	BMS-641988	androgen receptor antagonist	AR		4.62, 2.69	23.23	2.52, 0.60	17.09	-47.88	7.11	-1.30	8.22	8.77	23.23	87.30	63.20	27.51	12.84	65.89	-64.29	-3.49	99.51	-41.70	68.30	21.66	79.92	72.67	8.92	21.39	47.59	95.34	53.37	77.69	29.21	66.07	22.51
BRD-K32830106	CP	guanfacine	adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker	ADRA2A, ADRA2B, ADRA2C, CYP3A5, HCN1, HCN2, HCN3, HCN4		5.00, 3.08	23.22	0.63, 0.09	18.10	-20.13	11.60	3.21	80.00	10.01	60.16	81.31	20.30	24.39	5.18	19.65	1.09	13.92	23.00	-5.20	45.46	4.42	64.04	83.79	80.22	32.31	10.92	95.88	40.60	23.22	46.21	96.79	40.97
BRD-U51951544	CP	ZG-10	JNK inhibitor	MAPK8		3.85, 2.69	23.17	1.19, 0.61	0.81	98.84	20.69	1.97	60.52	32.15	22.05	-54.00	7.55	23.17	30.54	75.38	2.57	0.00	42.16	59.09	30.96	23.74	-39.39	32.06	42.05	25.11	15.25	-3.17	-0.95	7.22	25.74	32.19	22.23
BRD-K34508425	CP	KUC103898N	G protein coupled receptor			1.54, 0.77	23.16	1.42, 0.42	23.16	10.70	1.92	8.62	26.76	12.79	22.14	76.44	8.63	65.27	28.92	48.58	2.92	59.79	47.38	5.10	88.61	9.75	40.25	43.50	4.90	16.96	11.25	-4.02	37.43	49.24	12.95	49.57	28.34
BRD-K69032158	CP	diprotin-a	dipeptidyl peptidase inhibitor	DPP4		3.05, 0.76	23.14	1.52, 0.38	18.19	-8.10	14.04	35.26	27.69	22.46	23.82	72.66	-0.11	10.38	99.12	55.01	-0.11	-10.35	25.54	62.68	96.30	-13.54	-19.25	65.17	83.62	75.82	18.10	NaN	-28.69	7.13	83.47	70.09	12.86
BRD-K27351809	CP	nomegestrol	progesterone receptor agonist	PGR	Progesterone receptor agonist	2.31, 0.77	23.09	1.19, 0.25	10.14	0.00	14.94	-4.30	33.98	12.53	89.08	67.58	31.76	23.03	18.35	11.37	9.01	5.11	18.50	2.01	97.16	18.30	35.37	73.77	29.77	22.14	87.37	23.09	44.02	93.03	59.75	82.25	33.62
BRD-A23683907	CP	NAS-181	serotonin receptor antagonist	HTR1B		3.08, 1.54	23.07	0.82, 0.19	6.87	27.98	75.78	26.93	85.59	5.56	19.83	12.64	13.75	13.43	11.33	36.48	7.57	0.70	68.08	3.14	15.17	21.10	-14.29	70.86	59.46	53.42	33.86	32.33	16.15	75.99	23.07	32.82	37.47
BRD-A62182663	CP	YK-4279	apoptosis stimulant, binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor, EWS-FLI1 inhibitor	DHX9, EWSR1, FLI1		0.77, 0.38	23.07	1.40, 0.68	4.72	-15.64	10.94	8.48	15.21	41.33	68.47	38.85	0.21	10.89	18.38	11.90	46.38	23.07	21.45	49.80	30.32	8.71	69.56	80.77	15.82	22.80	13.71	69.33	74.94	57.47	71.72	34.27	34.56
BRD-K93258693	CP	GW-9662	PPAR receptor antagonist	PPARG, NCOA2, RXRA		3.46, 2.31	23.07	1.00, 0.25	3.67	10.58	57.61	9.16	-8.08	10.82	60.22	80.34	34.08	8.28	25.90	49.17	-2.78	1.97	50.22	-0.85	87.79	0.74	12.31	53.86	44.98	23.07	12.94	0.88	50.64	95.71	22.19	49.54	81.14
BRD-K38449220	CP	seneciphylline	cytochrome P450 inhibitor			3.85, 1.92	23.06	0.83, 0.28	71.41	-22.20	52.04	1.44	53.91	9.71	18.05	59.55	-3.92	35.56	85.14	60.23	-22.59	2.91	-1.77	-6.73	89.92	3.83	23.06	73.34	26.26	29.25	-4.21	-1.68	55.13	13.28	11.30	97.31	88.77
BRD-A68039575	CP	liquiritigenin	aromatase inhibitor	CYP19A1		4.08, 2.45	23.04	1.30, 0.45	52.02	43.47	18.02	24.07	18.89	99.72	3.49	36.82	13.29	63.16	8.02	83.96	-3.28	24.84	72.83	23.04	81.95	8.58	4.30	41.31	9.30	14.80	18.45	5.30	-2.01	44.25	51.03	34.54	18.62
BRD-K17823458	CP	danoprevir	HCV inhibitor, serine protease inhibitor			3.08, 0.77	23.04	0.92, 0.30	9.76	-95.65	54.84	-11.49	74.14	-0.03	75.84	68.29	5.92	47.79	4.70	-48.94	-7.09	-8.56	84.05	-88.85	87.94	0.46	83.67	22.88	48.01	84.47	9.49	99.51	39.90	12.19	62.40	23.04	41.22
BRD-A04668240	CP	CGP-52432	GABA receptor antagonist	GABBR1, GABBR2	GABA receptor antagonist	6.92, 3.85	23.03	1.38, 0.45	81.47	-58.41	11.82	15.37	-3.02	14.43	99.86	93.15	55.68	3.98	14.42	-8.85	2.09	0.60	66.72	-2.54	85.88	-1.27	95.57	98.41	12.76	47.30	76.56	34.13	74.38	60.66	23.03	99.33	0.81
BRD-K09638361	CP	SA-63133	casein kinase inhibitor, tubulin inhibitor	CSNK1E, CSNK1A1, CSNK1D, CSNK1G2	Tubulin inhibitor	3.46, 0.77	23.03	1.23, 0.53	23.03	12.36	35.76	68.11	38.61	52.08	-14.10	29.71	-8.39	2.40	20.01	9.27	87.93	5.99	38.98	97.09	83.12	18.89	-14.66	80.37	8.28	68.62	3.28	-39.87	-86.05	2.80	39.45	36.57	32.98
BRD-A79314293	CP	cephalosporanic-acid	core structure for synthesis of cephalosporin antibiotics			6.37, 3.18	22.99	1.76, 0.66	15.65	10.95	8.90	4.90	22.99	91.00	39.71	-6.30	94.29	21.28	55.20	85.02	-23.18	-16.75	59.87	-1.27	7.26	42.66	66.98	91.99	79.60	3.28	28.45	1.30	2.11	99.58	15.10	28.07	24.41
BRD-K92726801	CP	hydrastinine	alkaloid with hemostatic properties			6.15, 2.31	22.99	1.15, 0.42	58.82	26.92	1.48	4.97	-16.15	6.98	95.97	81.02	76.92	22.99	67.32	8.42	-7.96	4.81	-33.06	2.68	19.18	-14.07	66.89	74.72	65.09	91.05	-40.57	-0.85	51.24	51.17	10.79	99.37	28.49
BRD-K81709173	CP	halcinonide	glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	5.00, 2.69	22.98	1.38, 0.75	28.00	10.81	7.53	84.07	32.68	38.61	9.69	47.26	36.55	24.37	-1.13	18.73	10.21	17.59	-73.98	10.25	55.50	14.22	5.43	98.34	22.98	89.05	6.97	-4.22	59.15	35.53	13.69	94.33	84.57
BRD-K01555864	CP	dibenzoylmethane	tumorigenesis inhibitor			3.27, 1.63	22.91	0.65, 0.11	80.86	-4.74	34.44	-6.48	8.02	71.96	15.26	54.55	8.10	57.19	7.74	31.09	2.36	10.67	-66.66	14.04	53.76	-1.90	23.28	24.31	23.97	22.91	11.53	68.61	13.93	-17.18	25.55	53.01	37.69
BRD-A79803969	CP	memantine	glutamate receptor antagonist, glutamate release inhibitor	GRIN1, CHRFAM7A, CYP2E1, DRD2, GRIN2A, GRIN2B, GRIN3A, HTR3A		5.71, 2.86	22.80	1.36, 0.72	16.78	-28.11	7.68	22.80	-24.80	-0.04	24.87	96.84	0.00	23.56	7.43	5.92	0.00	74.94	24.40	3.22	-5.53	67.24	63.40	8.80	9.47	36.27	39.76	99.82	56.84	38.92	24.98	0.00	71.21
BRD-K26373640	CP	IKK-2-inhibitor	IKK inhibitor, syk inhibitor	IKBKB		3.46, 2.69	22.76	0.81, 0.20	15.77	-39.34	1.48	2.77	-2.19	-8.38	31.97	37.27	7.24	82.29	66.11	60.14	-8.21	-0.92	63.07	-59.49	8.38	22.76	86.15	47.04	-63.62	51.88	10.23	0.00	76.49	35.94	49.86	31.51	90.64
BRD-K81376179	CP	TCS-359	FLT3 inhibitor	FLT3		4.49, 3.27	22.76	1.22, 0.43	72.66	31.25	43.05	13.46	48.84	99.93	27.73	44.30	13.34	55.49	11.24	85.71	-76.62	22.76	-13.85	9.64	82.80	16.15	18.17	68.00	11.68	20.06	9.11	-6.05	1.62	21.78	41.96	62.90	87.79
BRD-K29673530	CP	hypericin	PKC inhibitor, tyrosine kinase inhibitor, unidentified pharmacological activity			3.46, 1.54	22.74	0.75, 0.20	98.64	30.96	8.22	27.95	15.92	89.10	24.30	65.88	6.20	14.79	55.83	72.99	-1.87	8.17	28.84	-4.05	59.01	14.97	6.51	22.74	38.54	-32.75	-5.79	-99.30	2.85	72.98	2.75	52.14	91.64
BRD-K41260949	CP	valproic-acid	HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker	ABAT, HDAC1, SCN1A, SCN3A, ACADSB, ALDH5A1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1B, SCN2A, SCN2B, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A		5.38, 3.46	22.69	0.66, 0.19	83.40	-44.57	10.54	1.94	4.12	39.09	43.89	88.60	52.67	0.39	22.69	21.02	-80.02	-1.73	30.73	-7.15	25.40	5.07	67.54	64.65	-7.10	29.95	20.17	98.73	20.39	91.77	29.51	21.58	71.96
BRD-K80970344	CP	pyrrolidine-dithiocarbamate	NFkB pathway inhibitor	HSD11B1, RELA	NFkB pathway inhibitor	3.08, 1.15	22.66	1.64, 0.73	81.74	79.14	13.89	17.94	31.33	-25.93	25.64	22.66	12.88	3.40	37.03	69.45	89.92	92.18	-2.78	97.52	22.23	62.18	15.84	73.38	0.00	67.84	58.29	0.78	10.61	14.10	8.70	21.44	40.24
BRD-K86003836	CP	flubendazole	acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor	TUBB	Tubulin inhibitor	3.56, 0.89	22.62	0.89, 0.45	0.78	-3.63	3.51	57.21	4.56	5.18	4.68	77.97	-53.88	87.88	45.35	27.55	73.18	87.41	7.15	85.89	22.62	26.78	24.27	10.96	27.80	4.49	50.46	0.04	26.98	43.92	22.48	7.47	0.56
BRD-K75295174	CP	alisertib	Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKA	Aurora kinase inhibitor	3.00, 2.15	22.54	0.98, 0.51	13.33	30.56	20.06	66.27	28.77	8.85	7.96	22.54	0.63	22.69	18.10	66.09	55.85	24.11	9.69	99.96	-15.30	30.24	15.14	48.92	31.70	34.75	-3.56	19.58	6.84	25.15	56.04	15.74	-1.34
BRD-K94689771	CP	pinocembrin	androgen receptor ligand, CYP1B1 inhibitor, reducing agent, steroid 5alpha-reductase inhibitor	AR, CYP1B1, SRD5A1, SRD5A2		6.54, 4.23	22.54	0.90, 0.34	35.35	8.66	9.18	14.22	20.12	47.40	-17.03	-36.95	62.57	10.50	14.79	24.11	-44.83	4.81	46.20	2.04	48.13	34.81	18.14	99.26	55.11	98.10	13.31	97.32	36.21	8.26	62.96	94.37	22.54
BRD-K18905250	CP	ST-91	adrenergic receptor agonist			3.46, 2.31	22.42	1.31, 0.35	52.12	-79.11	-55.39	20.27	-46.96	7.51	74.51	96.55	13.86	13.50	35.82	7.32	-1.83	0.70	94.03	-9.05	92.32	10.60	60.33	73.89	22.42	81.43	7.03	4.37	66.13	67.91	63.60	59.22	93.23
BRD-K01192156	CP	tyrphostin-AG-112	protein tyrosine kinase inhibitor	EGFR		2.31, 0.38	22.38	1.78, 0.49	83.10	8.17	14.39	-15.04	19.90	29.79	12.94	37.26	2.33	7.86	29.31	40.10	-79.85	11.72	63.08	-24.22	92.56	10.09	11.10	75.40	13.36	26.96	10.51	27.10	22.38	87.63	42.61	77.05	27.50
BRD-K66766661	CP	17-beta-estradiol	estrogen receptor agonist	ESR1	Estrogen receptor agonist	6.42, 4.59	22.35	1.56, 0.55	74.17	2.50	0.03	0.00	21.42	17.73	0.32	94.54	18.49	7.31	0.00	3.84	0.00	-0.25	82.70	0.14	96.21	29.86	56.16	65.27	21.14	22.35	67.30	99.15	23.25	99.79	83.53	36.01	63.63
BRD-K00317371	CP	RITA	MDM inhibitor, thioredoxin reductase inhibitor	MDM2, TXNRD1, TXNRD2	MDM inhibitor	1.54, 0.00	22.19	0.65, 0.14	90.36	77.42	16.08	5.23	-15.42	69.35	63.59	86.61	24.58	4.81	27.96	63.60	-22.67	30.88	27.64	-11.03	12.78	10.70	78.53	20.46	-76.06	5.40	0.60	-0.28	22.19	70.71	14.87	42.65	87.68
BRD-K82109576	CP	vincristine	tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB, TUBA4A	Tubulin inhibitor	1.33, 0.44	22.06	1.57, 0.50	10.96	29.34	22.06	8.63	54.02	72.84	18.09	93.23	10.69	63.23	21.67	10.20	70.57	80.48	-63.38	77.81	64.96	4.67	13.21	24.35	88.83	12.84	10.10	-0.74	-0.18	64.02	25.56	11.42	90.56
BRD-K28667196	CP	fillalbin	increases arterial blood pressure			2.69, 1.15	22.04	0.75, 0.22	2.84	27.05	5.52	23.67	19.87	3.83	95.20	63.91	22.04	37.43	60.78	12.54	-2.96	3.10	-27.07	-8.52	26.10	9.34	59.25	63.89	20.12	35.04	22.59	-1.90	15.19	79.60	5.73	49.50	57.02
BRD-K43236057	CP	piceid	glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor	GAA, XDH		6.67, 4.00	22.04	0.99, 0.28	7.10	22.04	12.70	31.49	21.74	9.64	13.89	47.72	23.49	66.01	97.18	82.34	-6.50	-0.39	44.13	-2.61	91.85	5.85	10.72	29.46	78.83	21.42	67.63	-0.85	0.18	40.42	22.45	55.18	14.06
BRD-K20714604	CP	RS-56812	serotonin receptor antagonist, serotonin receptor partial agonist	HTR3A		3.46, 2.31	21.99	0.95, 0.38	23.50	51.19	89.67	19.24	13.95	83.23	75.83	-57.40	22.14	8.37	43.56	60.59	0.00	10.37	94.31	-2.01	20.86	0.60	13.53	8.64	52.09	21.99	15.44	-5.82	20.46	88.97	71.42	89.10	37.35
BRD-A77118605	CP	BML-ST330	phospholipase inhibitor, DNA inhibitor, RNA synthesis inhibitor			3.85, 2.69	21.98	0.82, 0.33	2.47	38.38	65.12	1.41	56.31	26.09	13.17	-33.18	-15.72	21.98	8.14	46.68	1.87	-0.60	77.57	13.31	87.69	4.23	12.81	75.12	42.50	94.74	33.26	99.15	8.33	15.62	39.31	16.76	73.12
BRD-A83855350	CP	naltrexone	opioid receptor antagonist, opioid receptor ligand	OPRK1, OPRM1, OPRD1, SIGMAR1		5.31, 3.67	21.98	1.51, 0.63	21.98	23.96	5.24	9.73	-12.91	99.89	-4.37	70.53	25.49	11.91	6.84	82.76	-14.71	1.87	33.88	7.35	67.32	20.15	36.17	70.06	65.78	27.63	44.69	0.85	7.38	13.85	27.80	7.78	96.90
BRD-K08589866	CP	linsitinib	insulin growth factor receptor inhibitor, insulin receptor antagonist	IGF1R, INSR, INSRR	IGF-1 inhibitor	2.69, 1.15	21.95	1.02, 0.38	21.95	38.29	25.10	82.35	24.17	15.16	42.75	53.87	18.72	12.67	52.86	41.45	-70.64	-1.16	12.73	-3.40	11.23	42.17	14.24	70.89	53.82	17.54	42.72	-1.02	15.86	69.55	13.55	41.43	17.70
BRD-K07117950	CP	imperatorin	acetylcholinesterase inhibitor, nitric oxide production inhibitor, Sodium Channel  Blockers	ACHE, HTR7		6.15, 3.08	21.83	0.82, 0.20	73.48	-65.40	-41.20	44.90	17.06	11.15	14.57	64.82	43.05	31.47	21.81	38.86	-2.74	-34.31	61.78	3.17	64.16	44.66	14.99	97.23	-16.64	97.03	-13.49	0.00	21.83	50.41	11.31	99.12	61.17
BRD-K53959060	CP	indirubin	CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor	CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2	Glycogen synthase kinase inhibitor	3.27, 1.22	21.77	1.80, 0.53	50.91	43.63	14.51	83.41	14.73	7.12	12.99	20.24	10.54	5.00	8.69	66.40	90.47	86.05	28.08	99.54	45.02	54.92	21.77	11.27	6.20	27.56	0.63	24.36	69.22	30.02	9.79	15.30	1.37
BRD-A28318179	CP	aminomethyltransferase	nitric oxide synthase inhibitor	NOS2		5.38, 2.31	21.76	1.30, 0.47	17.32	-6.41	16.67	7.75	2.76	34.09	27.73	86.39	45.26	21.76	-7.81	-10.14	-2.96	-5.29	75.84	-6.64	39.00	-14.10	88.29	70.49	9.83	78.34	9.82	91.36	71.49	44.14	67.35	98.13	17.52
BRD-K32536677	CP	AGK-2	SIRT inhibitor, SIRT pathway	SIRT2		3.85, 1.92	21.76	0.83, 0.23	88.67	1.91	8.12	2.01	19.97	79.16	26.28	45.15	15.12	8.07	36.05	27.97	-88.41	-5.19	73.75	-5.46	10.34	0.67	7.29	48.44	62.56	76.87	21.76	-80.53	-11.26	26.34	43.86	55.78	38.20
BRD-K82823804	CP	SA-792987	PKC inhibitor	WEE1	PKC inhibitor	10.77, 7.31	21.76	1.32, 0.30	8.80	97.92	15.68	99.74	16.20	79.31	-5.74	-35.19	6.41	13.58	18.56	58.15	96.55	99.23	21.26	99.93	22.92	59.22	30.08	58.50	21.76	46.23	9.11	-94.54	11.71	-66.05	16.20	46.23	55.55
BRD-K54472332	CP	elvitegravir	HIV integrase inhibitor, HIV inhibitor			4.62, 1.92	21.75	1.10, 0.33	32.09	43.28	48.04	44.28	64.14	10.99	11.49	91.56	21.75	7.01	19.55	83.98	8.61	11.36	15.33	89.06	36.48	14.24	5.88	74.25	97.32	31.22	-15.74	-62.44	-0.42	15.05	5.57	64.72	46.27
BRD-K68246049	CP	TTNPB	RAR agonist, retinoid receptor agonist	RARB, RARA, RARG	Retinoid receptor agonist	3.46, 1.15	21.74	1.40, 0.33	58.66	-6.20	9.74	56.05	-8.13	15.88	80.37	76.43	13.55	12.68	21.74	44.76	2.26	1.20	13.38	16.97	36.00	6.50	75.31	8.09	-3.38	17.35	32.50	22.25	73.06	90.96	63.75	80.40	43.38
BRD-K35687265	CP	ON-01910	PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor	CDK1, FLT1, FYN, MCL1, PDGFRA, PLK1, PLK2, SRC		2.31, 0.38	21.66	1.68, 0.69	8.14	14.06	-5.28	54.10	-0.67	68.45	31.70	71.39	-9.94	26.75	15.80	28.82	52.07	20.05	-90.86	21.79	53.79	14.32	34.73	23.22	17.77	31.05	-12.10	16.63	35.64	25.40	12.63	21.66	13.83
BRD-K28137194	CP	loreclezole	GABA receptor agonist	GABRB2, GABRB3		4.23, 1.92	21.63	0.78, 0.26	5.81	23.76	1.90	0.00	47.41	34.03	78.33	37.37	41.60	38.73	70.23	15.64	-2.11	0.56	-15.01	-2.01	28.11	-7.27	82.41	37.84	44.24	-3.55	9.02	0.78	96.62	87.14	2.50	21.63	1.94
BRD-K43764301	CP	dexketoprofen	cyclooxygenase inhibitor	CXCR1, PTGS1, PTGS2, SLC5A8		3.85, 1.54	21.60	0.97, 0.20	32.47	9.30	21.63	53.04	0.67	7.23	62.73	97.08	9.79	74.21	65.51	6.08	2.78	79.18	-82.30	79.50	-42.80	8.35	-11.59	34.47	9.01	45.26	-5.00	9.67	60.09	87.47	21.60	13.05	42.15
BRD-A62035778	CP	scopolamine	acetylcholine receptor antagonist	CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI		1.92, 0.77	21.54	0.86, 0.33	90.35	24.78	1.13	18.77	46.19	8.12	80.14	42.07	16.74	80.83	35.55	52.07	4.47	9.57	59.69	-6.48	22.76	7.06	21.27	75.15	21.54	17.46	-4.27	-9.62	24.03	44.16	11.22	59.80	2.33
BRD-K19416115	CP	sitagliptin	dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor	DPP4, CYP2C8, FASLG, HMGCR, SLC22A8		5.38, 2.69	21.52	2.65, 0.89	8.14	-25.13	-0.88	4.33	-28.26	20.31	49.32	96.91	47.62	14.12	4.55	28.94	-74.60	-5.24	47.10	-97.28	76.69	5.11	56.94	66.45	25.66	39.64	21.52	94.12	50.87	7.86	16.13	29.77	48.35
BRD-K49519092	CP	immethridine	histamine receptor agonist	HRH3		1.92, 1.15	21.50	0.53, 0.11	-10.20	-22.58	41.39	4.37	29.64	30.24	43.27	37.19	25.57	35.58	10.60	4.69	-6.87	-16.45	44.03	-6.86	78.87	16.69	26.18	84.56	25.41	16.21	15.15	19.22	13.72	21.34	21.50	64.50	48.41
BRD-K07691486	CP	roscovitine	CDK inhibitor, apoptosis stimulant	CDK2, CDK9, CDK7, CDK1, CDK5	CDK inhibitor	3.46, 0.77	21.49	0.91, 0.40	11.05	84.15	48.79	21.49	31.07	12.52	20.14	-47.87	5.60	8.71	43.66	29.87	13.56	4.83	65.40	3.79	65.74	25.63	17.27	89.31	32.19	88.88	16.95	-19.19	3.70	2.08	28.20	75.70	65.02
BRD-A65440446	CP	cimaterol	adrenergic receptor agonist		Beta-adrenergic receptor agonist	4.49, 3.27	21.46	0.82, 0.26	18.27	-9.13	78.82	18.74	21.46	68.29	17.98	69.71	99.65	41.52	6.08	31.07	2.08	2.86	53.34	4.21	40.05	21.91	17.45	15.54	6.80	27.15	29.08	71.41	19.60	61.20	11.09	10.43	27.32
BRD-A80383043	CP	BRD-A80383043	glutamate receptor agonist, glutamate receptor antagonist	GRM1, GRM2		5.73, 5.10	21.45	2.20, 0.90	6.19	-52.45	-46.04	2.47	25.98	7.08	55.86	92.31	68.81	-11.84	31.13	11.64	-13.94	-82.79	93.81	-97.03	-57.23	3.95	92.04	99.37	69.34	21.45	6.53	44.67	7.14	46.52	25.61	71.27	99.10
BRD-A22380646	CP	pantoprazole	ATPase inhibitor	ATP4A, CYP2C19, CYP3A4		0.77, 0.77	21.40	0.58, 0.15	15.58	20.37	-1.37	17.89	41.53	14.22	26.56	77.71	43.97	50.67	76.68	88.74	8.26	10.92	85.51	-1.44	84.27	16.48	9.97	19.04	4.93	40.15	23.29	-0.04	1.94	21.40	63.25	64.29	60.69
BRD-K74763371	CP	bosentan	endothelin receptor antagonist	EDNRB, EDNRA, ABCB1, CYP2C19, CYP3A4		4.49, 1.22	21.28	1.00, 0.30	89.79	42.51	1.90	11.85	-56.40	53.10	81.16	74.08	20.30	0.81	73.60	75.85	1.83	0.32	70.93	2.04	65.91	21.28	99.82	43.02	20.84	15.21	-42.13	0.04	6.27	84.52	77.35	93.64	7.30
BRD-K91900765	CP	VX-745	p38 MAPK inhibitor	MAPK14, MAPK11, MAPK12	P38 MAPK inhibitor	3.46, 1.54	21.27	0.86, 0.30	12.24	-4.79	2.50	0.00	22.78	13.82	65.09	91.83	14.46	83.03	14.69	56.94	-43.12	0.78	-11.94	-31.06	68.69	6.71	94.91	63.68	18.03	5.46	52.08	97.43	64.76	89.16	58.10	21.27	36.53
BRD-K19894101	CP	MST-312	telomerase inhibitor	TERT		3.85, 1.92	21.20	1.36, 0.32	55.72	26.97	39.42	47.45	5.13	6.23	21.20	18.97	13.69	16.40	11.32	97.74	87.35	85.27	-10.60	90.39	57.62	9.92	80.52	16.86	9.51	26.61	25.97	0.00	17.29	8.76	27.42	22.25	20.02
BRD-A29731977	CP	17-hydroxyprogesterone-caproate	progesterone receptor agonist	CYP1A2, CYP2B6, CYP3A5, PGR	Progesterone receptor agonist	6.15, 2.69	20.88	0.80, 0.18	42.07	-41.40	1.44	9.73	-11.85	21.93	93.00	54.13	13.28	-16.41	3.70	14.80	0.00	0.00	99.82	-18.86	47.53	9.07	97.40	60.19	-6.24	27.60	7.41	89.61	32.22	43.21	45.30	20.88	49.68
BRD-K23875128	CP	RHO-kinase-inhibitor-III[rockout]	ROCK inhibitor	IMPDH2, ROCK1		1.92, 0.77	20.84	1.26, 0.76	50.63	28.31	5.36	-1.59	9.22	33.67	80.02	26.63	24.52	4.12	5.01	20.62	-83.99	-6.47	27.64	-89.49	11.50	-5.55	53.90	49.20	22.40	22.41	11.70	21.15	20.84	54.67	1.73	25.28	20.44
BRD-A13133631	CP	fluorometholone	corticosteroid agonist, glucocorticoid receptor agonist	NR3C1	Glucocorticoid receptor agonist	3.67, 2.45	20.82	1.45, 0.72	31.36	20.82	16.28	65.70	4.76	79.99	4.44	-32.42	11.10	5.30	12.37	46.67	-2.26	70.61	85.39	38.15	2.59	62.29	18.79	50.41	-7.46	49.98	28.54	1.83	10.76	46.24	29.73	4.98	43.11
BRD-K35498378	CP	alrestatin	aldose reductase inhibitor	AKR1B1		4.62, 1.92	20.81	1.06, 0.25	82.65	-31.06	2.12	16.92	33.30	-12.62	88.53	68.30	18.11	6.41	30.36	17.30	-1.44	6.93	-49.59	20.24	93.40	-10.30	82.64	22.23	20.49	5.63	34.95	99.37	82.10	71.04	24.88	58.83	20.81
BRD-A72703248	CP	SKF-96365	calcium channel blocker, cytochrome P450 inhibitor	CYP3A4, TRPC1, PKD2, TRPC3, TRPC4, TRPC5, TRPV2		5.00, 0.77	20.75	0.49, 0.23	6.61	21.53	5.25	2.82	67.07	15.86	15.40	55.86	85.34	17.96	9.90	20.75	72.94	5.26	46.09	74.07	33.73	34.53	-25.35	14.79	24.92	20.37	-3.91	-83.00	52.76	11.65	31.54	79.65	94.95
BRD-K20313525	CP	rosmarinic-acid	antioxidant	MCL1, TYR		2.31, 1.15	20.66	0.98, 0.19	48.64	-3.76	18.36	5.60	9.43	0.03	70.92	84.32	17.05	77.27	14.25	63.63	2.22	4.20	-29.11	-0.60	7.86	20.66	41.80	83.02	3.70	80.29	5.28	43.99	66.27	93.85	64.88	53.44	90.18
BRD-A58955223	CP	sulforaphane	anticancer agent, aryl hydrocarbon receptor antagonist, nuclear factor erythroid derived, like (NRF2) activator	NFE2L2		0.77, 0.38	20.61	0.83, 0.22	27.91	23.58	4.75	2.92	14.19	40.01	20.61	28.63	18.94	14.80	18.06	49.24	41.25	40.87	1.98	77.21	0.35	2.50	19.79	21.12	33.85	52.65	18.36	0.81	48.30	14.67	15.71	32.21	33.63
BRD-K28120222	CP	parthenolide	NFkB pathway inhibitor, adiponectin receptor agonist	ADIPOR2, IKBKB, RELA		2.31, 0.38	20.57	1.69, 0.69	8.71	15.92	30.48	8.65	-9.21	2.47	1.62	75.44	18.01	0.74	1.55	32.03	78.67	87.24	23.28	30.96	89.52	37.91	18.83	2.01	3.45	34.10	20.57	23.30	44.69	4.87	13.95	30.78	91.80
BRD-K89687904	CP	PKCbeta-inhibitor	PKC inhibitor	PRKCB		0.77, 0.38	20.53	0.83, 0.27	26.02	49.33	14.48	3.54	29.86	17.56	16.43	27.31	5.17	2.61	8.47	20.53	-77.92	79.19	-20.69	6.47	28.74	4.39	24.95	39.21	21.97	40.13	-4.67	-24.90	32.02	30.42	13.59	72.55	37.97
BRD-K36324071	CP	NF-449	purinergic receptor antagonist	P2RX1		2.69, 1.54	20.51	1.60, 0.48	69.70	-28.16	9.17	-6.54	18.28	86.53	11.08	59.04	11.38	10.36	27.25	22.95	-85.53	3.10	82.84	-98.37	59.55	-6.60	77.03	98.23	20.51	10.23	52.25	13.74	20.17	84.28	86.51	64.77	75.90
BRD-U44618005	CP	WH-4023	src inhibitor	ABL1, LCK, SRC	SRC inhibitor	6.15, 3.08	20.50	1.25, 0.47	2.71	1.83	62.13	93.74	4.24	32.62	-0.85	59.37	50.18	4.59	-3.91	41.76	3.03	17.52	78.97	-16.16	20.50	94.71	-16.11	33.35	68.95	13.20	59.97	12.34	98.11	0.00	5.05	23.98	71.27
BRD-A23637604	CP	oxymetholone	androgen receptor agonist, synthetic hormone with anabolic and androgenic properties	AR	Androgen receptor modulator	6.22, 3.11	20.44	0.65, 0.24	10.39	-5.27	0.03	20.44	68.51	-20.45	14.25	40.65	8.39	0.11	79.73	51.75	70.60	72.13	97.58	3.14	96.12	48.64	-87.53	16.74	-26.60	-41.74	4.40	51.97	73.33	73.88	81.24	11.40	28.63
BRD-K24576554	CP	AT-9283	Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor	AURKA, AURKB, ABL1, BCR, FLT3, JAK2, JAK3, RPS6KA6, STK17A	Aurora kinase inhibitor	2.58, 1.72	20.42	0.88, 0.31	20.42	79.58	69.81	75.15	34.43	16.02	6.29	-38.18	6.45	3.81	13.25	61.79	20.51	4.19	66.97	99.93	7.26	78.78	20.24	41.36	47.75	15.41	2.50	0.00	28.10	-1.48	10.98	21.21	42.23
BRD-K49404994	CP	levetiracetam	acetylcholine receptor agonist, N-type calcium channel blocker, synaptic vesicle glycoprotein ligand	SV2A, CACNA1B, SCN1A		4.89, 2.22	20.35	0.77, 0.24	53.75	-35.74	44.39	10.79	9.38	19.62	32.47	56.00	3.52	6.47	35.48	93.52	-13.60	-25.23	96.24	4.51	91.61	12.49	26.38	38.13	39.75	15.47	20.35	-11.52	-7.01	79.78	59.30	0.60	21.43
BRD-K84895041	CP	BMY-45778	IP1 prostacyclin receptor agonist	PTGIR		2.86, 0.82	20.28	1.58, 0.56	81.77	20.28	6.32	42.45	0.00	-5.38	11.95	12.54	2.26	8.00	-3.79	39.01	76.05	88.75	12.99	92.40	85.07	29.72	80.31	47.80	-7.93	24.23	10.91	74.45	43.02	33.50	10.61	11.20	6.94
BRD-A32161980	CP	carbetocin	analogue of oxytocin	OXTR		3.85, 1.92	20.27	1.08, 0.42	12.82	20.27	-68.01	4.02	24.14	-11.51	28.08	96.67	24.53	12.69	42.68	8.92	-5.92	-29.54	-16.79	-42.03	43.10	2.26	95.53	8.87	63.16	65.60	0.44	-40.96	48.07	28.41	25.20	59.05	24.43
BRD-K05926469	CP	lenalidomide	angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist	CRBN, TNF, CDH5, PTGS2, TNFSF11		4.62, 0.38	20.26	1.30, 0.36	33.36	-40.17	-2.26	3.88	-46.71	92.44	59.03	80.48	20.15	11.91	-3.35	-11.02	-70.18	-60.25	92.75	-99.07	95.72	4.90	96.37	96.05	28.32	13.20	7.29	20.26	75.92	73.77	40.81	30.55	51.40
BRD-K18678457	CP	ZD-7288	HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker	HCN1, HCN2, HCN3, HCN4		3.85, 2.31	20.21	1.08, 0.36	16.17	-18.68	16.24	22.12	8.60	29.53	15.39	46.29	34.69	6.63	1.34	60.72	-12.96	-50.77	20.21	-13.38	22.70	5.42	56.33	92.06	-21.93	24.58	8.45	0.00	20.26	64.23	40.94	97.27	86.71
BRD-K61097567	CP	SB-218795	tachykinin antagonist	TACR3		8.85, 5.38	20.20	1.00, 0.34	9.08	-82.23	3.64	3.98	25.74	13.72	15.35	97.89	12.81	13.64	35.62	54.10	-17.56	2.43	72.52	-0.83	25.47	-11.39	87.83	99.58	56.97	34.57	7.05	98.08	13.37	96.04	56.73	96.58	20.20
BRD-A52650764	CP	ingenol	PKC activator	PRKCD, PRKCE	PKC activator	6.15, 3.08	20.16	3.22, 0.82	14.19	47.05	7.75	95.21	4.34	22.37	7.62	57.91	6.88	32.99	18.13	28.81	95.67	51.05	47.69	99.58	35.13	19.51	20.16	43.29	12.86	-3.52	-12.83	45.64	3.88	15.34	14.92	23.95	5.22
BRD-K70241288	CP	L-692585	growth hormone releasing peptide ligand agonist, growth hormone secretagogue	GH1, GHSR		5.38, 3.08	20.11	1.06, 0.24	10.52	-11.46	11.66	9.17	18.92	20.11	-8.77	73.35	17.75	24.04	84.23	7.04	-2.43	0.70	82.92	4.76	81.36	13.75	40.86	98.84	48.24	53.07	29.49	3.85	39.47	78.53	16.69	39.50	97.53
BRD-A67605442	CP	tetrahydrobiopterin	nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator	PAH, TH, DBH, NOS3, TPH1		6.53, 3.67	20.10	1.30, 0.36	6.42	45.92	25.97	24.50	20.10	13.64	13.92	97.85	19.25	10.24	43.69	24.17	0.00	-1.52	93.73	-5.14	68.31	0.00	89.45	20.63	26.89	3.27	13.34	99.47	8.99	99.57	54.66	-13.70	11.39
BRD-K14329163	CP	BAY-K8644	L-type calcium channel activator	CACNA1C		2.69, 2.31	20.10	1.02, 0.26	19.52	-10.15	92.18	17.55	6.11	51.75	14.41	79.52	2.91	30.73	6.10	20.10	-59.71	-1.76	10.50	-5.35	57.26	3.52	47.95	63.09	56.52	61.23	13.41	40.48	0.56	21.87	28.40	25.67	73.77
BRD-K31699485	CP	DMEOB	glutamate receptor modulator			3.08, 0.77	20.03	1.68, 0.51	12.35	-51.07	-10.10	-10.70	70.79	-17.05	33.13	84.63	-5.68	36.27	20.03	16.22	2.96	2.01	90.10	-22.13	89.18	9.59	74.98	78.50	-69.75	16.91	24.88	8.62	60.40	83.12	26.55	70.16	37.91
BRD-A01145011	CP	zebularine	DNA methyltransferase inhibitor, cytidine deaminase inhibitor	CDA, DNMT1		3.08, 1.54	19.99	0.63, 0.20	88.99	19.99	6.39	9.19	46.60	64.19	12.28	36.87	21.38	8.10	17.13	63.68	-83.98	13.31	76.01	2.04	15.88	4.77	28.55	44.52	15.18	5.26	13.19	48.23	-26.67	94.55	55.28	55.85	45.05
BRD-K20986251	CP	lithocholic-acid	FXR antagonist, MDM inhibitor, PXR ligand, tyrosine phosphatase inhibitor, vitamin D receptor ligand	NR1I2, VDR, GPBAR1, MDM2, MDM4, NR1H4, PTPN1	Bile acid, FXR antagonist, Vitamin D receptor agonist	4.62, 2.31	19.91	1.42, 0.32	6.21	-4.39	17.23	-42.11	21.81	11.86	51.97	98.80	19.91	19.19	86.95	95.14	-64.68	14.49	63.28	18.79	55.32	6.45	16.53	54.27	-11.78	11.91	98.56	-1.94	54.46	87.39	69.16	34.75	96.59
BRD-K66792149	CP	quinoclamine	algicide			5.38, 3.85	19.85	2.48, 0.58	45.92	68.10	70.24	86.30	25.36	-5.92	0.67	19.89	13.17	19.85	10.09	40.83	97.78	77.15	-24.60	99.82	13.59	36.70	20.44	15.09	26.96	18.25	13.33	0.00	13.27	9.28	25.86	18.00	8.35
BRD-K66019333	CP	oxantel	fumarate reductase inhibitor			4.62, 1.92	19.83	0.78, 0.15	16.22	18.40	41.73	31.46	81.90	20.87	5.68	15.33	17.69	8.62	19.83	66.76	1.83	4.79	90.12	4.58	26.12	3.92	31.07	46.13	10.43	55.93	25.63	1.87	-2.40	40.41	54.82	84.42	0.88
BRD-K14791739	CP	fluticasone	glucocorticoid receptor agonist	NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A	Glucocorticoid receptor agonist	1.92, 0.77	19.71	1.40, 0.78	25.92	-15.76	0.88	49.40	19.98	11.94	50.10	40.47	21.58	3.60	15.53	35.59	-8.74	5.52	54.75	2.71	9.30	2.47	19.71	63.65	6.17	41.42	32.27	0.00	-1.23	5.43	29.48	54.70	72.95
BRD-K11558771	CP	droxinostat	HDAC inhibitor	HDAC6, HDAC8	HDAC inhibitor	1.63, 0.00	19.69	0.93, 0.40	5.77	17.12	8.09	62.45	47.85	0.02	2.02	56.34	15.73	2.99	14.94	41.34	34.56	18.00	81.01	3.89	46.68	33.00	7.81	40.15	14.79	-36.49	19.69	6.01	26.35	58.05	31.65	30.70	48.78
BRD-A03359064	CP	ICI-89406	adrenergic receptor antagonist	ADRB1, ADRB2		4.62, 3.08	19.68	1.63, 0.44	14.05	-78.09	48.61	14.52	8.62	28.52	68.16	68.32	83.56	0.49	-0.85	6.06	-74.84	-1.34	93.10	-7.09	83.24	11.05	-34.73	99.89	13.31	8.49	19.68	23.17	74.45	25.38	60.33	84.34	83.64
BRD-K82731415	CP	olomoucine	CDK inhibitor	CDK1, CDK2, CDK5, MAPK1		3.85, 1.92	19.58	0.93, 0.22	32.90	13.62	14.71	1.52	4.54	21.16	19.58	41.81	14.73	42.17	96.20	24.51	-38.66	2.62	7.93	2.35	16.96	17.86	61.16	46.55	77.18	94.54	4.37	-19.11	98.37	80.53	-0.03	67.02	45.28
BRD-A32836748	CP	leu-enkephalin	opioid receptor agonist	OPRD1, OPRM1		4.08, 2.04	19.56	1.40, 0.56	28.77	11.23	48.54	5.60	14.88	99.75	62.19	32.19	25.28	28.03	4.81	8.31	-2.82	10.82	-93.86	-3.41	48.69	19.56	33.31	36.23	13.58	60.80	-15.73	-15.86	-9.03	20.98	21.39	3.73	89.55
BRD-K28075147	CP	biochanin-a	estrogen receptor agonist			5.00, 3.46	19.22	1.30, 0.38	11.03	30.52	-14.41	19.22	8.68	30.20	98.34	63.80	10.65	32.05	62.11	60.94	-67.68	-0.78	10.53	5.14	-0.53	3.83	98.17	90.46	85.93	1.62	65.37	1.35	8.99	89.05	17.56	98.86	33.58
BRD-A62184259	CP	cycloheximide	glycogen synthase kinase inhibitor, protein synthesis inhibitor	GSK3B, RPL3	Protein synthesis inhibitor	2.31, 1.54	19.21	2.40, 0.60	13.66	85.22	71.76	84.55	21.15	50.45	1.34	38.91	13.97	20.90	3.59	46.01	88.69	-1.30	37.85	98.52	32.16	-5.60	9.97	19.21	10.05	34.01	14.97	-0.18	-0.32	9.55	18.89	63.01	17.81
BRD-K34092021	CP	arvanil	TRPV agonist, cannabinoid receptor agonist	CNR1, TRPV1		3.85, 1.92	19.20	0.99, 0.31	14.97	38.49	2.43	30.49	5.23	-50.92	-16.20	69.05	32.04	6.41	6.31	13.85	6.81	20.27	77.41	20.33	18.29	15.59	9.27	90.50	33.88	92.63	23.41	-96.43	19.20	-30.92	82.77	66.60	73.65
BRD-K55420858	CP	mirin	inhibitor of MRE11A exonuclease activity	MRE11A		1.15, 0.38	19.12	1.16, 0.47	19.32	21.72	2.03	4.76	20.54	-18.95	12.27	71.45	5.11	16.98	59.33	19.12	8.15	19.22	26.33	4.77	42.93	-0.85	9.55	44.57	11.80	20.58	9.19	-1.15	38.21	65.27	20.29	43.96	16.59
BRD-K59773493	CP	benzohydroxamic-acid	metal chelator, anti bacterial			2.58, 0.43	19.07	0.43, 0.34	61.57	30.48	11.87	9.41	15.96	61.92	16.76	12.94	22.58	14.44	22.31	49.93	-1.30	5.11	55.08	6.26	77.63	15.78	7.13	22.26	32.65	28.66	15.05	-84.78	-36.22	19.07	19.72	31.21	47.54
BRD-M07438658	CP	lapatinib	EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor	EGFR, ERBB2, CYP3A5		8.57, 4.90	18.96	0.85, 0.32	59.58	-96.97	0.78	45.86	-98.55	-46.77	1.62	93.75	7.28	1.84	4.02	7.11	2.82	70.37	97.57	2.87	18.96	38.41	98.64	87.74	-30.39	0.00	28.91	99.93	96.43	95.80	7.53	62.84	98.94
BRD-K77998258	CP	ganglioside	src activator			3.46, 2.31	18.94	0.86, 0.34	16.07	-10.22	29.67	9.65	49.21	7.14	10.49	27.20	-0.32	12.79	24.08	4.55	-2.79	3.68	96.83	36.22	69.06	12.58	49.31	49.94	13.42	63.72	7.29	99.12	18.94	56.59	64.49	93.19	13.36
BRD-K44084986	CP	Y-27632	ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor	ROCK1, ROCK2, LRRK2, PKIA, PKN2, PRKACA, PRKCE	Rho associated kinase inhibitor	4.08, 0.82	18.92	1.06, 0.25	48.50	9.72	51.82	18.92	21.77	96.26	14.47	15.30	13.50	8.68	7.93	20.55	-43.79	41.60	47.59	4.42	10.94	31.36	17.11	32.82	14.36	27.49	10.87	-0.88	62.30	52.04	30.01	14.90	29.75
BRD-K43978949	CP	PIT	purinergic receptor antagonist	P2RY1		7.69, 3.46	18.89	0.84, 0.32	97.52	-6.85	-1.52	6.66	4.01	3.67	87.34	80.58	19.15	14.81	6.90	27.72	-4.47	18.89	25.59	3.10	-12.65	2.68	94.61	84.25	21.36	79.37	-7.29	0.00	76.34	47.58	41.20	97.57	-40.52
BRD-A16754160	CP	ampicillin	cell wall synthesis inhibitor	SLC15A1		5.71, 2.86	18.86	1.13, 0.38	40.66	76.06	18.86	6.45	61.86	36.30	7.82	-35.14	14.92	13.68	49.84	58.67	2.71	5.00	35.53	40.09	9.34	-3.49	15.48	18.03	68.01	43.34	5.46	-13.74	0.35	93.43	81.56	58.05	20.46
BRD-K03406345	CP	azacitidine	DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor, DNA synthesis inhibitor, RNA synthesis inhibitor	DNMT1		5.31, 2.86	18.79	2.08, 0.81	48.73	9.38	18.79	92.94	48.02	0.03	12.96	58.31	17.98	0.00	37.22	52.42	96.16	5.65	2.82	99.93	88.64	14.19	11.49	8.12	22.56	17.63	34.58	2.94	0.81	24.05	27.74	20.06	3.38
BRD-K79131256	CP	albendazole	tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor	CYP1A2, CYP2J2, TUBA1A, TUBB, TUBB4B	Tubulin inhibitor	1.92, 0.38	18.78	0.83, 0.44	53.14	6.11	-20.71	18.28	-24.14	66.32	40.78	89.65	18.78	13.55	14.44	27.62	23.66	14.29	9.83	38.85	66.10	12.77	34.71	44.95	-47.19	10.56	-4.69	-83.27	-13.71	76.28	34.05	51.64	79.36
BRD-K01638814	CP	rilmenidine	adrenergic receptor agonist, imidazoline receptor agonist	NISCH	Imidazoline ligand	4.62, 1.92	18.77	2.49, 0.59	98.21	-20.25	5.68	-26.60	-9.85	5.81	61.52	92.18	44.49	5.32	16.81	25.80	-84.04	-7.64	25.99	-98.56	15.36	2.33	74.22	57.88	-4.09	58.55	12.65	18.77	57.52	94.80	35.33	43.15	66.40
BRD-K67566344	CP	KU-0063794	mTOR inhibitor	MTOR	MTOR inhibitor	2.69, 0.77	18.73	2.21, 0.76	4.16	32.99	17.88	95.02	10.43	26.95	18.73	14.37	14.94	17.70	18.15	57.83	81.88	-22.37	91.90	92.59	82.65	56.93	10.92	40.32	20.48	26.62	9.54	0.85	4.55	42.36	9.72	29.99	5.23
BRD-A80928489	CP	1-monopalmitin	P glycoprotein inhibitor	ABCB1		5.73, 4.46	18.66	1.44, 0.56	57.91	10.76	11.84	-11.76	32.51	-7.19	44.45	80.37	17.08	25.96	14.02	27.55	-0.63	3.70	-18.94	-2.54	28.53	44.16	83.16	18.58	26.14	98.77	7.04	-24.91	7.15	40.99	44.61	91.10	18.66
BRD-K99451608	CP	lopinavir	HIV protease inhibitor		HIV protease inhibitor	2.69, 0.77	18.66	1.15, 0.41	6.50	-47.80	3.14	23.60	0.00	3.14	40.56	96.27	6.87	18.66	6.46	-34.45	5.71	0.00	47.32	31.15	93.07	12.72	46.84	52.81	54.23	47.74	-8.10	-0.85	88.49	16.26	72.19	86.04	63.65
BRD-K51318897	CP	fenbendazole	cytochrome P450 inhibitor, tubulin inhibitor	CYP2C19, CYP2D6, CYP2J2, CYP3A4, TUBB	Tubulin inhibitor	4.23, 1.92	18.62	0.88, 0.42	2.54	34.75	98.80	8.89	58.57	41.52	13.88	72.64	8.58	10.88	8.25	-29.42	65.96	15.14	39.27	74.81	41.43	27.17	-18.57	73.94	-9.23	36.86	9.22	-0.03	18.62	-8.05	29.32	26.29	9.95
BRD-K51941867	CP	LM-1685	cyclooxygenase inhibitor	PTGS2		6.53, 3.67	18.54	0.82, 0.22	29.67	-4.16	9.16	14.74	32.57	61.73	2.99	91.71	18.54	2.80	16.09	47.44	-2.82	8.77	33.70	-17.86	68.17	9.34	70.63	77.48	12.62	17.25	4.49	98.85	87.11	99.19	57.88	74.38	8.13
BRD-K02407574	CP	parbendazole	tubulin inhibitor	TUBB	Tubulin inhibitor	1.54, 0.38	18.45	0.89, 0.42	8.04	39.78	60.93	0.95	62.79	2.82	36.83	53.30	8.44	8.77	16.08	52.71	42.52	18.45	-4.77	-2.01	21.10	7.05	41.34	54.50	14.27	17.70	8.46	-79.34	-43.31	19.42	35.79	82.95	55.21
BRD-K71926323	CP	marbofloxacin	DNA gyrase inhibitor		Bacterial DNA gyrase inhibitor	6.12, 3.27	18.45	1.03, 0.36	20.14	32.33	6.07	7.23	-21.54	27.09	7.19	96.67	2.22	18.45	8.42	90.40	0.00	11.01	89.20	0.00	10.54	1.20	55.08	38.09	76.31	61.76	9.34	59.28	7.01	98.91	26.65	75.63	15.16
BRD-K82746043	CP	navitoclax	BCL inhibitor, apoptosis stimulant	BCL2, BCL2L1, BCL2L2		2.31, 0.38	18.36	1.28, 0.36	47.05	-47.67	59.32	3.53	11.10	91.31	-7.78	83.60	50.60	3.60	8.14	15.32	-89.53	4.21	49.23	-27.96	58.90	3.40	60.97	92.79	45.51	43.57	25.38	-0.85	69.00	16.29	18.36	62.72	7.75
BRD-K81062487	CP	taurocholic-acid	bile acid	CEL, FXR, NR1H4, FABP6, SLCO1C1	Bile acid	3.85, 1.54	18.23	0.78, 0.30	44.90	-20.71	30.30	2.82	18.50	5.49	18.63	46.02	69.84	12.55	42.39	24.66	-5.08	9.63	69.12	-0.67	76.96	10.41	67.40	16.08	40.44	26.86	13.63	18.23	13.42	69.43	12.29	17.20	11.16
BRD-K91696562	CP	orantinib	PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist	PDGFRB, AURKA, AURKB, KDR, EGFR, FGFR1, FGFR2, PDGFRA, TBK1	FGFR inhibitor	3.08, 2.31	18.05	0.91, 0.41	-44.45	-53.08	12.17	22.52	18.29	0.03	36.45	99.05	18.18	6.82	14.00	24.61	-77.68	-24.37	-33.27	-97.48	14.90	10.88	11.84	54.35	18.05	51.23	8.46	79.86	75.84	21.60	38.21	40.12	72.41
BRD-K28168037	CP	fenretinide	apoptosis stimulant, retinoid receptor agonist, RAR agonist	CYP2C8, CYP3A5, RARA, RARG	Retinoid receptor agonist	5.38, 3.08	17.96	0.82, 0.16	8.98	-3.91	58.05	60.65	35.99	17.96	-16.47	19.03	-6.20	3.31	3.33	30.06	88.39	66.60	97.60	99.75	95.58	20.42	-23.66	42.50	10.61	16.96	11.24	87.71	-11.29	4.82	15.95	35.14	0.53
BRD-K84175871	CP	pseudoephedrine	histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor	ADRA1A, ADRA2A, ADRB1, ADRB2, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6, ATF7, CXCL8, FOS, HRH1, IL2, JDP2, JUN, NFATC1, SLC6A2, SLC6A3, SLC6A4, TNF		5.77, 3.85	17.87	1.17, 0.32	65.90	-54.60	6.75	11.52	16.51	-6.23	25.58	33.18	18.23	-41.22	17.87	6.50	-6.40	-48.19	99.08	-55.49	90.62	5.46	60.57	99.89	-3.77	53.96	9.90	99.65	-39.02	52.89	41.10	74.32	30.72
BRD-K23922020	CP	arecaidine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4		5.38, 3.46	17.81	1.28, 0.36	28.87	9.16	78.21	17.81	34.01	13.24	-47.60	94.01	61.97	3.68	10.32	13.31	2.04	-1.69	97.82	2.75	97.71	10.94	-91.94	93.27	-24.47	39.44	41.85	0.85	23.93	7.43	77.51	32.60	58.35
BRD-A15914070	CP	4-hydroxy-2-nonenal	cytotoxic lipid peroxidation product	IKBKB		1.27, 0.00	17.79	1.76, 0.58	17.79	33.71	-16.74	15.04	7.07	7.36	1.76	-16.96	6.92	66.42	5.79	35.80	59.12	79.37	63.07	7.52	1.80	76.54	18.37	61.61	30.37	80.53	16.34	1.80	90.78	11.63	63.21	47.98	-1.30
BRD-A55815733	CP	phylloquinone	antifibrinolytic agent, gamma carboxylase enzyme	BGLAP, GGCX		5.31, 2.86	17.73	1.17, 0.43	71.17	2.96	38.66	31.81	32.68	30.67	19.93	97.85	17.73	6.74	46.78	5.67	1.36	0.00	14.35	-21.69	-2.57	6.13	70.25	10.53	-92.52	15.41	58.63	95.60	15.15	99.72	38.11	15.13	85.33
BRD-A09495397	CP	bicuculline	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1	GABA receptor antagonist	10.83, 7.64	17.66	1.27, 0.46	7.17	15.81	31.34	1.87	-91.83	17.66	49.90	66.19	4.93	12.55	7.47	6.65	0.11	36.45	85.47	1.02	49.66	59.55	98.66	5.75	97.80	99.79	4.19	27.24	35.17	-37.45	44.47	26.03	1.73
BRD-K20152659	CP	gamma-homolinolenic-acid	cholesterol inhibitor, platelet aggregation inhibitor, prostaglandin G/H synthase 1, prostanoid receptor stimulant	PTGS1, PTGS2		4.08, 2.04	17.66	1.63, 0.60	7.15	34.17	53.48	-4.40	8.30	97.71	60.05	38.10	18.63	21.83	5.21	11.26	-36.11	2.04	-89.79	3.03	94.74	30.79	23.24	48.95	62.22	17.66	-3.98	-12.22	-8.52	18.60	13.14	13.86	84.43
BRD-K02581333	CP	protein-tyrosine-phosphatase-inhibitor-IV	tyrosine phosphatase inhibitor	PTPN1, PTPN11		3.46, 1.15	17.61	1.25, 0.42	8.70	-28.50	8.20	-7.65	58.81	63.32	-0.92	57.40	7.36	61.82	63.00	78.34	-5.74	5.53	82.69	12.77	94.64	11.73	-13.54	57.75	70.49	59.16	17.61	-0.81	-8.20	-12.90	50.99	82.26	44.10
BRD-A16665823	CP	butoconazole	cell wall synthesis inhibitor, sterol demethylase inhibitor			2.69, 1.92	17.57	0.58, 0.18	30.94	0.00	2.75	6.31	17.33	-6.13	17.57	39.09	0.00	41.40	10.28	6.13	6.13	9.29	43.39	92.73	59.03	77.39	50.89	69.82	22.96	5.06	-5.66	99.82	75.74	81.93	8.26	73.34	-11.10
BRD-K62609077	CP	scoulerine	adrenergic receptor antagonist, GABA receptor antagonist, serotonin receptor antagonist	ADRA1D, ADRA2A, GABRA1		4.62, 1.54	17.43	0.44, 0.09	32.47	17.43	6.71	32.39	33.87	7.07	49.03	26.64	14.05	19.11	23.49	45.25	2.92	16.17	13.73	16.20	-42.05	9.69	83.85	32.94	9.27	27.70	3.78	-56.55	9.04	86.28	6.44	84.91	34.00
BRD-M30523314	CP	vinorelbine	tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid	TUBB	Tubulin inhibitor	0.77, 0.38	17.43	1.24, 0.56	10.62	12.41	2.96	57.99	1.13	-0.04	17.43	81.27	3.22	34.72	0.70	-56.31	67.34	33.45	54.63	30.09	36.91	32.87	28.78	24.39	-4.15	13.36	24.01	4.16	7.67	13.97	48.45	-8.80	65.30
BRD-K52512893	CP	SC-19220	prostanoid receptor antagonist	PTGER1		5.71, 4.49	17.41	1.01, 0.36	15.81	14.03	30.37	15.23	2.69	99.89	36.66	61.30	20.26	44.17	11.39	89.65	-4.76	-22.79	8.48	4.05	55.38	17.41	48.90	60.10	-31.02	69.25	15.22	0.56	6.24	69.08	37.29	7.48	81.95
BRD-K57011718	CP	UK-356618	metalloproteinase inhibitor	MMP3, MMP13, MMP14, MMP2, MMP9		3.46, 1.15	17.31	0.81, 0.19	10.96	17.31	95.16	49.99	38.17	81.73	-7.42	30.07	8.16	6.64	4.02	47.84	38.28	6.05	10.77	69.16	65.62	3.59	16.83	43.46	82.62	14.46	3.59	1.34	11.24	22.70	16.28	33.33	18.61
BRD-K99498722	CP	NPI-2358	tubulin inhibitor, angiogenesis inhibitor, tubulin polymerisation inhibitor		Tubulin inhibitor	3.46, 1.15	17.17	1.63, 0.59	86.59	11.22	1.89	75.56	14.61	47.65	-8.64	17.17	-4.33	76.63	7.91	13.36	87.07	56.19	2.78	99.47	33.74	10.08	30.59	41.36	8.08	52.62	16.94	39.67	-53.33	81.56	74.90	9.36	6.21
BRD-K32107296	CP	temozolomide	DNA alkylating drug, DNA damage inducer, DNA inhibitor, topoisomerase inhibitor	TOP2A		3.85, 1.92	17.08	0.50, 0.16	58.71	-7.79	54.16	-0.57	-3.24	28.37	45.11	53.82	9.71	9.38	1.23	71.19	-67.50	1.09	91.84	-2.92	84.09	-1.69	17.08	56.09	13.03	35.54	11.98	1.87	14.31	42.32	46.42	40.49	23.70
BRD-K11905747	CP	spectinomycin	30S ribosomal subunit inhibitor		Bacterial 30S ribosomal subunit inhibitor	6.12, 3.67	17.01	0.88, 0.34	4.16	-95.62	17.60	8.29	53.38	17.01	56.74	87.08	29.40	6.63	89.90	14.81	2.22	0.35	91.44	-0.18	42.54	24.64	26.18	31.83	1.22	3.10	44.86	10.55	6.43	99.79	10.03	-31.44	63.02
BRD-K72264770	CP	QW-BI-011	histone lyinse methyltransferase inhibitor	EHMT2		3.27, 2.04	16.97	1.02, 0.31	56.25	-6.10	4.16	28.08	-77.02	11.15	0.00	93.24	-57.46	7.69	16.97	14.52	-59.43	0.00	22.64	-93.21	84.41	-3.57	20.66	67.25	11.61	2.89	37.00	91.72	28.50	65.72	33.82	19.89	20.12
BRD-K80527266	CP	triacsin-c	adrenergic receptor antagonist	ACSL1		2.31, 1.15	16.76	1.22, 0.30	13.70	-26.97	76.15	0.00	1.55	15.69	22.46	76.53	7.23	3.38	13.79	16.76	-86.57	-18.97	57.33	-91.92	37.35	-2.96	30.79	97.64	83.50	43.02	11.44	75.94	31.24	52.95	13.44	76.56	87.78
BRD-K29582115	CP	ziprasidone	dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor	DRD2, HTR2A, HTR1A, HTR1D, HRH1, HTR1B, HTR1E, HTR2C, HTR7, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, DRD4, DRD5, HTR3A, HTR6, SLC6A4		4.23, 1.92	16.73	1.74, 0.64	4.56	-26.54	46.16	10.60	67.41	17.76	3.59	78.55	15.42	27.90	38.32	2.47	-2.15	1.90	37.96	3.14	30.77	3.14	16.73	66.23	98.34	8.13	12.18	88.82	-70.20	57.97	0.49	35.15	46.61
BRD-K28428262	CP	brivanib	alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor	FGFR1, KDR, FLT1, CYP3A4, FGFR2, FGFR3, FLT4, KCNH2	FGFR inhibitor	2.31, 1.92	16.67	0.83, 0.31	0.00	77.76	6.53	17.65	18.78	-23.08	0.70	75.45	27.41	9.17	35.14	55.31	-21.46	0.78	10.86	28.84	33.51	-1.59	5.10	44.49	75.13	27.58	3.94	-98.34	-49.25	5.44	16.67	50.68	56.80
BRD-K98426715	CP	tubacin	HDAC inhibitor	HDAC6		5.38, 2.31	16.66	0.88, 0.25	5.35	-56.36	50.11	3.49	-34.21	-22.91	7.89	96.90	8.61	6.23	28.43	16.66	-5.30	-20.97	93.15	-97.11	67.50	15.72	91.98	42.78	-11.95	47.85	12.65	52.52	93.21	79.52	39.47	32.25	84.80
BRD-K86873305	CP	piperacillin	cell wall synthesis inhibitor			6.53, 2.86	16.60	1.52, 0.67	13.78	30.36	19.38	4.88	28.58	14.71	4.79	95.33	8.05	13.50	16.60	50.46	-4.39	0.00	0.88	5.41	0.35	4.38	19.60	22.07	92.53	55.53	11.73	-63.87	20.55	88.93	33.12	82.88	18.10
BRD-K45252063	CP	clofibrate	PPAR receptor agonist	PPARA, LPL		3.85, 2.69	16.56	0.58, 0.24	43.87	-11.64	-14.59	16.56	52.21	6.98	94.23	90.23	76.74	3.88	8.21	27.47	-17.35	-1.09	-24.51	2.15	84.03	8.09	47.67	63.76	30.73	2.54	15.09	4.73	57.81	33.33	7.85	51.93	30.65
BRD-K90864987	CP	cobalt(II)-chloride	HSP agonist	HIF1A	HIF activator	4.49, 2.86	16.55	1.67, 0.59	-2.82	45.14	7.68	14.55	96.92	44.93	28.47	91.93	16.55	4.90	9.43	29.55	0.00	0.00	-35.06	-10.41	39.58	17.32	-26.41	33.63	97.57	22.39	8.46	-67.55	-89.45	27.06	23.43	44.56	4.57
BRD-K91370081	CP	anisomycin	DNA synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1		6.01, 2.58	16.42	3.61, 0.86	14.63	70.11	34.63	97.75	27.75	58.72	2.18	25.67	11.50	7.89	6.69	40.34	97.96	6.42	49.52	99.54	24.58	15.45	-5.70	16.42	22.58	33.46	5.64	-1.16	7.12	9.34	21.74	11.16	2.08
BRD-A17411484	CP	carprofen	cyclooxygenase inhibitor, prostanoid receptor inhibitor	PTGS2, PTGS1		2.31, 0.77	16.33	0.85, 0.24	40.32	-45.61	64.51	5.45	76.92	12.16	17.31	76.52	6.17	14.63	14.96	16.33	-12.52	-19.56	32.34	-0.88	85.51	9.64	16.76	29.11	73.52	8.93	31.06	-0.04	5.44	22.11	52.89	74.43	15.02
BRD-K55424922	CP	anpirtoline	serotonin receptor agonist, serotonin receptor antagonist	HTR1B, HTR3A		3.27, 2.04	16.21	1.08, 0.35	10.50	10.77	12.52	16.21	4.20	80.94	4.55	64.73	6.17	17.93	5.21	73.80	3.11	3.87	97.42	-2.71	59.00	3.14	34.51	78.49	-11.61	59.44	26.92	76.59	39.73	69.66	15.91	15.09	22.57
BRD-K93325701	CP	damnacanthal	src inhibitor			4.58, 3.82	16.14	1.81, 0.50	93.63	-9.00	7.11	15.14	79.42	-12.39	99.93	-45.32	0.14	38.28	77.96	87.72	-15.16	-0.28	-67.91	42.70	7.64	-31.76	4.19	66.07	89.54	78.36	17.15	NaN	-0.28	51.19	35.98	99.14	-6.88
BRD-A29260609	CP	acebutolol	adrenergic receptor antagonist	ADRB1, ADRB2		5.71, 2.86	16.13	1.13, 0.31	20.46	5.86	8.78	26.25	64.34	10.05	76.18	96.41	91.53	6.79	52.92	62.72	0.00	-38.46	6.22	2.18	23.24	0.00	16.13	3.44	2.86	8.72	20.39	0.03	53.86	81.47	47.69	77.62	-2.68
BRD-K95402279	CP	geranylgeraniol	farnesyltransferase inhibitor			2.69, 1.54	16.04	1.39, 0.45	6.58	11.17	5.57	3.27	68.19	0.03	16.04	95.03	7.50	31.08	27.50	56.56	-8.28	29.17	2.65	0.53	90.43	17.96	29.76	1.13	21.24	40.04	3.56	-5.94	60.62	15.91	91.47	86.19	8.28
BRD-K84266862	CP	BRL-50481	phosphodiesterase inhibitor	PDE7A, PDE7B		6.15, 5.00	15.98	0.89, 0.26	85.01	-27.70	37.43	4.87	17.33	20.00	-9.08	89.38	13.29	1.97	8.54	13.97	-2.43	-26.81	98.15	-29.12	96.55	5.80	15.80	98.41	10.58	39.29	8.01	99.86	15.98	65.59	17.64	82.21	37.41
BRD-K59184148	CP	SB-216763	glycogen synthase kinase inhibitor	GSK3B, CCNA2, CDK2, GSK3A	Glycogen synthase kinase inhibitor	2.31, 1.15	15.93	0.36, 0.17	22.91	5.49	60.89	-44.31	4.30	9.43	18.73	30.85	21.66	2.85	-0.99	47.83	-3.36	4.05	26.16	9.47	29.01	5.94	15.93	58.96	24.91	14.15	-10.69	99.75	19.07	23.11	6.24	10.47	47.42
BRD-K11158509	CP	tyrphostin-B44	EGFR inhibitor			5.77, 3.85	15.65	1.33, 0.44	24.24	-54.06	52.09	26.06	25.29	73.52	11.74	96.31	10.35	15.65	40.82	12.86	-2.92	-15.26	63.42	10.47	65.26	2.82	-14.75	84.24	4.69	8.91	12.02	-6.16	10.78	54.28	70.04	97.64	75.55
BRD-K77625572	CP	etomoxir	carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor	CPT1A, CPT1B		3.08, 1.54	15.64	0.90, 0.38	14.52	-28.62	5.64	-22.59	17.58	45.94	38.15	71.08	9.54	45.17	6.08	35.64	-28.15	0.00	-2.92	-33.61	27.94	0.46	38.57	20.64	4.57	15.64	18.43	7.93	23.34	18.42	10.72	42.80	85.54
BRD-K08924299	CP	palonosetron	serotonin receptor antagonist	HTR3A		2.69, 0.77	15.60	1.28, 0.34	14.60	4.90	4.05	5.67	4.78	-0.03	15.60	72.03	10.04	21.99	60.31	25.01	-21.07	0.85	76.01	-57.05	38.42	0.74	40.75	53.28	23.89	56.04	9.12	13.93	15.16	94.49	32.85	43.75	70.26
BRD-A25687296	CP	emetine	protein synthesis inhibitor	RPS2	Protein synthesis inhibitor	6.01, 2.58	15.54	2.92, 0.68	8.95	31.96	7.39	93.23	35.97	29.07	-5.71	49.68	5.88	23.18	6.21	50.96	95.80	4.93	22.61	99.72	15.54	10.89	12.09	11.28	10.87	62.49	8.12	-0.32	7.05	42.31	8.17	32.41	15.56
BRD-A68631409	CP	evodiamine	ATPase inhibitor, TRPV agonist	TRPV1		0.77, 0.38	15.54	0.84, 0.34	4.68	28.40	81.07	3.49	-6.77	15.77	8.35	69.81	6.41	13.82	3.07	6.65	-75.26	-29.41	35.96	-31.16	86.88	32.42	94.28	71.15	8.13	18.29	15.54	87.74	21.09	27.90	10.62	52.87	-0.79
BRD-A99571536	CP	dubinidine	anticonvulsant that reduces motor activity			5.71, 4.08	15.52	2.11, 0.59	5.76	89.92	97.98	42.17	50.96	98.13	7.61	-81.78	36.69	17.11	15.30	57.84	-3.05	5.84	-60.16	17.26	71.39	14.35	13.91	15.52	79.05	33.86	34.68	-96.71	-33.69	11.86	5.95	7.54	98.45
BRD-K78659596	CP	MLN-2238	proteasome inhibitor	PSMB1	Proteasome inhibitor	3.08, 1.54	15.22	2.44, 0.85	51.67	63.12	11.54	69.86	75.68	14.44	0.00	15.22	12.23	14.30	14.95	56.08	96.50	93.02	14.63	99.58	8.74	20.91	18.27	29.40	31.21	18.12	67.87	3.95	12.47	-8.04	11.27	11.16	10.57
BRD-K48692744	CP	NU-1025	PARP inhibitor, DNA dependent protein kinase inhibitor	PARP1		5.00, 3.08	15.08	0.85, 0.18	69.33	8.25	8.79	2.54	15.08	10.38	84.36	83.72	36.56	10.61	53.82	18.92	-83.66	6.46	-77.92	-45.83	50.43	9.64	34.30	97.78	33.74	14.80	-9.52	-89.35	-16.07	52.06	25.76	42.34	75.54
BRD-K33483813	CP	actarit	interleukin receptor agonist			4.44, 2.67	15.05	1.20, 0.30	2.22	8.22	-20.73	13.43	67.71	79.50	15.05	88.56	8.51	3.38	74.81	10.92	-0.21	-0.25	90.75	32.58	76.85	0.11	-99.79	77.45	-41.17	13.53	29.61	8.13	27.01	65.68	93.23	22.51	28.14
BRD-K64451768	CP	GANT-58	GLI antagonist	DHH, GLI1, IHH		3.46, 1.15	15.02	0.66, 0.23	11.67	-42.11	75.96	5.16	12.88	89.88	7.19	44.21	8.31	3.47	5.25	21.50	-70.78	13.09	90.85	-3.95	34.11	15.16	18.59	42.08	44.39	5.21	15.02	-3.98	13.92	58.00	41.73	75.18	53.36
BRD-A01787639	CP	naftopidil	adrenergic receptor antagonist, calcium channel antagonist	ADRA1A, ADRA1D		8.44, 7.56	14.98	0.68, 0.25	16.78	-44.46	19.79	30.58	34.60	3.17	-23.04	48.57	8.39	3.88	21.75	14.98	14.29	2.09	99.98	3.97	96.30	6.17	6.06	36.40	-52.75	-31.54	47.61	36.84	0.32	91.66	34.42	37.54	0.18
BRD-K61341215	CP	vecuronium	acetylcholine receptor antagonist	CHRNA2		4.23, 1.54	14.73	0.75, 0.28	33.45	-44.41	9.58	2.92	9.41	37.98	56.16	24.28	5.71	15.98	-19.94	39.58	-37.24	-65.94	75.43	-69.70	86.88	10.41	76.70	87.69	-22.36	14.73	79.61	89.61	15.26	74.33	6.67	1.52	12.74
BRD-K07996107	CP	harpagoside	acetylcholinesterase inhibitor	ACHE		5.77, 3.08	14.72	0.94, 0.26	8.11	-28.14	44.96	8.13	26.87	5.55	12.96	87.16	24.24	0.63	19.08	14.72	-2.54	-11.19	97.34	3.17	49.65	5.94	28.25	70.05	13.59	58.92	12.06	-1.62	10.87	68.96	56.42	98.80	20.40
BRD-K48427617	CP	U-0124	MEK inhibitor			6.94, 5.31	14.65	1.41, 0.60	81.53	10.47	27.60	9.93	16.07	99.93	-20.08	14.65	11.40	5.25	3.03	45.37	-12.23	13.00	63.09	-24.52	22.55	67.73	62.25	71.14	-30.33	7.51	10.90	11.41	4.72	63.72	18.85	45.10	97.44
BRD-A48237631	CP	mitomycin-c	DNA alkylating drug, DNA inhibitor, DNA synthesis inhibitor		DNA synthesis inhibitor	3.46, 1.15	14.62	1.81, 0.56	7.97	97.96	6.49	63.61	50.84	5.59	-3.47	-35.09	19.06	14.08	35.19	62.56	83.78	72.08	-7.36	98.94	-19.12	-0.74	20.61	15.85	26.01	51.91	-20.17	-0.78	-7.45	14.62	2.75	38.50	7.24
BRD-K43164539	CP	cholic-acid	ferrochelatase inhibitor, unidentified pharmacological activity	CES1, FECH, PLA2G1B, ADH1C, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, GPBAR1, MT-CO1, MT-CO2, MT-CO3	Bile acid	6.54, 2.69	14.61	1.40, 0.41	42.41	-49.68	2.29	-60.60	-37.01	0.03	42.89	99.33	4.37	24.47	7.13	17.32	-79.38	-1.16	77.25	-92.57	64.43	2.40	98.14	14.61	-74.38	9.06	33.38	99.47	83.04	95.13	26.45	9.49	58.33
BRD-A91555231	CP	norepinephrine	adrenergic receptor agonist, DNA inhibitor, free radical scavenger	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB3, ADRB2, DRD1, DRD5, PAH, SLC18A1, SLC18A2		7.76, 6.12	14.47	1.61, 0.43	14.47	-32.50	5.61	0.00	-36.08	9.26	7.92	99.75	99.93	9.94	36.47	70.37	-35.01	-77.13	12.25	-55.65	63.84	7.89	91.64	98.45	-39.41	0.00	24.10	93.04	19.39	99.78	19.77	79.86	31.83
BRD-K76805682	CP	SB-415286	glycogen synthase kinase inhibitor	GSK3B, GSK3A, RPS6KB1	Glycogen synthase kinase inhibitor	2.31, 1.92	14.47	0.70, 0.20	14.47	44.77	48.84	63.28	73.86	11.56	11.35	-27.04	11.10	81.44	9.00	28.01	1.95	2.61	37.83	98.10	34.23	3.03	34.71	35.78	20.92	14.20	4.89	11.45	13.89	19.47	12.41	34.70	10.42
BRD-K91623615	CP	ABT-751	tubulin inhibitor, dihydropteroate synthase inhibitor, microtubule inhibitor, PABA antagonist, tubulin polymerisation inhibitor	TUBB	Tubulin inhibitor	1.92, 1.15	14.36	1.51, 0.73	14.36	20.36	2.26	17.27	4.83	36.49	80.93	45.90	1.02	7.25	4.51	11.38	17.58	60.56	-10.25	33.16	30.29	6.13	80.25	40.12	-8.29	12.83	5.64	77.18	32.73	11.67	5.36	-17.38	39.43
BRD-K76674262	CP	homoharringtonine	apoptosis stimulant, protein synthesis inhibitor	RPL3	Protein synthesis inhibitor	5.58, 2.15	14.26	2.88, 0.75	0.37	65.01	9.89	91.92	29.09	14.26	12.53	37.02	12.45	2.36	6.04	41.31	96.19	2.04	7.61	99.54	36.94	5.18	7.75	-2.72	19.83	47.80	15.23	-6.13	0.00	47.16	14.84	17.03	12.59
BRD-A25775766	CP	securinine	GABA receptor antagonist, TP53 activator	GABRA1		2.31, 1.15	14.14	1.26, 0.41	37.11	-84.97	2.78	4.97	7.71	5.63	-12.19	-16.86	6.50	0.74	1.07	20.79	80.13	86.96	37.21	-7.46	29.01	39.95	11.49	38.24	14.14	26.28	18.13	63.49	28.24	19.75	6.02	11.80	37.80
BRD-K24994810	CP	androstenol	GABA receptor modulator	NR1I3		4.23, 0.77	13.88	1.14, 0.36	42.12	-10.43	13.28	-23.68	1.13	7.68	69.79	76.50	39.27	11.50	13.88	12.63	-36.19	-0.88	76.78	-0.46	72.65	0.00	50.13	57.67	27.01	47.31	4.86	3.49	37.34	7.65	72.11	82.31	66.47
BRD-K37456065	CP	VU-0365114-2	acetylcholine receptor allosteric modulator, M5 modulator	CHRM5		2.59, 1.29	13.87	1.65, 0.58	18.45	-39.57	12.54	62.48	-16.57	33.05	13.00	82.26	14.54	7.73	2.15	3.14	83.83	39.63	-5.74	90.52	13.87	2.15	64.51	2.96	0.00	20.25	-2.36	9.69	39.88	28.96	10.65	20.04	72.66
BRD-M86331534	CP	pyrvinium-pamoate	AKT inhibitor, androgen receptor (AR) inhibitor, androgen receptor antagonist	AR		5.77, 4.23	13.87	2.96, 0.81	6.09	81.82	9.22	93.74	62.27	0.03	-22.17	-58.16	26.70	30.55	10.17	72.30	97.82	92.93	-60.72	99.93	38.51	61.45	9.97	12.00	31.10	9.12	20.60	0.78	-9.27	16.87	13.87	10.87	4.26
BRD-K91145395	CP	prostratin	NFkB pathway activator, PKC activator	PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCQ	PKC activator	4.62, 2.69	13.82	3.63, 1.03	12.27	61.56	3.64	86.13	4.30	19.49	6.30	60.89	6.48	8.60	-0.88	5.11	92.04	-20.75	-38.02	99.75	66.70	22.96	50.43	28.64	-4.16	4.97	2.75	59.64	13.82	6.11	29.40	30.26	31.95
BRD-K11433652	CP	aspirin	cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer	PTGS1, PTGS2, TP53, AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, RPS6KA3		6.53, 4.49	13.76	1.47, 0.43	2.18	-64.47	74.70	9.63	80.43	5.46	-8.48	99.61	0.00	42.40	47.24	13.76	-3.14	-1.23	56.86	6.60	2.68	19.34	12.06	85.21	42.26	56.08	53.35	3.37	-15.43	99.72	59.23	72.68	11.48
BRD-K50384076	CP	7,4'-dihydroxyflavone	opioid receptor antagonist	CYP19A1		3.82, 2.55	13.58	2.32, 0.66	93.36	29.09	0.18	24.39	14.42	8.88	13.58	-42.14	2.33	4.79	31.87	55.47	-0.39	79.14	56.41	11.98	-51.69	33.26	80.45	-62.01	66.59	91.10	-9.64	1.87	-16.73	98.45	21.18	12.03	0.00
BRD-K17349619	CP	HLI-373	MDM inhibitor	MDM2	MDM inhibitor	1.92, 1.15	13.28	0.85, 0.25	54.18	-9.37	77.20	-41.36	2.48	49.08	19.23	75.93	11.65	8.76	17.31	4.65	-83.50	-27.81	9.27	-60.62	25.95	3.56	43.07	61.51	47.21	55.63	3.59	1.30	0.00	81.37	13.28	54.02	24.25
BRD-K22096725	CP	ALW-II-49-7	ephrin inhibitor	DDR1, EPHA2, EPHA4, EPHA7, EPHB2, EPHB4, EPHB6		1.92, 1.54	13.12	2.11, 0.55	9.70	-49.96	-8.63	1.16	-52.64	13.40	57.03	56.90	13.12	15.41	19.17	3.93	0.00	-1.62	-63.91	0.56	76.58	-51.70	56.90	70.89	-87.84	-3.10	46.00	55.97	49.48	35.13	69.00	2.70	94.35
BRD-K15402119	CP	huperzine-a	acetylcholinesterase inhibitor, glutamate receptor antagonist	ACHE		4.49, 2.86	13.00	0.98, 0.39	13.00	-22.29	-12.48	5.51	-17.68	29.63	34.54	91.90	8.39	3.31	6.06	-4.26	-71.62	-26.97	26.33	-2.75	95.74	6.66	35.21	26.00	-10.94	-4.23	61.95	71.82	38.15	60.38	19.76	32.60	97.71
BRD-A36707673	CP	hydroxycholesterol	LXR agonist, ABC transporter expression enhancer, alpha secretase activator, beta secretase inhibitor, glutamate receptor modulator	ABCA1, NR1H2, NR1H3		1.92, 1.54	12.96	0.92, 0.36	4.70	-74.57	1.34	7.08	33.64	8.29	15.90	38.95	-36.62	32.12	28.16	12.53	1.52	-13.97	32.11	2.04	58.98	6.31	24.06	9.80	20.16	15.03	12.96	90.91	0.88	86.67	23.21	53.98	0.92
BRD-A35338386	CP	NECA	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1	Adenosine receptor agonist	4.62, 2.69	12.68	0.91, 0.36	12.52	-20.16	18.94	20.70	2.01	3.31	10.70	71.77	17.94	32.08	2.75	47.56	-33.18	2.25	42.37	-0.53	38.28	5.56	12.68	71.85	56.96	9.30	7.61	-1.34	41.85	19.72	3.82	86.88	64.47
BRD-K93095519	CP	SJ-172550	MDM inhibitor	MDM4	MDM inhibitor	5.77, 3.46	12.15	2.57, 0.65	76.77	-63.36	-15.69	-0.92	-23.99	6.56	42.40	93.80	27.24	4.03	-7.55	3.45	-81.16	28.68	99.72	-98.03	68.36	-52.15	98.59	65.98	10.52	8.69	-11.94	99.93	94.96	98.74	12.15	23.74	85.63
BRD-K59633790	CP	VU-0420363-1	SARS coronavirus 3C-like protease inhibitor			6.47, 3.45	12.13	1.59, 0.39	28.63	-49.44	1.97	-37.33	-61.61	17.70	12.13	99.08	2.47	61.26	9.23	-17.16	-0.11	1.80	10.54	-3.42	97.83	30.26	99.79	24.54	-11.62	7.10	-12.04	99.47	83.67	50.14	27.40	47.12	78.20
BRD-K12539581	CP	nocodazole	tubulin inhibitor, Tubulin Polymerization Inhibitors	HPGDS	Tubulin inhibitor	3.46, 1.54	12.11	1.52, 0.57	15.00	18.58	2.15	64.07	7.12	27.43	16.89	78.33	5.71	39.48	11.23	17.21	74.57	71.13	9.46	78.76	12.11	-9.18	10.45	34.13	11.42	9.98	-8.23	-70.64	-59.71	4.76	4.70	26.37	48.72
BRD-K31491153	CP	1-phenylbiguanide	serotonin receptor agonist	HTR3A, HTR3B		8.28, 4.46	12.09	1.35, 0.42	3.42	46.96	0.06	0.00	11.80	24.38	18.66	-78.95	5.50	68.06	5.23	3.05	-0.07	55.41	90.73	7.47	65.49	68.18	95.53	-31.17	95.28	98.41	9.94	-72.20	12.09	-57.82	20.14	36.80	26.63
BRD-K14550461	CP	doxercalciferol	vitamin D receptor agonist	VDR	Vitamin D receptor agonist	4.08, 2.04	12.06	1.52, 0.33	8.07	3.31	24.72	12.27	-6.91	36.24	20.77	95.56	20.36	12.06	40.92	7.41	-15.96	-4.19	-11.46	-6.27	1.92	-2.85	49.34	22.99	50.21	2.78	10.72	-16.70	6.91	67.44	21.41	28.71	79.69
BRD-K94325918	CP	kinetin-riboside	apoptosis inducer			4.23, 3.46	11.22	2.90, 0.75	11.22	-56.92	2.18	74.16	4.30	3.78	6.09	69.06	12.41	6.89	5.95	9.41	97.96	19.92	-13.21	99.05	35.48	10.44	62.72	19.36	7.47	4.09	13.39	19.47	20.84	10.31	1.66	22.30	15.11
BRD-K83636919	CP	entacapone	catechol O methyltransferase inhibitor	COMT		7.76, 6.53	11.09	1.48, 0.48	7.16	-87.63	48.23	9.02	11.22	-0.03	7.66	99.33	3.73	65.98	3.88	11.09	-2.22	-43.66	72.85	-4.25	33.41	3.81	-37.33	39.64	-18.77	40.59	7.58	99.99	57.93	98.59	24.53	84.92	27.56
BRD-K83289131	CP	CAY-10618	NAMPT inhibitor, niacinamide phosphoribosyltransferase inhibitor	NAMPT		3.85, 2.31	11.05	1.57, 0.45	12.56	23.94	2.26	93.89	1.97	11.05	-7.80	-16.76	4.72	2.40	11.15	40.03	96.34	89.00	-49.17	99.47	7.89	72.70	10.08	49.05	9.69	-58.87	5.60	1.88	17.01	24.87	13.24	25.00	2.08
BRD-K08273968	CP	griseofulvin	microtubule inhibitor, microtubule stabilizing agent, mitosis inhibitor	KRT12		7.35, 4.90	10.95	1.07, 0.24	41.15	-69.16	0.21	4.05	-20.25	10.65	93.86	99.86	41.99	0.56	27.20	4.49	0.00	-41.74	82.53	-95.67	65.67	3.95	96.55	49.90	-77.74	19.43	8.39	0.07	81.46	75.39	10.95	28.16	85.24
BRD-K81783531	CP	VX-222	HCV inhibitor, RNA-directed RNA polymerase inhibitor			3.46, 1.15	10.95	0.59, 0.25	25.16	8.81	-10.12	0.95	67.02	3.81	10.65	53.54	-21.04	22.11	20.47	40.27	-9.44	-1.06	1.44	-0.81	31.94	-25.84	11.25	31.84	25.91	7.71	12.82	-1.34	10.95	16.04	58.12	46.17	-25.61
BRD-K50720187	CP	flupirtine	glutamate receptor antagonist, apoptosis inhibitor, opioid receptor agonist, potassium channel agonist	KCNQ2, ADRA2A, KCNQ1, KCNQ3		3.08, 1.92	10.78	1.90, 0.58	-10.49	-4.12	-4.16	-7.75	-10.80	7.94	49.61	97.25	20.41	2.11	15.01	29.38	-73.96	-1.69	-36.00	-89.57	72.40	13.46	10.78	28.63	3.38	19.57	10.29	-62.68	72.78	89.07	19.68	58.87	68.49
BRD-K37720887	CP	SB-525334	TGF beta receptor inhibitor	TGFBR1	TGF beta receptor inhibitor	3.46, 1.54	10.56	1.60, 0.44	5.88	-24.44	35.55	0.00	4.12	-5.67	20.58	60.71	10.56	56.83	8.36	-12.58	-3.44	-46.49	62.30	-1.27	41.96	-0.78	27.65	18.65	12.15	-29.24	7.62	84.96	1.97	24.56	64.54	20.83	19.94
BRD-K06878038	CP	deferiprone	chelating agent, cytochrome P450 inhibitor, iron absorption inhibitor, reducing agent	CYP4F2		4.00, 1.33	10.50	0.51, 0.17	10.89	10.29	11.83	-46.52	67.32	-13.34	23.02	22.12	0.07	32.13	-3.00	38.31	-15.95	2.71	96.83	3.12	94.65	5.24	-11.66	10.50	-19.56	5.19	27.63	6.07	28.74	22.59	35.87	40.08	9.63
BRD-K59753975	CP	vindesine	tubulin inhibitor, microtubule inhibitor, vinca alkaloid	TUBB, TUBB1	Tubulin inhibitor	4.89, 2.22	10.50	1.41, 0.49	8.07	38.47	36.67	2.52	58.41	19.18	-2.43	23.77	10.38	41.93	4.75	10.50	68.07	80.10	-26.72	42.75	97.47	73.51	-12.98	-28.56	93.39	3.95	66.04	-69.16	6.24	4.16	3.18	-0.53	93.80
BRD-K74430258	CP	1,2-dichlorobenzene	hepatotoxicant that induces oxidative stress and inflammatory response			5.77, 2.31	9.96	0.97, 0.27	55.82	-54.14	0.81	2.73	60.56	-25.10	95.71	69.28	-17.64	8.64	9.96	6.94	-22.24	29.91	77.21	-0.56	32.94	-44.70	22.29	66.88	9.63	43.19	7.05	-0.97	50.30	42.51	44.66	98.77	-33.99
BRD-A37052580	CP	physostigmine	acetylcholinesterase inhibitor, cholinesterase inhibitor	ACHE, BCHE		6.67, 5.78	9.84	0.83, 0.26	22.86	-26.27	7.76	6.67	2.54	14.22	-2.50	-78.03	-20.17	-70.72	2.89	67.79	-0.18	9.84	99.86	2.61	99.26	4.33	6.38	38.28	74.46	19.21	57.93	99.44	-83.57	54.26	46.75	34.30	37.45
BRD-K94070024	CP	depomedrol	glucocorticoid receptor agonist		Glucocorticoid receptor agonist	5.71, 2.86	9.76	1.47, 0.75	21.87	19.74	4.66	41.11	-23.62	45.75	22.28	73.38	3.63	7.41	28.76	38.33	3.42	9.76	61.31	4.67	9.51	4.90	-10.25	33.01	-29.30	8.03	29.83	7.48	5.22	99.20	82.74	8.30	94.41
BRD-K57546357	CP	prunetin	breast cancer resistance protein inhibitor	ABCG2, ALDH2		0.76, 0.76	9.74	1.04, 0.31	49.57	9.28	38.74	-6.45	81.03	0.92	12.97	-44.17	-14.94	-6.36	10.21	17.59	3.10	2.58	15.24	24.41	67.03	12.25	-21.28	8.57	51.25	16.22	2.36	NaN	20.45	12.81	8.22	8.74	-18.81
BRD-U66370498	CP	androstanol	constitutive androstane receptor (CAR) inhibitor	NR1I3		2.69, 1.15	9.73	0.99, 0.40	9.73	4.44	4.84	0.56	3.74	2.72	34.71	0.00	69.34	13.80	25.29	90.11	1.92	-1.59	32.70	-6.35	96.81	3.68	17.03	72.28	4.23	33.05	11.14	-99.12	0.99	9.53	38.64	57.74	60.43
BRD-A14985772	CP	ascorbyl-palmitate	antioxidant			4.23, 1.54	9.60	1.15, 0.44	3.79	-32.96	1.48	15.43	-17.76	-14.58	2.92	93.81	25.22	6.13	-1.23	6.87	1.79	21.15	63.96	0.56	93.93	-10.29	91.27	38.71	-3.91	9.60	45.86	99.75	65.41	71.15	8.72	16.01	31.76
BRD-K22009844	CP	phenprobamate	skeletal muscle relaxant			4.44, 2.67	9.00	0.67, 0.23	31.81	6.62	-23.35	-51.80	-33.72	21.42	6.31	73.63	3.49	20.96	-0.18	72.61	-13.62	-61.29	99.01	45.51	98.52	-16.69	-33.33	34.25	9.00	59.52	7.89	6.82	44.85	8.98	66.57	92.20	71.23
BRD-K15262564	CP	mupirocin	isoleucyl-tRNA synthetase inhibitor			6.94, 4.08	8.56	2.06, 0.55	2.84	-94.10	2.08	4.99	-48.92	36.60	8.56	95.95	3.80	71.86	3.98	49.64	-16.81	-66.41	76.81	-56.45	31.32	2.57	93.15	83.25	-90.69	-9.74	0.63	97.20	70.33	99.58	60.03	22.74	98.06
BRD-K55991774	CP	BAS-09104376	HIV integrase inhibitor			5.77, 2.31	7.54	1.69, 0.53	7.15	-93.79	-18.51	8.84	-26.81	-17.65	27.67	95.03	-85.33	52.30	5.94	-25.84	2.01	-19.26	34.09	-75.60	-55.00	-30.77	99.72	7.54	-5.11	32.45	29.31	99.26	61.08	16.47	46.32	49.22	82.33
BRD-K22631935	CP	neurodazine	neurogenesis of non-pluripotent C2C12 myoblast inducer			5.77, 3.85	6.34	1.91, 0.64	35.41	2.29	6.34	8.01	0.81	88.90	24.83	97.02	6.95	28.41	27.73	-21.95	-52.92	3.56	47.62	0.67	-28.89	3.67	-11.41	62.39	-15.77	-10.18	3.59	-2.01	0.85	98.17	33.83	24.17	99.51
BRD-A62890442	CP	3-methyl-GABA	GABA aminotransferase activator			7.01, 3.82	5.97	2.52, 0.88	12.49	-96.34	-99.61	5.97	-83.78	92.77	4.30	85.89	26.77	-1.92	5.14	24.54	-4.62	0.00	88.92	-2.18	94.88	3.58	-51.42	96.68	-46.56	3.07	21.74	0.00	30.34	99.93	53.69	78.47	99.93
BRD-K13356952	CP	methazolamide	carbonic anhydrase inhibitor, insulin sensitizer	CA1, CA2, CA4, CA7, CA12, CA14, INS		4.49, 2.45	5.91	1.56, 0.56	-12.58	-27.03	5.64	0.00	-25.64	7.51	7.22	81.00	4.02	5.91	-63.24	38.55	-0.11	-9.73	99.22	-89.86	86.72	5.88	14.73	83.90	-25.98	2.33	1.83	22.72	22.93	97.34	35.70	36.65	43.10
